assays_ss_d,assays_src_d,assays_dscrptn,assays_ss_rgnsm,assays_cnfdnc_scr,assays_td,assays_ss_sbclllr_frctn,assays_rltnshp_tp,assays_crtd_b,assays_src_ss_d,assays_chmbl_d,assays_cll_d,assays_b_frmt,assays_tss_d,assays_vrnt_d
7524,1,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618647,,BAO_0000218,2113.0,
7525,1,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618648,,BAO_0000218,2113.0,
7526,1,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618649,,BAO_0000218,2113.0,
7527,1,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618650,,BAO_0000218,2107.0,
7528,1,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618651,,BAO_0000218,2107.0,
7529,1,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876497,,BAO_0000218,2107.0,
7530,1,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618652,,BAO_0000218,2048.0,
7531,1,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618653,,BAO_0000218,2048.0,
7532,1,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618654,,BAO_0000218,2048.0,
7533,1,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618655,,BAO_0000218,,
7534,1,Compound was tested for solubility in water,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618656,,BAO_0000218,,
7535,1,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),,0,22229,,U,Intermediate,,CHEMBL618657,,BAO_0000100,,
7536,1,Solubility was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618658,,BAO_0000218,,
7537,1,solubility in water (ug/mL) at 37 degree C.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618659,,BAO_0000218,,
7538,1,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618660,,BAO_0000218,,
7539,1,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618661,,BAO_0000218,,
7540,1,Half life in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873807,,BAO_0000218,,
7541,1,Half life in Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618662,,BAO_0000218,,
7542,1,Half life period after 3 mg/kg iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618663,,BAO_0000218,,
7543,1,Half life period after 3 mg/kg iv administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618664,,BAO_0000218,,
7544,1,Half life period after 3 mg/kg iv administration in the rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618665,,BAO_0000218,,
7545,1,Half life period in female Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876498,,BAO_0000218,,
7546,1,Half life period in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618666,,BAO_0000218,,
7547,1,Half-life in rats was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620440,,BAO_0000218,,
7548,1,Half-life in rats with metabolic oxidation,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620441,,BAO_0000218,,
7549,1,Half-life in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620442,,BAO_0000218,,
7550,1,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620443,,BAO_0000218,,
7551,1,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620444,,BAO_0000218,,
7552,1,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620445,,BAO_0000218,,
7553,1,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620446,,BAO_0000218,,
7554,1,Biological half-life measured in plasma of rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620447,,BAO_0000218,1969.0,
7555,1,Biological half-life measured in plasma of rat; 22-25,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621129,,BAO_0000218,1969.0,
7556,1,Biological half-life measured in plasma of rat; 9-16,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621130,,BAO_0000218,1969.0,
7557,1,Compound was evaluated for its half life when administered intravenously in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873808,,BAO_0000218,,
7558,1,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876598,,BAO_0000218,,
7559,1,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621131,,BAO_0000218,,
7560,1,Half life (T1/2) after oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621132,,BAO_0000218,,
7561,1,Half life of compound after iv administration of 20 mg/kg dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621133,,BAO_0000218,,
7562,1,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL621312,,BAO_0000218,,
7563,1,Half life of compound was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621313,,BAO_0000218,,
7564,1,Half life of compound was determined in rat blood,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621314,,BAO_0000218,178.0,
7565,1,Half life at 1 mg/kg was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621315,,BAO_0000218,,
7566,1,Half life at 10 mg/kg was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621316,,BAO_0000218,,
7567,1,Half life in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621317,,BAO_0000218,,
7568,1,Half life in rats in hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621318,,BAO_0000218,,
7569,1,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621319,,BAO_0000218,,
7570,1,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621377,,BAO_0000218,,
7571,1,Half life was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621378,,BAO_0000218,,
7572,1,Half life after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876599,,BAO_0000218,,
7573,1,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621379,,BAO_0000218,,
7574,1,Half life in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621380,,BAO_0000218,1969.0,
7575,1,Half life in rat plasma; Not detected,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621381,,BAO_0000218,1969.0,
7576,1,Half life in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618515,,BAO_0000218,,
7577,1,Half life period of compound was determined after peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618516,,BAO_0000218,,
7578,1,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618517,,BAO_0000218,,
7579,1,Half life period in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618518,,BAO_0000218,,
7580,1,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618519,,BAO_0000218,,
7581,1,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618698,,BAO_0000218,,
7582,1,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618862,,BAO_0000218,,
7583,1,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618863,,BAO_0000218,,
7584,1,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618864,,BAO_0000218,,
7585,1,Half life time in rat the dose of 2 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618865,,BAO_0000218,,
7586,1,Half-life 24 hr after 10 mg/kg iv administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618866,,BAO_0000218,,
7587,1,Half-life 24 hr after 2 mg/kg iv administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618867,,BAO_0000218,,
7588,1,Half-life consistent with the observed metabolic steady state in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875828,,BAO_0000218,,
7589,1,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618868,,BAO_0000218,,
7590,1,Half-life for oxidative metabolic stability was determined using male human,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618869,,BAO_0000218,,
7591,1,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618870,,BAO_0000218,,
7592,1,Half-life in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618871,,BAO_0000218,1969.0,
7593,1,Half-life in rat plasma was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618872,,BAO_0000218,1969.0,
7594,1,Half-life in rats was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873816,,BAO_0000218,,
7595,1,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,,0,22224,,U,Autocuration,,CHEMBL618873,,BAO_0000218,,
7596,1,Area under curve after oral dose of 0.1 mg//kg,,0,22224,,U,Autocuration,,CHEMBL621602,,BAO_0000019,,
7597,1,Area under curve after oral dose of 0.3 mg/kg,,0,22224,,U,Autocuration,,CHEMBL621603,,BAO_0000218,,
7598,1,Area under curve after oral dose of 1 mg/kg,,0,22224,,U,Autocuration,,CHEMBL621604,,BAO_0000218,,
7599,1,Area under curve after oral dose of 10 mg/kg,,0,22224,,U,Autocuration,,CHEMBL621605,,BAO_0000218,,
7600,1,Area under curve after oral dose of 23.4 mg/kg,,0,22224,,U,Autocuration,,CHEMBL621606,,BAO_0000218,,
7601,1,Area under curve after oral dose of 3 mg/kg,,0,22224,,U,Autocuration,,CHEMBL621607,,BAO_0000218,,
7602,1,Area under curve after oral dose of 3.87 mg/kg,,0,22224,,U,Autocuration,,CHEMBL621608,,BAO_0000218,,
7603,1,Area under curve was determined,,0,22224,,U,Autocuration,,CHEMBL621609,,BAO_0000019,,
7604,1,Area under curve at a dose of 10 mg/kg,,0,22224,,U,Autocuration,,CHEMBL621610,,BAO_0000218,,
7605,1,Area under curve was determined; ND=No data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621611,,BAO_0000218,,
7606,1,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621612,,BAO_0000218,,
7607,1,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622308,,BAO_0000218,,
7608,1,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622309,,BAO_0000218,,
7609,1,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622310,,BAO_0000218,,
7610,1,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622311,,BAO_0000218,,
7611,1,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622312,,BAO_0000218,,
7612,1,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622931,,BAO_0000218,,
7613,1,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622932,,BAO_0000218,,
7614,1,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622736,,BAO_0000218,1969.0,
7615,1,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622737,,BAO_0000218,1969.0,
7616,1,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622738,,BAO_0000218,1969.0,
7617,1,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622739,,BAO_0000218,1969.0,
7618,1,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622740,,BAO_0000218,1969.0,
7619,1,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622741,,BAO_0000218,1969.0,
7620,1,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622742,,BAO_0000218,1969.0,
7621,1,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622743,,BAO_0000218,1969.0,
7622,1,AUC in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622744,,BAO_0000218,1969.0,
7623,1,Area under curve was measured from the graph obtained from concentration Vs time,,0,22224,,U,Autocuration,,CHEMBL624134,,BAO_0000019,,
7624,1,Area under curve value of compound per hour after oral administration,,0,22224,,U,Autocuration,,CHEMBL624135,,BAO_0000019,,
7625,1,Area under curve was determined after oral administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624136,,BAO_0000218,,
7626,1,Area under curve was determined after oral administration in rats; No data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624137,,BAO_0000218,,
7627,1,Area under curve was determined after oral administration in rats;No data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624320,,BAO_0000218,,
7628,1,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624321,,BAO_0000218,,
7629,1,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624322,,BAO_0000218,,
7630,1,Area under curve was determined for the compound after iv dose of 5.06 in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624323,,BAO_0000218,,
7631,1,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624324,,BAO_0000218,,
7632,1,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624325,,BAO_0000218,,
7633,1,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624326,,BAO_0000218,,
7634,1,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624327,,BAO_0000218,,
7635,1,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624328,,BAO_0000218,,
7636,1,Area under curve was determined in Dogs after peroral administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627848,,BAO_0000218,,
7637,1,Area under curve was determined in Rats after peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627849,,BAO_0000218,,
7638,1,Area under curve was determined in carotid blood of rat when administered intradermally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627850,,BAO_0000218,,
7639,1,Area under curve was determined in portal blood of rat when administered intradermally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627851,,BAO_0000218,,
7640,1,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627852,,BAO_0000218,,
7641,1,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627853,,BAO_0000218,,
7642,1,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627854,,BAO_0000218,,
7643,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627855,,BAO_0000218,,
7644,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627856,,BAO_0000218,,
7645,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL875339,,BAO_0000218,,
7646,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627857,,BAO_0000218,,
7647,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627858,,BAO_0000218,2106.0,
7648,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627859,,BAO_0000218,178.0,
7649,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627860,,BAO_0000218,955.0,
7650,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627019,,BAO_0000218,948.0,
7651,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627020,,BAO_0000218,2107.0,
7652,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627021,,BAO_0000218,2048.0,
7653,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627022,,BAO_0000218,2385.0,
7654,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627023,,BAO_0000218,,
7655,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627024,,BAO_0000218,2106.0,
7656,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627025,,BAO_0000218,2046.0,
7657,1,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627026,,BAO_0000218,2113.0,
7658,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627027,,BAO_0000218,178.0,
7659,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627028,,BAO_0000218,955.0,
7660,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627029,,BAO_0000218,948.0,
7661,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627030,,BAO_0000218,2113.0,
7662,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627031,,BAO_0000218,2107.0,
7663,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627032,,BAO_0000218,2048.0,
7664,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627033,,BAO_0000218,2385.0,
7665,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627034,,BAO_0000218,,
7666,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627035,,BAO_0000218,2106.0,
7667,1,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627036,,BAO_0000218,2046.0,
7668,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875340,,BAO_0000218,178.0,
7669,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627037,,BAO_0000218,948.0,
7670,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627038,,BAO_0000218,2113.0,
7671,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627039,,BAO_0000218,2107.0,
7672,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627040,,BAO_0000218,2385.0,
7673,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624663,,BAO_0000218,2106.0,
7674,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625963,,BAO_0000218,2046.0,
7675,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876799,,BAO_0000218,955.0,
7676,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626133,,BAO_0000218,2048.0,
7677,1,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626134,,BAO_0000218,,
7678,1,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626135,,BAO_0000218,,
7679,1,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626136,,BAO_0000218,,
7680,1,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626137,,BAO_0000218,,
7681,1,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626138,,BAO_0000218,,
7682,1,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626139,,BAO_0000218,,
7683,1,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626140,,BAO_0000218,,
7684,1,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626141,,BAO_0000218,,
7685,1,C24h in rat p.o. at 20 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626142,,BAO_0000218,,
7686,1,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627930,,BAO_0000218,2385.0,
7687,1,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627931,,BAO_0000218,2385.0,
7688,1,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627932,,BAO_0000218,2385.0,
7689,1,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627933,,BAO_0000218,2106.0,
7690,1,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627934,,BAO_0000218,2106.0,
7691,1,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627935,,BAO_0000218,2106.0,
7692,1,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627936,,BAO_0000218,178.0,
7693,1,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627937,,BAO_0000218,178.0,
7694,1,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627938,,BAO_0000218,178.0,
7695,1,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627939,,BAO_0000218,178.0,
7696,1,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627940,,BAO_0000218,178.0,
7697,1,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627941,,BAO_0000218,178.0,
7698,1,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876800,,BAO_0000218,178.0,
7699,1,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627942,,BAO_0000218,178.0,
7700,1,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627943,,BAO_0000218,178.0,
7701,1,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627944,,BAO_0000218,178.0,
7702,1,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627945,,BAO_0000218,178.0,
7703,1,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628584,,BAO_0000218,178.0,
7704,1,Biodistribution in rat blood in the presence of GdDTPA at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628585,,BAO_0000218,178.0,
7705,1,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628586,,BAO_0000218,178.0,
7706,1,Biodistribution in rat blood in the presence of GdDTPA at 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628587,,BAO_0000218,178.0,
7707,1,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628588,,BAO_0000218,178.0,
7708,1,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628589,,BAO_0000218,178.0,
7709,1,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625304,,BAO_0000218,178.0,
7710,1,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625305,,BAO_0000218,178.0,
7711,1,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625306,,BAO_0000218,178.0,
7712,1,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625307,,BAO_0000218,178.0,
7713,1,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625308,,BAO_0000218,178.0,
7714,1,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627740,,BAO_0000218,178.0,
7715,1,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627741,,BAO_0000218,178.0,
7716,1,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627742,,BAO_0000218,178.0,
7717,1,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627743,,BAO_0000218,178.0,
7718,1,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627744,,BAO_0000218,178.0,
7719,1,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627745,,BAO_0000218,10000001.0,
7720,1,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627746,,BAO_0000218,10000001.0,
7721,1,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627747,,BAO_0000218,10000001.0,
7722,1,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876810,,BAO_0000218,10000001.0,
7723,1,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627748,,BAO_0000218,10000001.0,
7724,1,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627749,,BAO_0000218,10000001.0,
7725,1,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627750,,BAO_0000218,10000001.0,
7726,1,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618728,,BAO_0000218,10000001.0,
7727,1,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618729,,BAO_0000218,10000001.0,
7728,1,Biodistribution in rat bone in the presence of GdDTPA at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618730,,BAO_0000218,10000001.0,
7729,1,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618731,,BAO_0000218,10000001.0,
7730,1,Biodistribution in rat bone in the presence of GdDTPA at 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618732,,BAO_0000218,10000001.0,
7731,1,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618733,,BAO_0000218,10000001.0,
7732,1,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618734,,BAO_0000218,10000001.0,
7733,1,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618735,,BAO_0000218,10000001.0,
7734,1,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876602,,BAO_0000218,10000001.0,
7735,1,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618736,,BAO_0000218,10000001.0,
7736,1,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618737,,BAO_0000218,10000001.0,
7737,1,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618738,,BAO_0000218,10000001.0,
7738,1,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618739,,BAO_0000218,10000001.0,
7739,1,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618740,,BAO_0000218,10000001.0,
7740,1,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618741,,BAO_0000218,10000001.0,
7741,1,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618742,,BAO_0000218,10000001.0,
7742,1,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618743,,BAO_0000218,10000001.0,
7743,1,Half-life from rat plasma at a single oral dose of 25 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618744,,BAO_0000218,1969.0,
7744,1,Half-life in male rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618745,,BAO_0000218,,
7745,1,Half-life in rat after peroral administration at 10 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620479,,BAO_0000218,,
7746,1,Half-life in rat after peroral administration at 5 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620480,,BAO_0000218,,
7747,1,Half-life in rat at a dose of 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620481,,BAO_0000218,,
7748,1,Half-life was evaluated in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620482,,BAO_0000218,,
7749,1,Half-life was measured in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876603,,BAO_0000218,,
7750,1,Half-life period for the compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620483,,BAO_0000218,,
7751,1,Half-life period in rats after intravenous administration at 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620484,,BAO_0000218,,
7752,1,Half-life period in rat at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620485,,BAO_0000218,,
7753,1,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620486,,BAO_0000218,,
7754,1,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620487,,BAO_0000218,,
7755,1,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620488,,BAO_0000218,,
7756,1,Half-life time in rat the dose of 2 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620489,,BAO_0000218,,
7757,1,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620490,,BAO_0000218,,
7758,1,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620491,,BAO_0000218,,
7759,1,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876604,,BAO_0000218,1969.0,
7760,1,Oral half life was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620492,,BAO_0000218,,
7761,1,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620493,,BAO_0000218,,
7762,1,Pharmacokinetic property (t1/2) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620494,,BAO_0000218,,
7763,1,Plasma elimination half-life was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620495,,BAO_0000218,1969.0,
7764,1,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620496,,BAO_0000218,1969.0,
7765,1,Plasma half life was observed after intravenous administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620497,,BAO_0000218,1969.0,
7766,1,Plasma half-life was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620498,,BAO_0000218,1969.0,
7767,1,Plasma half-life following oral administration in Fisher rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620499,,BAO_0000218,1969.0,
7768,1,Plasma half-life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620500,,BAO_0000218,1969.0,
7769,1,Plasmatic Half-life after intravenous administration to rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873809,,BAO_0000218,1969.0,
7770,1,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620501,,BAO_0000218,,
7771,1,Terminal half life after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620502,,BAO_0000218,,
7772,1,Terminal half life in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620503,,BAO_0000218,,
7773,1,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620504,,BAO_0000218,,
7774,1,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876605,,BAO_0000218,,
7775,1,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620505,,BAO_0000218,,
7776,1,plasma half life was observed after intravenous administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873811,,BAO_0000218,1969.0,
7777,1,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL624016,,BAO_0000218,,
7778,1,Half life of compound determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624017,,BAO_0000218,,
7779,1,Mean residence time determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624018,,BAO_0000218,,
7780,1,Plasma half life determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624019,,BAO_0000218,,
7781,1,Compound was evaluated for Tmax in brain after intravenous administration in male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624020,,BAO_0000218,955.0,
7782,1,Compound was evaluated for pharmacokinetic parameter maximum time period,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624201,,BAO_0000218,,
7783,1,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL872528,,BAO_0000218,,
7784,1,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624202,,BAO_0000218,,
7785,1,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624203,,BAO_0000218,,
7786,1,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624350,,BAO_0000218,,
7787,1,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621320,,BAO_0000218,,
7788,1,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621321,,BAO_0000218,,
7789,1,Maximum time (Tmax) required to reach Cmax in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621322,,BAO_0000218,,
7790,1,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621323,,BAO_0000218,,
7791,1,Maximum time of clearance of compound in rats after peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621324,,BAO_0000218,,
7792,1,Maximum time at the dose of 2 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621325,,BAO_0000218,,
7793,1,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875837,,BAO_0000218,1969.0,
7794,1,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621326,,BAO_0000218,1969.0,
7795,1,Tmax in Guinea pig (PO dose),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621327,,BAO_0000218,,
7796,1,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621328,,BAO_0000218,,
7797,1,Pharmacokinetic parameter (Tmax) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621329,,BAO_0000218,,
7798,1,Pharmacokinetic parameter (Tmax) was estimated,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621330,,BAO_0000218,,
7799,1,Pharmacokinetic property (Tmax) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621331,,BAO_0000218,,
7800,1,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621332,,BAO_0000218,,
7801,1,T max in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621333,,BAO_0000218,,
7802,1,T max was determined at 10 mg/kg po dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621334,,BAO_0000218,,
7803,1,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),Mus musculus,1,50594,,N,Intermediate,,CHEMBL621335,,BAO_0000218,,
7804,1,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621336,,BAO_0000218,,
7805,1,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621337,,BAO_0000218,,
7806,1,Area under curve was measured after i.v. administration into Beagle dog.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621338,,BAO_0000218,,
7807,1,Area under curve was measured after iv administration into Beagle dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL875838,,BAO_0000218,,
7808,1,Area under curve was measured after po administration into Beagle dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621339,,BAO_0000218,,
7809,1,Area under curve was measured after po administration into Beagle dog.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621340,,BAO_0000218,,
7810,1,Area under curve was measured at peroral dose of 3 mg/kg,,0,22224,,U,Autocuration,,CHEMBL621341,,BAO_0000218,,
7811,1,Area under curve was measured by using concentration Vs time,,0,22224,,U,Autocuration,,CHEMBL621342,,BAO_0000019,,
7812,1,Area under curve was measured by using concentration Vs time; not tested,,0,22224,,U,Autocuration,,CHEMBL621343,,BAO_0000019,,
7813,1,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),Mus musculus,1,50594,,N,Intermediate,,CHEMBL621344,,BAO_0000218,,
7814,1,Area under curve(AUC) was measured in mice after oral administration.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL621345,,BAO_0000218,,
7815,1,Area under curve(AUC) value of the compound,,0,22224,,U,Autocuration,,CHEMBL621346,,BAO_0000019,,
7816,1,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,,0,22224,,U,Autocuration,,CHEMBL621347,,BAO_0000218,,
7817,1,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621348,,BAO_0000218,,
7818,1,Area under curve(carotid artery) was determined by the availability in blood,,0,22224,,U,Autocuration,,CHEMBL621349,,BAO_0000019,178.0,
7819,1,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,,0,22224,,U,Autocuration,,CHEMBL621350,,BAO_0000019,178.0,
7820,1,Area under curve(carotid artery) was determined by the availability in blood; No data,,0,22224,,U,Autocuration,,CHEMBL875839,,BAO_0000019,178.0,
7821,1,Area under curve(portal vein) was determined by the availability in blood,,0,22224,,U,Autocuration,,CHEMBL620211,,BAO_0000019,178.0,
7822,1,Area under curve(portal vein) was determined by the availability in blood; ND means no data,,0,22224,,U,Autocuration,,CHEMBL620212,,BAO_0000019,178.0,
7823,1,Area under curve(portal vein) was determined by the availability in blood; No data,,0,22224,,U,Autocuration,,CHEMBL620213,,BAO_0000019,178.0,
7824,1,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Macaca mulatta,1,50797,,N,Intermediate,,CHEMBL620214,,BAO_0000218,1969.0,
7825,1,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",Macaca mulatta,1,50797,,N,Intermediate,,CHEMBL620215,,BAO_0000218,1969.0,
7826,1,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,Macaca mulatta,1,50797,,N,Intermediate,,CHEMBL620216,,BAO_0000218,1969.0,
7827,1,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL620888,,BAO_0000218,1969.0,
7828,1,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL620889,,BAO_0000218,1969.0,
7829,1,Area under plasma concentration vs time curve observed in rats for 0-3 h,,0,22224,,U,Autocuration,,CHEMBL620890,,BAO_0000019,1969.0,
7830,1,Area under plasma time curve determined in male rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620891,,BAO_0000218,1969.0,
7831,1,Area under the MAP curve measured over 5 min.,,0,22224,,U,Autocuration,,CHEMBL620892,,BAO_0000019,,
7832,1,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL621079,,BAO_0000218,,
7833,1,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL621080,,BAO_0000218,,
7834,1,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621081,,BAO_0000218,,
7835,1,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,Cricetinae,1,100712,,N,Intermediate,,CHEMBL621082,,BAO_0000218,,
7836,1,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621083,,BAO_0000218,,
7837,1,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621084,,BAO_0000218,,
7838,1,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621085,,BAO_0000218,,
7839,1,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621086,,BAO_0000218,,
7840,1,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621087,,BAO_0000218,,
7841,1,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622607,,BAO_0000218,,
7842,1,Serum AUC in marmosets (IV dose),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622608,,BAO_0000218,,
7843,1,Area under the curve after intravenous administration at a dose of 10 umol/kg,,0,22224,,U,Autocuration,,CHEMBL624481,,BAO_0000019,,
7844,1,Area under the curve after intravenous administration at a dose of 2 umol/kg,,0,22224,,U,Autocuration,,CHEMBL624482,,BAO_0000019,,
7845,1,Area under the curve after intravenous administration at a dose of 4 umol/kg,,0,22224,,U,Autocuration,,CHEMBL624483,,BAO_0000019,,
7846,1,Area under the curve after intravenous administration at a dose of 40 umol/kg,,0,22224,,U,Autocuration,,CHEMBL624484,,BAO_0000019,,
7847,1,Area under the curve after intravenous administration at a dose of 5 umol/kg,,0,22224,,U,Autocuration,,CHEMBL624485,,BAO_0000019,,
7848,1,Area under the curve for fumarate salt was evaluated in F344 Rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624486,,BAO_0000218,,
7849,1,Area under the curve for the compound was calculated.,,0,22224,,U,Autocuration,,CHEMBL624487,,BAO_0000019,,
7850,1,Area under the curve in concentration/ time,,0,22224,,U,Autocuration,,CHEMBL624488,,BAO_0000019,,
7851,1,Area under the curve administered intraintestinal in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624489,,BAO_0000218,,
7852,1,Area under the curve administered intravenously in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625184,,BAO_0000218,,
7853,1,Area under the curve during intravenous administration,,0,22224,,U,Autocuration,,CHEMBL625185,,BAO_0000019,,
7854,1,Area under the curve during intravenous administration; Not determined,,0,22224,,U,Autocuration,,CHEMBL875954,,BAO_0000019,,
7855,1,Area under the curve during systemic administration,,0,22224,,U,Autocuration,,CHEMBL625186,,BAO_0000019,,
7856,1,Area under the curve during systemic administration; Not determined,,0,22224,,U,Autocuration,,CHEMBL625187,,BAO_0000019,,
7857,1,Area under the curve was calculated for the compound.,,0,22224,,U,Autocuration,,CHEMBL625188,,BAO_0000019,,
7858,1,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625189,,BAO_0000218,,
7859,1,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625190,,BAO_0000218,,
7860,1,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621733,,BAO_0000218,,
7861,1,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621734,,BAO_0000218,,
7862,1,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621735,,BAO_0000218,,
7863,1,Clearance of the drug was measured in the plasma of rat; No data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621736,,BAO_0000218,1969.0,
7864,1,The pharmacokinetic parameter plasma clearance in vivo in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621737,,BAO_0000218,1969.0,
7865,1,Plasma clearance at the dose of 2 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621738,,BAO_0000218,,
7866,1,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622806,,BAO_0000218,,
7867,1,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623519,,BAO_0000218,,
7868,1,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623520,,BAO_0000218,,
7869,1,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623521,,BAO_0000218,,
7870,1,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623522,,BAO_0000218,,
7871,1,Clearance rate in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623523,,BAO_0000218,,
7872,1,Clearance rate in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623690,,BAO_0000218,,
7873,1,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623691,,BAO_0000218,,
7874,1,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623692,,BAO_0000218,,
7875,1,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623693,,BAO_0000218,,
7876,1,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623694,,BAO_0000218,,
7877,1,Clearance of compound after iv administration of 20 mg/kg dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623695,,BAO_0000218,,
7878,1,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623696,,BAO_0000218,,
7879,1,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623697,,BAO_0000218,,
7880,1,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Macaca mulatta,0,22224,,U,Intermediate,,CHEMBL623698,,BAO_0000218,1969.0,
7881,1,Compound was tested for its plasma clearance rate in Sprague Dawley rats,Rattus norvegicus,0,22224,,U,Intermediate,,CHEMBL623699,,BAO_0000218,1969.0,
7882,1,Mean (%CV) PK parameters for CL(mL/min/kg).,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623700,,BAO_0000218,,
7883,1,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623701,,BAO_0000218,,
7884,1,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623702,,BAO_0000218,1969.0,
7885,1,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623703,,BAO_0000218,,
7886,1,Plasma clearance in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623704,,BAO_0000218,,
7887,1,Plasma clearance in rat after administration of 2 mg/kg iv,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623705,,BAO_0000218,,
7888,1,Plasma clearance in rat after administration of 2 mg/kg iv,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623706,,BAO_0000218,,
7889,1,Plasma clearance was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623707,,BAO_0000218,,
7890,1,Plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623708,,BAO_0000218,,
7891,1,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623709,,BAO_0000218,,
7892,1,Plasma clearance in rat by iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623710,,BAO_0000218,,
7893,1,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623711,,BAO_0000218,,
7894,1,Plasma clearance in rat p.o.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623712,,BAO_0000218,,
7895,1,Plasma clearance in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623713,,BAO_0000218,,
7896,1,Plasma clearance was determined; ND denotes no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623714,,BAO_0000218,,
7897,1,Plasma clearance was determined; ND denotes not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623715,,BAO_0000218,,
7898,1,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623716,,BAO_0000218,,
7899,1,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622980,,BAO_0000218,,
7900,1,Plasma administration to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622981,,BAO_0000218,,
7901,1,Plasma clearance of the compound in female Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622982,,BAO_0000218,,
7902,1,Plasma clearance was observed after intravenous administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622983,,BAO_0000218,,
7903,1,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622984,,BAO_0000218,,
7904,1,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622985,,BAO_0000218,,
7905,1,plasma clearance was observed after intravenous administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623631,,BAO_0000218,1969.0,
7906,1,In vivo CL/F determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623632,,BAO_0000218,,
7907,1,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623633,,BAO_0000218,1969.0,
7908,1,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623634,,BAO_0000218,1969.0,
7909,1,Compound was tested for the lower blood clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623635,,BAO_0000218,,
7910,1,Evaluated for the low clearance in rat (in vivo),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621195,,BAO_0000218,,
7911,1,Pharmacokinetic property (CLb)of the compound was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621196,,BAO_0000218,,
7912,1,Rapid clearance after intravenous administration in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875287,,BAO_0000218,,
7913,1,Clearance measured in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621197,,BAO_0000218,,
7914,1,Compound was evaluated for plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621198,,BAO_0000218,1969.0,
7915,1,Low plasma clearance was calculated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621199,,BAO_0000218,1969.0,
7916,1,Pharmacokinetic property (Clp) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621200,,BAO_0000218,,
7917,1,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621201,,BAO_0000218,,
7918,1,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621202,,BAO_0000218,,
7919,1,Plasma clearance after IV dosing at 0.5 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621203,,BAO_0000218,,
7920,1,Plasma clearance after IV dosing at 1 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621204,,BAO_0000218,,
7921,1,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621205,,BAO_0000218,948.0,
7922,1,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621206,,BAO_0000218,948.0,
7923,1,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621207,,BAO_0000218,948.0,
7924,1,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621208,,BAO_0000218,948.0,
7925,1,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621209,,BAO_0000218,948.0,
7926,1,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876484,,BAO_0000218,948.0,
7927,1,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621210,,BAO_0000218,948.0,
7928,1,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621211,,BAO_0000218,948.0,
7929,1,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621212,,BAO_0000218,948.0,
7930,1,Biodistribution in rat heart in the presence of GdDTPA at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621213,,BAO_0000218,948.0,
7931,1,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621214,,BAO_0000218,948.0,
7932,1,Biodistribution in rat heart in the presence of GdDTPA at 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621215,,BAO_0000218,948.0,
7933,1,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621216,,BAO_0000218,948.0,
7934,1,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621217,,BAO_0000218,948.0,
7935,1,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621218,,BAO_0000218,948.0,
7936,1,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621219,,BAO_0000218,948.0,
7937,1,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621220,,BAO_0000218,948.0,
7938,1,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621221,,BAO_0000218,948.0,
7939,1,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621222,,BAO_0000218,948.0,
7940,1,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621223,,BAO_0000218,948.0,
7941,1,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876485,,BAO_0000218,948.0,
7942,1,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621224,,BAO_0000218,948.0,
7943,1,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621225,,BAO_0000218,948.0,
7944,1,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621226,,BAO_0000218,948.0,
7945,1,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621227,,BAO_0000218,2113.0,
7946,1,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621228,,BAO_0000218,2113.0,
7947,1,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621229,,BAO_0000218,2113.0,
7948,1,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621230,,BAO_0000218,2113.0,
7949,1,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621231,,BAO_0000218,2113.0,
7950,1,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621232,,BAO_0000218,2113.0,
7951,1,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621233,,BAO_0000218,2113.0,
7952,1,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621234,,BAO_0000218,2113.0,
7953,1,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621235,,BAO_0000218,2113.0,
7954,1,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621236,,BAO_0000218,2113.0,
7955,1,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621237,,BAO_0000218,2113.0,
7956,1,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876486,,BAO_0000218,2113.0,
7957,1,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622436,,BAO_0000218,160.0,
7958,1,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622437,,BAO_0000218,160.0,
7959,1,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622438,,BAO_0000218,160.0,
7960,1,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622439,,BAO_0000218,2107.0,
7961,1,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622440,,BAO_0000218,2107.0,
7962,1,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622441,,BAO_0000218,2107.0,
7963,1,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622442,,BAO_0000218,2107.0,
7964,1,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622443,,BAO_0000218,2107.0,
7965,1,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622444,,BAO_0000218,2107.0,
7966,1,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622445,,BAO_0000218,2107.0,
7967,1,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622446,,BAO_0000218,2107.0,
7968,1,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622447,,BAO_0000218,2107.0,
7969,1,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622448,,BAO_0000218,2107.0,
7970,1,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622449,,BAO_0000218,2107.0,
7971,1,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622450,,BAO_0000218,2107.0,
7972,1,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622451,,BAO_0000218,2107.0,
7973,1,Biodistribution in rat liver in the presence of GdDTPA at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622452,,BAO_0000218,2107.0,
7974,1,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622453,,BAO_0000218,2107.0,
7975,1,Biodistribution in rat liver in the presence of GdDTPA at 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622454,,BAO_0000218,2107.0,
7976,1,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622455,,BAO_0000218,2107.0,
7977,1,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876024,,BAO_0000218,2107.0,
7978,1,T max was determined at 3 mg/kg po dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622456,,BAO_0000218,,
7979,1,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622457,,BAO_0000218,,
7980,1,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622458,,BAO_0000218,,
7981,1,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622459,,BAO_0000218,,
7982,1,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873343,,BAO_0000218,,
7983,1,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622460,,BAO_0000218,,
7984,1,Time for maximum plasma concentration determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622461,,BAO_0000218,1969.0,
7985,1,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622462,,BAO_0000218,1969.0,
7986,1,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622463,,BAO_0000218,,
7987,1,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622464,,BAO_0000218,,
7988,1,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622465,,BAO_0000218,,
7989,1,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622466,,BAO_0000218,,
7990,1,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622467,,BAO_0000218,,
7991,1,Time of maximum plasma concentration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622468,,BAO_0000218,1969.0,
7992,1,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876025,,BAO_0000218,1969.0,
7993,1,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622469,,BAO_0000218,1969.0,
7994,1,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622470,,BAO_0000218,1969.0,
7995,1,Time required to reach maximum concentration (Cmax) after oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622471,,BAO_0000218,,
7996,1,Time required to reach maximum concentration in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622472,,BAO_0000218,1969.0,
7997,1,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622473,,BAO_0000218,1969.0,
7998,1,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624282,,BAO_0000218,1969.0,
7999,1,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624283,,BAO_0000218,1969.0,
8000,1,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624284,,BAO_0000218,1969.0,
8001,1,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624285,,BAO_0000218,1969.0,
8002,1,Time to reach Cmax after oral administration to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624286,,BAO_0000218,,
8003,1,Time to reach Cmax when a dose of 1 mg/kg is administered orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624287,,BAO_0000218,,
8004,1,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624288,,BAO_0000218,,
8005,1,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624289,,BAO_0000218,1969.0,
8006,1,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873344,,BAO_0000218,1969.0,
8007,1,Tmax after peroral administration (10 mg/kg) was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619623,,BAO_0000218,,
8008,1,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL621399,,BAO_0000218,,
8009,1,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621400,,BAO_0000218,,
8010,1,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621401,,BAO_0000218,,
8011,1,Tmax was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621402,,BAO_0000218,,
8012,1,Tmax was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621403,,BAO_0000218,,
8013,1,Tmax after oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621121,,BAO_0000218,,
8014,1,Tmax after peroral administration in rats at 2.4 uM/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL872525,,BAO_0000218,,
8015,1,Tmax in male rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621122,,BAO_0000218,,
8016,1,Tmax in rat at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621123,,BAO_0000218,,
8017,1,Tmax in rat by po administration at a dose of 40 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621124,,BAO_0000218,,
8018,1,Tmax in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621125,,BAO_0000218,,
8019,1,Tmax was measured in rats after peroral administration at 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621126,,BAO_0000218,,
8020,1,Tmax value after oral dose at a dose of 10 mg/kg in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621127,,BAO_0000218,,
8021,1,Tmax value after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621128,,BAO_0000218,,
8022,1,Tmax value at a dose of 10 mg/kg in male SD rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618263,,BAO_0000218,,
8023,1,Tmax value at a dose of 100 mg/kg in male SD rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618264,,BAO_0000218,,
8024,1,Tmax value at a dose of 50 mg/kg in male SD rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618265,,BAO_0000218,,
8025,1,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618266,,BAO_0000218,1969.0,
8026,1,time required to reach maximum concentration (Cmax) after oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618267,,BAO_0000218,,
8027,1,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618450,,BAO_0000218,1088.0,
8028,1,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618451,,BAO_0000218,1088.0,
8029,1,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618452,,BAO_0000218,,
8030,1,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618453,,BAO_0000218,1088.0,
8031,1,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618454,,BAO_0000218,1088.0,
8032,1,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618455,,BAO_0000218,1088.0,
8033,1,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618456,,BAO_0000218,,
8034,1,Compound distribution in rat tissues was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618457,,BAO_0000218,,
8035,1,Volume of distribution was evaluated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618458,,BAO_0000218,,
8036,1,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618459,,BAO_0000218,,
8037,1,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876733,,BAO_0000218,,
8038,1,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL618460,,BAO_0000218,,
8039,1,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618461,,BAO_0000218,,
8040,1,Area under the curve was determined after oral administration (300 uM/Kg),,0,22224,,U,Autocuration,,CHEMBL618462,,BAO_0000019,,
8041,1,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618463,,BAO_0000218,,
8042,1,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618464,,BAO_0000218,,
8043,1,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618465,,BAO_0000218,,
8044,1,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618466,,BAO_0000218,,
8045,1,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618467,,BAO_0000218,,
8046,1,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618468,,BAO_0000218,,
8047,1,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL618469,,BAO_0000218,1969.0,
8048,1,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL618470,,BAO_0000218,1969.0,
8049,1,Plasma drug AUC in rat (PO dose),,0,22224,,U,Autocuration,,CHEMBL618471,,BAO_0000218,,
8050,1,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618472,,BAO_0000218,,
8051,1,Area under was determined at a dose of 30 mg/kg,,0,22224,,U,Autocuration,,CHEMBL618473,,BAO_0000218,,
8052,1,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,Mustela putorius furo,1,50506,,N,Intermediate,,CHEMBL621699,,BAO_0000218,,
8053,1,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621700,,BAO_0000218,,
8054,1,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621701,,BAO_0000218,,
8055,1,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,Mustela putorius furo,1,50506,,N,Intermediate,,CHEMBL621702,,BAO_0000218,,
8056,1,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621703,,BAO_0000218,,
8057,1,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621704,,BAO_0000218,,
8058,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624259,,BAO_0000218,,
8059,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624260,,BAO_0000218,,
8060,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624430,,BAO_0000218,,
8061,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624431,,BAO_0000218,,
8062,1,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624432,,BAO_0000218,,
8063,1,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624433,,BAO_0000218,,
8064,1,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624434,,BAO_0000218,,
8065,1,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624435,,BAO_0000218,,
8066,1,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618570,,BAO_0000218,,
8067,1,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,1,50594,,N,Intermediate,,CHEMBL618571,,BAO_0000218,,
8068,1,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618572,,BAO_0000218,,
8069,1,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,1,50594,,N,Intermediate,,CHEMBL618573,,BAO_0000218,,
8070,1,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL619267,,BAO_0000218,,
8071,1,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,1,50594,,N,Intermediate,,CHEMBL619431,,BAO_0000218,,
8072,1,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL619432,,BAO_0000218,,
8073,1,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),Mus musculus,1,50594,,N,Intermediate,,CHEMBL619433,,BAO_0000218,,
8074,1,AUC in mice after oral dose (50 mg/kg),,0,22224,,U,Autocuration,,CHEMBL619434,,BAO_0000218,1969.0,
8075,1,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,Mus musculus,1,50594,,N,Intermediate,,CHEMBL619435,,BAO_0000218,1977.0,
8076,1,AUC (0-4 hr) ug/ml/h,,0,22224,,U,Autocuration,,CHEMBL619436,,BAO_0000019,1969.0,
8077,1,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619437,,BAO_0000218,,
8078,1,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,,0,22224,,U,Autocuration,,CHEMBL619438,,BAO_0000218,,
8079,1,Compound was evaluated for Area under curve in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL619439,,BAO_0000218,,
8080,1,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619440,,BAO_0000218,,
8081,1,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,,0,22224,,U,Autocuration,,CHEMBL619441,,BAO_0000218,,
8082,1,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619442,,BAO_0000218,,
8083,1,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,,0,22224,,U,Autocuration,,CHEMBL875156,,BAO_0000019,,
8084,1,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,,0,22224,,U,Autocuration,,CHEMBL619443,,BAO_0000019,,
8085,1,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,,0,22224,,U,Autocuration,,CHEMBL619444,,BAO_0000019,,
8086,1,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,,0,22224,,U,Autocuration,,CHEMBL623464,,BAO_0000019,,
8087,1,Compound was evaluated for area under curve when administered through oral route in mouse,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623465,,BAO_0000218,,
8088,1,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623466,,BAO_0000218,,
8089,1,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623467,,BAO_0000218,,
8090,1,Plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623468,,BAO_0000218,,
8091,1,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622660,,BAO_0000218,,
8092,1,Plasma clearance rate in Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622661,,BAO_0000218,,
8093,1,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622662,,BAO_0000218,,
8094,1,Pharmacokinetic property (total body clearance) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622663,,BAO_0000218,,
8095,1,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622664,,BAO_0000218,,
8096,1,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622665,,BAO_0000218,,
8097,1,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622666,,BAO_0000218,,
8098,1,Cl in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621615,,BAO_0000218,,
8099,1,Clearance of compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621616,,BAO_0000218,,
8100,1,Clearance was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621617,,BAO_0000218,,
8101,1,Clearance by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621618,,BAO_0000218,,
8102,1,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621619,,BAO_0000218,,
8103,1,Clearance rate after i.v. administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621620,,BAO_0000218,,
8104,1,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621786,,BAO_0000218,,
8105,1,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621787,,BAO_0000218,,
8106,1,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621788,,BAO_0000218,,
8107,1,Clearance (Cl) after oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621789,,BAO_0000218,,
8108,1,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621790,,BAO_0000218,,
8109,1,Compound was tested for plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621791,,BAO_0000218,1969.0,
8110,1,In vitro microsome metabolism clearance in rat was determined,Rattus norvegicus,1,50597,Microsomes,N,Intermediate,,CHEMBL621792,,BAO_0000218,,
8111,1,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,Rattus norvegicus,1,50597,Microsomes,N,Intermediate,,CHEMBL621793,,BAO_0000218,,
8112,1,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621794,,BAO_0000218,,
8113,1,In vivo plasma clearance was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621795,,BAO_0000218,1969.0,
8114,1,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621796,,BAO_0000218,,
8115,1,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621797,401.0,BAO_0000218,2107.0,
8116,1,Pharmacokinetic property (Plasma clearance) was measured in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621798,,BAO_0000218,,
8117,1,Pharmacokinetic property (clearance) in rat i.v.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621799,,BAO_0000218,,
8118,1,"Plasma Clearance was evaluated in rats, iv",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621800,,BAO_0000218,,
8119,1,Plasma clearance (in vivo) in rats was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621801,,BAO_0000218,,
8120,1,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621802,,BAO_0000218,,
8121,1,Plasma clearance was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618596,,BAO_0000218,,
8122,1,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618597,,BAO_0000218,,
8123,1,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618598,,BAO_0000218,,
8124,1,Plasma clearance in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618599,,BAO_0000218,,
8125,1,Plasma clearance rate determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618600,,BAO_0000218,,
8126,1,Plasma clearance was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618601,,BAO_0000218,,
8127,1,Plasma clearance was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618602,,BAO_0000218,,
8128,1,Plasma clearance value in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618603,,BAO_0000218,,
8129,1,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618604,,BAO_0000218,2107.0,
8130,1,Clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618605,,BAO_0000218,,
8131,1,Total body clearance in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618606,,BAO_0000218,,
8132,1,Clearance of compound in rats after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618607,,BAO_0000218,,
8133,1,Clearance after iv administration to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618608,,BAO_0000218,,
8134,1,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618609,,BAO_0000218,,
8135,1,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618610,,BAO_0000218,,
8136,1,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618611,,BAO_0000218,,
8137,1,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618612,,BAO_0000218,,
8138,1,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618613,,BAO_0000218,,
8139,1,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621076,,BAO_0000218,,
8140,1,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621077,,BAO_0000218,,
8141,1,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621078,,BAO_0000218,,
8142,1,Clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621251,,BAO_0000218,,
8143,1,Clearance in rat after oral administration at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621252,,BAO_0000218,,
8144,1,Clearance in rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621253,,BAO_0000218,,
8145,1,Clearance rate following an oral dose of 20 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621254,,BAO_0000218,,
8146,1,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621255,,BAO_0000218,,
8147,1,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621256,,BAO_0000218,1969.0,
8148,1,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621257,,BAO_0000218,2107.0,
8149,1,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621258,,BAO_0000218,2107.0,
8150,1,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621259,,BAO_0000218,2107.0,
8151,1,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621260,,BAO_0000218,2107.0,
8152,1,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876494,,BAO_0000218,2107.0,
8153,1,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621261,,BAO_0000218,2107.0,
8154,1,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621262,,BAO_0000218,2107.0,
8155,1,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621263,,BAO_0000218,2107.0,
8156,1,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621264,,BAO_0000218,2107.0,
8157,1,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621265,,BAO_0000218,2385.0,
8158,1,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621266,,BAO_0000218,2385.0,
8159,1,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621267,,BAO_0000218,2385.0,
8160,1,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621268,,BAO_0000218,2385.0,
8161,1,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621269,,BAO_0000218,2385.0,
8162,1,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621270,,BAO_0000218,2385.0,
8163,1,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621271,,BAO_0000218,2385.0,
8164,1,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621272,,BAO_0000218,2385.0,
8165,1,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621273,,BAO_0000218,2385.0,
8166,1,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621274,,BAO_0000218,2385.0,
8167,1,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876495,,BAO_0000218,2385.0,
8168,1,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621275,,BAO_0000218,2385.0,
8169,1,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621276,,BAO_0000218,2385.0,
8170,1,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621277,,BAO_0000218,2385.0,
8171,1,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621278,,BAO_0000218,160.0,
8172,1,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621279,,BAO_0000218,160.0,
8173,1,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621280,,BAO_0000218,160.0,
8174,1,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621281,,BAO_0000218,2106.0,
8175,1,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621282,,BAO_0000218,2106.0,
8176,1,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621283,,BAO_0000218,2106.0,
8177,1,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621284,,BAO_0000218,2106.0,
8178,1,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621285,,BAO_0000218,2106.0,
8179,1,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621286,,BAO_0000218,2106.0,
8180,1,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623220,,BAO_0000218,2106.0,
8181,1,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623221,,BAO_0000218,2106.0,
8182,1,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876029,,BAO_0000218,2106.0,
8183,1,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623222,,BAO_0000218,945.0,
8184,1,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623223,,BAO_0000218,945.0,
8185,1,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621445,,BAO_0000218,945.0,
8186,1,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621446,,BAO_0000218,178.0,
8187,1,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621447,,BAO_0000218,178.0,
8188,1,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619681,,BAO_0000218,178.0,
8189,1,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619682,,BAO_0000218,178.0,
8190,1,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619683,,BAO_0000218,178.0,
8191,1,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619684,,BAO_0000218,955.0,
8192,1,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619685,,BAO_0000218,955.0,
8193,1,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619686,,BAO_0000218,955.0,
8194,1,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619687,,BAO_0000218,955.0,
8195,1,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619688,,BAO_0000218,955.0,
8196,1,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619689,,BAO_0000218,948.0,
8197,1,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619690,,BAO_0000218,948.0,
8198,1,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619691,,BAO_0000218,948.0,
8199,1,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619692,,BAO_0000218,,
8200,1,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL619693,,BAO_0000218,,
8201,1,Vc value after IV dose at a dose of 5 mg/kg in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619694,,BAO_0000218,,
8202,1,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619695,,BAO_0000218,,
8203,1,Compound was evaluated for pharmacokinetic parameter volume of distribution,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619696,,BAO_0000218,,
8204,1,Compound was evaluated for volume of distribution in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619697,,BAO_0000218,,
8205,1,Steady state volume distribution was determined; steady state(ss),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619698,,BAO_0000218,,
8206,1,Steady state volume of distribution after iv administration to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619699,,BAO_0000218,,
8207,1,Steady state volume of distribution dosing at 3 mg/kg iv,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619700,,BAO_0000218,,
8208,1,The compound was evaluated for volume of distribution in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619701,,BAO_0000218,,
8209,1,The compound was tested for volume of distribution in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619702,,BAO_0000218,,
8210,1,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620335,,BAO_0000218,,
8211,1,Volume distribution (VD) after oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620336,,BAO_0000218,,
8212,1,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620337,,BAO_0000218,,
8213,1,Volume distribution in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620520,,BAO_0000218,,
8214,1,Volume distribution in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620521,,BAO_0000218,,
8215,1,Volume distribution in rat after peroral administration at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875825,,BAO_0000218,,
8216,1,Volume distribution in rat after peroral administration at 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620522,,BAO_0000218,,
8217,1,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620523,,BAO_0000218,,
8218,1,Volume of distribution in rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620524,,BAO_0000218,,
8219,1,Volume of distribution in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620525,,BAO_0000218,,
8220,1,Volume of distribution in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620526,,BAO_0000218,,
8221,1,Volume of distribution in rat by iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620527,,BAO_0000218,,
8222,1,Volume of distribution in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620528,,BAO_0000218,,
8223,1,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620529,,BAO_0000218,,
8224,1,Volume distribution at the dose of 2 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620530,,BAO_0000218,,
8225,1,Steady state volume of distribution was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620531,,BAO_0000218,,
8226,1,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,Macaca mulatta,0,22224,,U,Intermediate,,CHEMBL620532,,BAO_0000218,,
8227,1,Compound was tested for its plasma volume distribution in Sprague Dawley rats,Rattus norvegicus,0,22224,,U,Intermediate,,CHEMBL620533,,BAO_0000218,,
8228,1,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,Rattus norvegicus,0,22224,,U,Intermediate,,CHEMBL620534,,BAO_0000218,,
8229,1,Mean (%CV) PK parameters for Vdss(mL/kg).,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620535,,BAO_0000218,,
8230,1,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875826,,BAO_0000218,,
8231,1,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620536,,BAO_0000218,,
8232,1,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620537,,BAO_0000218,,
8233,1,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618526,,BAO_0000218,,
8234,1,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618527,,BAO_0000218,,
8235,1,Pharmacokinetic property (Vdss) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618528,,BAO_0000218,,
8236,1,Pharmacokinetic property (vdss) was measured in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618529,,BAO_0000218,,
8237,1,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618530,,BAO_0000218,,
8238,1,Volume of distribution in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618531,,BAO_0000218,,
8239,1,The pharmacokinetic parameter volume of distribution in vivo in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618532,,BAO_0000218,,
8240,1,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618533,,BAO_0000218,,
8241,1,Vdss in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618534,,BAO_0000218,,
8242,1,Volume distribution after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618535,,BAO_0000218,,
8243,1,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618536,,BAO_0000218,,
8244,1,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618537,,BAO_0000218,,
8245,1,Volume distribution at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618538,,BAO_0000218,,
8246,1,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618539,,BAO_0000218,,
8247,1,Volume distribution was calculated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618540,,BAO_0000218,,
8248,1,Volume distribution was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618541,,BAO_0000218,,
8249,1,Volume of distribution after intravenous administration was evaluated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618542,,BAO_0000218,,
8250,1,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622544,,BAO_0000218,,
8251,1,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622545,,BAO_0000218,,
8252,1,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622546,,BAO_0000218,,
8253,1,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622547,,BAO_0000218,,
8254,1,Volume of distribution in steady state was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622548,,BAO_0000218,,
8255,1,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622549,,BAO_0000218,,
8256,1,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622550,,BAO_0000218,,
8257,1,Compound was evaluated for area under curve when administered through oral route to mouse,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622551,,BAO_0000218,,
8258,1,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622552,,BAO_0000218,,
8259,1,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622553,,BAO_0000218,,
8260,1,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,,0,22224,,U,Autocuration,,CHEMBL622554,,BAO_0000218,,
8261,1,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622555,,BAO_0000218,,
8262,1,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622556,,BAO_0000218,,
8263,1,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622557,,BAO_0000218,,
8264,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622558,,BAO_0000218,178.0,
8265,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622559,,BAO_0000218,178.0,
8266,1,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622560,,BAO_0000218,,
8267,1,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622561,,BAO_0000218,,
8268,1,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622562,,BAO_0000218,,
8269,1,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622563,,BAO_0000218,,
8270,1,Concentration of compound in Central nervous system,,0,22224,,U,Autocuration,,CHEMBL622564,,BAO_0000019,,
8271,1,Concentration of compound in Central nervous system; Not detectable,,0,22224,,U,Autocuration,,CHEMBL622565,,BAO_0000019,,
8272,1,"Concentration of diester in the blood, following oral administration in mice",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622566,,BAO_0000218,,
8273,1,"Concentration of monoester in the blood, following oral administration in mice",Mus musculus,1,50594,,N,Intermediate,,CHEMBL624515,,BAO_0000218,,
8274,1,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL624516,,BAO_0000218,,
8275,1,Evaluated for Pharmacokinetic property: Area under the curve,,0,22224,,U,Autocuration,,CHEMBL624517,,BAO_0000019,,
8276,1,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL624518,,BAO_0000218,,
8277,1,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL624519,,BAO_0000218,,
8278,1,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL624520,,BAO_0000218,,
8279,1,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL624521,,BAO_0000218,,
8280,1,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL624522,,BAO_0000218,,
8281,1,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL624523,,BAO_0000218,,
8282,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL624409,,BAO_0000218,,
8283,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL624410,,BAO_0000218,,
8284,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL624411,,BAO_0000218,,
8285,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL623531,,BAO_0000218,,
8286,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL623532,,BAO_0000218,,
8287,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL623533,,BAO_0000218,,
8288,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL623534,,BAO_0000218,,
8289,1,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623535,,BAO_0000218,,
8290,1,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623536,,BAO_0000218,,
8291,1,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623537,,BAO_0000218,,
8292,1,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623538,,BAO_0000218,,
8293,1,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623539,,BAO_0000218,,
8294,1,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623540,,BAO_0000218,,
8295,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",Mus musculus,1,50594,,N,Intermediate,,CHEMBL623541,,BAO_0000218,,
8296,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL623542,,BAO_0000218,,
8297,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL623543,,BAO_0000218,,
8298,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",Mus musculus,1,50594,,N,Intermediate,,CHEMBL623544,,BAO_0000218,,
8299,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL623545,,BAO_0000218,,
8300,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL623546,,BAO_0000218,,
8301,1,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623547,,BAO_0000218,1969.0,
8302,1,High i.v. clearance in Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623548,,BAO_0000218,,
8303,1,In vitro clearance in rat liver microsomes,Rattus norvegicus,1,50597,Microsomes,N,Intermediate,,CHEMBL623549,,BAO_0000218,2107.0,
8304,1,Intrinsic clearance in rat liver microsomes was determined,Rattus norvegicus,1,50597,Microsomes,N,Intermediate,,CHEMBL623550,,BAO_0000218,2107.0,
8305,1,Intrinsic clearance in rat hepatocytes was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875276,401.0,BAO_0000218,2107.0,
8306,1,Plasma Clearance was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621872,,BAO_0000218,,
8307,1,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621873,,BAO_0000218,,
8308,1,Plasma clearance in rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621874,,BAO_0000218,,
8309,1,Plasma clearance in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621875,,BAO_0000218,,
8310,1,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621876,,BAO_0000218,,
8311,1,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621877,,BAO_0000218,,
8312,1,Plasma clearance was measured in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621878,,BAO_0000218,,
8313,1,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621879,,BAO_0000218,,
8314,1,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621880,,BAO_0000218,1969.0,
8315,1,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621881,,BAO_0000218,,
8316,1,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621882,,BAO_0000218,,
8317,1,Total clearance at 1 mg/kg was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875283,,BAO_0000218,,
8318,1,Total clearance at 10 mg/kg was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621883,,BAO_0000218,,
8319,1,Clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621884,,BAO_0000218,,
8320,1,Plasma clearance rate determined in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621885,,BAO_0000218,,
8321,1,Clearance of compound in rat was evaluated,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621886,,BAO_0000218,,
8322,1,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621887,,BAO_0000218,1969.0,
8323,1,Pharmacokinetic property (blood clearance) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621888,,BAO_0000218,,
8324,1,Plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621889,,BAO_0000218,,
8325,1,Plasma clearance in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621890,,BAO_0000218,,
8326,1,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,Rattus norvegicus,1,50597,Microsomes,N,Intermediate,,CHEMBL621891,,BAO_0000218,2107.0,
8327,1,Clearance in Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621892,,BAO_0000218,,
8328,1,Clearance rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621893,,BAO_0000218,,
8329,1,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621894,,BAO_0000218,,
8330,1,Clearance rat; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621895,,BAO_0000218,,
8331,1,Clearance rate was determined in rat at a dose of 1 mpk i.v.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875284,,BAO_0000218,,
8332,1,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618699,,BAO_0000218,,
8333,1,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618700,,BAO_0000218,,
8334,1,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618701,,BAO_0000218,,
8335,1,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876600,,BAO_0000218,1969.0,
8336,1,Clearance of compound in rat after 1 mg/kg i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618702,,BAO_0000218,,
8337,1,Compound was evaluated for Hepatic clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618703,,BAO_0000218,,
8338,1,In vivo clearance after 5 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618704,,BAO_0000218,,
8339,1,Compound was tested for plasma clearance in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618705,,BAO_0000218,1969.0,
8340,1,Hepatic clearance after intravenous administration was evaluated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618706,,BAO_0000218,,
8341,1,Lower clearance in rat (i.v.) at 0.5 mpk,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618707,,BAO_0000218,,
8342,1,Pharmacokinetic parameter expressed as plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618708,,BAO_0000218,1969.0,
8343,1,Pharmacokinetic property (Clp) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618709,,BAO_0000218,,
8344,1,Plasma clearance in Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618710,,BAO_0000218,,
8345,1,Plasma clearance (Clp) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618711,,BAO_0000218,,
8346,1,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618712,,BAO_0000218,,
8347,1,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618713,,BAO_0000218,,
8348,1,Plasma clearance after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618714,,BAO_0000218,,
8349,1,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618715,,BAO_0000218,,
8350,1,Plasma clearance in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618716,,BAO_0000218,,
8351,1,Plasma clearance measured in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876601,,BAO_0000218,,
8352,1,Plasma clearance was calculated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618717,,BAO_0000218,,
8353,1,Plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618718,,BAO_0000218,,
8354,1,Plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618719,,BAO_0000218,,
8355,1,Plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618720,,BAO_0000218,,
8356,1,Plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618721,,BAO_0000218,,
8357,1,Plasma clearance in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621477,,BAO_0000218,,
8358,1,Plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621478,,BAO_0000218,,
8359,1,Plasma clearance was evaluated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621479,,BAO_0000218,,
8360,1,Plasma clearance was evaluated in rat; Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621480,,BAO_0000218,,
8361,1,Plasma clearance rate was determined for the compound in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621481,,BAO_0000218,,
8362,1,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621482,,BAO_0000218,,
8363,1,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621483,,BAO_0000218,,
8364,1,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621484,,BAO_0000218,,
8365,1,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621485,,BAO_0000218,948.0,
8366,1,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621486,,BAO_0000218,948.0,
8367,1,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621487,,BAO_0000218,160.0,
8368,1,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621488,,BAO_0000218,160.0,
8369,1,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621489,,BAO_0000218,160.0,
8370,1,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621490,,BAO_0000218,160.0,
8371,1,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621491,,BAO_0000218,160.0,
8372,1,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621492,,BAO_0000218,2113.0,
8373,1,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621493,,BAO_0000218,2113.0,
8374,1,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621494,,BAO_0000218,2113.0,
8375,1,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621495,,BAO_0000218,2113.0,
8376,1,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621496,,BAO_0000218,2113.0,
8377,1,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621497,,BAO_0000218,2107.0,
8378,1,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621498,,BAO_0000218,2107.0,
8379,1,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621499,,BAO_0000218,2107.0,
8380,1,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618634,,BAO_0000218,2107.0,
8381,1,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618635,,BAO_0000218,2107.0,
8382,1,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618636,,BAO_0000218,2048.0,
8383,1,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619737,,BAO_0000218,2048.0,
8384,1,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619738,,BAO_0000218,2048.0,
8385,1,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624329,,BAO_0000218,2048.0,
8386,1,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624330,,BAO_0000218,2048.0,
8387,1,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624331,,BAO_0000218,2385.0,
8388,1,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624332,,BAO_0000218,2385.0,
8389,1,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624333,,BAO_0000218,2385.0,
8390,1,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624334,,BAO_0000218,2385.0,
8391,1,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624335,,BAO_0000218,2385.0,
8392,1,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620016,,BAO_0000218,2106.0,
8393,1,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620169,,BAO_0000218,2106.0,
8394,1,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620170,,BAO_0000218,2106.0,
8395,1,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620171,,BAO_0000218,2106.0,
8396,1,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620172,,BAO_0000218,2106.0,
8397,1,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620173,,BAO_0000218,945.0,
8398,1,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620174,,BAO_0000218,945.0,
8399,1,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620175,,BAO_0000218,945.0,
8400,1,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620176,,BAO_0000218,945.0,
8401,1,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620177,,BAO_0000218,945.0,
8402,1,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620178,,BAO_0000218,2037.0,
8403,1,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620179,,BAO_0000218,2037.0,
8404,1,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620180,,BAO_0000218,,
8405,1,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620181,,BAO_0000218,,
8406,1,Volume of distribution of compound in rats after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620182,,BAO_0000218,,
8407,1,Volume of distribution in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620183,,BAO_0000218,,
8408,1,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620184,,BAO_0000218,,
8409,1,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620185,,BAO_0000218,,
8410,1,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620186,,BAO_0000218,,
8411,1,Volume of distribution was determined in Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620187,,BAO_0000218,,
8412,1,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620188,,BAO_0000218,,
8413,1,Volume of distribution was reported in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620189,,BAO_0000218,,
8414,1,Volumes of distribution in rat after peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620190,,BAO_0000218,,
8415,1,Volumes of distribution in rat after po administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620191,,BAO_0000218,,
8416,1,Volumes of distribution in rat after po administration; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620192,,BAO_0000218,,
8417,1,Pharmacokinetic property (Volume) in rat i.v.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620193,,BAO_0000218,,
8418,1,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620194,,BAO_0000218,,
8419,1,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876730,,BAO_0000218,,
8420,1,Volume distribution in rat after oral administration at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620195,,BAO_0000218,,
8421,1,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620196,,BAO_0000218,,
8422,1,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620197,,BAO_0000218,,
8423,1,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620198,,BAO_0000218,,
8424,1,Volume of distribution in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620199,,BAO_0000218,,
8425,1,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620200,,BAO_0000218,,
8426,1,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620201,,BAO_0000218,,
8427,1,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620202,,BAO_0000218,,
8428,1,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620203,,BAO_0000218,,
8429,1,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620204,,BAO_0000218,,
8430,1,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620205,,BAO_0000218,,
8431,1,Pharmacokinetic parameter (Vss) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624664,,BAO_0000218,,
8432,1,Pharmacokinetic property (Volume) in rat i.v.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624665,,BAO_0000218,,
8433,1,Pharmacokinetic property (Vss) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624666,,BAO_0000218,,
8434,1,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624667,,BAO_0000218,,
8435,1,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624668,,BAO_0000218,,
8436,1,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624669,,BAO_0000218,,
8437,1,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624670,,BAO_0000218,,
8438,1,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624671,,BAO_0000218,,
8439,1,Steady state volume distribution in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624672,,BAO_0000218,,
8440,1,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624673,,BAO_0000218,1969.0,
8441,1,Steady state volume of distribution determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624674,,BAO_0000218,,
8442,1,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624675,,BAO_0000218,,
8443,1,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621728,,BAO_0000218,,
8444,1,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621729,,BAO_0000218,,
8445,1,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621730,,BAO_0000218,,
8446,1,Volume distribution in rat after administration of 2 mg/kg iv,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621731,,BAO_0000218,,
8447,1,Volume distribution in rat after administration of 2 mg/kg iv,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621732,,BAO_0000218,,
8448,1,Volume in steady state distribution value was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621908,,BAO_0000218,,
8449,1,Volume in steady state distribution value was determined; ND denotes no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875347,,BAO_0000218,,
8450,1,Volume in steady state distribution value was determined; ND denotes not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621909,,BAO_0000218,,
8451,1,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621910,,BAO_0000218,,
8452,1,Volume of distribution at steady state was evaluated in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621911,,BAO_0000218,,
8453,1,Volume of distribution at steady state was observed after intravenous administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621912,,BAO_0000218,,
8454,1,Volume of distribution in steady state was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621913,,BAO_0000218,,
8455,1,Volume of distribution in steady state was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621914,,BAO_0000218,,
8456,1,Volume of distribution after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621915,,BAO_0000218,,
8457,1,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621916,,BAO_0000218,,
8458,1,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Mus musculus,1,50594,,N,Intermediate,,CHEMBL621917,,BAO_0000218,2107.0,
8459,1,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Mus musculus,1,50594,,N,Intermediate,,CHEMBL621918,,BAO_0000218,2107.0,
8460,1,Biodistribution of compound (oxidized form) in spleen tissue,Mus musculus,1,50594,,N,Intermediate,,CHEMBL621919,,BAO_0000218,2106.0,
8461,1,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",Mus musculus,1,50594,,N,Intermediate,,CHEMBL621920,,BAO_0000218,2106.0,
8462,1,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",Mus musculus,1,50594,,N,Intermediate,,CHEMBL621921,,BAO_0000218,2106.0,
8463,1,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622401,,BAO_0000218,2106.0,
8464,1,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",Mus musculus,1,50594,,N,Intermediate,,CHEMBL875348,,BAO_0000218,2106.0,
8465,1,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622402,,BAO_0000218,2106.0,
8466,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622403,,BAO_0000218,178.0,
8467,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622404,,BAO_0000218,178.0,
8468,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622405,,BAO_0000218,955.0,
8469,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622406,,BAO_0000218,955.0,
8470,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622407,,BAO_0000218,955.0,
8471,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622408,,BAO_0000218,948.0,
8472,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622409,,BAO_0000218,948.0,
8473,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622410,,BAO_0000218,948.0,
8474,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622411,,BAO_0000218,2113.0,
8475,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",Mus musculus,1,50594,,N,Intermediate,,CHEMBL627864,,BAO_0000218,2113.0,
8476,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,1,50594,,N,Intermediate,,CHEMBL627865,,BAO_0000218,2113.0,
8477,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627866,,BAO_0000218,2107.0,
8478,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,1,50594,,N,Intermediate,,CHEMBL627751,,BAO_0000218,2107.0,
8479,1,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627752,,BAO_0000218,2106.0,
8480,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",Mus musculus,1,50594,,N,Intermediate,,CHEMBL627753,,BAO_0000218,2106.0,
8481,1,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",Mus musculus,1,50594,,N,Intermediate,,CHEMBL627754,,BAO_0000218,2106.0,
8482,1,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627755,,BAO_0000218,,
8483,1,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627756,,BAO_0000218,955.0,
8484,1,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627757,,BAO_0000218,955.0,
8485,1,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627758,,BAO_0000218,955.0,
8486,1,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627759,,BAO_0000218,955.0,
8487,1,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627760,,BAO_0000218,955.0,
8488,1,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627761,,BAO_0000218,955.0,
8489,1,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL876811,,BAO_0000218,948.0,
8490,1,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627762,,BAO_0000218,948.0,
8491,1,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627763,,BAO_0000218,948.0,
8492,1,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627764,,BAO_0000218,948.0,
8493,1,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627765,,BAO_0000218,948.0,
8494,1,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627766,,BAO_0000218,948.0,
8495,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627767,,BAO_0000218,2113.0,
8496,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627768,,BAO_0000218,2113.0,
8497,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL628422,,BAO_0000218,2113.0,
8498,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL628423,,BAO_0000218,2113.0,
8499,1,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628424,,BAO_0000218,,
8500,1,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628425,,BAO_0000218,,
8501,1,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628426,,BAO_0000218,,
8502,1,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628427,,BAO_0000218,,
8503,1,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626938,,BAO_0000218,,
8504,1,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626939,,BAO_0000218,,
8505,1,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626940,,BAO_0000218,,
8506,1,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626941,,BAO_0000218,,
8507,1,Plasma clearance was reported in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626942,,BAO_0000218,,
8508,1,Plasma clearance after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876812,,BAO_0000218,,
8509,1,Plasma clearance of compound in rats was evaluated,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626943,,BAO_0000218,,
8510,1,Plasma clearance of compound in rats was evaluated; ND indicates not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626944,,BAO_0000218,,
8511,1,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626945,,BAO_0000218,,
8512,1,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626946,,BAO_0000218,,
8513,1,Plasma clearance rate in Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626856,,BAO_0000218,,
8514,1,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626857,,BAO_0000218,,
8515,1,The compound was evaluated for plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626858,,BAO_0000218,1969.0,
8516,1,Total plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627018,,BAO_0000218,1969.0,
8517,1,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625331,,BAO_0000218,178.0,
8518,1,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625332,,BAO_0000218,178.0,
8519,1,C max was determined at 10 mg/kg po dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877590,,BAO_0000218,,
8520,1,C max was determined at 3 mg/kg po dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625333,,BAO_0000218,,
8521,1,Cmax after repeated oral dose of compound at 1 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625334,,BAO_0000218,,
8522,1,Cmax after single intravenous bolus of 1 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625335,,BAO_0000218,,
8523,1,Cmax of compound at 5 mg/kg after po administration was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625336,,BAO_0000218,,
8524,1,Cmax 24 hr after 10 mg/kg oral administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625337,,BAO_0000218,,
8525,1,Cmax 24 hr after 2 mg/kg oral administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625338,,BAO_0000218,,
8526,1,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625339,,BAO_0000218,1969.0,
8527,1,Cmax in rat after administration of 2 mg/kg iv,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625340,,BAO_0000218,,
8528,1,Cmax in rat after administration of 2 mg/kg iv,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625341,,BAO_0000218,,
8529,1,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622687,,BAO_0000218,,
8530,1,Cmax wa determined in rat plasma at 30 mg/kg after po administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622688,,BAO_0000218,1969.0,
8531,1,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622689,,BAO_0000218,178.0,
8532,1,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620295,,BAO_0000218,178.0,
8533,1,Cmax after 10 mg/kg oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620296,,BAO_0000218,,
8534,1,Cmax after IV dosing at 0.5 mg/kg in rat; no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620297,,BAO_0000218,,
8535,1,Cmax after IV dosing at 1 mg/kg in rat; no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620298,,BAO_0000218,,
8536,1,Cmax after oral administration at 20 mpk in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620299,,BAO_0000218,,
8537,1,Cmax after oral administration at 20 mpk in rats; Not performed.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620300,,BAO_0000218,,
8538,1,Cmax after oral administration at 20 mpk in rats d; Not performed.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620301,,BAO_0000218,,
8539,1,Cmax after oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620302,,BAO_0000218,,
8540,1,Cmax after oral administration at a dose of 2 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620303,,BAO_0000218,,
8541,1,Cmax after oral administration at a dose of 4 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620304,,BAO_0000218,,
8542,1,Cmax in rats after 20 mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620305,,BAO_0000218,,
8543,1,Cmax after peroral administration in rats at 2.4 uM/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620306,,BAO_0000218,,
8544,1,Cmax at the dose of 2 mg/Kg administered perorally in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620307,,BAO_0000218,,
8545,1,Cmax at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620308,,BAO_0000218,,
8546,1,Cmax by administering at 20 mg/kg p.o. in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620309,,BAO_0000218,,
8547,1,Cmax in male rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620310,,BAO_0000218,,
8548,1,Cmax in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620311,,BAO_0000218,,
8549,1,Cmax in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620312,,BAO_0000218,,
8550,1,Cmax in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620313,,BAO_0000218,,
8551,1,Cmax in rat at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620314,,BAO_0000218,,
8552,1,Cmax in rat at the dose of 1 mg/kg i.v.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620315,,BAO_0000218,,
8553,1,Cmax in rat by po administration at a dose of 40 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620316,,BAO_0000218,,
8554,1,Cmax in rat p.o. at 20 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620317,,BAO_0000218,,
8555,1,Cmax in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620318,,BAO_0000218,,
8556,1,Cmax in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620319,,BAO_0000218,,
8557,1,Cmax was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620320,,BAO_0000218,,
8558,1,Cmax was measured in rats after peroral administration at 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620321,,BAO_0000218,,
8559,1,Cmax value after oral dose at a dose of 10 mg/kg in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620322,,BAO_0000218,,
8560,1,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620323,,BAO_0000218,,
8561,1,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620324,,BAO_0000218,1870.0,
8562,1,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620325,,BAO_0000218,1870.0,
8563,1,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620326,,BAO_0000218,10000000.0,
8564,1,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620327,,BAO_0000218,10000000.0,
8565,1,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620328,,BAO_0000218,,
8566,1,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620329,,BAO_0000218,,
8567,1,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620330,,BAO_0000218,1891.0,
8568,1,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875286,,BAO_0000218,1891.0,
8569,1,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620331,,BAO_0000218,,
8570,1,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620332,,BAO_0000218,,
8571,1,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620333,,BAO_0000218,2435.0,
8572,1,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620334,,BAO_0000218,2435.0,
8573,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621015,,BAO_0000218,178.0,
8574,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621016,,BAO_0000218,178.0,
8575,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621191,,BAO_0000218,178.0,
8576,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621192,,BAO_0000218,178.0,
8577,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621193,,BAO_0000218,178.0,
8578,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621194,,BAO_0000218,178.0,
8579,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624204,,BAO_0000218,178.0,
8580,1,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624205,,BAO_0000218,178.0,
8581,1,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624206,,BAO_0000218,178.0,
8582,1,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624207,,BAO_0000218,178.0,
8583,1,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624208,,BAO_0000218,178.0,
8584,1,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624209,,BAO_0000218,178.0,
8585,1,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624210,,BAO_0000218,178.0,
8586,1,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624211,,BAO_0000218,178.0,
8587,1,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624212,,BAO_0000218,178.0,
8588,1,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624213,,BAO_0000218,178.0,
8589,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876611,,BAO_0000218,178.0,
8590,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624214,,BAO_0000218,178.0,
8591,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624215,,BAO_0000218,178.0,
8592,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624216,,BAO_0000218,178.0,
8593,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624217,,BAO_0000218,178.0,
8594,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624218,,BAO_0000218,178.0,
8595,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624219,,BAO_0000218,178.0,
8596,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624220,,BAO_0000218,178.0,
8597,1,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624221,,BAO_0000218,178.0,
8598,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624222,,BAO_0000218,,
8599,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624223,,BAO_0000218,,
8600,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624224,,BAO_0000218,,
8601,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624225,,BAO_0000218,,
8602,1,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622420,,BAO_0000218,,
8603,1,Volume of steady state distribution after i.v. administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622421,,BAO_0000218,,
8604,1,Vss after intravenous administration (5.0 mg/kg) was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622422,,BAO_0000218,,
8605,1,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622423,,BAO_0000218,,
8606,1,Vss was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622424,,BAO_0000218,,
8607,1,Vss in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622425,,BAO_0000218,,
8608,1,Vss was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876612,,BAO_0000218,,
8609,1,volume of distribution at steady state was observed after intravenous administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622426,,BAO_0000218,,
8610,1,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622427,,BAO_0000218,,
8611,1,Pharmacokinetic (PK) parameter Vz in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622428,,BAO_0000218,,
8612,1,Volume distribution in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622429,,BAO_0000218,,
8613,1,Volume of distribution in rat; No data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622430,,BAO_0000218,,
8614,1,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622431,,BAO_0000218,,
8615,1,% absorption predicted from in vitro rat ileum transport studies,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622432,,BAO_0000218,2116.0,
8616,1,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622433,,BAO_0000218,,
8617,1,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622434,,BAO_0000218,,
8618,1,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622435,,BAO_0000218,,
8619,1,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618748,,BAO_0000218,,
8620,1,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618749,,BAO_0000218,,
8621,1,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618750,,BAO_0000218,,
8622,1,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618751,,BAO_0000218,,
8623,1,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618752,,BAO_0000218,,
8624,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618753,,BAO_0000218,,
8625,1,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618754,,BAO_0000218,1969.0,
8626,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618755,,BAO_0000218,,
8627,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618756,,BAO_0000218,,
8628,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618757,,BAO_0000218,,
8629,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618758,,BAO_0000218,,
8630,1,Oral bioavailability in rat (dose 30 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621088,,BAO_0000218,,
8631,1,Pharmacokinetic property (cLogP) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621089,,BAO_0000218,,
8632,1,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621090,,BAO_0000218,178.0,
8633,1,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621091,,BAO_0000218,178.0,
8634,1,Clearance in rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876731,,BAO_0000218,,
8635,1,Compound was evaluated for its clearance when administered intravenously in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621092,,BAO_0000218,,
8636,1,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621093,,BAO_0000218,,
8637,1,Blood: Brain distribution ratio is determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621094,,BAO_0000218,,
8638,1,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621095,,BAO_0000218,,
8639,1,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621096,,BAO_0000218,,
8640,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621097,,BAO_0000218,2113.0,
8641,1,Percent dose excreted in 0-48 hours administered ip to male rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621098,,BAO_0000218,,
8642,1,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621099,,BAO_0000218,2037.0,
8643,1,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621100,,BAO_0000218,2037.0,
8644,1,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621101,,BAO_0000218,2037.0,
8645,1,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621102,,BAO_0000218,2037.0,
8646,1,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876732,,BAO_0000218,2037.0,
8647,1,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621103,,BAO_0000218,,
8648,1,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621104,,BAO_0000218,,
8649,1,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621105,,BAO_0000218,,
8650,1,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621106,,BAO_0000218,,
8651,1,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621107,,BAO_0000218,,
8652,1,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621108,,BAO_0000218,,
8653,1,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621109,,BAO_0000218,,
8654,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL621110,,BAO_0000218,2113.0,
8655,1,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL621111,,BAO_0000218,2113.0,
8656,1,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL622541,,BAO_0000218,2107.0,
8657,1,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL622542,,BAO_0000218,2107.0,
8658,1,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL622543,,BAO_0000218,2107.0,
8659,1,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624412,,BAO_0000218,2107.0,
8660,1,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624413,,BAO_0000218,2107.0,
8661,1,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624414,,BAO_0000218,2107.0,
8662,1,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624415,,BAO_0000218,2048.0,
8663,1,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624416,,BAO_0000218,2048.0,
8664,1,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624417,,BAO_0000218,2048.0,
8665,1,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624418,,BAO_0000218,2048.0,
8666,1,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624419,,BAO_0000218,2048.0,
8667,1,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624420,,BAO_0000218,2048.0,
8668,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624421,,BAO_0000218,2385.0,
8669,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624422,,BAO_0000218,2385.0,
8670,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624423,,BAO_0000218,2385.0,
8671,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625123,,BAO_0000218,2385.0,
8672,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625124,,BAO_0000218,2385.0,
8673,1,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625125,,BAO_0000218,2385.0,
8674,1,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625126,,BAO_0000218,14.0,
8675,1,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626947,,BAO_0000218,14.0,
8676,1,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626948,,BAO_0000218,14.0,
8677,1,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626949,,BAO_0000218,14.0,
8678,1,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626950,,BAO_0000218,14.0,
8679,1,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626951,,BAO_0000218,14.0,
8680,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626952,,BAO_0000218,2106.0,
8681,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626953,,BAO_0000218,2106.0,
8682,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626954,,BAO_0000218,2106.0,
8683,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626955,,BAO_0000218,2106.0,
8684,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626956,,BAO_0000218,2106.0,
8685,1,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626957,,BAO_0000218,2106.0,
8686,1,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626958,,BAO_0000218,178.0,
8687,1,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626959,,BAO_0000218,178.0,
8688,1,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626960,,BAO_0000218,178.0,
8689,1,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626961,,BAO_0000218,178.0,
8690,1,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627589,,BAO_0000218,178.0,
8691,1,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627590,,BAO_0000218,178.0,
8692,1,Time taken for EC90 was determined when tested in mouse,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627591,,BAO_0000218,,
8693,1,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627592,,BAO_0000218,,
8694,1,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627593,,BAO_0000218,,
8695,1,Half life in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627594,,BAO_0000218,,
8696,1,Half life period in mouse after 10 mg/Kg dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL876813,,BAO_0000218,,
8697,1,Half life period in mouse after 10 mg/kg dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627595,,BAO_0000218,,
8698,1,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627596,,BAO_0000218,,
8699,1,Cmax value at 5 mg/kg po was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627597,,BAO_0000218,,
8700,1,Cmax value evaluated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627598,,BAO_0000218,,
8701,1,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627599,,BAO_0000218,955.0,
8702,1,Cmax value after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627600,,BAO_0000218,,
8703,1,Cmax value at 1 mg/kg po in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627601,,BAO_0000218,,
8704,1,Cmax value at 5 mg/kg po in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627776,,BAO_0000218,,
8705,1,Cmax value at a dose of 10 mg/kg in male SD rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627777,,BAO_0000218,,
8706,1,Cmax value at a dose of 100 mg/kg in male SD rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627778,,BAO_0000218,,
8707,1,Cmax value at a dose of 50 mg/kg in male SD rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627779,,BAO_0000218,,
8708,1,Cmax value in rats at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876814,,BAO_0000218,,
8709,1,Cmax value was evaluated in rats at a dose of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627780,,BAO_0000218,,
8710,1,Cmax value was determined after peroral administration of 20 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627781,,BAO_0000218,,
8711,1,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627782,,BAO_0000218,,
8712,1,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627783,,BAO_0000218,1969.0,
8713,1,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627784,,BAO_0000218,1969.0,
8714,1,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627785,,BAO_0000218,,
8715,1,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627786,,BAO_0000218,,
8716,1,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627787,,BAO_0000218,1969.0,
8717,1,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627788,,BAO_0000218,1969.0,
8718,1,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626579,,BAO_0000218,1969.0,
8719,1,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626580,,BAO_0000218,1969.0,
8720,1,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876815,,BAO_0000218,,
8721,1,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626581,,BAO_0000218,1969.0,
8722,1,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626582,,BAO_0000218,1969.0,
8723,1,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626583,,BAO_0000218,,
8724,1,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626205,,BAO_0000218,,
8725,1,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626206,,BAO_0000218,,
8726,1,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626207,,BAO_0000218,,
8727,1,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623882,,BAO_0000218,,
8728,1,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623883,,BAO_0000218,,
8729,1,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623884,,BAO_0000218,,
8730,1,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623885,,BAO_0000218,1969.0,
8731,1,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623886,,BAO_0000218,1969.0,
8732,1,Maximal concentration in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623887,,BAO_0000218,,
8733,1,Maximal concentration after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623888,,BAO_0000218,,
8734,1,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623889,,BAO_0000218,1969.0,
8735,1,Maximal plasma concentration in rat after oral administration at 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623890,,BAO_0000218,1969.0,
8736,1,Cmax in rat plasma after oral dose (50 mg/Kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623891,,BAO_0000218,1969.0,
8737,1,Maximal plasma concentration was determined.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623892,,BAO_0000218,1969.0,
8738,1,Maximal plasma drug concentration was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623893,,BAO_0000218,1969.0,
8739,1,Maximal concentration in rats after peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877616,,BAO_0000218,,
8740,1,Maximum concentration in rat after 2 mg/kg peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623894,,BAO_0000218,,
8741,1,Maximum concentration in rat plasma after 5 mg/kg oral gavage,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623895,,BAO_0000218,1969.0,
8742,1,Maximum concentration of compound in rat was evaluated.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623896,,BAO_0000218,,
8743,1,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623897,,BAO_0000218,,
8744,1,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623898,,BAO_0000218,,
8745,1,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623899,,BAO_0000218,,
8746,1,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623900,,BAO_0000218,,
8747,1,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623901,,BAO_0000218,,
8748,1,Maximum concentration was evaluated in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623902,,BAO_0000218,,
8749,1,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623903,,BAO_0000218,1359.0,
8750,1,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623904,,BAO_0000218,1969.0,
8751,1,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877617,,BAO_0000218,1969.0,
8752,1,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623905,,BAO_0000218,,
8753,1,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623906,,BAO_0000218,,
8754,1,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623907,,BAO_0000218,1969.0,
8755,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623908,,BAO_0000218,,
8756,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623909,,BAO_0000218,,
8757,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623910,,BAO_0000218,,
8758,1,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623911,,BAO_0000218,,
8759,1,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623912,,BAO_0000218,,
8760,1,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624616,,BAO_0000218,,
8761,1,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624617,,BAO_0000218,,
8762,1,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624618,,BAO_0000218,,
8763,1,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624619,,BAO_0000218,,
8764,1,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624794,,BAO_0000218,,
8765,1,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624795,,BAO_0000218,,
8766,1,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623921,,BAO_0000218,,
8767,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623922,,BAO_0000218,,
8768,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623923,,BAO_0000218,,
8769,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623924,,BAO_0000218,,
8770,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623925,,BAO_0000218,,
8771,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623926,,BAO_0000218,,
8772,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623927,,BAO_0000218,,
8773,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623928,,BAO_0000218,,
8774,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623929,,BAO_0000218,,
8775,1,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623930,,BAO_0000218,,
8776,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623931,,BAO_0000218,955.0,
8777,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622165,,BAO_0000218,955.0,
8778,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621249,,BAO_0000218,955.0,
8779,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621250,,BAO_0000218,955.0,
8780,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621448,,BAO_0000218,955.0,
8781,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621449,,BAO_0000218,955.0,
8782,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621450,,BAO_0000218,955.0,
8783,1,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621451,,BAO_0000218,955.0,
8784,1,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621452,,BAO_0000218,955.0,
8785,1,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621453,,BAO_0000218,955.0,
8786,1,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621454,,BAO_0000218,955.0,
8787,1,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621455,,BAO_0000218,955.0,
8788,1,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621456,,BAO_0000218,955.0,
8789,1,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625145,,BAO_0000218,955.0,
8790,1,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875847,,BAO_0000218,955.0,
8791,1,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625146,,BAO_0000218,955.0,
8792,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625147,,BAO_0000218,955.0,
8793,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625148,,BAO_0000218,955.0,
8794,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625149,,BAO_0000218,955.0,
8795,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625150,,BAO_0000218,955.0,
8796,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625151,,BAO_0000218,955.0,
8797,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625152,,BAO_0000218,955.0,
8798,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625153,,BAO_0000218,955.0,
8799,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625154,,BAO_0000218,955.0,
8800,1,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625155,,BAO_0000218,955.0,
8801,1,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625156,,BAO_0000218,,
8802,1,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624354,,BAO_0000218,,
8803,1,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624355,,BAO_0000218,10000000.0,
8804,1,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624356,,BAO_0000218,10000000.0,
8805,1,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624357,,BAO_0000218,10000000.0,
8806,1,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624358,,BAO_0000218,10000000.0,
8807,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624359,,BAO_0000218,2435.0,
8808,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624360,,BAO_0000218,2435.0,
8809,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624361,,BAO_0000218,2435.0,
8810,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624362,,BAO_0000218,2435.0,
8811,1,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624363,,BAO_0000218,2435.0,
8812,1,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624364,,BAO_0000218,178.0,
8813,1,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624365,,BAO_0000218,178.0,
8814,1,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624366,,BAO_0000218,178.0,
8815,1,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624367,,BAO_0000218,178.0,
8816,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624368,,BAO_0000218,955.0,
8817,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624369,,BAO_0000218,955.0,
8818,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624370,,BAO_0000218,955.0,
8819,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625069,,BAO_0000218,955.0,
8820,1,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625070,,BAO_0000218,955.0,
8821,1,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626051,,BAO_0000218,948.0,
8822,1,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626052,,BAO_0000218,948.0,
8823,1,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626053,,BAO_0000218,948.0,
8824,1,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626054,,BAO_0000218,948.0,
8825,1,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626055,,BAO_0000218,948.0,
8826,1,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626056,,BAO_0000218,2113.0,
8827,1,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626057,,BAO_0000218,2113.0,
8828,1,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625193,,BAO_0000218,2113.0,
8829,1,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625194,,BAO_0000218,2113.0,
8830,1,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625195,,BAO_0000218,2107.0,
8831,1,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625196,,BAO_0000218,2107.0,
8832,1,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625197,,BAO_0000218,2107.0,
8833,1,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625198,,BAO_0000218,2107.0,
8834,1,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627929,,BAO_0000218,2107.0,
8835,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627074,,BAO_0000218,2048.0,
8836,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627075,,BAO_0000218,2048.0,
8837,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627076,,BAO_0000218,2048.0,
8838,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627077,,BAO_0000218,2048.0,
8839,1,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627078,,BAO_0000218,2048.0,
8840,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627079,,BAO_0000218,2385.0,
8841,1,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL873824,,BAO_0000218,,
8842,1,Half life in mouse plasma was determined at dose 25 mg/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627080,,BAO_0000218,1969.0,
8843,1,Half life was determined,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627081,,BAO_0000218,,
8844,1,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627082,,BAO_0000218,,
8845,1,Half-life in male mice after 1 mg/kg intravenous dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627083,,BAO_0000218,,
8847,1,Half life in mice plasma,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627085,,BAO_0000218,1969.0,
8848,1,Half life in mouse,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627086,,BAO_0000218,,
8849,1,Half life in mouse plasma at dose 25 mg/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627087,,BAO_0000218,1969.0,
8850,1,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627088,,BAO_0000218,,
8851,1,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627089,,BAO_0000218,,
8852,1,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627090,,BAO_0000218,,
8853,1,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627091,,BAO_0000218,,
8854,1,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",Mus musculus,1,50594,,N,Intermediate,,CHEMBL627092,,BAO_0000218,,
8855,1,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",Mus musculus,1,50594,,N,Intermediate,,CHEMBL876785,,BAO_0000218,,
8856,1,Half-life by iv administration in mouse,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627093,,BAO_0000218,,
8857,1,Half-life by oral administration in mouse,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627094,,BAO_0000218,,
8858,1,Half-life in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627095,,BAO_0000218,,
8859,1,Half-life using mouse brain homogenate,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627096,,BAO_0000218,955.0,
8860,1,Half-life was measured in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627097,,BAO_0000218,,
8861,1,Half-life was measured in mouse after an iv dose of 1 mg/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627098,,BAO_0000218,,
8862,1,Half-life period was determined in mouse blood,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627099,,BAO_0000218,178.0,
8863,1,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",Mus musculus,1,50594,,N,Intermediate,,CHEMBL627100,,BAO_0000218,955.0,
8864,1,Plasma half life in mouse,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627101,,BAO_0000218,1969.0,
8865,1,Stability of the peptide in the presence of mouse serum,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627102,,BAO_0000218,,
8866,1,Terminal half life of compound was determined in mouse,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627103,,BAO_0000218,,
8867,1,Terminal half life was evaluated in mice after intravenous administration,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627104,,BAO_0000218,,
8868,1,Terminal half life was evaluated in mice after oral administration,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627105,,BAO_0000218,,
8869,1,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL876786,,BAO_0000218,,
8870,1,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL873825,,BAO_0000218,,
8871,1,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627106,,BAO_0000218,,
8872,1,half life period is evaluated by administering intravenously at 25 mg/kg in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626336,,BAO_0000218,,
8873,1,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",Mus musculus,1,50594,,N,Intermediate,,CHEMBL877462,,BAO_0000218,,
8874,1,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626337,,BAO_0000218,,
8875,1,Half life after intraperitoneal administration of 100 mg/kg in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626338,,BAO_0000218,,
8876,1,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626339,,BAO_0000218,,
8877,1,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626340,,BAO_0000218,,
8878,1,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625377,,BAO_0000218,,
8879,1,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625378,,BAO_0000218,,
8880,1,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625379,,BAO_0000218,,
8881,1,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),Sus scrofa,0,22224,Microsomes,U,Autocuration,,CHEMBL625380,,BAO_0000251,,
8882,1,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),Sus scrofa,0,22224,Microsomes,U,Autocuration,,CHEMBL625381,,BAO_0000251,,
8883,1,Stability to porcine renal DHP-I,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL625382,,BAO_0000019,,
8884,1,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL873828,,BAO_0000218,,
8885,1,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL625383,,BAO_0000218,,
8886,1,Half-life of the parent prodrug in porcine esterase solution,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL625384,,BAO_0000019,,
8887,1,"First order rate constant, k was determined in in pig liver Esterase",Sus scrofa,0,22224,,U,Autocuration,,CHEMBL625385,,BAO_0000019,,
8888,1,Half life of the in pig liver Esterase,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL625386,,BAO_0000221,2107.0,
8889,1,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL623571,,BAO_0000221,2107.0,
8890,1,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL623572,,BAO_0000221,2107.0,
8891,1,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL623573,,BAO_0000221,2107.0,
8892,1,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL623574,,BAO_0000221,2107.0,
8893,1,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL623575,,BAO_0000221,2107.0,
8894,1,Half-life in the presence of pig liver esterase(PLE) was evaluated.,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL623749,,BAO_0000221,2107.0,
8895,1,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL623750,,BAO_0000221,2107.0,
8896,1,Half-life in vitro in pig liver,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL623751,,BAO_0000221,2107.0,
8897,1,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,Sus scrofa,0,22224,,U,Autocuration,,CHEMBL623752,,BAO_0000221,2107.0,
8898,1,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623753,,BAO_0000218,1969.0,
8899,1,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623754,,BAO_0000218,1969.0,
8900,1,Maximum concentration in rat plasma was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623755,,BAO_0000218,1969.0,
8901,1,Maximum concentration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623756,,BAO_0000218,,
8902,1,Maximum concentration in rats at 1-2 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623757,,BAO_0000218,,
8903,1,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623758,,BAO_0000218,,
8904,1,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623759,,BAO_0000218,955.0,
8905,1,Maximum concentration at the dose of 2 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623760,,BAO_0000218,,
8906,1,Maximum concentration was evaluated in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623761,,BAO_0000218,,
8907,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623762,,BAO_0000218,1969.0,
8908,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877594,,BAO_0000218,1969.0,
8909,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623763,,BAO_0000218,1969.0,
8910,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623764,,BAO_0000218,1969.0,
8911,1,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623765,,BAO_0000218,1969.0,
8912,1,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623766,,BAO_0000218,178.0,
8913,1,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623767,,BAO_0000218,178.0,
8914,1,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623768,,BAO_0000218,178.0,
8915,1,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623769,,BAO_0000218,1969.0,
8916,1,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623770,,BAO_0000218,1969.0,
8917,1,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623771,,BAO_0000218,1969.0,
8918,1,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623772,,BAO_0000218,1969.0,
8919,1,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623773,,BAO_0000218,1969.0,
8920,1,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623774,,BAO_0000218,1969.0,
8921,1,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623775,,BAO_0000218,1969.0,
8922,1,Cmax in rat (PO dose),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623776,,BAO_0000218,,
8923,1,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622191,,BAO_0000218,1969.0,
8924,1,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622192,,BAO_0000218,1969.0,
8925,1,Maximum plasma concentration determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622193,,BAO_0000218,1969.0,
8926,1,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622194,,BAO_0000218,1969.0,
8927,1,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622195,,BAO_0000218,1969.0,
8928,1,Maximum plasma concentration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622196,,BAO_0000218,1969.0,
8929,1,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622197,,BAO_0000218,1969.0,
8930,1,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622198,,BAO_0000218,1969.0,
8931,1,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622199,,BAO_0000218,1969.0,
8932,1,Maximum plasma concentration of compound was measured in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622200,,BAO_0000218,1969.0,
8933,1,Maximum plasma concentration after 20 mg/kg oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622201,,BAO_0000218,1969.0,
8934,1,Maximum plasma concentration after oral administration to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623990,,BAO_0000218,1969.0,
8935,1,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623991,,BAO_0000218,1969.0,
8936,1,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623992,,BAO_0000218,1969.0,
8937,1,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623993,,BAO_0000218,1969.0,
8938,1,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623994,,BAO_0000218,1969.0,
8939,1,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623995,,BAO_0000218,1969.0,
8940,1,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623996,,BAO_0000218,1969.0,
8941,1,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623997,,BAO_0000218,1969.0,
8942,1,Maximum plasma concentration dosed orally in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623998,,BAO_0000218,1969.0,
8943,1,Maximum plasma concentration dosed orally in rats after 6 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623999,,BAO_0000218,1969.0,
8944,1,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624000,,BAO_0000218,1969.0,
8945,1,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624001,,BAO_0000218,1969.0,
8946,1,Maximum plasma concentration in rat after po administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624002,,BAO_0000218,1969.0,
8947,1,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624003,,BAO_0000218,1969.0,
8948,1,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624004,,BAO_0000218,1969.0,
8949,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624005,,BAO_0000218,948.0,
8950,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624006,,BAO_0000218,948.0,
8951,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624007,,BAO_0000218,948.0,
8952,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624008,,BAO_0000218,948.0,
8953,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624009,,BAO_0000218,948.0,
8954,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874387,,BAO_0000218,948.0,
8955,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624010,,BAO_0000218,948.0,
8956,1,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624011,,BAO_0000218,948.0,
8957,1,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624012,,BAO_0000218,948.0,
8958,1,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624013,,BAO_0000218,948.0,
8959,1,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624736,,BAO_0000218,948.0,
8960,1,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624737,,BAO_0000218,948.0,
8961,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624738,,BAO_0000218,948.0,
8962,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624739,,BAO_0000218,948.0,
8963,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624740,,BAO_0000218,948.0,
8964,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624896,,BAO_0000218,948.0,
8965,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624897,,BAO_0000218,948.0,
8966,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624108,,BAO_0000218,948.0,
8967,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624109,,BAO_0000218,948.0,
8968,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624110,,BAO_0000218,948.0,
8969,1,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624111,,BAO_0000218,948.0,
8970,1,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624112,,BAO_0000218,948.0,
8971,1,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624113,,BAO_0000218,948.0,
8972,1,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619709,,BAO_0000218,948.0,
8973,1,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619710,,BAO_0000218,948.0,
8974,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619711,,BAO_0000218,2113.0,
8975,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619712,,BAO_0000218,2113.0,
8976,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619713,,BAO_0000218,2113.0,
8977,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619714,,BAO_0000218,2113.0,
8978,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619715,,BAO_0000218,2113.0,
8979,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619716,,BAO_0000218,2113.0,
8980,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619717,,BAO_0000218,2113.0,
8981,1,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619718,,BAO_0000218,2113.0,
8982,1,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619719,,BAO_0000218,2113.0,
8983,1,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875329,,BAO_0000218,2113.0,
8984,1,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619720,,BAO_0000218,2113.0,
8985,1,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619721,,BAO_0000218,2113.0,
8986,1,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619722,,BAO_0000218,2113.0,
8987,1,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619723,,BAO_0000218,2113.0,
8988,1,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619724,,BAO_0000218,2113.0,
8989,1,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619725,,BAO_0000218,2113.0,
8990,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619726,,BAO_0000218,2113.0,
8991,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619727,,BAO_0000218,2113.0,
8992,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619728,,BAO_0000218,2113.0,
8993,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619729,,BAO_0000218,2113.0,
8994,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619730,,BAO_0000218,2385.0,
8995,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619731,,BAO_0000218,2385.0,
8996,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619732,,BAO_0000218,2385.0,
8997,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619733,,BAO_0000218,2385.0,
8998,1,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619734,,BAO_0000218,2385.0,
8999,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619735,,BAO_0000218,14.0,
9000,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875330,,BAO_0000218,14.0,
9001,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628465,,BAO_0000218,14.0,
9002,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628466,,BAO_0000218,14.0,
9003,1,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628467,,BAO_0000218,14.0,
9004,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628468,,BAO_0000218,2106.0,
9005,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628469,,BAO_0000218,2106.0,
9006,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628470,,BAO_0000218,2106.0,
9007,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628471,,BAO_0000218,2106.0,
9008,1,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628472,,BAO_0000218,2106.0,
9009,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625191,,BAO_0000218,2046.0,
9010,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625192,,BAO_0000218,2046.0,
9011,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875337,,BAO_0000218,2046.0,
9012,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626341,,BAO_0000218,2046.0,
9013,1,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626342,,BAO_0000218,2046.0,
9014,1,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621943,,BAO_0000218,2107.0,
9015,1,Half life in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621944,,BAO_0000218,,
9016,1,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621945,,BAO_0000218,,
9017,1,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621946,,BAO_0000218,,
9018,1,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621947,,BAO_0000218,,
9019,1,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621948,,BAO_0000218,,
9020,1,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621949,,BAO_0000218,,
9021,1,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621950,,BAO_0000218,,
9022,1,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621951,,BAO_0000218,,
9023,1,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621952,,BAO_0000218,178.0,
9024,1,Stability (%) in rat liver microsomes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621953,,BAO_0000218,2107.0,
9025,1,Area under curve was calculated after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621954,,BAO_0000218,,
9026,1,Area under the curve was calculated after iv administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621955,,BAO_0000218,,
9027,1,Area under the curve was calculated in rat after peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621956,,BAO_0000218,,
9028,1,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621957,,BAO_0000218,,
9029,1,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621958,,BAO_0000218,,
9030,1,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621959,,BAO_0000218,,
9031,1,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621960,,BAO_0000218,,
9032,1,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621961,,BAO_0000218,,
9033,1,p value of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621962,,BAO_0000218,,
9034,1,p value of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876787,,BAO_0000218,,
9035,1,p value of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621963,,BAO_0000218,,
9036,1,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622637,,BAO_0000218,945.0,
9037,1,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622638,,BAO_0000218,945.0,
9038,1,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626561,,BAO_0000218,945.0,
9039,1,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626562,,BAO_0000019,,
9040,1,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626563,,BAO_0000218,,
9041,1,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626564,,BAO_0000218,,
9042,1,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626565,,BAO_0000218,,
9043,1,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626566,,BAO_0000218,,
9044,1,Clearance rate in rabbits,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626567,,BAO_0000218,,
9045,1,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626568,,BAO_0000218,,
9046,1,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626569,,BAO_0000218,,
9047,1,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626570,,BAO_0000218,,
9048,1,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626571,,BAO_0000218,,
9049,1,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626572,,BAO_0000218,,
9050,1,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626573,,BAO_0000218,1969.0,
9051,1,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,Oryctolagus cuniculus,0,22224,Microsomes,U,Autocuration,,CHEMBL626574,,BAO_0000251,2107.0,
9052,1,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,Oryctolagus cuniculus,0,22224,Microsomes,U,Autocuration,,CHEMBL626575,,BAO_0000251,2107.0,
9053,1,Dose at which bioavailability of intravenously administered compound was tested in rabbit,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626576,,BAO_0000218,,
9054,1,Dose at which bioavailability of perorally administered compound was tested in rabbit,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626577,,BAO_0000218,,
9055,1,The compound was tested for its bioavailability in rabbit (by oral dosage).,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL626578,,BAO_0000218,,
9056,1,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL625263,,BAO_0000218,,
9057,1,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL625264,,BAO_0000218,,
9058,1,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL625265,,BAO_0000218,,
9059,1,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),Oryctolagus cuniculus,0,22224,Microsomes,U,Autocuration,,CHEMBL625266,,BAO_0000251,,
9060,1,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),Oryctolagus cuniculus,0,22224,Microsomes,U,Autocuration,,CHEMBL876796,,BAO_0000251,,
9061,1,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL625267,,BAO_0000218,,
9062,1,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL625268,,BAO_0000218,1969.0,
9063,1,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL625269,,BAO_0000218,1969.0,
9064,1,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL624689,,BAO_0000218,1969.0,
9065,1,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL624690,,BAO_0000218,,
9066,1,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL624691,,BAO_0000218,1088.0,
9067,1,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL624692,,BAO_0000218,1088.0,
9068,1,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL624693,,BAO_0000218,,
9069,1,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL624694,,BAO_0000218,,
9070,1,In vitro Biological half-life in crude homogenate of rabbit renal cortex,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL877596,,BAO_0000221,,
9071,1,Time within which only 10% of the drug was degraded,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL624695,,BAO_0000019,,
9072,1,Half life period in rabbit liver homogenate,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL624696,,BAO_0000221,2107.0,
9073,1,Half life value in rabbits,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL624697,,BAO_0000019,,
9074,1,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL624698,,BAO_0000218,178.0,
9075,1,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL624699,,BAO_0000218,178.0,
9076,1,Half-life period in rabbits following intravenous administration at 2 mg/kg,Oryctolagus cuniculus,0,22224,,U,Autocuration,,CHEMBL624700,,BAO_0000218,,
9077,1,AUC 0-8 hr value in rats at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622903,,BAO_0000218,1969.0,
9078,1,AUC after administration at 2000 mg/kg/day in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622904,,BAO_0000218,1969.0,
9079,1,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622905,,BAO_0000218,1969.0,
9080,1,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622906,,BAO_0000218,1969.0,
9081,1,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622907,,BAO_0000218,1969.0,
9082,1,AUC in rat after oral administration at 10.5 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622908,,BAO_0000218,1969.0,
9083,1,AUC in rat after oral administration at 11.2 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622909,,BAO_0000218,1969.0,
9084,1,AUC in rat after oral administration at 9.7 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622910,,BAO_0000218,1969.0,
9085,1,AUC in rat brain after oral administration at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622911,,BAO_0000218,955.0,
9086,1,AUC in rat p.o.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622912,,BAO_0000218,1969.0,
9087,1,AUC in rat p.o. at 20 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622913,,BAO_0000218,1969.0,
9088,1,AUC in rat plasma after oral administration at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622914,,BAO_0000218,1969.0,
9089,1,AUC in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622915,,BAO_0000218,1969.0,
9090,1,AUC value after IV dose at a dose of 5 mg/kg in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622916,,BAO_0000218,1969.0,
9091,1,AUC value after oral dose at a dose of 10 mg/kg in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622917,,BAO_0000218,1969.0,
9092,1,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622918,,BAO_0000218,1969.0,
9093,1,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622919,,BAO_0000218,1969.0,
9094,1,Maximum plasma concentration was evaluated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622920,,BAO_0000218,1969.0,
9095,1,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622921,,BAO_0000218,1969.0,
9096,1,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622922,,BAO_0000218,1969.0,
9097,1,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622923,,BAO_0000218,1969.0,
9098,1,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877604,,BAO_0000218,1969.0,
9099,1,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622924,,BAO_0000218,1969.0,
9100,1,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622925,,BAO_0000218,1969.0,
9101,1,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622926,,BAO_0000218,1969.0,
9102,1,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623625,,BAO_0000218,1969.0,
9103,1,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL623626,,BAO_0000218,1969.0,
9104,1,Maximum plasma drug concentration was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623627,,BAO_0000218,1969.0,
9105,1,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623628,,BAO_0000218,,
9106,1,Mean peak plasma concentration was observed after intravenous administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623629,,BAO_0000218,1969.0,
9107,1,Mean peak plasma concentration was observed after oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623630,,BAO_0000218,1969.0,
9108,1,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623804,,BAO_0000218,,
9109,1,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623805,,BAO_0000218,,
9110,1,Peak oral plasma concentration was determined in rats by oral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623806,,BAO_0000218,1969.0,
9111,1,Peak plasma concentration (Cmax) was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623807,,BAO_0000218,1969.0,
9112,1,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623808,,BAO_0000218,1969.0,
9113,1,Peak plasma concentration (Cmax) in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623809,,BAO_0000218,1969.0,
9114,1,Peak plasma concentration at 1 mg/kg peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623810,,BAO_0000218,1969.0,
9115,1,Peak plasma concentration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623811,,BAO_0000218,1969.0,
9116,1,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623812,,BAO_0000218,1969.0,
9117,1,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877605,,BAO_0000218,,
9118,1,Pharmacokinetic property (Cmax) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623813,,BAO_0000218,,
9119,1,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623814,,BAO_0000218,,
9120,1,Cmax in rat after 3mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623815,,BAO_0000218,,
9121,1,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623816,,BAO_0000218,,
9122,1,Cmax in rats after 20 mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623145,,BAO_0000218,,
9123,1,Cmax in rat plasma after 30mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623146,,BAO_0000218,1969.0,
9124,1,Plasma concentration after oral administration of 100 mg/kg to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623147,,BAO_0000218,1969.0,
9125,1,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623042,,BAO_0000218,955.0,
9126,1,Tested for the Cmax in rat at 10 mg/kg per orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623043,,BAO_0000218,,
9127,1,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623044,,BAO_0000218,,
9128,1,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623045,,BAO_0000218,,
9129,1,Bioavailability as oral Cmax in rats at 30 mins,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623046,,BAO_0000218,,
9130,1,Bioavailability as oral Cmax in rats at 6hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623226,,BAO_0000218,,
9131,1,The maximum concentration of compound was measured at the dose of 100 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623227,,BAO_0000218,,
9132,1,The maximum concentration of compound was measured at the dose of 300 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623228,,BAO_0000218,,
9133,1,The maximum concentration of compound was measured at the dose of 30 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623229,,BAO_0000218,,
9134,1,The maximum plasma levels for the compounds were determined by LC-MS.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623230,,BAO_0000218,1969.0,
9135,1,mean peak plasma concentration was observed after intravenous administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623231,,BAO_0000218,1969.0,
9136,1,mean peak plasma concentration was observed after oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623232,,BAO_0000218,1969.0,
9137,1,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623233,,BAO_0000218,,
9138,1,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623234,,BAO_0000218,,
9139,1,Concentration in plasma (portal) following oral dose in rats at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623235,,BAO_0000218,,
9140,1,Concentration in plasma (portal) following oral dose in rats at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623236,,BAO_0000218,,
9141,1,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623237,,BAO_0000218,,
9142,1,Concentration in plasma (systemic) following oral dose in rats at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623238,,BAO_0000218,,
9143,1,Concentration in plasma (systemic) following oral dose in rats at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623239,,BAO_0000218,,
9144,1,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,Rattus norvegicus,0,22224,,U,Intermediate,,CHEMBL623240,,BAO_0000218,1969.0,
9145,1,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623241,,BAO_0000218,1898.0,
9146,1,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623242,,BAO_0000218,1898.0,
9147,1,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874394,,BAO_0000218,,
9148,1,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623243,,BAO_0000218,,
9149,1,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623244,,BAO_0000218,,
9150,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623245,,BAO_0000218,2113.0,
9151,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623246,,BAO_0000218,2113.0,
9152,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623247,,BAO_0000218,2113.0,
9153,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623248,,BAO_0000218,2113.0,
9154,1,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623249,,BAO_0000218,2113.0,
9155,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625072,,BAO_0000218,2107.0,
9156,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625073,,BAO_0000218,2107.0,
9157,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625074,,BAO_0000218,2107.0,
9158,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625075,,BAO_0000218,2107.0,
9159,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625076,,BAO_0000218,2107.0,
9160,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625077,,BAO_0000218,2107.0,
9161,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625078,,BAO_0000218,2107.0,
9162,1,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874395,,BAO_0000218,2107.0,
9163,1,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625079,,BAO_0000218,2107.0,
9164,1,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625080,,BAO_0000218,2107.0,
9165,1,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625081,,BAO_0000218,2107.0,
9166,1,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625082,,BAO_0000218,2107.0,
9167,1,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625083,,BAO_0000218,2107.0,
9168,1,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625084,,BAO_0000218,2107.0,
9169,1,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625085,,BAO_0000218,2107.0,
9170,1,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625086,,BAO_0000218,2107.0,
9171,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625087,,BAO_0000218,2107.0,
9172,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625088,,BAO_0000218,2107.0,
9173,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622205,,BAO_0000218,2107.0,
9174,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622206,,BAO_0000218,2107.0,
9175,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622207,,BAO_0000218,2107.0,
9176,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622366,,BAO_0000218,2107.0,
9177,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622367,,BAO_0000218,2107.0,
9178,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875331,,BAO_0000218,2107.0,
9179,1,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622368,,BAO_0000218,2107.0,
9180,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622369,,BAO_0000218,2048.0,
9181,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622370,,BAO_0000218,2048.0,
9182,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622371,,BAO_0000218,2048.0,
9183,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622372,,BAO_0000218,2048.0,
9184,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622373,,BAO_0000218,2048.0,
9185,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622374,,BAO_0000218,2048.0,
9186,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622375,,BAO_0000218,2048.0,
9187,1,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622376,,BAO_0000218,2048.0,
9188,1,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622377,,BAO_0000218,2048.0,
9189,1,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622378,,BAO_0000218,2048.0,
9190,1,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622379,,BAO_0000218,2048.0,
9191,1,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622380,,BAO_0000218,2048.0,
9192,1,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622381,,BAO_0000218,2048.0,
9193,1,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622382,,BAO_0000218,2048.0,
9194,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622383,,BAO_0000218,2048.0,
9195,1,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875332,,BAO_0000218,945.0,
9196,1,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622384,,BAO_0000218,945.0,
9197,1,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622385,,BAO_0000218,945.0,
9198,1,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622386,,BAO_0000218,945.0,
9199,1,The compound was tested for the plasma binding in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622387,,BAO_0000218,,
9200,1,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622388,,BAO_0000218,,
9201,1,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622389,,BAO_0000218,,
9202,1,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622390,,BAO_0000218,,
9203,1,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622391,,BAO_0000218,,
9204,1,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622392,,BAO_0000218,,
9205,1,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622393,,BAO_0000218,,
9206,1,Plasma level at 2 hr after administration of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622394,,BAO_0000218,,
9207,1,plasma level at 2 hr after administration of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622395,,BAO_0000218,,
9208,1,Stability in rat serum measured as % recovery at 1 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622396,,BAO_0000218,1977.0,
9209,1,Stability in rat serum measured as % recovery at 10 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624894,,BAO_0000218,1977.0,
9210,1,Stability in rat serum measured as % recovery at 10 mins,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624895,,BAO_0000218,1977.0,
9211,1,Stability in rat serum measured as % recovery at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624058,,BAO_0000218,1977.0,
9212,1,Stability in rat serum measured as % recovery at 3 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624059,,BAO_0000218,1977.0,
9213,1,Stability in rat serum measured as % recovery at 3 mins,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624060,,BAO_0000218,1977.0,
9214,1,Stability in rat serum measured as % recovery at 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624061,,BAO_0000218,1977.0,
9215,1,Stability in rat serum measured as % recovery at 5 mins,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624062,,BAO_0000218,1977.0,
9216,1,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624063,,BAO_0000218,,
9217,1,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624064,,BAO_0000218,,
9218,1,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624065,,BAO_0000218,1969.0,
9219,1,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624066,,BAO_0000218,1969.0,
9220,1,Half life tested in mature male rat at a dose of 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877490,,BAO_0000218,,
9221,1,Half life after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874442,,BAO_0000218,,
9222,1,Half life period after administration (30 mg/kg) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626890,,BAO_0000218,,
9223,1,Half life period in rat after 5 mg/Kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626891,,BAO_0000218,,
9224,1,Half life period in rat after 5 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626892,,BAO_0000218,,
9225,1,Half life period was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626893,,BAO_0000218,,
9226,1,Half life period was evaluated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626894,,BAO_0000218,,
9227,1,Half life period was evaluated in rat; 0.5-1.0,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626895,,BAO_0000218,,
9228,1,Half life period was evaluated in rat; 5.9-7.5,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626896,,BAO_0000218,,
9229,1,Half-life in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626897,,BAO_0000218,1969.0,
9230,1,Half-life time in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626898,,BAO_0000218,,
9231,1,Terminal half-life after iv administration to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626899,,BAO_0000218,,
9232,1,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626900,,BAO_0000218,,
9233,1,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626901,,BAO_0000218,,
9234,1,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626902,,BAO_0000218,,
9235,1,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626903,,BAO_0000218,,
9236,1,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874443,,BAO_0000218,,
9237,1,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626904,,BAO_0000218,,
9238,1,Half life in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626905,,BAO_0000218,,
9239,1,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873830,,BAO_0000218,1969.0,
9240,1,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626906,,BAO_0000218,,
9241,1,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631076,,BAO_0000218,1969.0,
9242,1,Biological half-life was measured in plasma of rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631077,,BAO_0000218,1969.0,
9243,1,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631078,,BAO_0000218,,
9244,1,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631079,,BAO_0000218,,
9245,1,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631080,,BAO_0000218,,
9246,1,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631081,,BAO_0000218,,
9247,1,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631239,,BAO_0000218,,
9248,1,Compound was evaluated for plasma half life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631240,,BAO_0000218,1969.0,
9249,1,AUC value at a dose of 5 mg/kg (p.o.) in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631241,,BAO_0000218,1969.0,
9250,1,AUC value after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631242,,BAO_0000218,1969.0,
9251,1,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631243,,BAO_0000218,1969.0,
9252,1,AUC0-96 after administration at 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874444,,BAO_0000218,1969.0,
9253,1,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631244,,BAO_0000218,1969.0,
9254,1,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631245,,BAO_0000218,,
9255,1,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627162,,BAO_0000218,,
9256,1,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627163,,BAO_0000218,,
9257,1,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627164,,BAO_0000218,,
9258,1,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627165,,BAO_0000218,2113.0,
9259,1,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627166,,BAO_0000218,,
9260,1,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627167,,BAO_0000218,,
9261,1,Area under curve (AUC) at a dose of 30 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627822,,BAO_0000218,,
9262,1,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627823,,BAO_0000218,,
9263,1,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627824,,BAO_0000218,,
9264,1,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627825,,BAO_0000218,,
9265,1,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627826,,BAO_0000218,,
9266,1,Area under curve (Pharmacokinetic property) was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627827,,BAO_0000218,,
9267,1,Area under curve (Pharmacokinetic property) of the compound; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627828,,BAO_0000218,,
9268,1,Area under curve after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627829,,BAO_0000218,,
9269,1,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627830,,BAO_0000218,,
9270,1,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627831,,BAO_0000218,,
9271,1,Area under curve in male SD rats was observed after oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627832,,BAO_0000218,,
9272,1,Area under curve of compound after iv administration of 20 mg/kg dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627833,,BAO_0000218,,
9273,1,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL627834,,BAO_0000218,,
9274,1,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL628004,,BAO_0000218,,
9275,1,Area under curve at 5 mg/kg po was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628005,,BAO_0000218,,
9276,1,Area under curve in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628006,,BAO_0000218,,
9277,1,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628007,,BAO_0000218,,
9278,1,Area under curve was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625676,,BAO_0000218,,
9279,1,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631309,,BAO_0000218,,
9280,1,Area under curve after intravenous administration at 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631310,,BAO_0000218,,
9281,1,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631311,,BAO_0000218,,
9282,1,Area under curve at 4 hr in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631312,,BAO_0000218,,
9283,1,Area under curve at a dose of 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631313,,BAO_0000218,,
9284,1,Area under curve at the dose of 2 mg/Kg administered perorally in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631314,,BAO_0000218,,
9285,1,Area under curve at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631315,,BAO_0000218,,
9286,1,Area under curve for a 2-mpk po dose in SD rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631316,,BAO_0000218,,
9287,1,Area under curve in SD rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631317,,BAO_0000218,,
9288,1,Area under curve in rat after oral administration at 13 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874471,,BAO_0000218,,
9289,1,Area under curve in rat by po administration at 0-24 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631318,,BAO_0000218,,
9290,1,Area under curve in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631319,,BAO_0000218,1969.0,
9291,1,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631320,,BAO_0000218,,
9292,1,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631321,,BAO_0000218,,
9293,1,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631322,,BAO_0000218,,
9294,1,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631323,,BAO_0000218,,
9295,1,Area under curve value in rat at a dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631324,,BAO_0000218,,
9296,1,Area under curve was determined after oral administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631325,,BAO_0000218,,
9297,1,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631326,,BAO_0000218,,
9298,1,Area under curve was determined after peroral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631327,,BAO_0000218,,
9299,1,Area under curve was determined at a dose 30 mpk administered orally.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631328,,BAO_0000218,,
9300,1,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631329,,BAO_0000218,,
9301,1,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627217,,BAO_0000218,,
9302,1,Area under curve was determined in male rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626352,,BAO_0000218,,
9303,1,Area under curve was determined in rat after PO administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626353,,BAO_0000218,,
9304,1,Area under curve was determined in rat after a 3 mg/kg of oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626354,,BAO_0000218,,
9305,1,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626355,,BAO_0000218,,
9306,1,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626356,,BAO_0000218,,
9307,1,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626357,,BAO_0000218,,
9308,1,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626358,,BAO_0000218,,
9309,1,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626359,,BAO_0000218,,
9310,1,Peak plasma concentration in rat at a dose of 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626360,,BAO_0000218,1969.0,
9311,1,Plasma concentration at 2 hr in rats was evaluated.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626361,,BAO_0000218,,
9312,1,Plasma concentration at 2 hr in rats was evaluated; Not available,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626362,,BAO_0000218,,
9313,1,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626363,,BAO_0000218,,
9314,1,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626970,,BAO_0000218,,
9315,1,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626971,,BAO_0000218,,
9316,1,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626972,,BAO_0000218,1969.0,
9317,1,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626973,,BAO_0000218,1969.0,
9318,1,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626974,,BAO_0000218,1969.0,
9319,1,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874592,,BAO_0000218,1969.0,
9320,1,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626975,,BAO_0000218,,
9321,1,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626976,,BAO_0000218,,
9322,1,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626977,,BAO_0000218,,
9323,1,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626978,,BAO_0000218,,
9324,1,PK study was carried to determine the relative absorption ranking in rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626979,,BAO_0000218,,
9325,1,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626980,,BAO_0000218,1969.0,
9326,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626981,,BAO_0000218,178.0,
9327,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626982,,BAO_0000218,178.0,
9328,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626983,,BAO_0000218,178.0,
9329,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622522,,BAO_0000218,178.0,
9330,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622523,,BAO_0000218,178.0,
9331,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622524,,BAO_0000218,178.0,
9332,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622525,,BAO_0000218,955.0,
9333,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622526,,BAO_0000218,955.0,
9334,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619849,,BAO_0000218,955.0,
9335,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619850,,BAO_0000218,955.0,
9336,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623864,,BAO_0000218,955.0,
9337,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623865,,BAO_0000218,955.0,
9338,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623866,,BAO_0000218,948.0,
9339,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623867,,BAO_0000218,948.0,
9340,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877615,,BAO_0000218,948.0,
9341,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623868,,BAO_0000218,948.0,
9342,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623869,,BAO_0000218,948.0,
9343,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623870,,BAO_0000218,948.0,
9344,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623871,,BAO_0000218,2048.0,
9345,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623872,,BAO_0000218,2048.0,
9346,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622129,,BAO_0000218,2048.0,
9347,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622130,,BAO_0000218,2048.0,
9348,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622131,,BAO_0000218,2048.0,
9349,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622132,,BAO_0000218,2048.0,
9350,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622133,,BAO_0000218,2048.0,
9351,1,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622134,,BAO_0000218,2048.0,
9352,1,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622135,,BAO_0000218,2048.0,
9353,1,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622136,,BAO_0000218,2048.0,
9354,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622137,,BAO_0000218,2385.0,
9355,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622138,,BAO_0000218,2385.0,
9356,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623017,,BAO_0000218,2385.0,
9357,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623018,,BAO_0000218,2385.0,
9358,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623019,,BAO_0000218,2385.0,
9359,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623020,,BAO_0000218,2385.0,
9360,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623021,,BAO_0000218,2385.0,
9361,1,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623022,,BAO_0000218,2385.0,
9362,1,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623023,,BAO_0000218,2385.0,
9363,1,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623024,,BAO_0000218,2385.0,
9364,1,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623025,,BAO_0000218,2385.0,
9365,1,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620545,,BAO_0000218,2385.0,
9366,1,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620546,,BAO_0000218,2385.0,
9367,1,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620547,,BAO_0000218,2385.0,
9368,1,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620548,,BAO_0000218,2385.0,
9369,1,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620549,,BAO_0000218,2385.0,
9370,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620550,,BAO_0000218,2385.0,
9371,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620551,,BAO_0000218,2385.0,
9372,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620552,,BAO_0000218,2385.0,
9373,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620553,,BAO_0000218,2385.0,
9374,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620554,,BAO_0000218,2385.0,
9375,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875845,,BAO_0000218,2385.0,
9376,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620555,,BAO_0000218,2385.0,
9377,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620556,,BAO_0000218,2385.0,
9378,1,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620557,,BAO_0000218,2385.0,
9379,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620558,,BAO_0000218,,
9380,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620559,,BAO_0000218,,
9381,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622939,,BAO_0000218,,
9382,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622940,,BAO_0000218,,
9383,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622941,,BAO_0000218,,
9384,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622942,,BAO_0000218,,
9385,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622943,,BAO_0000218,,
9386,1,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622944,,BAO_0000218,,
9387,1,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622945,,BAO_0000218,,
9388,1,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622946,,BAO_0000218,,
9389,1,Compound was evaluated for terminal half life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622947,,BAO_0000218,,
9390,1,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622948,,BAO_0000218,1969.0,
9391,1,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622949,,BAO_0000218,1969.0,
9392,1,Compound was tested for its half life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622950,,BAO_0000218,,
9393,1,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,Macaca mulatta,0,22224,,U,Intermediate,,CHEMBL622951,,BAO_0000218,1969.0,
9394,1,Compound was tested for its plasma half life in Sprague Dawley rats,Rattus norvegicus,0,22224,,U,Intermediate,,CHEMBL622952,,BAO_0000366,1969.0,
9395,1,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,Rattus norvegicus,0,22224,,U,Intermediate,,CHEMBL622953,,BAO_0000366,1969.0,
9396,1,Compound was tested for plasma half-life period in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873818,,BAO_0000218,1969.0,
9397,1,Elimination half life after i.v. administration of compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622954,,BAO_0000218,,
9398,1,Elimination half-life after IV dosing at 0.5 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622955,,BAO_0000218,,
9399,1,Elimination half-life after IV dosing at 1 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875229,,BAO_0000218,,
9400,1,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622956,,BAO_0000218,,
9401,1,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622957,,BAO_0000218,,
9402,1,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622958,,BAO_0000218,955.0,
9403,1,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622959,,BAO_0000218,1969.0,
9404,1,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622960,,BAO_0000218,955.0,
9405,1,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622961,,BAO_0000218,1969.0,
9406,1,Evaluated for the half life in rat (in vivo),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622962,,BAO_0000218,,
9407,1,Hafl life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622963,,BAO_0000218,,
9408,1,Hafl life rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622964,,BAO_0000218,,
9409,1,Hafl life rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622965,,BAO_0000218,,
9410,1,Hafl life rat; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622966,,BAO_0000218,,
9411,1,Hafl life rat; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622967,,BAO_0000218,,
9412,1,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622968,,BAO_0000218,2113.0,
9413,1,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622969,,BAO_0000218,2107.0,
9414,1,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875327,,BAO_0000218,2048.0,
9415,1,Half life in rat after 1 mg/kg i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628638,,BAO_0000218,,
9416,1,Half life in rat after 2 mg/kg peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628639,,BAO_0000218,,
9417,1,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625840,,BAO_0000218,,
9418,1,Half life of 10 mg/kg oral dose determined in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625841,,BAO_0000218,,
9419,1,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625842,,BAO_0000218,,
9420,1,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625843,,BAO_0000218,,
9421,1,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625844,,BAO_0000218,,
9422,1,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873822,,BAO_0000218,,
9423,1,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625845,,BAO_0000218,,
9424,1,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627059,,BAO_0000218,,
9425,1,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627060,,BAO_0000218,,
9426,1,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627061,,BAO_0000218,,
9427,1,Half life of compound at 5 mg/kg after po administration was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627709,,BAO_0000218,,
9428,1,Half life of compound determined after intravenous administration to rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627710,,BAO_0000218,,
9429,1,Half life of compound was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627711,,BAO_0000218,,
9430,1,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627712,,BAO_0000218,1969.0,
9431,1,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627713,,BAO_0000218,,
9432,1,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627714,,BAO_0000218,,
9433,1,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,Macaca fascicularis,0,22224,,U,Intermediate,,CHEMBL627889,,BAO_0000218,,
9434,1,Half life determined in rat by intravenous administration,Rattus norvegicus,0,22224,,U,Intermediate,,CHEMBL627890,,BAO_0000218,,
9435,1,Half life determined in rats after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627891,,BAO_0000218,,
9436,1,Half life in rat plasma after administration of 2 mg/kg iv,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627892,,BAO_0000218,1969.0,
9437,1,Half life in rat plasma after administration of 2 mg/kg iv,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627893,,BAO_0000218,1969.0,
9438,1,Half life in rat plasma was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627894,,BAO_0000218,1969.0,
9439,1,Half life in rat plasma was determined; NA means not applicable,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627895,,BAO_0000218,1969.0,
9440,1,Half life in rat was tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627896,,BAO_0000218,,
9441,1,Half life measured in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627897,,BAO_0000218,1969.0,
9442,1,Half life recorded in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627898,,BAO_0000218,,
9443,1,Half life was calculated,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627899,,BAO_0000218,,
9444,1,Half life was calculated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873823,,BAO_0000218,,
9445,1,Half life was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627900,,BAO_0000218,,
9446,1,Half life after 10 mg/kg oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627901,,BAO_0000218,,
9447,1,Half life after administering orally a dose of 10 mg/kg to a fasting rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627902,,BAO_0000218,,
9448,1,Half life after administering orally a dose of 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627903,,BAO_0000218,,
9449,1,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627904,,BAO_0000218,,
9450,1,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627905,,BAO_0000218,,
9451,1,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627906,,BAO_0000218,,
9452,1,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627907,,BAO_0000218,,
9453,1,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876783,,BAO_0000218,,
9454,1,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627908,,BAO_0000218,,
9455,1,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627909,,BAO_0000218,,
9456,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627910,,BAO_0000218,,
9457,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627911,,BAO_0000218,,
9458,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627912,,BAO_0000218,,
9459,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627913,,BAO_0000218,,
9460,1,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627914,,BAO_0000218,,
9461,1,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627915,,BAO_0000218,,
9462,1,Area under the curve was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627916,,BAO_0000218,,
9463,1,Area under the curve was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627917,,BAO_0000218,,
9464,1,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627918,,BAO_0000218,,
9465,1,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627919,,BAO_0000218,,
9466,1,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627920,,BAO_0000218,,
9467,1,Area under the curve was evaluated at an oral dose of 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627921,,BAO_0000218,,
9468,1,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627922,,BAO_0000218,,
9469,1,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876784,,BAO_0000218,,
9470,1,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627923,,BAO_0000218,,
9471,1,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626208,,BAO_0000218,,
9472,1,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626209,,BAO_0000218,,
9473,1,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626210,,BAO_0000218,,
9474,1,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627994,,BAO_0000218,1969.0,
9475,1,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627995,,BAO_0000218,,
9476,1,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627996,,BAO_0000218,,
9477,1,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627997,,BAO_0000218,,
9478,1,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627998,,BAO_0000218,,
9479,1,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628640,,BAO_0000218,,
9480,1,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628641,,BAO_0000218,,
9481,1,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628642,,BAO_0000218,,
9482,1,Compound was evaluated for area under the curve expressed as (h*ug/ml),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628643,,BAO_0000218,,
9483,1,Compound was tested for area under curve in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628644,,BAO_0000218,,
9484,1,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628645,,BAO_0000218,,
9485,1,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628646,,BAO_0000218,,
9486,1,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628647,,BAO_0000218,,
9487,1,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628648,,BAO_0000218,,
9488,1,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625358,,BAO_0000218,,
9489,1,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625359,,BAO_0000218,,
9490,1,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625360,,BAO_0000218,,
9491,1,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625361,,BAO_0000218,,
9492,1,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625362,,BAO_0000218,,
9493,1,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625363,,BAO_0000218,,
9494,1,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625364,,BAO_0000218,,
9495,1,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625365,,BAO_0000218,,
9496,1,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625366,,BAO_0000218,,
9497,1,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625367,,BAO_0000218,,
9498,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625368,,BAO_0000218,2113.0,
9499,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625369,,BAO_0000218,2113.0,
9500,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625370,,BAO_0000218,2113.0,
9501,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625371,,BAO_0000218,2113.0,
9502,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625372,,BAO_0000218,2113.0,
9503,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625373,,BAO_0000218,2113.0,
9504,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625374,,BAO_0000218,2107.0,
9505,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877593,,BAO_0000218,2107.0,
9506,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625375,,BAO_0000218,2107.0,
9507,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625376,,BAO_0000218,2107.0,
9508,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621973,,BAO_0000218,2107.0,
9509,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621974,,BAO_0000218,2107.0,
9510,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621975,,BAO_0000218,2048.0,
9511,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622166,,BAO_0000218,2048.0,
9512,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622167,,BAO_0000218,2048.0,
9513,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622168,,BAO_0000218,2048.0,
9514,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622169,,BAO_0000218,2048.0,
9515,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622170,,BAO_0000218,2048.0,
9516,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622171,,BAO_0000218,2046.0,
9517,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622172,,BAO_0000218,2046.0,
9518,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622173,,BAO_0000218,2046.0,
9519,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622174,,BAO_0000218,2046.0,
9520,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622175,,BAO_0000218,2046.0,
9521,1,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622176,,BAO_0000218,2046.0,
9522,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622177,,BAO_0000218,2046.0,
9523,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622178,,BAO_0000218,2046.0,
9524,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622179,,BAO_0000218,2046.0,
9525,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622180,,BAO_0000218,2046.0,
9526,1,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622181,,BAO_0000218,,
9527,1,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622182,,BAO_0000218,,
9528,1,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622183,,BAO_0000218,,
9529,1,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622184,,BAO_0000218,,
9530,1,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622185,,BAO_0000218,,
9531,1,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622186,,BAO_0000218,,
9532,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622187,,BAO_0000218,,
9533,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625002,,BAO_0000218,,
9534,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622090,,BAO_0000218,,
9535,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622091,,BAO_0000218,,
9536,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622092,,BAO_0000218,,
9537,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622093,,BAO_0000218,,
9538,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622094,,BAO_0000218,,
9539,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622095,,BAO_0000218,,
9540,1,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622264,,BAO_0000218,,
9541,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622265,,BAO_0000218,2106.0,
9542,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622266,,BAO_0000218,2106.0,
9543,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622267,,BAO_0000218,2106.0,
9544,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622268,,BAO_0000218,2106.0,
9545,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622269,,BAO_0000218,2106.0,
9546,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625071,,BAO_0000218,2106.0,
9547,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621621,,BAO_0000218,2106.0,
9548,1,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621622,,BAO_0000218,2106.0,
9549,1,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621623,,BAO_0000218,2106.0,
9550,1,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621624,,BAO_0000218,2106.0,
9551,1,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621625,,BAO_0000218,2106.0,
9552,1,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621626,,BAO_0000218,2106.0,
9553,1,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621627,,BAO_0000218,2106.0,
9554,1,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621628,,BAO_0000218,2106.0,
9555,1,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875328,,BAO_0000218,2106.0,
9556,1,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621629,,BAO_0000218,2106.0,
9557,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621630,,BAO_0000218,2106.0,
9558,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621631,,BAO_0000218,2106.0,
9559,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621632,,BAO_0000218,2106.0,
9560,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621633,,BAO_0000218,2106.0,
9561,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621634,,BAO_0000218,2106.0,
9562,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621635,,BAO_0000218,2106.0,
9563,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621636,,BAO_0000218,2106.0,
9564,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621637,,BAO_0000218,2106.0,
9565,1,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621638,,BAO_0000218,2106.0,
9566,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618883,,BAO_0000218,,
9567,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618884,,BAO_0000218,,
9568,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628627,,BAO_0000218,,
9569,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628628,,BAO_0000218,,
9570,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628629,,BAO_0000218,,
9571,1,Half life after administering orally a dose of 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628630,,BAO_0000218,,
9572,1,Half life after administering orally a dose of 3 mg/kg to a fasting rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628631,,BAO_0000218,,
9573,1,Half life after administering intravenously a dose of 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628632,,BAO_0000218,,
9574,1,Half life after oral dosing in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628633,,BAO_0000218,,
9575,1,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628634,,BAO_0000218,,
9576,1,Half life by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627789,,BAO_0000218,,
9577,1,Half life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627790,,BAO_0000218,,
9578,1,Half life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627791,,BAO_0000218,,
9579,1,Half life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627792,,BAO_0000218,,
9580,1,Half life in rat after intravenous administration of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627793,,BAO_0000218,,
9581,1,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627794,,BAO_0000218,1969.0,
9582,1,Half life in rat after po administration of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627795,,BAO_0000218,,
9583,1,Half life in rat after po administration of the compound; ND means Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627796,,BAO_0000218,,
9584,1,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875335,,BAO_0000218,1969.0,
9585,1,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627797,,BAO_0000218,1969.0,
9586,1,Half life in rat i.v.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627798,,BAO_0000218,,
9587,1,Half life in rat i.v. at 2 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627799,,BAO_0000218,,
9588,1,Half life in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627800,,BAO_0000218,,
9589,1,Half life in rats after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627801,,BAO_0000218,,
9590,1,Half life in rats at the dose of 1.0 mpk by i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627802,,BAO_0000218,,
9591,1,Half life in rat,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL627803,,BAO_0000218,,
9592,1,Half life was evaluated after intravenous administration to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873820,,BAO_0000218,,
9593,1,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627804,,BAO_0000218,,
9594,1,Half life was evaluated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627805,,BAO_0000218,,
9595,1,Half life was evaluated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627806,,BAO_0000218,,
9596,1,Half life was evaluated in rat; Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627107,,BAO_0000218,,
9597,1,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627108,,BAO_0000218,,
9598,1,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627109,,BAO_0000218,,
9599,1,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627110,,BAO_0000218,178.0,
9600,1,Half life was measured in monkey at dose of 10 mg/kg by po administration,Primates,0,22224,,U,Intermediate,,CHEMBL627111,,BAO_0000218,,
9601,1,Half life was measured in monkey at dose of 10 mg/kg by po administration,Primates,0,22224,,U,Intermediate,,CHEMBL627112,,BAO_0000218,,
9602,1,Half life was measured in rat at dose of 30 mg/kg by iv administration,Rattus norvegicus,0,22224,,U,Intermediate,,CHEMBL627113,,BAO_0000218,,
9603,1,Half life was measured in rat at dose of 30 mg/kg by po administration,Rattus norvegicus,0,22224,,U,Intermediate,,CHEMBL627114,,BAO_0000218,,
9604,1,Half life (t1/2) was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627115,,BAO_0000218,,
9605,1,Half life period at a dose of 10 uM/kg in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627116,,BAO_0000218,,
9606,1,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627117,,BAO_0000218,,
9607,1,Half life period was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627118,,BAO_0000218,,
9608,1,Half life period after intravenous administration at 20 mpk in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627119,,BAO_0000218,,
9609,1,Half life period after intravenous administration at 20 mpk in rats; Not performed.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627120,,BAO_0000218,,
9610,1,Half life period after intravenous administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626922,,BAO_0000218,,
9611,1,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626923,,BAO_0000218,,
9612,1,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626924,,BAO_0000218,,
9613,1,Half life period in 80% rat plasma at 37 degree Centigrade,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626925,,BAO_0000218,1969.0,
9614,1,Half life period in SD rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626926,,BAO_0000218,,
9615,1,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626927,,BAO_0000218,1969.0,
9616,1,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626928,,BAO_0000218,1969.0,
9617,1,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626929,,BAO_0000218,1969.0,
9618,1,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626930,,BAO_0000218,1969.0,
9619,1,Half life period in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626931,,BAO_0000218,,
9620,1,Half life period in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626932,,BAO_0000218,,
9621,1,Half life period in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626933,,BAO_0000218,,
9622,1,Half life period in rat after oral administration at 10.5 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873826,,BAO_0000218,,
9623,1,Half life period in rat after oral administration at 11.2 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626934,,BAO_0000218,,
9624,1,Half life period in rat after oral administration at 13 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626935,,BAO_0000218,,
9625,1,Half life period in rat after oral administration at 9.7 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626936,,BAO_0000218,,
9626,1,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626937,,BAO_0000218,,
9627,1,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625906,,BAO_0000218,,
9628,1,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625907,,BAO_0000218,,
9629,1,PK study was carried to determine AUC (area under curve) value in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625908,,BAO_0000218,,
9630,1,Pharmacokinetic parameter AUC after intravenous administration to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625909,,BAO_0000218,,
9631,1,Pharmacokinetic parameter AUC after oral administration to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625910,,BAO_0000218,,
9632,1,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625911,,BAO_0000218,,
9633,1,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625912,,BAO_0000218,,
9634,1,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626538,,BAO_0000218,,
9635,1,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876794,,BAO_0000218,,
9636,1,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626539,,BAO_0000218,,
9637,1,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626540,,BAO_0000218,,
9638,1,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626541,,BAO_0000218,,
9639,1,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626542,,BAO_0000218,,
9640,1,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626543,,BAO_0000218,,
9641,1,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626544,,BAO_0000218,,
9642,1,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626545,,BAO_0000218,,
9643,1,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626546,,BAO_0000218,,
9644,1,Pharmacokinetic parameter area under curve was reported,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626547,,BAO_0000218,,
9645,1,Pharmacokinetic property (AUC) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626548,,BAO_0000218,,
9646,1,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626549,,BAO_0000218,,
9647,1,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626550,,BAO_0000218,,
9648,1,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626551,,BAO_0000218,,
9649,1,Pharmacokinetic property was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623777,,BAO_0000218,,
9650,1,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623778,,BAO_0000218,,
9651,1,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623779,,BAO_0000218,,
9652,1,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623780,,BAO_0000218,1969.0,
9653,1,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622015,,BAO_0000218,1969.0,
9654,1,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622016,,BAO_0000218,1969.0,
9655,1,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622017,,BAO_0000218,,
9656,1,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622018,,BAO_0000218,,
9657,1,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622019,,BAO_0000218,,
9658,1,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622020,,BAO_0000218,,
9659,1,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622021,,BAO_0000218,,
9660,1,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622022,,BAO_0000218,,
9661,1,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622023,,BAO_0000218,,
9662,1,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622024,,BAO_0000218,,
9663,1,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622693,,BAO_0000218,,
9664,1,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622694,,BAO_0000218,,
9665,1,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622695,,BAO_0000218,,
9666,1,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622696,,BAO_0000218,,
9667,1,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622697,,BAO_0000218,,
9668,1,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622874,,BAO_0000218,,
9669,1,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622875,,BAO_0000218,,
9670,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622876,,BAO_0000218,,
9671,1,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622877,,BAO_0000218,,
9672,1,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622878,,BAO_0000218,,
9673,1,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622879,,BAO_0000218,1969.0,
9674,1,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877602,,BAO_0000218,,
9675,1,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622880,,BAO_0000218,,
9676,1,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622881,,BAO_0000218,,
9677,1,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622882,,BAO_0000218,,
9678,1,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622883,,BAO_0000218,,
9679,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622884,,BAO_0000218,2046.0,
9680,1,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622885,,BAO_0000218,2046.0,
9681,1,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622886,,BAO_0000218,,
9682,1,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622887,,BAO_0000218,,
9683,1,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622888,,BAO_0000218,1088.0,
9684,1,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622889,,BAO_0000218,178.0,
9685,1,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622890,,BAO_0000218,178.0,
9686,1,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622891,,BAO_0000218,178.0,
9687,1,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877603,,BAO_0000218,178.0,
9688,1,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622892,,BAO_0000218,955.0,
9689,1,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622893,,BAO_0000218,955.0,
9690,1,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622894,,BAO_0000218,955.0,
9691,1,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622895,,BAO_0000218,955.0,
9692,1,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622896,,BAO_0000218,955.0,
9693,1,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622897,,BAO_0000218,948.0,
9694,1,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622898,,BAO_0000218,948.0,
9695,1,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622899,,BAO_0000218,948.0,
9696,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622900,,BAO_0000218,2113.0,
9697,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624114,,BAO_0000218,2113.0,
9698,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624115,,BAO_0000218,2113.0,
9699,1,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624116,,BAO_0000218,2113.0,
9700,1,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624117,,BAO_0000218,2107.0,
9701,1,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624118,,BAO_0000218,2107.0,
9702,1,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624119,,BAO_0000218,2107.0,
9703,1,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624120,,BAO_0000218,2107.0,
9704,1,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624121,,BAO_0000218,2048.0,
9705,1,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624122,,BAO_0000218,2048.0,
9706,1,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624123,,BAO_0000218,2048.0,
9707,1,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624124,,BAO_0000218,2048.0,
9708,1,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624125,,BAO_0000218,2385.0,
9709,1,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624126,,BAO_0000218,2385.0,
9710,1,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624127,,BAO_0000218,2385.0,
9711,1,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624128,,BAO_0000218,2385.0,
9712,1,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624129,,BAO_0000218,14.0,
9713,1,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624130,,BAO_0000218,14.0,
9714,1,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622340,,BAO_0000218,14.0,
9715,1,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622341,,BAO_0000218,14.0,
9716,1,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622342,,BAO_0000218,160.0,
9717,1,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622343,,BAO_0000218,160.0,
9718,1,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622344,,BAO_0000218,160.0,
9719,1,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622345,,BAO_0000218,160.0,
9720,1,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622346,,BAO_0000218,2106.0,
9721,1,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622347,,BAO_0000218,2106.0,
9722,1,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622348,,BAO_0000218,2106.0,
9723,1,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622349,,BAO_0000218,2106.0,
9724,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622350,,BAO_0000218,,
9725,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622351,,BAO_0000218,,
9726,1,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622352,,BAO_0000218,,
9727,1,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622353,,BAO_0000218,,
9728,1,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622354,,BAO_0000218,,
9729,1,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622355,,BAO_0000218,,
9730,1,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622356,,BAO_0000218,,
9731,1,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622357,,BAO_0000218,,
9732,1,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622358,,BAO_0000218,,
9733,1,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622359,,BAO_0000218,,
9734,1,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874393,,BAO_0000218,,
9735,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622872,,BAO_0000218,,
9736,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622873,,BAO_0000218,,
9737,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623047,,BAO_0000218,,
9738,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623048,,BAO_0000218,,
9739,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623049,,BAO_0000218,,
9740,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623050,,BAO_0000218,,
9741,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623051,,BAO_0000218,,
9742,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623052,,BAO_0000218,,
9743,1,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626343,,BAO_0000218,,
9744,1,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626344,,BAO_0000218,,
9745,1,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626345,,BAO_0000218,,
9746,1,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626346,,BAO_0000218,,
9747,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626347,,BAO_0000218,,
9748,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626348,,BAO_0000218,,
9749,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626349,,BAO_0000218,,
9750,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626350,,BAO_0000218,,
9751,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626351,,BAO_0000218,,
9752,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627650,,BAO_0000218,,
9753,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627651,,BAO_0000218,,
9754,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627652,,BAO_0000218,,
9755,1,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627653,,BAO_0000218,,
9756,1,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627654,,BAO_0000218,,
9757,1,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627835,,BAO_0000218,,
9758,1,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627836,,BAO_0000218,,
9759,1,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627837,,BAO_0000218,,
9760,1,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627838,,BAO_0000218,,
9761,1,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875338,,BAO_0000218,,
9762,1,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627839,,BAO_0000218,,
9763,1,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627840,,BAO_0000218,,
9764,1,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627841,,BAO_0000218,,
9765,1,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627842,,BAO_0000218,,
9766,1,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627843,,BAO_0000218,,
9767,1,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627844,,BAO_0000218,,
9768,1,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627845,,BAO_0000218,,
9769,1,Half life period in rat by iv administration at a dose of 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627846,,BAO_0000218,,
9770,1,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627847,,BAO_0000218,1969.0,
9771,1,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873821,,BAO_0000218,1969.0,
9772,1,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626079,,BAO_0000218,1969.0,
9773,1,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626080,,BAO_0000218,1969.0,
9774,1,Half life period was evaluated in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626081,,BAO_0000218,1969.0,
9775,1,Half life period was evaluated in rat plasma; Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875344,,BAO_0000218,1969.0,
9776,1,Half life period was evaluated in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626082,,BAO_0000218,,
9777,1,"Half life period was evaluated in rats, iv",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626250,,BAO_0000218,,
9778,1,Half life period after intravenous administration at 5 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626251,,BAO_0000218,,
9779,1,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626252,,BAO_0000218,,
9780,1,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626253,,BAO_0000218,,
9781,1,Half life stability of compound was evaluated in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626254,,BAO_0000218,1969.0,
9782,1,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626255,,BAO_0000218,,
9783,1,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626256,,BAO_0000218,,
9784,1,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626257,,BAO_0000218,,
9785,1,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626258,,BAO_0000218,,
9786,1,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626259,,BAO_0000218,,
9787,1,Half in rat i.v.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626260,,BAO_0000218,,
9788,1,Half period in rat after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875345,,BAO_0000218,,
9789,1,Half-life after repeated oral dose of compound at 1 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626261,,BAO_0000218,,
9790,1,Half-life measured in in vitro Cathepsin B assay in rat liver,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626262,,BAO_0000218,2107.0,
9791,1,Half-life of compound was determined in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626263,,BAO_0000218,,
9792,1,Half-life at 10 mg/kg in rat upon intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625270,,BAO_0000218,,
9793,1,Half-life determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625271,,BAO_0000218,,
9794,1,Half-life determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625272,,BAO_0000218,,
9795,1,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625273,,BAO_0000218,955.0,
9796,1,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625274,,BAO_0000218,1969.0,
9797,1,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625275,,BAO_0000218,,
9798,1,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625276,,BAO_0000218,1969.0,
9799,1,Half-life in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625277,,BAO_0000218,1969.0,
9800,1,Half-life in rat plasma was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625278,,BAO_0000218,1969.0,
9801,1,Half-life in rat plasma; Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625279,,BAO_0000218,1969.0,
9802,1,Half-life in rat serum,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625280,,BAO_0000218,1977.0,
9803,1,Half-life in rat serum; na is not available,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876797,,BAO_0000218,1977.0,
9804,1,Half-life was calculated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625281,,BAO_0000218,,
9805,1,Half-life was calculated in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873827,,BAO_0000218,1969.0,
9806,1,Half-life was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625282,,BAO_0000218,,
9807,1,Half-life was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625283,,BAO_0000218,,
9808,1,Half-life after administration of 20 mg/Kg oral dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625284,,BAO_0000218,,
9809,1,Half-life after administration of 3.2 mg/kg intravenously in male rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625285,,BAO_0000218,,
9810,1,Half-life after intravenous administration in female rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625286,,BAO_0000218,,
9811,1,Half-life after intravenous administration in male rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625287,,BAO_0000218,,
9812,1,Half-life after intravenous dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625288,,BAO_0000218,,
9813,1,Half-life in a rat liver homogenate preparation,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625289,,BAO_0000218,2107.0,
9814,1,Half-life in plasma of rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625290,,BAO_0000218,1969.0,
9815,1,Half-life in plasma of rat at dose of 3-10 mgkg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876798,,BAO_0000218,1969.0,
9816,1,Half-life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625291,,BAO_0000218,,
9817,1,Half-life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625292,,BAO_0000218,,
9818,1,Half-life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625293,,BAO_0000218,,
9819,1,Half-life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622832,,BAO_0000218,,
9820,1,Half-life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622833,,BAO_0000218,,
9821,1,Half-life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622834,,BAO_0000218,,
9822,1,Half-life in rat after oral administration at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622835,,BAO_0000218,,
9823,1,Half-life in rat after po administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622836,,BAO_0000218,,
9824,1,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622837,,BAO_0000218,,
9825,1,Half-life in rat at 3 mg/kg dose administered intravenously,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622838,,BAO_0000218,,
9826,1,Half-life in rat brain homogenate,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622839,,BAO_0000218,955.0,
9827,1,Half-life in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622840,,BAO_0000218,1969.0,
9828,1,Half-life in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622841,,BAO_0000218,,
9829,1,Half-life in Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622842,,BAO_0000218,,
9830,1,Half-life in vitro in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622843,,BAO_0000218,1969.0,
9831,1,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622844,,BAO_0000218,1969.0,
9832,1,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622845,,BAO_0000218,,
9833,1,The area under the curve of compound was measured at the dose of 100 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622846,,BAO_0000218,,
9834,1,The area under the curve of compound was measured at the dose of 300 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622847,,BAO_0000218,,
9835,1,The area under the curve of compound was measured at the dose of 30 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622848,,BAO_0000218,,
9836,1,Bioavailability as oral AUC in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622849,,BAO_0000218,,
9837,1,The plasma concentration versus time curve (AUC) was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622850,,BAO_0000218,1969.0,
9838,1,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876807,,BAO_0000218,,
9839,1,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622851,,BAO_0000218,,
9840,1,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622852,,BAO_0000218,,
9841,1,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622853,,BAO_0000218,,
9842,1,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622854,,BAO_0000218,,
9843,1,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622855,,BAO_0000218,,
9844,1,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622856,,BAO_0000218,1969.0,
9845,1,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622857,,BAO_0000218,1969.0,
9846,1,AUC in rat after po administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622858,,BAO_0000218,1969.0,
9847,1,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622859,,BAO_0000218,1969.0,
9848,1,Area under curve value 24 hr after 10 mg/kg iv administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622860,,BAO_0000218,,
9849,1,Area under curve value 24 hr after 10 mg/kg oral administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622861,,BAO_0000218,,
9850,1,Area under curve value 24 hr after 2 mg/kg iv administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622862,,BAO_0000218,,
9851,1,Area under curve value 24 hr after 2 mg/kg oral administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622863,,BAO_0000218,,
9852,1,Area under curve value 6 hr after po administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623817,,BAO_0000218,,
9853,1,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623818,,BAO_0000218,,
9854,1,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623819,,BAO_0000218,,
9855,1,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623820,,BAO_0000218,,
9856,1,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623821,,BAO_0000218,,
9857,1,AUC normalized for dose (AUCN) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623822,,BAO_0000218,1969.0,
9858,1,Area under curve in rat after p.o. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623823,,BAO_0000218,,
9859,1,Area under curve in rat after p.o. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623824,,BAO_0000218,,
9860,1,Area under curve in rat after p.o. administration; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623825,,BAO_0000218,,
9861,1,Area under curve in rat after peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622070,,BAO_0000218,,
9862,1,Area under curve (carotid artery) value of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622071,,BAO_0000218,,
9863,1,Bioavailability expressed as the area under curve of rat carotid artery,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622072,,BAO_0000218,,
9864,1,Area under curve in male SD rats was observed after intravenous administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622073,,BAO_0000218,,
9865,1,Area under curve of the compound was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622074,,BAO_0000218,,
9866,1,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622075,,BAO_0000218,,
9867,1,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622076,,BAO_0000218,1969.0,
9868,1,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622077,,BAO_0000218,1969.0,
9869,1,Area under curve (portal vein) value of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622078,,BAO_0000218,,
9870,1,Bioavailability expressed as the area under curve of rat portal vein,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622079,,BAO_0000218,,
9871,1,Area Under plasma concentration time curve in rat upon peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622080,,BAO_0000218,1969.0,
9872,1,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877612,,BAO_0000218,,
9873,1,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622081,,BAO_0000218,,
9874,1,Compound was evaluated for oral bioavailability in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622082,,BAO_0000218,,
9875,1,Compound was evaluated for oral bioavailability in rats after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622083,,BAO_0000218,,
9876,1,Compound was evaluated for oral bioavailability in rats; 30-80,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622084,,BAO_0000218,,
9877,1,Compound was evaluated for oral bioavailability in rats; 50-60,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622085,,BAO_0000218,,
9878,1,Compound was evaluated for oral bioavailability in rats; no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622086,,BAO_0000218,,
9879,1,Compound was evaluated for oral bioavailability in rats; peptide,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622087,,BAO_0000218,,
9880,1,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622088,,BAO_0000218,178.0,
9881,1,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622089,,BAO_0000218,178.0,
9882,1,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623685,,BAO_0000218,178.0,
9883,1,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623686,,BAO_0000218,178.0,
9884,1,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623687,,BAO_0000218,945.0,
9885,1,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623688,,BAO_0000218,945.0,
9886,1,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623689,,BAO_0000218,945.0,
9887,1,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622485,,BAO_0000218,945.0,
9888,1,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622486,,BAO_0000218,2046.0,
9889,1,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877613,,BAO_0000218,2046.0,
9890,1,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622487,,BAO_0000218,2046.0,
9891,1,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622488,,BAO_0000218,2046.0,
9892,1,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622489,,BAO_0000218,948.0,
9893,1,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622490,,BAO_0000218,1088.0,
9894,1,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622491,,BAO_0000218,1088.0,
9895,1,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622492,,BAO_0000218,2107.0,
9896,1,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622493,,BAO_0000218,1088.0,
9897,1,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622494,,BAO_0000218,1088.0,
9898,1,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622495,,BAO_0000218,2385.0,
9899,1,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622496,,BAO_0000218,,
9900,1,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622497,,BAO_0000218,1088.0,
9901,1,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622498,,BAO_0000218,,
9902,1,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624918,,BAO_0000218,1088.0,
9903,1,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624919,,BAO_0000218,1088.0,
9904,1,Biodistribution of compound in rat blood after 5 min of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624920,,BAO_0000218,178.0,
9905,1,Biodistribution of compound in rat blood after 5 min of administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624921,,BAO_0000218,178.0,
9906,1,Biodistribution of compound in rat brain after 5 min of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624922,,BAO_0000218,955.0,
9907,1,Biodistribution of compound in rat heart after 5 min of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624923,,BAO_0000218,948.0,
9908,1,Biodistribution of compound in rat heart after 5 min of administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624924,,BAO_0000218,948.0,
9909,1,Biodistribution of compound in rat kidney after 5 min of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624925,,BAO_0000218,2113.0,
9910,1,Biodistribution of compound in rat kidney after 5 min of administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624926,,BAO_0000218,2113.0,
9911,1,Biodistribution of compound in rat liver after 5 min of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624927,,BAO_0000218,2107.0,
9912,1,Biodistribution of compound in rat liver after 5 min of administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874402,,BAO_0000218,2107.0,
9913,1,Biodistribution of compound in rat lung after 5 min of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624928,,BAO_0000218,2048.0,
9914,1,Biodistribution of compound in rat lung after 5 min of administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624929,,BAO_0000218,2048.0,
9915,1,Biodistribution of compound in rat muscle after 5 min of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624930,,BAO_0000218,2385.0,
9916,1,Biodistribution of compound in rat muscle after 5 min of administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624931,,BAO_0000218,2385.0,
9917,1,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624932,,BAO_0000218,948.0,
9918,1,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624933,,BAO_0000218,948.0,
9919,1,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624934,,BAO_0000218,2107.0,
9920,1,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624935,,BAO_0000218,2107.0,
9921,1,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624936,,BAO_0000218,,
9922,1,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624937,,BAO_0000218,,
9923,1,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624938,,BAO_0000218,2106.0,
9924,1,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624939,,BAO_0000218,2106.0,
9925,1,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624940,,BAO_0000218,,
9926,1,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874403,,BAO_0000218,,
9927,1,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624941,,BAO_0000218,,
9928,1,Dose required to lower urine osmolality to 300 mOsm/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624942,,BAO_0000218,1088.0,
9929,1,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624943,,BAO_0000218,1088.0,
9930,1,% Bioavailability after 1 day of the drug administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624944,,BAO_0000218,,
9931,1,% Bioavailability after 4 day of the drug administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624945,,BAO_0000218,,
9932,1,Absolute bioavailability was evaluated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624946,,BAO_0000218,,
9933,1,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624947,,BAO_0000218,,
9934,1,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624948,,BAO_0000218,,
9935,1,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624949,,BAO_0000218,,
9936,1,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622025,,BAO_0000218,2113.0,
9937,1,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622026,,BAO_0000218,2113.0,
9938,1,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622027,,BAO_0000218,2113.0,
9939,1,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622028,,BAO_0000218,2113.0,
9940,1,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622029,,BAO_0000218,2107.0,
9941,1,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622208,,BAO_0000218,2107.0,
9942,1,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622209,,BAO_0000218,2107.0,
9943,1,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622210,,BAO_0000218,2107.0,
9944,1,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622211,,BAO_0000218,,
9945,1,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622212,,BAO_0000218,,
9946,1,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622213,,BAO_0000218,,
9947,1,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874404,,BAO_0000218,,
9948,1,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620452,,BAO_0000218,2385.0,
9949,1,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620453,,BAO_0000218,2385.0,
9950,1,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620454,,BAO_0000218,2385.0,
9951,1,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624067,,BAO_0000218,2385.0,
9952,1,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624068,,BAO_0000218,,
9953,1,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624069,,BAO_0000218,992.0,
9954,1,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624070,,BAO_0000218,992.0,
9955,1,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624071,,BAO_0000218,992.0,
9956,1,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624072,,BAO_0000218,995.0,
9957,1,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624073,,BAO_0000218,995.0,
9958,1,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624788,,BAO_0000218,995.0,
9959,1,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624789,,BAO_0000218,995.0,
9960,1,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624790,,BAO_0000218,,
9961,1,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624791,,BAO_0000218,,
9962,1,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624792,,BAO_0000218,,
9963,1,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624793,,BAO_0000218,,
9964,1,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877491,,BAO_0000218,2385.0,
9965,1,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624957,,BAO_0000218,2385.0,
9966,1,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624958,,BAO_0000218,2385.0,
9967,1,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624959,,BAO_0000218,2385.0,
9968,1,Dissociation constant was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624960,,BAO_0000218,,
9969,1,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624961,,BAO_0000218,,
9970,1,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624962,,BAO_0000218,,
9971,1,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624963,,BAO_0000218,,
9972,1,Observed rate constant in 80% rat plasma at 37 degree Centigrade,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624964,,BAO_0000218,,
9973,1,LogP value was evaluated in the in situ rat gut perfusion assay,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624965,,BAO_0000218,,
9974,1,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624966,,BAO_0000218,,
9975,1,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624967,,BAO_0000218,,
9976,1,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624968,,BAO_0000218,,
9977,1,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624969,,BAO_0000218,,
9978,1,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL624970,,BAO_0000218,,
9979,1,Half-life was evaluated after 10 uM/kg of intra arterial administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624971,,BAO_0000218,,
9980,1,Half-life was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624972,,BAO_0000218,,
9981,1,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624973,,BAO_0000218,,
9982,1,Half-life was evaluated in plasma of rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624974,,BAO_0000218,1969.0,
9983,1,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624975,,BAO_0000218,,
9984,1,Half-life was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877492,,BAO_0000218,,
9985,1,Half-life was measured in rat after an iv dose of 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624976,,BAO_0000218,,
9986,1,Half-life period of compound in rats after peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624977,,BAO_0000218,,
9987,1,Half-life period of compound was measured in rat plasma.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626848,,BAO_0000218,1969.0,
9988,1,Half-life period of compound was measured in rat plasma; ND is not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626849,,BAO_0000218,1969.0,
9989,1,Half-life period of compound was measured in rat plasma; not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626850,,BAO_0000218,1969.0,
9990,1,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626851,,BAO_0000218,,
9991,1,Half-life period in rat by iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626852,,BAO_0000218,,
9992,1,Half-life period in rats following intravenous administration at 2 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626853,,BAO_0000218,,
9993,1,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626854,,BAO_0000218,,
9994,1,Half-life period was determined for the compound in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627486,,BAO_0000218,,
9995,1,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627487,,BAO_0000218,,
9996,1,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627488,,BAO_0000218,,
9997,1,Half-life value after IV dose at a dose of 5 mg/kg in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627489,,BAO_0000218,,
9998,1,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627490,,BAO_0000218,,
9999,1,Half-life was determined in rat after intravenous administration (0.5 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873829,,BAO_0000218,,
10000,1,Half-life was determined in rat at a dose of 1 mpk i.v.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627655,,BAO_0000218,,
10001,1,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625994,,BAO_0000218,,
10002,1,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625995,,BAO_0000218,,
10003,1,Half-life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625996,,BAO_0000218,,
10004,1,In vitro half life in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625850,,BAO_0000218,1969.0,
10005,1,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625851,,BAO_0000218,1969.0,
10006,1,In vitro half life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625852,,BAO_0000218,,
10007,1,In vivo half life period after intravenous administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625853,,BAO_0000218,,
10008,1,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625854,,BAO_0000218,,
10009,1,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874450,,BAO_0000218,,
10010,1,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625855,,BAO_0000218,,
10011,1,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625856,,BAO_0000218,,
10012,1,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625857,,BAO_0000218,,
10013,1,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873831,,BAO_0000218,,
10014,1,Longer half-life in rat (i.v.) at 0.5 mpk,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625858,,BAO_0000218,,
10015,1,Longer half-life in rat (p.o.) at 2.0 mpk,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625859,,BAO_0000218,,
10016,1,Pharmacokinetic property (half life) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625860,,BAO_0000218,,
10017,1,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625861,,BAO_0000218,,
10018,1,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625862,,BAO_0000218,,
10019,1,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625863,,BAO_0000218,,
10020,1,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625864,,BAO_0000218,,
10021,1,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625865,,BAO_0000218,,
10022,1,Pharmacokinetic half time was determined intravenously in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625866,,BAO_0000218,,
10023,1,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625867,,BAO_0000218,1969.0,
10024,1,Plasma half life of hydrolysis of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625868,,BAO_0000218,1969.0,
10025,1,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625869,,BAO_0000218,1969.0,
10026,1,Plasma half life period was calculated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874451,,BAO_0000218,1969.0,
10027,1,Plasma half-life in Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625870,,BAO_0000218,1969.0,
10028,1,Plasma half-life in Sprague-Dawley rats; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625871,,BAO_0000218,1969.0,
10029,1,Plasma half-life in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625872,,BAO_0000218,1969.0,
10030,1,Plasma half-life in rats; <MQL,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625873,,BAO_0000218,1969.0,
10031,1,Plasma half-life period (0-8 h) was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625874,,BAO_0000218,1969.0,
10032,1,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625875,,BAO_0000218,1969.0,
10033,1,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625876,,BAO_0000218,1969.0,
10034,1,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631258,,BAO_0000218,1969.0,
10035,1,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631259,,BAO_0000218,1969.0,
10036,1,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631260,,BAO_0000218,1969.0,
10037,1,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631261,,BAO_0000218,178.0,
10038,1,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631262,,BAO_0000218,178.0,
10039,1,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631263,,BAO_0000218,178.0,
10040,1,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631264,,BAO_0000218,,
10041,1,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631265,,BAO_0000218,,
10042,1,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631266,,BAO_0000218,,
10043,1,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631267,,BAO_0000218,,
10044,1,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631268,,BAO_0000218,,
10045,1,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631269,,BAO_0000218,,
10046,1,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631270,,BAO_0000218,,
10047,1,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631271,,BAO_0000218,948.0,
10048,1,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631272,,BAO_0000218,948.0,
10049,1,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631273,,BAO_0000218,948.0,
10050,1,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631274,,BAO_0000218,948.0,
10051,1,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631275,,BAO_0000218,948.0,
10052,1,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626984,,BAO_0000218,948.0,
10053,1,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626985,,BAO_0000218,948.0,
10054,1,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626986,,BAO_0000218,2107.0,
10055,1,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626987,,BAO_0000218,2107.0,
10056,1,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626988,,BAO_0000218,2107.0,
10057,1,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626989,,BAO_0000218,2107.0,
10058,1,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626990,,BAO_0000218,2107.0,
10059,1,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626991,,BAO_0000218,2107.0,
10060,1,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626992,,BAO_0000218,2107.0,
10061,1,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626993,,BAO_0000218,2048.0,
10062,1,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874593,,BAO_0000218,2048.0,
10063,1,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626994,,BAO_0000218,2048.0,
10064,1,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626995,,BAO_0000218,2048.0,
10065,1,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626190,,BAO_0000218,2048.0,
10066,1,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626191,,BAO_0000218,2048.0,
10067,1,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626364,,BAO_0000218,2048.0,
10068,1,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626365,,BAO_0000218,2046.0,
10069,1,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626366,,BAO_0000218,2046.0,
10070,1,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626367,,BAO_0000218,2046.0,
10071,1,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626368,,BAO_0000218,2046.0,
10072,1,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626369,,BAO_0000218,2046.0,
10073,1,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626370,,BAO_0000218,2046.0,
10074,1,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626371,,BAO_0000218,,
10075,1,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626372,,BAO_0000218,,
10076,1,Bioavailability after a dose of 10 mg/kg p.o.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626373,,BAO_0000218,,
10077,1,Bioavailability after peroral administration (10 mg/kg) was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626374,,BAO_0000218,,
10078,1,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626375,,BAO_0000218,,
10079,1,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626376,,BAO_0000218,,
10080,1,Bioavailability in rat po was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626377,,BAO_0000218,,
10081,1,Bioavailability of compound at 10 mg/kg in rat after oral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626378,,BAO_0000218,,
10082,1,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626379,,BAO_0000218,,
10083,1,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626380,,BAO_0000218,,
10084,1,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626381,,BAO_0000218,,
10085,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626382,,BAO_0000218,,
10086,1,Bioavailability in rat (Sprague-Dawley) (female),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626383,,BAO_0000218,,
10087,1,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874652,,BAO_0000218,,
10088,1,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626384,,BAO_0000218,,
10089,1,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626385,,BAO_0000218,,
10090,1,Bioavailability in rat at an oral dose of 2 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626386,,BAO_0000218,,
10091,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626387,,BAO_0000218,,
10092,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626388,,BAO_0000218,,
10093,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626389,,BAO_0000218,,
10094,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626390,,BAO_0000218,,
10095,1,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626391,,BAO_0000218,,
10096,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626392,,BAO_0000218,,
10097,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626393,,BAO_0000218,,
10098,1,Bioavailability was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623026,,BAO_0000218,,
10099,1,Bioavailability,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623027,,BAO_0000218,,
10100,1,Bioavailability,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623028,,BAO_0000218,,
10101,1,Bioavailability in rat after 1 day dosing,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623029,,BAO_0000218,,
10102,1,Bioavailability in rat after 4 day dosing,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623030,,BAO_0000218,,
10103,1,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623031,,BAO_0000218,,
10104,1,Bioavailability after IV dosing at 1 mg/kg in rat; no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623032,,BAO_0000218,,
10105,1,Bioavailability after oral administration at a dose of 2 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623033,,BAO_0000218,,
10106,1,Bioavailability after oral administration at a dose of 4 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623034,,BAO_0000218,,
10107,1,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623035,,BAO_0000218,,
10108,1,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623036,,BAO_0000218,,
10109,1,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623037,,BAO_0000218,,
10110,1,Bioavailability by intravenous administration of 3.4 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623038,,BAO_0000218,,
10111,1,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874385,,BAO_0000218,1969.0,
10112,1,Bioavailability in rat (Fisher) (fasted),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623039,,BAO_0000218,,
10113,1,Bioavailability in monkey after po administration of 10 mg/kg dose,Primates,0,22224,,U,Intermediate,,CHEMBL623040,,BAO_0000218,,
10114,1,Oral bioavailability in monkey (dose 10 mg/kg),Primates,0,22224,,U,Intermediate,,CHEMBL623041,,BAO_0000218,,
10115,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623741,,BAO_0000218,,
10116,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623742,,BAO_0000218,,
10117,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623743,,BAO_0000218,,
10118,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623744,,BAO_0000218,,
10119,1,Bioavailability in rat (dose 2.0 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623745,,BAO_0000218,,
10120,1,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623746,,BAO_0000218,,
10121,1,Oral bioavailability in rat (dose 5 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623747,,BAO_0000218,,
10122,1,Bioavailability in rat after po administration of 30 mg/kg dose,Rattus norvegicus,0,22224,,U,Intermediate,,CHEMBL623748,,BAO_0000218,,
10123,1,Bioavailability in rat after po administration of 30 mg/kg dose,Rattus norvegicus,0,22224,,U,Intermediate,,CHEMBL623916,,BAO_0000218,,
10124,1,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623917,,BAO_0000218,,
10125,1,Bioavailability in rat (dose 2 mg/kg i.v.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623918,,BAO_0000218,,
10126,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874386,,BAO_0000218,,
10127,1,Bioavailability in rat; Only traces detected in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623919,,BAO_0000218,1969.0,
10128,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623920,,BAO_0000218,,
10129,1,Bioavailability upon oral administration of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623148,,BAO_0000218,,
10130,1,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623149,,BAO_0000218,,
10131,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623150,,BAO_0000218,,
10132,1,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623151,,BAO_0000218,,
10133,1,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623152,,BAO_0000218,,
10134,1,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL623153,,BAO_0000218,,
10135,1,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL623154,,BAO_0000218,,
10136,1,In vitro and metabolic stability was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623155,,BAO_0000218,,
10137,1,In vitro metabolic stability in rat hepatocytes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623156,,BAO_0000218,,
10138,1,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623157,,BAO_0000218,,
10139,1,Metabolic rate for compound was observed in rat hepatocytes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623158,401.0,BAO_0000218,2107.0,
10140,1,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623159,,BAO_0000218,,
10141,1,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874390,,BAO_0000218,,
10142,1,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623160,,BAO_0000218,,
10143,1,Metabolism of compound in rat S9 microsomes; Trace,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623161,,BAO_0000218,,
10144,1,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623162,,BAO_0000218,,
10145,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623163,,BAO_0000218,,
10146,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623164,,BAO_0000218,,
10147,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623165,,BAO_0000218,,
10148,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623166,,BAO_0000218,,
10149,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624983,,BAO_0000218,,
10150,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624984,,BAO_0000218,,
10151,1,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624985,,BAO_0000218,,
10152,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622970,,BAO_0000218,,
10153,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622971,,BAO_0000218,,
10154,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622972,,BAO_0000218,,
10155,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622973,,BAO_0000218,,
10156,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622974,,BAO_0000218,,
10157,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622975,,BAO_0000218,,
10158,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622976,,BAO_0000218,,
10159,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622977,,BAO_0000218,,
10160,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624351,,BAO_0000218,,
10161,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624352,,BAO_0000218,,
10162,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624353,,BAO_0000218,,
10163,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622397,,BAO_0000218,,
10164,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622398,,BAO_0000218,,
10165,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622399,,BAO_0000218,,
10166,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622400,,BAO_0000218,,
10167,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628428,,BAO_0000218,,
10168,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628590,,BAO_0000218,,
10169,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628591,,BAO_0000218,,
10170,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628592,,BAO_0000218,,
10171,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628593,,BAO_0000218,,
10172,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875333,,BAO_0000218,,
10173,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628594,,BAO_0000218,,
10174,1,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628595,,BAO_0000218,1969.0,
10175,1,Stability in rat plasma was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628596,,BAO_0000218,1969.0,
10176,1,Stability in rat plasma was determined; ND= no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628597,,BAO_0000218,1969.0,
10177,1,Tested for plasma half life period in rat (0-8 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628598,,BAO_0000218,1969.0,
10178,1,Tested for plasma half life period in rat (0-8 hr); Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628599,,BAO_0000218,1969.0,
10179,1,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628600,,BAO_0000218,,
10180,1,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628601,,BAO_0000218,,
10181,1,Tested for the half life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628602,,BAO_0000218,,
10182,1,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628603,,BAO_0000218,,
10183,1,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628604,,BAO_0000218,,
10184,1,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628605,,BAO_0000218,,
10185,1,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628606,,BAO_0000218,,
10186,1,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628607,,BAO_0000218,,
10187,1,The biological half life the compound was measured at the dose of 100 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628608,,BAO_0000218,,
10188,1,The biological half life the compound was measured at the dose of 30 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628609,,BAO_0000218,,
10189,1,The compound was evaluated for plasma half life period in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628610,,BAO_0000218,1969.0,
10190,1,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL873819,,BAO_0000218,,
10191,1,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628611,,BAO_0000218,,
10192,1,The pharmacokinetic parameter half-life period in vivo in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628612,,BAO_0000218,,
10193,1,"The pharmacokinetic property, Half-life was determined",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628613,,BAO_0000218,,
10194,1,"The pharmacokinetic property, Half-life in rat in vivo",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628614,,BAO_0000218,,
10195,1,"The pharmacokinetic property, Half-life was determined; ND denotes no data",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628615,,BAO_0000218,,
10196,1,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628616,,BAO_0000218,,
10197,1,The plasma half life period in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627924,,BAO_0000218,1969.0,
10198,1,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627925,,BAO_0000218,2107.0,
10199,1,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627926,,BAO_0000218,,
10200,1,t1/2 (apparent elimination)of the compound was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627927,,BAO_0000218,,
10201,1,t1/2 value in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627928,,BAO_0000218,,
10202,1,Half life in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627539,,BAO_0000218,,
10203,1,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876790,,BAO_0000218,1969.0,
10204,1,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL858186,,BAO_0000218,,
10205,1,Half-life period in fasted rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627540,,BAO_0000218,,
10206,1,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627541,,BAO_0000218,,
10207,1,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627715,,BAO_0000218,,
10208,1,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627716,,BAO_0000218,,
10209,1,Maximum time required to achieve Cmax was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627717,,BAO_0000218,,
10210,1,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627718,,BAO_0000218,,
10211,1,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627719,,BAO_0000218,,
10212,1,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627720,,BAO_0000218,,
10213,1,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627721,,BAO_0000218,,
10214,1,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627722,,BAO_0000218,,
10215,1,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627723,,BAO_0000218,,
10216,1,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626058,,BAO_0000218,,
10217,1,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626059,,BAO_0000218,,
10218,1,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626060,,BAO_0000218,,
10219,1,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626061,,BAO_0000218,1969.0,
10220,1,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876791,,BAO_0000218,,
10221,1,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626062,,BAO_0000218,,
10222,1,Tmax at the dose of 2 mg/Kg administered perorally in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626063,,BAO_0000218,,
10223,1,Tmax at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626064,,BAO_0000218,,
10224,1,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626065,,BAO_0000218,1969.0,
10225,1,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626066,,BAO_0000218,1969.0,
10226,1,tmax upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626067,,BAO_0000218,,
10227,1,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626068,,BAO_0000218,,
10228,1,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626069,,BAO_0000218,,
10229,1,Percent total excretion of 3-methoxyacetaminophen glucuronide,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626070,,BAO_0000218,,
10230,1,Percent total excretion of N-methoxyacetaminophen glucuronide,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626071,,BAO_0000218,,
10231,1,Percent total excretion of N-methoxyacetaminophen sulfate,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626072,,BAO_0000218,,
10232,1,Percent total excretion of acetaminophen,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626073,,BAO_0000218,,
10233,1,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626741,,BAO_0000218,2046.0,
10234,1,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626742,,BAO_0000218,,
10235,1,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626743,,BAO_0000218,,
10236,1,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876792,,BAO_0000218,,
10237,1,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626744,,BAO_0000218,,
10238,1,Compound was tested for antidiuretic activity in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626745,,BAO_0000218,,
10239,1,AUC in rat after 3mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626746,,BAO_0000218,1969.0,
10240,1,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626747,,BAO_0000218,,
10241,1,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626748,,BAO_0000218,,
10242,1,Bioavailability administered orally at a dose of 10 mg/kg to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626749,,BAO_0000218,,
10243,1,Oral Bioavailability was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626750,,BAO_0000218,,
10244,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626751,,BAO_0000218,,
10245,1,Oral bioavailability in rat; Not performed.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626913,,BAO_0000218,,
10246,1,Bioavailability,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626914,,BAO_0000218,,
10247,1,Bioavailability was determined; ND denotes no data,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626915,,BAO_0000218,,
10248,1,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626916,,BAO_0000218,,
10249,1,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626917,,BAO_0000218,,
10250,1,Binding towards rat plasma protein at 10 uM,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626918,,BAO_0000218,,
10251,1,Binding towards rat plasma protein at 100 uM,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626919,,BAO_0000218,,
10252,1,Bioavailability in rat (dose 20 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626920,,BAO_0000218,,
10253,1,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621976,,BAO_0000218,,
10254,1,Bioavailability in rat after 5 mg/kg oral gavage,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877599,,BAO_0000218,,
10255,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621977,,BAO_0000218,,
10256,1,Bioavailability in rat (dose 1 mg/kg i.v.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621978,,BAO_0000218,,
10257,1,Bioavailability in rat (dose 3 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621979,,BAO_0000218,,
10258,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621980,,BAO_0000218,,
10259,1,Bioavailability of the compound in rats after administration of 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621981,,BAO_0000218,,
10260,1,Bioavailability after administration of 10 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621982,,BAO_0000218,,
10261,1,Bioavailability after administration of 2 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL882953,,BAO_0000218,,
10262,1,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621983,,BAO_0000218,,
10263,1,Bioavailability in dogs was determined; high,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621984,,BAO_0000218,,
10264,1,Bioavailability in monkey after intravenous administration at 1 mpk,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621985,,BAO_0000218,,
10265,1,Bioavailability in monkey after peroral administration at 10 mpk,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621986,,BAO_0000218,,
10266,1,Bioavailability in rat after intravenous administration at 1 mpk,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621987,,BAO_0000218,,
10267,1,Bioavailability in rat after intravenous administration at 2 mpk,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877600,,BAO_0000218,,
10268,1,Bioavailability in rat after peroral administration at 30 mpk,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621988,,BAO_0000218,,
10269,1,Bioavailability in rat after peroral administration at at 100 mpk,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621989,,BAO_0000218,,
10270,1,Bioavailability in rats was evaluated,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621990,,BAO_0000218,,
10271,1,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621991,,BAO_0000218,,
10272,1,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621992,,BAO_0000218,,
10273,1,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621993,,BAO_0000218,,
10274,1,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621994,,BAO_0000218,,
10275,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621995,,BAO_0000218,,
10276,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621996,,BAO_0000218,,
10277,1,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621997,,BAO_0000218,,
10278,1,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621998,,BAO_0000218,,
10279,1,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621999,,BAO_0000218,,
10280,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622000,,BAO_0000218,,
10281,1,Bioavailability was measured in rat after oral administration; 2-4,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622001,,BAO_0000218,,
10282,1,Bioavailability was measured in rat after oral administration; 3-7,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622002,,BAO_0000218,,
10283,1,Bioavailability in rat (intraduodenal administration),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622003,,BAO_0000218,,
10284,1,Bioavailability in rat (intraduodenal administration),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877601,,BAO_0000218,,
10285,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624871,,BAO_0000218,,
10286,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622004,,BAO_0000218,,
10287,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL882954,,BAO_0000218,,
10288,1,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622005,,BAO_0000218,,
10289,1,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622006,,BAO_0000218,,
10290,1,Bioavailability was measured in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622007,,BAO_0000218,,
10291,1,Bioavailability was reported,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622008,,BAO_0000218,,
10292,1,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622009,,BAO_0000218,,
10293,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622010,,BAO_0000218,,
10294,1,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622011,,BAO_0000218,,
10295,1,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622012,,BAO_0000218,,
10296,1,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622013,,BAO_0000218,,
10297,1,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622014,,BAO_0000218,,
10298,1,Bioavailability was determined at 3 mg/kg po dose in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624749,,BAO_0000218,,
10299,1,Oral bioavailability in rat (dose 2 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624750,,BAO_0000218,,
10300,1,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624751,,BAO_0000218,,
10301,1,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624752,,BAO_0000218,,
10302,1,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624753,,BAO_0000218,,
10303,1,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624754,,BAO_0000218,,
10304,1,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624755,,BAO_0000218,,
10305,1,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624756,,BAO_0000218,,
10306,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624757,,BAO_0000218,,
10307,1,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624758,,BAO_0000218,,
10308,1,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622270,,BAO_0000218,,
10309,1,Bioavailability in rat (Sprague-Dawley),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622271,,BAO_0000218,,
10310,1,Bioavailability in rat at the dose of 2 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622272,,BAO_0000218,,
10311,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622273,,BAO_0000218,,
10312,1,Bioavailability in rat (cannulated) (dose 2 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622274,,BAO_0000218,,
10313,1,Bioavailability value of compound in rats was determined after peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622275,,BAO_0000218,,
10314,1,Oral bioavailability in rat (dose 20 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622276,,BAO_0000218,,
10315,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622277,,BAO_0000218,,
10316,1,Oral bioavailability in rat (dose 5 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622278,,BAO_0000218,,
10317,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622279,,BAO_0000218,,
10318,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622280,,BAO_0000218,,
10319,1,Compound was evaluated for oral bioavailability in rats; 15-27 %,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624083,,BAO_0000218,,
10320,1,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624084,,BAO_0000218,,
10321,1,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624085,,BAO_0000218,,
10322,1,Compound was tested for bioavailability in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624086,,BAO_0000218,,
10323,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624087,,BAO_0000218,,
10324,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624088,,BAO_0000218,,
10325,1,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,Macaca mulatta,0,22224,,U,Intermediate,,CHEMBL624089,,BAO_0000218,,
10326,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),Rattus norvegicus,0,22224,,U,Intermediate,,CHEMBL624090,,BAO_0000218,,
10327,1,Evaluated for the bioavailability in rat (in vivo),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624091,,BAO_0000218,,
10328,1,F value of compound in rats was determined after peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624092,,BAO_0000218,,
10329,1,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624093,,BAO_0000218,,
10330,1,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624094,,BAO_0000218,,
10331,1,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624095,,BAO_0000218,,
10332,1,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624096,,BAO_0000218,,
10333,1,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624097,,BAO_0000218,,
10334,1,Maximum fall in carotid flow in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624098,,BAO_0000218,,
10335,1,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874392,,BAO_0000218,,
10336,1,Oral bioavailability in rat (dose 5 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624099,,BAO_0000218,,
10337,1,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624100,,BAO_0000218,,
10338,1,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624101,,BAO_0000218,,
10339,1,Oral bioavailability in rat (male Wistar),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624102,,BAO_0000218,,
10340,1,Oral bioavailability after administration (30 mg/kg) in rat; good,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624103,,BAO_0000218,,
10341,1,Oral bioavailability at the dose of 2 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624104,,BAO_0000218,,
10342,1,Oral bioavailability determined in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624105,,BAO_0000218,,
10343,1,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624106,,BAO_0000218,,
10344,1,Oral bioavailability in rat (dose single 10 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624107,,BAO_0000218,,
10345,1,Oral bioavailability in rat (dose single 10 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623943,,BAO_0000218,,
10346,1,Oral bioavailability in rat (dose 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623944,,BAO_0000218,,
10347,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623945,,BAO_0000218,,
10348,1,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623946,,BAO_0000218,,
10349,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623947,,BAO_0000218,,
10350,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623948,,BAO_0000218,,
10351,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623949,,BAO_0000218,,
10352,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623950,,BAO_0000218,,
10353,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874398,,BAO_0000218,,
10354,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623951,,BAO_0000218,,
10355,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623952,,BAO_0000218,,
10356,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623953,,BAO_0000218,,
10357,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623954,,BAO_0000218,,
10358,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623955,,BAO_0000218,,
10359,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623956,,BAO_0000218,,
10360,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627807,,BAO_0000218,,
10361,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627808,,BAO_0000218,,
10362,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627809,,BAO_0000218,,
10363,1,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627810,,BAO_0000218,,
10364,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627811,,BAO_0000218,,
10365,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627812,,BAO_0000218,,
10366,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627813,,BAO_0000218,,
10367,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627814,,BAO_0000218,,
10368,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875336,,BAO_0000218,,
10369,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627815,,BAO_0000218,,
10370,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627816,,BAO_0000218,,
10371,1,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627817,,BAO_0000218,,
10372,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627818,,BAO_0000218,,
10373,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627819,,BAO_0000218,,
10374,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627820,,BAO_0000218,,
10375,1,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627821,,BAO_0000218,,
10376,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628464,,BAO_0000218,,
10377,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626239,,BAO_0000218,,
10378,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626240,,BAO_0000218,,
10379,1,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626241,,BAO_0000218,,
10380,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626242,,BAO_0000218,,
10381,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626243,,BAO_0000218,,
10382,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626244,,BAO_0000218,,
10383,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626907,,BAO_0000218,,
10384,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626908,,BAO_0000218,,
10385,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626909,,BAO_0000218,,
10386,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626910,,BAO_0000218,,
10387,1,Percent total excretion of acetaminophen cysteine conjugate,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875342,,BAO_0000218,,
10388,1,Percent total excretion of acetaminophen glucuronide,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626911,,BAO_0000218,,
10389,1,Percent total excretion of acetaminophen sulfate,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626912,,BAO_0000218,,
10390,1,Percent total excretion of acetaminophen-mercapturic acid,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627065,,BAO_0000218,,
10391,1,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627066,,BAO_0000218,1088.0,
10392,1,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627067,,BAO_0000218,,
10393,1,Biodistribution of compound in rat muscle after 5 min of administration,ratrat,0,22224,,U,Autocuration,,CHEMBL627068,,BAO_0000218,2385.0,
10394,1,Biodistribution of compound in rat muscle after 5 min of administration.,ratrat,0,22224,,U,Autocuration,,CHEMBL627069,,BAO_0000218,2385.0,
10395,1,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,0,22224,,U,Autocuration,,CHEMBL627070,,BAO_0000218,,
10396,1,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,0,22224,,U,Autocuration,,CHEMBL627071,,BAO_0000218,,
10397,1,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,0,22224,,U,Autocuration,,CHEMBL627072,,BAO_0000218,,
10398,1,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,0,22224,,U,Autocuration,,CHEMBL627073,,BAO_0000218,,
10399,1,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,0,22224,,U,Autocuration,,CHEMBL625387,,BAO_0000218,,
10400,1,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,0,22224,,U,Autocuration,,CHEMBL625388,,BAO_0000218,,
10401,1,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),Ovis aries,0,22224,,U,Autocuration,,CHEMBL625389,,BAO_0000218,1969.0,
10402,1,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),Ovis aries,0,22224,,U,Autocuration,,CHEMBL875343,,BAO_0000218,1969.0,
10403,1,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),Serpentes,1,50497,,N,Intermediate,,CHEMBL876795,,BAO_0000218,,
10404,1,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,Serpentes,1,50497,,N,Intermediate,,CHEMBL626552,,BAO_0000218,,
10405,1,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,Serpentes,1,50497,,N,Intermediate,,CHEMBL626553,,BAO_0000218,,
10406,1,The human biological plasma half life of the compound,Homo sapiens,0,22224,,U,Autocuration,,CHEMBL626554,,BAO_0000366,1969.0,
10407,1,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626555,,BAO_0000218,1088.0,
10408,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626556,,BAO_0000218,,
10409,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626557,,BAO_0000218,,
10410,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626558,,BAO_0000218,,
10411,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626559,,BAO_0000218,,
10412,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626560,,BAO_0000218,,
10413,1,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876803,,BAO_0000218,,
10414,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627964,,BAO_0000218,,
10415,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627965,,BAO_0000218,,
10416,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627966,,BAO_0000218,,
10417,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627967,,BAO_0000218,,
10418,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627968,,BAO_0000218,,
10419,1,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627969,,BAO_0000218,,
10420,1,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627970,,BAO_0000218,,
10421,1,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627971,,BAO_0000218,178.0,
10422,1,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627972,,BAO_0000218,178.0,
10423,1,Dissociation constant against binding to human cyclophilin A,Homo sapiens,9,180,,D,Expert,,CHEMBL856029,,BAO_0000357,,
10424,1,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,Bos taurus,8,11591,,H,Expert,,CHEMBL627973,,BAO_0000019,,
10425,1,-Log C was determined by performing the electroshock minimum test,,0,22224,,U,Autocuration,,CHEMBL627974,,BAO_0000019,,
10426,1,-Log C was determined by performing the foot shock test,,0,22224,,U,Autocuration,,CHEMBL627975,,BAO_0000019,,
10427,1,-Log C was determined by performing the incl screen test,,0,22224,,U,Autocuration,,CHEMBL627976,,BAO_0000019,,
10428,1,-Log C was determined by performing the maximum electroshock test,,0,22224,,U,Autocuration,,CHEMBL627977,,BAO_0000019,,
10429,1,-Log C was determined by performing the pentylenetetrazole test,,0,22224,,U,Autocuration,,CHEMBL627978,,BAO_0000019,,
10430,1,Tested for experimental arotinoid inhibitory dose,,0,22224,,U,Autocuration,,CHEMBL627979,,BAO_0000019,,
10431,1,Negative log transformed activity,,0,22224,,U,Autocuration,,CHEMBL876804,,BAO_0000019,,
10432,1,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",,0,22224,,U,Autocuration,,CHEMBL627980,,BAO_0000019,,
10433,1,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL627981,,BAO_0000218,,
10434,1,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL627982,,BAO_0000218,,
10435,1,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL627983,,BAO_0000218,,
10436,1,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL627984,,BAO_0000218,2116.0,
10437,1,Solubility in water was determined; values expressed as -log,,0,22229,,U,Autocuration,,CHEMBL627985,,BAO_0000100,,
10438,1,Ratio of Kcat to that of Km was determined,,0,22224,,U,Autocuration,,CHEMBL627986,,BAO_0000019,,
10439,1,Observed first order rate constant,,0,22224,,U,Autocuration,,CHEMBL627987,,BAO_0000019,,
10440,1,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,,0,22224,,U,Autocuration,,CHEMBL627988,,BAO_0000019,,
10441,1,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627989,,BAO_0000218,,
10442,1,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627990,,BAO_0000218,,
10443,1,Oral Bioavailability after administration of 10 mg/kg in male rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876805,,BAO_0000218,,
10444,1,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627991,,BAO_0000218,,
10445,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627992,,BAO_0000218,,
10446,1,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627993,,BAO_0000218,,
10447,1,Oral bioavailability at 1 mg/kg was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622817,,BAO_0000218,,
10448,1,Oral bioavailability at 10 mg/kg was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622818,,BAO_0000218,,
10449,1,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622819,,BAO_0000218,,
10450,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL872267,,BAO_0000218,,
10451,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622820,,BAO_0000218,,
10452,1,Oral bioavailability after intravenous administration in rats at 24 uM/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622821,,BAO_0000218,,
10453,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622822,,BAO_0000218,,
10454,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622823,,BAO_0000218,,
10455,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622824,,BAO_0000218,,
10456,1,Oral bioavailability in rat at a dose of 3 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622825,,BAO_0000218,,
10457,1,Oral bioavailability in rat after oral administration at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622901,,BAO_0000218,,
10458,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622902,,BAO_0000218,,
10459,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621844,,BAO_0000218,,
10460,1,Oral bioavailability in Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621845,,BAO_0000218,,
10461,1,Oral bioavailability,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621846,,BAO_0000218,,
10462,1,Oral bioavailability in rat (dose 30 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621847,,BAO_0000218,,
10463,1,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877609,,BAO_0000218,,
10464,1,Bioavailability in rat (dose 3 mg/kg i.v.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621848,,BAO_0000218,,
10465,1,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621849,,BAO_0000218,,
10466,1,Oral bioavailability in rat (dose 60 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622030,,BAO_0000218,,
10467,1,Percent oral bioavailability determined in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622031,,BAO_0000218,,
10468,1,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622032,,BAO_0000218,,
10469,1,The compound was evaluated for bioavailability in rats; 32-51,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622033,,BAO_0000218,,
10470,1,Bioavailability in rat (dose 20 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622034,,BAO_0000218,,
10471,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622035,,BAO_0000218,,
10472,1,Bioavailability percent in rat at the dose of 2 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL882966,,BAO_0000218,,
10473,1,Bioavailability was evaluated after 20 uM/kg of peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622036,,BAO_0000218,,
10474,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622037,,BAO_0000218,,
10475,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622038,,BAO_0000218,,
10476,1,Bioavailability in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622039,,BAO_0000218,,
10477,1,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622040,,BAO_0000218,178.0,
10478,1,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622041,,BAO_0000218,178.0,
10479,1,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622042,,BAO_0000218,178.0,
10480,1,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622043,,BAO_0000218,178.0,
10481,1,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622044,,BAO_0000218,178.0,
10482,1,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622045,,BAO_0000218,10000001.0,
10483,1,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622046,,BAO_0000218,10000001.0,
10484,1,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622047,,BAO_0000218,10000001.0,
10485,1,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877610,,BAO_0000218,10000001.0,
10486,1,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622048,,BAO_0000218,955.0,
10487,1,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622049,,BAO_0000218,955.0,
10488,1,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622050,,BAO_0000218,955.0,
10489,1,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622051,,BAO_0000218,955.0,
10490,1,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622052,,BAO_0000218,,
10491,1,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622053,,BAO_0000218,,
10492,1,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622054,,BAO_0000218,,
10493,1,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622055,,BAO_0000218,,
10494,1,Oral bioavailability in rats was determined; High,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622056,,BAO_0000218,,
10495,1,Oral bioavailability in the rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622057,,BAO_0000218,,
10496,1,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628008,,BAO_0000218,,
10497,1,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622058,,BAO_0000218,,
10498,1,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622059,,BAO_0000218,,
10499,1,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622060,,BAO_0000218,,
10500,1,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622061,,BAO_0000218,,
10501,1,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622062,,BAO_0000218,,
10502,1,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622063,,BAO_0000218,,
10503,1,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL877611,,BAO_0000218,,
10504,1,Oral bioavailability of compound in Sprague Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622064,,BAO_0000218,,
10505,1,Oral bioavailability of compound in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622065,,BAO_0000218,,
10506,1,Oral bioavailability in rat (dose 2 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622066,,BAO_0000218,,
10507,1,Oral bioavailability of compound in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622067,,BAO_0000218,,
10508,1,Oral bioavailability of compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622068,,BAO_0000218,,
10509,1,Oral bioavailability of compound was determined in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622069,,BAO_0000218,,
10510,1,Oral bioavailability at a dose of 30 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624796,,BAO_0000218,,
10511,1,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624797,,BAO_0000218,,
10512,1,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623053,,BAO_0000218,,
10513,1,Oral bioavailability evaluated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623054,,BAO_0000218,,
10514,1,Oral bioavailability in fasted rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623055,,BAO_0000218,,
10515,1,Oral bioavailability in fed rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623056,,BAO_0000218,,
10516,1,Oral bioavailability in rat (mature male) (dose 30 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623057,,BAO_0000218,,
10517,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623058,,BAO_0000218,,
10518,1,Oral bioavailability in rat (dose 10 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623059,,BAO_0000218,,
10519,1,Oral bioavailability in rat after administration of 10 mg/kg po,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623060,,BAO_0000218,,
10520,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623061,,BAO_0000218,,
10521,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623062,,BAO_0000218,,
10522,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623063,,BAO_0000218,,
10523,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623064,,BAO_0000218,,
10524,1,Oral bioavailability in ratrs,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623065,,BAO_0000218,,
10525,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623066,,BAO_0000218,,
10526,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623067,,BAO_0000218,,
10527,1,Oral bioavailability in rats was determined; High,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623068,,BAO_0000218,,
10528,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623069,,BAO_0000218,,
10529,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623070,,BAO_0000218,,
10530,1,Oral bioavailability was calculated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623071,,BAO_0000218,,
10531,1,Oral bioavailability,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623072,,BAO_0000218,,
10532,1,Oral bioavailability,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623073,,BAO_0000218,,
10533,1,Oral bioavailability,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623074,,BAO_0000218,,
10534,1,Oral bioavailability,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623075,,BAO_0000218,,
10535,1,Oral bioavailability after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623076,,BAO_0000218,,
10536,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623077,,BAO_0000218,,
10537,1,Oral bioavailability in rat (Sprague-Dawley),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623078,,BAO_0000218,,
10538,1,Oral bioavailability in Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623079,,BAO_0000218,,
10539,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623080,,BAO_0000218,,
10540,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623081,,BAO_0000218,,
10541,1,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623082,,BAO_0000218,,
10542,1,Oral bioavailability in fasted rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874400,,BAO_0000218,,
10543,1,Oral bioavailability in fed rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623083,,BAO_0000218,,
10544,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623084,,BAO_0000218,,
10545,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623085,,BAO_0000218,,
10546,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623086,,BAO_0000218,,
10547,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623087,,BAO_0000218,,
10548,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623088,,BAO_0000218,,
10549,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623089,,BAO_0000218,,
10550,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623090,,BAO_0000218,,
10551,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623091,,BAO_0000218,,
10552,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623092,,BAO_0000218,,
10553,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623093,,BAO_0000218,,
10554,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874401,,BAO_0000218,,
10555,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623094,,BAO_0000218,,
10556,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623095,,BAO_0000218,,
10557,1,Oral bioavailability in rat after peroral administration at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623096,,BAO_0000218,,
10558,1,Oral bioavailability in rat after peroral administration at 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624913,,BAO_0000218,,
10559,1,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624914,,BAO_0000218,,
10560,1,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624915,,BAO_0000218,,
10561,1,Oral bioavailability in rat; Not measured,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624916,,BAO_0000218,,
10562,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624917,,BAO_0000218,,
10563,1,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625157,,BAO_0000218,,
10564,1,In vitro metabolic potential in rat liver microsomes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625158,,BAO_0000218,2107.0,
10565,1,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625159,,BAO_0000218,,
10566,1,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625160,,BAO_0000218,,
10567,1,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625161,,BAO_0000218,,
10568,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625162,,BAO_0000218,,
10569,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625163,,BAO_0000218,,
10570,1,Oral bioavailability in rats at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625164,,BAO_0000218,,
10571,1,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625165,,BAO_0000218,,
10572,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625166,,BAO_0000218,,
10573,1,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625167,,BAO_0000218,,
10574,1,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625168,,BAO_0000218,,
10575,1,Plasma clearance of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625169,,BAO_0000218,,
10576,1,Plasma clearance at 10 mg/kg in rat upon intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626264,,BAO_0000218,,
10577,1,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626265,,BAO_0000218,,
10578,1,The compound was tested for plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626266,,BAO_0000218,1969.0,
10579,1,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626267,,BAO_0000218,1969.0,
10580,1,Plasma concentration upon oral administration of 1 mg/Kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626268,,BAO_0000218,,
10581,1,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626269,,BAO_0000218,,
10582,1,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626270,,BAO_0000218,,
10583,1,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626271,,BAO_0000218,,
10584,1,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626272,,BAO_0000218,,
10585,1,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626273,,BAO_0000218,,
10586,1,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875346,,BAO_0000218,,
10587,1,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626274,,BAO_0000218,,
10588,1,Compound was tested for protein binding in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626275,,BAO_0000218,,
10589,1,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624646,,BAO_0000218,,
10590,1,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624647,,BAO_0000218,,
10591,1,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624648,,BAO_0000218,2107.0,
10592,1,Area under curve ratio was determined (po/iv) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624649,,BAO_0000218,,
10593,1,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624650,,BAO_0000218,,
10594,1,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624651,,BAO_0000218,,
10595,1,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624652,,BAO_0000218,,
10596,1,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624653,,BAO_0000218,,
10597,1,Ratio of AUCbrain to AUCplasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624654,,BAO_0000218,,
10598,1,Ratio of brain to plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624655,,BAO_0000218,,
10599,1,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624656,,BAO_0000218,,
10600,1,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624657,,BAO_0000218,,
10601,1,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624658,,BAO_0000218,,
10602,1,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624659,,BAO_0000218,,
10603,1,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624660,,BAO_0000218,,
10604,1,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624661,,BAO_0000218,,
10605,1,Steady state brain :blood ratio was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624662,,BAO_0000218,,
10606,1,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625199,,BAO_0000218,,
10607,1,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625200,,BAO_0000218,,
10608,1,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625201,,BAO_0000218,,
10609,1,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625202,,BAO_0000218,,
10610,1,Percentage recovery after 3h incubation with rat hapatocytes was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625203,,BAO_0000218,,
10611,1,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625204,,BAO_0000218,,
10612,1,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625205,,BAO_0000218,,
10613,1,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625206,,BAO_0000218,,
10614,1,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",,0,22224,,U,Autocuration,,CHEMBL625207,,BAO_0000019,,
10615,1,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,,0,22224,,U,Autocuration,,CHEMBL625208,,BAO_0000019,,
10616,1,In vivo absorption in Caco-2 cell line monolayers was determined,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL625209,495.0,BAO_0000218,,
10617,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625210,,BAO_0000100,,
10618,1,Area under curve was determine after peroral administration at 10 mpk in Rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625211,,BAO_0000218,,
10619,1,Area under curve was determine after peroral administration at 10 mpk in Rhesus,Macaca mulatta,1,50797,,N,Intermediate,,CHEMBL625212,,BAO_0000218,,
10620,1,Area under curve was determine after peroral administration at 160 mpk in Rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625213,,BAO_0000218,,
10621,1,Area under curve was determine after peroral administration at 20 mpk in Rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625214,,BAO_0000218,,
10622,1,Area under curve was determine after peroral administration at 50 mpk in Rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874542,,BAO_0000218,,
10623,1,Calculated partition coefficient (clogP) (AlogP),,0,22229,,U,Autocuration,,CHEMBL625215,,BAO_0000100,,
10624,1,Activated partial thromboplastin time measured,,0,22224,,U,Autocuration,,CHEMBL625216,,BAO_0000019,,
10625,1,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),,0,22224,,U,Autocuration,,CHEMBL625217,,BAO_0000100,,
10626,1,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),,0,22224,,U,Autocuration,,CHEMBL625218,,BAO_0000100,,
10627,1,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622864,,BAO_0000218,1969.0,
10628,1,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622865,,BAO_0000218,1969.0,
10629,1,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622866,,BAO_0000218,1969.0,
10630,1,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622867,,BAO_0000218,1969.0,
10631,1,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL876808,,BAO_0000218,1969.0,
10632,1,AUC in brain,,0,22224,,U,Autocuration,,CHEMBL627725,,BAO_0000019,955.0,
10633,1,AUC in serum,,0,22224,,U,Autocuration,,CHEMBL627726,,BAO_0000019,1977.0,
10634,1,AUC was determined,,0,22224,,U,Autocuration,,CHEMBL627727,,BAO_0000019,1969.0,
10635,1,AUC of the compound.,,0,22224,,U,Autocuration,,CHEMBL627728,,BAO_0000019,1969.0,
10636,1,AUC value (0-4 hr),,0,22224,,U,Autocuration,,CHEMBL627729,,BAO_0000019,1969.0,
10637,1,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",,0,22224,,U,Autocuration,,CHEMBL627730,,BAO_0000019,1969.0,
10638,1,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,,0,22224,,U,Autocuration,,CHEMBL627731,,BAO_0000019,1969.0,
10639,1,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",,0,22224,,U,Autocuration,,CHEMBL627732,,BAO_0000019,1969.0,
10640,1,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",,0,22224,,U,Autocuration,,CHEMBL627733,,BAO_0000019,1969.0,
10641,1,AUC(area under curve) was determined after intravenous administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627734,,BAO_0000218,1969.0,
10642,1,AUC(area under curve) was determined after oral administration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627735,,BAO_0000218,1969.0,
10643,1,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL627736,,BAO_0000218,1969.0,
10644,1,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876809,,BAO_0000218,1969.0,
10645,1,Area Under Curve after oral dosing of 100 uM/Kg,,0,22224,,U,Autocuration,,CHEMBL627737,,BAO_0000019,,
10646,1,Area Under Curve after oral dosing of 30 uM/Kg,,0,22224,,U,Autocuration,,CHEMBL627738,,BAO_0000019,,
10647,1,Area Under Curve was measured by ploting the graph between concentration verses time,,0,22224,,U,Autocuration,,CHEMBL627739,,BAO_0000019,,
10648,1,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626143,,BAO_0000218,,
10649,1,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,Simiiformes,0,22224,,U,Autocuration,,CHEMBL626144,,BAO_0000218,,
10650,1,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL626145,,BAO_0000218,,
10651,1,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626146,,BAO_0000218,,
10652,1,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626147,,BAO_0000218,178.0,
10653,1,Area under curve (AUC) was determined,,0,22224,,U,Autocuration,,CHEMBL626148,,BAO_0000019,,
10654,1,Area under curve (AUC) following ip administration at 1 mg/kg,,0,22224,,U,Autocuration,,CHEMBL626149,,BAO_0000218,,
10655,1,Area under curve (AUC) was determined; ND is Not determined,,0,22224,,U,Autocuration,,CHEMBL626150,,BAO_0000019,,
10656,1,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626151,,BAO_0000218,,
10657,1,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626152,,BAO_0000218,,
10658,1,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626153,,BAO_0000218,,
10659,1,Area under curve (AUR) was determined,,0,22224,,U,Autocuration,,CHEMBL626154,,BAO_0000019,,
10660,1,Area under curve at 1 uM/dg administered intravenously,,0,22224,,U,Autocuration,,CHEMBL626155,,BAO_0000019,,
10661,1,Area under curve at 10 uM/dg administered perorally,,0,22224,,U,Autocuration,,CHEMBL626156,,BAO_0000019,,
10662,1,Area under curve at 2 uM/dg administered intravenously,,0,22224,,U,Autocuration,,CHEMBL626157,,BAO_0000019,,
10663,1,Area under curve at 20 uM/dg administered perorally,,0,22224,,U,Autocuration,,CHEMBL626158,,BAO_0000019,,
10664,1,Area under curve at a peroral dose of 3 mg/kg in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626159,,BAO_0000218,,
10665,1,Area under curve at a peroral dose of 3 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626160,,BAO_0000218,,
10666,1,Area under curve at an iv dose of 1 mg/kg in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626161,,BAO_0000218,,
10667,1,Area under curve at an iv dose of 1 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626162,,BAO_0000218,,
10668,1,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,,0,22224,,U,Autocuration,,CHEMBL626163,,BAO_0000019,,
10669,1,Area under curve gives the effective duration for the angiotensin II antagonist effect.,,0,22224,,U,Autocuration,,CHEMBL626164,,BAO_0000019,,
10670,1,Area under curve measured as conc vs time after intravenous administration to mice.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626165,,BAO_0000218,,
10671,1,Area under curve measured as conc vs time after peroral administration to mice.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626166,,BAO_0000218,,
10672,1,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626167,,BAO_0000218,,
10673,1,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626168,,BAO_0000218,,
10674,1,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL877463,,BAO_0000218,,
10675,1,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626169,,BAO_0000218,,
10676,1,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626170,,BAO_0000218,948.0,
10677,1,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626171,,BAO_0000218,948.0,
10678,1,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626172,,BAO_0000218,948.0,
10679,1,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626173,,BAO_0000218,948.0,
10680,1,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626174,,BAO_0000218,2113.0,
10681,1,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626175,,BAO_0000218,2113.0,
10682,1,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626176,,BAO_0000218,2113.0,
10683,1,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626177,,BAO_0000218,2113.0,
10684,1,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622499,,BAO_0000218,2113.0,
10685,1,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622500,,BAO_0000218,2107.0,
10686,1,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622501,,BAO_0000218,2107.0,
10687,1,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622502,,BAO_0000218,2107.0,
10688,1,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622503,,BAO_0000218,2107.0,
10689,1,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877614,,BAO_0000218,2107.0,
10690,1,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624839,,BAO_0000218,2048.0,
10691,1,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624840,,BAO_0000218,2048.0,
10692,1,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624841,,BAO_0000218,2048.0,
10693,1,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624842,,BAO_0000218,2048.0,
10694,1,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624843,,BAO_0000218,2385.0,
10695,1,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624844,,BAO_0000218,2385.0,
10696,1,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624845,,BAO_0000218,2385.0,
10697,1,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621904,,BAO_0000218,2385.0,
10698,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621905,,BAO_0000218,178.0,
10699,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874382,,BAO_0000218,178.0,
10700,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621906,,BAO_0000218,178.0,
10701,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621907,,BAO_0000218,955.0,
10702,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622096,,BAO_0000218,955.0,
10703,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622097,,BAO_0000218,955.0,
10704,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622098,,BAO_0000218,948.0,
10705,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622099,,BAO_0000218,948.0,
10706,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622100,,BAO_0000218,948.0,
10707,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622101,,BAO_0000218,2113.0,
10708,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622102,,BAO_0000218,2113.0,
10709,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622103,,BAO_0000218,2113.0,
10710,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622104,,BAO_0000218,2107.0,
10711,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622105,,BAO_0000218,2107.0,
10712,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622106,,BAO_0000218,2107.0,
10713,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622107,,BAO_0000218,2048.0,
10714,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622108,,BAO_0000218,2048.0,
10715,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622109,,BAO_0000218,2048.0,
10716,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622110,,BAO_0000218,2385.0,
10717,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622111,,BAO_0000218,2385.0,
10718,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874383,,BAO_0000218,2385.0,
10719,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622112,,BAO_0000218,14.0,
10720,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622113,,BAO_0000218,14.0,
10721,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622114,,BAO_0000218,14.0,
10722,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622115,,BAO_0000218,2106.0,
10723,1,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622116,,BAO_0000218,2106.0,
10724,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622117,,BAO_0000218,,
10725,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622118,,BAO_0000218,,
10726,1,Oral bioavailability in rats at 6 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622119,,BAO_0000218,,
10727,1,Oral bioavailability in rat (dose 6 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622120,,BAO_0000218,,
10728,1,Oral bioavailability in rats at 6 mg/kg dose; Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622121,,BAO_0000218,,
10729,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622122,,BAO_0000218,,
10730,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622123,,BAO_0000218,,
10731,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622124,,BAO_0000218,,
10732,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622125,,BAO_0000218,,
10733,1,Oral bioavailability,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622126,,BAO_0000218,,
10734,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620455,,BAO_0000218,,
10735,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620456,,BAO_0000218,,
10736,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620457,,BAO_0000218,,
10737,1,Oral bioavailability was evaluated; Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620458,,BAO_0000218,,
10738,1,Oral bioavailability,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620459,,BAO_0000218,,
10739,1,Oral bioavailability in rat by oral dosing,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620460,,BAO_0000218,,
10740,1,Oral bioavailability in rat (dose 10 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620461,,BAO_0000218,,
10741,1,Oral bioavailability in rat (Sprague-Dawley),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620462,,BAO_0000218,,
10742,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620463,,BAO_0000218,,
10743,1,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620464,,BAO_0000218,,
10744,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620465,,BAO_0000218,,
10745,1,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620466,,BAO_0000218,,
10746,1,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620467,,BAO_0000218,,
10747,1,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620468,,BAO_0000218,,
10748,1,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620469,,BAO_0000218,,
10749,1,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620470,,BAO_0000218,,
10750,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620471,,BAO_0000218,,
10751,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620472,,BAO_0000218,,
10752,1,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620473,,BAO_0000218,,
10753,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620474,,BAO_0000218,,
10754,1,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620475,,BAO_0000218,,
10755,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620476,,BAO_0000218,,
10756,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620477,,BAO_0000218,,
10757,1,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620478,,BAO_0000218,,
10758,1,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618768,,BAO_0000218,,
10759,1,Oral bioavailability in rat after oral administration at 13 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618769,,BAO_0000218,,
10760,1,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618770,,BAO_0000218,,
10761,1,Oral bioavailability (dose 20 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618771,,BAO_0000218,,
10762,1,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618772,,BAO_0000218,,
10763,1,Oral bioavailability in rat at 10 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618773,,BAO_0000218,,
10764,1,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875842,,BAO_0000218,,
10765,1,Bioavailability in rat (dose 3 mg/kg i.v.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618774,,BAO_0000218,,
10766,1,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618775,,BAO_0000218,,
10767,1,Oral bioavailability in rat (dose 60 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618776,,BAO_0000218,,
10768,1,Percent bioavailability (F) in rats after iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618777,,BAO_0000218,,
10769,1,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618778,,BAO_0000218,,
10770,1,Bioavailability in rat (dose 5 uM/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618779,,BAO_0000218,,
10771,1,Oral bioavailability,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618780,,BAO_0000218,,
10772,1,Bioavailability in rat (dose 2 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618781,,BAO_0000218,,
10773,1,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618782,,BAO_0000218,,
10774,1,Oral bioavailability in rat (dose 20 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618783,,BAO_0000218,,
10775,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618784,,BAO_0000218,,
10776,1,Percent oral bioavailability evaluated in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618785,,BAO_0000218,,
10777,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618786,,BAO_0000218,,
10778,1,Percent oral bioavailability in rat; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618787,,BAO_0000218,,
10779,1,Oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618788,,BAO_0000218,,
10780,1,Bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618789,,BAO_0000218,,
10781,1,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618790,,BAO_0000218,,
10782,1,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618791,,BAO_0000218,,
10783,1,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875843,,BAO_0000218,,
10784,1,Oral bioavailability in rat (dose 20 mg/kg p.o.),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL618792,,BAO_0000218,,
10785,1,Cmax at a dose of 30 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623395,,BAO_0000218,,
10786,1,Cmax in monkeys at a dose of 1 mg/kg,Simiiformes,0,22224,,U,Autocuration,,CHEMBL623396,,BAO_0000218,,
10787,1,Cmax in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623397,,BAO_0000218,,
10788,1,Cmax in rats at a dose of 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623398,,BAO_0000218,,
10789,1,Cmax was measured in mice after an oral dose of 50 mg/kg.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623399,,BAO_0000218,,
10790,1,"Cmax value at a dose of 12.7 uM/kg, po",,0,22224,,U,Autocuration,,CHEMBL623400,,BAO_0000218,,
10791,1,"Cmax value at a dose of 6.3 uM/kg, iv",,0,22224,,U,Autocuration,,CHEMBL623401,,BAO_0000218,,
10792,1,"Cmax value at a dose of 7.1 uM/kg, iv",,0,22224,,U,Autocuration,,CHEMBL623402,,BAO_0000218,,
10793,1,Cmax value of compound was determined after 1 hr,,0,22224,,U,Autocuration,,CHEMBL623403,,BAO_0000218,,
10794,1,Cmax value of the compound,,0,22224,,U,Autocuration,,CHEMBL623404,,BAO_0000218,,
10795,1,Cmax value administered intraintestinal in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625997,,BAO_0000218,,
10796,1,Cmax value administered perorally was determined in rat; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625998,,BAO_0000218,,
10797,1,Cmax value at the dose of 2.3 mg/kg,,0,22224,,U,Autocuration,,CHEMBL625999,,BAO_0000218,,
10798,1,Cmax value at the dose of 5 mg/kg,,0,22224,,U,Autocuration,,CHEMBL626000,,BAO_0000218,,
10799,1,Cmax value in the period of 8 hr after dosing. ,,0,22224,,U,Autocuration,,CHEMBL626001,,BAO_0000218,,
10800,1,Cmax value at a oral dose of 20 mg/kg; Not tested,,0,22224,,U,Autocuration,,CHEMBL626002,,BAO_0000218,,
10801,1,Cmax value at a oral dose of 20 mg/kg,,0,22224,,U,Autocuration,,CHEMBL626003,,BAO_0000218,,
10802,1,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626004,,BAO_0000218,,
10803,1,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL626005,,BAO_0000218,,
10804,1,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626006,,BAO_0000218,,
10805,1,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626007,,BAO_0000218,1969.0,
10806,1,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626008,,BAO_0000218,1969.0,
10807,1,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626009,,BAO_0000218,2107.0,
10808,1,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626010,,BAO_0000218,,
10809,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626011,,BAO_0000218,178.0,
10810,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626012,,BAO_0000218,178.0,
10811,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626013,,BAO_0000218,178.0,
10812,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626014,,BAO_0000218,178.0,
10813,1,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL877496,,BAO_0000218,178.0,
10814,1,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626015,,BAO_0000218,,
10815,1,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626016,,BAO_0000218,,
10816,1,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626017,,BAO_0000218,,
10817,1,Bioavailability as maximal plasma concentration in dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626018,,BAO_0000218,1969.0,
10818,1,Bioavailability as maximal plasma concentration in dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626692,,BAO_0000218,1969.0,
10819,1,Bioavailability as maximal plasma concentration in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626693,,BAO_0000218,1969.0,
10820,1,Bioavailability as maximal plasma concentration in rats,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL626694,,BAO_0000218,1969.0,
10821,1,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626695,,BAO_0000218,178.0,
10822,1,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626696,,BAO_0000218,178.0,
10823,1,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626697,,BAO_0000218,178.0,
10824,1,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626859,,BAO_0000218,178.0,
10825,1,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626860,,BAO_0000218,178.0,
10826,1,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626861,,BAO_0000218,178.0,
10827,1,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626296,,BAO_0000218,,
10828,1,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,,0,22224,,U,Autocuration,,CHEMBL626297,,BAO_0000218,,
10829,1,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,,0,22224,,U,Autocuration,,CHEMBL626298,,BAO_0000218,1969.0,
10830,1,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626299,,BAO_0000218,1969.0,
10831,1,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626300,,BAO_0000218,1969.0,
10832,1,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626301,,BAO_0000218,1969.0,
10833,1,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626962,,BAO_0000218,1969.0,
10834,1,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626963,,BAO_0000218,1969.0,
10835,1,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626964,,BAO_0000218,1969.0,
10836,1,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL626965,,BAO_0000218,1969.0,
10837,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626966,,BAO_0000218,1969.0,
10838,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626967,,BAO_0000218,1969.0,
10839,1,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL626968,,BAO_0000218,1969.0,
10840,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626969,,BAO_0000218,948.0,
10841,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627126,,BAO_0000218,948.0,
10842,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631276,,BAO_0000218,948.0,
10843,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631277,,BAO_0000218,948.0,
10844,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631278,,BAO_0000218,948.0,
10845,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874457,,BAO_0000218,948.0,
10846,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631279,,BAO_0000218,948.0,
10847,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631280,,BAO_0000218,948.0,
10848,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631281,,BAO_0000218,948.0,
10849,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631968,,BAO_0000218,948.0,
10850,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631969,,BAO_0000218,948.0,
10851,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631970,,BAO_0000218,948.0,
10852,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631971,,BAO_0000218,948.0,
10853,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631972,,BAO_0000218,948.0,
10854,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630435,,BAO_0000218,948.0,
10855,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630436,,BAO_0000218,948.0,
10856,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630437,,BAO_0000218,948.0,
10857,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630438,,BAO_0000218,948.0,
10858,1,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630439,,BAO_0000218,948.0,
10859,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630440,,BAO_0000218,2113.0,
10860,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630441,,BAO_0000218,2113.0,
10861,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630442,,BAO_0000218,2113.0,
10862,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625234,,BAO_0000218,2113.0,
10863,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625235,,BAO_0000218,2113.0,
10864,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625236,,BAO_0000218,2113.0,
10865,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625237,,BAO_0000218,2113.0,
10866,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626125,,BAO_0000218,2113.0,
10867,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626126,,BAO_0000218,2113.0,
10868,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626127,,BAO_0000218,2113.0,
10869,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626128,,BAO_0000218,2113.0,
10870,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626129,,BAO_0000218,2113.0,
10871,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626130,,BAO_0000218,2113.0,
10872,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626131,,BAO_0000218,2113.0,
10873,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626132,,BAO_0000218,2113.0,
10874,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626752,,BAO_0000218,2113.0,
10875,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626753,,BAO_0000218,2113.0,
10876,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626754,,BAO_0000218,2113.0,
10877,1,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626755,,BAO_0000218,2113.0,
10878,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626756,,BAO_0000218,2107.0,
10879,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626757,,BAO_0000218,2107.0,
10880,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626758,,BAO_0000218,2107.0,
10881,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626759,,BAO_0000218,2107.0,
10882,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626760,,BAO_0000218,2107.0,
10883,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626394,,BAO_0000218,,
10884,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626395,,BAO_0000218,,
10885,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626396,,BAO_0000218,,
10886,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626397,,BAO_0000218,,
10887,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626398,,BAO_0000218,,
10888,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626399,,BAO_0000218,,
10889,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874653,,BAO_0000218,,
10890,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626400,,BAO_0000218,,
10891,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626401,,BAO_0000218,,
10892,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626402,,BAO_0000218,,
10893,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626403,,BAO_0000218,,
10894,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626404,,BAO_0000218,,
10895,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626405,,BAO_0000218,,
10896,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625529,,BAO_0000218,,
10897,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625530,,BAO_0000218,,
10898,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625531,,BAO_0000218,,
10899,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625532,,BAO_0000218,,
10900,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625533,,BAO_0000218,,
10901,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875474,,BAO_0000218,,
10902,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625534,,BAO_0000218,,
10903,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625535,,BAO_0000218,,
10904,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625536,,BAO_0000218,,
10905,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625537,,BAO_0000218,,
10906,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625538,,BAO_0000218,,
10907,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625539,,BAO_0000218,,
10908,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625540,,BAO_0000218,,
10909,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625541,,BAO_0000218,,
10910,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625542,,BAO_0000218,,
10911,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625543,,BAO_0000218,,
10912,1,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625544,,BAO_0000218,,
10913,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625545,,BAO_0000218,,
10914,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625546,,BAO_0000218,,
10915,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625547,,BAO_0000218,,
10916,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625548,,BAO_0000218,,
10917,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625549,,BAO_0000218,,
10918,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625550,,BAO_0000218,,
10919,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625551,,BAO_0000218,,
10920,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL875475,,BAO_0000218,,
10921,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625552,,BAO_0000218,,
10922,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625553,,BAO_0000218,,
10923,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625554,,BAO_0000218,,
10924,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625555,,BAO_0000218,,
10925,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625556,,BAO_0000218,,
10926,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624986,,BAO_0000218,,
10927,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624987,,BAO_0000218,,
10928,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624988,,BAO_0000218,,
10929,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624989,,BAO_0000218,1637.0,
10930,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624990,,BAO_0000218,1637.0,
10931,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL874391,,BAO_0000218,1637.0,
10932,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624991,,BAO_0000218,1637.0,
10933,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624992,,BAO_0000218,1637.0,
10934,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624993,,BAO_0000218,1637.0,
10935,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624994,,BAO_0000218,1637.0,
10936,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624995,,BAO_0000218,1637.0,
10937,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624996,,BAO_0000218,1637.0,
10938,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624997,,BAO_0000218,1637.0,
10939,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624998,,BAO_0000218,1637.0,
10940,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624999,,BAO_0000218,1637.0,
10941,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL882955,,BAO_0000218,1637.0,
10942,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625000,,BAO_0000218,1637.0,
10943,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625001,,BAO_0000218,1637.0,
10944,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625089,,BAO_0000218,1637.0,
10945,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625090,,BAO_0000218,1637.0,
10946,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625091,,BAO_0000218,1637.0,
10947,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625092,,BAO_0000218,1637.0,
10948,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625093,,BAO_0000218,1637.0,
10949,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625094,,BAO_0000218,1637.0,
10950,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625095,,BAO_0000218,1637.0,
10951,1,Compound was evaluated for its bioavailability in the dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625096,,BAO_0000218,,
10952,1,Compound was evaluated for its bioavailability in the rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625097,,BAO_0000218,,
10953,1,Compound was evaluated for oral bioavailability,,0,22224,,U,Autocuration,,CHEMBL882956,,BAO_0000218,,
10954,1,Compound was evaluated for percentage of Oral bioavailability in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625098,,BAO_0000218,,
10955,1,Bioavailability in guinea pig,Cavia porcellus,0,22224,,U,Autocuration,,CHEMBL625099,,BAO_0000218,,
10956,1,Compound was evaluated for the oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625100,,BAO_0000218,,
10957,1,Compound was evaluated for the oral bioavailability in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625101,,BAO_0000218,,
10958,1,Compound was evaluated for the oral bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874396,,BAO_0000218,,
10959,1,Bioavailability in dog (dosed i.v.),Canis lupus familiaris,0,22224,,U,Autocuration,,CHEMBL625102,,BAO_0000218,,
10960,1,Compound was tested for in vivo bioavailability in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625103,,BAO_0000218,,
10961,1,Compound was tested for in vivo bioavailability in hamsters,Cricetinae,1,100712,,N,Intermediate,,CHEMBL625104,,BAO_0000218,,
10962,1,Compound was tested for in vivo bioavailability in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL625105,,BAO_0000218,,
10963,1,Compound was tested for in vivo bioavailability in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625106,,BAO_0000218,,
10964,1,Oral bioavailability in mouse,Mus musculus,0,22224,,U,Autocuration,,CHEMBL625107,,BAO_0000218,,
10965,1,Compound was tested for percent of oral bioavailability in mice; 56-74,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625108,,BAO_0000218,,
10966,1,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),Mus musculus,0,22224,,U,Autocuration,,CHEMBL625109,,BAO_0000218,,
10967,1,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),Macaca fascicularis,0,22224,,U,Autocuration,,CHEMBL625110,,BAO_0000218,,
10968,1,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),Macaca fascicularis,0,22224,,U,Autocuration,,CHEMBL625111,,BAO_0000218,,
10969,1,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625112,,BAO_0000218,,
10970,1,Oral bioavailability in nude mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL875334,,BAO_0000218,,
10971,1,Bioavailability in monkey (i.d. dosing),Primates,0,22224,,U,Autocuration,,CHEMBL628617,,BAO_0000218,,
10972,1,Bioavailability in rat,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL628618,,BAO_0000218,,
10973,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,,0,22224,,U,Autocuration,,CHEMBL628619,,BAO_0000218,,
10974,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,,0,22224,,U,Autocuration,,CHEMBL628620,,BAO_0000218,,
10975,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL628621,,BAO_0000218,,
10976,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL628622,,BAO_0000218,,
10977,1,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL628623,,BAO_0000218,,
10978,1,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL628624,,BAO_0000218,1969.0,
10979,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL628625,,BAO_0000218,1969.0,
10980,1,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL628626,,BAO_0000218,1969.0,
10981,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627041,,BAO_0000218,1969.0,
10982,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627042,,BAO_0000218,1969.0,
10983,1,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627043,,BAO_0000218,1969.0,
10984,1,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,,0,22224,,U,Autocuration,,CHEMBL627044,,BAO_0000218,1969.0,
10985,1,Cmax in mouse plasma,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627045,,BAO_0000218,1969.0,
10986,1,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,,0,22224,,U,Autocuration,,CHEMBL627046,,BAO_0000218,1969.0,
10987,1,Maximal plasma concentration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627047,,BAO_0000218,1969.0,
10988,1,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627048,,BAO_0000218,1969.0,
10989,1,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627049,,BAO_0000218,,
10990,1,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627050,,BAO_0000218,,
10991,1,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627051,,BAO_0000218,,
10992,1,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627052,,BAO_0000218,,
10993,1,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627053,,BAO_0000218,,
10994,1,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627054,,BAO_0000218,,
10995,1,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627055,,BAO_0000218,,
10996,1,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627056,,BAO_0000218,,
10997,1,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),Mus musculus,1,50594,,N,Intermediate,,CHEMBL627057,,BAO_0000218,,
10998,1,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627058,,BAO_0000218,,
10999,1,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626211,,BAO_0000218,,
11000,1,Maximum Concentration of the compound.,,0,22224,,U,Autocuration,,CHEMBL626212,,BAO_0000218,,
11001,1,Maximum Concentration was measured after iv administration into Beagle dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626213,,BAO_0000218,,
11002,1,Maximum Concentration was measured after iv administration into Beagle dog.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626214,,BAO_0000218,,
11003,1,Maximum Concentration was measured after po administration into Beagle dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626215,,BAO_0000218,,
11004,1,Maximum Concentration was measured after po administration into Beagle dog.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626216,,BAO_0000218,,
11005,1,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,,0,22224,,U,Autocuration,,CHEMBL626217,,BAO_0000218,178.0,
11006,1,Maximum blood level reached after an iv dose of 12.2 uM/kg,,0,22224,,U,Autocuration,,CHEMBL626218,,BAO_0000218,178.0,
11007,1,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,,0,22224,,U,Autocuration,,CHEMBL626219,,BAO_0000218,178.0,
11008,1,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,,0,22224,,U,Autocuration,,CHEMBL626220,,BAO_0000218,178.0,
11009,1,Maximum blood level reached after an oral dose of 5.0 mg/kg,,0,22224,,U,Autocuration,,CHEMBL626221,,BAO_0000218,178.0,
11010,1,Maximum blood level reached at dose of 10.6 uM/kg orally,,0,22224,,U,Autocuration,,CHEMBL626222,,BAO_0000218,178.0,
11011,1,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL626223,,BAO_0000218,,
11012,1,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL626224,,BAO_0000218,,
11013,1,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626225,,BAO_0000218,955.0,
11014,1,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626226,,BAO_0000218,955.0,
11015,1,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626227,,BAO_0000218,955.0,
11016,1,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626228,,BAO_0000218,955.0,
11017,1,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626229,,BAO_0000218,,
11018,1,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626921,,BAO_0000218,,
11019,1,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876793,,BAO_0000218,,
11020,1,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625309,,BAO_0000218,,
11021,1,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),Bacillus subtilis,1,50278,,N,Intermediate,,CHEMBL625310,,BAO_0000218,,
11022,1,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,Simiiformes,0,22224,,U,Autocuration,,CHEMBL625311,,BAO_0000218,,
11023,1,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625312,,BAO_0000218,,
11024,1,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,,0,22224,,U,Autocuration,,CHEMBL625313,,BAO_0000218,,
11025,1,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625314,,BAO_0000218,,
11026,1,Maximum concentration in male rats after iv administration of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625315,,BAO_0000218,,
11027,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625316,,BAO_0000218,2107.0,
11028,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625317,,BAO_0000218,2107.0,
11029,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625318,,BAO_0000218,2107.0,
11030,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625319,,BAO_0000218,2107.0,
11031,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625320,,BAO_0000218,2107.0,
11032,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625321,,BAO_0000218,2107.0,
11033,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625322,,BAO_0000218,2107.0,
11034,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876801,,BAO_0000218,2107.0,
11035,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625323,,BAO_0000218,2107.0,
11036,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625324,,BAO_0000218,2107.0,
11037,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625325,,BAO_0000218,2107.0,
11038,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625326,,BAO_0000218,2107.0,
11039,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625327,,BAO_0000218,2107.0,
11040,1,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625328,,BAO_0000218,2107.0,
11041,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625329,,BAO_0000218,2048.0,
11042,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625330,,BAO_0000218,2048.0,
11043,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627774,,BAO_0000218,2048.0,
11044,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627775,,BAO_0000218,2048.0,
11045,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627949,,BAO_0000218,2048.0,
11046,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627950,,BAO_0000218,2048.0,
11047,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627951,,BAO_0000218,2048.0,
11048,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627952,,BAO_0000218,2048.0,
11049,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627953,,BAO_0000218,2048.0,
11050,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627954,,BAO_0000218,2048.0,
11051,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627955,,BAO_0000218,2048.0,
11052,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627956,,BAO_0000218,2048.0,
11053,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876802,,BAO_0000218,2048.0,
11054,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627957,,BAO_0000218,2048.0,
11055,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627958,,BAO_0000218,2048.0,
11056,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627959,,BAO_0000218,2048.0,
11057,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627960,,BAO_0000218,2048.0,
11058,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627961,,BAO_0000218,2048.0,
11059,1,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627962,,BAO_0000218,2048.0,
11060,1,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627963,,BAO_0000218,,
11061,1,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624759,,BAO_0000218,,
11062,1,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624760,,BAO_0000218,,
11063,1,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624761,,BAO_0000218,,
11064,1,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877607,,BAO_0000218,,
11065,1,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624762,,BAO_0000218,2107.0,
11066,1,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624763,,BAO_0000218,2107.0,
11067,1,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624764,,BAO_0000218,2107.0,
11068,1,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624765,,BAO_0000218,2107.0,
11069,1,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624766,,BAO_0000218,2107.0,
11070,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624767,,BAO_0000218,,
11071,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624768,,BAO_0000218,,
11072,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624769,,BAO_0000218,,
11073,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624770,,BAO_0000218,,
11074,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624771,,BAO_0000218,,
11075,1,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624772,,BAO_0000218,,
11076,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624773,,BAO_0000218,,
11077,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624774,,BAO_0000218,,
11078,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624775,,BAO_0000218,,
11079,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624776,,BAO_0000218,,
11080,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624777,,BAO_0000218,,
11081,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624778,,BAO_0000218,,
11082,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624779,,BAO_0000218,,
11083,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624780,,BAO_0000218,,
11084,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624781,,BAO_0000218,,
11085,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877608,,BAO_0000218,,
11086,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624782,,BAO_0000218,,
11087,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624783,,BAO_0000218,,
11088,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624784,,BAO_0000218,,
11089,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624785,,BAO_0000218,,
11090,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624786,,BAO_0000218,,
11091,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624787,,BAO_0000218,,
11092,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628676,,BAO_0000218,,
11093,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621842,,BAO_0000218,,
11094,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621843,,BAO_0000218,,
11095,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623873,,BAO_0000218,,
11096,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623874,,BAO_0000218,,
11097,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623875,,BAO_0000218,,
11098,1,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623876,,BAO_0000218,,
11099,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623877,,BAO_0000218,,
11100,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623878,,BAO_0000218,,
11101,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623879,,BAO_0000218,,
11102,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623880,,BAO_0000218,,
11103,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623881,,BAO_0000218,,
11104,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623957,,BAO_0000218,,
11105,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623958,,BAO_0000218,,
11106,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623959,,BAO_0000218,,
11107,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623960,,BAO_0000218,,
11108,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623961,,BAO_0000218,,
11109,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623962,,BAO_0000218,,
11110,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624676,,BAO_0000218,,
11111,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624677,,BAO_0000218,,
11112,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624678,,BAO_0000218,,
11113,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624679,,BAO_0000218,,
11114,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624680,,BAO_0000218,,
11115,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,,0,22224,,U,Autocuration,,CHEMBL624849,,BAO_0000218,,
11116,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,,0,22224,,U,Autocuration,,CHEMBL624850,,BAO_0000218,,
11117,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,,0,22224,,U,Autocuration,,CHEMBL874399,,BAO_0000218,,
11118,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,,0,22224,,U,Autocuration,,CHEMBL624851,,BAO_0000218,,
11119,1,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,,0,22224,,U,Autocuration,,CHEMBL624852,,BAO_0000218,,
11120,1,Oral bioavailability in rat (dose 10 mg/kg),Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL624853,,BAO_0000218,,
11121,1,Oral bioavailability in rat (Sprague-Dawley),Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL624854,,BAO_0000218,,
11122,1,Oral bioavailability in rat,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL624855,,BAO_0000218,,
11123,1,Oral bioavailability in rats was determined in vivo,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL624856,,BAO_0000218,,
11124,1,Oral bioavailability in dog,Canis lupus familiaris,0,22224,,U,Autocuration,,CHEMBL882957,,BAO_0000218,,
11125,1,Oral bioavailability of compound in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL624857,,BAO_0000218,,
11126,1,Oral bioavailability of compound in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622202,,BAO_0000218,,
11127,1,Bioavailability in rat of PMEA prodrug,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL622203,,BAO_0000218,,
11128,1,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625522,,BAO_0000218,,
11129,1,Serum conc at 3 hours following 25 mg/kg dose,Macaca mulatta,0,22224,,U,Autocuration,,CHEMBL622868,,BAO_0000218,,
11130,1,Urine conc 0-5 hours following 25 mg/kg dose,Macaca mulatta,0,22224,,U,Autocuration,,CHEMBL622869,,BAO_0000218,1088.0,
11131,1,Urine conc 0-24 hours following 25 mg/kg dose,Macaca mulatta,0,22224,,U,Autocuration,,CHEMBL622870,,BAO_0000218,1088.0,
11132,1,Oral bioavailability in African green monkeys; 20-25,Chlorocebus aethiops,0,22224,,U,Autocuration,,CHEMBL622871,,BAO_0000218,,
11133,1,Oral bioavailability in cynomolgus monkey.,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL620560,,BAO_0000218,,
11134,1,Oral bioavailability in dog,Canis lupus familiaris,0,22224,,U,Autocuration,,CHEMBL620561,,BAO_0000218,,
11135,1,Oral bioavailability in dog at 10 mg/kg oral dose,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL620562,,BAO_0000218,,
11136,1,Oral bioavailability in hamster at 10 mg/kg oral dose,Cricetinae,1,100712,,N,Intermediate,,CHEMBL620563,,BAO_0000218,,
11137,1,Oral bioavailability in rat at 10 mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL620564,,BAO_0000218,,
11138,1,Oral bioavailability in rat,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL872265,,BAO_0000218,,
11139,1,Oral bioavailability in rat,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL620565,,BAO_0000218,,
11140,1,Oral bioavailability,Eutheria,0,22224,,U,Autocuration,,CHEMBL620566,,BAO_0000218,,
11141,1,Oral bioavailability was determined; range 49-102%,,0,22224,,U,Autocuration,,CHEMBL620567,,BAO_0000218,,
11142,1,Oral bioavailability was determined in dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL620568,,BAO_0000218,,
11143,1,Oral bioavailability in rat,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL620569,,BAO_0000218,,
11144,1,Oral bioavailability,Eutheria,0,22224,,U,Autocuration,,CHEMBL620570,,BAO_0000218,,
11145,1,Oral bioavailability was determined; Not orally available,,0,22224,,U,Autocuration,,CHEMBL620571,,BAO_0000218,,
11146,1,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),Mus musculus,1,50594,,N,Intermediate,,CHEMBL620572,,BAO_0000218,,
11147,1,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),Mus musculus,0,22224,,U,Autocuration,,CHEMBL620573,,BAO_0000218,,
11148,1,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,Mus musculus,0,22224,,U,Autocuration,,CHEMBL620574,,BAO_0000218,,
11149,1,Oral bioavailability in Rhesus monkey,Macaca mulatta,0,22224,,U,Autocuration,,CHEMBL620575,,BAO_0000218,,
11150,1,Oral bioavailability in dog (female mongrel),Canis lupus familiaris,0,22224,,U,Autocuration,,CHEMBL620576,,BAO_0000218,,
11151,1,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,,0,22224,,U,Autocuration,,CHEMBL875846,,BAO_0000218,,
11152,1,Oral bioavailability in dog,Canis lupus familiaris,0,22224,,U,Autocuration,,CHEMBL620577,,BAO_0000218,,
11153,1,Percentage Bioavailability was evaluated.,,0,22224,,U,Autocuration,,CHEMBL620578,,BAO_0000218,,
11154,1,Bioavailability in rat administered i.d.,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL620579,,BAO_0000218,,
11155,1,Bioavailability,Eutheria,0,22224,,U,Autocuration,,CHEMBL621248,,BAO_0000218,,
11156,1,Bioavailability in dog (male Beagle) i.v. administration,Canis lupus familiaris,0,22224,,U,Autocuration,,CHEMBL625390,,BAO_0000218,,
11157,1,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL625391,,BAO_0000218,,
11158,1,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),Primates,0,22224,,U,Autocuration,,CHEMBL872266,,BAO_0000218,,
11159,1,Oral bioavailability in rat (Sprague-Dawley) (male),Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL625392,,BAO_0000218,,
11160,1,The oral bioavailability was measured on rats after oral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625393,,BAO_0000218,,
11161,1,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625394,,BAO_0000218,,
11162,1,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Macaca mulatta,1,50797,,N,Intermediate,,CHEMBL625395,,BAO_0000218,,
11163,1,Bioavailability in rat (dose 10 mg/kg i.d.),Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL625396,,BAO_0000218,,
11164,1,Bioavailability in dog (male Beagle) i.v. administration,Canis lupus familiaris,0,22224,,U,Autocuration,,CHEMBL625397,,BAO_0000218,,
11165,1,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625398,,BAO_0000218,,
11166,1,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625399,,BAO_0000218,178.0,
11167,1,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626074,,BAO_0000218,2037.0,
11168,1,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL626075,,BAO_0000218,,
11169,1,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626076,,BAO_0000218,1969.0,
11170,1,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,Macaca mulatta,1,50797,,N,Intermediate,,CHEMBL626077,,BAO_0000218,1969.0,
11171,1,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626078,,BAO_0000218,178.0,
11172,1,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),,0,22224,,U,Autocuration,,CHEMBL625846,,BAO_0000218,178.0,
11173,1,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),,0,22224,,U,Autocuration,,CHEMBL625847,,BAO_0000218,178.0,
11174,1,Maximum concentration observed in rats at an oral dose of 50 mg/kg,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL625848,,BAO_0000218,,
11175,1,Maximum concentration of compound in plasma administered orally to rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625849,,BAO_0000218,1969.0,
11176,1,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626023,,BAO_0000218,1969.0,
11177,1,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626024,,BAO_0000218,1969.0,
11178,1,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626025,,BAO_0000218,1969.0,
11179,1,Maximum concentration after 10 mg/kg by oral administration,,0,22224,,U,Autocuration,,CHEMBL626026,,BAO_0000218,,
11180,1,Maximum concentration at a dose of 1.5 mg/kg,,0,22224,,U,Autocuration,,CHEMBL626027,,BAO_0000218,,
11181,1,Maximum concentration at a dose of 2.0 mg/kg,,0,22224,,U,Autocuration,,CHEMBL626028,,BAO_0000218,,
11182,1,Maximum concentration in dog plasma,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626029,,BAO_0000218,1969.0,
11183,1,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,,0,22224,,U,Autocuration,,CHEMBL626030,,BAO_0000218,1969.0,
11184,1,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,,0,22224,,U,Autocuration,,CHEMBL626031,,BAO_0000218,1969.0,
11185,1,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,,0,22224,,U,Autocuration,,CHEMBL626032,,BAO_0000218,1969.0,
11186,1,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,,0,22224,,U,Autocuration,,CHEMBL626033,,BAO_0000218,1969.0,
11187,1,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,,0,22224,,U,Autocuration,,CHEMBL626034,,BAO_0000218,1969.0,
11188,1,Maximum concentration in plasma after oral administration in dog (25 mg/kg),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626035,,BAO_0000218,1969.0,
11189,1,Maximum concentration in plasma at Tmax,,0,22224,,U,Autocuration,,CHEMBL626036,,BAO_0000218,1969.0,
11190,1,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,Canis lupus familiaris,1,50588,,N,Expert,,CHEMBL626037,,BAO_0000218,1969.0,
11191,1,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,Cricetinae,1,100712,,N,Intermediate,,CHEMBL626038,,BAO_0000218,1969.0,
11192,1,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626039,,BAO_0000218,1969.0,
11193,1,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626040,,BAO_0000218,1969.0,
11194,1,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL626041,,BAO_0000218,1969.0,
11195,1,Maximum concentration was calculated,,0,22224,,U,Autocuration,,CHEMBL626042,,BAO_0000218,,
11196,1,Maximum concentration was calculated.,,0,22224,,U,Autocuration,,CHEMBL626043,,BAO_0000218,,
11197,1,Maximum concentration at a peroral dose of 10 mg/kg,,0,22224,,U,Autocuration,,CHEMBL626044,,BAO_0000218,,
11198,1,Maximum concentration of the drug at 10 uM/dg administered perorally,,0,22224,,U,Autocuration,,CHEMBL626045,,BAO_0000218,,
11199,1,Maximum concentration of the drug at 2 uM/dg administered intravenously,,0,22224,,U,Autocuration,,CHEMBL626046,,BAO_0000218,,
11200,1,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626047,,BAO_0000218,1969.0,
11201,1,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",Cricetinae,1,100712,,N,Intermediate,,CHEMBL626048,,BAO_0000218,1969.0,
11202,1,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626049,,BAO_0000218,1969.0,
11203,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626050,,BAO_0000218,1969.0,
11204,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL874541,,BAO_0000218,1969.0,
11205,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,Cricetinae,1,100712,,N,Intermediate,,CHEMBL622826,,BAO_0000218,1969.0,
11206,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,Cricetinae,1,100712,,N,Intermediate,,CHEMBL622827,,BAO_0000218,1969.0,
11207,1,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622828,,BAO_0000218,1969.0,
11208,1,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622829,,BAO_0000218,1969.0,
11209,1,Maximum concentration reached following intravenous administration in male rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876806,,BAO_0000218,,
11210,1,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622830,,BAO_0000218,,
11211,1,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622831,,BAO_0000218,,
11212,1,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626794,,BAO_0000218,,
11213,1,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626795,,BAO_0000218,,
11214,1,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626796,,BAO_0000218,,
11215,1,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626797,,BAO_0000218,,
11216,1,Maximum drug concentration is determined after oral dosing in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626798,,BAO_0000218,,
11217,1,Maximum observed concentration in oral (5 mg/kg) fasted dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626799,,BAO_0000218,,
11218,1,Maximum observed concentration in oral (5 mg/kg) fed dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626800,,BAO_0000218,,
11219,1,Maximum plasma concentration,,0,22224,,U,Autocuration,,CHEMBL626801,,BAO_0000218,1969.0,
11220,1,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876816,,BAO_0000218,1969.0,
11221,1,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626802,,BAO_0000218,1969.0,
11222,1,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626803,,BAO_0000218,1969.0,
11223,1,Maximum plasma concentration following oral administration of 30 umol/kg,,0,22224,,U,Autocuration,,CHEMBL626804,,BAO_0000218,1969.0,
11224,1,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626805,,BAO_0000218,1969.0,
11225,1,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626309,,BAO_0000218,1969.0,
11226,1,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626310,,BAO_0000218,1969.0,
11227,1,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626311,,BAO_0000218,1969.0,
11228,1,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626312,,BAO_0000218,1969.0,
11229,1,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626313,,BAO_0000218,995.0,
11230,1,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626314,,BAO_0000218,995.0,
11231,1,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626315,,BAO_0000218,995.0,
11232,1,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626316,,BAO_0000218,995.0,
11233,1,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626317,,BAO_0000218,995.0,
11234,1,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626318,,BAO_0000218,,
11235,1,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626319,,BAO_0000218,,
11236,1,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626320,,BAO_0000218,,
11237,1,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875053,,BAO_0000218,,
11238,1,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626321,,BAO_0000218,,
11239,1,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626322,,BAO_0000218,,
11240,1,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626323,,BAO_0000218,,
11241,1,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626324,,BAO_0000218,,
11242,1,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626325,,BAO_0000218,,
11243,1,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626326,,BAO_0000218,,
11244,1,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626327,,BAO_0000218,,
11245,1,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626328,,BAO_0000218,,
11246,1,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626329,,BAO_0000218,178.0,
11247,1,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626330,,BAO_0000218,178.0,
11248,1,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626331,,BAO_0000218,178.0,
11249,1,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626332,,BAO_0000218,178.0,
11250,1,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626333,,BAO_0000218,178.0,
11251,1,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626334,,BAO_0000218,178.0,
11252,1,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626335,,BAO_0000218,178.0,
11253,1,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624798,,BAO_0000218,178.0,
11254,1,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624799,,BAO_0000218,955.0,
11255,1,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624800,,BAO_0000218,955.0,
11256,1,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624801,,BAO_0000218,955.0,
11257,1,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624802,,BAO_0000218,955.0,
11258,1,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624803,,BAO_0000218,955.0,
11259,1,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624804,,BAO_0000218,955.0,
11260,1,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624805,,BAO_0000218,955.0,
11261,1,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624806,,BAO_0000218,955.0,
11262,1,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624807,,BAO_0000218,,
11263,1,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624808,,BAO_0000218,,
11264,1,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624809,,BAO_0000218,,
11265,1,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624810,,BAO_0000218,,
11266,1,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877618,,BAO_0000218,,
11267,1,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624811,,BAO_0000218,,
11268,1,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624812,,BAO_0000218,,
11269,1,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624813,,BAO_0000218,,
11270,1,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624814,,BAO_0000218,,
11271,1,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624815,,BAO_0000218,,
11272,1,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624816,,BAO_0000218,,
11273,1,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624817,,BAO_0000218,,
11274,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624818,,BAO_0000218,,
11275,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624819,,BAO_0000218,,
11276,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624820,,BAO_0000218,,
11277,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624821,,BAO_0000218,,
11278,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624822,,BAO_0000218,,
11279,1,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624823,,BAO_0000218,,
11280,1,Observed diffusion coefficient in organic solvent for Escherichia coli,Escherichia coli,1,50212,,N,Intermediate,,CHEMBL624824,,BAO_0000218,,
11281,1,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624825,,BAO_0000218,178.0,
11282,1,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624826,,BAO_0000218,178.0,
11283,1,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876817,,BAO_0000218,2081.0,
11284,1,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624827,,BAO_0000218,2081.0,
11285,1,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624828,,BAO_0000218,,
11286,1,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624829,,BAO_0000218,,
11287,1,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624830,,BAO_0000218,2107.0,
11288,1,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624831,,BAO_0000218,2107.0,
11289,1,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624832,,BAO_0000218,2081.0,
11290,1,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624833,,BAO_0000218,2081.0,
11291,1,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624834,,BAO_0000218,,
11292,1,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624835,,BAO_0000218,,
11293,1,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624836,,BAO_0000218,2106.0,
11294,1,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624837,,BAO_0000218,2106.0,
11295,1,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624838,,BAO_0000218,178.0,
11296,1,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622188,,BAO_0000218,178.0,
11297,1,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622189,,BAO_0000218,948.0,
11298,1,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622190,,BAO_0000218,948.0,
11299,1,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625170,,BAO_0000218,948.0,
11300,1,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625171,,BAO_0000218,2113.0,
11301,1,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625172,,BAO_0000218,2113.0,
11302,1,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625173,,BAO_0000218,2113.0,
11303,1,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625174,,BAO_0000218,2107.0,
11304,1,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625175,,BAO_0000218,2107.0,
11305,1,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625176,,BAO_0000218,2107.0,
11306,1,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625177,,BAO_0000218,2048.0,
11307,1,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625178,,BAO_0000218,2048.0,
11308,1,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625179,,BAO_0000218,2048.0,
11309,1,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625180,,BAO_0000218,2048.0,
11310,1,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",,0,22224,,U,Autocuration,,CHEMBL625181,,BAO_0000218,,
11311,1,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625182,,BAO_0000218,1088.0,
11312,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625183,,BAO_0000218,,
11313,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875848,,BAO_0000218,,
11314,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622260,,BAO_0000218,,
11315,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622261,,BAO_0000218,,
11316,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622262,,BAO_0000218,,
11317,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622263,,BAO_0000218,2113.0,
11318,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622418,,BAO_0000218,2113.0,
11319,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622419,,BAO_0000218,2107.0,
11320,1,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL623388,,BAO_0000218,,
11321,1,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL623389,,BAO_0000218,2107.0,
11322,1,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL623390,,BAO_0000218,,
11323,1,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL623391,,BAO_0000218,,
11324,1,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL623392,,BAO_0000218,178.0,
11325,1,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL623393,,BAO_0000218,2037.0,
11326,1,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL623394,,BAO_0000218,,
11327,1,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL618885,,BAO_0000218,,
11328,1,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL618886,,BAO_0000218,2107.0,
11329,1,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL618887,,BAO_0000218,,
11330,1,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL619535,,BAO_0000218,,
11331,1,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL619536,,BAO_0000218,178.0,
11332,1,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL619537,,BAO_0000218,2037.0,
11333,1,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL619705,,BAO_0000218,,
11334,1,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL619706,,BAO_0000218,,
11335,1,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL619707,,BAO_0000218,2107.0,
11336,1,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL619708,,BAO_0000218,,
11337,1,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625219,,BAO_0000218,,
11338,1,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625220,,BAO_0000218,178.0,
11339,1,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625221,,BAO_0000218,2037.0,
11340,1,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625222,,BAO_0000218,,
11341,1,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625223,,BAO_0000218,,
11342,1,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625224,,BAO_0000218,2107.0,
11343,1,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625225,,BAO_0000218,,
11344,1,Biodistribution in Rat blood after 24 hours of iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625226,,BAO_0000218,178.0,
11345,1,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625227,,BAO_0000218,178.0,
11346,1,Biodistribution in Rat blood after 30 minutes of iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625228,,BAO_0000218,178.0,
11347,1,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875354,,BAO_0000218,178.0,
11348,1,Biodistribution in Rat blood after 5 minutes of iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625229,,BAO_0000218,178.0,
11349,1,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625230,,BAO_0000218,178.0,
11350,1,Biodistribution in Rat heart after 24 hours of iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625231,,BAO_0000218,948.0,
11351,1,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625900,,BAO_0000218,948.0,
11352,1,Biodistribution in Rat heart after 30 minutes of iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625901,,BAO_0000218,948.0,
11353,1,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625902,,BAO_0000218,948.0,
11354,1,Biodistribution in Rat heart after 5 minutes of iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625903,,BAO_0000218,948.0,
11355,1,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625904,,BAO_0000218,948.0,
11356,1,Biodistribution in Rat liver after 24 hours of iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625905,,BAO_0000218,2107.0,
11357,1,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627861,,BAO_0000218,2107.0,
11358,1,Biodistribution in Rat liver after 30 minutes of iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627862,,BAO_0000218,2107.0,
11359,1,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627863,,BAO_0000218,2107.0,
11360,1,Biodistribution in Rat liver after 30 minutes of iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627769,,BAO_0000218,2107.0,
11361,1,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627770,,BAO_0000218,1969.0,
11362,1,Cmax in cynomolgus monkey (PO dose),Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL627771,,BAO_0000218,,
11363,1,Cmax in rat (PO dose),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627772,,BAO_0000218,,
11364,1,Cmax in rat (PO dose),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627773,,BAO_0000218,,
11365,1,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621922,,BAO_0000218,1969.0,
11366,1,Cmax in rat plasma after oral dose (10 mg/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621923,,BAO_0000218,1969.0,
11367,1,Cmax in plasma after oral dose (10 mg/kg),,0,22224,,U,Autocuration,,CHEMBL621924,,BAO_0000218,1969.0,
11368,1,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621925,,BAO_0000218,1969.0,
11369,1,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,Simiiformes,0,22224,,U,Autocuration,,CHEMBL621926,,BAO_0000218,1969.0,
11370,1,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL621927,,BAO_0000218,1969.0,
11371,1,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621928,,BAO_0000218,1969.0,
11372,1,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621929,,BAO_0000218,1969.0,
11373,1,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL621930,,BAO_0000218,1969.0,
11374,1,Maximum plasma concentration after oral dosing in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621931,,BAO_0000218,1969.0,
11375,1,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL621932,,BAO_0000218,1969.0,
11376,1,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL621933,,BAO_0000218,1969.0,
11377,1,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621934,,BAO_0000218,1969.0,
11378,1,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL621935,,BAO_0000218,1969.0,
11379,1,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621936,,BAO_0000218,1969.0,
11380,1,Maximum plasma concentration was determined,,0,22224,,U,Autocuration,,CHEMBL621937,,BAO_0000218,1969.0,
11381,1,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL621938,,BAO_0000218,1969.0,
11382,1,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL621939,,BAO_0000218,1969.0,
11383,1,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL621940,,BAO_0000218,1969.0,
11384,1,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL621941,,BAO_0000218,1969.0,
11385,1,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL621942,,BAO_0000218,1969.0,
11386,1,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL626178,,BAO_0000218,1969.0,
11387,1,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL626179,,BAO_0000218,1969.0,
11388,1,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL626180,,BAO_0000218,1969.0,
11389,1,Plasma Cmax in rat (PO dose),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626181,,BAO_0000218,1969.0,
11390,1,Maximum serum concentration after po dose of 5.22 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626182,,BAO_0000218,,
11391,1,Maximum serum concentration after po dose of 5.46 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626183,,BAO_0000218,,
11392,1,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626184,,BAO_0000218,,
11393,1,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626185,,BAO_0000218,,
11394,1,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626186,,BAO_0000218,1969.0,
11395,1,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL877589,,BAO_0000218,1969.0,
11396,1,Maximum concentration of the drug at 1 uM/dg administered intravenously,,0,22224,,U,Autocuration,,CHEMBL626187,,BAO_0000218,,
11397,1,Maximum concentration of the drug at 20 uM/dg administered perorally,,0,22224,,U,Autocuration,,CHEMBL626188,,BAO_0000218,,
11398,1,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,,0,22224,,U,Autocuration,,CHEMBL626189,,BAO_0000218,,
11399,1,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,0,22224,,U,Autocuration,,CHEMBL626855,,BAO_0000218,178.0,
11400,1,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,0,22224,,U,Autocuration,,CHEMBL623781,,BAO_0000218,178.0,
11401,1,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,0,22224,,U,Autocuration,,CHEMBL623782,,BAO_0000218,178.0,
11402,1,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623783,,BAO_0000218,1969.0,
11403,1,Cmax in dog plasma after 1mg/kg oral dose,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623784,,BAO_0000218,1969.0,
11404,1,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623785,,BAO_0000218,1969.0,
11405,1,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623786,,BAO_0000218,1969.0,
11406,1,Oral maximum concentration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623787,,BAO_0000218,,
11407,1,Oral maximum concentration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623788,,BAO_0000218,,
11408,1,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623789,,BAO_0000218,1969.0,
11409,1,Peak concentration in blood after intravenous administration to mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623790,,BAO_0000218,178.0,
11410,1,Peak concentration in blood after peroral administration to mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623791,,BAO_0000218,178.0,
11411,1,Peak concentration in rat plasma was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623792,,BAO_0000218,1969.0,
11412,1,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,Simiiformes,0,22224,,U,Autocuration,,CHEMBL623793,,BAO_0000218,1969.0,
11413,1,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623794,,BAO_0000218,1969.0,
11414,1,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623795,,BAO_0000218,1969.0,
11415,1,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623796,,BAO_0000218,,
11416,1,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623797,,BAO_0000218,,
11417,1,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623798,,BAO_0000218,,
11418,1,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623799,,BAO_0000218,,
11419,1,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624490,,BAO_0000218,160.0,
11420,1,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624491,,BAO_0000218,160.0,
11421,1,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624492,,BAO_0000218,160.0,
11422,1,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624493,,BAO_0000218,160.0,
11423,1,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877595,,BAO_0000218,160.0,
11424,1,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624494,,BAO_0000218,160.0,
11425,1,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624495,,BAO_0000218,160.0,
11426,1,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624681,,BAO_0000218,160.0,
11427,1,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624682,,BAO_0000218,,
11428,1,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624683,,BAO_0000218,,
11429,1,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624684,,BAO_0000218,,
11430,1,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624685,,BAO_0000218,,
11431,1,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624686,,BAO_0000218,,
11432,1,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624687,,BAO_0000218,,
11433,1,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624688,,BAO_0000218,,
11434,1,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627161,,BAO_0000218,,
11435,1,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622127,,BAO_0000218,,
11436,1,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622128,,BAO_0000218,,
11437,1,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874384,,BAO_0000218,,
11438,1,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624898,,BAO_0000218,,
11439,1,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624899,,BAO_0000218,,
11440,1,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624900,,BAO_0000218,,
11441,1,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624901,,BAO_0000218,,
11442,1,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624902,,BAO_0000218,,
11443,1,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624903,,BAO_0000218,,
11444,1,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624904,,BAO_0000218,,
11445,1,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624905,,BAO_0000218,,
11446,1,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624906,,BAO_0000218,,
11447,1,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624907,,BAO_0000218,,
11448,1,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624908,,BAO_0000218,,
11449,1,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624909,,BAO_0000218,,
11450,1,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624910,,BAO_0000218,,
11451,1,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624911,,BAO_0000218,2385.0,
11452,1,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874388,,BAO_0000218,2385.0,
11453,1,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624912,,BAO_0000218,2385.0,
11454,1,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622930,,BAO_0000218,2385.0,
11455,1,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623121,,BAO_0000218,2385.0,
11456,1,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623122,,BAO_0000218,2385.0,
11457,1,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623123,,BAO_0000218,2385.0,
11458,1,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623124,,BAO_0000218,2385.0,
11459,1,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623125,,BAO_0000218,,
11460,1,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623126,,BAO_0000218,,
11461,1,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623127,,BAO_0000218,,
11462,1,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623128,,BAO_0000218,,
11463,1,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623129,,BAO_0000218,,
11464,1,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623130,,BAO_0000218,,
11465,1,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623131,,BAO_0000218,,
11466,1,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623132,,BAO_0000218,,
11467,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623133,,BAO_0000218,2107.0,
11468,1,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623134,,BAO_0000218,,
11469,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874389,,BAO_0000218,,
11470,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623135,,BAO_0000218,,
11471,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623136,,BAO_0000218,,
11472,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623137,,BAO_0000218,,
11473,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623138,,BAO_0000218,,
11474,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623139,,BAO_0000218,2113.0,
11475,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623140,,BAO_0000218,2113.0,
11476,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623141,,BAO_0000218,2107.0,
11477,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623142,,BAO_0000218,2107.0,
11478,1,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623143,,BAO_0000218,,
11479,1,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623144,,BAO_0000218,1088.0,
11480,1,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623405,,BAO_0000218,1088.0,
11481,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624074,,BAO_0000218,,
11482,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624075,,BAO_0000218,,
11483,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624076,,BAO_0000218,,
11484,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624077,,BAO_0000218,,
11485,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624078,,BAO_0000218,,
11486,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624079,,BAO_0000218,2113.0,
11487,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624261,,BAO_0000218,2113.0,
11488,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624262,,BAO_0000218,,
11489,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624263,,BAO_0000218,,
11490,1,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624264,,BAO_0000218,,
11491,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624265,,BAO_0000218,,
11492,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624266,,BAO_0000218,,
11493,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624267,,BAO_0000218,,
11494,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624268,,BAO_0000218,,
11495,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875227,,BAO_0000218,,
11496,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624269,,BAO_0000218,2113.0,
11497,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624270,,BAO_0000218,2113.0,
11498,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624271,,BAO_0000218,,
11499,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624272,,BAO_0000218,,
11500,1,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624273,,BAO_0000218,,
11501,1,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624274,,BAO_0000218,1088.0,
11502,1,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624275,,BAO_0000218,1088.0,
11503,1,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624276,,BAO_0000218,1088.0,
11504,1,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624277,,BAO_0000218,1088.0,
11505,1,% dose converted to 2-amino-5-chlorophenyl sulfate,,0,22224,,U,Autocuration,,CHEMBL624278,,BAO_0000019,,
11506,1,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),,0,22224,,U,Autocuration,,CHEMBL624279,,BAO_0000019,,
11507,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624280,,BAO_0000218,1988.0,
11508,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624281,,BAO_0000218,1988.0,
11509,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622933,,BAO_0000218,1988.0,
11510,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622934,,BAO_0000218,1988.0,
11511,1,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622935,,BAO_0000218,2107.0,
11512,1,Biodistribution in Rat liver after 5 minutes of iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622936,,BAO_0000218,2107.0,
11513,1,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875228,,BAO_0000218,2107.0,
11514,1,Biodistribution in Rat lung after 24 hours of iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622937,,BAO_0000218,2048.0,
11515,1,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622938,,BAO_0000218,2048.0,
11516,1,Biodistribution in Rat lung after 30 minutes of iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL619736,,BAO_0000218,2048.0,
11517,1,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625117,,BAO_0000218,2048.0,
11518,1,Biodistribution in Rat lung after 5 minutes of iv administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625118,,BAO_0000218,2048.0,
11519,1,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625119,,BAO_0000218,2048.0,
11520,1,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625120,,BAO_0000218,2037.0,
11521,1,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625121,,BAO_0000218,,
11522,1,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625122,,BAO_0000218,10000006.0,
11523,1,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622204,,BAO_0000218,178.0,
11524,1,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877503,,BAO_0000218,178.0,
11525,1,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627127,,BAO_0000218,178.0,
11526,1,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,,0,22224,,U,Autocuration,,CHEMBL627128,,BAO_0000218,10000000.0,
11527,1,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,,0,22224,,U,Autocuration,,CHEMBL627129,,BAO_0000218,10000000.0,
11528,1,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,,0,22224,,U,Autocuration,,CHEMBL627130,,BAO_0000218,10000000.0,
11529,1,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627131,,BAO_0000218,955.0,
11530,1,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627132,,BAO_0000218,955.0,
11531,1,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627133,,BAO_0000218,955.0,
11532,1,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627134,,BAO_0000218,2037.0,
11533,1,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627135,,BAO_0000218,2037.0,
11534,1,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627136,,BAO_0000218,2037.0,
11535,1,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628435,,BAO_0000218,,
11536,1,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628436,,BAO_0000218,,
11537,1,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628437,,BAO_0000218,,
11538,1,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628438,,BAO_0000218,948.0,
11539,1,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628439,,BAO_0000218,948.0,
11540,1,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628440,,BAO_0000218,948.0,
11541,1,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628441,,BAO_0000218,10000000.0,
11542,1,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628442,,BAO_0000218,10000000.0,
11543,1,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628443,,BAO_0000218,10000000.0,
11544,1,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628444,,BAO_0000218,2113.0,
11545,1,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628445,,BAO_0000218,2113.0,
11546,1,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877504,,BAO_0000218,2113.0,
11547,1,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628446,,BAO_0000218,2107.0,
11548,1,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626874,,BAO_0000218,2107.0,
11549,1,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626875,,BAO_0000218,2107.0,
11550,1,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626876,,BAO_0000218,2048.0,
11551,1,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626877,,BAO_0000218,2048.0,
11552,1,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626878,,BAO_0000218,2048.0,
11553,1,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626879,,BAO_0000218,2385.0,
11554,1,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,Simiiformes,0,22224,,U,Autocuration,,CHEMBL626880,,BAO_0000218,1969.0,
11555,1,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626881,,BAO_0000218,1969.0,
11556,1,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626882,,BAO_0000218,1969.0,
11557,1,Peak plasma concentration was measured in dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626883,,BAO_0000218,1969.0,
11558,1,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626884,,BAO_0000218,,
11559,1,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626885,,BAO_0000218,,
11560,1,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626886,,BAO_0000218,,
11561,1,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626887,,BAO_0000218,,
11562,1,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626888,,BAO_0000218,,
11563,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626889,,BAO_0000218,,
11564,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL626761,,BAO_0000218,,
11565,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626762,,BAO_0000218,,
11566,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626763,,BAO_0000218,,
11567,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626764,,BAO_0000218,,
11568,1,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626765,,BAO_0000218,,
11569,1,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626766,,BAO_0000218,,
11570,1,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626767,,BAO_0000218,,
11571,1,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626768,,BAO_0000218,,
11572,1,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626769,,BAO_0000218,,
11573,1,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL874463,,BAO_0000218,,
11574,1,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL626770,,BAO_0000218,,
11575,1,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,Simiiformes,0,22224,,U,Autocuration,,CHEMBL626771,,BAO_0000218,,
11576,1,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626772,,BAO_0000218,,
11577,1,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL626773,,BAO_0000218,,
11578,1,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626774,,BAO_0000218,,
11579,1,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626775,,BAO_0000218,,
11580,1,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626776,,BAO_0000218,,
11581,1,Maximum concentration (Cmax) in rat when administered orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626777,,BAO_0000218,,
11582,1,Maximal concentration in monkey plasma after 25 mg/kg oral dose,Simiiformes,0,22224,,U,Autocuration,,CHEMBL626778,,BAO_0000218,1969.0,
11583,1,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL626779,,BAO_0000218,,
11584,1,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL626780,,BAO_0000218,,
11585,1,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,,0,22224,,U,Autocuration,,CHEMBL626781,,BAO_0000218,1969.0,
11586,1,Pharmacokinetic profile Cmax was evaluated in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632164,,BAO_0000218,,
11587,1,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632165,,BAO_0000218,,
11588,1,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),Mus musculus,1,50594,,N,Intermediate,,CHEMBL632166,,BAO_0000218,,
11589,1,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632167,,BAO_0000218,,
11590,1,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),Mus musculus,1,50594,,N,Intermediate,,CHEMBL632168,,BAO_0000218,,
11591,1,Cmax in rat plasma,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL632169,,BAO_0000218,1969.0,
11592,1,Cmax in dog plasma after 30mg/kg oral dose,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632170,,BAO_0000218,1969.0,
11593,1,Cmax in rat plasma after 30mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632171,,BAO_0000218,1969.0,
11594,1,Plasma level in rats at 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632172,,BAO_0000218,1969.0,
11595,1,Tested for maximum plasma concentration in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL632173,,BAO_0000218,1969.0,
11596,1,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632174,,BAO_0000218,,
11597,1,The Cmax values in female wistar rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632175,,BAO_0000218,,
11598,1,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632176,,BAO_0000218,1969.0,
11599,1,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632177,,BAO_0000218,1969.0,
11600,1,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632178,,BAO_0000218,1969.0,
11601,1,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632179,,BAO_0000218,,
11602,1,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632180,,BAO_0000218,178.0,
11603,1,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632181,,BAO_0000218,178.0,
11604,1,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632182,,BAO_0000218,178.0,
11605,1,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,Mus musculus,0,22224,,U,Autocuration,,CHEMBL632183,,BAO_0000218,178.0,
11606,1,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632184,,BAO_0000218,,
11607,1,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874470,,BAO_0000218,,
11608,1,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631302,,BAO_0000218,,
11609,1,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631303,,BAO_0000218,,
11610,1,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631304,,BAO_0000218,,
11611,1,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631305,,BAO_0000218,,
11612,1,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631306,,BAO_0000218,,
11613,1,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631307,,BAO_0000218,,
11614,1,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631308,,BAO_0000218,,
11615,1,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625557,,BAO_0000218,,
11616,1,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625558,,BAO_0000218,2106.0,
11617,1,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625559,,BAO_0000218,2106.0,
11618,1,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625560,,BAO_0000218,2106.0,
11619,1,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625561,,BAO_0000218,2106.0,
11620,1,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625562,,BAO_0000218,2106.0,
11621,1,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875320,,BAO_0000218,2106.0,
11622,1,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625563,,BAO_0000218,2106.0,
11623,1,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625564,,BAO_0000218,2106.0,
11624,1,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625565,,BAO_0000218,995.0,
11625,1,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625566,,BAO_0000218,995.0,
11626,1,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625567,,BAO_0000218,995.0,
11627,1,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625568,,BAO_0000218,995.0,
11628,1,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628217,,BAO_0000218,995.0,
11629,1,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628218,,BAO_0000218,995.0,
11630,1,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628219,,BAO_0000218,995.0,
11631,1,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628220,,BAO_0000218,995.0,
11632,1,Distribution in the blood after 120 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628221,,BAO_0000019,,
11633,1,Distribution in the blood after 15 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628222,,BAO_0000019,,
11634,1,Distribution in the blood after 30 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628223,,BAO_0000019,,
11635,1,Distribution in the blood after 5 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628224,,BAO_0000019,,
11636,1,Distribution in the blood after 60 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628225,,BAO_0000019,,
11637,1,Distribution in the blood after 90 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628226,,BAO_0000019,,
11638,1,Distribution in the bone after 120 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628227,,BAO_0000019,,
11639,1,Distribution in the bone after 15 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL875481,,BAO_0000019,,
11640,1,Distribution in the bone after 30 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628228,,BAO_0000019,,
11641,1,Distribution in the bone after 5 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628229,,BAO_0000019,,
11642,1,Distribution in the bone after 60 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628230,,BAO_0000019,,
11643,1,Distribution in the bone after 90 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628231,,BAO_0000019,,
11644,1,Distribution in the heart after 120 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628232,,BAO_0000019,,
11645,1,Distribution in the heart after 15 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628233,,BAO_0000019,,
11646,1,Distribution in the heart after 30 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628234,,BAO_0000019,,
11647,1,Distribution in the heart after 5 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628235,,BAO_0000019,,
11648,1,Distribution in the heart after 60 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628236,,BAO_0000019,,
11649,1,Distribution in the heart after 90 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628237,,BAO_0000019,,
11650,1,Distribution in the kidneys after 120 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628238,,BAO_0000019,,
11651,1,Distribution in the kidneys after 15 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628239,,BAO_0000019,,
11652,1,Distribution in the kidneys after 30 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628240,,BAO_0000019,,
11653,1,Distribution in the kidneys after 5 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628241,,BAO_0000019,,
11654,1,Distribution in the kidneys after 60 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628242,,BAO_0000019,,
11655,1,Distribution in the kidneys after 90 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL875482,,BAO_0000019,,
11656,1,Distribution in the liver after 120 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628243,,BAO_0000019,,
11657,1,Distribution in the liver after 15 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628244,,BAO_0000019,,
11658,1,Distribution in the liver after 30 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628245,,BAO_0000019,,
11659,1,Distribution in the liver after 5 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628246,,BAO_0000019,,
11660,1,Distribution in the liver after 60 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628247,,BAO_0000019,,
11661,1,Distribution in the liver after 90 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628248,,BAO_0000019,,
11662,1,Distribution in the lung after 120 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628249,,BAO_0000019,,
11663,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL625452,,BAO_0000218,,
11664,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL625453,,BAO_0000218,,
11665,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL625454,,BAO_0000218,,
11666,1,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL623844,,BAO_0000218,,
11667,1,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623845,,BAO_0000218,,
11668,1,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623846,,BAO_0000218,,
11669,1,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,,0,22224,,U,Autocuration,,CHEMBL623847,,BAO_0000218,,
11670,1,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL623848,,BAO_0000218,,
11671,1,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL623849,,BAO_0000218,,
11672,1,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL623850,,BAO_0000218,,
11673,1,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL623851,,BAO_0000218,,
11674,1,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL623852,,BAO_0000218,,
11675,1,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Mustela putorius furo,1,50506,,N,Intermediate,,CHEMBL624551,,BAO_0000218,,
11676,1,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Mustela putorius furo,1,50506,,N,Intermediate,,CHEMBL624552,,BAO_0000218,,
11677,1,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL624553,,BAO_0000218,,
11678,1,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,Simiiformes,0,22224,,U,Autocuration,,CHEMBL624554,,BAO_0000218,,
11679,1,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624555,,BAO_0000218,,
11680,1,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624741,,BAO_0000218,,
11681,1,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624742,,BAO_0000218,,
11682,1,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",Cricetinae,1,100712,,N,Intermediate,,CHEMBL624743,,BAO_0000218,,
11683,1,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877606,,BAO_0000218,,
11684,1,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,,0,22224,,U,Autocuration,,CHEMBL624744,,BAO_0000218,,
11685,1,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,,0,22224,,U,Autocuration,,CHEMBL624745,,BAO_0000218,178.0,
11686,1,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,,0,22224,,U,Autocuration,,CHEMBL624746,,BAO_0000218,178.0,
11687,1,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,,0,22224,,U,Autocuration,,CHEMBL624747,,BAO_0000218,178.0,
11688,1,Oral absorption expressed as Area under curve was determined,,0,22224,,U,Autocuration,,CHEMBL624748,,BAO_0000019,,
11689,1,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622504,,BAO_0000218,,
11690,1,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622505,,BAO_0000218,,
11691,1,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Cricetinae,1,100712,,N,Intermediate,,CHEMBL622506,,BAO_0000218,,
11692,1,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",Cricetinae,1,100712,,N,Intermediate,,CHEMBL622507,,BAO_0000218,,
11693,1,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622508,,BAO_0000218,,
11694,1,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,,0,22224,,U,Autocuration,,CHEMBL622509,,BAO_0000019,,
11695,1,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622510,,BAO_0000218,,
11696,1,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622511,,BAO_0000218,,
11697,1,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL622512,,BAO_0000218,,
11698,1,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL622513,,BAO_0000218,,
11699,1,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL622514,,BAO_0000218,,
11700,1,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622515,,BAO_0000218,,
11701,1,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622516,,BAO_0000218,,
11702,1,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622517,,BAO_0000218,,
11703,1,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622518,,BAO_0000218,,
11704,1,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622519,,BAO_0000218,,
11705,1,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622520,,BAO_0000218,2385.0,
11706,1,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622521,,BAO_0000218,2385.0,
11707,1,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625113,,BAO_0000218,14.0,
11708,1,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625114,,BAO_0000218,14.0,
11709,1,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874397,,BAO_0000218,14.0,
11710,1,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625115,,BAO_0000218,2106.0,
11711,1,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625116,,BAO_0000218,2106.0,
11712,1,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623932,,BAO_0000218,2106.0,
11713,1,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623933,,BAO_0000218,2435.0,
11714,1,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623934,,BAO_0000218,2435.0,
11715,1,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623935,,BAO_0000218,2435.0,
11716,1,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623936,,BAO_0000218,2046.0,
11717,1,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623937,,BAO_0000218,2046.0,
11718,1,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623938,,BAO_0000218,2046.0,
11719,1,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623939,,BAO_0000218,,
11720,1,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623940,,BAO_0000218,,
11721,1,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623941,,BAO_0000218,,
11722,1,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627216,,BAO_0000218,,
11723,1,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623942,,BAO_0000218,,
11724,1,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618793,,BAO_0000218,955.0,
11725,1,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618794,,BAO_0000218,955.0,
11726,1,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618795,,BAO_0000218,955.0,
11727,1,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618796,,BAO_0000218,,
11728,1,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618797,,BAO_0000218,,
11729,1,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618798,,BAO_0000218,2113.0,
11730,1,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618799,,BAO_0000218,2113.0,
11731,1,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618800,,BAO_0000218,2113.0,
11732,1,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618801,,BAO_0000218,2113.0,
11733,1,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618802,,BAO_0000218,2113.0,
11734,1,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618803,,BAO_0000218,2113.0,
11735,1,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618804,,BAO_0000218,2107.0,
11736,1,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618805,,BAO_0000218,2107.0,
11737,1,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618806,,BAO_0000218,2107.0,
11738,1,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618807,,BAO_0000218,2107.0,
11739,1,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618808,,BAO_0000218,2107.0,
11740,1,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618809,,BAO_0000218,2107.0,
11741,1,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618810,,BAO_0000218,2385.0,
11742,1,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618811,,BAO_0000218,2385.0,
11743,1,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL875844,,BAO_0000218,2385.0,
11744,1,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618812,,BAO_0000218,2385.0,
11745,1,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618813,,BAO_0000218,2385.0,
11746,1,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618814,,BAO_0000218,,
11747,1,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618815,,BAO_0000218,,
11748,1,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618816,,BAO_0000218,,
11749,1,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL618817,,BAO_0000218,,
11750,1,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL620544,,BAO_0000218,,
11751,1,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626230,,BAO_0000218,,
11752,1,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626231,,BAO_0000218,,
11753,1,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626232,,BAO_0000218,,
11754,1,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626233,,BAO_0000218,1969.0,
11755,1,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626234,,BAO_0000218,1969.0,
11756,1,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875341,,BAO_0000218,1969.0,
11757,1,The maximum plasma concentration (100 mg/kg) administered orally in human,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL626235,,BAO_0000218,1969.0,
11758,1,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,Callithrix,0,22224,,U,Autocuration,,CHEMBL626236,,BAO_0000218,1969.0,
11759,1,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL626237,,BAO_0000218,1969.0,
11760,1,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626238,,BAO_0000218,1969.0,
11761,1,The maximum plasma concentration (200 mg/kg) administered orally in human,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL622412,,BAO_0000218,1969.0,
11762,1,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623114,,BAO_0000218,1969.0,
11763,1,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,Callithrix,0,22224,,U,Autocuration,,CHEMBL623115,,BAO_0000218,1969.0,
11764,1,The maximum plasma concentration (25 mg/kg) administered orally in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL623116,,BAO_0000218,1969.0,
11765,1,The maximum plasma concentration (30 mg/kg) administered orally in dog,Canis lupus familiaris,0,22224,,U,Autocuration,,CHEMBL623117,,BAO_0000218,1969.0,
11766,1,The maximum plasma concentration (400 mg/kg) administered orally in human,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL623118,,BAO_0000218,1969.0,
11767,1,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623119,,BAO_0000218,1969.0,
11768,1,The maximum plasma concentration (50 mg/kg) administered orally in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623120,,BAO_0000218,1969.0,
11769,1,The maximum plasma concentration (800 mg/kg) administered orally in human,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL623286,,BAO_0000218,1969.0,
11770,1,The maximum plasma concentration was measured on rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623287,,BAO_0000218,1969.0,
11771,1,The maximum plasma concentration was measured on rats after oral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623288,,BAO_0000218,1969.0,
11772,1,Plasma drug Cmax in rat (PO dose),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623289,,BAO_0000218,1969.0,
11773,1,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,,0,22224,,U,Autocuration,,CHEMBL623290,,BAO_0000218,,
11774,1,maximum Plasma concentration in Dog was determined after Peroral administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623291,,BAO_0000218,1969.0,
11775,1,maximum Plasma concentration in Rats was determined after Peroral administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623292,,BAO_0000218,1969.0,
11776,1,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623293,,BAO_0000218,1969.0,
11777,1,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL623294,,BAO_0000218,1969.0,
11778,1,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623295,,BAO_0000218,1969.0,
11779,1,maximum concentration was measured when administered through oral route in mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623296,,BAO_0000218,,
11780,1,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,Mus musculus,1,50594,,N,Intermediate,,CHEMBL875349,,BAO_0000218,,
11781,1,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,Simiiformes,0,22224,,U,Autocuration,,CHEMBL623297,,BAO_0000019,,
11782,1,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,Simiiformes,0,22224,,U,Autocuration,,CHEMBL623298,,BAO_0000019,,
11783,1,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,Simiiformes,0,22224,,U,Autocuration,,CHEMBL623299,,BAO_0000019,,
11784,1,Pharmacokinetic parameter was evaluated in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623300,,BAO_0000218,,
11785,1,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623301,,BAO_0000218,,
11786,1,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623302,,BAO_0000218,,
11787,1,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623303,,BAO_0000218,,
11788,1,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623304,,BAO_0000218,,
11789,1,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623305,,BAO_0000218,,
11790,1,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623306,,BAO_0000218,1969.0,
11791,1,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623307,,BAO_0000218,1969.0,
11792,1,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623308,,BAO_0000218,1969.0,
11793,1,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623309,,BAO_0000218,1969.0,
11794,1,Plasma Concentration after 120 min of oral administration to mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623310,,BAO_0000218,,
11795,1,Plasma Concentration after 30 min of oral administration to mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623311,,BAO_0000218,,
11796,1,Plasma Concentration after 60 min of oral administration to mice,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL623312,,BAO_0000218,,
11797,1,Plasma Concentration after 60 min of oral administration to mice; Not determined,Mus musculus,1,50594,,N,Intermediate,,CHEMBL875350,,BAO_0000218,,
11798,1,Plasma Concentration after 90 min of oral administration to mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL628635,,BAO_0000218,,
11799,1,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628636,,BAO_0000218,,
11800,1,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628637,,BAO_0000218,,
11801,1,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628058,,BAO_0000218,,
11802,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628059,,BAO_0000218,,
11803,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628060,,BAO_0000218,,
11804,1,Distribution in the lung after 15 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628061,,BAO_0000019,,
11805,1,Distribution in the lung after 30 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628062,,BAO_0000019,,
11806,1,Distribution in the lung after 5 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628063,,BAO_0000019,,
11807,1,Distribution in the lung after 60 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628064,,BAO_0000019,,
11808,1,Distribution in the lung after 90 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628065,,BAO_0000019,,
11809,1,Distribution in the muscle after 120 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628066,,BAO_0000019,2385.0,
11810,1,Distribution in the muscle after 15 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628067,,BAO_0000019,2385.0,
11811,1,Distribution in the muscle after 30 min of intravenous administration,Mus musculus,1,50594,,N,Intermediate,,CHEMBL874646,,BAO_0000218,2385.0,
11812,1,Distribution in the muscle after 5 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628068,,BAO_0000019,2385.0,
11813,1,Distribution in the muscle after 60 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628069,,BAO_0000019,2385.0,
11814,1,Distribution in the muscle after 90 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628070,,BAO_0000019,2385.0,
11815,1,Distribution in the spleen after 120 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628071,,BAO_0000019,2106.0,
11816,1,Distribution in the spleen after 15 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628072,,BAO_0000019,2106.0,
11817,1,Distribution in the spleen after 30 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628073,,BAO_0000019,2106.0,
11818,1,Distribution in the spleen after 5 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628074,,BAO_0000019,2106.0,
11819,1,Distribution in the spleen after 60 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628075,,BAO_0000019,2106.0,
11820,1,Distribution in the spleen after 90 min of intravenous administration,,0,22224,,U,Autocuration,,CHEMBL628076,,BAO_0000019,2106.0,
11821,1,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628077,,BAO_0000218,1235.0,
11822,1,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628078,,BAO_0000218,178.0,
11823,1,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628079,,BAO_0000218,2107.0,
11824,1,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628080,,BAO_0000218,992.0,
11825,1,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628081,,BAO_0000218,2046.0,
11826,1,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628082,,BAO_0000218,1235.0,
11827,1,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874647,,BAO_0000218,178.0,
11828,1,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626406,,BAO_0000218,2107.0,
11829,1,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626407,,BAO_0000218,992.0,
11830,1,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626408,,BAO_0000218,2046.0,
11831,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626409,,BAO_0000218,178.0,
11832,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626410,,BAO_0000218,178.0,
11833,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626411,,BAO_0000218,178.0,
11834,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626412,,BAO_0000218,178.0,
11835,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626413,,BAO_0000218,178.0,
11836,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626414,,BAO_0000218,178.0,
11837,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626415,,BAO_0000218,178.0,
11838,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626416,,BAO_0000218,178.0,
11839,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627062,,BAO_0000218,178.0,
11840,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627063,,BAO_0000218,178.0,
11841,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627064,,BAO_0000218,178.0,
11842,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627227,,BAO_0000218,178.0,
11843,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627228,,BAO_0000218,178.0,
11844,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627229,,BAO_0000218,178.0,
11845,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625792,,BAO_0000218,178.0,
11846,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625793,,BAO_0000218,178.0,
11847,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625794,,BAO_0000218,178.0,
11848,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625795,,BAO_0000218,178.0,
11849,1,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625796,,BAO_0000218,,
11850,1,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625797,,BAO_0000218,,
11851,1,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625798,,BAO_0000218,,
11852,1,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL875613,,BAO_0000218,,
11853,1,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL625799,,BAO_0000218,,
11854,1,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL625800,,BAO_0000218,,
11855,1,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL625801,,BAO_0000218,,
11856,1,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL625802,,BAO_0000218,,
11857,1,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL625803,,BAO_0000218,,
11858,1,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,,0,22224,,U,Autocuration,,CHEMBL625804,,BAO_0000019,,
11859,1,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL622530,,BAO_0000218,,
11860,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622531,,BAO_0000218,,
11861,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL622532,,BAO_0000218,,
11862,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL623176,,BAO_0000218,,
11863,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL623177,,BAO_0000218,,
11864,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL623178,,BAO_0000218,,
11865,1,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623179,,BAO_0000218,,
11866,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL623180,,BAO_0000218,,
11867,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL623181,,BAO_0000218,,
11868,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624131,,BAO_0000218,,
11869,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624132,,BAO_0000218,,
11870,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624133,,BAO_0000218,,
11871,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,Mus musculus,1,50594,,N,Intermediate,,CHEMBL624846,,BAO_0000218,,
11872,1,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624847,,BAO_0000218,,
11873,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL624848,,BAO_0000218,,
11874,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625012,,BAO_0000218,,
11875,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625013,,BAO_0000218,,
11876,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625014,,BAO_0000218,,
11877,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625015,,BAO_0000218,,
11878,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625016,,BAO_0000218,,
11879,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625017,,BAO_0000218,,
11880,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625018,,BAO_0000218,,
11881,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625019,,BAO_0000218,,
11882,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL625020,,BAO_0000218,,
11883,1,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625021,,BAO_0000218,,
11884,1,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625022,,BAO_0000218,,
11885,1,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625023,,BAO_0000218,,
11886,1,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL625024,,BAO_0000218,,
11887,1,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL627626,,BAO_0000218,,
11888,1,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,0,22224,,U,Autocuration,,CHEMBL627627,,BAO_0000218,955.0,
11889,1,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,,0,22224,,U,Autocuration,,CHEMBL627628,,BAO_0000218,1977.0,
11890,1,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,0,22224,,U,Autocuration,,CHEMBL627629,,BAO_0000218,955.0,
11891,1,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,,0,22224,,U,Autocuration,,CHEMBL627630,,BAO_0000218,1977.0,
11892,1,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),,0,22224,,U,Autocuration,,CHEMBL627631,,BAO_0000019,,
11893,1,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),,0,22224,,U,Autocuration,,CHEMBL629515,,BAO_0000218,,
11894,1,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629516,,BAO_0000218,2106.0,
11895,1,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629517,,BAO_0000218,2106.0,
11896,1,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629518,,BAO_0000218,2106.0,
11897,1,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,Mus musculus,1,50594,,N,Intermediate,,CHEMBL877499,,BAO_0000218,,
11898,1,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629519,,BAO_0000218,,
11899,1,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629520,,BAO_0000218,,
11900,1,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629521,,BAO_0000218,,
11901,1,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),Mus musculus,1,50594,,N,Intermediate,,CHEMBL629522,,BAO_0000218,,
11902,1,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),Mus musculus,1,50594,,N,Intermediate,,CHEMBL629523,,BAO_0000218,,
11903,1,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),Mus musculus,1,50594,,N,Intermediate,,CHEMBL629524,,BAO_0000218,,
11904,1,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),Mus musculus,1,50594,,N,Intermediate,,CHEMBL629525,,BAO_0000218,,
11905,1,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),Mus musculus,1,50594,,N,Intermediate,,CHEMBL629526,,BAO_0000218,,
11906,1,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),Mus musculus,1,50594,,N,Intermediate,,CHEMBL629527,,BAO_0000218,,
11907,1,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),Mus musculus,1,50594,,N,Intermediate,,CHEMBL629528,,BAO_0000218,,
11908,1,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),Mus musculus,1,50594,,N,Intermediate,,CHEMBL629529,,BAO_0000218,,
11909,1,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),Mus musculus,1,50594,,N,Intermediate,,CHEMBL629530,,BAO_0000218,,
11910,1,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),Mus musculus,1,50594,,N,Intermediate,,CHEMBL629531,,BAO_0000218,,
11911,1,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),Mus musculus,1,50594,,N,Intermediate,,CHEMBL628656,,BAO_0000218,,
11912,1,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),Mus musculus,1,50594,,N,Intermediate,,CHEMBL628657,,BAO_0000218,,
11913,1,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628658,,BAO_0000218,,
11914,1,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628659,,BAO_0000218,,
11915,1,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877500,,BAO_0000218,,
11916,1,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628660,,BAO_0000218,,
11917,1,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628661,,BAO_0000218,,
11918,1,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628662,,BAO_0000218,,
11919,1,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628663,,BAO_0000218,,
11920,1,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628664,,BAO_0000218,,
11921,1,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628665,,BAO_0000218,178.0,
11922,1,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628666,,BAO_0000218,178.0,
11923,1,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628667,,BAO_0000218,178.0,
11924,1,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628668,,BAO_0000218,178.0,
11925,1,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628669,,BAO_0000218,178.0,
11926,1,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628670,,BAO_0000218,178.0,
11927,1,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628671,,BAO_0000218,178.0,
11928,1,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628672,,BAO_0000218,10000001.0,
11929,1,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630300,,BAO_0000218,10000001.0,
11930,1,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629787,,BAO_0000218,10000001.0,
11931,1,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629788,,BAO_0000218,10000001.0,
11932,1,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629789,,BAO_0000218,955.0,
11933,1,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629790,,BAO_0000218,955.0,
11934,1,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629791,,BAO_0000218,955.0,
11935,1,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629792,,BAO_0000218,955.0,
11936,1,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629793,,BAO_0000218,955.0,
11937,1,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629794,,BAO_0000218,955.0,
11938,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874459,,BAO_0000218,,
11939,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629795,,BAO_0000218,,
11940,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629796,,BAO_0000218,,
11941,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629797,,BAO_0000218,,
11942,1,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629798,,BAO_0000218,,
11943,1,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629799,,BAO_0000218,2369.0,
11944,1,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629800,,BAO_0000218,2369.0,
11945,1,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629801,,BAO_0000218,2369.0,
11946,1,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629802,,BAO_0000218,2369.0,
11947,1,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629803,,BAO_0000218,2369.0,
11948,1,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629804,,BAO_0000218,178.0,
11949,1,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629805,,BAO_0000218,178.0,
11950,1,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629806,,BAO_0000218,178.0,
11951,1,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629807,,BAO_0000218,178.0,
11952,1,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629808,,BAO_0000218,178.0,
11953,1,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629809,,BAO_0000218,955.0,
11954,1,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629810,,BAO_0000218,955.0,
11955,1,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629811,,BAO_0000218,955.0,
11956,1,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629812,,BAO_0000218,955.0,
11957,1,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629813,,BAO_0000218,955.0,
11958,1,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874460,,BAO_0000218,955.0,
11959,1,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629814,,BAO_0000218,,
11960,1,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629815,,BAO_0000218,,
11961,1,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629816,,BAO_0000218,,
11962,1,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629817,,BAO_0000218,,
11963,1,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626643,,BAO_0000218,2113.0,
11964,1,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626644,,BAO_0000218,2113.0,
11965,1,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626806,,BAO_0000218,2113.0,
11966,1,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626807,,BAO_0000218,2113.0,
11967,1,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627261,,BAO_0000218,2107.0,
11968,1,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627262,,BAO_0000218,2107.0,
11969,1,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627263,,BAO_0000218,2107.0,
11970,1,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627264,,BAO_0000218,2107.0,
11971,1,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627265,,BAO_0000218,2048.0,
11972,1,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627266,,BAO_0000218,2048.0,
11973,1,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627267,,BAO_0000218,2048.0,
11974,1,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627268,,BAO_0000218,2048.0,
11975,1,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627269,,BAO_0000218,2385.0,
11976,1,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627270,,BAO_0000218,2385.0,
11977,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627271,,BAO_0000218,,
11978,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627946,,BAO_0000218,,
11979,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875472,,BAO_0000218,,
11980,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627947,,BAO_0000218,,
11981,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627948,,BAO_0000218,,
11982,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628113,,BAO_0000218,,
11983,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628114,,BAO_0000218,,
11984,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628115,,BAO_0000218,,
11985,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628116,,BAO_0000218,,
11986,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628117,,BAO_0000218,,
11987,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628118,,BAO_0000218,,
11988,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628119,,BAO_0000218,,
11989,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628120,,BAO_0000218,,
11990,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628121,,BAO_0000218,,
11991,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628122,,BAO_0000218,,
11992,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627297,,BAO_0000218,,
11993,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627298,,BAO_0000218,,
11994,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627299,,BAO_0000218,,
11995,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627300,,BAO_0000218,,
11996,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627301,,BAO_0000218,,
11997,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627302,,BAO_0000218,,
11998,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627303,,BAO_0000218,,
11999,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627304,,BAO_0000218,,
12000,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627305,,BAO_0000218,,
12001,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627306,,BAO_0000218,,
12002,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623982,,BAO_0000218,,
12003,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623983,,BAO_0000218,,
12004,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623984,,BAO_0000218,,
12005,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623985,,BAO_0000218,,
12006,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623986,,BAO_0000218,,
12007,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623987,,BAO_0000218,,
12008,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623988,,BAO_0000218,,
12009,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623989,,BAO_0000218,,
12010,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622215,,BAO_0000218,,
12011,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622216,,BAO_0000218,,
12012,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877481,,BAO_0000218,,
12013,1,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),,0,22224,,U,Autocuration,,CHEMBL622217,,BAO_0000218,,
12014,1,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),Mus musculus,1,50594,,N,Intermediate,,CHEMBL622218,,BAO_0000218,,
12015,1,Pharmacokinetic profile AUC was evaluated in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622219,,BAO_0000218,,
12016,1,Pharmacokinetic property (Area under curve),,0,22224,,U,Autocuration,,CHEMBL622220,,BAO_0000019,,
12017,1,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622221,,BAO_0000218,,
12018,1,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622222,,BAO_0000218,,
12019,1,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622223,,BAO_0000218,,
12020,1,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622224,,BAO_0000218,,
12021,1,Plasma concentration (AUC) was determined,,0,22224,,U,Autocuration,,CHEMBL622225,,BAO_0000019,,
12022,1,Plasma concentration (AUC) was determined; Not detectable,,0,22224,,U,Autocuration,,CHEMBL622226,,BAO_0000019,,
12023,1,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL624154,,BAO_0000218,,
12024,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624155,,BAO_0000218,,
12025,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624156,,BAO_0000218,,
12026,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624157,,BAO_0000218,,
12027,1,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624158,,BAO_0000218,,
12028,1,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624159,,BAO_0000218,,
12029,1,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624160,,BAO_0000218,,
12030,1,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624161,,BAO_0000218,,
12031,1,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624162,,BAO_0000218,,
12032,1,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624163,,BAO_0000218,,
12033,1,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624164,,BAO_0000218,,
12034,1,The AUC(0-infinity) values in female wistar rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624165,,BAO_0000218,,
12035,1,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624166,,BAO_0000218,,
12036,1,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624167,,BAO_0000218,,
12037,1,The AUC(0-t)values in female wistar rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624168,,BAO_0000218,,
12038,1,The Area under the concentration time curve of compound was measured on rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624169,,BAO_0000218,,
12039,1,The area under curve (100 mg/kg) administered orally in humans,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL624170,,BAO_0000218,,
12040,1,The area under curve (12.5 mg/kg) administered intravenously in marmoset,Callithrix,0,22224,,U,Autocuration,,CHEMBL624171,,BAO_0000218,,
12041,1,The area under curve (12.5 mg/kg) administered intravenously in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL624172,,BAO_0000218,,
12042,1,The area under curve (15 mg/kg) administered intravenously in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624173,,BAO_0000218,,
12043,1,The area under curve (200 mg/kg) administered orally in humans,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL877488,,BAO_0000218,,
12044,1,The area under curve (25 mg/kg) administered intravenously in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624174,,BAO_0000218,,
12045,1,The area under curve (25 mg/kg) administered orally in marmoset,Callithrix,0,22224,,U,Autocuration,,CHEMBL624175,,BAO_0000218,,
12046,1,The area under curve (25 mg/kg) administered orally in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL624176,,BAO_0000218,,
12047,1,The area under curve (30 mg/kg) administered orally in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624177,,BAO_0000218,,
12048,1,The area under curve (400 mg/kg) administered orally in humans,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL624178,,BAO_0000218,,
12049,1,The area under curve (50 mg/kg) administered orally in fasted rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624179,,BAO_0000218,,
12050,1,The area under curve (50 mg/kg) administered orally in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627689,,BAO_0000218,,
12051,1,The area under curve (800 mg/kg) administered orally in humans,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL627690,,BAO_0000218,,
12052,1,The compound was evaluated for area under the curve,,0,22224,,U,Autocuration,,CHEMBL627691,,BAO_0000019,,
12053,1,The compound was evaluated for area under the curve in marmosets,Callithrix,0,22224,,U,Autocuration,,CHEMBL627692,,BAO_0000019,,
12054,1,The compound was evaluated for area under the curve in marmosets,Callithrix,0,22224,,U,Autocuration,,CHEMBL627693,,BAO_0000019,,
12055,1,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627694,,BAO_0000218,,
12056,1,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627695,,BAO_0000218,,
12057,1,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),,0,22224,,U,Autocuration,,CHEMBL627696,,BAO_0000218,,
12058,1,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627697,,BAO_0000218,,
12059,1,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627698,,BAO_0000218,,
12060,1,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627699,,BAO_0000218,,
12061,1,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627700,,BAO_0000218,,
12062,1,Total drug exposure is determined after oral dosing in rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627701,,BAO_0000218,,
12063,1,Total drug exposure (5 mg/kg) when administered intravenously,,0,22224,,U,Autocuration,,CHEMBL627702,,BAO_0000218,,
12064,1,Total drug exposure (5 mg/kg) when administered orally,,0,22224,,U,Autocuration,,CHEMBL627703,,BAO_0000218,,
12065,1,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL626873,,BAO_0000218,,
12066,1,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629583,,BAO_0000218,,
12067,1,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629584,,BAO_0000218,,
12068,1,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629585,,BAO_0000218,,
12069,1,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629586,,BAO_0000218,955.0,
12070,1,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629587,,BAO_0000218,955.0,
12071,1,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629588,,BAO_0000218,,
12072,1,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629589,,BAO_0000218,,
12073,1,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629590,,BAO_0000218,,
12074,1,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629591,,BAO_0000218,,
12075,1,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629592,,BAO_0000218,,
12076,1,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629593,,BAO_0000218,,
12077,1,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629594,,BAO_0000218,,
12078,1,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629595,,BAO_0000218,948.0,
12079,1,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630290,,BAO_0000218,948.0,
12080,1,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627137,,BAO_0000218,948.0,
12081,1,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627138,,BAO_0000218,948.0,
12082,1,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627139,,BAO_0000218,948.0,
12083,1,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627140,,BAO_0000218,948.0,
12084,1,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627141,,BAO_0000218,948.0,
12085,1,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627142,,BAO_0000218,2113.0,
12086,1,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627143,,BAO_0000218,2113.0,
12087,1,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874449,,BAO_0000218,2113.0,
12088,1,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627144,,BAO_0000218,2113.0,
12089,1,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627145,,BAO_0000218,2113.0,
12090,1,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627146,,BAO_0000218,2113.0,
12091,1,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627147,,BAO_0000218,2113.0,
12092,1,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627148,,BAO_0000218,2107.0,
12093,1,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627149,,BAO_0000218,2048.0,
12094,1,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632160,,BAO_0000218,2048.0,
12095,1,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632161,,BAO_0000218,2048.0,
12096,1,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632162,,BAO_0000218,2048.0,
12097,1,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632163,,BAO_0000218,2048.0,
12098,1,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874469,,BAO_0000218,2048.0,
12099,1,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627182,,BAO_0000218,2048.0,
12100,1,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627183,,BAO_0000218,2385.0,
12101,1,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627184,,BAO_0000218,2385.0,
12102,1,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627185,,BAO_0000218,2385.0,
12103,1,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627186,,BAO_0000218,2385.0,
12104,1,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627187,,BAO_0000218,2385.0,
12105,1,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627188,,BAO_0000218,2385.0,
12106,1,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627189,,BAO_0000218,2385.0,
12107,1,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627190,,BAO_0000218,,
12108,1,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627191,,BAO_0000218,2107.0,
12109,1,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627192,,BAO_0000218,2107.0,
12110,1,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627193,,BAO_0000218,2107.0,
12111,1,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874590,,BAO_0000218,2385.0,
12112,1,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627194,,BAO_0000218,2385.0,
12113,1,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627195,,BAO_0000218,2385.0,
12114,1,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627196,,BAO_0000218,992.0,
12115,1,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627197,,BAO_0000218,992.0,
12116,1,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627198,,BAO_0000218,992.0,
12117,1,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627199,,BAO_0000218,992.0,
12118,1,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627200,,BAO_0000218,992.0,
12119,1,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627201,,BAO_0000218,1969.0,
12120,1,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627202,,BAO_0000218,1969.0,
12121,1,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627203,,BAO_0000218,1969.0,
12122,1,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627204,,BAO_0000218,1969.0,
12123,1,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627205,,BAO_0000218,2106.0,
12124,1,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627206,,BAO_0000218,2106.0,
12125,1,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627207,,BAO_0000218,2106.0,
12126,1,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627208,,BAO_0000218,2106.0,
12127,1,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627209,,BAO_0000218,2046.0,
12128,1,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627210,,BAO_0000218,2046.0,
12129,1,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627211,,BAO_0000218,2046.0,
12130,1,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627212,,BAO_0000218,2046.0,
12131,1,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627213,,BAO_0000218,995.0,
12132,1,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626599,,BAO_0000218,995.0,
12133,1,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626600,,BAO_0000218,995.0,
12134,1,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626601,,BAO_0000218,995.0,
12135,1,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,,0,22224,,U,Autocuration,,CHEMBL627484,,BAO_0000019,,
12136,1,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL627485,,BAO_0000218,1969.0,
12137,1,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL628147,,BAO_0000218,1969.0,
12138,1,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL628148,,BAO_0000218,1969.0,
12139,1,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628149,,BAO_0000218,1969.0,
12140,1,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628150,,BAO_0000218,1969.0,
12141,1,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628318,,BAO_0000218,1969.0,
12142,1,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628319,,BAO_0000218,1969.0,
12143,1,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL875609,,BAO_0000218,,
12144,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,,0,22224,,U,Autocuration,,CHEMBL628320,,BAO_0000019,,
12145,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,,0,22224,,U,Autocuration,,CHEMBL628321,,BAO_0000019,,
12146,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,,0,22224,,U,Autocuration,,CHEMBL628322,,BAO_0000019,,
12147,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,,0,22224,,U,Autocuration,,CHEMBL628323,,BAO_0000019,,
12148,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,,0,22224,,U,Autocuration,,CHEMBL628324,,BAO_0000019,,
12149,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,,0,22224,,U,Autocuration,,CHEMBL628325,,BAO_0000019,,
12150,1,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,,0,22224,,U,Autocuration,,CHEMBL628326,,BAO_0000019,,
12151,1,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628327,,BAO_0000218,1236.0,
12152,1,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628328,,BAO_0000218,1236.0,
12153,1,"Concentration of compound in blood of dog 1, after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628329,,BAO_0000218,178.0,
12154,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628330,,BAO_0000218,2107.0,
12155,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628331,,BAO_0000218,2107.0,
12156,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628332,,BAO_0000218,2107.0,
12157,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628333,,BAO_0000218,2107.0,
12158,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628334,,BAO_0000218,2107.0,
12159,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628335,,BAO_0000218,2107.0,
12160,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628336,,BAO_0000218,2107.0,
12161,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628337,,BAO_0000218,2107.0,
12162,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628338,,BAO_0000218,2107.0,
12163,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875610,,BAO_0000218,2107.0,
12164,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628339,,BAO_0000218,2107.0,
12165,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628340,,BAO_0000218,2107.0,
12166,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628341,,BAO_0000218,2107.0,
12167,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622214,,BAO_0000218,2107.0,
12168,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623167,,BAO_0000218,2107.0,
12169,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623168,,BAO_0000218,2107.0,
12170,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623169,,BAO_0000218,2107.0,
12171,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623170,,BAO_0000218,2107.0,
12172,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627224,,BAO_0000218,2048.0,
12173,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875634,,BAO_0000218,2048.0,
12174,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627225,,BAO_0000218,2048.0,
12175,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627226,,BAO_0000218,2048.0,
12176,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626083,,BAO_0000218,2048.0,
12177,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626084,,BAO_0000218,2048.0,
12178,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626085,,BAO_0000218,2048.0,
12179,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626086,,BAO_0000218,2048.0,
12180,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626087,,BAO_0000218,2048.0,
12181,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626088,,BAO_0000218,2048.0,
12182,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626089,,BAO_0000218,2048.0,
12183,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626090,,BAO_0000218,2048.0,
12184,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626091,,BAO_0000218,2048.0,
12185,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626092,,BAO_0000218,2048.0,
12186,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626093,,BAO_0000218,2048.0,
12187,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626094,,BAO_0000218,2048.0,
12188,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626095,,BAO_0000218,2048.0,
12189,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626096,,BAO_0000218,2048.0,
12190,1,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL626097,,BAO_0000218,,
12191,1,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626098,,BAO_0000218,,
12192,1,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,,0,22224,,U,Autocuration,,CHEMBL626099,,BAO_0000218,1969.0,
12193,1,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,,0,22224,,U,Autocuration,,CHEMBL626100,,BAO_0000218,1969.0,
12194,1,AUC 0-inf in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626101,,BAO_0000218,1969.0,
12195,1,AUC 0-inf in guinea pig,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL626102,,BAO_0000218,1969.0,
12196,1,AUC 0-t in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626103,,BAO_0000218,1969.0,
12197,1,AUC 0-t in guinea pig,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL628391,,BAO_0000218,1969.0,
12198,1,The compound was tested for brain to plasma partition in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628392,,BAO_0000218,,
12199,1,The compound was tested for brain to plasma partition in rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628393,,BAO_0000218,,
12200,1,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,,0,22224,,U,Autocuration,,CHEMBL628394,,BAO_0000019,178.0,
12201,1,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628395,,BAO_0000218,,
12202,1,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,Simiiformes,0,22224,,U,Autocuration,,CHEMBL628396,,BAO_0000218,,
12203,1,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628397,,BAO_0000218,,
12204,1,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628398,,BAO_0000218,,
12205,1,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,Macaca mulatta,1,50797,,N,Intermediate,,CHEMBL628399,,BAO_0000218,,
12206,1,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628400,,BAO_0000218,,
12207,1,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874907,,BAO_0000218,,
12208,1,Area under curve of the compound was determined,,0,22224,,U,Autocuration,,CHEMBL628401,,BAO_0000019,,
12209,1,AUC in monkeys at a dose of 1 mg/kg,Simiiformes,0,22224,,U,Autocuration,,CHEMBL628402,,BAO_0000218,1969.0,
12210,1,AUC in rats at a dose of 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628403,,BAO_0000218,1969.0,
12211,1,Compound was evaluated for the overall absorbance loss at pH of 2,,0,22224,,U,Autocuration,,CHEMBL628404,,BAO_0000019,,
12212,1,Compound was evaluated for the overall absorbance loss at pH of 4,,0,22224,,U,Autocuration,,CHEMBL628405,,BAO_0000019,,
12213,1,Compound was evaluated for the overall absorbance loss at pH of 7,,0,22224,,U,Autocuration,,CHEMBL628406,,BAO_0000019,,
12214,1,Compound was evaluated for its absorption in the rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628407,,BAO_0000218,,
12215,1,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628408,,BAO_0000218,1088.0,
12216,1,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629171,,BAO_0000218,1088.0,
12217,1,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629172,,BAO_0000218,1088.0,
12218,1,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629173,,BAO_0000218,1088.0,
12219,1,In vitro percent permeability into rat ileum,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629174,,BAO_0000218,,
12220,1,In vitro percent permeability into rat ileum; Range is 10-17,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629175,,BAO_0000218,,
12221,1,In vitro percent permeability into rat ileum; Range is 10-18,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629176,,BAO_0000218,,
12222,1,In vitro percent permeability into rat ileum; Range is 10-19,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629177,,BAO_0000218,,
12223,1,In vitro percent permeability into rat ileum; Range is 12-15,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629178,,BAO_0000218,,
12224,1,In vitro percent permeability into rat ileum; Range is 13-19,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631869,,BAO_0000218,,
12225,1,In vitro percent permeability into rat ileum; Range is 14-17,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631870,,BAO_0000218,,
12226,1,In vitro percent permeability into rat ileum; Range is 15-18,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631871,,BAO_0000218,,
12227,1,In vitro percent permeability into rat ileum; Range is 2-5,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631872,,BAO_0000218,,
12228,1,In vitro percent permeability into rat ileum; Range is 23-42,,0,22224,,U,Autocuration,,CHEMBL875775,,BAO_0000221,2116.0,
12229,1,In vitro percent permeability into rat ileum; Range is 28-36,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631873,,BAO_0000218,,
12230,1,In vitro percent permeability into rat ileum; Range is 29-35,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631874,,BAO_0000218,,
12231,1,In vitro percent permeability into rat ileum; Range is 46-66,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631875,,BAO_0000218,,
12232,1,In vitro percent permeability into rat ileum; Range is 50-68,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631876,,BAO_0000218,,
12233,1,In vitro percent permeability into rat ileum; Range is 78-81,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631877,,BAO_0000218,,
12234,1,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631878,,BAO_0000218,,
12235,1,In vitro percent permeability into rat ileum; nd indicates not detected,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631879,,BAO_0000218,,
12236,1,In vitro percent permeability into rat ileum; nt indicates not detected,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631880,,BAO_0000218,,
12237,1,In vitro percent permeability into rat ileum; nt indicates not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631881,,BAO_0000218,,
12238,1,Compound was tested for oral absorption in bile-duct cannulated rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631882,,BAO_0000218,,
12239,1,Compound was tested for oral absorption in bile-duct cannulated rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630749,,BAO_0000218,,
12240,1,Oral absorption using Caco-2 cell monolayers.,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL630750,,BAO_0000218,,
12241,1,Percent of the drug absorbed after administration to humans was determined,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL630253,,BAO_0000218,,
12242,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630254,,BAO_0000218,1969.0,
12243,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630255,,BAO_0000218,1969.0,
12244,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630256,,BAO_0000218,1969.0,
12245,1,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875781,,BAO_0000218,2107.0,
12246,1,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630257,,BAO_0000218,2107.0,
12247,1,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630258,,BAO_0000218,2107.0,
12248,1,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630259,,BAO_0000218,,
12249,1,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630260,,BAO_0000218,2435.0,
12250,1,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630261,,BAO_0000218,2435.0,
12251,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630262,,BAO_0000218,,
12252,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630263,,BAO_0000218,,
12253,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630264,,BAO_0000218,,
12254,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630265,,BAO_0000218,,
12255,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630266,,BAO_0000218,,
12256,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630267,,BAO_0000218,2113.0,
12257,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630268,,BAO_0000218,2113.0,
12258,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630269,,BAO_0000218,,
12259,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630270,,BAO_0000218,,
12260,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630141,,BAO_0000218,2048.0,
12261,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630142,,BAO_0000218,2048.0,
12262,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630143,,BAO_0000218,2385.0,
12263,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630144,,BAO_0000218,2385.0,
12264,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630145,,BAO_0000218,2367.0,
12265,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630146,,BAO_0000218,2367.0,
12266,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630147,,BAO_0000218,,
12267,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630148,,BAO_0000218,,
12268,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630149,,BAO_0000218,,
12269,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630150,,BAO_0000218,2106.0,
12270,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630151,,BAO_0000218,2106.0,
12271,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632031,,BAO_0000218,2046.0,
12272,1,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632032,,BAO_0000218,2046.0,
12273,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632033,,BAO_0000218,,
12274,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632034,,BAO_0000218,,
12275,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632035,,BAO_0000218,2385.0,
12276,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632036,,BAO_0000218,,
12277,1,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632037,,BAO_0000218,2046.0,
12278,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632038,,BAO_0000218,178.0,
12279,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632039,,BAO_0000218,178.0,
12280,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632040,,BAO_0000218,178.0,
12281,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632041,,BAO_0000218,178.0,
12282,1,"Concentration of compound in blood of dog 2, after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632042,,BAO_0000218,178.0,
12283,1,"Concentration of compound in left ventricle of dog 1, after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632043,,BAO_0000218,,
12284,1,"Concentration of compound in left ventricle of dog 2, after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632044,,BAO_0000218,,
12285,1,"Concentration of compound in liver of dog 1, after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632045,,BAO_0000218,2107.0,
12286,1,"Concentration of compound in liver of dog 2, after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632046,,BAO_0000218,2107.0,
12287,1,"Concentration of compound in lung of dog 1, after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632047,,BAO_0000218,2048.0,
12288,1,"Concentration of compound in lung of dog 2, after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632048,,BAO_0000218,2048.0,
12289,1,"Concentration of compound in muscle of dog 1, after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632049,,BAO_0000218,2385.0,
12290,1,"Concentration of compound in muscle of dog 2, after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL876418,,BAO_0000218,2385.0,
12291,1,"Concentration of compound in spleen of dog 1,after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632050,,BAO_0000218,2106.0,
12292,1,"Concentration of compound in spleen of dog 2, after administering intravenously",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL632051,,BAO_0000218,2106.0,
12293,1,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,,0,22224,,U,Autocuration,,CHEMBL632052,,BAO_0000218,,
12294,1,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,,0,22224,,U,Autocuration,,CHEMBL632053,,BAO_0000218,,
12295,1,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,0,22224,,U,Autocuration,,CHEMBL632054,,BAO_0000218,,
12296,1,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,,0,22224,,U,Autocuration,,CHEMBL632055,,BAO_0000218,,
12297,1,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,,0,22224,,U,Autocuration,,CHEMBL631181,,BAO_0000218,,
12298,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,,0,22224,,U,Autocuration,,CHEMBL631182,,BAO_0000218,,
12299,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,0,22224,,U,Autocuration,,CHEMBL631183,,BAO_0000218,,
12300,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,0,22224,,U,Autocuration,,CHEMBL631184,,BAO_0000218,,
12301,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,0,22224,,U,Autocuration,,CHEMBL629774,,BAO_0000218,,
12302,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,0,22224,,U,Autocuration,,CHEMBL629775,,BAO_0000218,,
12303,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,0,22224,,U,Autocuration,,CHEMBL876549,,BAO_0000218,,
12304,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,0,22224,,U,Autocuration,,CHEMBL628172,,BAO_0000218,,
12305,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,0,22224,,U,Autocuration,,CHEMBL628173,,BAO_0000218,,
12306,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,,0,22224,,U,Autocuration,,CHEMBL628174,,BAO_0000218,,
12307,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,,0,22224,,U,Autocuration,,CHEMBL628175,,BAO_0000218,,
12308,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,0,22224,,U,Autocuration,,CHEMBL628176,,BAO_0000218,,
12309,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,0,22224,,U,Autocuration,,CHEMBL628177,,BAO_0000218,,
12310,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,0,22224,,U,Autocuration,,CHEMBL628178,,BAO_0000218,,
12311,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,0,22224,,U,Autocuration,,CHEMBL628179,,BAO_0000218,,
12312,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,,0,22224,,U,Autocuration,,CHEMBL628180,,BAO_0000218,,
12313,1,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,,0,22224,,U,Autocuration,,CHEMBL628181,,BAO_0000218,,
12314,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,0,22224,,U,Autocuration,,CHEMBL628182,,BAO_0000218,,
12315,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,0,22224,,U,Autocuration,,CHEMBL628183,,BAO_0000218,,
12316,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,,0,22224,,U,Autocuration,,CHEMBL628184,,BAO_0000218,,
12317,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,0,22224,,U,Autocuration,,CHEMBL628185,,BAO_0000218,,
12318,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,0,22224,,U,Autocuration,,CHEMBL875617,,BAO_0000218,,
12319,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,0,22224,,U,Autocuration,,CHEMBL628186,,BAO_0000218,,
12320,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,0,22224,,U,Autocuration,,CHEMBL628187,,BAO_0000218,,
12321,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,0,22224,,U,Autocuration,,CHEMBL628188,,BAO_0000218,,
12322,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,0,22224,,U,Autocuration,,CHEMBL628189,,BAO_0000218,,
12323,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,,0,22224,,U,Autocuration,,CHEMBL628190,,BAO_0000218,,
12324,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,0,22224,,U,Autocuration,,CHEMBL628191,,BAO_0000218,,
12325,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,,0,22224,,U,Autocuration,,CHEMBL626513,,BAO_0000218,,
12326,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626514,,BAO_0000218,2046.0,
12327,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626515,,BAO_0000218,2046.0,
12328,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626516,,BAO_0000218,2046.0,
12329,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626517,,BAO_0000218,2046.0,
12330,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626518,,BAO_0000218,2046.0,
12331,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626519,,BAO_0000218,2046.0,
12332,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626520,,BAO_0000218,2046.0,
12333,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626521,,BAO_0000218,2046.0,
12334,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626522,,BAO_0000218,2046.0,
12335,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626523,,BAO_0000218,2046.0,
12336,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626524,,BAO_0000218,2046.0,
12337,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626688,,BAO_0000218,2046.0,
12338,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626689,,BAO_0000218,2046.0,
12339,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626690,,BAO_0000218,2046.0,
12340,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626691,,BAO_0000218,2046.0,
12341,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627319,,BAO_0000218,2046.0,
12342,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624052,,BAO_0000218,2046.0,
12343,1,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624053,,BAO_0000218,2046.0,
12344,1,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624054,,BAO_0000218,,
12345,1,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624055,,BAO_0000218,,
12346,1,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624056,,BAO_0000218,,
12347,1,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624057,,BAO_0000218,995.0,
12348,1,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622281,,BAO_0000218,995.0,
12349,1,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622282,,BAO_0000218,995.0,
12350,1,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622283,,BAO_0000218,995.0,
12351,1,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622284,,BAO_0000218,995.0,
12352,1,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622285,,BAO_0000218,995.0,
12353,1,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622286,,BAO_0000218,995.0,
12354,1,Distribution coefficient (D %) between octanol and buffer of pH 7.4,,0,22224,,U,Autocuration,,CHEMBL622287,,BAO_0000100,,
12355,1,Partition coefficient (logD7.4),Mus musculus,1,50594,,N,Intermediate,,CHEMBL622288,,BAO_0000218,,
12356,1,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622289,,BAO_0000218,,
12357,1,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622290,,BAO_0000218,955.0,
12358,1,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622291,,BAO_0000218,,
12359,1,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622292,,BAO_0000218,955.0,
12360,1,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622293,,BAO_0000218,,
12361,1,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL622294,,BAO_0000218,955.0,
12362,1,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,Mus musculus,1,50594,,N,Intermediate,,CHEMBL622295,,BAO_0000218,,
12363,1,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622296,,BAO_0000218,955.0,
12364,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874409,,BAO_0000218,1969.0,
12365,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622297,,BAO_0000218,1969.0,
12366,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622298,,BAO_0000218,1969.0,
12367,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622299,,BAO_0000218,1969.0,
12368,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622300,,BAO_0000218,1969.0,
12369,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622301,,BAO_0000218,1969.0,
12370,1,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622302,,BAO_0000218,1969.0,
12371,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622303,,BAO_0000218,1969.0,
12372,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622304,,BAO_0000218,1969.0,
12373,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622305,,BAO_0000218,1969.0,
12374,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622306,,BAO_0000218,1969.0,
12375,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626864,,BAO_0000218,1969.0,
12376,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626865,,BAO_0000218,1969.0,
12377,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626866,,BAO_0000218,1969.0,
12378,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626867,,BAO_0000218,1969.0,
12379,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626868,,BAO_0000218,1969.0,
12380,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626869,,BAO_0000218,1969.0,
12381,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626870,,BAO_0000218,1969.0,
12382,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626871,,BAO_0000218,1969.0,
12383,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626872,,BAO_0000218,1969.0,
12384,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632185,,BAO_0000218,1969.0,
12385,1,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632186,,BAO_0000218,1969.0,
12386,1,Amount of acetic acid produced by the compound,,0,22224,,U,Autocuration,,CHEMBL629310,,BAO_0000019,,
12387,1,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,,0,22224,,U,Autocuration,,CHEMBL629311,,BAO_0000019,,
12388,1,Log of (Cbrain/Cblood) in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629312,,BAO_0000218,,
12389,1,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629313,,BAO_0000221,,
12390,1,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629314,,BAO_0000221,,
12391,1,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629315,,BAO_0000221,,
12392,1,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629316,,BAO_0000219,,
12393,1,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629317,,BAO_0000221,,
12394,1,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629318,,BAO_0000019,,
12395,1,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL877497,,BAO_0000019,,
12396,1,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629319,,BAO_0000019,,
12397,1,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629320,,BAO_0000019,,
12398,1,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629496,,BAO_0000019,,
12399,1,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629497,,BAO_0000019,,
12400,1,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629498,,BAO_0000019,,
12401,1,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629499,,BAO_0000019,,
12402,1,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629500,,BAO_0000019,,
12403,1,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629501,,BAO_0000019,,
12404,1,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),,0,22224,,U,Autocuration,,CHEMBL629502,,BAO_0000019,,
12405,1,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,,0,22224,,U,Autocuration,,CHEMBL629503,,BAO_0000218,,
12406,1,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629504,,BAO_0000218,,
12407,1,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,,0,22224,,U,Autocuration,,CHEMBL629505,,BAO_0000019,,
12408,1,Compound was evaluated for total body clearance,,0,22224,,U,Autocuration,,CHEMBL629506,,BAO_0000019,,
12409,1,Compound was evaluated for volume of distribution at steady state,,0,22224,,U,Autocuration,,CHEMBL629507,,BAO_0000019,,
12410,1,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,,0,22224,,U,Autocuration,,CHEMBL877498,,BAO_0000019,,
12411,1,Percentage of the diamine which is monoprotonated at pH 7.4,,0,22224,,U,Autocuration,,CHEMBL629508,,BAO_0000019,,
12412,1,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,,0,22224,,U,Autocuration,,CHEMBL629509,,BAO_0000019,,
12413,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629510,,BAO_0000218,178.0,
12414,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629511,,BAO_0000218,178.0,
12415,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629512,,BAO_0000218,178.0,
12416,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629513,,BAO_0000218,178.0,
12417,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629514,,BAO_0000218,178.0,
12418,1,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628447,,BAO_0000218,178.0,
12419,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628448,,BAO_0000218,178.0,
12420,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628449,,BAO_0000218,178.0,
12421,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631119,,BAO_0000218,178.0,
12422,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631120,,BAO_0000218,178.0,
12423,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631121,,BAO_0000218,178.0,
12424,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874458,,BAO_0000218,178.0,
12425,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631122,,BAO_0000218,178.0,
12426,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631123,,BAO_0000218,178.0,
12427,1,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631124,,BAO_0000218,178.0,
12428,1,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631125,,BAO_0000218,178.0,
12429,1,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631290,,BAO_0000218,178.0,
12430,1,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631291,,BAO_0000218,178.0,
12431,1,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631292,,BAO_0000218,178.0,
12432,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631293,,BAO_0000218,178.0,
12433,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631294,,BAO_0000218,178.0,
12434,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631295,,BAO_0000218,178.0,
12435,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631296,,BAO_0000218,178.0,
12436,1,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631297,,BAO_0000218,178.0,
12437,1,Maximum biodistribution (Bmax) was determined.,,0,22224,,U,Autocuration,,CHEMBL631298,,BAO_0000218,,
12438,1,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631299,,BAO_0000218,,
12439,1,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631300,,BAO_0000218,,
12440,1,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631301,,BAO_0000218,,
12441,1,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630291,,BAO_0000218,,
12442,1,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,,0,22224,,U,Autocuration,,CHEMBL630292,,BAO_0000218,,
12443,1,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,,0,22224,,U,Autocuration,,CHEMBL630293,,BAO_0000218,,
12444,1,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,,0,22224,,U,Autocuration,,CHEMBL630294,,BAO_0000218,,
12445,1,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,,0,22224,,U,Autocuration,,CHEMBL630295,,BAO_0000218,,
12446,1,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,,0,22224,,U,Autocuration,,CHEMBL630296,,BAO_0000218,,
12447,1,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,,0,22224,,U,Autocuration,,CHEMBL626782,,BAO_0000218,,
12448,1,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,,0,22224,,U,Autocuration,,CHEMBL626783,,BAO_0000218,,
12449,1,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,,0,22224,,U,Autocuration,,CHEMBL626784,,BAO_0000218,,
12450,1,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,,0,22224,,U,Autocuration,,CHEMBL626785,,BAO_0000218,,
12451,1,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,,0,22224,,U,Autocuration,,CHEMBL626786,,BAO_0000218,,
12452,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,0,22224,,U,Autocuration,,CHEMBL626787,,BAO_0000218,,
12453,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,,0,22224,,U,Autocuration,,CHEMBL626788,,BAO_0000218,,
12454,1,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,0,22224,,U,Autocuration,,CHEMBL625927,,BAO_0000218,,
12455,1,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625928,,BAO_0000218,178.0,
12456,1,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625929,,BAO_0000218,178.0,
12457,1,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625930,,BAO_0000218,178.0,
12458,1,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625931,,BAO_0000218,178.0,
12459,1,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627230,,BAO_0000218,178.0,
12460,1,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627231,,BAO_0000218,178.0,
12461,1,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627232,,BAO_0000218,178.0,
12462,1,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627233,,BAO_0000218,178.0,
12463,1,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875470,,BAO_0000218,178.0,
12464,1,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627234,,BAO_0000218,178.0,
12465,1,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627235,,BAO_0000218,178.0,
12466,1,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627236,,BAO_0000218,178.0,
12467,1,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627237,,BAO_0000218,178.0,
12468,1,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627238,,BAO_0000218,178.0,
12469,1,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627239,,BAO_0000218,178.0,
12470,1,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627240,,BAO_0000218,178.0,
12471,1,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627241,,BAO_0000218,178.0,
12472,1,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627242,,BAO_0000218,178.0,
12473,1,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627243,,BAO_0000218,178.0,
12474,1,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627244,,BAO_0000218,178.0,
12475,1,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627245,,BAO_0000218,178.0,
12476,1,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627246,,BAO_0000218,178.0,
12477,1,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627247,,BAO_0000218,178.0,
12478,1,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627248,,BAO_0000218,178.0,
12479,1,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627249,,BAO_0000218,178.0,
12480,1,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625569,,BAO_0000218,178.0,
12481,1,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625570,,BAO_0000218,178.0,
12482,1,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625571,,BAO_0000218,178.0,
12483,1,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625572,,BAO_0000218,178.0,
12484,1,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625573,,BAO_0000218,178.0,
12485,1,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625574,,BAO_0000218,178.0,
12486,1,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626245,,BAO_0000218,178.0,
12487,1,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626246,,BAO_0000218,178.0,
12488,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,0,22224,,U,Autocuration,,CHEMBL626247,,BAO_0000218,,
12489,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,0,22224,,U,Autocuration,,CHEMBL626248,,BAO_0000218,,
12490,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,0,22224,,U,Autocuration,,CHEMBL626249,,BAO_0000218,,
12491,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,0,22224,,U,Autocuration,,CHEMBL626420,,BAO_0000218,,
12492,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,0,22224,,U,Autocuration,,CHEMBL626421,,BAO_0000218,,
12493,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,0,22224,,U,Autocuration,,CHEMBL626422,,BAO_0000218,,
12494,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,0,22224,,U,Autocuration,,CHEMBL626423,,BAO_0000218,,
12495,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,0,22224,,U,Autocuration,,CHEMBL626424,,BAO_0000218,,
12496,1,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626425,,BAO_0000218,,
12497,1,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875476,,BAO_0000218,,
12498,1,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL626426,,BAO_0000218,,
12499,1,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,,0,22224,,U,Autocuration,,CHEMBL626427,,BAO_0000100,,
12500,1,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,,0,22224,,U,Autocuration,,CHEMBL626428,,BAO_0000100,,
12501,1,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,,0,22224,,U,Autocuration,,CHEMBL626429,,BAO_0000019,,
12502,1,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,,0,22224,,U,Autocuration,,CHEMBL625025,,BAO_0000019,1088.0,
12503,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625026,,BAO_0000218,178.0,
12504,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625027,,BAO_0000218,178.0,
12505,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874410,,BAO_0000218,178.0,
12506,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625028,,BAO_0000218,178.0,
12507,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625029,,BAO_0000218,178.0,
12508,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625030,,BAO_0000218,178.0,
12509,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625031,,BAO_0000218,178.0,
12510,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625032,,BAO_0000218,178.0,
12511,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625033,,BAO_0000218,178.0,
12512,1,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625034,,BAO_0000218,178.0,
12513,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624872,,BAO_0000218,948.0,
12514,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624873,,BAO_0000218,948.0,
12515,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624874,,BAO_0000218,948.0,
12516,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624875,,BAO_0000218,948.0,
12517,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624876,,BAO_0000218,948.0,
12518,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624877,,BAO_0000218,948.0,
12519,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624878,,BAO_0000218,948.0,
12520,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624879,,BAO_0000218,948.0,
12521,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624880,,BAO_0000218,948.0,
12522,1,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624881,,BAO_0000218,948.0,
12523,1,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624882,,BAO_0000218,948.0,
12524,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624883,,BAO_0000218,2113.0,
12525,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624884,,BAO_0000218,2113.0,
12526,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624885,,BAO_0000218,2113.0,
12527,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624886,,BAO_0000218,2113.0,
12528,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624887,,BAO_0000218,2113.0,
12529,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624888,,BAO_0000218,2113.0,
12530,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624889,,BAO_0000218,2113.0,
12531,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624890,,BAO_0000218,2113.0,
12532,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621964,,BAO_0000218,2113.0,
12533,1,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621965,,BAO_0000218,2113.0,
12534,1,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621966,,BAO_0000218,2107.0,
12535,1,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL621967,,BAO_0000218,2107.0,
12536,1,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622164,,BAO_0000218,2107.0,
12537,1,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),,0,22224,,U,Autocuration,,CHEMBL623097,,BAO_0000019,,
12538,1,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),,0,22224,,U,Autocuration,,CHEMBL623098,,BAO_0000019,,
12539,1,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,,0,22224,,U,Autocuration,,CHEMBL623099,,BAO_0000019,,
12540,1,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,,0,22224,,U,Autocuration,,CHEMBL623100,,BAO_0000019,,
12541,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628673,,BAO_0000218,,
12542,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628674,,BAO_0000218,,
12543,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628675,,BAO_0000218,,
12544,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627644,,BAO_0000218,,
12545,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627645,,BAO_0000218,,
12546,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627646,,BAO_0000218,,
12547,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627647,,BAO_0000218,,
12548,1,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627648,,BAO_0000218,,
12549,1,Free level in rat plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627649,,BAO_0000218,,
12550,1,Level reaching in blood plasma of rat or human was determined,,0,22224,,U,Autocuration,,CHEMBL628313,,BAO_0000019,,
12551,1,Log (Cbrain/Cblood) in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628314,,BAO_0000218,,
12552,1,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,,0,22224,,U,Autocuration,,CHEMBL628315,,BAO_0000019,,
12553,1,Mean percentage of compound transport through membrane; expressed as membrane transport,,0,22224,,U,Autocuration,,CHEMBL628316,,BAO_0000019,,
12554,1,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,,0,22224,,U,Autocuration,,CHEMBL628317,,BAO_0000218,,
12555,1,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,,0,22224,,U,Autocuration,,CHEMBL628473,,BAO_0000019,,
12556,1,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",,0,22224,,U,Autocuration,,CHEMBL628474,,BAO_0000019,,
12557,1,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,,0,22224,,U,Autocuration,,CHEMBL628475,,BAO_0000019,,
12558,1,Net water uptake by a carrier mediated transport (%cm) mechanism,,0,22224,,U,Autocuration,,CHEMBL628476,,BAO_0000019,,
12559,1,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL628477,,BAO_0000218,,
12560,1,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,Mustela putorius furo,1,50506,,N,Intermediate,,CHEMBL628478,,BAO_0000218,,
12561,1,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",Mustela putorius furo,1,50506,,N,Intermediate,,CHEMBL628479,,BAO_0000218,,
12562,1,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL628480,,BAO_0000218,,
12563,1,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",Simiiformes,0,22224,,U,Autocuration,,CHEMBL628481,,BAO_0000218,,
12564,1,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628482,,BAO_0000218,,
12565,1,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628483,,BAO_0000218,,
12566,1,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628484,,BAO_0000218,1969.0,
12567,1,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628485,,BAO_0000218,1969.0,
12568,1,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL628486,,BAO_0000218,1969.0,
12569,1,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",Homo sapiens,1,50587,,N,Intermediate,,CHEMBL628487,,BAO_0000218,1969.0,
12570,1,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628488,,BAO_0000218,1969.0,
12571,1,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628489,,BAO_0000218,1969.0,
12572,1,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628490,,BAO_0000218,1969.0,
12573,1,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL628491,,BAO_0000218,,
12574,1,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL877507,,BAO_0000218,,
12575,1,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,,0,22224,,U,Autocuration,,CHEMBL628492,,BAO_0000218,,
12576,1,% metabolized in monkey S-9 after 2 hours (10 ug/mL),Simiiformes,0,22224,,U,Autocuration,,CHEMBL628493,,BAO_0000019,,
12577,1,% metabolized in monkey S-9 after 2 hours (1 ug/ml),Simiiformes,0,22224,,U,Autocuration,,CHEMBL628494,,BAO_0000019,,
12578,1,% metabolized in monkey S-9 after 2 hours (10 ug/ml),Simiiformes,0,22224,,U,Autocuration,,CHEMBL628495,,BAO_0000019,,
12579,1,Permeability in Caco-2 assay at 10E-6,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL628496,,BAO_0000218,,
12580,1,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,,0,22224,,U,Autocuration,,CHEMBL628497,,BAO_0000218,955.0,
12581,1,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,,0,22224,,U,Autocuration,,CHEMBL628498,,BAO_0000218,955.0,
12582,1,Plasma protein binding was determined,,0,22224,,U,Autocuration,,CHEMBL628499,,BAO_0000019,,
12583,1,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,,0,22224,,U,Autocuration,,CHEMBL627656,,BAO_0000218,,
12584,1,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,,0,22224,,U,Autocuration,,CHEMBL627657,,BAO_0000218,,
12585,1,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,,0,22224,,U,Autocuration,,CHEMBL626808,,BAO_0000218,,
12586,1,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,,0,22224,,U,Autocuration,,CHEMBL626809,,BAO_0000218,,
12587,1,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,,0,22224,,U,Autocuration,,CHEMBL626810,,BAO_0000218,,
12588,1,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,,0,22224,,U,Autocuration,,CHEMBL626811,,BAO_0000218,,
12589,1,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,,0,22224,,U,Autocuration,,CHEMBL874465,,BAO_0000218,,
12590,1,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,,0,22224,,U,Autocuration,,CHEMBL626812,,BAO_0000218,,
12591,1,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,,0,22224,,U,Autocuration,,CHEMBL626813,,BAO_0000218,,
12592,1,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,,0,22224,,U,Autocuration,,CHEMBL626814,,BAO_0000218,,
12593,1,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,,0,22224,,U,Autocuration,,CHEMBL626815,,BAO_0000019,,
12594,1,Partition coefficient (logP),,0,22224,,U,Autocuration,,CHEMBL628566,,BAO_0000019,,
12595,1,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,0,22229,,U,Autocuration,,CHEMBL628567,,BAO_0000100,,
12596,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL628568,,BAO_0000100,,
12597,1,C max in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628569,,BAO_0000218,,
12598,1,C max in guinea pig,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL628570,,BAO_0000218,,
12599,1,C max value was evaluated,,0,22224,,U,Autocuration,,CHEMBL628571,,BAO_0000218,,
12600,1,Cmax value after oral dose of 0.1 mg//kg,,0,22224,,U,Autocuration,,CHEMBL628572,,BAO_0000218,,
12601,1,Cmax value after oral dose of 0.3 mg/kg,,0,22224,,U,Autocuration,,CHEMBL628573,,BAO_0000218,,
12602,1,Cmax value after oral dose of 1 mg/kg,,0,22224,,U,Autocuration,,CHEMBL628574,,BAO_0000218,,
12603,1,Cmax value after oral dose of 10 mg/kg,,0,22224,,U,Autocuration,,CHEMBL628575,,BAO_0000218,,
12604,1,Cmax value after oral dose of 23.4 mg/kg,,0,22224,,U,Autocuration,,CHEMBL628576,,BAO_0000218,,
12605,1,Cmax value after oral dose of 3 mg/kg,,0,22224,,U,Autocuration,,CHEMBL628577,,BAO_0000218,,
12606,1,Cmax value after oral dose of 3.87 mg/kg,,0,22224,,U,Autocuration,,CHEMBL628578,,BAO_0000218,,
12607,1,Cmax value in female Beagle dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL874466,,BAO_0000218,,
12608,1,Cmax value in male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628579,,BAO_0000218,,
12609,1,Cmax value in rat plasma when administered 20 mg/kg perorally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628580,,BAO_0000218,1969.0,
12610,1,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628581,,BAO_0000218,1969.0,
12611,1,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628582,,BAO_0000218,1969.0,
12612,1,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628583,,BAO_0000218,,
12613,1,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,Simiiformes,0,22224,,U,Autocuration,,CHEMBL625782,,BAO_0000218,,
12614,1,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL625783,,BAO_0000218,,
12615,1,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625784,,BAO_0000218,,
12616,1,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,Macaca mulatta,1,50797,,N,Intermediate,,CHEMBL625785,,BAO_0000218,1969.0,
12617,1,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625786,,BAO_0000218,,
12618,1,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,,0,22224,,U,Autocuration,,CHEMBL874467,,BAO_0000019,,
12619,1,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625787,,BAO_0000218,,
12620,1,cytotoxicity against HIV protease enzyme.,Human immunodeficiency virus,1,50677,,N,Intermediate,,CHEMBL625964,,BAO_0000218,,
12621,1,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625965,,BAO_0000218,,
12622,1,Apparent clearance in mice after oral administration of 100 mg/kg of dose,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625966,,BAO_0000218,,
12623,1,The plasma clearance in dog.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625967,,BAO_0000218,1969.0,
12624,1,The plasma clearance in rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625968,,BAO_0000218,1969.0,
12625,1,Clearance from plasma in male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625969,,BAO_0000218,1969.0,
12626,1,Clearance from plasma in male cynomolgus monkeys,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL625970,,BAO_0000218,1969.0,
12627,1,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625971,,BAO_0000218,1969.0,
12628,1,Clearance of compound in dog plasma,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625972,,BAO_0000218,1969.0,
12629,1,Clearance of compound in human plasma,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL625973,,BAO_0000218,1969.0,
12630,1,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625974,,BAO_0000218,,
12631,1,Clearance of compound when administered intravenously as an individual dose to a single dog.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625975,,BAO_0000218,,
12632,1,"Clearance (10 mg/kg, intravenously) in dog plasma",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625976,,BAO_0000218,1969.0,
12633,1,Clearance value in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625977,,BAO_0000218,,
12634,1,Clearance value in guinea pig,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL625978,,BAO_0000218,,
12635,1,Clearance values in rats after iv administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874468,,BAO_0000218,,
12636,1,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,,0,22224,,U,Autocuration,,CHEMBL625421,,BAO_0000218,1969.0,
12637,1,In vivo clearance (5 mg/kg) was determined in rabbits,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL625422,,BAO_0000218,,
12638,1,Plasma Clearance rate was determined for the compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625423,,BAO_0000218,,
12639,1,Plasma Clearance rate was determined for the compound in squirrel monkeys,Saimiri,0,22224,,U,Autocuration,,CHEMBL625424,,BAO_0000218,,
12640,1,Plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625425,,BAO_0000218,,
12641,1,Plasma clearance of the compound,,0,22224,,U,Autocuration,,CHEMBL625426,,BAO_0000218,,
12642,1,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL625427,,BAO_0000218,,
12643,1,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL625428,,BAO_0000218,,
12644,1,Plasma clearance was determined,,0,22224,,U,Autocuration,,CHEMBL625429,,BAO_0000218,,
12645,1,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625430,,BAO_0000218,,
12646,1,Plasma clearance rate was determined for the compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625431,,BAO_0000218,,
12647,1,Plasma clearance rate was determined for the compound in squirrel monkeys,Saimiri,0,22224,,U,Autocuration,,CHEMBL627307,,BAO_0000218,,
12648,1,Slow clearance (CL) was determined,,0,22224,,U,Autocuration,,CHEMBL627308,,BAO_0000218,,
12649,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,,0,22224,,U,Autocuration,,CHEMBL627309,,BAO_0000218,,
12650,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,,0,22224,,U,Autocuration,,CHEMBL627310,,BAO_0000218,,
12651,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,0,22224,,U,Autocuration,,CHEMBL627311,,BAO_0000218,,
12652,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,,0,22224,,U,Autocuration,,CHEMBL627312,,BAO_0000218,,
12653,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,0,22224,,U,Autocuration,,CHEMBL627313,,BAO_0000218,,
12654,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,0,22224,,U,Autocuration,,CHEMBL627314,,BAO_0000218,,
12655,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,0,22224,,U,Autocuration,,CHEMBL627315,,BAO_0000218,,
12656,1,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,0,22224,,U,Autocuration,,CHEMBL627316,,BAO_0000218,,
12657,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,,0,22224,,U,Autocuration,,CHEMBL627317,,BAO_0000218,,
12658,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,,0,22224,,U,Autocuration,,CHEMBL627318,,BAO_0000218,,
12659,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,,0,22224,,U,Autocuration,,CHEMBL627999,,BAO_0000218,,
12660,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,,0,22224,,U,Autocuration,,CHEMBL628000,,BAO_0000218,,
12661,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,,0,22224,,U,Autocuration,,CHEMBL628001,,BAO_0000218,,
12662,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,,0,22224,,U,Autocuration,,CHEMBL628002,,BAO_0000218,,
12663,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,,0,22224,,U,Autocuration,,CHEMBL625610,,BAO_0000218,,
12664,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,,0,22224,,U,Autocuration,,CHEMBL625611,,BAO_0000218,,
12665,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,,0,22224,,U,Autocuration,,CHEMBL625612,,BAO_0000218,,
12666,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,,0,22224,,U,Autocuration,,CHEMBL625613,,BAO_0000218,,
12667,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,,0,22224,,U,Autocuration,,CHEMBL875479,,BAO_0000218,,
12668,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,,0,22224,,U,Autocuration,,CHEMBL625614,,BAO_0000218,,
12669,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,,0,22224,,U,Autocuration,,CHEMBL625615,,BAO_0000218,,
12670,1,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,,0,22224,,U,Autocuration,,CHEMBL626302,,BAO_0000218,,
12671,1,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626303,,BAO_0000218,178.0,
12672,1,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627420,,BAO_0000218,178.0,
12673,1,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627421,,BAO_0000218,,
12674,1,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625695,,BAO_0000218,,
12675,1,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625696,,BAO_0000218,,
12676,1,Distribution of compound in mice brain was measured after 1 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL875606,,BAO_0000218,955.0,
12677,1,Distribution of compound in mice brain was measured after 24 hr r,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625697,,BAO_0000218,955.0,
12678,1,Distribution of compound in mice brain was measured after 2 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625698,,BAO_0000218,955.0,
12679,1,Distribution of compound in mice brain was measured after 3 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625699,,BAO_0000218,955.0,
12680,1,Distribution of compound in mice brain was measured after 6 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625700,,BAO_0000218,955.0,
12681,1,Distribution of compound in mice liver was measured after 1 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625701,,BAO_0000218,,
12682,1,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625702,,BAO_0000218,,
12683,1,Distribution of compound in mice liver was measured after 2 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625703,,BAO_0000218,,
12684,1,Distribution of compound in mice liver was measured after 3 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625704,,BAO_0000218,,
12685,1,Distribution of compound in mice liver was measured after 6 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625705,,BAO_0000218,,
12686,1,Distribution in dog adrenal medulla 30 min after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625706,,BAO_0000218,1236.0,
12687,1,Distribution in dog adrenal medulla 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625707,,BAO_0000218,1236.0,
12688,1,Distribution in female dog Ovary 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625708,,BAO_0000218,,
12689,1,Distribution in female dog Ovary 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625709,,BAO_0000218,,
12690,1,Distribution in female dog adipose 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624180,,BAO_0000218,,
12691,1,Distribution in female dog adipose 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624181,,BAO_0000218,,
12692,1,Distribution in female dog adrenal cortex 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624182,,BAO_0000218,1235.0,
12693,1,Distribution in female dog adrenal cortex 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624183,,BAO_0000218,1235.0,
12694,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624184,,BAO_0000218,2107.0,
12695,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877489,,BAO_0000218,2107.0,
12696,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624185,,BAO_0000218,2107.0,
12697,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624186,,BAO_0000218,2107.0,
12698,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624187,,BAO_0000218,2107.0,
12699,1,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624188,,BAO_0000218,2107.0,
12700,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624189,,BAO_0000218,2048.0,
12701,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624190,,BAO_0000218,2048.0,
12702,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624191,,BAO_0000218,2048.0,
12703,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624192,,BAO_0000218,2048.0,
12704,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624193,,BAO_0000218,2048.0,
12705,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624194,,BAO_0000218,2048.0,
12706,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624891,,BAO_0000218,2048.0,
12707,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624892,,BAO_0000218,2048.0,
12708,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624893,,BAO_0000218,2048.0,
12709,1,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627632,,BAO_0000218,2048.0,
12710,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627633,,BAO_0000218,,
12711,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627634,,BAO_0000218,,
12712,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627635,,BAO_0000218,,
12713,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627636,,BAO_0000218,,
12714,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626816,,BAO_0000218,,
12715,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626817,,BAO_0000218,,
12716,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626818,,BAO_0000218,,
12717,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626819,,BAO_0000218,,
12718,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626820,,BAO_0000218,,
12719,1,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626821,,BAO_0000218,,
12720,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626822,,BAO_0000218,2046.0,
12721,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626823,,BAO_0000218,2046.0,
12722,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626824,,BAO_0000218,2046.0,
12723,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626825,,BAO_0000218,2046.0,
12724,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626826,,BAO_0000218,2046.0,
12725,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626827,,BAO_0000218,2046.0,
12726,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626828,,BAO_0000218,2046.0,
12727,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626829,,BAO_0000218,2046.0,
12728,1,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626830,,BAO_0000218,2046.0,
12729,1,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627150,,BAO_0000218,,
12730,1,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627151,,BAO_0000218,,
12731,1,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627152,,BAO_0000218,,
12732,1,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627153,,BAO_0000218,,
12733,1,Rate of acetate production by the compound was determined,,0,22224,,U,Autocuration,,CHEMBL627154,,BAO_0000019,,
12734,1,Rate of acetate production by the compound was determined; Not determined,,0,22224,,U,Autocuration,,CHEMBL627155,,BAO_0000019,,
12735,1,Rate of hydrolysis of nitrocefin by compound was evaluated in water,,0,22224,,U,Autocuration,,CHEMBL627156,,BAO_0000019,,
12736,1,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,,0,22224,,U,Autocuration,,CHEMBL627157,,BAO_0000019,,
12737,1,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL627158,,BAO_0000218,,
12738,1,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL627159,,BAO_0000218,1969.0,
12739,1,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627160,,BAO_0000218,,
12740,1,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628540,,BAO_0000218,,
12741,1,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628541,,BAO_0000218,1969.0,
12742,1,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628542,,BAO_0000218,1969.0,
12743,1,Solubility after at a pH 1.2,,0,22229,,U,Autocuration,,CHEMBL628543,,BAO_0000100,,
12744,1,Solubility after at pH 1.2,,0,22229,,U,Autocuration,,CHEMBL628544,,BAO_0000100,,
12745,1,Solubility after injection of water,,0,22229,,U,Autocuration,,CHEMBL628545,,BAO_0000100,,
12746,1,Statistical significance of IC 50 values; Expressed as R value,,0,22224,,U,Autocuration,,CHEMBL628546,,BAO_0000019,,
12747,1,Systemic availability with respect to methyldopa was determined,,0,22224,,U,Autocuration,,CHEMBL874455,,BAO_0000019,,
12748,1,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628547,,BAO_0000218,,
12749,1,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628548,,BAO_0000218,1969.0,
12750,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628549,,BAO_0000218,1988.0,
12751,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628550,,BAO_0000218,1988.0,
12752,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628551,,BAO_0000218,1988.0,
12753,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628552,,BAO_0000218,1088.0,
12754,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628553,,BAO_0000218,1088.0,
12755,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628554,,BAO_0000218,1088.0,
12756,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628555,,BAO_0000218,1088.0,
12757,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628556,,BAO_0000218,1088.0,
12758,1,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628557,,BAO_0000218,2113.0,
12759,1,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628558,,BAO_0000218,1988.0,
12760,1,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628559,,BAO_0000218,1988.0,
12761,1,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628560,,BAO_0000218,1988.0,
12762,1,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL874456,,BAO_0000218,1088.0,
12763,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628561,,BAO_0000218,1988.0,
12764,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628562,,BAO_0000218,1988.0,
12765,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628563,,BAO_0000218,1088.0,
12766,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628564,,BAO_0000218,1088.0,
12767,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628565,,BAO_0000218,1088.0,
12768,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL631248,,BAO_0000218,1088.0,
12769,1,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL631249,,BAO_0000218,1088.0,
12770,1,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL627214,,BAO_0000218,2113.0,
12771,1,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL874591,,BAO_0000218,1988.0,
12772,1,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL627215,,BAO_0000218,1988.0,
12773,1,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL625471,,BAO_0000218,1988.0,
12774,1,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL625472,,BAO_0000218,,
12775,1,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL625473,,BAO_0000218,,
12776,1,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625474,,BAO_0000218,,
12777,1,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625475,,BAO_0000218,,
12778,1,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625476,,BAO_0000218,,
12779,1,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625477,,BAO_0000218,,
12780,1,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625478,,BAO_0000218,,
12781,1,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625479,,BAO_0000218,,
12782,1,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625480,,BAO_0000218,,
12783,1,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625481,,BAO_0000218,1969.0,
12784,1,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625482,,BAO_0000218,,
12785,1,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625483,,BAO_0000218,,
12786,1,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625484,,BAO_0000218,,
12787,1,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625485,,BAO_0000218,,
12788,1,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625486,,BAO_0000218,1969.0,
12789,1,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625487,,BAO_0000218,1969.0,
12790,1,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625488,,BAO_0000218,1969.0,
12791,1,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625489,,BAO_0000218,1969.0,
12792,1,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625490,,BAO_0000218,1969.0,
12793,1,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625491,,BAO_0000218,1969.0,
12794,1,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625492,,BAO_0000218,1969.0,
12795,1,plasma clearance in human,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL625493,,BAO_0000218,1969.0,
12796,1,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625494,,BAO_0000218,,
12797,1,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625495,,BAO_0000218,,
12798,1,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625496,,BAO_0000218,,
12799,1,1-Octanol/water partition coefficient measured at 7.4,,0,22229,,U,Autocuration,,CHEMBL625497,,BAO_0000100,,
12800,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625498,,BAO_0000100,,
12801,1,Partition coefficient (logP),,0,22224,,U,Autocuration,,CHEMBL625499,,BAO_0000019,,
12802,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625500,,BAO_0000100,,
12803,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625501,,BAO_0000100,,
12804,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625502,,BAO_0000100,,
12805,1,Calculated partition coefficient (clogP) (relative to BAY K 8644),,0,22229,,U,Autocuration,,CHEMBL625503,,BAO_0000100,,
12806,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625504,,BAO_0000100,,
12807,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625505,,BAO_0000100,,
12808,1,Calculated partition coefficient of the compound,,0,22229,,U,Autocuration,,CHEMBL625506,,BAO_0000100,,
12809,1,Partition coefficient (logP),,0,22224,,U,Autocuration,,CHEMBL625507,,BAO_0000019,,
12810,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625508,,BAO_0000100,,
12811,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625509,,BAO_0000100,,
12812,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625510,,BAO_0000100,,
12813,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL883125,,BAO_0000100,,
12814,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625511,,BAO_0000100,,
12815,1,Partition coefficient of the compound,,0,22224,,U,Autocuration,,CHEMBL874650,,BAO_0000019,,
12816,1,Partition coefficient of the compound,,0,22224,,U,Autocuration,,CHEMBL625512,,BAO_0000019,,
12817,1,Partition coefficient of compound was determined,,0,22224,,U,Autocuration,,CHEMBL625513,,BAO_0000019,,
12818,1,Partition coefficient was determined,,0,22224,,U,Autocuration,,CHEMBL625514,,BAO_0000019,,
12819,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625515,,BAO_0000100,,
12820,1,partition coefficient of compound was determined,,0,22229,,U,Autocuration,,CHEMBL625516,,BAO_0000100,,
12821,1,The total body administered intravenously in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625517,,BAO_0000218,,
12822,1,The total body administered intravenously in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625518,,BAO_0000218,,
12823,1,Time taken for the administration to female NIH mice weighing 25-30 g.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625519,,BAO_0000218,,
12824,1,Time taken for the administration,,0,22224,,U,Autocuration,,CHEMBL625520,,BAO_0000019,,
12825,1,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL874651,,BAO_0000218,,
12826,1,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,Simiiformes,0,22224,,U,Autocuration,,CHEMBL625521,,BAO_0000218,,
12827,1,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL623171,,BAO_0000218,,
12828,1,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623853,,BAO_0000218,,
12829,1,Plasma clearance for the compound was determined.,,0,22224,,U,Autocuration,,CHEMBL623854,,BAO_0000019,,
12830,1,CLog P value of the compound,,0,22224,,U,Autocuration,,CHEMBL874405,,BAO_0000100,,
12831,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL623855,,BAO_0000100,,
12832,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL623856,,BAO_0000100,,
12833,1,ClogP value of the compound; nd ='no data',,0,22224,,U,Autocuration,,CHEMBL623857,,BAO_0000100,,
12834,1,ClogP value of the compound; nd ='not determined',,0,22224,,U,Autocuration,,CHEMBL623858,,BAO_0000100,,
12835,1,CLog P was determined,,0,22224,,U,Autocuration,,CHEMBL623859,,BAO_0000100,,
12836,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL839829,,BAO_0000100,,
12837,1,CLogP was calculated,,0,22224,,U,Autocuration,,CHEMBL623860,,BAO_0000019,,
12838,1,CLogP value was determined,,0,22224,,U,Autocuration,,CHEMBL623861,,BAO_0000019,,
12839,1,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,,0,22224,,U,Autocuration,,CHEMBL623862,,BAO_0000019,,
12840,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL874406,,BAO_0000100,,
12841,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL623863,,BAO_0000100,,
12842,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL624021,,BAO_0000100,,
12843,1,Distribution in female dog adrenal medulla 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624022,,BAO_0000218,1236.0,
12844,1,Distribution in female dog adrenal medulla 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624023,,BAO_0000218,1236.0,
12845,1,Distribution in female dog bile 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624024,,BAO_0000218,,
12846,1,Distribution in female dog bile 72 hr after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624025,,BAO_0000218,,
12847,1,Distribution in female dog blood 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624026,,BAO_0000218,,
12848,1,Distribution in female dog blood 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624027,,BAO_0000218,,
12849,1,Distribution in female dog heart 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624028,,BAO_0000218,,
12850,1,Distribution in female dog heart 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624029,,BAO_0000218,,
12851,1,Distribution in female dog kidney 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624030,,BAO_0000218,,
12852,1,Distribution in female dog kidney 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624031,,BAO_0000218,,
12853,1,Distribution in female dog large intestine 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624032,,BAO_0000218,160.0,
12854,1,Distribution in female dog large intestine 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL874407,,BAO_0000218,160.0,
12855,1,Distribution in female dog liver 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624033,,BAO_0000218,,
12856,1,Distribution in female dog liver 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624034,,BAO_0000218,,
12857,1,Distribution in female dog lung 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624035,,BAO_0000218,,
12858,1,Distribution in female dog lung 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624036,,BAO_0000218,,
12859,1,Distribution in female dog muscle 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624037,,BAO_0000218,2385.0,
12860,1,Distribution in female dog muscle 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624038,,BAO_0000218,2385.0,
12861,1,Distribution in female dog pancreas 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624039,,BAO_0000218,,
12862,1,Distribution in female dog pancreas 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624040,,BAO_0000218,,
12863,1,Distribution in female dog small intestine 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624041,,BAO_0000218,160.0,
12864,1,Distribution in female dog small intestine 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624042,,BAO_0000218,160.0,
12865,1,Distribution in female dog spleen 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624043,,BAO_0000218,2106.0,
12866,1,Distribution in female dog spleen 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624044,,BAO_0000218,2106.0,
12867,1,Distribution in female dog stomach 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624045,,BAO_0000218,945.0,
12868,1,Distribution in female dog stomach 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624046,,BAO_0000218,945.0,
12869,1,Distribution in female dog thyroid 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624047,,BAO_0000218,2046.0,
12870,1,Distribution in female dog thyroid 72 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624048,,BAO_0000218,2046.0,
12871,1,Distribution in female dog urine 24 hours after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL874408,,BAO_0000218,1088.0,
12872,1,Distribution in female dog urine 72 hr after administration.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624049,,BAO_0000218,1088.0,
12873,1,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,,0,22224,,U,Autocuration,,CHEMBL624050,,BAO_0000218,1969.0,
12874,1,Plasma concentration at 7 hr after intravenous dosing,,0,22224,,U,Autocuration,,CHEMBL624051,,BAO_0000019,,
12875,1,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623278,,BAO_0000218,,
12876,1,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623279,,BAO_0000218,,
12877,1,Plasma concentration of 3 mg/kg iv after 1 hr in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623280,,BAO_0000218,,
12878,1,Plasma concentration of 3 mg/kg iv after 2 hr in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623963,,BAO_0000218,,
12879,1,Plasma concentration of 3 mg/kg iv after 4 hr in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623964,,BAO_0000218,,
12880,1,Plasma concentration of 3 mg/kg iv after 6 hr in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623965,,BAO_0000218,,
12881,1,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623966,,BAO_0000218,,
12882,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874415,,BAO_0000218,,
12883,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623967,,BAO_0000218,,
12884,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623968,,BAO_0000218,,
12885,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623969,,BAO_0000218,,
12886,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628409,,BAO_0000218,,
12887,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628410,,BAO_0000218,,
12888,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628411,,BAO_0000218,,
12889,1,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628412,,BAO_0000218,,
12890,1,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,,0,22224,,U,Autocuration,,CHEMBL628413,,BAO_0000019,,
12891,1,The concentration in plasmat; Not determined,,0,22224,,U,Autocuration,,CHEMBL628414,,BAO_0000019,1969.0,
12892,1,Tissue level at 10 mg/kg/po in wistar rats in blood,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628415,,BAO_0000218,,
12893,1,Tissue level at 10 mg/kg/po in wistar rats in brown fat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628416,,BAO_0000218,,
12894,1,Tissue level at 10 mg/kg/po in wistar rats in heart,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628417,,BAO_0000218,,
12895,1,Tissue level at 10 mg/kg/po in wistar rats in liver,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874908,,BAO_0000218,2107.0,
12896,1,Tissue level at 10 mg/kg/po in wistar rats in plasma,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628418,,BAO_0000218,,
12897,1,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628419,,BAO_0000218,2385.0,
12898,1,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628420,,BAO_0000218,,
12899,1,Water solubility at 37 degree C.,,0,22224,,U,Autocuration,,CHEMBL628421,,BAO_0000019,,
12900,1,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,0,22229,,U,Autocuration,,CHEMBL626726,,BAO_0000100,,
12901,1,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,0,22229,,U,Autocuration,,CHEMBL626727,,BAO_0000100,,
12902,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626728,,BAO_0000218,178.0,
12903,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626729,,BAO_0000218,178.0,
12904,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626730,,BAO_0000218,178.0,
12905,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626731,,BAO_0000218,178.0,
12906,1,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626732,,BAO_0000218,178.0,
12907,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626733,,BAO_0000218,948.0,
12908,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626734,,BAO_0000218,948.0,
12909,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626735,,BAO_0000218,948.0,
12910,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874909,,BAO_0000218,948.0,
12911,1,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626736,,BAO_0000218,948.0,
12912,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626737,,BAO_0000218,2113.0,
12913,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630999,,BAO_0000218,2113.0,
12914,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631000,,BAO_0000218,2113.0,
12915,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631001,,BAO_0000218,2113.0,
12916,1,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631002,,BAO_0000218,2113.0,
12917,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631003,,BAO_0000218,2107.0,
12918,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631004,,BAO_0000218,2107.0,
12919,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631005,,BAO_0000218,2107.0,
12920,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631006,,BAO_0000218,2107.0,
12921,1,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631007,,BAO_0000218,2107.0,
12922,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631008,,BAO_0000218,2048.0,
12923,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631009,,BAO_0000218,2048.0,
12924,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631010,,BAO_0000218,2048.0,
12925,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631011,,BAO_0000218,2048.0,
12926,1,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631012,,BAO_0000218,2048.0,
12927,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630271,,BAO_0000218,2046.0,
12928,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630272,,BAO_0000218,2046.0,
12929,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630273,,BAO_0000218,2046.0,
12930,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630274,,BAO_0000218,2046.0,
12931,1,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630275,,BAO_0000218,2046.0,
12932,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875782,,BAO_0000218,,
12933,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630276,,BAO_0000218,,
12934,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630277,,BAO_0000218,,
12935,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630278,,BAO_0000218,,
12936,1,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630279,,BAO_0000218,,
12937,1,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,,0,22224,,U,Autocuration,,CHEMBL630280,,BAO_0000019,,
12938,1,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,0,22224,,U,Autocuration,,CHEMBL630281,,BAO_0000019,,
12939,1,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630282,,BAO_0000218,,
12940,1,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630283,,BAO_0000218,,
12941,1,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),,0,22224,,U,Autocuration,,CHEMBL630284,,BAO_0000019,,
12942,1,Alkylating activity was determined,,0,22224,,U,Autocuration,,CHEMBL630285,,BAO_0000019,,
12943,1,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),,0,22224,Microsomes,U,Autocuration,,CHEMBL630286,,BAO_0000251,,
12944,1,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630069,,BAO_0000218,,
12945,1,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630070,,BAO_0000218,,
12946,1,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630071,,BAO_0000218,,
12947,1,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630072,,BAO_0000218,,
12948,1,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL875110,,BAO_0000218,,
12949,1,Compound was tested for antidiuretic activity in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630073,,BAO_0000218,,
12950,1,Compound was tested for inactivation kinetic values,,0,22224,,U,Autocuration,,CHEMBL630074,,BAO_0000019,,
12951,1,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,,0,22224,,U,Autocuration,,CHEMBL630075,,BAO_0000218,,
12952,1,Dissociation rate calculated from the first-order equation using the t1/2 value,,0,22224,,U,Autocuration,,CHEMBL630076,,BAO_0000019,,
12953,1,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,,0,22229,,U,Autocuration,,CHEMBL630077,,BAO_0000100,,
12954,1,Aqueous solubility was measured,,0,22229,,U,Autocuration,,CHEMBL630078,,BAO_0000100,,
12955,1,Aqueous solubility was measured at a pH 4,,0,22229,,U,Autocuration,,CHEMBL630079,,BAO_0000100,,
12956,1,Aqueous solubility (pH 7),,0,22229,,U,Autocuration,,CHEMBL630080,,BAO_0000100,,
12957,1,Aqueous solubility was measured at a pH 9,,0,22229,,U,Autocuration,,CHEMBL630081,,BAO_0000100,,
12958,1,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",,0,22224,,U,Autocuration,,CHEMBL630082,,BAO_0000019,,
12959,1,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,0,22224,,U,Autocuration,,CHEMBL630083,,BAO_0000019,,
12960,1,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",,0,22224,,U,Autocuration,,CHEMBL630084,,BAO_0000019,,
12961,1,Aqueous solubility of the compound,,0,22229,,U,Autocuration,,CHEMBL629198,,BAO_0000100,,
12962,1,Aqueous solubility at 37 degree Celsius at pH 7.38,,0,22229,,U,Autocuration,,CHEMBL629199,,BAO_0000100,,
12963,1,Aqueous solubility in pH 7.4 phosphate buffer,,0,22229,,U,Autocuration,,CHEMBL629200,,BAO_0000100,,
12964,1,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629201,,BAO_0000218,,
12965,1,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629202,,BAO_0000218,,
12966,1,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL875111,,BAO_0000218,,
12967,1,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL629203,,BAO_0000218,,
12968,1,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL629204,,BAO_0000218,,
12969,1,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL629205,,BAO_0000218,,
12970,1,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL629206,,BAO_0000218,,
12971,1,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,,0,22224,,U,Autocuration,,CHEMBL631185,,BAO_0000019,,
12972,1,Compound was evaluated for the average bile flow rat in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631186,,BAO_0000218,,
12973,1,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL631187,,BAO_0000218,,
12974,1,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL631188,,BAO_0000218,,
12975,1,Average half life period was determined,,0,22224,,U,Autocuration,,CHEMBL876419,,BAO_0000019,,
12976,1,Average half life period was determined,,0,22224,,U,Autocuration,,CHEMBL631189,,BAO_0000019,,
12977,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL631190,,BAO_0000218,,
12978,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL631191,,BAO_0000218,,
12979,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL631192,,BAO_0000218,,
12980,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL632400,,BAO_0000218,,
12981,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL630564,,BAO_0000218,,
12982,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL630565,,BAO_0000218,,
12983,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL630566,,BAO_0000218,,
12984,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL631229,,BAO_0000218,,
12985,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL631230,,BAO_0000218,,
12986,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL876428,,BAO_0000100,,
12987,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL631231,,BAO_0000100,,
12988,1,Calculated partition coefficient (clogP) (MacLogP),,0,22229,,U,Autocuration,,CHEMBL631232,,BAO_0000100,,
12989,1,Hydrophilicity was determined,,0,22224,,U,Autocuration,,CHEMBL631233,,BAO_0000019,,
12990,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL631234,,BAO_0000100,,
12991,1,Increased absorption was determined,,0,22224,,U,Autocuration,,CHEMBL883126,,BAO_0000019,,
12992,1,Lipophilicity value was evaluated,,0,22224,,U,Autocuration,,CHEMBL631235,,BAO_0000100,,
12993,1,Log P value of the compound.,,0,22224,,U,Autocuration,,CHEMBL631236,,BAO_0000100,,
12994,1,Partition coefficient of compound was determined,,0,22224,,U,Autocuration,,CHEMBL631237,,BAO_0000019,,
12995,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL631238,,BAO_0000100,,
12996,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL876429,,BAO_0000100,,
12997,1,Partition coefficient was measured by medchem software; Not calculated,,0,22224,,U,Autocuration,,CHEMBL631414,,BAO_0000019,,
12998,1,Partition coefficient was measured by octanol-water using standard shake-flask method,,0,22224,,U,Autocuration,,CHEMBL631415,,BAO_0000100,,
12999,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL631416,,BAO_0000100,,
13000,1,Partition coefficient (logP),,0,22224,,U,Autocuration,,CHEMBL631417,,BAO_0000019,,
13001,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL631418,,BAO_0000100,,
13002,1,The Octanol/Water partition coefficient CLogP,,0,22229,,U,Autocuration,,CHEMBL631419,,BAO_0000100,,
13003,1,The pharmacokinetic parameter C Log p was reported,,0,22224,,U,Autocuration,,CHEMBL631420,,BAO_0000019,,
13004,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL631421,,BAO_0000100,,
13005,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL631422,,BAO_0000100,,
13006,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL631423,,BAO_0000100,,
13007,1,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876430,,BAO_0000218,1969.0,
13008,1,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631424,,BAO_0000218,1969.0,
13009,1,Compound was administered intravenously in dog to evaluate plasma clearance values,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631425,,BAO_0000218,1969.0,
13010,1,Compound was administered intravenously in monkey to evaluate plasma clearance values,Simiiformes,0,22224,,U,Autocuration,,CHEMBL631426,,BAO_0000218,1969.0,
13011,1,Compound was administered intravenously in mouse to evaluate plasma clearance values,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631427,,BAO_0000218,1969.0,
13012,1,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631428,,BAO_0000218,1969.0,
13013,1,Intrinsic clearance in Rhesus liver microsome,Macaca mulatta,1,50797,Microsomes,N,Intermediate,,CHEMBL631429,,BAO_0000218,2107.0,
13014,1,Intrinsic clearance in dog liver microsome,Canis lupus familiaris,1,50588,Microsomes,N,Intermediate,,CHEMBL631430,,BAO_0000218,2107.0,
13015,1,Intrinsic clearance in rat liver microsome,Rattus norvegicus,1,50597,Microsomes,N,Intermediate,,CHEMBL631431,,BAO_0000218,2107.0,
13016,1,Low plasma clearance was calculated in rhesus monkey,Macaca mulatta,1,50797,,N,Intermediate,,CHEMBL631432,,BAO_0000218,1969.0,
13017,1,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631433,,BAO_0000218,,
13018,1,Plasma clearance after intravenous dose of 0.3 mg/kg,,0,22224,,U,Autocuration,,CHEMBL631434,,BAO_0000218,,
13019,1,Plasma clearance after intravenous dose of 1 mg/kg,,0,22224,,U,Autocuration,,CHEMBL631435,,BAO_0000218,,
13020,1,Plasma clearance after intravenous dose of 3 mg/kg,,0,22224,,U,Autocuration,,CHEMBL631436,,BAO_0000218,,
13021,1,Plasma clearance after intravenous dose of 3.87 mg/kg,,0,22224,,U,Autocuration,,CHEMBL631437,,BAO_0000218,,
13022,1,Plasma clearance after peroral administration at 10 mpk in Rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631438,,BAO_0000218,,
13023,1,Plasma clearance after peroral administration at 10 mpk in Rhesus,Macaca mulatta,1,50797,,N,Intermediate,,CHEMBL876431,,BAO_0000218,,
13024,1,Plasma clearance after peroral administration at 10 mpk in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631439,,BAO_0000218,,
13025,1,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631440,,BAO_0000218,,
13026,1,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),,0,22224,,U,Autocuration,,CHEMBL631441,,BAO_0000019,,
13027,1,Critical Micellar concentration was determined,,0,22224,,U,Autocuration,,CHEMBL631442,,BAO_0000019,,
13028,1,Critical Micellar concentration of the compound. was determined,,0,22224,,U,Autocuration,,CHEMBL626525,,BAO_0000019,,
13029,1,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,,0,22224,,U,Autocuration,,CHEMBL627168,,BAO_0000019,,
13030,1,Critical micellar concentration was measured in water by the dye solubilization method,,0,22224,,U,Autocuration,,CHEMBL875618,,BAO_0000019,,
13031,1,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,,0,22224,,U,Autocuration,,CHEMBL626612,,BAO_0000019,,
13032,1,CMR value (relative to BAY K 8644),,0,22224,,U,Autocuration,,CHEMBL626613,,BAO_0000019,,
13033,1,Carbamoylating activity was determined,,0,22224,,U,Autocuration,,CHEMBL626614,,BAO_0000019,,
13034,1,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL626615,,BAO_0000218,,
13035,1,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,,0,22224,,U,Autocuration,,CHEMBL626616,,BAO_0000019,,
13036,1,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,,0,22224,,U,Autocuration,,CHEMBL626617,,BAO_0000019,,
13037,1,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626618,,BAO_0000218,1969.0,
13038,1,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626619,,BAO_0000218,1969.0,
13039,1,"Clearance rate at 0.46 mg/kg, iv, in dogs",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626620,,BAO_0000218,,
13040,1,"Clearance rate at 5.5 mg/kg, iv, in rat",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626621,,BAO_0000218,,
13041,1,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL626622,,BAO_0000218,,
13042,1,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL626623,,BAO_0000218,,
13043,1,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626624,,BAO_0000218,,
13044,1,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626625,,BAO_0000218,,
13045,1,Clearance rate constant using isolated perfused rat liver (IPRL) assay,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626626,,BAO_0000218,2107.0,
13046,1,Tested for the total clearance of the compound,,0,22224,,U,Autocuration,,CHEMBL626627,,BAO_0000218,,
13047,1,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626628,,BAO_0000218,,
13048,1,Total body clearance was determined,,0,22224,,U,Autocuration,,CHEMBL626629,,BAO_0000218,,
13049,1,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626630,,BAO_0000218,,
13050,1,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626631,,BAO_0000218,,
13051,1,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,0,22229,,U,Autocuration,,CHEMBL626632,,BAO_0000100,,
13052,1,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,0,22229,,U,Autocuration,,CHEMBL626633,,BAO_0000100,,
13053,1,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,,0,22229,,U,Autocuration,,CHEMBL626634,,BAO_0000100,,
13054,1,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,,0,22229,,U,Autocuration,,CHEMBL626635,,BAO_0000100,,
13055,1,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,,0,22229,,U,Autocuration,,CHEMBL626636,,BAO_0000100,,
13056,1,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,,0,22229,,U,Autocuration,,CHEMBL626637,,BAO_0000100,,
13057,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),Pneumocystis carinii,1,50339,,N,Intermediate,,CHEMBL626638,,BAO_0000218,,
13058,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,Pneumocystis carinii,1,50339,,N,Intermediate,,CHEMBL626639,,BAO_0000218,,
13059,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,Pneumocystis carinii,1,50339,,N,Intermediate,,CHEMBL626640,,BAO_0000218,,
13060,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,Pneumocystis carinii,1,50339,,N,Intermediate,,CHEMBL626641,,BAO_0000218,,
13061,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,Pneumocystis carinii,1,50339,,N,Intermediate,,CHEMBL627272,,BAO_0000218,,
13062,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,Pneumocystis carinii,1,50339,,N,Intermediate,,CHEMBL627273,,BAO_0000218,,
13063,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),Pneumocystis carinii,1,50339,,N,Intermediate,,CHEMBL627441,,BAO_0000218,,
13064,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),Pneumocystis carinii,1,50339,,N,Intermediate,,CHEMBL628355,,BAO_0000218,,
13065,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),Pneumocystis carinii,1,50339,,N,Intermediate,,CHEMBL628356,,BAO_0000218,,
13066,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),Pneumocystis carinii,1,50339,,N,Intermediate,,CHEMBL628357,,BAO_0000218,,
13067,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),Pneumocystis carinii,1,50339,,N,Intermediate,,CHEMBL628358,,BAO_0000218,,
13068,1,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),Pneumocystis carinii,1,50339,,N,Intermediate,,CHEMBL622307,,BAO_0000218,,
13069,1,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,,0,22224,,U,Autocuration,,CHEMBL622527,,BAO_0000019,,
13070,1,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,,0,22224,,U,Autocuration,,CHEMBL622528,,BAO_0000019,,
13071,1,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,,0,22224,,U,Autocuration,,CHEMBL622529,,BAO_0000019,,
13072,1,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,,0,22224,,U,Autocuration,,CHEMBL622992,,BAO_0000019,,
13073,1,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,,0,22224,,U,Autocuration,,CHEMBL622993,,BAO_0000019,,
13074,1,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,,0,22224,,U,Autocuration,,CHEMBL622994,,BAO_0000019,,
13075,1,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622995,,BAO_0000218,,
13076,1,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622996,,BAO_0000218,,
13077,1,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622997,,BAO_0000218,,
13078,1,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622998,,BAO_0000218,,
13079,1,Cp max following ip administration at 1 mg/kg,,0,22224,,U,Autocuration,,CHEMBL622999,,BAO_0000218,,
13080,1,Maximum concentration in plasma was reported at 0.5 hour,,0,22224,,U,Autocuration,,CHEMBL623000,,BAO_0000218,1969.0,
13081,1,Maximum concentration in plasma was reported at 2 hour,,0,22224,,U,Autocuration,,CHEMBL623001,,BAO_0000218,1969.0,
13082,1,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,Mus musculus,1,50594,,N,Intermediate,,CHEMBL623002,,BAO_0000218,,
13083,1,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),,0,22229,,U,Autocuration,,CHEMBL623003,,BAO_0000100,,
13084,1,Steady state concentration was evaluated,,0,22224,,U,Autocuration,,CHEMBL623004,,BAO_0000019,,
13085,1,Partition coefficient (logP),,0,22224,,U,Autocuration,,CHEMBL623005,,BAO_0000019,,
13086,1,Partition coefficient (logD7.4),,0,22224,,U,Autocuration,,CHEMBL623006,,BAO_0000019,,
13087,1,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623007,,BAO_0000218,2107.0,
13088,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623008,,BAO_0000218,10000001.0,
13089,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876654,,BAO_0000218,2037.0,
13090,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623009,,BAO_0000218,,
13091,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623010,,BAO_0000218,,
13092,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623011,,BAO_0000218,948.0,
13093,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623012,,BAO_0000218,160.0,
13094,1,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,,0,22224,,U,Autocuration,,CHEMBL623013,,BAO_0000019,,
13095,1,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,,0,22224,,U,Autocuration,,CHEMBL623014,,BAO_0000019,,
13096,1,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,,0,22224,,U,Autocuration,,CHEMBL623015,,BAO_0000019,1088.0,
13097,1,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,,0,22224,,U,Autocuration,,CHEMBL623016,,BAO_0000019,1088.0,
13098,1,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,,0,22224,,U,Autocuration,,CHEMBL624858,,BAO_0000019,1088.0,
13099,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624859,,BAO_0000218,,
13100,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624860,,BAO_0000218,,
13101,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624861,,BAO_0000218,,
13102,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624862,,BAO_0000218,,
13103,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624863,,BAO_0000218,,
13104,1,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876655,,BAO_0000218,,
13105,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624864,,BAO_0000218,,
13106,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624865,,BAO_0000218,,
13107,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624866,,BAO_0000218,,
13108,1,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,Canis lupus familiaris,1,50588,,N,Expert,,CHEMBL624867,,BAO_0000218,,
13109,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624868,,BAO_0000218,,
13110,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628450,,BAO_0000218,,
13111,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628451,,BAO_0000218,,
13112,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628452,,BAO_0000218,,
13113,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628453,,BAO_0000218,,
13114,1,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628454,,BAO_0000218,,
13115,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628455,,BAO_0000218,,
13116,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628456,,BAO_0000218,,
13117,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628457,,BAO_0000218,,
13118,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL877505,,BAO_0000218,,
13119,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628458,,BAO_0000218,,
13120,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628459,,BAO_0000218,,
13121,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628460,,BAO_0000218,,
13122,1,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628461,,BAO_0000218,,
13123,1,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",,0,22224,,U,Autocuration,,CHEMBL628462,,BAO_0000218,,
13124,1,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628463,,BAO_0000218,,
13125,1,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",Rattus norvegicus,1,50597,,N,Expert,,CHEMBL625666,,BAO_0000218,,
13126,1,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,,0,22224,,U,Autocuration,,CHEMBL625667,,BAO_0000218,,
13127,1,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Rattus norvegicus,1,50597,,N,Expert,,CHEMBL625668,,BAO_0000218,,
13128,1,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625669,,BAO_0000218,,
13129,1,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,,0,22224,,U,Autocuration,,CHEMBL625670,,BAO_0000019,,
13130,1,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625671,,BAO_0000218,,
13131,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL625672,,BAO_0000218,,
13132,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL625673,,BAO_0000218,,
13133,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL625674,,BAO_0000218,,
13134,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL625675,,BAO_0000218,,
13135,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL627637,,BAO_0000218,,
13136,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL627638,,BAO_0000218,,
13137,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL627639,,BAO_0000218,,
13138,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL627640,,BAO_0000218,,
13139,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL627641,,BAO_0000218,,
13140,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL627642,,BAO_0000218,,
13141,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL877506,,BAO_0000218,,
13142,1,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627275,,BAO_0000218,,
13143,1,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",Mustela putorius furo,1,50506,,N,Intermediate,,CHEMBL627643,,BAO_0000218,,
13144,1,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Mustela putorius furo,1,50506,,N,Intermediate,,CHEMBL631246,,BAO_0000218,,
13145,1,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",Mustela putorius furo,1,50506,,N,Intermediate,,CHEMBL631247,,BAO_0000218,,
13146,1,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Mustela putorius furo,1,50506,,N,Intermediate,,CHEMBL629532,,BAO_0000218,,
13147,1,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,Mustela putorius furo,1,50506,,N,Intermediate,,CHEMBL629533,,BAO_0000218,,
13148,1,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,Mustela putorius furo,1,50506,,N,Intermediate,,CHEMBL629534,,BAO_0000218,,
13149,1,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,Mustela putorius furo,1,50506,,N,Intermediate,,CHEMBL629535,,BAO_0000218,,
13150,1,Pharmacokinetic parameter :drug bound to plasma was reported,,0,22224,,U,Autocuration,,CHEMBL625932,,BAO_0000019,,
13151,1,compound was evaluated for drug bound in plasma,,0,22224,,U,Autocuration,,CHEMBL625933,,BAO_0000019,,
13152,1,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625934,,BAO_0000218,,
13153,1,Bioavailability,Eutheria,0,22224,,U,Autocuration,,CHEMBL625935,,BAO_0000218,,
13154,1,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625936,,BAO_0000218,,
13155,1,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625937,,BAO_0000218,,
13156,1,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625938,,BAO_0000218,,
13157,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625939,,BAO_0000218,1970.0,
13158,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625940,,BAO_0000218,1970.0,
13159,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874464,,BAO_0000218,1970.0,
13160,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625941,,BAO_0000218,1970.0,
13161,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625942,,BAO_0000218,1970.0,
13162,1,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625943,,BAO_0000218,1970.0,
13163,1,In vitro protein binding in human serum at 5 ug/ml,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL625944,,BAO_0000218,1977.0,
13164,1,Serum protein binding ability was measured,,0,22224,,U,Autocuration,,CHEMBL625945,,BAO_0000019,,
13165,1,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),,0,22224,,U,Autocuration,,CHEMBL625946,,BAO_0000019,,
13166,1,Oral bioavailability in dog,Canis lupus familiaris,0,22224,,U,Autocuration,,CHEMBL625947,,BAO_0000218,,
13167,1,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625948,,BAO_0000218,,
13168,1,Absolute oral bioavailability at an iv dose of 14 mg/kg,,0,22224,,U,Autocuration,,CHEMBL625949,,BAO_0000218,,
13169,1,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,,0,22224,,U,Autocuration,,CHEMBL625950,,BAO_0000218,,
13170,1,Oral bioavailability (dose 15 mg/kg i.v.),Eutheria,0,22224,,U,Autocuration,,CHEMBL625951,,BAO_0000218,,
13171,1,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,,0,22224,,U,Autocuration,,CHEMBL625952,,BAO_0000218,,
13172,1,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,,0,22224,,U,Autocuration,,CHEMBL625953,,BAO_0000218,,
13173,1,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,,0,22224,,U,Autocuration,,CHEMBL625954,,BAO_0000218,,
13174,1,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,,0,22224,,U,Autocuration,,CHEMBL882959,,BAO_0000218,,
13175,1,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625955,,BAO_0000218,,
13176,1,Bioavailability in ferret,Mustela putorius furo,0,22224,,U,Autocuration,,CHEMBL625956,,BAO_0000218,,
13177,1,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL625957,,BAO_0000218,,
13178,1,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625958,,BAO_0000218,,
13179,1,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625959,,BAO_0000218,,
13180,1,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626642,,BAO_0000218,,
13181,1,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631330,,BAO_0000218,,
13182,1,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631331,,BAO_0000218,,
13183,1,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631332,,BAO_0000218,,
13184,1,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631333,,BAO_0000218,,
13185,1,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632018,,BAO_0000218,,
13186,1,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632019,,BAO_0000218,,
13187,1,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632020,,BAO_0000218,,
13188,1,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632021,,BAO_0000218,,
13189,1,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632022,,BAO_0000218,,
13190,1,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632023,,BAO_0000218,,
13191,1,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632024,,BAO_0000218,,
13192,1,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874472,,BAO_0000218,,
13193,1,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632025,,BAO_0000218,,
13194,1,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632026,,BAO_0000218,,
13195,1,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632027,,BAO_0000218,,
13196,1,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632028,,BAO_0000218,,
13197,1,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626430,,BAO_0000218,,
13198,1,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626431,,BAO_0000218,,
13199,1,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626432,,BAO_0000218,,
13200,1,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626433,,BAO_0000218,,
13201,1,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626434,,BAO_0000218,,
13202,1,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627280,,BAO_0000218,,
13203,1,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627281,,BAO_0000218,,
13204,1,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627282,,BAO_0000218,,
13205,1,Total body clearance was measured at given dose,,0,22224,,U,Autocuration,,CHEMBL627283,,BAO_0000019,,
13206,1,Total body clearance was measured at given dose.,,0,22224,,U,Autocuration,,CHEMBL627284,,BAO_0000218,,
13207,1,Metabolic clearance from the body in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627285,,BAO_0000218,,
13208,1,Renal clearance from the body,,0,22224,,U,Autocuration,,CHEMBL627286,,BAO_0000218,,
13209,1,Renal clearance from the body in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875477,,BAO_0000218,,
13210,1,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627287,,BAO_0000218,,
13211,1,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627288,,BAO_0000218,,
13212,1,Total clearance from the body in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627289,,BAO_0000218,,
13213,1,Clearance into cortex from rat plasma or PBS,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627290,,BAO_0000218,1969.0,
13214,1,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,,0,22224,,U,Autocuration,,CHEMBL627291,,BAO_0000218,,
13215,1,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,,0,22224,,U,Autocuration,,CHEMBL627292,,BAO_0000218,,
13216,1,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,,0,22224,,U,Autocuration,,CHEMBL627293,,BAO_0000218,,
13217,1,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,,0,22224,,U,Autocuration,,CHEMBL627294,,BAO_0000218,,
13218,1,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,,0,22224,,U,Autocuration,,CHEMBL875478,,BAO_0000218,,
13219,1,Clearance was determined,,0,22224,,U,Autocuration,,CHEMBL627295,,BAO_0000218,,
13220,1,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627296,,BAO_0000218,,
13221,1,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL626119,,BAO_0000218,,
13222,1,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626120,,BAO_0000218,,
13223,1,Clearance in rat after iv dose (100 ug/kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626121,,BAO_0000218,,
13224,1,Clearance in guinea pig,Cavia porcellus,0,22224,,U,Autocuration,,CHEMBL626122,,BAO_0000218,,
13225,1,Compound was evaluated for clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626123,,BAO_0000218,,
13226,1,Compound was evaluated for the clearance in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623456,,BAO_0000218,,
13227,1,Compound was evaluated for the clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623457,,BAO_0000218,,
13228,1,Compound was tested in vivo for clearance after iv administration in the rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623458,,BAO_0000218,,
13229,1,IV clearance determined at an iv dose of 14 mg/kg,,0,22224,,U,Autocuration,,CHEMBL623459,,BAO_0000218,,
13230,1,IV clearance determined at an iv dose of 15.2 mg/kg,,0,22224,,U,Autocuration,,CHEMBL875484,,BAO_0000218,,
13231,1,IV clearance determined at an iv dose of 15 mg/kg,,0,22224,,U,Autocuration,,CHEMBL623460,,BAO_0000218,,
13232,1,IV clearance determined at an peroral dose of 30 mg/kg.,,0,22224,,U,Autocuration,,CHEMBL623461,,BAO_0000218,,
13233,1,IV clearance determined at an peroral dose of 30.2 mg/kg.,,0,22224,,U,Autocuration,,CHEMBL623462,,BAO_0000218,,
13234,1,IV clearance determined at an peroral dose of 30.3 mg/kg.,,0,22224,,U,Autocuration,,CHEMBL627386,,BAO_0000218,,
13235,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627387,,BAO_0000218,2113.0,
13236,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627388,,BAO_0000218,2107.0,
13237,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627389,,BAO_0000218,2048.0,
13238,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627390,,BAO_0000218,2385.0,
13239,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627391,,BAO_0000218,1969.0,
13240,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627392,,BAO_0000218,,
13241,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627393,,BAO_0000218,2106.0,
13242,1,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627394,,BAO_0000218,3126.0,
13243,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627395,,BAO_0000218,10000001.0,
13244,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875485,,BAO_0000218,2037.0,
13245,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627396,,BAO_0000218,,
13246,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627397,,BAO_0000218,,
13247,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627398,,BAO_0000218,948.0,
13248,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627399,,BAO_0000218,10000001.0,
13249,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627400,,BAO_0000218,2113.0,
13250,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627401,,BAO_0000218,2107.0,
13251,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627402,,BAO_0000218,2048.0,
13252,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627403,,BAO_0000218,2385.0,
13253,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627404,,BAO_0000218,1969.0,
13254,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623101,,BAO_0000218,,
13255,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877480,,BAO_0000218,2106.0,
13256,1,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623102,,BAO_0000218,3126.0,
13257,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623103,,BAO_0000218,10000001.0,
13258,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623104,,BAO_0000218,2037.0,
13259,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623105,,BAO_0000218,,
13260,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623106,,BAO_0000218,,
13261,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623107,,BAO_0000218,948.0,
13262,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623108,,BAO_0000218,160.0,
13263,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623109,,BAO_0000218,2113.0,
13264,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623110,,BAO_0000218,2107.0,
13265,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623111,,BAO_0000218,2048.0,
13266,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625060,,BAO_0000218,2385.0,
13267,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625061,,BAO_0000218,1969.0,
13268,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625062,,BAO_0000218,,
13269,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625063,,BAO_0000218,2106.0,
13270,1,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625064,,BAO_0000218,3126.0,
13271,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625065,,BAO_0000218,10000001.0,
13272,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625066,,BAO_0000218,2037.0,
13273,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625067,,BAO_0000218,,
13274,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625068,,BAO_0000218,,
13275,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622159,,BAO_0000218,948.0,
13276,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622160,,BAO_0000218,160.0,
13277,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622161,,BAO_0000218,2113.0,
13278,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622162,,BAO_0000218,2048.0,
13279,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622163,,BAO_0000218,2385.0,
13280,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622313,,BAO_0000218,1969.0,
13281,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622314,,BAO_0000218,,
13282,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622315,,BAO_0000218,2106.0,
13283,1,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622316,,BAO_0000218,3126.0,
13284,1,Normal diffusion coefficient in water for Escherichia coli,Escherichia coli,1,50212,,N,Intermediate,,CHEMBL877486,,BAO_0000218,,
13285,1,Average max percent decrease in RVR (renal vascular resistance) was determined,,0,22224,,U,Autocuration,,CHEMBL622317,,BAO_0000019,,
13286,1,Average max percent decrease in RVR (renal vascular resistance) was determined.,,0,22224,,U,Autocuration,,CHEMBL622318,,BAO_0000019,,
13287,1,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,,0,22224,,U,Autocuration,,CHEMBL622319,,BAO_0000019,,
13288,1,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,,0,22224,,U,Autocuration,,CHEMBL622320,,BAO_0000019,,
13289,1,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,,0,22224,,U,Autocuration,,CHEMBL622321,,BAO_0000019,,
13290,1,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,,0,22224,,U,Autocuration,,CHEMBL622322,,BAO_0000019,,
13291,1,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,,0,22224,,U,Autocuration,,CHEMBL622323,,BAO_0000019,,
13292,1,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622324,,BAO_0000218,,
13293,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622325,,BAO_0000218,1088.0,
13294,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622326,,BAO_0000218,1088.0,
13295,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL877487,,BAO_0000218,1088.0,
13296,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622327,,BAO_0000218,1088.0,
13297,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622328,,BAO_0000218,1088.0,
13298,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622329,,BAO_0000218,1088.0,
13299,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622330,,BAO_0000218,1088.0,
13300,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622331,,BAO_0000218,1088.0,
13301,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622332,,BAO_0000218,1088.0,
13302,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622333,,BAO_0000218,1088.0,
13303,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL627658,,BAO_0000218,1088.0,
13304,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL630428,,BAO_0000218,1088.0,
13305,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL630429,,BAO_0000218,1088.0,
13306,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL630430,,BAO_0000218,1088.0,
13307,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL630431,,BAO_0000218,1088.0,
13308,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630432,,BAO_0000218,1088.0,
13309,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630433,,BAO_0000218,1088.0,
13310,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630434,,BAO_0000218,1088.0,
13311,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629372,,BAO_0000218,1088.0,
13312,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629553,,BAO_0000218,1088.0,
13313,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629554,,BAO_0000218,1088.0,
13314,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874447,,BAO_0000218,1088.0,
13315,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629555,,BAO_0000218,1088.0,
13316,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629556,,BAO_0000218,1088.0,
13317,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629557,,BAO_0000218,1088.0,
13318,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629558,,BAO_0000218,1088.0,
13319,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629559,,BAO_0000218,1088.0,
13320,1,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629560,,BAO_0000218,1088.0,
13321,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629561,,BAO_0000218,1088.0,
13322,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629562,,BAO_0000218,1088.0,
13323,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629563,,BAO_0000218,1088.0,
13324,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629564,,BAO_0000218,1088.0,
13325,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629565,,BAO_0000218,1088.0,
13326,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629566,,BAO_0000218,1088.0,
13327,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629567,,BAO_0000218,1088.0,
13328,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629568,,BAO_0000218,1088.0,
13329,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629569,,BAO_0000218,1088.0,
13330,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629570,,BAO_0000218,1088.0,
13331,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL629571,,BAO_0000218,1088.0,
13332,1,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL629572,,BAO_0000218,,
13333,1,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL629573,,BAO_0000218,,
13334,1,Bioavailability (dose 20 mg/kg),Eutheria,0,22224,,U,Autocuration,,CHEMBL629574,,BAO_0000218,,
13335,1,Bioavailability in dog,Canis lupus familiaris,0,22224,,U,Autocuration,,CHEMBL629575,,BAO_0000218,,
13336,1,Bioavailability in rat (Sprague-Dawley) (male),Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL874448,,BAO_0000218,,
13337,1,Bioavailability in monkey (dose 10 mg/kg i.d.),Primates,0,22224,,U,Autocuration,,CHEMBL629576,,BAO_0000218,,
13338,1,Bioavailability in rat,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL629577,,BAO_0000218,,
13339,1,Bioavailability in rat,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL629578,,BAO_0000218,,
13340,1,Bioavailability in dog (dose 3.0 mg/kg p.o.),Canis lupus familiaris,0,22224,,U,Autocuration,,CHEMBL629579,,BAO_0000218,,
13341,1,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,Canis lupus familiaris,0,22224,,U,Autocuration,,CHEMBL882958,,BAO_0000218,,
13342,1,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,Pan troglodytes,1,50505,,N,Intermediate,,CHEMBL629580,,BAO_0000218,,
13343,1,Bioavailability,Eutheria,0,22224,,U,Autocuration,,CHEMBL629581,,BAO_0000218,,
13344,1,Bioavailability in squirrel monkey,Saimiri,0,22224,,U,Autocuration,,CHEMBL629582,,BAO_0000218,,
13345,1,Bioavailability was evaluated in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628522,,BAO_0000218,,
13346,1,Bioavailability was evaluated in hamster,Cricetinae,1,100712,,N,Intermediate,,CHEMBL625432,,BAO_0000218,,
13347,1,Bioavailability in rat,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL625433,,BAO_0000218,,
13348,1,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625434,,BAO_0000218,1969.0,
13349,1,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625435,,BAO_0000218,1969.0,
13350,1,Bioavailability in rat (dose 10 mg/kg p.o.),Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL625436,,BAO_0000218,,
13351,1,Bioavailability was measured in cynomolgus monkeys.,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL874588,,BAO_0000218,,
13352,1,Bioavailability was measured in nude mice.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625437,,BAO_0000218,,
13353,1,Bioavailability in ferret (dose 10 mg/kg i.d.),Mustela putorius furo,0,22224,,U,Autocuration,,CHEMBL625438,,BAO_0000218,,
13354,1,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),Simiiformes,0,22224,,U,Autocuration,,CHEMBL625439,,BAO_0000218,,
13355,1,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",Simiiformes,0,22224,,U,Autocuration,,CHEMBL625440,,BAO_0000218,,
13356,1,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),Simiiformes,0,22224,,U,Autocuration,,CHEMBL625441,,BAO_0000218,,
13357,1,Bioavailability in rat (dose 10 mg/kg i.d.),Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL625442,,BAO_0000218,,
13358,1,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625443,,BAO_0000218,,
13359,1,Bioavailability was determined; extremely poor,,0,22224,,U,Autocuration,,CHEMBL625444,,BAO_0000218,,
13360,1,% bioavailability in mice after oral administration of prodrug,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625445,,BAO_0000218,,
13361,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625446,,BAO_0000218,,
13362,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL882960,,BAO_0000218,,
13363,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625447,,BAO_0000218,,
13364,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625448,,BAO_0000218,,
13365,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625449,,BAO_0000218,,
13366,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL874589,,BAO_0000218,,
13367,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625450,,BAO_0000218,,
13368,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625451,,BAO_0000218,,
13369,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626584,,BAO_0000218,,
13370,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626585,,BAO_0000218,,
13371,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626586,,BAO_0000218,,
13372,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626587,,BAO_0000218,,
13373,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626588,,BAO_0000218,,
13374,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626589,,BAO_0000218,,
13375,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626590,,BAO_0000218,,
13376,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626591,,BAO_0000218,,
13377,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627181,,BAO_0000218,,
13378,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628083,,BAO_0000218,,
13379,1,IV clearance determined at an peroral dose of 15 mg/kg.,,0,22224,,U,Autocuration,,CHEMBL628084,,BAO_0000218,,
13380,1,Mouse oral clearance was measured against Hymenolepiasis nana.,Hymenolepis nana,1,50064,,N,Expert,,CHEMBL628085,,BAO_0000218,,
13381,1,Mouse oral clearance was measured against Nematospiroides dubius,Heligmosomoides polygyrus,1,50545,,N,Expert,,CHEMBL628086,,BAO_0000218,,
13382,1,Mouse oral clearance was measured against N. dubius; NT is Not Tested,,0,22224,,U,Autocuration,,CHEMBL628087,,BAO_0000218,,
13383,1,Mouse oral clearance was measured against N. nana; NT is Not Tested,Mus musculus,1,50594,,N,Intermediate,,CHEMBL628088,,BAO_0000218,,
13384,1,Mouse oral clearance was measured against N. nana; NT is Not Tested,,0,22224,,U,Autocuration,,CHEMBL628089,,BAO_0000218,,
13385,1,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,,0,22224,,U,Autocuration,,CHEMBL628090,,BAO_0000218,,
13386,1,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,,0,22224,,U,Autocuration,,CHEMBL628091,,BAO_0000218,,
13387,1,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,,0,22224,,U,Autocuration,,CHEMBL628092,,BAO_0000218,,
13388,1,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,,0,22224,,U,Autocuration,,CHEMBL628093,,BAO_0000218,,
13389,1,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,,0,22224,,U,Autocuration,,CHEMBL875607,,BAO_0000218,,
13390,1,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,,0,22224,,U,Autocuration,,CHEMBL625710,,BAO_0000218,,
13391,1,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,,0,22224,,U,Autocuration,,CHEMBL625711,,BAO_0000218,,
13392,1,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,,0,22224,,U,Autocuration,,CHEMBL625712,,BAO_0000218,,
13393,1,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,,0,22224,,U,Autocuration,,CHEMBL625713,,BAO_0000218,,
13394,1,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625714,,BAO_0000218,,
13395,1,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,Macaca mulatta,1,50797,,N,Intermediate,,CHEMBL625715,,BAO_0000218,,
13396,1,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625716,,BAO_0000218,,
13397,1,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625717,,BAO_0000218,,
13398,1,Plasma clearance was determined for the compound in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625718,,BAO_0000218,,
13399,1,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625719,,BAO_0000218,,
13400,1,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625720,,BAO_0000218,,
13401,1,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625721,,BAO_0000218,,
13402,1,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625722,,BAO_0000218,,
13403,1,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625723,,BAO_0000218,,
13404,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,Heligmosomoides polygyrus,1,50545,,N,Intermediate,,CHEMBL625724,,BAO_0000218,,
13405,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,Heligmosomoides polygyrus,1,50545,,N,Intermediate,,CHEMBL625725,,BAO_0000218,,
13406,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,Heligmosomoides polygyrus,1,50545,,N,Intermediate,,CHEMBL625726,,BAO_0000218,,
13407,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,Heligmosomoides polygyrus,1,50545,,N,Intermediate,,CHEMBL875608,,BAO_0000218,,
13408,1,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,Heligmosomoides polygyrus,1,50545,,N,Intermediate,,CHEMBL625727,,BAO_0000218,,
13409,1,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL625728,,BAO_0000218,1088.0,
13410,1,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL625729,,BAO_0000218,,
13411,1,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL625730,,BAO_0000218,,
13412,1,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL625731,,BAO_0000218,1088.0,
13413,1,Urinary clearance was determined in rat at 25 mg/kg os dosage,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL626417,,BAO_0000218,1088.0,
13414,1,Urinary clearance was determined at 100 mg/kg oral dosage in human,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL626418,,BAO_0000218,1088.0,
13415,1,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626419,,BAO_0000218,1088.0,
13416,1,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626592,,BAO_0000218,1969.0,
13417,1,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626593,,BAO_0000218,1969.0,
13418,1,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626594,,BAO_0000218,,
13419,1,Clearance rate in dogs,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625035,,BAO_0000218,,
13420,1,Compound was measured for intrinsic clearance,,0,22224,,U,Autocuration,,CHEMBL625036,,BAO_0000019,,
13421,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625037,,BAO_0000100,,
13422,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625038,,BAO_0000100,,
13423,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625039,,BAO_0000100,,
13424,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625040,,BAO_0000100,,
13425,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625041,,BAO_0000100,,
13426,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625042,,BAO_0000100,,
13427,1,Partition coefficient of the compound,,0,22224,,U,Autocuration,,CHEMBL874411,,BAO_0000019,,
13428,1,Permeability,,0,22224,,U,Autocuration,,CHEMBL625043,,BAO_0000019,,
13429,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625044,,BAO_0000100,,
13430,1,Partition coefficient (logD),,0,22224,,U,Autocuration,,CHEMBL625045,,BAO_0000019,,
13431,1,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,0,22229,,U,Autocuration,,CHEMBL625046,,BAO_0000100,,
13432,1,Calculated partition coefficient (clogP) (CLOGP3 V3.4),,0,22229,,U,Autocuration,,CHEMBL625047,,BAO_0000100,,
13433,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625048,,BAO_0000100,,
13434,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625049,,BAO_0000100,,
13435,1,Calculated logarithm of partition coefficient (P) was determined,,0,22229,,U,Autocuration,,CHEMBL625050,,BAO_0000100,,
13436,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625051,,BAO_0000100,,
13437,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL874412,,BAO_0000100,,
13438,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625052,,BAO_0000100,,
13439,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL625053,,BAO_0000100,,
13440,1,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,,0,22224,,U,Autocuration,,CHEMBL623250,,BAO_0000019,,
13441,1,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,,0,22224,,U,Autocuration,,CHEMBL623251,,BAO_0000019,,
13442,1,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,,0,22224,,U,Autocuration,,CHEMBL623252,,BAO_0000019,,
13443,1,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,,0,22224,,U,Autocuration,,CHEMBL623253,,BAO_0000019,,
13444,1,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,,0,22224,,U,Autocuration,,CHEMBL623254,,BAO_0000019,,
13445,1,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,,0,22224,,U,Autocuration,,CHEMBL623255,,BAO_0000019,,
13446,1,Percent degradation of compound at a pH of 1 over a 18 hr period,,0,22224,,U,Autocuration,,CHEMBL626831,,BAO_0000019,,
13447,1,Percent degradation of compound at pH of 1 over an 18 hr period,,0,22224,,U,Autocuration,,CHEMBL877494,,BAO_0000019,,
13448,1,Delta Logarithm of Partition Coefficient value was determined.,,0,22224,,U,Autocuration,,CHEMBL626832,,BAO_0000019,,
13449,1,Delta logPoct-cyc,,0,22224,,U,Autocuration,,CHEMBL626833,,BAO_0000019,,
13450,1,Lipophilicity estimated on reversed phase TLC,,0,22224,,U,Autocuration,,CHEMBL626834,,BAO_0000100,,
13451,1,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,,0,22224,,U,Autocuration,,CHEMBL626835,,BAO_0000019,,
13452,1,Delta logPoct-cyc,,0,22224,,U,Autocuration,,CHEMBL626836,,BAO_0000019,,
13453,1,Change in logarithm of partition coefficient of the compound,,0,22229,,U,Autocuration,,CHEMBL626837,,BAO_0000100,,
13454,1,Delta logD (pH 6.5),,0,22224,,U,Autocuration,,CHEMBL626838,,BAO_0000019,,
13455,1,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",,0,22224,,U,Autocuration,,CHEMBL626839,,BAO_0000100,,
13456,1,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,,0,22224,,U,Autocuration,,CHEMBL626840,,BAO_0000019,,
13457,1,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),,0,22224,,U,Autocuration,,CHEMBL626841,,BAO_0000019,,
13458,1,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,,0,22224,,U,Autocuration,,CHEMBL626842,,BAO_0000219,,
13459,1,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,,0,22224,,U,Autocuration,,CHEMBL626843,,BAO_0000219,,
13460,1,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626844,,BAO_0000218,,
13461,1,Amount of deuterium retained was reported after normal workup in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877495,,BAO_0000218,,
13462,1,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626845,,BAO_0000218,,
13463,1,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626846,,BAO_0000218,,
13464,1,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626847,,BAO_0000218,,
13465,1,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628677,,BAO_0000218,,
13466,1,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628678,,BAO_0000218,,
13467,1,Compound was subjected to electrochemical oxidation,,0,22224,,U,Autocuration,,CHEMBL628679,,BAO_0000019,,
13468,1,Compound was subjected to photochemical oxidation,,0,22224,,U,Autocuration,,CHEMBL628680,,BAO_0000019,,
13469,1,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,,0,22224,,U,Autocuration,,CHEMBL628681,,BAO_0000019,,
13470,1,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,,0,22224,,U,Autocuration,,CHEMBL628682,,BAO_0000019,,
13471,1,Oxidation of compound by methemoglobin in presence of hydroperoxide,,0,22224,,U,Autocuration,,CHEMBL628683,,BAO_0000019,,
13472,1,Percent diffusion through fuzzy rat skin after 48 h of incubation,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628684,,BAO_0000218,,
13473,1,Dissociation constant (pKa),,0,22229,,U,Autocuration,,CHEMBL877501,,BAO_0000100,,
13474,1,Dissociation constant value of the compound; ND means not determined.,,0,22224,,U,Autocuration,,CHEMBL628685,,BAO_0000100,,
13475,1,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628686,,BAO_0000218,178.0,
13476,1,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628687,,BAO_0000218,178.0,
13477,1,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628688,,BAO_0000218,,
13478,1,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628689,,BAO_0000218,,
13479,1,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628690,,BAO_0000218,2107.0,
13480,1,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629363,,BAO_0000218,2107.0,
13481,1,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629364,,BAO_0000218,2106.0,
13482,1,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629365,,BAO_0000218,2106.0,
13483,1,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629366,,BAO_0000218,,
13484,1,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629367,,BAO_0000218,1088.0,
13485,1,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629368,,BAO_0000218,1988.0,
13486,1,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877502,,BAO_0000218,1088.0,
13487,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629369,,BAO_0000218,2037.0,
13488,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629370,,BAO_0000218,955.0,
13489,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL629371,,BAO_0000218,1088.0,
13490,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL626276,,BAO_0000218,1088.0,
13491,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL626277,,BAO_0000218,1088.0,
13492,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL631250,,BAO_0000218,1088.0,
13493,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631251,,BAO_0000218,1088.0,
13494,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631252,,BAO_0000218,1088.0,
13495,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631253,,BAO_0000218,1088.0,
13496,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631254,,BAO_0000218,1088.0,
13497,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631255,,BAO_0000218,1088.0,
13498,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631256,,BAO_0000218,1088.0,
13499,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631257,,BAO_0000218,1088.0,
13500,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628009,,BAO_0000218,1088.0,
13501,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628010,,BAO_0000218,1088.0,
13502,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628011,,BAO_0000218,1088.0,
13503,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628012,,BAO_0000218,1088.0,
13504,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628013,,BAO_0000218,1088.0,
13505,1,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628014,,BAO_0000218,1088.0,
13506,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628015,,BAO_0000218,1088.0,
13507,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628016,,BAO_0000218,1088.0,
13508,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL874461,,BAO_0000218,1088.0,
13509,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628017,,BAO_0000218,1088.0,
13510,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628018,,BAO_0000218,1088.0,
13511,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628019,,BAO_0000218,1088.0,
13512,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628020,,BAO_0000218,1088.0,
13513,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628021,,BAO_0000218,1088.0,
13514,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628022,,BAO_0000218,1088.0,
13515,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628023,,BAO_0000218,1088.0,
13516,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL628024,,BAO_0000218,1088.0,
13517,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL628025,,BAO_0000218,1088.0,
13518,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL628026,,BAO_0000218,1088.0,
13519,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL628027,,BAO_0000218,1088.0,
13520,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",Simiiformes,0,22224,,U,Autocuration,,CHEMBL628028,,BAO_0000218,1088.0,
13521,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628029,,BAO_0000218,1088.0,
13522,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628030,,BAO_0000218,1088.0,
13523,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628031,,BAO_0000218,1088.0,
13524,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628032,,BAO_0000218,1088.0,
13525,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628033,,BAO_0000218,1088.0,
13526,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628034,,BAO_0000218,1088.0,
13527,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628035,,BAO_0000218,1088.0,
13528,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628036,,BAO_0000218,1088.0,
13529,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874462,,BAO_0000218,1088.0,
13530,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628037,,BAO_0000218,,
13531,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628123,,BAO_0000218,,
13532,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628124,,BAO_0000218,,
13533,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628125,,BAO_0000218,,
13534,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628126,,BAO_0000218,,
13535,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628127,,BAO_0000218,,
13536,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628128,,BAO_0000218,,
13537,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628129,,BAO_0000218,,
13538,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628130,,BAO_0000218,,
13539,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628131,,BAO_0000218,,
13540,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628132,,BAO_0000218,,
13541,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628133,,BAO_0000218,,
13542,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628134,,BAO_0000218,,
13543,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628135,,BAO_0000218,,
13544,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628136,,BAO_0000218,,
13545,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628137,,BAO_0000218,,
13546,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628138,,BAO_0000218,,
13547,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628139,,BAO_0000218,,
13548,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628140,,BAO_0000218,,
13549,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628141,,BAO_0000218,,
13550,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628142,,BAO_0000218,,
13551,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628143,,BAO_0000218,,
13552,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628144,,BAO_0000218,,
13553,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628145,,BAO_0000218,,
13554,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL628146,,BAO_0000218,,
13555,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625355,,BAO_0000218,,
13556,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625356,,BAO_0000218,,
13557,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625357,,BAO_0000218,,
13558,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625527,,BAO_0000218,,
13559,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL875473,,BAO_0000218,,
13560,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625528,,BAO_0000218,,
13561,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626304,,BAO_0000218,,
13562,1,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624138,,BAO_0000218,1637.0,
13563,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL624139,,BAO_0000100,,
13564,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL624140,,BAO_0000100,,
13565,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL624141,,BAO_0000100,,
13566,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL624142,,BAO_0000100,,
13567,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL624143,,BAO_0000100,,
13568,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL624144,,BAO_0000100,,
13569,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL624145,,BAO_0000100,,
13570,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL624146,,BAO_0000100,,
13571,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL624147,,BAO_0000100,,
13572,1,Calculated partition coefficient (clogP) (MacLogP),,0,22229,,U,Autocuration,,CHEMBL883123,,BAO_0000100,,
13573,1,Partition coefficient (logP),,0,22224,,U,Autocuration,,CHEMBL624148,,BAO_0000019,,
13574,1,Kinetic parameter was determined,,0,22224,,U,Autocuration,,CHEMBL874416,,BAO_0000019,,
13575,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL624149,,BAO_0000100,,
13576,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL624150,,BAO_0000100,,
13577,1,Lipophilicity was determined,,0,22224,,U,Autocuration,,CHEMBL624151,,BAO_0000100,,
13578,1,Lipophilicity was determined,,0,22224,,U,Autocuration,,CHEMBL624152,,BAO_0000100,,
13579,1,Lipophilicity was determined,,0,22224,,U,Autocuration,,CHEMBL622139,,BAO_0000100,,
13580,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL622140,,BAO_0000100,,
13581,1,Lipophilicity was determined,,0,22224,,U,Autocuration,,CHEMBL622141,,BAO_0000100,,
13582,1,Lipophilicity in octanol-water,,0,22224,,U,Autocuration,,CHEMBL622142,,BAO_0000100,,
13583,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL622143,,BAO_0000100,,
13584,1,Octanol-water partition coefficient was determined,,0,22229,,U,Autocuration,,CHEMBL622144,,BAO_0000100,,
13585,1,Partition coefficient (logP),,0,22224,,U,Autocuration,,CHEMBL877473,,BAO_0000019,,
13586,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL622145,,BAO_0000100,,
13587,1,Partition coefficient was determined; ND means not determined,,0,22224,,U,Autocuration,,CHEMBL622146,,BAO_0000019,,
13588,1,Calculated partition coefficient (clogP),,0,22229,,U,Autocuration,,CHEMBL622147,,BAO_0000100,,
13589,1,Partition coefficient of the compound,,0,22224,,U,Autocuration,,CHEMBL622148,,BAO_0000019,,
13590,1,Permeability was determined,,0,22224,,U,Autocuration,,CHEMBL883124,,BAO_0000019,,
13591,1,The compound was evaluated for the partition coefficient,,0,22229,,U,Autocuration,,CHEMBL622149,,BAO_0000100,,
13592,1,Partition coefficient (logP),,0,22224,,U,Autocuration,,CHEMBL622150,,BAO_0000019,,
13593,1,The lipophilicity was reported,,0,22224,,U,Autocuration,,CHEMBL622151,,BAO_0000100,,
13594,1,logarithm of the octanol-water partition coefficient for the compound,,0,22229,,U,Autocuration,,CHEMBL622152,,BAO_0000100,,
13595,1,Clogp value was determined,,0,22224,,U,Autocuration,,CHEMBL622153,,BAO_0000019,,
13596,1,Clp at a dose of 1.5 mg/kg,,0,22224,,U,Autocuration,,CHEMBL877474,,BAO_0000218,,
13597,1,Clp at a dose of 2.0 mg/kg,,0,22224,,U,Autocuration,,CHEMBL622154,,BAO_0000218,,
13598,1,"Clp, plasma clearance at a dose of 10 mg/kg",,0,22224,,U,Autocuration,,CHEMBL622155,,BAO_0000218,1969.0,
13599,1,"Clp, plasma clearance at a dose of 50 mg/kg",,0,22224,,U,Autocuration,,CHEMBL622156,,BAO_0000218,1969.0,
13600,1,Compound was tested for plasma clearance in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622157,,BAO_0000218,1969.0,
13601,1,Compound was tested for plasma clearance in rat; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622158,,BAO_0000218,1969.0,
13602,1,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622807,,BAO_0000218,,
13603,1,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,Macaca mulatta,1,50797,,N,Intermediate,,CHEMBL622808,,BAO_0000218,,
13604,1,Plasma clearance by iv administration at a dose 0.003 ug/mL,,0,22224,,U,Autocuration,,CHEMBL622809,,BAO_0000218,,
13605,1,Plasma clearance determined,,0,22224,,U,Autocuration,,CHEMBL622810,,BAO_0000218,,
13606,1,Plasma clearance after iv administration at 3 mg/kg in hamster,Cricetinae,1,100712,,N,Intermediate,,CHEMBL876653,,BAO_0000218,,
13607,1,Plasma clearance after iv administration at 4 mg/kg in hamster,Cricetinae,1,100712,,N,Intermediate,,CHEMBL622811,,BAO_0000218,,
13608,1,Rate of clearance in rat was determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622986,,BAO_0000218,,
13609,1,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622987,,BAO_0000218,1969.0,
13610,1,Total plasma clearance after iv dose of 5.10 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622988,,BAO_0000218,1969.0,
13611,1,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622989,,BAO_0000218,1969.0,
13612,1,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622990,,BAO_0000218,1969.0,
13613,1,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,Simiiformes,0,22224,,U,Autocuration,,CHEMBL622991,,BAO_0000218,1969.0,
13614,1,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622227,,BAO_0000218,1969.0,
13615,1,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622228,,BAO_0000218,1969.0,
13616,1,Clpl value in rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622229,,BAO_0000218,,
13617,1,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL622230,,BAO_0000218,,
13618,1,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622231,,BAO_0000218,,
13619,1,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,Macaca fascicularis,1,100710,,N,Intermediate,,CHEMBL622232,,BAO_0000218,,
13620,1,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,,0,22224,,U,Autocuration,,CHEMBL622233,,BAO_0000218,,
13621,1,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,,0,22224,,U,Autocuration,,CHEMBL622234,,BAO_0000218,,
13622,1,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,,0,22224,,U,Autocuration,,CHEMBL622235,,BAO_0000218,,
13623,1,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,,0,22224,,U,Autocuration,,CHEMBL622236,,BAO_0000218,,
13624,1,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,,0,22224,,U,Autocuration,,CHEMBL622237,,BAO_0000218,,
13625,1,Cmax in minutes at a po dose of 10.0(pmol/g/h).,,0,22224,,U,Autocuration,,CHEMBL877482,,BAO_0000218,,
13626,1,Cmax in minutes at a po dose of 20.0(pmol/g/h).,,0,22224,,U,Autocuration,,CHEMBL622238,,BAO_0000218,,
13627,1,Cmax in minutes at a po dose of 40.0(pmol/g/h).,,0,22224,,U,Autocuration,,CHEMBL622239,,BAO_0000218,,
13628,1,Cmax was calculated as maximum concentration reached in the blood,,0,22224,,U,Autocuration,,CHEMBL622240,,BAO_0000218,178.0,
13629,1,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,,0,22224,,U,Autocuration,,CHEMBL622241,,BAO_0000218,178.0,
13630,1,Cmax was determine after peroral administration at 10 mpk in Rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631013,,BAO_0000218,,
13631,1,Cmax was determine after peroral administration at 10 mpk in Rhesus,Macaca mulatta,1,50797,,N,Intermediate,,CHEMBL631014,,BAO_0000218,,
13632,1,Cmax was determine after peroral administration at 10 mpk in dog,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631015,,BAO_0000218,,
13633,1,Cmax was determine after peroral administration at 160 mpk in Rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631016,,BAO_0000218,,
13634,1,Cmax was determine after peroral administration at 20 mpk in Rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631017,,BAO_0000218,,
13635,1,Cmax was determine after peroral administration at 50 mpk in Rat,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631018,,BAO_0000218,,
13636,1,Cmax was determined,,0,22224,,U,Autocuration,,CHEMBL631019,,BAO_0000218,,
13637,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,Mus musculus,1,50594,,N,Intermediate,,CHEMBL875761,,BAO_0000218,955.0,
13638,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631020,,BAO_0000218,955.0,
13639,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631669,,BAO_0000218,955.0,
13640,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631670,,BAO_0000218,955.0,
13641,1,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631671,,BAO_0000218,2435.0,
13642,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631672,,BAO_0000218,178.0,
13643,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631673,,BAO_0000218,178.0,
13644,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631856,,BAO_0000218,178.0,
13645,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631857,,BAO_0000218,178.0,
13646,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631858,,BAO_0000218,178.0,
13647,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631859,,BAO_0000218,178.0,
13648,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631860,,BAO_0000218,178.0,
13649,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631861,,BAO_0000218,178.0,
13650,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631862,,BAO_0000218,178.0,
13651,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631863,,BAO_0000218,178.0,
13652,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631864,,BAO_0000218,178.0,
13653,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631865,,BAO_0000218,178.0,
13654,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631866,,BAO_0000218,178.0,
13655,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629360,,BAO_0000218,178.0,
13656,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629361,,BAO_0000218,178.0,
13657,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629362,,BAO_0000218,178.0,
13658,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630740,,BAO_0000218,178.0,
13659,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630741,,BAO_0000218,178.0,
13660,1,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630742,,BAO_0000218,178.0,
13661,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630743,,BAO_0000218,,
13662,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630744,,BAO_0000218,,
13663,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630745,,BAO_0000218,,
13664,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630746,,BAO_0000218,,
13665,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630747,,BAO_0000218,,
13666,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630748,,BAO_0000218,,
13667,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632056,,BAO_0000218,,
13668,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632057,,BAO_0000218,,
13669,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632058,,BAO_0000218,,
13670,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632059,,BAO_0000218,,
13671,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632060,,BAO_0000218,,
13672,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632061,,BAO_0000218,,
13673,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629207,,BAO_0000218,,
13674,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629208,,BAO_0000218,,
13675,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629209,,BAO_0000218,,
13676,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629210,,BAO_0000218,,
13677,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629211,,BAO_0000218,,
13678,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629212,,BAO_0000218,,
13679,1,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629213,,BAO_0000218,,
13680,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629214,,BAO_0000218,1088.0,
13681,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629215,,BAO_0000218,1088.0,
13682,1,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL635154,,BAO_0000218,1088.0,
13683,1,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629216,,BAO_0000218,,
13684,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629217,,BAO_0000218,,
13685,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629218,,BAO_0000218,,
13686,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629219,,BAO_0000218,,
13687,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629220,,BAO_0000218,,
13688,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629221,,BAO_0000218,,
13689,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631127,,BAO_0000218,,
13690,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631128,,BAO_0000218,,
13691,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631129,,BAO_0000218,,
13692,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631130,,BAO_0000218,,
13693,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631131,,BAO_0000218,,
13694,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631132,,BAO_0000218,,
13695,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631133,,BAO_0000218,,
13696,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631134,,BAO_0000218,,
13697,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875120,,BAO_0000218,,
13698,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631135,,BAO_0000218,,
13699,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631136,,BAO_0000218,,
13700,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631137,,BAO_0000218,,
13701,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631138,,BAO_0000218,,
13702,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631139,,BAO_0000218,,
13703,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631140,,BAO_0000218,,
13704,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631141,,BAO_0000218,,
13705,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631142,,BAO_0000218,,
13706,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631143,,BAO_0000218,,
13707,1,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631144,,BAO_0000218,,
13708,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631145,,BAO_0000218,,
13709,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631146,,BAO_0000218,,
13710,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631147,,BAO_0000218,,
13711,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631148,,BAO_0000218,,
13712,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631149,,BAO_0000218,,
13713,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631150,,BAO_0000218,,
13714,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631151,,BAO_0000218,,
13715,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631152,,BAO_0000218,,
13716,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631443,,BAO_0000218,,
13717,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631444,,BAO_0000218,,
13718,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631445,,BAO_0000218,,
13719,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631446,,BAO_0000218,,
13720,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631447,,BAO_0000218,,
13721,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631448,,BAO_0000218,,
13722,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631449,,BAO_0000218,,
13723,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL631450,,BAO_0000218,,
13724,1,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629724,,BAO_0000218,,
13725,1,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL629725,,BAO_0000218,14.0,
13726,1,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL629726,,BAO_0000218,14.0,
13727,1,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL629727,,BAO_0000218,2106.0,
13728,1,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL630404,,BAO_0000218,2106.0,
13729,1,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL630405,,BAO_0000218,2106.0,
13730,1,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL630406,,BAO_0000218,2106.0,
13731,1,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL630407,,BAO_0000218,945.0,
13732,1,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL630573,,BAO_0000218,945.0,
13733,1,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL630574,,BAO_0000218,945.0,
13734,1,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL630575,,BAO_0000218,945.0,
13735,1,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL630576,,BAO_0000218,,
13736,1,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL630577,,BAO_0000218,,
13737,1,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL630578,,BAO_0000218,,
13738,1,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",Mus musculus,1,50594,,N,Intermediate,,CHEMBL630579,,BAO_0000218,,
13739,1,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),Mus musculus,1,50594,,N,Intermediate,,CHEMBL630580,,BAO_0000218,2113.0,
13740,1,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630581,,BAO_0000218,2113.0,
13741,1,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),Mus musculus,1,50594,,N,Intermediate,,CHEMBL630582,,BAO_0000218,2113.0,
13742,1,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630583,,BAO_0000218,,
13743,1,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),Mus musculus,1,50594,,N,Intermediate,,CHEMBL630584,,BAO_0000218,,
13744,1,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630585,,BAO_0000218,,
13745,1,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),Mus musculus,1,50594,,N,Intermediate,,CHEMBL630586,,BAO_0000218,,
13746,1,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630587,,BAO_0000218,,
13747,1,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),Mus musculus,1,50594,,N,Intermediate,,CHEMBL630588,,BAO_0000218,,
13748,1,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630589,,BAO_0000218,,
13749,1,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),Mus musculus,1,50594,,N,Intermediate,,CHEMBL630590,,BAO_0000218,,
13750,1,Removal of 238-Plutonium(IV) in feces at 24 h,,0,22224,,U,Autocuration,,CHEMBL630591,,BAO_0000019,1988.0,
13751,1,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),,0,22224,,U,Autocuration,,CHEMBL630592,,BAO_0000019,1988.0,
13752,1,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,,0,22224,,U,Autocuration,,CHEMBL630593,,BAO_0000019,,
13753,1,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),,0,22224,,U,Autocuration,,CHEMBL630594,,BAO_0000019,,
13754,1,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),,0,22224,,U,Autocuration,,CHEMBL630595,,BAO_0000019,1088.0,
13755,1,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),,0,22224,,U,Autocuration,,CHEMBL630596,,BAO_0000019,1088.0,
13756,1,Removal of 238-Plutonium(IV) in urine after 0-24 h,,0,22224,,U,Autocuration,,CHEMBL630597,,BAO_0000019,1088.0,
13757,1,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),,0,22224,,U,Autocuration,,CHEMBL630598,,BAO_0000019,1088.0,
13758,1,Removal of 238-Plutonium(IV) in urine after 0-4 h,,0,22224,,U,Autocuration,,CHEMBL630599,,BAO_0000019,1088.0,
13759,1,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),,0,22224,,U,Autocuration,,CHEMBL630600,,BAO_0000019,1088.0,
13760,1,Removal of 238-Plutonium(IV) in urine after 4-24 h,,0,22224,,U,Autocuration,,CHEMBL630601,,BAO_0000019,1088.0,
13761,1,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),,0,22224,,U,Autocuration,,CHEMBL630602,,BAO_0000019,1088.0,
13762,1,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),,0,22224,,U,Autocuration,,CHEMBL630603,,BAO_0000019,1088.0,
13763,1,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),,0,22224,,U,Autocuration,,CHEMBL630604,,BAO_0000019,1088.0,
13764,1,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624869,,BAO_0000218,178.0,
13765,1,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624870,,BAO_0000218,178.0,
13766,1,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623189,,BAO_0000218,178.0,
13767,1,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623190,,BAO_0000218,178.0,
13768,1,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623191,,BAO_0000218,178.0,
13769,1,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623192,,BAO_0000218,,
13770,1,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623193,,BAO_0000218,,
13771,1,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623194,,BAO_0000218,,
13772,1,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623195,,BAO_0000218,,
13773,1,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623196,,BAO_0000218,,
13774,1,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623197,,BAO_0000218,,
13775,1,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623198,,BAO_0000218,,
13776,1,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623199,,BAO_0000218,,
13777,1,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623200,,BAO_0000218,2385.0,
13778,1,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623201,,BAO_0000218,2385.0,
13779,1,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623202,,BAO_0000218,2385.0,
13780,1,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623203,,BAO_0000218,2385.0,
13781,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623204,,BAO_0000218,2385.0,
13782,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623205,,BAO_0000218,2385.0,
13783,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623206,,BAO_0000218,2385.0,
13784,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623207,,BAO_0000218,2385.0,
13785,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623208,,BAO_0000218,2385.0,
13786,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623209,,BAO_0000218,2385.0,
13787,1,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623210,,BAO_0000218,2385.0,
13788,1,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623211,,BAO_0000218,,
13789,1,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623212,,BAO_0000218,995.0,
13790,1,Tested in vitro for intrinsic activity relative to quinpirole,,0,22224,,U,Autocuration,,CHEMBL623213,,BAO_0000019,,
13791,1,"Relative ion enhancement, determined in pulsed ultrafiltration",,0,22224,,U,Autocuration,,CHEMBL623214,,BAO_0000019,,
13792,1,% ionization at the pH 7.4 at 37 degree Centigrade,,0,22224,,U,Autocuration,,CHEMBL623215,,BAO_0000019,,
13793,1,Percentage ionization was measured,,0,22224,,U,Autocuration,,CHEMBL623216,,BAO_0000019,,
13794,1,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,Bos taurus,1,50591,,N,Intermediate,,CHEMBL623217,,BAO_0000218,,
13795,1,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,,0,22224,,U,Autocuration,,CHEMBL623218,,BAO_0000019,,
13796,1,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,,0,22224,,U,Autocuration,,CHEMBL623913,,BAO_0000019,,
13797,1,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,,0,22224,,U,Autocuration,,CHEMBL623914,,BAO_0000019,,
13798,1,Compound was evaluated for the partition coefficient in octanol/water,,0,22229,,U,Autocuration,,CHEMBL623915,,BAO_0000100,,
13799,1,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),,0,22229,,U,Autocuration,,CHEMBL624080,,BAO_0000100,,
13800,1,Equilibrium constant measured by the pulse radiolysis at pH 7,,0,22224,,U,Autocuration,,CHEMBL624081,,BAO_0000019,,
13801,1,In vitro hydrolytic rate constant determined in human blood,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL624082,,BAO_0000218,,
13802,1,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL625054,,BAO_0000218,,
13803,1,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,,0,22224,,U,Autocuration,,CHEMBL877485,,BAO_0000019,,
13804,1,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625055,,BAO_0000218,,
13805,1,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625056,,BAO_0000218,,
13806,1,In vitro oxidation of compound in presence of human plasma,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL625057,,BAO_0000218,,
13807,1,In vitro oxidation of compound in presence of hydrogen peroxide,,0,22224,,U,Autocuration,,CHEMBL625058,,BAO_0000019,,
13808,1,In vitro oxidation of compound in presence of mouse brain homogenate,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625059,,BAO_0000218,,
13809,1,In vitro oxidation of compound in presence of mouse liver homogenate,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629536,,BAO_0000218,,
13810,1,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629537,,BAO_0000218,,
13811,1,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629538,,BAO_0000218,,
13812,1,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629539,,BAO_0000218,,
13813,1,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874445,,BAO_0000218,,
13814,1,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629540,,BAO_0000218,,
13815,1,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629541,,BAO_0000218,,
13816,1,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629542,,BAO_0000218,,
13817,1,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630243,,BAO_0000218,,
13818,1,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630244,,BAO_0000218,,
13819,1,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630245,,BAO_0000218,,
13820,1,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630246,,BAO_0000218,,
13821,1,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630247,,BAO_0000218,,
13822,1,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630248,,BAO_0000218,,
13823,1,Biodistribution in rat blood at 240 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630249,,BAO_0000218,178.0,
13824,1,Biodistribution in rat blood at 30 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630250,,BAO_0000218,178.0,
13825,1,Biodistribution in rat blood at 360 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630251,,BAO_0000218,178.0,
13826,1,Biodistribution in rat blood at 3 hr after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630252,,BAO_0000218,178.0,
13827,1,Biodistribution in rat blood at 60 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630408,,BAO_0000218,178.0,
13828,1,Biodistribution in rat cerebellum at 120 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630409,,BAO_0000218,2037.0,
13829,1,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874446,,BAO_0000218,2037.0,
13830,1,Biodistribution in rat cerebellum at 15 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630410,,BAO_0000218,2037.0,
13831,1,Biodistribution in rat cerebellum at 240 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630411,,BAO_0000218,2037.0,
13832,1,Biodistribution in rat cerebellum at 30 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630412,,BAO_0000218,2037.0,
13833,1,Biodistribution in rat cerebellum at 360 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630413,,BAO_0000218,2037.0,
13834,1,Biodistribution in rat cerebellum at 3 hr after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630414,,BAO_0000218,2037.0,
13835,1,Biodistribution in rat cerebellum at 60 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630415,,BAO_0000218,2037.0,
13836,1,Biodistribution in rat cortex at 120 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630416,,BAO_0000218,,
13837,1,Biodistribution in rat cortex at 1440 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630417,,BAO_0000218,,
13838,1,Biodistribution in rat cortex at 15 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630418,,BAO_0000218,,
13839,1,Biodistribution in rat cortex at 240 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630419,,BAO_0000218,,
13840,1,Biodistribution in rat cortex at 30 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630420,,BAO_0000218,,
13841,1,Biodistribution in rat cortex at 360 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630421,,BAO_0000218,,
13842,1,Biodistribution in rat cortex at 3 hr after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630422,,BAO_0000218,,
13843,1,Biodistribution in rat cortex at 60 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630423,,BAO_0000218,,
13844,1,Biodistribution in rat heart at 120 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630424,,BAO_0000218,948.0,
13845,1,Biodistribution in rat heart at 15 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630425,,BAO_0000218,948.0,
13846,1,Biodistribution in rat heart at 240 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629462,,BAO_0000218,948.0,
13847,1,Biodistribution in rat heart at 30 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630426,,BAO_0000218,948.0,
13848,1,Biodistribution in rat heart at 360 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630427,,BAO_0000218,948.0,
13849,1,Biodistribution in rat heart at 3 hr after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625877,,BAO_0000218,948.0,
13850,1,Biodistribution in rat heart at 60 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625878,,BAO_0000218,948.0,
13851,1,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625879,,BAO_0000218,10000000.0,
13852,1,Biodistribution in rat hippocampus at 240 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625880,,BAO_0000218,10000000.0,
13853,1,Biodistribution in rat hippocampus at 30 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625881,,BAO_0000218,10000000.0,
13854,1,Biodistribution in rat hippocampus at 360 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625882,,BAO_0000218,10000000.0,
13855,1,Biodistribution in rat hippocampus at 15 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625883,,BAO_0000218,10000000.0,
13856,1,Biodistribution in rat kidney at 120 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625884,,BAO_0000218,2113.0,
13857,1,Biodistribution in rat kidney at 1440 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625885,,BAO_0000218,2113.0,
13858,1,Biodistribution in rat kidney at 15 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628649,,BAO_0000218,2113.0,
13859,1,Biodistribution in rat kidney at 240 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628650,,BAO_0000218,2113.0,
13860,1,Biodistribution in rat kidney at 30 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628651,,BAO_0000218,2113.0,
13861,1,Biodistribution in rat kidney at 360 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628652,,BAO_0000218,2113.0,
13862,1,Biodistribution in rat kidney at 60 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628653,,BAO_0000218,2113.0,
13863,1,Biodistribution in rat liver at 120 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628654,,BAO_0000218,2107.0,
13864,1,Biodistribution in rat liver at 1440 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628655,,BAO_0000218,2107.0,
13865,1,Biodistribution in rat liver at 15 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625238,,BAO_0000218,2107.0,
13866,1,Biodistribution in rat liver at 240 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625239,,BAO_0000218,2107.0,
13867,1,Biodistribution in rat liver at 30 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625240,,BAO_0000218,2107.0,
13868,1,Biodistribution in rat liver at 360 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625241,,BAO_0000218,2107.0,
13869,1,Biodistribution in rat liver at 60 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625242,,BAO_0000218,2107.0,
13870,1,Biodistribution in rat lung at 120 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874587,,BAO_0000218,2048.0,
13871,1,Biodistribution in rat lung at 1440 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625405,,BAO_0000218,2048.0,
13872,1,Biodistribution in rat lung at 15 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625406,,BAO_0000218,2048.0,
13873,1,Biodistribution in rat lung at 240 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625407,,BAO_0000218,2048.0,
13874,1,Biodistribution in rat lung at 30 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625408,,BAO_0000218,2048.0,
13875,1,Biodistribution in rat lung at 360 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625409,,BAO_0000218,2048.0,
13876,1,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625410,,BAO_0000218,1515.0,
13877,1,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625411,,BAO_0000218,1515.0,
13878,1,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625412,,BAO_0000218,1515.0,
13879,1,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625413,,BAO_0000218,1515.0,
13880,1,Percent of maximal contractile response to compound in rat thoracic aorta strips v,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625414,,BAO_0000218,1515.0,
13881,1,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625415,,BAO_0000218,1515.0,
13882,1,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625416,,BAO_0000218,1515.0,
13883,1,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625417,,BAO_0000218,1088.0,
13884,1,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625418,,BAO_0000218,1988.0,
13885,1,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625419,,BAO_0000218,1088.0,
13886,1,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625420,,BAO_0000218,,
13887,1,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626996,,BAO_0000218,,
13888,1,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626997,,BAO_0000218,1988.0,
13889,1,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626998,,BAO_0000218,1088.0,
13890,1,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626999,,BAO_0000218,,
13891,1,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627000,,BAO_0000218,,
13892,1,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627001,,BAO_0000218,,
13893,1,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627002,,BAO_0000218,,
13894,1,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627003,,BAO_0000218,,
13895,1,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627004,,BAO_0000218,1088.0,
13896,1,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627005,,BAO_0000218,1088.0,
13897,1,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL874594,,BAO_0000218,1088.0,
13898,1,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627006,,BAO_0000218,1088.0,
13899,1,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627007,,BAO_0000218,1088.0,
13900,1,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627884,,BAO_0000218,1088.0,
13901,1,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627885,,BAO_0000218,1088.0,
13902,1,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627886,,BAO_0000218,1088.0,
13903,1,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627887,,BAO_0000218,1088.0,
13904,1,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627888,,BAO_0000218,1088.0,
13905,1,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL628057,,BAO_0000218,1088.0,
13906,1,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627405,,BAO_0000218,1088.0,
13907,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627406,,BAO_0000218,1088.0,
13908,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627407,,BAO_0000218,1088.0,
13909,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627408,,BAO_0000218,1088.0,
13910,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627409,,BAO_0000218,1088.0,
13911,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL875486,,BAO_0000218,1088.0,
13912,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627410,,BAO_0000218,1088.0,
13913,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627411,,BAO_0000218,1088.0,
13914,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627412,,BAO_0000218,1088.0,
13915,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627413,,BAO_0000218,1088.0,
13916,1,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627414,,BAO_0000218,1088.0,
13917,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627415,,BAO_0000218,1088.0,
13918,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627416,,BAO_0000218,1088.0,
13919,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627417,,BAO_0000218,1088.0,
13920,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627418,,BAO_0000218,1088.0,
13921,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627419,,BAO_0000218,1088.0,
13922,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627320,,BAO_0000218,1088.0,
13923,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627321,,BAO_0000218,1088.0,
13924,1,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627322,,BAO_0000218,2113.0,
13925,1,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627323,,BAO_0000218,2113.0,
13926,1,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627491,,BAO_0000218,2113.0,
13927,1,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627492,,BAO_0000218,2113.0,
13928,1,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627493,,BAO_0000218,2113.0,
13929,1,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627494,,BAO_0000218,2107.0,
13930,1,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627495,,BAO_0000218,2107.0,
13931,1,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627496,,BAO_0000218,2107.0,
13932,1,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627497,,BAO_0000218,2107.0,
13933,1,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627498,,BAO_0000218,2107.0,
13934,1,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627499,,BAO_0000218,2048.0,
13935,1,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627500,,BAO_0000218,2048.0,
13936,1,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627501,,BAO_0000218,2048.0,
13937,1,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625616,,BAO_0000218,2048.0,
13938,1,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625617,,BAO_0000218,2048.0,
13939,1,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625618,,BAO_0000218,2385.0,
13940,1,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625619,,BAO_0000218,2385.0,
13941,1,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625620,,BAO_0000218,2385.0,
13942,1,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625621,,BAO_0000218,2385.0,
13943,1,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625622,,BAO_0000218,2385.0,
13944,1,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625788,,BAO_0000218,2106.0,
13945,1,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625789,,BAO_0000218,2106.0,
13946,1,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625790,,BAO_0000218,2106.0,
13947,1,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625791,,BAO_0000218,2106.0,
13948,1,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622334,,BAO_0000218,2106.0,
13949,1,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622335,,BAO_0000218,2046.0,
13950,1,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622336,,BAO_0000218,2046.0,
13951,1,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622337,,BAO_0000218,2046.0,
13952,1,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622338,,BAO_0000218,2046.0,
13953,1,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622339,,BAO_0000218,2046.0,
13954,1,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624153,,BAO_0000218,,
13955,1,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628430,,BAO_0000218,,
13956,1,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628431,,BAO_0000218,,
13957,1,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628432,,BAO_0000218,,
13958,1,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628433,,BAO_0000218,,
13959,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628434,,BAO_0000218,2106.0,
13960,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626789,,BAO_0000218,2106.0,
13961,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626790,,BAO_0000218,2106.0,
13962,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626791,,BAO_0000218,2106.0,
13963,1,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626792,,BAO_0000218,2106.0,
13964,1,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626793,,BAO_0000218,2106.0,
13965,1,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627436,,BAO_0000218,,
13966,1,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627437,,BAO_0000218,,
13967,1,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627438,,BAO_0000218,,
13968,1,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627439,,BAO_0000218,,
13969,1,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627440,,BAO_0000218,,
13970,1,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627602,,BAO_0000218,,
13971,1,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627603,,BAO_0000218,,
13972,1,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627604,,BAO_0000218,,
13973,1,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627605,,BAO_0000218,,
13974,1,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627606,,BAO_0000218,,
13975,1,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627607,,BAO_0000218,,
13976,1,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627608,,BAO_0000218,,
13977,1,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627609,,BAO_0000218,,
13978,1,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627610,,BAO_0000218,,
13979,1,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627611,,BAO_0000218,,
13980,1,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627612,,BAO_0000218,,
13981,1,Octanol:water partition coefficient is evaluated,,0,22229,,U,Autocuration,,CHEMBL627613,,BAO_0000100,,
13982,1,Partition coefficient in 1-octanol/water system,,0,22224,,U,Autocuration,,CHEMBL627614,,BAO_0000100,,
13983,1,Partition coefficient in 1-octanol/water system measured using radio active compounds,,0,22224,,U,Autocuration,,CHEMBL627615,,BAO_0000100,,
13984,1,Partition coefficient in octanol/water system was determined,,0,22224,,U,Autocuration,,CHEMBL627616,,BAO_0000100,,
13985,1,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,,0,22224,,U,Autocuration,,CHEMBL627617,,BAO_0000100,,
13986,1,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,,0,22224,,U,Autocuration,,CHEMBL627618,,BAO_0000019,,
13987,1,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",,0,22224,,U,Autocuration,,CHEMBL627619,,BAO_0000019,,
13988,1,Pseudo-first-order rate constant of the compound,,0,22224,,U,Autocuration,,CHEMBL627620,,BAO_0000019,,
13989,1,Pseudo-first-order rate constant with 1-min time point,,0,22224,,U,Autocuration,,CHEMBL627621,,BAO_0000019,,
13990,1,Pseudo-first-order rate constant without 1-min time point,,0,22224,,U,Autocuration,,CHEMBL627622,,BAO_0000019,,
13991,1,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,,0,22224,,U,Autocuration,,CHEMBL627623,,BAO_0000019,,
13992,1,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,,0,22224,,U,Autocuration,,CHEMBL627624,,BAO_0000019,,
13993,1,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,,0,22224,,U,Autocuration,,CHEMBL627625,,BAO_0000019,,
13994,1,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,,0,22224,,U,Autocuration,,CHEMBL628523,,BAO_0000019,,
13995,1,The alkaline hydrolysis second order rate constant(K OH) of the compound,,0,22224,,U,Autocuration,,CHEMBL628524,,BAO_0000019,,
13996,1,The efflux rate constant of the compound,,0,22224,,U,Autocuration,,CHEMBL628525,,BAO_0000019,,
13997,1,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,0,22224,,U,Autocuration,,CHEMBL625732,,BAO_0000019,,
13998,1,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,0,22224,,U,Autocuration,,CHEMBL625733,,BAO_0000019,,
13999,1,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,,0,22224,,U,Autocuration,,CHEMBL625734,,BAO_0000019,,
14000,1,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,,0,22224,,U,Autocuration,,CHEMBL625913,,BAO_0000019,,
14001,1,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,,0,22224,,U,Autocuration,,CHEMBL625914,,BAO_0000019,,
14002,1,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,,0,22224,,U,Autocuration,,CHEMBL625915,,BAO_0000019,,
14003,1,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,,0,22224,,U,Autocuration,,CHEMBL625916,,BAO_0000019,,
14004,1,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),,0,22224,,U,Autocuration,,CHEMBL625917,,BAO_0000019,,
14005,1,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL625918,,BAO_0000019,,
14006,1,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL625919,,BAO_0000019,,
14007,1,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL625920,,BAO_0000019,,
14008,1,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL874453,,BAO_0000019,,
14009,1,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL625921,,BAO_0000019,,
14010,1,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,,0,22224,,U,Autocuration,,CHEMBL625922,,BAO_0000019,,
14011,1,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL625923,,BAO_0000019,,
14012,1,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL625924,,BAO_0000019,,
14013,1,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL625925,,BAO_0000019,,
14014,1,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL625926,,BAO_0000019,,
14015,1,Biodistribution in rat lung at 60 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627704,,BAO_0000218,2048.0,
14016,1,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627705,,BAO_0000218,,
14017,1,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627706,,BAO_0000218,,
14018,1,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627707,,BAO_0000218,,
14019,1,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627708,,BAO_0000218,,
14020,1,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628361,,BAO_0000218,,
14021,1,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628362,,BAO_0000218,,
14022,1,Biodistribution in rat striatum at 120 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628363,,BAO_0000218,2435.0,
14023,1,Biodistribution in rat striatum at 1440 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628364,,BAO_0000218,2435.0,
14024,1,Biodistribution in rat striatum at 15 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628365,,BAO_0000218,2435.0,
14025,1,Biodistribution in rat striatum at 240 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874454,,BAO_0000218,2435.0,
14026,1,Biodistribution in rat striatum at 30 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628531,,BAO_0000218,2435.0,
14027,1,Biodistribution in rat striatum at 360 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628532,,BAO_0000218,2435.0,
14028,1,Biodistribution in rat striatum at 3 hr after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628533,,BAO_0000218,2435.0,
14029,1,Biodistribution in rat striatum at 60 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628534,,BAO_0000218,2435.0,
14030,1,Biodistribution in rat thyroid at 120 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628535,,BAO_0000218,2046.0,
14031,1,Biodistribution in rat thyroid at 1440 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628536,,BAO_0000218,2046.0,
14032,1,Biodistribution in rat thyroid at 15 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628537,,BAO_0000218,2046.0,
14033,1,Biodistribution in rat thyroid at 240 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628538,,BAO_0000218,2046.0,
14034,1,Biodistribution in rat thyroid at 30 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628539,,BAO_0000218,2046.0,
14035,1,Biodistribution in rat thyroid at 360 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630297,,BAO_0000218,2046.0,
14036,1,Biodistribution in rat thyroid at 60 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630298,,BAO_0000218,2046.0,
14037,1,Biodistribution in rest of brain of rat 120 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630299,,BAO_0000218,955.0,
14038,1,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628094,,BAO_0000218,955.0,
14039,1,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628095,,BAO_0000218,955.0,
14040,1,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874648,,BAO_0000218,955.0,
14041,1,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628096,,BAO_0000218,955.0,
14042,1,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628097,,BAO_0000218,955.0,
14043,1,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628098,,BAO_0000218,955.0,
14044,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",,0,22224,,U,Autocuration,,CHEMBL628099,,BAO_0000019,,
14045,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,0,22224,,U,Autocuration,,CHEMBL628100,,BAO_0000019,,
14046,1,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),,0,22224,,U,Autocuration,,CHEMBL628101,,BAO_0000019,,
14047,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",,0,22224,,U,Autocuration,,CHEMBL628102,,BAO_0000019,,
14048,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",,0,22224,,U,Autocuration,,CHEMBL628103,,BAO_0000019,,
14049,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",,0,22224,,U,Autocuration,,CHEMBL628104,,BAO_0000019,,
14050,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",,0,22224,,U,Autocuration,,CHEMBL628105,,BAO_0000019,,
14051,1,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",,0,22224,,U,Autocuration,,CHEMBL628106,,BAO_0000019,,
14052,1,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628107,,BAO_0000218,1088.0,
14053,1,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,,0,22224,,U,Autocuration,,CHEMBL628108,,BAO_0000218,1088.0,
14054,1,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628109,,BAO_0000218,1088.0,
14055,1,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,,0,22224,,U,Autocuration,,CHEMBL625299,,BAO_0000218,1088.0,
14056,1,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625300,,BAO_0000218,1088.0,
14057,1,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625301,,BAO_0000218,1088.0,
14058,1,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625302,,BAO_0000218,1088.0,
14059,1,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874649,,BAO_0000218,1088.0,
14060,1,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625303,,BAO_0000218,,
14061,1,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625463,,BAO_0000218,,
14062,1,In vitro metabolism in human liver microsomes,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL625464,,BAO_0000218,2107.0,
14063,1,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL625465,,BAO_0000218,,
14064,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625466,,BAO_0000218,1088.0,
14065,1,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625467,,BAO_0000218,1088.0,
14066,1,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625468,,BAO_0000218,1088.0,
14067,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625469,,BAO_0000218,1088.0,
14068,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625470,,BAO_0000218,1088.0,
14069,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632418,,BAO_0000218,1088.0,
14070,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627250,,BAO_0000218,1088.0,
14071,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627251,,BAO_0000218,1088.0,
14072,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627252,,BAO_0000218,1088.0,
14073,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627253,,BAO_0000218,1088.0,
14074,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627254,,BAO_0000218,1088.0,
14075,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875471,,BAO_0000218,1088.0,
14076,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627255,,BAO_0000218,1088.0,
14077,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627256,,BAO_0000218,1088.0,
14078,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627257,,BAO_0000218,1088.0,
14079,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627258,,BAO_0000218,1088.0,
14080,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627259,,BAO_0000218,1088.0,
14081,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627260,,BAO_0000218,1088.0,
14082,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623256,,BAO_0000218,1088.0,
14083,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874413,,BAO_0000218,1088.0,
14084,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623257,,BAO_0000218,1088.0,
14085,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623258,,BAO_0000218,1088.0,
14086,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623259,,BAO_0000218,1088.0,
14087,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623260,,BAO_0000218,1088.0,
14088,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623261,,BAO_0000218,1088.0,
14089,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623262,,BAO_0000218,1088.0,
14090,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623263,,BAO_0000218,1088.0,
14091,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623264,,BAO_0000218,1088.0,
14092,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623265,,BAO_0000218,1088.0,
14093,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623266,,BAO_0000218,1088.0,
14094,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623267,,BAO_0000218,1088.0,
14095,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623268,,BAO_0000218,1088.0,
14096,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623269,,BAO_0000218,1088.0,
14097,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623270,,BAO_0000218,1088.0,
14098,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623271,,BAO_0000218,1088.0,
14099,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623272,,BAO_0000218,1088.0,
14100,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623273,,BAO_0000218,1088.0,
14101,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623274,,BAO_0000218,1088.0,
14102,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874414,,BAO_0000218,1088.0,
14103,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623275,,BAO_0000218,1088.0,
14104,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629150,,BAO_0000218,1088.0,
14105,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623276,,BAO_0000218,1088.0,
14106,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623277,,BAO_0000218,1088.0,
14107,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623112,,BAO_0000218,1088.0,
14108,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623113,,BAO_0000218,1088.0,
14109,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623800,,BAO_0000218,1088.0,
14110,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623801,,BAO_0000218,1088.0,
14111,1,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623802,,BAO_0000218,2106.0,
14112,1,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623803,,BAO_0000218,995.0,
14113,1,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623970,,BAO_0000218,995.0,
14114,1,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623971,,BAO_0000218,995.0,
14115,1,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623972,,BAO_0000218,178.0,
14116,1,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623973,,BAO_0000218,178.0,
14117,1,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623974,,BAO_0000218,178.0,
14118,1,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623975,,BAO_0000218,178.0,
14119,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623976,,BAO_0000218,955.0,
14120,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623977,,BAO_0000218,955.0,
14121,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623978,,BAO_0000218,955.0,
14122,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623979,,BAO_0000218,955.0,
14123,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623980,,BAO_0000218,,
14124,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623981,,BAO_0000218,,
14125,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626278,,BAO_0000218,,
14126,1,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626279,,BAO_0000218,,
14127,1,Biodistribution in mice bladder plus excreted urine was determined,Mus musculus,1,50594,,N,Intermediate,,CHEMBL626280,,BAO_0000218,,
14128,1,"Percentage biodistribution in mouse blood, 10 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626281,,BAO_0000218,,
14129,1,"Percentage biodistribution in mouse blood, 30 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626282,,BAO_0000218,,
14130,1,"Percentage biodistribution in mouse blood, 5 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626283,,BAO_0000218,,
14131,1,"Percentage biodistribution in mouse blood, 60 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626284,,BAO_0000218,,
14132,1,"Percentage biodistribution in mouse brain, 10 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626285,,BAO_0000218,955.0,
14133,1,"Percentage biodistribution in mouse brain, 30 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626286,,BAO_0000218,955.0,
14134,1,"Percentage biodistribution in mouse brain, 5 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626287,,BAO_0000218,955.0,
14135,1,"Percentage biodistribution in mouse brain, 60 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626288,,BAO_0000218,955.0,
14136,1,"Percentage biodistribution in mouse heart, 10 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626289,,BAO_0000218,,
14137,1,"Percentage biodistribution in mouse heart, 30 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626290,,BAO_0000218,,
14138,1,"Percentage biodistribution in mouse heart, 5 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626291,,BAO_0000218,,
14139,1,"Percentage biodistribution in mouse heart, 60 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL839888,,BAO_0000218,,
14140,1,"Percentage biodistribution in mouse intestine, 10 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626292,,BAO_0000218,160.0,
14141,1,"Percentage biodistribution in mouse intestine, 30 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626293,,BAO_0000218,160.0,
14142,1,"Percentage biodistribution in mouse intestine, 5 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626294,,BAO_0000218,160.0,
14143,1,"Percentage biodistribution in mouse intestine, 60 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL626295,,BAO_0000218,160.0,
14144,1,"Percentage biodistribution in mouse liver, 10 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL627659,,BAO_0000218,2107.0,
14145,1,"Percentage biodistribution in mouse liver, 30 minutes of post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL627660,,BAO_0000218,2107.0,
14146,1,"Percentage biodistribution in mouse liver, 5 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL627661,,BAO_0000218,2107.0,
14147,1,Biodistribution in mice liver at 60 minutes of post injection,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627662,,BAO_0000218,2107.0,
14148,1,Biodistribution in mice lungs at 10 min of post injection,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627663,,BAO_0000218,2048.0,
14149,1,"Percentage biodistribution in mouse lung, 30 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL627664,,BAO_0000218,,
14150,1,"Percentage biodistribution in mousee lung, 5 minutes post injection",Mus musculus,1,50594,,N,Intermediate,,CHEMBL627665,,BAO_0000218,,
14151,1,Biodistribution in mice lungs at 60 min of post injection,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627666,,BAO_0000218,2048.0,
14152,1,Percentage biodistribution in mouse spleen,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627667,,BAO_0000218,2106.0,
14153,1,Percentage biodistribution in mouse stomach,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627668,,BAO_0000218,945.0,
14154,1,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,Mus musculus,1,50594,,N,Intermediate,,CHEMBL627669,,BAO_0000218,1088.0,
14155,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,,0,22224,,U,Autocuration,,CHEMBL627670,,BAO_0000218,1255.0,
14156,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,,0,22224,,U,Autocuration,,CHEMBL627671,,BAO_0000218,178.0,
14157,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,,0,22224,,U,Autocuration,,CHEMBL627672,,BAO_0000218,1474.0,
14158,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,,0,22224,,U,Autocuration,,CHEMBL627673,,BAO_0000218,,
14159,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,,0,22224,,U,Autocuration,,CHEMBL627674,,BAO_0000218,2113.0,
14160,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,,0,22224,,U,Autocuration,,CHEMBL627675,,BAO_0000218,2107.0,
14161,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,,0,22224,,U,Autocuration,,CHEMBL627676,,BAO_0000218,2048.0,
14162,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,,0,22224,,U,Autocuration,,CHEMBL627677,,BAO_0000218,2385.0,
14163,1,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL627678,,BAO_0000019,,
14164,1,Affinity for protein binding expressed as association constant in fresh rat serum,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627679,,BAO_0000218,1977.0,
14165,1,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,0,22224,,U,Autocuration,,CHEMBL627680,,BAO_0000019,,
14166,1,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,0,22224,,U,Autocuration,,CHEMBL627681,,BAO_0000019,,
14167,1,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,,0,22224,,U,Autocuration,,CHEMBL627682,,BAO_0000019,,
14168,1,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,,0,22224,,U,Autocuration,,CHEMBL627683,,BAO_0000019,,
14169,1,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,,0,22224,,U,Autocuration,,CHEMBL627684,,BAO_0000019,,
14170,1,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,0,22224,,U,Autocuration,,CHEMBL874441,,BAO_0000019,,
14171,1,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,,0,22224,,U,Autocuration,,CHEMBL627685,,BAO_0000019,,
14172,1,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",,0,22224,,U,Autocuration,,CHEMBL627686,,BAO_0000019,,
14173,1,Apparent rate constant Koff for inactivation of dTMP synthase.,,0,22224,,U,Autocuration,,CHEMBL627687,,BAO_0000019,,
14174,1,The irreversible inhibitor activity by second order rate equation.,,0,22224,,U,Autocuration,,CHEMBL627688,,BAO_0000019,,
14175,1,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628038,,BAO_0000218,,
14176,1,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628039,,BAO_0000218,,
14177,1,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628040,,BAO_0000218,,
14178,1,Dissociation rate calculated from the first-order equation using t1/2 value,,0,22224,,U,Autocuration,,CHEMBL628041,,BAO_0000019,,
14179,1,The compound was tested for Binding constant against DNA,,0,22224,,U,Autocuration,,CHEMBL630226,,BAO_0000019,,
14180,1,First order rate constant for cyclization of the compound,,0,22224,,U,Autocuration,,CHEMBL628042,,BAO_0000019,,
14181,1,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,0,22224,,U,Autocuration,,CHEMBL625232,,BAO_0000019,,
14182,1,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,0,22224,,U,Autocuration,,CHEMBL625233,,BAO_0000019,,
14183,1,Hydrolysis rate constant was determined,,0,22224,,U,Autocuration,,CHEMBL625979,,BAO_0000019,,
14184,1,Observed first order rate constant,,0,22224,,U,Autocuration,,CHEMBL625980,,BAO_0000019,,
14185,1,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,0,22224,,U,Autocuration,,CHEMBL625981,,BAO_0000019,,
14186,1,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,0,22224,,U,Autocuration,,CHEMBL625982,,BAO_0000019,,
14187,1,Second-order rate constant for attack on PNPA at 25 degree Centigrade,,0,22224,,U,Autocuration,,CHEMBL625983,,BAO_0000019,,
14188,1,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL625984,,BAO_0000019,,
14189,1,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL625985,,BAO_0000019,,
14190,1,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL625986,,BAO_0000019,,
14191,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL625987,,BAO_0000019,,
14192,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL625988,,BAO_0000019,,
14193,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL625989,,BAO_0000019,,
14194,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL625990,,BAO_0000019,,
14195,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL625991,,BAO_0000019,,
14196,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL625992,,BAO_0000019,,
14197,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL625993,,BAO_0000019,,
14198,1,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL631973,,BAO_0000019,,
14199,1,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL632143,,BAO_0000019,,
14200,1,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL632144,,BAO_0000019,,
14201,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL632145,,BAO_0000019,,
14202,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL632146,,BAO_0000019,,
14203,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL632147,,BAO_0000019,,
14204,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL632148,,BAO_0000019,,
14205,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL632149,,BAO_0000019,,
14206,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL632150,,BAO_0000019,,
14207,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL632151,,BAO_0000019,,
14208,1,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL632152,,BAO_0000218,,
14209,1,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL632153,,BAO_0000218,,
14210,1,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL632154,,BAO_0000218,,
14211,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL632155,,BAO_0000218,,
14212,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL632156,,BAO_0000218,,
14213,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL632157,,BAO_0000218,,
14214,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL632158,,BAO_0000218,,
14215,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL632159,,BAO_0000218,,
14216,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL626305,,BAO_0000218,,
14217,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL626306,,BAO_0000218,,
14218,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL626307,,BAO_0000218,,
14219,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL626308,,BAO_0000218,,
14220,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL626479,,BAO_0000218,,
14221,1,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,Human herpesvirus 1,1,50602,,N,Intermediate,,CHEMBL626480,,BAO_0000218,,
14222,1,Calculated partition coefficient (clogP) (MlogP),,0,22229,,U,Autocuration,,CHEMBL626481,,BAO_0000100,,
14223,1,Equipotent potent ratio relative to carbachol (nicotinic activity),,0,22224,,U,Autocuration,,CHEMBL626482,,BAO_0000019,,
14224,1,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626483,,BAO_0000218,,
14225,1,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626484,,BAO_0000218,,
14226,1,Solubility at pH 7.4 in micro g/mL;NA denotes available,,0,22229,,U,Autocuration,,CHEMBL626485,,BAO_0000100,,
14227,1,Solubility at pH 7.4 in micro g/mL;NA denotes not available,,0,22229,,U,Autocuration,,CHEMBL626486,,BAO_0000100,,
14228,1,Solubility at pH 7.4 in ug/mL;NA denotes not available,,0,22229,,U,Autocuration,,CHEMBL626487,,BAO_0000100,,
14229,1,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL626488,,BAO_0000218,1969.0,
14230,1,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626489,,BAO_0000218,1977.0,
14231,1,Area under the MAP curve measured over 5 min; ND means Not determined,,0,22224,,U,Autocuration,,CHEMBL626490,,BAO_0000019,,
14232,1,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,,0,22224,,U,Autocuration,,CHEMBL626491,,BAO_0000100,,
14233,1,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,,0,22229,,U,Autocuration,,CHEMBL626492,,BAO_0000100,,
14234,1,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,,0,22224,,U,Autocuration,,CHEMBL626493,,BAO_0000019,,
14235,1,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626494,,BAO_0000218,,
14236,1,Half life after oral tested,,0,22224,,U,Autocuration,,CHEMBL626495,,BAO_0000218,,
14237,1,Half life was determined in plasma of rat; NT indicates not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626496,,BAO_0000218,1969.0,
14238,1,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626497,,BAO_0000218,,
14239,1,Oral bioavailability after oral tested,,0,22224,,U,Autocuration,,CHEMBL626498,,BAO_0000218,,
14240,1,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626499,,BAO_0000218,,
14241,1,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626500,,BAO_0000218,,
14242,1,half life was determined in plasma of rat; NT indicates not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626501,,BAO_0000218,1969.0,
14243,1,half life was determined in plasma of rat; NT means not tested,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626502,,BAO_0000218,1969.0,
14244,1,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626503,,BAO_0000218,,
14245,1,Mean sodium excretion in rats (Control/Drug treatment value); inactive,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626504,,BAO_0000218,,
14246,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626505,,BAO_0000218,,
14247,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626506,,BAO_0000218,,
14248,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626507,,BAO_0000218,,
14249,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626508,,BAO_0000218,,
14250,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626509,,BAO_0000218,,
14251,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875480,,BAO_0000218,,
14252,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626510,,BAO_0000218,,
14253,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626511,,BAO_0000218,,
14254,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626512,,BAO_0000218,,
14255,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628208,,BAO_0000218,,
14256,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628209,,BAO_0000218,,
14257,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628210,,BAO_0000218,,
14258,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628211,,BAO_0000218,,
14259,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628212,,BAO_0000218,,
14260,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628213,,BAO_0000218,,
14261,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628214,,BAO_0000218,1088.0,
14262,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628215,,BAO_0000218,1088.0,
14263,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628216,,BAO_0000218,1088.0,
14264,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626595,,BAO_0000218,1088.0,
14265,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626596,,BAO_0000218,1088.0,
14266,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626597,,BAO_0000218,1088.0,
14267,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626598,,BAO_0000218,1088.0,
14268,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622242,,BAO_0000218,1088.0,
14269,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622243,,BAO_0000218,1088.0,
14270,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622244,,BAO_0000218,1088.0,
14271,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622245,,BAO_0000218,1088.0,
14272,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622246,,BAO_0000218,1088.0,
14273,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622247,,BAO_0000218,1088.0,
14274,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622248,,BAO_0000218,1088.0,
14275,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877483,,BAO_0000218,1088.0,
14276,1,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL622249,,BAO_0000218,1088.0,
14277,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622250,,BAO_0000218,1088.0,
14278,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622251,,BAO_0000218,1088.0,
14279,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622252,,BAO_0000218,1088.0,
14280,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622253,,BAO_0000218,1088.0,
14281,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622254,,BAO_0000218,1088.0,
14282,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622255,,BAO_0000218,1088.0,
14283,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622256,,BAO_0000218,1088.0,
14284,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622257,,BAO_0000218,1088.0,
14285,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622258,,BAO_0000218,1088.0,
14286,1,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622259,,BAO_0000218,1088.0,
14287,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622927,,BAO_0000218,1088.0,
14288,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622928,,BAO_0000218,1088.0,
14289,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL622929,,BAO_0000218,1088.0,
14290,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623182,,BAO_0000218,1088.0,
14291,1,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL623183,,BAO_0000218,1088.0,
14292,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623184,,BAO_0000218,1088.0,
14293,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623185,,BAO_0000218,1088.0,
14294,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877484,,BAO_0000218,1088.0,
14295,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627274,,BAO_0000218,1088.0,
14296,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623186,,BAO_0000218,1088.0,
14297,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623187,,BAO_0000218,1088.0,
14298,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL623188,,BAO_0000218,1088.0,
14299,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628055,,BAO_0000218,1088.0,
14300,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628056,,BAO_0000218,1088.0,
14301,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628200,,BAO_0000218,1088.0,
14302,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628201,,BAO_0000218,1088.0,
14303,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628202,,BAO_0000218,1088.0,
14304,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628203,,BAO_0000218,1088.0,
14305,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628204,,BAO_0000218,1088.0,
14306,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628205,,BAO_0000218,1088.0,
14307,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628206,,BAO_0000218,1088.0,
14308,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),,0,22224,,U,Autocuration,,CHEMBL628207,,BAO_0000218,2367.0,
14309,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,,0,22224,,U,Autocuration,,CHEMBL627220,,BAO_0000218,2367.0,
14310,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,,0,22224,,U,Autocuration,,CHEMBL627221,,BAO_0000218,2385.0,
14311,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),,0,22224,,U,Autocuration,,CHEMBL627222,,BAO_0000218,2367.0,
14312,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,,0,22224,,U,Autocuration,,CHEMBL627223,,BAO_0000218,,
14313,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,,0,22224,,U,Autocuration,,CHEMBL632062,,BAO_0000218,2385.0,
14314,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,,0,22224,,U,Autocuration,,CHEMBL632063,,BAO_0000218,2106.0,
14315,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,,0,22224,,U,Autocuration,,CHEMBL632064,,BAO_0000218,1255.0,
14316,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,,0,22224,,U,Autocuration,,CHEMBL632065,,BAO_0000218,178.0,
14317,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,,0,22224,,U,Autocuration,,CHEMBL632066,,BAO_0000218,1474.0,
14318,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,,0,22224,,U,Autocuration,,CHEMBL632067,,BAO_0000218,,
14319,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,,0,22224,,U,Autocuration,,CHEMBL629188,,BAO_0000218,2113.0,
14320,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,,0,22224,,U,Autocuration,,CHEMBL629189,,BAO_0000218,2107.0,
14321,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,,0,22224,,U,Autocuration,,CHEMBL629190,,BAO_0000218,2048.0,
14322,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,,0,22224,,U,Autocuration,,CHEMBL629191,,BAO_0000218,2385.0,
14323,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),,0,22224,,U,Autocuration,,CHEMBL629192,,BAO_0000218,2367.0,
14324,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,,0,22224,,U,Autocuration,,CHEMBL629193,,BAO_0000218,2385.0,
14325,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),,0,22224,,U,Autocuration,,CHEMBL629194,,BAO_0000218,2367.0,
14326,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,,0,22224,,U,Autocuration,,CHEMBL629195,,BAO_0000218,,
14327,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,,0,22224,,U,Autocuration,,CHEMBL629373,,BAO_0000218,2385.0,
14328,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,,0,22224,,U,Autocuration,,CHEMBL629374,,BAO_0000218,2106.0,
14329,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,,0,22224,,U,Autocuration,,CHEMBL629375,,BAO_0000218,2367.0,
14330,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,,0,22224,,U,Autocuration,,CHEMBL629376,,BAO_0000218,1255.0,
14331,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,,0,22224,,U,Autocuration,,CHEMBL629377,,BAO_0000218,178.0,
14332,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,,0,22224,,U,Autocuration,,CHEMBL629378,,BAO_0000218,1474.0,
14333,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,,0,22224,,U,Autocuration,,CHEMBL629379,,BAO_0000218,,
14334,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,,0,22224,,U,Autocuration,,CHEMBL629151,,BAO_0000218,2113.0,
14335,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,,0,22224,,U,Autocuration,,CHEMBL629152,,BAO_0000218,2107.0,
14336,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,,0,22224,,U,Autocuration,,CHEMBL629153,,BAO_0000218,2048.0,
14337,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,,0,22224,,U,Autocuration,,CHEMBL629154,,BAO_0000218,2385.0,
14338,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),,0,22224,,U,Autocuration,,CHEMBL629155,,BAO_0000218,2367.0,
14339,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,,0,22224,,U,Autocuration,,CHEMBL629156,,BAO_0000218,2367.0,
14340,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,,0,22224,,U,Autocuration,,CHEMBL629157,,BAO_0000218,2385.0,
14341,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),,0,22224,,U,Autocuration,,CHEMBL629158,,BAO_0000218,2367.0,
14342,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,,0,22224,,U,Autocuration,,CHEMBL629159,,BAO_0000218,,
14343,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,,0,22224,,U,Autocuration,,CHEMBL629160,,BAO_0000218,2385.0,
14344,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,,0,22224,,U,Autocuration,,CHEMBL629161,,BAO_0000218,2106.0,
14345,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,,0,22224,,U,Autocuration,,CHEMBL629162,,BAO_0000218,1255.0,
14346,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,,0,22224,,U,Autocuration,,CHEMBL629163,,BAO_0000218,178.0,
14347,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,,0,22224,,U,Autocuration,,CHEMBL629164,,BAO_0000218,1474.0,
14348,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,,0,22224,,U,Autocuration,,CHEMBL629165,,BAO_0000218,,
14349,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,,0,22224,,U,Autocuration,,CHEMBL629166,,BAO_0000218,2107.0,
14350,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,,0,22224,,U,Autocuration,,CHEMBL629167,,BAO_0000218,2048.0,
14351,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,,0,22224,,U,Autocuration,,CHEMBL629168,,BAO_0000218,2385.0,
14352,1,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,,0,22224,,U,Autocuration,,CHEMBL629169,,BAO_0000019,,
14353,1,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,,0,22224,,U,Autocuration,,CHEMBL629170,,BAO_0000019,,
14354,1,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,,0,22224,,U,Autocuration,,CHEMBL631153,,BAO_0000019,,
14355,1,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,,0,22224,,U,Autocuration,,CHEMBL875121,,BAO_0000019,,
14356,1,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,,0,22224,,U,Autocuration,,CHEMBL631154,,BAO_0000019,,
14357,1,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,,0,22224,,U,Autocuration,,CHEMBL631155,,BAO_0000019,,
14358,1,Hydrolysis rate constant was determined,,0,22224,,U,Autocuration,,CHEMBL631156,,BAO_0000019,,
14359,1,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",,0,22224,,U,Autocuration,,CHEMBL631157,,BAO_0000019,,
14360,1,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,0,22224,,U,Autocuration,,CHEMBL631158,,BAO_0000019,,
14361,1,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,0,22224,,U,Autocuration,,CHEMBL631159,,BAO_0000019,,
14362,1,Observed second order rate constant,,0,22224,,U,Autocuration,,CHEMBL631160,,BAO_0000019,,
14363,1,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,,0,22224,,U,Autocuration,,CHEMBL631161,,BAO_0000019,,
14364,1,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,,0,22224,,U,Autocuration,,CHEMBL631162,,BAO_0000019,,
14365,1,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,,0,22224,,U,Autocuration,,CHEMBL630313,,BAO_0000019,,
14366,1,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",,0,22224,,U,Autocuration,,CHEMBL630314,,BAO_0000019,,
14367,1,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",,0,22224,,U,Autocuration,,CHEMBL630315,,BAO_0000019,,
14368,1,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL630316,,BAO_0000019,,
14369,1,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL630986,,BAO_0000019,,
14370,1,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL630987,,BAO_0000019,,
14371,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL630988,,BAO_0000019,,
14372,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL630989,,BAO_0000019,,
14373,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL630990,,BAO_0000019,,
14374,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL630991,,BAO_0000019,,
14375,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL630992,,BAO_0000019,,
14376,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL630993,,BAO_0000019,,
14377,1,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,,0,22224,,U,Autocuration,,CHEMBL630994,,BAO_0000019,,
14378,1,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630995,,BAO_0000218,,
14379,1,Association constant for compound at 31 degree C was determined,,0,22224,,U,Autocuration,,CHEMBL629252,,BAO_0000019,,
14380,1,Calculated antagonist equilibrium dissociation constant of the compound,,0,22224,,U,Autocuration,,CHEMBL629253,,BAO_0000019,,
14381,1,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,,0,22224,,U,Autocuration,,CHEMBL629944,,BAO_0000019,,
14382,1,Dissociation constants vs LTE4 on guinea pig trachea,Cavia porcellus,1,50512,,N,Intermediate,,CHEMBL629945,,BAO_0000218,3126.0,
14383,1,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",,0,22224,,U,Autocuration,,CHEMBL629946,,BAO_0000019,,
14384,1,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",,0,22224,,U,Autocuration,,CHEMBL629947,,BAO_0000019,,
14385,1,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",,0,22224,,U,Autocuration,,CHEMBL629948,,BAO_0000019,,
14386,1,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",,0,22224,,U,Autocuration,,CHEMBL856024,,BAO_0000019,,
14387,1,Affinity constant KD value was derived from TMP,,0,22224,,U,Autocuration,,CHEMBL629949,,BAO_0000019,,
14388,1,Apparent dissociation (binding) rate constant was evaluated,,0,22224,,U,Autocuration,,CHEMBL629950,,BAO_0000019,,
14389,1,Dissociation constant (KD) of the compound,,0,22224,,U,Autocuration,,CHEMBL630127,,BAO_0000100,,
14390,1,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,,0,22224,,U,Autocuration,,CHEMBL630128,,BAO_0000100,,
14391,1,Dissociation constant from ESR titration experiments,,0,22224,,U,Autocuration,,CHEMBL630129,,BAO_0000100,,
14392,1,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),,0,22224,,U,Autocuration,,CHEMBL630130,,BAO_0000019,,
14393,1,Dissociation constant was evaluated.,,0,22224,,U,Autocuration,,CHEMBL875234,,BAO_0000100,,
14394,1,Dissociation constant was reported,,0,22224,,U,Autocuration,,CHEMBL630131,,BAO_0000100,,
14395,1,Dissociation constant was determined in rat pituitary cells.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630132,,BAO_0000218,,
14396,1,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,,0,22224,,U,Autocuration,,CHEMBL630133,,BAO_0000019,,
14397,1,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,,0,22224,,U,Autocuration,,CHEMBL630134,,BAO_0000019,,
14398,1,Equilibrium dissociation constant of the compound,,0,22224,,U,Autocuration,,CHEMBL630135,,BAO_0000019,,
14399,1,Equilibrium dissociation constant was determined,,0,22224,,U,Autocuration,,CHEMBL630136,,BAO_0000019,,
14400,1,Kinetic constant KD was evaluated,,0,22224,,U,Autocuration,,CHEMBL630137,,BAO_0000019,,
14401,1,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,,0,22224,,U,Autocuration,,CHEMBL630138,,BAO_0000019,,
14402,1,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,,0,22224,,U,Autocuration,,CHEMBL630139,,BAO_0000019,,
14403,1,Rate constant for hydrolysis in aqueous acetone.,,0,22224,,U,Autocuration,,CHEMBL630140,,BAO_0000019,,
14404,1,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,,0,22224,,U,Autocuration,,CHEMBL875235,,BAO_0000019,,
14405,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876439,,BAO_0000218,,
14406,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630605,,BAO_0000218,,
14407,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630606,,BAO_0000218,,
14408,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630607,,BAO_0000218,,
14409,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630608,,BAO_0000218,,
14410,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630609,,BAO_0000218,,
14411,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630610,,BAO_0000218,,
14412,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630611,,BAO_0000218,,
14413,1,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629552,,BAO_0000218,,
14414,1,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629733,,BAO_0000218,,
14415,1,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629734,,BAO_0000218,,
14416,1,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629735,,BAO_0000218,,
14417,1,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629736,,BAO_0000218,,
14418,1,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629737,,BAO_0000218,,
14419,1,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629738,,BAO_0000218,,
14420,1,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629739,,BAO_0000218,,
14421,1,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629740,,BAO_0000218,,
14422,1,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629741,,BAO_0000218,,
14423,1,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629742,,BAO_0000218,,
14424,1,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629743,,BAO_0000218,,
14425,1,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629744,,BAO_0000218,,
14426,1,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629745,,BAO_0000218,,
14427,1,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629746,,BAO_0000218,,
14428,1,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629747,,BAO_0000218,,
14429,1,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629748,,BAO_0000218,,
14430,1,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629749,,BAO_0000218,,
14431,1,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629750,,BAO_0000218,,
14432,1,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629751,,BAO_0000218,,
14433,1,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629752,,BAO_0000218,,
14434,1,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629753,,BAO_0000218,,
14435,1,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629754,,BAO_0000218,,
14436,1,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629755,,BAO_0000218,,
14437,1,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629756,,BAO_0000218,,
14438,1,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629757,,BAO_0000218,,
14439,1,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629758,,BAO_0000218,,
14440,1,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629759,,BAO_0000218,,
14441,1,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629760,,BAO_0000218,,
14442,1,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876443,,BAO_0000218,,
14443,1,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629761,,BAO_0000218,,
14444,1,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629762,,BAO_0000218,,
14445,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629763,,BAO_0000218,,
14446,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629764,,BAO_0000218,,
14447,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629765,,BAO_0000218,,
14448,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629766,,BAO_0000218,,
14449,1,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629767,,BAO_0000218,,
14450,1,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629768,,BAO_0000218,,
14451,1,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629769,,BAO_0000218,,
14452,1,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629770,,BAO_0000218,,
14453,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL629771,,BAO_0000218,,
14454,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629772,,BAO_0000218,,
14455,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,Mus musculus,1,50594,,N,Intermediate,,CHEMBL629773,,BAO_0000218,,
14456,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625455,,BAO_0000218,,
14457,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625456,,BAO_0000218,,
14458,1,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,Mus musculus,1,50594,,N,Intermediate,,CHEMBL625457,,BAO_0000218,,
14459,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625458,,BAO_0000218,1088.0,
14460,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625459,,BAO_0000218,1088.0,
14461,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875483,,BAO_0000218,1088.0,
14462,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL634779,,BAO_0000218,1088.0,
14463,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625460,,BAO_0000218,1088.0,
14464,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626117,,BAO_0000218,1088.0,
14465,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626118,,BAO_0000218,1088.0,
14466,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628342,,BAO_0000218,1088.0,
14467,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628343,,BAO_0000218,1088.0,
14468,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628344,,BAO_0000218,1088.0,
14469,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628345,,BAO_0000218,1088.0,
14470,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628346,,BAO_0000218,1088.0,
14471,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628347,,BAO_0000218,1088.0,
14472,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628348,,BAO_0000218,1088.0,
14473,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628349,,BAO_0000218,1088.0,
14474,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875611,,BAO_0000218,1088.0,
14475,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628350,,BAO_0000218,1088.0,
14476,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628351,,BAO_0000218,1088.0,
14477,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628352,,BAO_0000218,1088.0,
14478,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628353,,BAO_0000218,1088.0,
14479,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628354,,BAO_0000218,1088.0,
14480,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626667,,BAO_0000218,1088.0,
14481,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626668,,BAO_0000218,1088.0,
14482,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626669,,BAO_0000218,1088.0,
14483,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626670,,BAO_0000218,1088.0,
14484,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626671,,BAO_0000218,1088.0,
14485,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626672,,BAO_0000218,1088.0,
14486,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626673,,BAO_0000218,1088.0,
14487,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626674,,BAO_0000218,1088.0,
14488,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626675,,BAO_0000218,1088.0,
14489,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626676,,BAO_0000218,1088.0,
14490,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626677,,BAO_0000218,1088.0,
14491,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626678,,BAO_0000218,1088.0,
14492,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626679,,BAO_0000218,1088.0,
14493,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875612,,BAO_0000218,1088.0,
14494,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626680,,BAO_0000218,1088.0,
14495,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626681,,BAO_0000218,1088.0,
14496,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626682,,BAO_0000218,1088.0,
14497,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626683,,BAO_0000218,1088.0,
14498,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626684,,BAO_0000218,1088.0,
14499,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626685,,BAO_0000218,1088.0,
14500,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626686,,BAO_0000218,1088.0,
14501,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626687,,BAO_0000218,1088.0,
14502,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624978,,BAO_0000218,1088.0,
14503,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624979,,BAO_0000218,1088.0,
14504,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624980,,BAO_0000218,1088.0,
14505,1,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL624981,,BAO_0000218,1088.0,
14506,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL624982,,BAO_0000218,1088.0,
14507,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),,0,22224,,U,Autocuration,,CHEMBL627564,,BAO_0000218,2367.0,
14508,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),,0,22224,,U,Autocuration,,CHEMBL627565,,BAO_0000218,2367.0,
14509,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,,0,22224,,U,Autocuration,,CHEMBL627566,,BAO_0000218,,
14510,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,,0,22224,,U,Autocuration,,CHEMBL627567,,BAO_0000218,2385.0,
14511,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,,0,22224,,U,Autocuration,,CHEMBL627568,,BAO_0000218,2106.0,
14512,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,,0,22224,,U,Autocuration,,CHEMBL627569,,BAO_0000218,2113.0,
14513,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,,0,22224,,U,Autocuration,,CHEMBL627570,,BAO_0000218,1255.0,
14514,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,,0,22224,,U,Autocuration,,CHEMBL627571,,BAO_0000218,178.0,
14515,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,,0,22224,,U,Autocuration,,CHEMBL627572,,BAO_0000218,1474.0,
14516,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,,0,22224,,U,Autocuration,,CHEMBL627573,,BAO_0000218,,
14517,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,,0,22224,,U,Autocuration,,CHEMBL627574,,BAO_0000218,2113.0,
14518,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,,0,22224,,U,Autocuration,,CHEMBL627575,,BAO_0000218,2107.0,
14519,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,,0,22224,,U,Autocuration,,CHEMBL627576,,BAO_0000218,2048.0,
14520,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,,0,22224,,U,Autocuration,,CHEMBL627577,,BAO_0000218,2385.0,
14521,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),,0,22224,,U,Autocuration,,CHEMBL627578,,BAO_0000218,2367.0,
14522,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,,0,22224,,U,Autocuration,,CHEMBL627579,,BAO_0000218,2367.0,
14523,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,,0,22224,,U,Autocuration,,CHEMBL627580,,BAO_0000218,2385.0,
14524,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),,0,22224,,U,Autocuration,,CHEMBL627581,,BAO_0000218,2367.0,
14525,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,,0,22224,,U,Autocuration,,CHEMBL627582,,BAO_0000218,,
14526,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,,0,22224,,U,Autocuration,,CHEMBL627583,,BAO_0000218,2385.0,
14527,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,,0,22224,,U,Autocuration,,CHEMBL627584,,BAO_0000218,2106.0,
14528,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,,0,22224,,U,Autocuration,,CHEMBL627585,,BAO_0000218,2367.0,
14529,1,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,,0,22224,,U,Autocuration,,CHEMBL627586,,BAO_0000218,2385.0,
14530,1,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627587,,BAO_0000218,,
14531,1,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627588,,BAO_0000218,,
14532,1,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628250,,BAO_0000218,,
14533,1,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628251,,BAO_0000218,,
14534,1,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628252,,BAO_0000218,10000000.0,
14535,1,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628253,,BAO_0000218,10000000.0,
14536,1,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628254,,BAO_0000218,1898.0,
14537,1,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL877493,,BAO_0000218,1898.0,
14538,1,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628255,,BAO_0000218,,
14539,1,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628256,,BAO_0000218,,
14540,1,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628257,,BAO_0000218,10000000.0,
14541,1,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628258,,BAO_0000218,1898.0,
14542,1,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628259,,BAO_0000218,,
14543,1,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628429,,BAO_0000218,,
14544,1,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626862,,BAO_0000218,10000000.0,
14545,1,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626863,,BAO_0000218,1898.0,
14546,1,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625886,,BAO_0000218,2037.0,
14547,1,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625887,,BAO_0000218,2037.0,
14548,1,Biodistribution of the [11C]-radiolabeled compound in rat cortex,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625888,,BAO_0000218,,
14549,1,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625889,,BAO_0000218,,
14550,1,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625890,,BAO_0000218,10000000.0,
14551,1,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625891,,BAO_0000218,10000000.0,
14552,1,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625892,,BAO_0000218,1898.0,
14553,1,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625893,,BAO_0000218,1898.0,
14554,1,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625894,,BAO_0000218,2037.0,
14555,1,Biodistribution of the [18F]-radiolabeled compound in rat cortex,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625895,,BAO_0000218,,
14556,1,Reaction rate parameter value for phosphate with transfer with respect to ATP,,0,22224,,U,Autocuration,,CHEMBL625896,,BAO_0000019,,
14557,1,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",,0,22224,,U,Autocuration,,CHEMBL625897,,BAO_0000019,,
14558,1,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,0,22224,,U,Autocuration,,CHEMBL625898,,BAO_0000019,,
14559,1,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",,0,22224,,U,Autocuration,,CHEMBL625899,,BAO_0000019,,
14560,1,Reaction rate parameter value for phosphate with transfer with respect to ATP,,0,22224,,U,Autocuration,,CHEMBL626124,,BAO_0000019,,
14561,1,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,Escherichia coli,1,50212,,N,Intermediate,,CHEMBL628500,,BAO_0000218,,
14562,1,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL857856,,BAO_0000218,,
14563,1,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628501,,BAO_0000218,,
14564,1,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",,0,22224,,U,Autocuration,,CHEMBL628502,,BAO_0000019,,
14565,1,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,,0,22224,,U,Autocuration,,CHEMBL628503,,BAO_0000019,,
14566,1,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,,0,22224,,U,Autocuration,,CHEMBL628504,,BAO_0000019,,
14567,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,0,22224,,U,Autocuration,,CHEMBL628505,,BAO_0000019,,
14568,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",,0,22224,,U,Autocuration,,CHEMBL874452,,BAO_0000019,,
14569,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",,0,22224,,U,Autocuration,,CHEMBL628506,,BAO_0000019,,
14570,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",,0,22224,,U,Autocuration,,CHEMBL628507,,BAO_0000019,,
14571,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",,0,22224,,U,Autocuration,,CHEMBL628508,,BAO_0000019,,
14572,1,Michaelis constant (KM) was evaluated,,0,22224,,U,Autocuration,,CHEMBL628509,,BAO_0000019,,
14573,1,Reaction rate parameter value for phosphate with transfer with respect to ATP,,0,22224,,U,Autocuration,,CHEMBL628510,,BAO_0000019,,
14574,1,Substrate concentration for half maximal velocity was reported for rat hexokinase I,,0,22224,,U,Autocuration,,CHEMBL628511,,BAO_0000019,,
14575,1,Substrate concentration for half maximal velocity was reported for rat hexokinase II,,0,22224,,U,Autocuration,,CHEMBL628512,,BAO_0000019,,
14576,1,Substrate concentration for half maximal velocity was reported for rat hexokinase III,,0,22224,,U,Autocuration,,CHEMBL628513,,BAO_0000019,,
14577,1,Substrate concentration for half maximal velocity was reported for yeast hexokinase,,0,22224,,U,Autocuration,,CHEMBL628514,,BAO_0000019,,
14578,1,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,,0,22224,,U,Autocuration,,CHEMBL628515,,BAO_0000019,,
14579,1,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,,0,22224,,U,Autocuration,,CHEMBL628516,,BAO_0000019,,
14580,1,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,0,22224,,U,Autocuration,,CHEMBL628517,,BAO_0000019,,
14581,1,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),,0,22224,,U,Autocuration,,CHEMBL628518,,BAO_0000019,,
14582,1,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,,0,22224,,U,Autocuration,,CHEMBL628519,,BAO_0000019,,
14583,1,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,,0,22224,,U,Autocuration,,CHEMBL628520,,BAO_0000019,,
14584,1,Binding constant was determined,,0,22224,,U,Autocuration,,CHEMBL628521,,BAO_0000019,,
14585,1,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,,0,22224,,U,Autocuration,,CHEMBL630443,,BAO_0000019,,
14586,1,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,,0,22224,,U,Autocuration,,CHEMBL630444,,BAO_0000019,,
14587,1,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,,0,22224,,U,Autocuration,,CHEMBL857732,,BAO_0000019,,
14588,1,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,,0,22224,,U,Autocuration,,CHEMBL630445,,BAO_0000100,,
14589,1,Catalytic rate constant of the compound,,0,22224,,U,Autocuration,,CHEMBL630446,,BAO_0000019,,
14590,1,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,,0,22224,,U,Autocuration,,CHEMBL630447,,BAO_0000019,,
14591,1,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),,0,22224,,U,Autocuration,,CHEMBL630448,,BAO_0000019,,
14592,1,Catalytic rate constant against phospholipase A2 was determined,,0,22224,,U,Autocuration,,CHEMBL630449,,BAO_0000019,,
14593,1,"Compound was evaluated for catalytic constant, Kcat",,0,22224,,U,Autocuration,,CHEMBL630450,,BAO_0000019,,
14594,1,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,,0,22224,,U,Autocuration,,CHEMBL630451,,BAO_0000019,,
14595,1,Kcat calculated from 0.693/T1/2,,0,22224,,U,Autocuration,,CHEMBL630452,,BAO_0000019,,
14596,1,Kcat was determined,,0,22224,,U,Autocuration,,CHEMBL630453,,BAO_0000019,,
14597,1,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,,0,22224,,U,Autocuration,,CHEMBL630454,,BAO_0000019,,
14598,1,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,,0,22224,,U,Autocuration,,CHEMBL630455,,BAO_0000019,,
14599,1,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,,0,22224,,U,Autocuration,,CHEMBL631487,,BAO_0000019,,
14600,1,Kcat value was determined,,0,22224,,U,Autocuration,,CHEMBL631488,,BAO_0000019,,
14601,1,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,,0,22224,,U,Autocuration,,CHEMBL876440,,BAO_0000019,,
14602,1,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,,0,22224,,U,Autocuration,,CHEMBL631489,,BAO_0000019,,
14603,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,0,22224,,U,Autocuration,,CHEMBL857742,,BAO_0000019,,
14604,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",,0,22224,,U,Autocuration,,CHEMBL631490,,BAO_0000019,,
14605,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",,0,22224,,U,Autocuration,,CHEMBL631491,,BAO_0000019,,
14606,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",,0,22224,,U,Autocuration,,CHEMBL631492,,BAO_0000019,,
14607,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",,0,22224,,U,Autocuration,,CHEMBL631493,,BAO_0000019,,
14608,1,Kinetic parameter for rate of conversion to PABA was determined,,0,22224,,U,Autocuration,,CHEMBL631494,,BAO_0000019,,
14609,1,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,0,22224,,U,Autocuration,,CHEMBL631495,,BAO_0000019,,
14610,1,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631496,,BAO_0000218,1988.0,
14611,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631497,,BAO_0000218,1088.0,
14612,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631498,,BAO_0000218,1088.0,
14613,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629776,,BAO_0000218,1088.0,
14614,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629777,,BAO_0000218,1088.0,
14615,1,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629778,,BAO_0000218,1088.0,
14616,1,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630456,,BAO_0000218,,
14617,1,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630457,,BAO_0000218,,
14618,1,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630458,,BAO_0000218,,
14619,1,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630459,,BAO_0000218,,
14620,1,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630460,,BAO_0000218,,
14621,1,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876550,,BAO_0000218,,
14622,1,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630461,,BAO_0000218,,
14623,1,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630462,,BAO_0000218,,
14624,1,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630463,,BAO_0000218,,
14625,1,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630464,,BAO_0000218,,
14626,1,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630465,,BAO_0000218,,
14627,1,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630466,,BAO_0000218,,
14628,1,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630467,,BAO_0000218,,
14629,1,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630633,,BAO_0000218,,
14630,1,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630634,,BAO_0000218,,
14631,1,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630635,,BAO_0000218,,
14632,1,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630636,,BAO_0000218,,
14633,1,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630637,,BAO_0000218,,
14634,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630638,,BAO_0000218,1988.0,
14635,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630639,,BAO_0000218,1988.0,
14636,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630640,,BAO_0000218,1988.0,
14637,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL876551,,BAO_0000218,1988.0,
14638,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630641,,BAO_0000218,1088.0,
14639,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630642,,BAO_0000218,1088.0,
14640,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630643,,BAO_0000218,1088.0,
14641,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630644,,BAO_0000218,1088.0,
14642,1,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL630645,,BAO_0000218,1088.0,
14643,1,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL625599,,BAO_0000218,1988.0,
14644,1,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL625600,,BAO_0000218,1988.0,
14645,1,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL625601,,BAO_0000218,1988.0,
14646,1,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL625602,,BAO_0000218,1988.0,
14647,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL627470,,BAO_0000218,1088.0,
14648,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL627471,,BAO_0000218,1088.0,
14649,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL627472,,BAO_0000218,1088.0,
14650,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL627473,,BAO_0000218,1088.0,
14651,1,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL627474,,BAO_0000218,1088.0,
14652,1,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627475,,BAO_0000218,178.0,
14653,1,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL627476,,BAO_0000218,178.0,
14654,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627477,,BAO_0000218,1088.0,
14655,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627478,,BAO_0000218,1088.0,
14656,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627479,,BAO_0000218,1088.0,
14657,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627480,,BAO_0000218,1088.0,
14658,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627481,,BAO_0000218,1088.0,
14659,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627482,,BAO_0000218,1088.0,
14660,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL627483,,BAO_0000218,1088.0,
14661,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL875636,,BAO_0000218,1088.0,
14662,1,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625764,,BAO_0000218,1088.0,
14663,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625765,,BAO_0000218,1088.0,
14664,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625766,,BAO_0000218,1088.0,
14665,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625767,,BAO_0000218,1088.0,
14666,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625768,,BAO_0000218,1088.0,
14667,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625769,,BAO_0000218,1088.0,
14668,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625770,,BAO_0000218,1088.0,
14669,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625771,,BAO_0000218,1088.0,
14670,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625772,,BAO_0000218,1088.0,
14671,1,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,Canis lupus familiaris,1,50588,,N,Intermediate,,CHEMBL625773,,BAO_0000218,1088.0,
14672,1,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625774,,BAO_0000218,1088.0,
14673,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625775,,BAO_0000218,1088.0,
14674,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625776,,BAO_0000218,1088.0,
14675,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625777,,BAO_0000218,1088.0,
14676,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625778,,BAO_0000218,1088.0,
14677,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625779,,BAO_0000218,1088.0,
14678,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625780,,BAO_0000218,1088.0,
14679,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625781,,BAO_0000218,1088.0,
14680,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875637,,BAO_0000218,1088.0,
14681,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626473,,BAO_0000218,1088.0,
14682,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626474,,BAO_0000218,1088.0,
14683,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626475,,BAO_0000218,1088.0,
14684,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626476,,BAO_0000218,1088.0,
14685,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL634397,,BAO_0000218,1088.0,
14686,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL626477,,BAO_0000218,1088.0,
14687,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631069,,BAO_0000218,1088.0,
14688,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631070,,BAO_0000218,1088.0,
14689,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631071,,BAO_0000218,1088.0,
14690,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631072,,BAO_0000218,1088.0,
14691,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631073,,BAO_0000218,1088.0,
14692,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631074,,BAO_0000218,1088.0,
14693,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631075,,BAO_0000218,1088.0,
14694,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631725,,BAO_0000218,1088.0,
14695,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631726,,BAO_0000218,1088.0,
14696,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631727,,BAO_0000218,1088.0,
14697,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631728,,BAO_0000218,1088.0,
14698,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631729,,BAO_0000218,1088.0,
14699,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631730,,BAO_0000218,1088.0,
14700,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631731,,BAO_0000218,1088.0,
14701,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631910,,BAO_0000218,1088.0,
14702,1,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631911,,BAO_0000218,10000000.0,
14703,1,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631912,,BAO_0000218,1898.0,
14704,1,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631913,,BAO_0000218,1898.0,
14705,1,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631914,,BAO_0000218,178.0,
14706,1,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631915,,BAO_0000218,178.0,
14707,1,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875778,,BAO_0000218,178.0,
14708,1,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631916,,BAO_0000218,178.0,
14709,1,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631917,,BAO_0000218,178.0,
14710,1,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631918,,BAO_0000218,178.0,
14711,1,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631919,,BAO_0000218,178.0,
14712,1,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631920,,BAO_0000218,178.0,
14713,1,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631921,,BAO_0000218,178.0,
14714,1,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631922,,BAO_0000218,178.0,
14715,1,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631923,,BAO_0000218,178.0,
14716,1,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631924,,BAO_0000218,,
14717,1,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630234,,BAO_0000218,,
14718,1,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630235,,BAO_0000218,,
14719,1,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630236,,BAO_0000218,,
14720,1,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630237,,BAO_0000218,,
14721,1,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630238,,BAO_0000218,,
14722,1,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630239,,BAO_0000218,,
14723,1,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630303,,BAO_0000218,,
14724,1,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630304,,BAO_0000218,,
14725,1,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630305,,BAO_0000218,,
14726,1,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630306,,BAO_0000218,2113.0,
14727,1,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630307,,BAO_0000218,2113.0,
14728,1,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630308,,BAO_0000218,2113.0,
14729,1,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630309,,BAO_0000218,2113.0,
14730,1,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629309,,BAO_0000218,2113.0,
14731,1,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629993,,BAO_0000218,2113.0,
14732,1,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629994,,BAO_0000218,2113.0,
14733,1,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629995,,BAO_0000218,2113.0,
14734,1,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631993,,BAO_0000218,2113.0,
14735,1,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631994,,BAO_0000218,2113.0,
14736,1,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631995,,BAO_0000218,2113.0,
14737,1,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631996,,BAO_0000218,2107.0,
14738,1,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631997,,BAO_0000218,2107.0,
14739,1,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631998,,BAO_0000218,2107.0,
14740,1,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631999,,BAO_0000218,2107.0,
14741,1,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632000,,BAO_0000218,2107.0,
14742,1,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632001,,BAO_0000218,2107.0,
14743,1,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL874424,,BAO_0000218,2107.0,
14744,1,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632002,,BAO_0000218,2107.0,
14745,1,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632003,,BAO_0000218,2107.0,
14746,1,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,,0,22224,,U,Autocuration,,CHEMBL632004,,BAO_0000019,,
14747,1,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,,0,22224,,U,Autocuration,,CHEMBL632005,,BAO_0000019,,
14748,1,Compound was tested for amidase rate in the presence of N62C screen enzyme,,0,22224,,U,Autocuration,,CHEMBL632006,,BAO_0000019,,
14749,1,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,,0,22224,,U,Autocuration,,CHEMBL632007,,BAO_0000019,,
14750,1,Compound was tested for amidase rate in the presence of S166C screen enzyme,,0,22224,,U,Autocuration,,CHEMBL632008,,BAO_0000019,,
14751,1,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,,0,22224,,U,Autocuration,,CHEMBL632009,,BAO_0000019,,
14752,1,Compound was tested for esterase rate in the presence of N62C screen enzyme,,0,22224,,U,Autocuration,,CHEMBL632010,,BAO_0000019,,
14753,1,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,,0,22224,,U,Autocuration,,CHEMBL857750,,BAO_0000019,,
14754,1,Compound was tested for esterase rate in the presence of S166C screen enzyme,,0,22224,,U,Autocuration,,CHEMBL632011,,BAO_0000019,,
14755,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,0,22224,,U,Autocuration,,CHEMBL632012,,BAO_0000019,,
14756,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,0,22224,,U,Autocuration,,CHEMBL632013,,BAO_0000019,,
14757,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",,0,22224,,U,Autocuration,,CHEMBL632014,,BAO_0000019,,
14758,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,0,22224,,U,Autocuration,,CHEMBL629622,,BAO_0000019,,
14759,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",,0,22224,,U,Autocuration,,CHEMBL629623,,BAO_0000019,,
14760,1,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",,0,22224,,U,Autocuration,,CHEMBL629624,,BAO_0000019,,
14761,1,Ratio of Kcat to that of Km was determined,,0,22224,,U,Autocuration,,CHEMBL629625,,BAO_0000019,,
14762,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,0,22224,,U,Autocuration,,CHEMBL629626,,BAO_0000019,,
14763,1,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",,0,22224,,U,Autocuration,,CHEMBL629627,,BAO_0000019,,
14764,1,"Compound was evaluated for constant, Kd",,0,22224,,U,Autocuration,,CHEMBL629628,,BAO_0000019,,
14765,1,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,,0,22224,,U,Autocuration,,CHEMBL629629,,BAO_0000019,,
14766,1,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,,0,22224,,U,Autocuration,,CHEMBL629630,,BAO_0000019,,
14767,1,Dissociation Constant of compound determined,,0,22224,,U,Autocuration,,CHEMBL856030,,BAO_0000019,,
14768,1,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,,0,22224,,U,Autocuration,,CHEMBL629631,,BAO_0000019,,
14769,1,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,,0,22224,,U,Autocuration,,CHEMBL629632,,BAO_0000019,,
14770,1,Dissociation constant of compound with Fructose was determined,,0,22224,,U,Autocuration,,CHEMBL629633,,BAO_0000100,,
14771,1,Dissociation constant of compound with Fructose was determined; Not determined,,0,22224,,U,Autocuration,,CHEMBL629634,,BAO_0000100,,
14772,1,Dissociation constant of compound with Lactulose was determined,,0,22224,,U,Autocuration,,CHEMBL629635,,BAO_0000100,,
14773,1,Dissociation constant of compound with Lactulose was determined; Not determined,,0,22224,,U,Autocuration,,CHEMBL629636,,BAO_0000100,,
14774,1,Dissociation constant of the Compound,,0,22224,,U,Autocuration,,CHEMBL629637,,BAO_0000100,,
14775,1,Dissociation constant by non-linear regression analysis,,0,22224,,U,Autocuration,,CHEMBL629638,,BAO_0000100,,
14776,1,Dissociation constant was determined,,0,22224,,U,Autocuration,,CHEMBL629639,,BAO_0000100,,
14777,1,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,,0,22224,,U,Autocuration,,CHEMBL629640,,BAO_0000100,,
14778,1,Dissociation constant was determined,,0,22224,,U,Autocuration,,CHEMBL629641,,BAO_0000100,,
14779,1,Dissociation constant was determined,,0,22224,,U,Autocuration,,CHEMBL631344,,BAO_0000100,,
14780,1,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631345,,BAO_0000218,2385.0,
14781,1,The dissociation constant determined by fluorescence displacement assay,,0,22224,,U,Autocuration,,CHEMBL631346,,BAO_0000019,,
14782,1,kd value surface plasmon resonance (SPR) method,,0,22224,,U,Autocuration,,CHEMBL631524,,BAO_0000019,,
14783,1,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631525,,BAO_0000218,2385.0,
14784,1,First dissociation constant of the binding of compound to V30M TTR,,0,22224,,U,Autocuration,,CHEMBL631526,,BAO_0000019,,
14785,1,Second dissociation constant of the binding of compound to V30M TTR,,0,22224,,U,Autocuration,,CHEMBL631527,,BAO_0000019,,
14786,1,"Compound was evaluated for equilibrium constant, Ke",,0,22224,,U,Autocuration,,CHEMBL631528,,BAO_0000019,,
14787,1,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,,0,22224,,U,Autocuration,,CHEMBL631529,,BAO_0000019,1898.0,
14788,1,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,,0,22224,,U,Autocuration,,CHEMBL631530,,BAO_0000019,1898.0,
14789,1,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,,0,22224,,U,Autocuration,,CHEMBL631531,,BAO_0000019,,
14790,1,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,,0,22224,,U,Autocuration,,CHEMBL631532,,BAO_0000019,,
14791,1,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,,0,22224,,U,Autocuration,,CHEMBL631533,,BAO_0000019,,
14792,1,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,1,50594,,N,Intermediate,,CHEMBL876552,,BAO_0000218,,
14793,1,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631534,,BAO_0000218,,
14794,1,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631535,,BAO_0000218,,
14795,1,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631536,,BAO_0000218,,
14796,1,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631537,,BAO_0000218,,
14797,1,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631538,,BAO_0000218,,
14798,1,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631539,,BAO_0000218,,
14799,1,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,Mus musculus,1,50594,,N,Intermediate,,CHEMBL631540,,BAO_0000218,,
14800,1,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625637,,BAO_0000218,,
14801,1,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625638,,BAO_0000218,,
14802,1,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625639,,BAO_0000218,,
14803,1,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625640,,BAO_0000218,955.0,
14804,1,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625641,,BAO_0000218,955.0,
14805,1,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625642,,BAO_0000218,948.0,
14806,1,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625643,,BAO_0000218,948.0,
14807,1,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625644,,BAO_0000218,2113.0,
14808,1,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625645,,BAO_0000218,2113.0,
14809,1,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625646,,BAO_0000218,2107.0,
14810,1,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625647,,BAO_0000218,2107.0,
14811,1,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625648,,BAO_0000218,2048.0,
14812,1,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625649,,BAO_0000218,2048.0,
14813,1,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625650,,BAO_0000218,2385.0,
14814,1,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625651,,BAO_0000218,2385.0,
14815,1,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625652,,BAO_0000218,14.0,
14816,1,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625653,,BAO_0000218,14.0,
14817,1,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625654,,BAO_0000218,2106.0,
14818,1,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625655,,BAO_0000218,2106.0,
14819,1,Biodistribution of Compound in rat blood after 15 minutes of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625656,,BAO_0000218,178.0,
14820,1,Biodistribution of Compound in rat blood after 2 minutes of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625657,,BAO_0000218,178.0,
14821,1,Biodistribution of Compound in rat brain after 15 minutes of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625658,,BAO_0000218,955.0,
14822,1,Biodistribution of Compound in rat brain after 2 minutes of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625659,,BAO_0000218,955.0,
14823,1,Biodistribution of Compound in rat heart after 15 minutes of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625660,,BAO_0000218,948.0,
14824,1,Biodistribution of Compound in rat heart after 2 minutes of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625661,,BAO_0000218,948.0,
14825,1,Biodistribution of Compound in rat liver after 15 minutes of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625662,,BAO_0000218,2107.0,
14826,1,Biodistribution of Compound in rat liver after 2 minutes of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL625663,,BAO_0000218,2107.0,
14827,1,Biodistribution of Compound in rat lung after 15 minutes of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875621,,BAO_0000218,2048.0,
14828,1,Biodistribution of Compound in rat lung after 2 minutes of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628382,,BAO_0000218,2048.0,
14829,1,Biodistribution of Compound in rat muscle after 15 minutes of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628383,,BAO_0000218,2385.0,
14830,1,Biodistribution of Compound in rat muscle after 2 minutes of administration,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628384,,BAO_0000218,2385.0,
14831,1,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628385,,BAO_0000218,,
14832,1,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875753,,BAO_0000218,,
14833,1,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628386,,BAO_0000218,,
14834,1,Organ distribution in rat blood 2 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628387,,BAO_0000218,,
14835,1,Organ distribution in rat blood 2 hr after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628388,,BAO_0000218,,
14836,1,Organ distribution in rat blood 30 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628389,,BAO_0000218,,
14837,1,Organ distribution in rat blood 30 min after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632756,,BAO_0000218,,
14838,1,Organ distribution in rat brain 2 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628390,,BAO_0000218,,
14839,1,Organ distribution in rat brain 2 hr after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631811,,BAO_0000218,,
14840,1,Organ distribution in rat brain 30 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631812,,BAO_0000218,,
14841,1,Organ distribution in rat heart 2 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631813,,BAO_0000218,,
14842,1,Organ distribution in rat heart 2 hr after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631814,,BAO_0000218,,
14843,1,Organ distribution in rat heart 30 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631815,,BAO_0000218,,
14844,1,Organ distribution in rat kidney 2 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631816,,BAO_0000218,,
14845,1,Organ distribution in rat kidney 2 hr after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875758,,BAO_0000218,,
14846,1,Organ distribution in rat kidney 30 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631817,,BAO_0000218,,
14847,1,Organ distribution in rat liver 2 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631818,,BAO_0000218,2107.0,
14848,1,Organ distribution in rat liver 2 hr after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631819,,BAO_0000218,2107.0,
14849,1,Organ distribution in rat liver 30 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631820,,BAO_0000218,2107.0,
14850,1,Organ distribution in rat lung 2 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631821,,BAO_0000218,,
14851,1,Organ distribution in rat lung 2 hr after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631822,,BAO_0000218,,
14852,1,Organ distribution in rat lung 30 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631823,,BAO_0000218,,
14853,1,Organ distribution in rat muscle 2 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631824,,BAO_0000218,2385.0,
14854,1,Organ distribution in rat muscle 2 hr after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631825,,BAO_0000218,2385.0,
14855,1,Organ distribution in rat muscle 30 minutes after intravenous injection,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631826,,BAO_0000218,2385.0,
14856,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),Mus musculus,1,50594,,N,Intermediate,,CHEMBL631827,,BAO_0000218,,
14857,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),Mus musculus,1,50594,,N,Intermediate,,CHEMBL631828,,BAO_0000218,,
14858,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),Mus musculus,1,50594,,N,Intermediate,,CHEMBL631829,,BAO_0000218,,
14859,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875759,,BAO_0000218,1088.0,
14860,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631830,,BAO_0000218,1088.0,
14861,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631831,,BAO_0000218,1088.0,
14862,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631832,,BAO_0000218,1088.0,
14863,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631833,,BAO_0000218,1088.0,
14864,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631834,,BAO_0000218,1088.0,
14865,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631835,,BAO_0000218,1088.0,
14866,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631836,,BAO_0000218,1088.0,
14867,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631837,,BAO_0000218,1088.0,
14868,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631838,,BAO_0000218,1088.0,
14869,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631839,,BAO_0000218,1088.0,
14870,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631840,,BAO_0000218,1088.0,
14871,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631841,,BAO_0000218,1088.0,
14872,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631842,,BAO_0000218,1088.0,
14873,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631843,,BAO_0000218,1088.0,
14874,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631844,,BAO_0000218,1088.0,
14875,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631845,,BAO_0000218,1088.0,
14876,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631846,,BAO_0000218,1088.0,
14877,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL875760,,BAO_0000218,1088.0,
14878,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL632199,,BAO_0000218,1088.0,
14879,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631847,,BAO_0000218,1088.0,
14880,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631848,,BAO_0000218,1088.0,
14881,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628707,,BAO_0000218,1088.0,
14882,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628708,,BAO_0000218,1088.0,
14883,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628709,,BAO_0000218,1088.0,
14884,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628710,,BAO_0000218,1088.0,
14885,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628711,,BAO_0000218,1088.0,
14886,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628712,,BAO_0000218,1088.0,
14887,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628713,,BAO_0000218,1088.0,
14888,1,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628714,,BAO_0000218,1088.0,
14889,1,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL628715,,BAO_0000218,,
14890,1,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,,0,22224,,U,Autocuration,,CHEMBL629179,,BAO_0000019,,
14891,1,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,,0,22224,,U,Autocuration,,CHEMBL629180,,BAO_0000019,,
14892,1,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,,0,22224,,U,Autocuration,,CHEMBL875108,,BAO_0000019,,
14893,1,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629181,,BAO_0000019,1235.0,
14894,1,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629182,,BAO_0000019,1235.0,
14895,1,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629183,,BAO_0000019,,
14896,1,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629184,,BAO_0000019,,
14897,1,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629185,,BAO_0000019,1235.0,
14898,1,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629186,,BAO_0000019,1235.0,
14899,1,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629187,,BAO_0000019,,
14900,1,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629887,,BAO_0000019,,
14901,1,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629888,,BAO_0000019,,
14902,1,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629889,,BAO_0000019,,
14903,1,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629890,,BAO_0000019,1235.0,
14904,1,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629891,,BAO_0000019,,
14905,1,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629892,,BAO_0000019,,
14906,1,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629893,,BAO_0000019,1235.0,
14907,1,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629894,,BAO_0000019,,
14908,1,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,,0,22224,,U,Autocuration,,CHEMBL629895,,BAO_0000019,,
14909,1,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",Canis lupus familiaris,0,22224,,U,Autocuration,,CHEMBL875109,,BAO_0000218,,
14910,1,Absolute bioavailability in male cynomolgus monkeys,Macaca fascicularis,0,22224,,U,Autocuration,,CHEMBL629896,,BAO_0000218,,
14911,1,Absolute bioavailability in maleSprague-Dawley rats,Rattus norvegicus,0,22224,,U,Autocuration,,CHEMBL629897,,BAO_0000218,,
14912,1,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL629898,,BAO_0000218,2107.0,
14913,1,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630057,,BAO_0000218,2107.0,
14914,1,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630058,,BAO_0000218,2107.0,
14915,1,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630059,,BAO_0000218,2048.0,
14916,1,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630060,,BAO_0000218,2048.0,
14917,1,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630061,,BAO_0000218,2048.0,
14918,1,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630062,,BAO_0000218,2048.0,
14919,1,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630063,,BAO_0000218,2048.0,
14920,1,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630064,,BAO_0000218,2048.0,
14921,1,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630065,,BAO_0000218,2048.0,
14922,1,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630066,,BAO_0000218,2048.0,
14923,1,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630067,,BAO_0000218,2048.0,
14924,1,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630068,,BAO_0000218,2048.0,
14925,1,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631113,,BAO_0000218,2385.0,
14926,1,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631114,,BAO_0000218,2385.0,
14927,1,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631115,,BAO_0000218,2385.0,
14928,1,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL631116,,BAO_0000218,2385.0,
14929,1,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630528,,BAO_0000218,2385.0,
14930,1,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630529,,BAO_0000218,2385.0,
14931,1,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630530,,BAO_0000218,2385.0,
14932,1,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630531,,BAO_0000218,2385.0,
14933,1,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630532,,BAO_0000218,2385.0,
14934,1,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630533,,BAO_0000218,2385.0,
14935,1,Biodistribution in normal mice blood after 120 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630534,,BAO_0000218,178.0,
14936,1,Biodistribution in normal mice blood after 24 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630535,,BAO_0000218,178.0,
14937,1,Biodistribution in normal mice blood after 4 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630536,,BAO_0000218,178.0,
14938,1,Biodistribution in normal mice bone after 120 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630537,,BAO_0000218,10000001.0,
14939,1,Biodistribution in normal mice bone after 24 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630538,,BAO_0000218,10000001.0,
14940,1,Biodistribution in normal mice bone after 4 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630539,,BAO_0000218,10000001.0,
14941,1,Biodistribution in normal mice heart after 120 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630540,,BAO_0000218,948.0,
14942,1,Biodistribution in normal mice heart after 24 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630541,,BAO_0000218,948.0,
14943,1,Biodistribution in normal mice heart after 4 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630542,,BAO_0000218,948.0,
14944,1,Biodistribution in normal mice kidney after 120 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630543,,BAO_0000218,2113.0,
14945,1,Biodistribution in normal mice kidney after 24 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630544,,BAO_0000218,2113.0,
14946,1,Biodistribution in normal mice kidney after 4 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630545,,BAO_0000218,2113.0,
14947,1,Biodistribution in normal mice liver after 120 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630546,,BAO_0000218,2107.0,
14948,1,Biodistribution in normal mice liver after 24 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630547,,BAO_0000218,2107.0,
14949,1,Biodistribution in normal mice liver after 4 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630548,,BAO_0000218,2107.0,
14950,1,Biodistribution in normal mice spleen after 120 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630549,,BAO_0000218,2106.0,
14951,1,Biodistribution in normal mice spleen after 24 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL630550,,BAO_0000218,2106.0,
14952,1,Biodistribution in normal mice spleen after 4 hr,Mus musculus,1,50594,,N,Intermediate,,CHEMBL876426,,BAO_0000218,2106.0,
14953,1,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630551,,BAO_0000218,2106.0,
14954,1,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630552,,BAO_0000218,2106.0,
14955,1,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630553,,BAO_0000218,2106.0,
14956,1,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630554,,BAO_0000218,2106.0,
14957,1,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630555,,BAO_0000218,2106.0,
14958,1,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630556,,BAO_0000218,2106.0,
14959,1,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630557,,BAO_0000218,2106.0,
14960,1,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630558,,BAO_0000218,2106.0,
14961,1,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630559,,BAO_0000218,2106.0,
14962,1,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630560,,BAO_0000218,2106.0,
14963,1,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL876427,,BAO_0000218,2046.0,
14964,1,The Kel values in female wistar rats.,Rattus norvegicus,1,50597,,N,Intermediate,,CHEMBL630561,,BAO_0000218,,
14965,1,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,,0,22224,,U,Autocuration,,CHEMBL630562,,BAO_0000019,,
14966,1,Hydrolysis rate constant of the compound,,0,22224,,U,Autocuration,,CHEMBL630563,,BAO_0000019,,
14967,1,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,,0,22229,,U,Autocuration,,CHEMBL629673,,BAO_0000100,,
14968,1,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",,0,22224,,U,Autocuration,,CHEMBL629674,,BAO_0000019,,
14969,1,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",,0,22224,,U,Autocuration,,CHEMBL629675,,BAO_0000019,,
14970,1,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",,0,22224,,U,Autocuration,,CHEMBL629676,,BAO_0000019,,
14971,1,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",,0,22224,,U,Autocuration,,CHEMBL629677,,BAO_0000019,,
14972,1,Apparent inactivation rate constant was evaluated,,0,22224,,U,Autocuration,,CHEMBL629678,,BAO_0000019,,
14973,1,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,,0,22224,,U,Autocuration,,CHEMBL629679,,BAO_0000019,,
14974,1,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,,0,22224,,U,Autocuration,,CHEMBL629680,,BAO_0000019,,
14975,1,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,,0,22224,,U,Autocuration,,CHEMBL629681,,BAO_0000019,,
14976,1,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,,0,22224,,U,Autocuration,,CHEMBL629682,,BAO_0000019,,
14977,1,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,,0,22224,,U,Autocuration,,CHEMBL629683,,BAO_0000019,,
14978,1,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,,0,22224,,U,Autocuration,,CHEMBL629684,,BAO_0000019,,
14979,1,Dissociation constant was determined,,0,22224,,U,Autocuration,,CHEMBL629685,,BAO_0000100,,
14980,1,Dissociation constant was determined,,0,22224,,U,Autocuration,,CHEMBL629686,,BAO_0000100,,
14981,1,Dissociation constant at pH 7.4,,0,22224,,U,Autocuration,,CHEMBL872932,,BAO_0000100,,
14982,1,Dissociation constant in presence of 1 mM dithiothreitol,,0,22224,,U,Autocuration,,CHEMBL629687,,BAO_0000100,,
14983,1,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,0,22224,,U,Autocuration,,CHEMBL872931,,BAO_0000019,,
14984,1,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,,0,22224,,U,Autocuration,,CHEMBL628151,,BAO_0000019,,
14985,1,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,0,22224,,U,Autocuration,,CHEMBL628152,,BAO_0000019,,
14986,1,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,,0,22224,,U,Autocuration,,CHEMBL628153,,BAO_0000019,,
14987,1,Kinetic constant for aromatization of androstenedione,,0,22224,,U,Autocuration,,CHEMBL628154,,BAO_0000019,,
14988,1,Kinetic constant for aromatization of testosterone,,0,22224,,U,Autocuration,,CHEMBL628155,,BAO_0000019,,
14989,1,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,,0,22224,,U,Autocuration,,CHEMBL628156,,BAO_0000019,,
14990,1,Local inhibition constant was determined,,0,22224,,U,Autocuration,,CHEMBL628157,,BAO_0000019,,
14991,1,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,Saccharomyces cerevisiae,1,50347,,N,Intermediate,,CHEMBL857533,,BAO_0000218,,
14992,1,Dissociation constant value of the compound,,0,22224,,U,Autocuration,,CHEMBL628158,,BAO_0000100,,
14993,1,In vitro permeability through cornea without epithelium,,0,22224,,U,Autocuration,,CHEMBL628159,,BAO_0000019,964.0,
14994,1,In vitro permeability through intact cornea,,0,22224,,U,Autocuration,,CHEMBL875616,,BAO_0000019,964.0,
14995,1,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,Oryctolagus cuniculus,1,50592,,N,Intermediate,,CHEMBL628160,,BAO_0000218,964.0,
14996,1,Rate of enzyme inactivation for the compound was determined,,0,22224,,U,Autocuration,,CHEMBL628161,,BAO_0000019,,
14997,1,In vitro permeability through cornea without epithelium,,0,22224,,U,Autocuration,,CHEMBL628162,,BAO_0000019,964.0,
14998,1,In vitro permeability through intact cornea,,0,22224,,U,Autocuration,,CHEMBL628163,,BAO_0000019,964.0,
14999,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL628164,,BAO_0000019,,
15000,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL628165,,BAO_0000019,,
15001,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL628166,,BAO_0000019,,
15002,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL628167,,BAO_0000019,,
15003,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL628168,,BAO_0000019,,
15004,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL628169,,BAO_0000019,,
15005,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL628170,,BAO_0000019,,
15006,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL628171,,BAO_0000019,,
15007,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL627434,,BAO_0000019,,
15008,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL627435,,BAO_0000019,,
15009,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL628110,,BAO_0000019,,
15010,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL628111,,BAO_0000019,,
15011,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL628112,,BAO_0000019,,
15012,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL628260,,BAO_0000019,,
15013,1,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",,0,22224,,U,Autocuration,,CHEMBL628261,,BAO_0000019,,
15014,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),Mus musculus,1,50594,,N,Intermediate,,CHEMBL628262,,BAO_0000218,,
15015,1,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL628263,,BAO_0000218,,
15016,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),Mus musculus,1,50594,,N,Intermediate,,CHEMBL628264,,BAO_0000218,,
15017,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),Mus musculus,1,50594,,N,Intermediate,,CHEMBL628265,,BAO_0000218,,
15018,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),Mus musculus,1,50594,,N,Intermediate,,CHEMBL628266,,BAO_0000218,,
15019,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),Mus musculus,1,50594,,N,Intermediate,,CHEMBL628267,,BAO_0000218,,
15020,1,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,Mus musculus,1,50594,,N,Intermediate,,CHEMBL628268,,BAO_0000218,,
15021,1,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),Mus musculus,1,50594,,N,Intermediate,,CHEMBL628269,,BAO_0000218,,
15022,1,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),Mus musculus,1,50594,,N,Intermediate,,CHEMBL628270,,BAO_0000218,,
15023,1,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),Mus musculus,1,50594,,N,Intermediate,,CHEMBL628271,,BAO_0000218,,
15024,1,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),Mus musculus,1,50594,,N,Intermediate,,CHEMBL628272,,BAO_0000218,,
1,1,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 30 uM,,8,12052,,H,Autocuration,,CHEMBL615117,,BAO_0000019,,
2,1,Compound was evaluated for its ability to mobilize calcium in 1321NI cells,,0,22226,,U,Autocuration,,CHEMBL615118,,BAO_0000219,,
3,1,,,0,22226,,U,Autocuration,,CHEMBL615119,,BAO_0000019,,
4,1,Binding affinity against A2 adenosine receptor in bovine striatal membranes using [3H]CGS-21680,Bos taurus,4,104729,,H,Autocuration,,CHEMBL615120,,BAO_0000249,,
5,1,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),Homo sapiens,1,80001,,N,Intermediate,,CHEMBL615121,163.0,BAO_0000219,,
6,1,In vitro cell cytotoxicity against 143-B cell lines (Human osteosarcoma cell line),Homo sapiens,1,80001,,N,Intermediate,,CHEMBL615122,163.0,BAO_0000219,,
7,1,Cytotoxic Activity was evaluated against 143B (TK-) tumor cells,Mus musculus,1,80001,,N,Intermediate,,CHEMBL615123,163.0,BAO_0000219,,
8,1,In vitro cell cytotoxicity was determined against 143B cell line,Homo sapiens,1,80001,,N,Expert,,CHEMBL615124,163.0,BAO_0000219,,
9,1,Inhibitory activity against tumor osteosarcoma cell line 143B after 72 hr continuous exposure to compound,Homo sapiens,1,80001,,N,Intermediate,,CHEMBL615125,163.0,BAO_0000219,,
10,1,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,Homo sapiens,1,80001,,N,Intermediate,,CHEMBL615126,163.0,BAO_0000219,,
11,1,In vitro cell cytotoxicity against 143B-LTK cell lines expressed in HSV-1 TK,Homo sapiens,1,80001,,N,Intermediate,,CHEMBL615127,163.0,BAO_0000219,,
12,1,In vitro cell cytotoxicity was determined against 143B-LTK cell line,Homo sapiens,1,80001,,N,Expert,,CHEMBL615128,163.0,BAO_0000219,,
13,1,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",Staphylococcus aureus,1,50185,,N,Intermediate,,CHEMBL857900,,BAO_0000218,,
14,1,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",Staphylococcus aureus,1,50185,,N,Intermediate,,CHEMBL615129,,BAO_0000218,,
15,1,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",Staphylococcus aureus,1,50185,,N,Intermediate,,CHEMBL615130,,BAO_0000218,,
16,1,"The compound was tested for minimum inhibitory concentration in Staphylococcus aureus,147N penicillin sensitive Staphylococcus aureus",Staphylococcus aureus,1,50185,,N,Intermediate,,CHEMBL615131,,BAO_0000218,,
17,1,Inhibition of cytochrome P450 progesterone 15-alpha hydroxylase,Rattus norvegicus,9,100122,,D,Expert,,CHEMBL884521,,BAO_0000357,,
18,1,Concentration that cause 50% activation of human reticulocyte 15-lipoxygenase (15-HLO),,8,12054,,H,Autocuration,,CHEMBL615132,,BAO_0000357,,
19,1,Inhibition of partially purified 15-lipoxygenase from human leukocytes,,8,12054,,H,Autocuration,,CHEMBL615133,,BAO_0000019,,
20,1,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),,8,12054,,H,Autocuration,,CHEMBL615134,,BAO_0000357,,
21,1,Compound was evaluated for the percent increase in activation concentration of human reticulocyte 15-lipoxygenase (15-HLO),,8,12054,,H,Autocuration,,CHEMBL615135,,BAO_0000357,,
22,1,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO),,8,12054,,H,Autocuration,,CHEMBL615136,,BAO_0000357,,
23,1,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,,8,12054,,H,Autocuration,,CHEMBL615137,,BAO_0000357,,
24,1,Inhibitory activity against human reticulocyte 15-lipoxygenase (15-HLO); NI is no inhibition,,8,12054,,H,Autocuration,,CHEMBL615138,,BAO_0000357,,
25,1,"Inhibitory concentration against 15-lipoxygenase, by inhibiting 15-HETE production by human umbilical vein endothelial cells (HUVEC) stimulated by calcium ionophore A 23187 at concentration of 10e-5 M.",,0,22226,,U,Autocuration,,CHEMBL836324,,BAO_0000219,,
26,1,In vitro inhibitory activity of compound on rabbit reticulocyte 15-lipoxygenase,Oryctolagus cuniculus,8,12054,,H,Autocuration,,CHEMBL615139,,BAO_0000357,,
27,1,Inhibition of rabbit reticulocyte 15-lipoxygenase by compound (30 uM),Oryctolagus cuniculus,8,12054,,H,Autocuration,,CHEMBL615140,,BAO_0000357,,
28,1,Inhibitory activity against 15-lipoxygenase in rat polymorphonuclear leukocytes,,8,12426,,H,Autocuration,,CHEMBL615141,,BAO_0000219,,
29,1,Inhibitory activity against 15-lipoxygenase was determined obtained from soya bean,soya bean,8,12054,,H,Autocuration,,CHEMBL615142,,BAO_0000357,,
30,1,Inhibitory activity against soybean 15-lipoxygenase was evaluated,Glycine max,8,12054,,H,Autocuration,,CHEMBL615143,,BAO_0000357,,
31,1,Inhibitory activity against soybean 15-lipoxygenase was evaluated at 100 uM,Glycine max,8,12054,,H,Autocuration,,CHEMBL615144,,BAO_0000357,,
32,1,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 10 uM,Glycine max,8,12054,,H,Autocuration,,CHEMBL872867,,BAO_0000357,,
33,1,The compound was tested for the in vitro inhibition of 15-lipoxygenase of soybean at a concentration of 100 uM,Glycine max,8,12054,,H,Autocuration,,CHEMBL615145,,BAO_0000357,,
34,1,Compound was tested in vitro for inhibition of 15-lipoxygenase soybean,Glycine max,8,12054,,H,Autocuration,,CHEMBL615146,,BAO_0000357,,
35,1,Compound at 100 uM was tested in vitro for inhibition of 15-lipoxygenase soybean,Glycine max,8,12054,,H,Autocuration,,CHEMBL615147,,BAO_0000357,,
36,1,Inhibition of cytochrome P450 progesterone 16-alpha hydroxylase,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615148,,BAO_0000019,,
37,1,Binding affinity against bacterial 16S rRNA using mass spectrometry based assay,Escherichia coli,0,22226,,U,Autocuration,,CHEMBL615149,,BAO_0000019,,
38,1,Dissociation constant with dimeric 16S rRNA RNA construct B,,0,22226,,U,Autocuration,,CHEMBL615150,,BAO_0000019,,
39,1,Dissociation constant towards 16S rRNA construct A,,3,22222,,M,Intermediate,,CHEMBL615151,,BAO_0000225,,
40,1,Dissociation constant towards 16S rRNA construct B,,3,22222,,M,Intermediate,,CHEMBL615152,,BAO_0000225,,
41,1,Binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli,Escherichia coli,3,100263,,M,Expert,,CHEMBL615153,,BAO_0000225,,
42,1,Binding affinity for the 16S ribosomal RNA A-site of Escherichia coli,Escherichia coli,3,100263,,M,Expert,,CHEMBL615154,,BAO_0000225,,
43,1,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,8,13053,,H,Autocuration,,CHEMBL615155,,BAO_0000019,,
44,1,Inhibitory constant against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,8,13053,,H,Autocuration,,CHEMBL615156,,BAO_0000019,,
45,1,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,Homo sapiens,8,20001,,H,Autocuration,,CHEMBL615157,,BAO_0000019,,
46,1,The compound was tested at a concentration of 1 uM for inhibitory activity against 17 beta-hydroxysteroid dehydrogenase from human placental microsomes,Homo sapiens,8,20001,,H,Autocuration,,CHEMBL615158,,BAO_0000019,,
47,1,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",Rattus norvegicus,9,12971,,D,Expert,,CHEMBL615159,,BAO_0000019,,
48,1,"Inhibition of 17-alpha-hydroxylase/17,20 lyase from rat testes microsomal preparation",Rattus norvegicus,9,12971,,D,Expert,,CHEMBL615172,,BAO_0000019,,
49,1,"Percent inhibition of 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",Rattus norvegicus,9,12971,,D,Expert,,CHEMBL615173,,BAO_0000019,,
50,1,"Percent inhibition of Steroid 17-alpha-hydroxylase/17,20 lyase of rat testes microsomes at 100 uM",Rattus norvegicus,9,12971,,D,Expert,,CHEMBL615174,,BAO_0000019,,
51,1,Inhibitory activity against human placenta 17-beta-hydroxysteroid dehydrogenase type 2 (17-beta-HSD type 2),,8,13053,,H,Autocuration,,CHEMBL884518,,BAO_0000019,,
52,1,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1),,8,11512,,H,Autocuration,,CHEMBL615175,,BAO_0000357,,
53,1,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 1 uM concentration,,8,11512,,H,Autocuration,,CHEMBL615176,,BAO_0000357,,
54,1,Compound was tested for the inhibition of 17-beta-hydroxysteroid dehydrogenase type 1(17-beta-HSD type 1) at 10 uM concentration,,8,11512,,H,Autocuration,,CHEMBL615177,,BAO_0000357,,
55,1,Selectivity ratio of binding affinity towards mu to delta receptors of rat brain membranes,Rattus norvegicus,5,104740,Membranes,D,Autocuration,,CHEMBL615178,,BAO_0000249,,
56,1,Cytotoxicity against ovarian cancer cell line (1A-9) of humans was determined,Homo sapiens,1,80002,,N,Intermediate,,CHEMBL615179,506.0,BAO_0000219,,
57,1,Functional antagonism by electrical assays in Xenopus oocytes expressing 1A/2A NMDA receptor subtype,Rattus norvegicus,7,104835,,D,Autocuration,,CHEMBL615180,,BAO_0000219,,
58,1,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2B NMDA receptor,Rattus norvegicus,7,104821,,D,Autocuration,,CHEMBL615181,,BAO_0000219,,
59,1,Functional antagonism by electrical assays in Xenopus oocytes expressing the 1A/2C NMDA receptor,Rattus norvegicus,7,104848,,D,Autocuration,,CHEMBL615182,,BAO_0000219,,
60,1,In vitro effective concentration required to reduce the number of human ovarian cancer (1A9) after 3-day incubation,Homo sapiens,1,80002,,N,Expert,,CHEMBL615183,506.0,BAO_0000219,,
61,1,In vitro effective concentration required to reduce the number of human ovarian cancer cells (1A9) after 3-day incubation,Homo sapiens,1,80002,,N,Intermediate,,CHEMBL615184,506.0,BAO_0000219,,
62,1,Cytotoxic activity against human ovarian cancer (1A9) cell line,Homo sapiens,1,80002,,N,Intermediate,,CHEMBL615185,506.0,BAO_0000219,,
63,1,Cytotoxic activity against human ovarian cancer (1A9) cell line; ND=Not determined,Homo sapiens,1,80002,,N,Intermediate,,CHEMBL615186,506.0,BAO_0000219,,
64,1,Effective dose of compound against replication of 1A9 cell line was evaluated,Homo sapiens,1,80002,,N,Intermediate,,CHEMBL615187,506.0,BAO_0000219,,
65,1,In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line,Homo sapiens,1,80002,,N,Expert,,CHEMBL885343,506.0,BAO_0000219,,
66,1,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line),Homo sapiens,1,80002,,N,Intermediate,,CHEMBL615188,506.0,BAO_0000219,,
67,1,In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line); NA is not active,Homo sapiens,1,80002,,N,Intermediate,,CHEMBL615189,506.0,BAO_0000219,,
68,1,In vitro percent inhibition evaluated against human ovarian cancer (1A9 cell line) at >20 ug/mL,Homo sapiens,1,80002,,N,Intermediate,,CHEMBL615190,506.0,BAO_0000219,,
69,1,Inhibitory activity against Taxol resistant 1A9 cell lines,Homo sapiens,1,80002,,N,Intermediate,,CHEMBL615191,506.0,BAO_0000219,,
70,1,Cytotoxicity against human ovarian cancer (1A9) cell lines.,Homo sapiens,1,80002,,N,Expert,,CHEMBL615192,506.0,BAO_0000219,,
71,1,Percentage inhibition of human ovarian cancer (1A9) cell lines.,Homo sapiens,1,80002,,N,Expert,,CHEMBL827083,506.0,BAO_0000219,,
72,1,Effective dose required for inhibitory activity against 1A9 human tumor cell line.,Homo sapiens,1,80002,,N,Expert,,CHEMBL615193,506.0,BAO_0000219,,
73,1,Percent inhibition against 1A9 human tumor cell line at 0.10 ug/mL,Homo sapiens,1,80002,,N,Intermediate,,CHEMBL615194,506.0,BAO_0000219,,
74,1,Percent inhibition against 1A9 human tumor cell line at <0.00008 ug/mL,Homo sapiens,1,80002,,N,Intermediate,,CHEMBL615195,506.0,BAO_0000219,,
75,1,Percent inhibition against 1A9 human tumor cell line at >10 ug/mL,Homo sapiens,1,80002,,N,Intermediate,,CHEMBL615196,506.0,BAO_0000219,,
76,1,Inhibitory concentration against Jurkat cells,Homo sapiens,1,81072,,N,Intermediate,,CHEMBL615197,503.0,BAO_0000219,,
77,1,In vitro anticancer activity against 2 NCI SCLC cell lines; inactive,,0,22226,,U,Intermediate,,CHEMBL615198,,BAO_0000019,,
78,1,Inhibition of cytochrome P450 progesterone 2-alpha-hydroxylase,Rattus norvegicus,9,100121,,D,Expert,,CHEMBL615199,,BAO_0000357,,
79,1,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",,8,11231,,H,Expert,,CHEMBL615200,,BAO_0000357,,
80,1,"In vitro inhibition of human 2,3-oxidosqualene cyclase.",,8,11231,,H,Expert,,CHEMBL615201,,BAO_0000357,,
81,1,"In vitro inhibition of human 2,3-oxidosqualene cyclase at 100 nM.",,8,11231,,H,Expert,,CHEMBL615202,,BAO_0000357,,
82,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Candida albicans microsomes",Candida albicans,8,11231,Microsomes,H,Autocuration,,CHEMBL615203,,BAO_0000251,,
83,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Candida albicans microsomes",Candida albicans,8,11231,Microsomes,H,Autocuration,,CHEMBL615204,,BAO_0000251,,
84,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in Saccharomyces cerevisiae microsomes",Saccharomyces cerevisiae,8,11231,Microsomes,H,Autocuration,,CHEMBL615205,,BAO_0000251,,
85,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in Saccharomyces cerevisiae microsomes",Saccharomyces cerevisiae,8,11231,Microsomes,H,Autocuration,,CHEMBL615206,,BAO_0000251,,
86,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in pig liver microsomes",Sus scrofa,8,12083,Microsomes,H,Autocuration,,CHEMBL615207,,BAO_0000251,2107.0,
87,1,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase",Rattus norvegicus,8,11231,,H,Autocuration,,CHEMBL827084,,BAO_0000019,,
88,1,"Concentration required to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase (OSC)",Rattus norvegicus,8,11231,,H,Autocuration,,CHEMBL615208,,BAO_0000019,,
89,1,"Evaluated for its activity to inhibit rat liver 2,3-oxidosqualene-lanosterol cyclase, activity expressed as Ki",Rattus norvegicus,8,11231,,H,Autocuration,,CHEMBL615209,,BAO_0000019,,
90,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene cyclase in rat liver microsomes",Rattus norvegicus,9,12083,Microsomes,D,Autocuration,,CHEMBL615210,,BAO_0000251,2107.0,
91,1,"Compound was evaluated for the inhibition of microsomal 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",Rattus norvegicus,9,12083,Microsomes,D,Autocuration,,CHEMBL615211,,BAO_0000251,2107.0,
92,1,"Compound was evaluated for inhibitory activity against 2,3-oxidosqualene-lanosterol cyclase in rat liver microsomes",Rattus norvegicus,9,12083,Microsomes,D,Autocuration,,CHEMBL615212,,BAO_0000251,2107.0,
93,1,Molar concentration needed to give 50% prevention of 2-5A (Adenosine dependent endoribonuclease),,8,11377,,H,Expert,,CHEMBL615213,,BAO_0000357,,
94,1,Molar concentration required to displace 50% of the radiolabeled probe from 2-5A (Adenosine dependent endoribonuclease) in endonuclease-nitrocellulose complex,,8,11377,,H,Expert,,CHEMBL615273,,BAO_0000357,,
95,1,In vitro cytotoxic concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,Homo sapiens,1,81020,,N,Expert,,CHEMBL615274,726.0,BAO_0000219,,
96,1,50% Effective concentration of compound required for inhibiting intracellular viral replicative intermediate DNA in HBV-transfected 2.2.15 cell line.,Homo sapiens,1,81020,,N,Intermediate,,CHEMBL615275,726.0,BAO_0000219,,
97,1,Antiviral activity against Hepatitis B virus in 2.2.15 cell line,Homo sapiens,1,81020,,N,Intermediate,,CHEMBL615276,726.0,BAO_0000219,,
98,1,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells,Homo sapiens,1,81020,,N,Intermediate,,CHEMBL615277,726.0,BAO_0000219,,
99,1,In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells; Not determined,Homo sapiens,1,81020,,N,Intermediate,,CHEMBL615326,726.0,BAO_0000219,,
100,1,In vitro effective concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line,Hepatitis B virus,1,50606,,N,Expert,,CHEMBL883130,,BAO_0000218,,
101,1,Ability to inhibit the episomal HBV-DNA in 2.2.15 cells.,Homo sapiens,1,81020,,N,Intermediate,,CHEMBL884519,726.0,BAO_0000219,,
102,1,Concentration required to inhibit 50% of 2.2.15 cell line,Homo sapiens,1,81020,,N,Intermediate,,CHEMBL615327,726.0,BAO_0000219,,
103,1,Anti viral activity against 2.2.15 cells (concentration required to reduce the log phase cell growth by 50%).,Homo sapiens,1,81020,,N,Intermediate,,CHEMBL615328,726.0,BAO_0000219,,
104,1,Cytotoxic activity of compound against uninfected 2.2.15 cells.,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL615329,,BAO_0000218,,
105,1,Anti hepatitis-B virus activity was evaluated in 2.2.15 cells.,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL615330,,BAO_0000218,,
106,1,"Inhibition of the replication of HBV in 2.2.15 cells, by DNA hybridization assay",Hepatitis B virus,1,50606,,N,Expert,,CHEMBL615331,,BAO_0000218,,
107,1,In vitro anti-HBV activity in 2.2.15 cells,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL615332,,BAO_0000218,,
108,1,In vitro anti-HBV activity in 2.2.15 cells; Not determined,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL615333,,BAO_0000218,,
109,1,The compound was tested in vitro for the anti-HBV activity against 2.2.15 cells,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL615334,,BAO_0000218,,
110,1,The compound was tested in vitro for the anti-HBV activity in 2.2.15 cells,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL615335,,BAO_0000218,,
111,1,Cytotoxicity in 2.2.15 cells,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL615336,,BAO_0000218,,
112,1,Cytotoxicity in 2.2.15 cells; Not determined,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL615337,,BAO_0000218,,
113,1,Inhibitory activity of compound against hepatitis B virus (HBV) in growing cultures of 2.2.15 cells,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL615338,,BAO_0000218,,
114,1,The growth inhibition activity for the compound was evaluated in 2.2.15 cells.,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL615339,,BAO_0000218,,
115,1,Selectivity index was determined from the ratio of IC50 to the EC50 values evaluated in 2.2.15 cells.,Homo sapiens,1,50587,,N,Intermediate,,CHEMBL615340,,BAO_0000218,,
116,1,Antiviral activity against HBV was determined in 2.215 cell line,Homo sapiens,1,81020,,N,Intermediate,,CHEMBL615341,726.0,BAO_0000219,,
117,1,Inhibition of 20-HETE synthesis in human renal microsomes,Homo sapiens,0,22226,Microsomes,U,Autocuration,,CHEMBL615342,,BAO_0000251,,
118,1,Inhibitory activity against 20-HETE production from arachidonic acid using human renal microsome 20-HETE synthase.,,0,22226,,U,Autocuration,,CHEMBL615343,,BAO_0000019,,
119,1,Inhibitory concentration against 2008 (ovarian) cells,Homo sapiens,1,80612,,N,Intermediate,,CHEMBL615344,388.0,BAO_0000219,,
120,1,50% Growth inhibitory concentration( GI 50 ) by using 2008 human ovarian carcinoma cell lines.,Homo sapiens,1,80612,,N,Intermediate,,CHEMBL615345,388.0,BAO_0000219,,
121,1,Compound was tested for 50% growth inhibitory concentration by using human ovarian carcinoma cell lines (2008),Homo sapiens,1,80612,,N,Intermediate,,CHEMBL615346,388.0,BAO_0000219,,
122,1,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells,Homo sapiens,1,80612,,N,Intermediate,,CHEMBL615347,388.0,BAO_0000219,,
123,1,Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells; not detected,Homo sapiens,1,80612,,N,Intermediate,,CHEMBL615348,388.0,BAO_0000219,,
124,1,In vitro inhibition of 2008/R ovarian cancer cell line,Homo sapiens,1,80613,,N,Intermediate,,CHEMBL827085,561.0,BAO_0000219,,
125,1,In vitro inhibition of 2008/R ovarian cancer cell line; NA= Not achievable,Homo sapiens,1,80613,,N,Intermediate,,CHEMBL615349,561.0,BAO_0000219,,
126,1,In vitro inhibition of 2008/S ovarian cancer cell line,Homo sapiens,1,80614,,N,Intermediate,,CHEMBL615350,389.0,BAO_0000219,,
127,1,In vitro inhibition of 2008/S ovarian cancer cell line; NA= Not achievable,Homo sapiens,1,80614,,N,Intermediate,,CHEMBL615351,389.0,BAO_0000219,,
128,1,Tested in vitro for inhibition of chymotrypsin like activity of purified human 20S proteasome,Homo sapiens,2,100256,,S,Expert,,CHEMBL615352,,BAO_0000220,,
129,1,Compound was evaluated for inhibitory activity against 20S proteasome from human liver and brain,Homo sapiens,2,100256,,S,Intermediate,,CHEMBL615353,,BAO_0000220,,
130,1,Inhibition of chymotrypsin-like activity of 20S proteasome,,2,100256,,S,Expert,,CHEMBL615354,,BAO_0000220,,
131,1,Inhibition of chymotrypsin-like activity of 20S proteasome; value ranges from 10-20 uM,,2,100256,,S,Expert,,CHEMBL615355,,BAO_0000220,,
132,1,Inhibitory activity against 20S proteosome,,2,100256,,S,Intermediate,,CHEMBL615356,,BAO_0000220,,
133,1,Compound was tested for inhibitory activity against tryptase,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615357,,BAO_0000019,,
134,1,Concentration required to inhibit 50% of extracellular circular replication of HBV DNA using 2215 cell line,Homo sapiens,1,81020,,N,Intermediate,,CHEMBL615358,726.0,BAO_0000219,,
135,1,Concentration required to inhibit 50% of intracellular circular replication of HBV DNA using 2215 cell line,Homo sapiens,1,81020,,N,Intermediate,,CHEMBL827086,726.0,BAO_0000219,,
136,1,Compound was tested for the inhibition of Alpha-glucosidase,,0,22226,,U,Autocuration,,CHEMBL615359,,BAO_0000019,,
137,1,Inhibitory concentration against human neutrophil elastase (HNE),,8,235,,H,Autocuration,,CHEMBL615360,,BAO_0000357,,
138,1,Change in heart rate was expressed in percent at at a dose 0.002 mg/kg iv in anesthetized rat,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615361,,BAO_0000218,948.0,
139,1,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,,8,19640,,H,Autocuration,,CHEMBL615362,,BAO_0000019,,
140,1,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,,8,19640,,H,Expert,,CHEMBL615363,,BAO_0000019,,
141,1,Minimum inhibitory concentration of compound against 20 Mycobacterium avium complex (MAC) clinical isolates,,8,19640,,H,Autocuration,,CHEMBL615364,,BAO_0000357,,
142,1,90% inhibition of the 20 Mycobacterium avium complex (MAC) clinical isolates,,8,19640,,H,Expert,,CHEMBL615365,,BAO_0000019,,
143,1,In Vitro evaluation for the growth inhibition of Subline (P388/AMSA) Leukemia cell lines,Mus musculus,1,80360,,N,Intermediate,,CHEMBL615366,524.0,BAO_0000219,,
144,1,In Vitro evaluation for the growth inhibition of Subline (P388/CP) Leukemia cell lines,Mus musculus,1,80360,,N,Intermediate,,CHEMBL615367,524.0,BAO_0000219,,
145,1,Compound was evaluated for the inhibition of cell replication human peripheral blood lymphocytes (PBL's).,Homo sapiens,1,80384,,N,Intermediate,,CHEMBL615368,554.0,BAO_0000219,,
146,1,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells,Ovis aries,0,22226,,U,Autocuration,,CHEMBL615369,,BAO_0000019,,
147,1,Compound was evaluated for the inhibition of cell replication sheep choroid plexus (SCP) cells.,Ovis aries,0,22226,,U,Autocuration,,CHEMBL615370,,BAO_0000019,,
148,1,Compound is evaluated in vitro for the inhibition single mutant of HIV-1 RT (Y181C),,8,191,,H,Autocuration,,CHEMBL615673,,BAO_0000357,,
149,1,Compound was evaluated for its inhibitory effect on thymidine [3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-5,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615674,,BAO_0000019,,
150,1,Compound was evaluated for its inhibitory effect on thymidine [3H]-dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-6,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615675,,BAO_0000019,,
151,1,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in at conc. 10e-7,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615676,635.0,BAO_0000219,,
152,1,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM cells in culture at conc. 10e-4,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615677,635.0,BAO_0000219,,
153,1,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-5,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615678,635.0,BAO_0000219,,
154,1,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM cells in culture at conc. 10e-6,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615679,635.0,BAO_0000219,,
155,1,Compound was evaluated for its inhibitory effect on thymidine ([3H]-dThd) incorporation into DNA of CEM/MTX cells in at conc. 10e-7.,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615680,,BAO_0000019,,
156,1,Compound was evaluated for its inhibitory effect on thymidine ([3H]dThd) incorporation into DNA of CEM/MTX cells in culture at conc. 10e-4,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615681,,BAO_0000019,,
157,1,In vitro binding affinity towards (alpha-4)2(beta-2)3 neuronal nicotinic acetylcholine receptor in P2 membrane fractions of rat forebrain,,6,104290,,H,Autocuration,,CHEMBL857972,,BAO_0000249,,
158,1,Minimum inhibitory concentration of compound against Streptococcus pyogenus septicemia in the mouse,Streptococcus pyogenes,1,50264,,N,Intermediate,,CHEMBL857899,,BAO_0000218,,
159,1,Antiviral activity against 07/1 strain of thymidine kinase negative (TK-) Varicella-Zoster Virus (VZV),Human herpesvirus 3,1,50527,,N,Intermediate,,CHEMBL615371,,BAO_0000218,,
160,1,Antiviral activity against 07/1 strain of VZV in HEL (human erythroleukemia) cells.,vericilla zoster virus,1,50527,,N,Expert,,CHEMBL615372,468.0,BAO_0000218,,
161,1,Antiviral activity against 07/1 strain of VZV; ND: No data,vericilla zoster virus,1,50527,,N,Intermediate,,CHEMBL615373,,BAO_0000218,,
162,1,Antiviral activity against 07/1 strain of VZV; ND=No data,vericilla zoster virus,1,50527,,N,Intermediate,,CHEMBL615374,,BAO_0000218,,
163,1,"Antibacterial activity was determined against gram negative organism, Enterobacter cloacae (MA2646)",escherichia cloac,1,50145,,N,Intermediate,,CHEMBL615375,,BAO_0000218,,
164,1,Ratio of Ki at A2 to Ki at A1 receptors,,0,22226,,U,Autocuration,,CHEMBL615376,,BAO_0000019,,
165,1,"In vitro inhibition of 1,3-beta-glucan synthase in Candida albicans membrane assay.",Candida albicans,8,11143,,H,Expert,,CHEMBL615377,,BAO_0000249,,
166,1,"Inhibition of 1,3-beta-glucan synthase",Candida glabrata CBS 138,8,18077,,H,Expert,,CHEMBL615378,,BAO_0000357,,
167,1,Inhibition of growth of 1-87 human tumor cell line,Homo sapiens,1,80609,,N,Intermediate,,CHEMBL615379,832.0,BAO_0000219,,
168,1,Inhibition of 1-lipoxygenase (LOX)in RBL cells,Rattus norvegicus,9,12166,,D,Expert,,CHEMBL615380,,BAO_0000219,,
169,1,Inhibitory activity against soybean 1-lipoxygenase (SLO),Glycine max,9,100171,,D,Autocuration,,CHEMBL615381,,BAO_0000357,,
170,1,Inhibitory activity against soybean 1-lipoxygenase (SLO); no effect,Glycine max,9,100171,,D,Autocuration,,CHEMBL615382,,BAO_0000357,,
171,1,% inhibition against soybean 1-lipoxygenase (SLO),Glycine max,9,100171,,D,Autocuration,,CHEMBL615383,,BAO_0000357,,
172,1,percent inhibition against soybean 1-lipoxygenase (SLO);NI is no inhibition,Glycine max,9,100171,,D,Autocuration,,CHEMBL615384,,BAO_0000357,,
173,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 10:90,Glycine max,9,100171,,D,Autocuration,,CHEMBL615385,,BAO_0000357,,
174,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 1:99,Glycine max,9,100171,,D,Autocuration,,CHEMBL615386,,BAO_0000357,,
175,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 25:75,Glycine max,9,100171,,D,Autocuration,,CHEMBL615387,,BAO_0000357,,
176,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 35:65,Glycine max,9,100171,,D,Autocuration,,CHEMBL615388,,BAO_0000357,,
177,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 50:50,Glycine max,9,100171,,D,Autocuration,,CHEMBL615214,,BAO_0000357,,
178,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 76:24,Glycine max,9,100171,,D,Autocuration,,CHEMBL827087,,BAO_0000357,,
179,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 87:13,Glycine max,9,100171,,D,Autocuration,,CHEMBL615215,,BAO_0000357,,
180,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 89:11,Glycine max,9,100171,,D,Autocuration,,CHEMBL615216,,BAO_0000357,,
181,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 95:5,Glycine max,9,100171,,D,Autocuration,,CHEMBL615217,,BAO_0000357,,
182,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 97:3,Glycine max,9,100171,,D,Autocuration,,CHEMBL615218,,BAO_0000357,,
183,1,Ratio of proximal to distal region oxidation by 1-lipoxygenase isolated from soybean; Ratio of proximal and distal was 99:1,Glycine max,9,100171,,D,Autocuration,,CHEMBL615219,,BAO_0000357,,
184,1,Evaluated for inhibitory activity on 10-formyltetrahydrofolate synthetase(L cell) at folate substrate concentration of 100 uM,Mus musculus,0,22226,,U,Autocuration,,CHEMBL615220,,BAO_0000019,,
185,1,Cells were harvested and were assayed for luciferase and -galactosidase activities (Transcriptional activity),Mus musculus,1,80049,,N,Intermediate,,CHEMBL615221,294.0,BAO_0000219,,
186,1,In vitro anticancer activity against 11 NCI NSCLC cell lines; inactive,,0,22226,,U,Intermediate,,CHEMBL615222,,BAO_0000019,,
187,1,In vitro inhibitory activity against human 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),,8,11489,,H,Autocuration,,CHEMBL615223,,BAO_0000357,,
188,1,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA),,8,11862,,H,Autocuration,,CHEMBL615224,,BAO_0000357,,
189,1,In vitro inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 1 using scintillation proximity assay (SPA).,,8,11862,,H,Autocuration,,CHEMBL615225,,BAO_0000357,,
190,1,Ability to convert [3H]cortisol to the tritium labeled cortisone in the presence of human 11 beta hydroxysteroid dehydrogenase type 2,,8,11489,,H,Autocuration,,CHEMBL615226,,BAO_0000357,,
191,1,Inhibitory activity against mouse 11 beta hydroxysteroid dehydrogenase type 2 at a concentration of 0.2 mM; NI means no inhibition,,8,11862,,H,Autocuration,,CHEMBL615227,,BAO_0000357,,
192,1,Evaluated for inhibition of bovine adrenal cortical mitochondrial 11 beta-hydroxylase,Bos taurus,9,12347,,D,Expert,,CHEMBL615228,,BAO_0000019,,
193,1,Effect on adrenal 11-beta-hydroxylase activity at 10e-4 M; No significant effect,Rattus norvegicus,9,100120,,D,Expert,,CHEMBL615229,,BAO_0000357,,
194,1,Inhibition of 11 beta-hydroxylase from rat adrenal gland,Rattus norvegicus,9,100120,,D,Expert,,CHEMBL615230,,BAO_0000357,2369.0,
195,1,Inhibition of rat adrenal 11-beta-hydroxylase,Rattus norvegicus,9,100120,,D,Expert,,CHEMBL615231,,BAO_0000357,,
196,1,Inhibition of rat adrenal 11-beta-hydroxylase,Rattus norvegicus,9,100120,,D,Expert,,CHEMBL884520,,BAO_0000357,,
197,1,Inhibition of rat adrenal 11-beta-hydroxylase at 10e-5 M,Rattus norvegicus,9,100120,,D,Expert,,CHEMBL615232,,BAO_0000357,,
198,1,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 1 of wistar rat liver cytosol at 10 uM was determined using [3H]cortisone,,8,10328,,H,Autocuration,,CHEMBL615233,,BAO_0000019,,
199,1,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,,8,11490,,H,Autocuration,,CHEMBL827088,,BAO_0000357,,
200,1,Percent inhibition against 11-beta-hydroxysteroid dehydrogenase 2 of wistar rat kidney at 10 uM was determined using [3H]cortisol,,8,11490,,H,Autocuration,,CHEMBL615234,,BAO_0000357,,
201,1,Compound was tested for the percent of inhibition against 12-LO at 10 uM,,8,11134,,H,Autocuration,,CHEMBL615235,,BAO_0000019,,
202,1,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,8,12052,,H,Autocuration,,CHEMBL615236,,BAO_0000019,,
203,1,Compound was tested in vitro for inhibition of 12-LO human platelet,,8,11134,,H,Autocuration,,CHEMBL615237,,BAO_0000019,,
204,1,Inhibitory concentration against human platelet 12-lipoxygenase,,8,11134,,H,Autocuration,,CHEMBL615238,,BAO_0000019,,
205,1,Compound at 100 uM was tested in vitro for inhibition of 12-LO human platelet,,8,11134,,H,Autocuration,,CHEMBL615239,,BAO_0000019,,
206,1,Inhibitory concentration against human platelet 12-lipoxygenase,Homo sapiens,9,11134,,D,Autocuration,,CHEMBL615240,,BAO_0000019,,
207,1,Tested for inhibition of 12-LO (12-lipoxygenase) as an inhibitor of 12(S)-HETE biosynthesis in mouse epidermal homogenates,,8,11835,,H,Expert,,CHEMBL615241,,BAO_0000019,,
208,1,Inhibitory activity against conversion of [1-14C]arachidonic acid to 12-HPETE and its reduction product 12-HETE by porcine leukocyte type 12-lipoxygenase,,8,11601,,H,Expert,,CHEMBL615242,,BAO_0000357,,
209,1,Inhibitory activity against human platelet 12-lipoxygenase (12-HLO),,8,11134,,H,Autocuration,,CHEMBL615243,,BAO_0000019,,
210,1,Inhibitory activity against human platelet 12-lipoxygenase,,8,11134,,H,Autocuration,,CHEMBL615244,,BAO_0000019,,
211,1,Inhibitory activity against human platelet 12-lipoxygenase was evaluated,,8,11134,,H,Autocuration,,CHEMBL615245,,BAO_0000019,,
212,1,% inhibition against human platelet 12-lipoxygenase (12-HLO),,8,11134,,H,Autocuration,,CHEMBL615246,,BAO_0000019,,
213,1,Inhibitory activity against human platelet 12-lipoxygenase was evaluated at 100 uM,,8,11134,,H,Autocuration,,CHEMBL615247,,BAO_0000019,,
214,1,percent inhibition against human platelet 12-lipoxygenase (12-HLO); NI is no inhibition,,8,11134,,H,Autocuration,,CHEMBL615248,,BAO_0000019,,
215,1,Inhibitory activity towards porcine 12-lipoxygenase,,8,11601,,H,Autocuration,,CHEMBL615249,,BAO_0000357,,
216,1,Tested for inhibition against porcine 12-LO,,8,11601,,H,Autocuration,,CHEMBL615250,,BAO_0000357,,
217,1,Inhibition of 12-lipoxygenase was evaluated in rat platelets stimulated by thrombin up to a concentration of 10 uM; NE means No effect,,8,12052,,H,Autocuration,,CHEMBL615251,,BAO_0000019,,
218,1,Inhibitory activity against 12-lipoxygenase in rat platelet rich plasma,,8,12052,,H,Autocuration,,CHEMBL615252,,BAO_0000019,,
219,1,In vitro inhibition of rat platelet 12-lipoxygenase,,8,12052,,H,Expert,,CHEMBL828340,,BAO_0000019,,
220,1,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,8,12052,,H,Autocuration,,CHEMBL615253,,BAO_0000019,,
221,1,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 100 uM,,8,12052,,H,Autocuration,,CHEMBL615254,,BAO_0000019,,
222,1,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 30 uM,,8,12052,,H,Autocuration,,CHEMBL615255,,BAO_0000019,,
223,1,In vitro inhibitory activity against rat platelet 12-lipoxygenase at 10 uM,,8,12052,,H,Autocuration,,CHEMBL615256,,BAO_0000019,,
224,1,In vitro inhibitory activity against rat platelet 12-lipoxygenase,,8,12052,,H,Autocuration,,CHEMBL615257,,BAO_0000019,,
225,1,The compound was tested for the in vitro inhibition of platelet 12-lipoxygenase at a concentration of 100 uM,,8,12052,,H,Autocuration,,CHEMBL615258,,BAO_0000019,,
226,1,Cytotoxic activity in a panel of Human ovarian tumor 41M cell line after 96h of drug exposure,Homo sapiens,1,80007,,N,Intermediate,,CHEMBL615259,621.0,BAO_0000219,,
227,1,In vitro antitumor activity against 41M cell line.,Homo sapiens,1,80007,,N,Expert,,CHEMBL615260,621.0,BAO_0000219,,
228,1,cytotoxicity against 41M cells incubated for 24 hr in MTT assay.,Homo sapiens,1,80007,,N,Intermediate,,CHEMBL615261,621.0,BAO_0000219,,
229,1,Cytotoxic activity in a panel of Human ovarian tumor 41M/CDDP cell line after 96h of drug exposure,Homo sapiens,1,80007,,N,Intermediate,,CHEMBL615262,621.0,BAO_0000219,,
230,1,In vitro antitumor activity against 41McisR cell line.,Homo sapiens,1,80007,,N,Expert,,CHEMBL615263,621.0,BAO_0000219,,
231,1,Resistant factor was determined between IC50 of cisplatin-resistant human tumor cell lines to that of 41McisR cell line,Homo sapiens,1,80007,,N,Expert,,CHEMBL838393,621.0,BAO_0000219,,
232,1,cytotoxicity against 41McisR cells incubated for 24 hr in MTT assay,Homo sapiens,1,80007,,N,Intermediate,,CHEMBL615264,621.0,BAO_0000219,,
233,1,Inhibition of 5'-inosine monophosphate dehydrogenase type I (IMPDH I),Homo sapiens,9,84,,D,Expert,,CHEMBL615265,,BAO_0000357,,
234,1,Inhibition of 5'-inosine monophosphate dehydrogenase type II (IMPDH II),Homo sapiens,9,68,,D,Expert,,CHEMBL615266,,BAO_0000357,,
235,1,Inhibitory activity against inosine 5'-inosine monophosphate dehydrogenase type II (IMPDH II),,8,68,,H,Expert,,CHEMBL615267,,BAO_0000357,,
236,1,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase,,8,10201,,H,Expert,,CHEMBL615268,,BAO_0000357,,
237,1,Equilibrium dissociation constant towards human 5'-methylthioadenosine phosphorylase; nd = Not determined,,8,10201,,H,Expert,,CHEMBL615269,,BAO_0000357,,
238,1,Initial dissociation constant towards human 5'-methylthioadenosine phosphorylase,,8,10201,,H,Expert,,CHEMBL615270,,BAO_0000357,,
239,1,"Evaluated for inhibitory activity on 5,10-Methenyl Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",,8,12220,,H,Autocuration,,CHEMBL615271,,BAO_0000357,,
240,1,"Inhibitory activity against 5,10-methylenetetrahydrofolate dehydrogenase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",Escherichia coli,8,11303,,H,Autocuration,,CHEMBL615272,,BAO_0000357,,
241,1,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM; NT=Not tested",Escherichia coli,8,11303,,H,Autocuration,,CHEMBL615103,,BAO_0000357,,
242,1,"Inhibitory activity against 5,10-Methylene Tetrahydrofolate Cyclohydrolase from Escherichia coli at a concentration of 0.1 mM;NT=Not tested",Escherichia coli,8,11303,,H,Autocuration,,CHEMBL615104,,BAO_0000357,,
243,1,"Evaluated for inhibitory activity on 5,10-Methylene Tetrahydrofolate Cyclohydrolase(L cell) at folate substrate concentration of 100 uM",,8,12220,,H,Autocuration,,CHEMBL615105,,BAO_0000357,,
244,1,"Evaluated for inhibitory activity on 5,10-methylenetetrahydrofolate dehydrogenase(L cell) at folate substrate concentration of 100 uM",,8,12220,,H,Autocuration,,CHEMBL872866,,BAO_0000357,,
245,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",Sus scrofa,8,11303,,H,Autocuration,,CHEMBL615106,,BAO_0000357,,
246,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (A,porcine liver) enzyme.",Sus scrofa,8,11303,,H,Autocuration,,CHEMBL615107,,BAO_0000019,,
247,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-4 M inhibitory concentration",Sus scrofa,8,11303,,H,Autocuration,,CHEMBL615108,,BAO_0000357,,
248,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-5 M inhibitory concentration",Sus scrofa,8,11303,,H,Autocuration,,CHEMBL615109,,BAO_0000357,,
249,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",Sus scrofa,8,11303,,H,Autocuration,,CHEMBL615110,,BAO_0000357,,
250,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",Sus scrofa,8,11303,,H,Autocuration,,CHEMBL840105,,BAO_0000019,,
251,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-5 M inhibitory concentration",Sus scrofa,8,11303,,H,Autocuration,,CHEMBL615111,,BAO_0000019,,
252,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-6 M inhibitory concentration",Sus scrofa,8,11303,,H,Autocuration,,CHEMBL615112,,BAO_0000019,,
253,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-7 M inhibitory concentration",Sus scrofa,8,11303,,H,Autocuration,,CHEMBL615113,,BAO_0000019,,
254,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme.",Sus scrofa,8,11303,,H,Autocuration,,CHEMBL615114,,BAO_0000019,,
255,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (L1210 tumor tissue) enzyme at 10E-6 M inhibitory concentration",Sus scrofa,8,11303,,H,Autocuration,,CHEMBL615115,,BAO_0000357,,
256,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Cyclohydrolase (porcine liver) enzyme at 10E-4 M inhibitory concentration",Sus scrofa,8,11303,,H,Autocuration,,CHEMBL615116,,BAO_0000019,,
257,1,"Compound was tested for in vitro inhibition of 5,10-Methylene Tetrahydrofolate Cyclohydrolase, competitive against (+)-L-5,10-methenyltetrahydrofolate",,8,11303,,H,Autocuration,,CHEMBL615698,,BAO_0000357,,
258,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme at 10E-4 M inhibitory concentration",Sus scrofa,0,22226,,U,Autocuration,,CHEMBL615699,,BAO_0000019,,
259,1,"Percent inhibition was measured against 5,10-Methylene Tetrahydrofolate Reductase (porcine kidney) enzyme.",Sus scrofa,0,22226,,U,Autocuration,,CHEMBL615700,,BAO_0000019,,
260,1,Inhibition of 5-Desaturase involved in ergosterol biosynthesis,Saccharomyces cerevisiae,8,100249,,H,Expert,,CHEMBL615701,,BAO_0000357,,
261,1,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615702,,BAO_0000019,,
262,1,Ability for reversible inhibition of Walker 256 5-Fluoro-2'-deoxyuridine Phosphorylase,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615703,,BAO_0000019,,
263,1,"Irreversible inhibition of Walker 256 FUDR phosphorylase; expressed as Vo/Vi, velocity without inhibitor to that of velocity with inhibitor",Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615704,,BAO_0000019,,
264,1,"Tested for 5-HT 3 receptor antagonist potency by ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",,6,104698,,H,Autocuration,,CHEMBL615705,,BAO_0000019,,
265,1,"Compound was tested for its 5-HT 3 receptor antagonist potency by their ability to inhibit the reflex bradycardia, the Bezold-Jarisch reflex in the rat",,6,104698,,H,Autocuration,,CHEMBL615706,,BAO_0000019,,
266,1,Relative ability to increase cholinergically mediated contractions in isolated ileum of guinea pig,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL615707,,BAO_0000221,2116.0,
267,1,Stimulatory activity of intragastric pressure was tested in the rat,,8,10623,,H,Expert,,CHEMBL615708,,BAO_0000019,,
268,1,% Decrease of 5-HT carrier-receptor -bound radioactivity using paroxetine as a radioligand.,,8,121,,H,Autocuration,,CHEMBL615709,,BAO_0000357,,
269,1,Dose to reduce neuronal firing against 5-HT cells in rats (iv),Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615710,,BAO_0000218,,
270,1,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,,8,12688,,H,Autocuration,,CHEMBL615711,,BAO_0000019,,
271,1,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine,Homo sapiens,9,121,,D,Expert,,CHEMBL615712,,BAO_0000357,,
272,1,Binding affinity at 5-HT reuptake site labeled with [3H]paroxetine; No data,Homo sapiens,9,121,,D,Expert,,CHEMBL836325,,BAO_0000357,,
273,1,Inhibition of high affinity 5-HT uptake at concentration of 1 uM,,8,12198,,H,Autocuration,,CHEMBL615713,,BAO_0000019,,
274,1,Inhibition constant of high-affinity 5-HT uptake,,8,12198,,H,Autocuration,,CHEMBL615714,,BAO_0000357,,
275,1,Michaelis-Menten constant was reported for high affinity transport of 5-HT,,8,12198,,H,Autocuration,,CHEMBL615715,,BAO_0000019,,
276,1,Maximum rate was determined for high affinity transport of 5-HT,,8,12198,,H,Autocuration,,CHEMBL615716,,BAO_0000019,,
277,1,Compound was tested for agonistic activity against 5-HT uptake,,4,104714,,H,Autocuration,,CHEMBL615717,,BAO_0000019,,
278,1,Inhibition affinity against 5-HT-1B receptor in rat frontal cortex using radio binding assay,,8,10577,,H,Expert,,CHEMBL881818,,BAO_0000019,,
279,1,Inhibition affinity against 5-HT-1D receptor in bovine caudate nucleus using radio binding assay,Bos taurus,8,105,,H,Expert,,CHEMBL884540,,BAO_0000357,,
280,1,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,Rattus norvegicus,5,104744,,D,Autocuration,,CHEMBL615718,,BAO_0000224,,
281,1,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1 using [3H]5-HT as radioligand,,4,104744,,H,Autocuration,,CHEMBL615719,,BAO_0000224,,
282,1,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M,,4,104744,Membranes,H,Autocuration,,CHEMBL615720,,BAO_0000249,,
283,1,Percent inhibition of binding of 3.0 nM [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat caudate membranes at 10 e -5 M.,,4,104744,Membranes,H,Autocuration,,CHEMBL615721,,BAO_0000249,,
284,1,Displacement of binding of [3H]-5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,4,104744,,H,Autocuration,,CHEMBL615722,,BAO_0000019,,
285,1,Dose required to reduce neuronal firing of 5-HT1A cells by 50%,,8,51,,H,Autocuration,,CHEMBL615723,,BAO_0000019,,
286,1,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615724,,BAO_0000221,10000000.0,
287,1,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615725,,BAO_0000221,10000000.0,
288,1,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615726,,BAO_0000221,10000000.0,
289,1,Antagonistic activity at postsynaptic 5-HT1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (.26-3.52),,8,10576,,H,Autocuration,,CHEMBL615727,,BAO_0000218,,
290,1,Effect on forskolin stimulated adenylate cyclase activity at 5-HT1D receptor of guinea pig substantia nigra.,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL615728,,BAO_0000019,,
291,1,Binding affinity towards 5-HT1F (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,8,279,,H,Autocuration,,CHEMBL857971,449.0,BAO_0000219,,
292,1,Compound was tested for the displacement of [125I]DOI from clone human 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL615729,,BAO_0000357,,
293,1,Efficacy against 5-hydroxytryptamine 2A receptor,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL615730,,BAO_0000019,,
294,1,Intrinsic activity towards 5-HT2A receptor of rat tail artery,,8,12687,,H,Expert,,CHEMBL615731,,BAO_0000019,,
295,1,Relative potency towards 5-HT2A receptor of rat tail artery,,8,12687,,H,Expert,,CHEMBL615732,,BAO_0000019,,
296,1,Blocking 5-HT2A receptor-mediated contractions of rat tail artery,,8,12687,,H,Expert,,CHEMBL615733,,BAO_0000019,,
297,1,Partial agonism at 5-HT2A receptor was evaluated in presence of ketanserin (3-10 nM) in isolated rat tail artery,,8,12687,,H,Expert,,CHEMBL615734,,BAO_0000019,,
298,1,Compound was tested for the intrinsic activity against 5-HT2A receptors of rat tail artery.,,8,12687,,H,Autocuration,,CHEMBL615735,,BAO_0000019,,
299,1,Effectiveness in blocking 5-HT2A receptor-mediated contractions of rat tail artery,,8,12687,,H,Expert,,CHEMBL615736,,BAO_0000019,,
300,1,Evaluated for the agonistic activity against 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL615737,,BAO_0000221,2116.0,
301,1,Agonistic activity against Serotonin 5-HT4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI),Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL615738,,BAO_0000221,2116.0,
302,1,Evaluated for the agonistic activity against Serotonin 5-HT4 receptor in non-electrically stimulated guinea-pig ileum.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL615739,,BAO_0000221,2116.0,
303,1,The binding affinity was measured on 5-hydroxytryptamine 4 receptor using [3H]- GR-113808 as radioligand.,,8,10623,,H,Autocuration,,CHEMBL615278,,BAO_0000357,,
304,1,Antagonist activity against 5-HT4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,Rattus norvegicus,9,10623,,D,Expert,,CHEMBL615279,,BAO_0000019,,
305,1,Binding affinity against 5-hydroxytryptamine 4 receptor,,8,168,,H,Expert,,CHEMBL615280,,BAO_0000357,,
306,1,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of chick intestine,Gallus gallus,0,22226,,U,Autocuration,,CHEMBL615281,,BAO_0000019,,
307,1,Inhibitory effect (10e-6 M) on the 25-OH-D3-1-hydroxylase activity,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615282,,BAO_0000019,,
308,1,25-OH-D3-1-hydroxylase activity (10e-6 M) was measured as %control,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615283,,BAO_0000019,,
309,1,Relative competitive index values for binding to 25-OH-D3-1-hydroxylase of human HL-60 cells,Homo sapiens,1,80156,,N,Autocuration,,CHEMBL615284,649.0,BAO_0000219,,
310,1,Inhibitory effect (10e-6 M) on the 25-hydroxyvitamin D3-1-hydroxylase activity,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615285,,BAO_0000019,,
311,1,25-hydroxyvitamin D3-1-hydroxylase activity (10e-6 M) was measured as %control,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615286,,BAO_0000019,,
312,1,Displacement of [3H]-Ro- 15-1788 from human GABA-A alpha-1-beta-3-gamma-2 receptor subunits expressed in Xenopus oocytes,Homo sapiens,7,104703,,D,Autocuration,,CHEMBL615287,,BAO_0000219,,
313,1,Chymotryptic inhibitory activity against 26S proteasome,,2,100256,,S,Intermediate,,CHEMBL615288,,BAO_0000220,,
314,1,Inhibitory activity against 26S proteasome degradation of IkB,,2,100256,,S,Intermediate,,CHEMBL615289,,BAO_0000220,,
315,1,In vitro inhibition of 2780/DOX ovarian cancer cell line,Homo sapiens,1,81034,,N,Intermediate,,CHEMBL615290,478.0,BAO_0000219,,
316,1,In vitro inhibition of 2780/S ovarian cancer cell line,Homo sapiens,1,81034,,N,Intermediate,,CHEMBL884522,478.0,BAO_0000219,,
317,1,Relative activity on the cellular accumulation of vincristine in multidrug-resistant (MDR) human ovarian cancer 2780AD cells,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615291,,BAO_0000019,,
318,1,Association constant for binding to AATT 28-mer AATT hairpin,,3,22222,,M,Intermediate,,CHEMBL615292,,BAO_0000225,,
319,1,Kinetically Defined Association Constant for 28-mer AATT hairpin.,,3,22222,,M,Intermediate,,CHEMBL615293,,BAO_0000225,,
320,1,Reaction Rate Parameter for 28-mer AATT hairpin,,3,22222,,M,Intermediate,,CHEMBL615294,,BAO_0000225,,
321,1,Reaction Rate Parameter for 28-mer AATT hairpin,,3,22222,,M,Intermediate,,CHEMBL615295,,BAO_0000225,,
322,1,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 1),Homo sapiens,0,22226,,U,Autocuration,,CHEMBL825021,,BAO_0000019,,
323,1,Antiviral activity against envelope deficient HIV-1 in a single cycle replication assay (experiment 2),Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615296,,BAO_0000019,,
324,1,Inhibitory concentration by single cycle replication assay using envelope deficient HIV-1,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615297,,BAO_0000019,,
325,1,Cytotoxicity against cell line 2SC/20 determined by MTT test,Cricetulus griseus,0,22226,,U,Autocuration,,CHEMBL615298,,BAO_0000019,,
326,1,Cytotoxicity against cell line 2SC/20 of hamster determined by MTT test,Cricetulus griseus,0,22226,,U,Autocuration,,CHEMBL615299,,BAO_0000019,,
327,1,Inhibitory concentration against the growth of 2SC/20 cell line after 72 hr of drug exposure by MTT test,Cricetulus griseus,0,22226,,U,Autocuration,,CHEMBL615300,,BAO_0000019,,
328,1,Binding affinity on 3 beta-hydroxysteroid dehydrogenase,,8,241,,H,Autocuration,,CHEMBL615301,,BAO_0000357,,
329,1,Binding affinity for 3-beta-hydroxysteroid dehydrogenase,Homo sapiens,9,241,,D,Expert,,CHEMBL615302,,BAO_0000357,,
330,1,Selectivity ratio of ID50 in liver and heart,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615303,,BAO_0000019,,
331,1,"Selectivity, ratio of relative ID50 in liver and heart",,8,12132,,H,Autocuration,,CHEMBL615304,,BAO_0000019,,
332,1,Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to T3,,8,12132,,H,Autocuration,,CHEMBL615305,,BAO_0000019,,
333,1,"Binding affinity to the receptor was determined in nuclei of heart In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,8,12132,,H,Autocuration,,CHEMBL615306,,BAO_0000218,,
334,1,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,8,12132,,H,Autocuration,,CHEMBL615307,,BAO_0000218,,
335,1,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,8,12132,,H,Autocuration,,CHEMBL615308,,BAO_0000218,,
336,1,"Binding affinity to the receptor was determined in nuclei of liver in vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,8,12132,,H,Autocuration,,CHEMBL615309,,BAO_0000218,,
337,1,"Binding affinity to the thyroid hormone receptor was determined in vitro in isolated nuclei of rat liver relative to 3,5,3' triiodothyronine",,0,22226,,U,Autocuration,,CHEMBL615310,,BAO_0000019,,
338,1,Binding affinity to the receptor was determined in vitro in isolated nuclei of rat liver relative to T3,,8,12132,,H,Autocuration,,CHEMBL615311,,BAO_0000019,,
339,1,"Binding affinity to thyroid hormone receptor beta, relative to 3,5,3' triiodothyronine receptor, in isolated nuclei of heart",Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615312,,BAO_0000019,,
340,1,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,,8,12132,,H,Autocuration,,CHEMBL615313,,BAO_0000019,,
341,1,In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to T3,,8,12132,,H,Autocuration,,CHEMBL615314,,BAO_0000019,,
342,1,"Binding affinity to the receptor was determined in isolated nuclei of heart(In vitro) relative to 3,5,3' triiodothyronine receptor",,8,12132,,H,Autocuration,,CHEMBL615315,,BAO_0000019,,
343,1,"In vivo binding affinity for 3,5,3'' triiodothyronine receptor of heart nuclei 1 hr after intravenous administration",Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615316,,BAO_0000218,,
344,1,Binding affinity to the receptor was determined in nuclei of heart in vivo 1 hour after intravenous administration relative to T3,,8,12132,,H,Autocuration,,CHEMBL615317,,BAO_0000218,,
345,1,"Binding affinity to the receptor was determined in nuclei of liver In vivo 1 hour after intravenous administration relative to 3,5,3' triiodothyronine receptor",,8,12132,,H,Autocuration,,CHEMBL615318,,BAO_0000218,,
346,1,"In vivo binding affinity for 3,5,3' triiodothyronine receptor of liver nuclei 1 hour after intravenous administration",Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615319,,BAO_0000218,,
347,1,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",,8,12132,,H,Autocuration,,CHEMBL615320,,BAO_0000019,,
348,1,"In vitro binding affinity to the receptor was determined in isolated nuclei of heart relative to 3,5,3' triiodothyronine receptor",,8,12132,,H,Autocuration,,CHEMBL615321,,BAO_0000019,,
349,1,"Inhibition of [125I]L-T3 binding to rat hepatic 3,5,3''-triiodo-L-thyronine receptor",Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615322,,BAO_0000019,,
350,1,Inhibition constant for binding to Co2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,Escherichia coli,8,19690,,H,Autocuration,,CHEMBL615323,,BAO_0000357,,
351,1,Inhibition constant for binding to Zn2+ form of 3-dehydroquinate synthase (DHQ) purified from Escherichia coli,Escherichia coli,8,19690,,H,Autocuration,,CHEMBL615407,,BAO_0000357,,
352,1,Kinetics expressed as Michaelis-Menten constant against Co2+ form of 3-dehydroquinate synthase purified from Escherichia coli,Escherichia coli,8,19690,,H,Autocuration,,CHEMBL857267,,BAO_0000357,,
353,1,Kinetics expressed as Michaelis-Menten constant against Zn2+ form of 3-dehydroquinate synthase purified from Escherichia coli,Escherichia coli,8,19690,,H,Autocuration,,CHEMBL615408,,BAO_0000357,,
354,1,Type of inhibition of 3-dehydroquinate synthase was determined; R - Slowly reversible,,8,19690,,H,Autocuration,,CHEMBL615409,,BAO_0000357,,
355,1,Compound was evaluated for its inhibitory constant against 3-dehydroquinate synthase,,8,19690,,H,Autocuration,,CHEMBL615410,,BAO_0000357,,
356,1,Inhibition constant against 3-dehydroquinate synthase,,8,19690,,H,Autocuration,,CHEMBL615411,,BAO_0000357,,
357,1,Association rate constant against 3-dehydroquinate synthase,,8,19690,,H,Autocuration,,CHEMBL615412,,BAO_0000357,,
358,1,Rate constant against 3-dehydroquinate synthase,,8,19690,,H,Autocuration,,CHEMBL615413,,BAO_0000357,,
359,1,Inhibitory activity against fuc-TVII,,0,22226,,U,Autocuration,,CHEMBL615414,,BAO_0000019,,
360,1,Ability of compound (2.5 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Rattus norvegicus,9,12236,Microsomes,D,Autocuration,,CHEMBL615415,,BAO_0000251,2107.0,
361,1,Ability of compound (2500 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Rattus norvegicus,9,12236,Microsomes,D,Autocuration,,CHEMBL615416,,BAO_0000251,2107.0,
362,1,Ability of compound (250 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Rattus norvegicus,9,12236,Microsomes,D,Autocuration,,CHEMBL615417,,BAO_0000251,2107.0,
363,1,Ability of compound (25 uM) to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Rattus norvegicus,9,12236,Microsomes,D,Autocuration,,CHEMBL615418,,BAO_0000251,2107.0,
364,1,Ability of compound at 0 uM to inhibit the activity of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) using [14C]mevalonate in rat liver microsomes,Rattus norvegicus,9,12236,Microsomes,D,Autocuration,,CHEMBL615419,,BAO_0000251,2107.0,
365,1,Ability of compound to inhibit the activity of 3-hydroxy-3-methylglutarylcoenzyme A(HMGR) reductase in rat liver microsomes,Rattus norvegicus,9,12236,Microsomes,D,Autocuration,,CHEMBL615420,,BAO_0000251,2107.0,
366,1,Percentage inhibition of 3-hydroxy-3-methyl glutaryl coenzyme A reductase in rat liver microsomes at 250 uM,Rattus norvegicus,9,12236,Microsomes,D,Autocuration,,CHEMBL615421,,BAO_0000251,2107.0,
367,1,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 0 uM,Rattus norvegicus,9,12236,Microsomes,D,Autocuration,,CHEMBL615422,,BAO_0000251,2107.0,
368,1,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2.5 uM,Rattus norvegicus,9,12236,Microsomes,D,Autocuration,,CHEMBL615423,,BAO_0000251,2107.0,
369,1,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 2500 uM,Rattus norvegicus,9,12236,Microsomes,D,Autocuration,,CHEMBL872868,,BAO_0000251,2107.0,
370,1,Percentage inhibition of 3-hydroxy -3- methyl glutanyl coenzyme A reductase(HMGR) in rat liver microsomes at 25 uM,Rattus norvegicus,9,12236,Microsomes,D,Autocuration,,CHEMBL615424,,BAO_0000251,2107.0,
371,1,Inhibitory activity against 3-phosphoglycerate kinase.,,4,104832,,H,Autocuration,,CHEMBL825022,,BAO_0000224,,
372,1,Binding affinity was evaluated towards 3-phosphoglycerate kinase at 37 degrees Celsius in 0.1 m NaCl pH 7.1,,4,104832,,H,Autocuration,,CHEMBL615425,,BAO_0000224,,
373,1,"Michaelis-Menten constant with 1,3-bisphosphoglyceric acid (1,3-BPG) against 3-phosphoglycerate kinase",,4,104832,,H,Autocuration,,CHEMBL615426,,BAO_0000224,,
374,1,Inhibition of human 3-phosphoinositide-dependent protein kinase 1 at 10 uM,Homo sapiens,9,10612,,D,Expert,,CHEMBL615427,,BAO_0000357,,
375,1,Cytotoxicity on 3677 melanoma cells,Homo sapiens,1,80616,,N,Intermediate,,CHEMBL615428,844.0,BAO_0000219,,
376,1,Cytotoxicity on 3677 melanoma cells in combination with L-49-sFv-bL,Homo sapiens,1,80616,,N,Intermediate,,CHEMBL615429,844.0,BAO_0000219,,
377,1,Antitumor activity against Mouse colon 38 at 500 ug/disk in disk diffusion assay,Mus musculus,1,80617,,N,Intermediate,,CHEMBL615430,700.0,BAO_0000219,,
378,1,Compound was evaluated for inhibition of tumor cell growth using sulforhodamine-B assay in 38 human cell lines,Homo sapiens,0,22226,,U,Intermediate,,CHEMBL615431,,BAO_0000019,,
379,1,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; NT= Not tested,,0,22226,,U,Autocuration,,CHEMBL615432,798.0,BAO_0000218,,
380,1,In vivo antitumor activity against 3B131 intraperitoneally implanted B16 melanoma cells; reproducible significant activity.,,0,22226,,U,Autocuration,,CHEMBL615433,798.0,BAO_0000218,,
381,1,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease,Human rhinovirus 14,9,12464,,D,Expert,,CHEMBL615434,,BAO_0000019,,
382,1,Inhibitory activity against Human RhinoVirus serotype-14 3C Protease; NI means No inhibition to 50 uM,Human rhinovirus sp.,1,50085,,N,Intermediate,,CHEMBL615435,,BAO_0000218,,
383,1,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as KI,human rhinovirus type 14,1,50679,,N,Intermediate,,CHEMBL615436,,BAO_0000218,,
384,1,Compound was evaluated for the inactivation of HRV 14 3C protease activity expressed as kinact,human rhinovirus type 14,1,50679,,N,Intermediate,,CHEMBL615437,,BAO_0000218,,
385,1,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,Human rhinovirus 14,9,12464,,D,Expert,,CHEMBL615438,,BAO_0000019,,
386,1,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,Human rhinovirus 14,9,12464,,D,Expert,,CHEMBL615439,,BAO_0000019,,
387,1,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay,Human rhinovirus 14,9,12464,,D,Expert,,CHEMBL615440,,BAO_0000019,,
388,1,Antiviral activity against human rhinovirus-14 (HRV-14) 3C protease using enzyme assay; inactive,Human rhinovirus 14,9,12464,,D,Expert,,CHEMBL615441,,BAO_0000019,,
389,1,Compound was tested for the inhibitory activity of compound towards human rhinovirus 3C protease,Enterovirus,1,50665,,N,Intermediate,,CHEMBL615641,,BAO_0000218,,
390,1,Compound was tested for the inhibitory activity of compound towards human rhinovirus-16 3C protease,Enterovirus,1,50665,,N,Intermediate,,CHEMBL872065,,BAO_0000218,,
391,1,Compound was tested for the inhibitory activity of compound towards human rhinovirus-2 3C protease,Enterovirus,1,50665,,N,Intermediate,,CHEMBL825023,,BAO_0000218,,
392,1,Compound was tested for the inhibitory activity of compound towards human rhinovirus-89 3C protease,Enterovirus,1,50665,,N,Intermediate,,CHEMBL615642,,BAO_0000218,,
393,1,Inhibition of human rhinovirus 3C protease,Human rhinovirus B,8,12464,,H,Expert,,CHEMBL615643,,BAO_0000357,,
394,1,Compound was tested for inhibition of a proteinase 3CL pro of human coronavirus; Inhibited,Homo sapiens,0,22226,,U,Autocuration,,CHEMBL615644,,BAO_0000019,,
395,1,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 100 mg/kg (Dose range 200-12.5),Mus musculus,1,80619,,N,Intermediate,,CHEMBL615645,833.0,BAO_0000218,,
396,1,Compound tested for activity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose of 128 mg/kg (Dose range 256-16),Mus musculus,1,80619,,N,Intermediate,,CHEMBL615646,833.0,BAO_0000218,,
397,1,Compound tested for toxicity against 3EM 37 Mouse Ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (10/10),Mus musculus,1,80619,,N,Intermediate,,CHEMBL615647,833.0,BAO_0000218,,
398,1,Compound tested for toxicity against 3EM 37 mouse ependymoblastoma after single ip injection on day 1 at optimal dose (OD) of 100 mg/kg on the 5th day after the injection of the compound; (6/6),Mus musculus,1,80619,,N,Intermediate,,CHEMBL615648,833.0,BAO_0000218,,
399,1,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as animal weight difference of the treated and the control (T-C) at OD of 100 mg/kg,Mus musculus,1,80619,,N,Intermediate,,CHEMBL615649,833.0,BAO_0000218,,
400,1,Effect of compound on 3EM 37 mouse ependymoblastoma after single ip injection on day 1 recorded as percentage of cured animals at OD of 100 mg/kg,Mus musculus,1,80619,,N,Intermediate,,CHEMBL615650,833.0,BAO_0000218,,
401,1,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing 15 mg/kg b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615651,847.0,BAO_0000218,,
402,1,In vivo anti-tumor and anti-metastatic activity was measured after oral dosing b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615652,847.0,BAO_0000218,,
403,1,In vivo anti-tumor and anti-metastatic activity following p.o. administration b.i.d. to B6D2F1 mice bearing metastatic 3LL Lewis lung tumor; Not tested.,Mus musculus,1,80620,,N,Expert,,CHEMBL615653,847.0,BAO_0000218,,
404,1,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 1 uM dose,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615654,847.0,BAO_0000219,,
405,1,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 10 uM dose,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615655,847.0,BAO_0000219,,
406,1,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 250 uM dose,Mus musculus,1,80620,,N,Intermediate,,CHEMBL825024,847.0,BAO_0000219,,
407,1,accumulation of compound in 3LL cells was measured with DFMO by HPLC at 50 uM dose,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615656,847.0,BAO_0000219,,
408,1,accumulation of compound in 3LL cells was measured with DFMO by ICP-AES at 50 uM dose,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615657,847.0,BAO_0000219,,
409,1,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 1 uM dose,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615658,847.0,BAO_0000219,,
410,1,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 10 uM dose,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615659,847.0,BAO_0000219,,
411,1,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 250 uM dose,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615660,847.0,BAO_0000219,,
412,1,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615661,847.0,BAO_0000219,,
413,1,accumulation of compound in 3LL cells was measured without DFMO by ICP-AES at 50 uM dose,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615662,847.0,BAO_0000219,,
414,1,Effect on the growth of 3LL cells by DFMO pretreatment at 48 hr incubation,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615663,847.0,BAO_0000219,,
415,1,Effect on the growth of 3LL cells was evaluated using an MTT assay at 48 hour incubation,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615664,847.0,BAO_0000219,,
416,1,Effect on the growth of 3LL cells was evaluated using an MTT assay at 72 hour incubation,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615665,847.0,BAO_0000219,,
417,1,accumulation of compound in 3LL cells was measured without DFMO by HPLC at 50 uM dose,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615666,847.0,BAO_0000219,,
418,1,putrescine levels in 3LL cells after the treatment of 1 uM of Compound,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615667,847.0,BAO_0000219,,
419,1,putrescine levels in 3LL cells after the treatment of 10 uM of Compound,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615668,847.0,BAO_0000219,,
420,1,putrescine levels in 3LL cells after the treatment of 250 uM of Compound,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615669,847.0,BAO_0000219,,
421,1,putrescine levels in 3LL cells after the treatment of 50 uM of Compound,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615670,847.0,BAO_0000219,,
422,1,spermidine levels in 3LL cells after the treatment of 1 uM of Compound,Mus musculus,1,80620,,N,Intermediate,,CHEMBL836739,847.0,BAO_0000219,,
423,1,spermidine levels in 3LL cells after the treatment of 10 uM of Compound,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615671,847.0,BAO_0000219,,
424,1,spermidine levels in 3LL cells after the treatment of 250 uM of Compound,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615672,847.0,BAO_0000219,,
425,1,spermidine levels in 3LL cells after the treatment of 50 uM of Compound,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615791,847.0,BAO_0000219,,
426,1,spermine levels in 3LL cells after the treatment of 1 uM of Compound,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615792,847.0,BAO_0000219,,
427,1,spermine levels in 3LL cells after the treatment of 10 uM of Compound,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615793,847.0,BAO_0000219,,
428,1,spermine levels in 3LL cells after the treatment of 250 uM of Compound,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615794,847.0,BAO_0000219,,
429,1,spermine levels in 3LL cells after the treatment of 50 uM of Compound,Mus musculus,1,80620,,N,Intermediate,,CHEMBL615795,847.0,BAO_0000219,,
430,1,Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50%,Homo sapiens,1,80621,,N,Intermediate,,CHEMBL615590,971.0,BAO_0000219,,
431,1,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible minimal activity,,0,22226,,U,Autocuration,,CHEMBL615591,,BAO_0000218,,
432,1,In vivo antitumor activity against 3M531 is the sarcoma M5076; reproducible significant activity.,,0,22226,,U,Autocuration,,CHEMBL615592,,BAO_0000218,,
433,1,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; NT= Not tested,,0,22226,,U,Autocuration,,CHEMBL615593,,BAO_0000218,,
434,1,In vivo antitumor activity against 3MBG5 subrenal capsule mammary carcinoma MX-1 xenograft; reproducible significant activity.,,0,22226,,U,Autocuration,,CHEMBL615594,,BAO_0000218,,
435,1,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615595,723.0,BAO_0000219,,
436,1,Effective dose required against Trypanosoma cruzi amastigotes in 3T3 Fibroblasts,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615596,723.0,BAO_0000219,,
437,1,Inhibition of 6 nM bombesin induced [3H]thymidine incorporation measured in swiss 3T3 cells using a mitogenicity assay,,8,11169,,H,Expert,,CHEMBL615597,723.0,BAO_0000219,,
438,1,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; na=Not active,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615598,723.0,BAO_0000219,,
439,1,Ability of the peptide to inhibit 6 nM bombesin induced [3H]thymidine incorporation was measured in swiss 3T3 cells using mitogenicity assay; nt=Not tested,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615599,723.0,BAO_0000219,,
440,1,Effective dose against murine 3T3 fibroblasts cells,Mus musculus,1,80951,,N,Expert,,CHEMBL615600,723.0,BAO_0000219,,
441,1,Dose required against murine 3T3 fibroblasts cells; 1-10 uM,Mus musculus,1,80951,,N,Expert,,CHEMBL615601,723.0,BAO_0000219,,
442,1,Cytotoxic effect on 3T3 cells,Mus musculus,1,80951,,N,Expert,,CHEMBL615602,723.0,BAO_0000219,,
443,1,Cytotoxic effect on 3T3 cells,Mus musculus,1,80951,,N,Expert,,CHEMBL615603,723.0,BAO_0000219,,
444,1,Compound was tested for the concentration necessary to inhibit swiss 3T3 Mouse Fibroblast cell growth rate by 50%.,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615604,723.0,BAO_0000219,,
445,1,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615605,723.0,BAO_0000219,,
446,1,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration; nd=No data,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615606,723.0,BAO_0000219,,
447,1,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration,Mus musculus,1,80951,,N,Expert,,CHEMBL884526,723.0,BAO_0000219,,
448,1,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.d.=no data,Mus musculus,1,80951,,N,Expert,,CHEMBL615607,723.0,BAO_0000219,,
449,1,In vitro cytotoxic concentration against mouse fibroblasts (3T3) cell line using MTT coloration; n.t.=not tested,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615608,723.0,BAO_0000219,,
450,1,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration,Mus musculus,1,80951,,N,Expert,,CHEMBL615609,723.0,BAO_0000219,,
451,1,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.d.=no data,Mus musculus,1,80951,,N,Expert,,CHEMBL615682,723.0,BAO_0000219,,
452,1,In vitro inhibitory activity against mouse fibroblasts (3T3) cell line using CV coloration; n.t.=not tested,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615683,723.0,BAO_0000219,,
453,1,In vivo inhibition of H-ras-transformed 3T3 fibroblasts in nude mouse tumor models,Mus musculus,1,80951,,N,Expert,,CHEMBL615684,723.0,BAO_0000218,,
454,1,Inhibition of PDGF-dependent autophosphorylation of PDGF-R in mouse BALB/c3T3 cells,Mus musculus,7,104860,,D,Autocuration,,CHEMBL615685,,BAO_0000219,,
455,1,Inhibition of Swiss 3T3 Mouse fibroblast proliferation,Mus musculus,1,80951,,N,Expert,,CHEMBL615686,723.0,BAO_0000219,,
456,1,Inhibitory activity against 3T3 cell line,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615687,723.0,BAO_0000219,,
457,1,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured,Mus musculus,1,80951,,N,Intermediate,,CHEMBL884523,723.0,BAO_0000219,,
458,1,Ability of peptide to inhibit binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane.,,8,11169,,H,Expert,,CHEMBL615688,,BAO_0000019,,
459,1,The ability of the peptide to inhibit the binding of 10 pM [125I]gastrin releasing peptide to S-3T3 cell membrane was measured; nt=Not tested,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615689,723.0,BAO_0000219,,
460,1,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells was measured,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615690,723.0,BAO_0000219,,
461,1,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells,,8,11169,,H,Expert,,CHEMBL615691,,BAO_0000019,,
462,1,The ability of the peptide to inhibit the binding of 50 pM [125I]gastrin releasing peptide to intact S-3T3 cells; nt=Not tested,,8,11169,,H,Expert,,CHEMBL615692,,BAO_0000019,,
463,1,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line in the presence of compound was determined using NR coloration,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615693,723.0,BAO_0000219,,
464,1,Concentration of NO in supernatant generated by mouse fibroblasts (3T3) cell line was determined using NR coloration; n.d.=no data,Mus musculus,1,80951,,N,Expert,,CHEMBL615324,723.0,BAO_0000219,,
465,1,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells,Homo sapiens,9,9,,D,Expert,,CHEMBL615325,723.0,BAO_0000219,,
466,1,Inhibition of ligand-induced proliferation in human EGF-R Kinase expressing 3T3 cells (Not tested),Homo sapiens,9,9,,D,Expert,,CHEMBL615490,723.0,BAO_0000219,,
467,1,Inhibition of ligand induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells,Homo sapiens,9,188,,D,Expert,,CHEMBL615491,723.0,BAO_0000219,,
468,1,Inhibition of ligand-induced proliferation in human Her-2 (p185erbB) tyrosine kinase expressing 3T3 cells (Not tested),Homo sapiens,9,188,,D,Expert,,CHEMBL615492,723.0,BAO_0000219,,
469,1,Inhibitory concentration of compound rwas calculated on 3T3 cells by [3H]Thd incorporation,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615493,723.0,BAO_0000219,,
470,1,Inhibitory concentration of compound was calculated on 3T3 cells by [14C]Leu incorporation,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615494,723.0,BAO_0000219,,
471,1,Inhibitory concentration of compound was calculated on 3T3 cells by using clonal assay,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615495,723.0,BAO_0000219,,
472,1,Inhibitory concentration was calculated on 3T3 cells by using growth assay,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615496,723.0,BAO_0000219,,
473,1,In vitro cytotoxicity was evaluated in mouse embryo BALB/c 3T3 cells,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615497,723.0,BAO_0000219,,
474,1,Inhibition of Swiss 3T3 mouse fibroblast proliferation,Mus musculus,1,80951,,N,Expert,,CHEMBL615498,723.0,BAO_0000219,,
475,1,The compound was tested for cytotoxicity against 3T3 fibroblast murine cell line.,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615499,723.0,BAO_0000219,,
476,1,Effective concentration required to inhibit the growth of murine 3T3 fibroblasts,Mus musculus,1,80951,,N,Expert,,CHEMBL835522,723.0,BAO_0000219,,
477,1,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014); Not tested,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615500,723.0,BAO_0000219,,
478,1,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),Mus musculus,1,80951,,N,Intermediate,,CHEMBL615501,723.0,BAO_0000219,,
479,1,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),Mus musculus,1,80951,,N,Intermediate,,CHEMBL615502,723.0,BAO_0000219,,
480,1,cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),Mus musculus,1,80951,,N,Intermediate,,CHEMBL615503,723.0,BAO_0000219,,
481,1,Cytotoxicity on 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),Mus musculus,1,80951,,N,Intermediate,,CHEMBL615504,723.0,BAO_0000219,,
482,1,Cytotoxicity against 3T3 fibroblasts (3T3F) murine cell line (O.D.=0.131+/-0.014),Mus musculus,1,80951,,N,Intermediate,,CHEMBL615505,723.0,BAO_0000219,,
483,1,Inhibition of swiss 3T3 mouse fibroblast proliferation,Mus musculus,1,80951,,N,Expert,,CHEMBL615506,723.0,BAO_0000219,,
484,1,Compound was tested for sublethal concentrations in 3T3 mouse fibroblast lysis.,Mus musculus,1,80951,,N,Intermediate,,CHEMBL615507,723.0,BAO_0000219,,
485,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,,1,80006,,N,Intermediate,,CHEMBL615508,620.0,BAO_0000218,,
486,1,Concentration required to stimulate glucose uptake in 3T3-L1 adipocytes after 48 hr incubation,Mus musculus,1,80006,,N,Intermediate,,CHEMBL615509,620.0,BAO_0000219,,
487,1,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 0.3 uM,Mus musculus,1,80006,,N,Intermediate,,CHEMBL615510,620.0,BAO_0000219,,
488,1,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 3 uM,Mus musculus,1,80006,,N,Intermediate,,CHEMBL615511,620.0,BAO_0000219,,
489,1,Effect on GLUT 1 glucose transporter expression in 3T3-L1 adipocytes at dose of 30 uM,Mus musculus,1,80006,,N,Intermediate,,CHEMBL615512,620.0,BAO_0000219,,
490,1,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 24 hr",Mus musculus,1,80006,,N,Intermediate,,CHEMBL615513,620.0,BAO_0000218,,
491,1,"In vitro ability to stimulate glucose transport in 3T3-L1 adipocytes, given at 100 mg/kg in mouse, after 3 hr",Mus musculus,1,80006,,N,Intermediate,,CHEMBL615514,620.0,BAO_0000218,,
492,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes,,1,80006,,N,Intermediate,,CHEMBL615515,620.0,BAO_0000219,,
493,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,,1,80006,,N,Intermediate,,CHEMBL615516,620.0,BAO_0000219,,
494,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,1,80006,,N,Intermediate,,CHEMBL615517,620.0,BAO_0000219,,
495,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,,1,80006,,N,Intermediate,,CHEMBL615518,620.0,BAO_0000219,,
496,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,1,80006,,N,Intermediate,,CHEMBL615519,620.0,BAO_0000219,,
497,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.3 uM dose.,,1,80006,,N,Intermediate,,CHEMBL615520,620.0,BAO_0000218,,
498,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 0.5 uM dose.,,1,80006,,N,Intermediate,,CHEMBL615521,620.0,BAO_0000218,,
499,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,,1,80006,,N,Intermediate,,CHEMBL615522,620.0,BAO_0000218,,
500,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,,1,80006,,N,Intermediate,,CHEMBL615523,620.0,BAO_0000218,,
501,1,In vitro measurements 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,,1,80006,,N,Expert,,CHEMBL615524,620.0,BAO_0000218,,
502,1,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,,1,80006,,N,Expert,,CHEMBL615525,620.0,BAO_0000218,,
503,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 1 uM dose.,,1,80006,,N,Intermediate,,CHEMBL615526,620.0,BAO_0000218,,
504,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,,1,80006,,N,Intermediate,,CHEMBL615527,620.0,BAO_0000218,,
505,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 300 uM dose.,,1,80006,,N,Intermediate,,CHEMBL615528,620.0,BAO_0000218,,
506,1,Acute effects in vitro by measuring 2-deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,,1,80006,,N,Expert,,CHEMBL615529,620.0,BAO_0000218,,
507,1,In vitro by measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,,1,80006,,N,Expert,,CHEMBL615530,620.0,BAO_0000218,,
508,1,In vitro measurements of 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,,1,80006,,N,Expert,,CHEMBL615531,620.0,BAO_0000218,,
509,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 10 micro M,,1,80006,,N,Intermediate,,CHEMBL615532,620.0,BAO_0000219,,
510,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 3 micro M,,1,80006,,N,Intermediate,,CHEMBL615533,620.0,BAO_0000219,,
511,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at concentration of 30 micro M,,1,80006,,N,Intermediate,,CHEMBL615534,620.0,BAO_0000219,,
512,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 100 uM dose.,,1,80006,,N,Intermediate,,CHEMBL615535,620.0,BAO_0000218,,
513,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 10 uM dose.,,1,80006,,N,Intermediate,,CHEMBL615536,620.0,BAO_0000218,,
514,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 30 uM dose.,,1,80006,,N,Intermediate,,CHEMBL615537,620.0,BAO_0000218,,
515,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 3 uM dose.,,1,80006,,N,Intermediate,,CHEMBL615538,620.0,BAO_0000218,,
516,1,compound was evaluated for their acute effects in vitro by measuring 2-Deoxyglucose (2DG) uptake in vehicle treated 3T3-L1 adipocytes at 60 uM dose.,,1,80006,,N,Intermediate,,CHEMBL836166,620.0,BAO_0000218,,
517,1,Inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells,,8,11214,,H,Expert,,CHEMBL615539,620.0,BAO_0000219,,
518,1,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; ND = No data,Mus musculus,1,80006,,N,Intermediate,,CHEMBL615540,620.0,BAO_0000219,,
519,1,Evaluated for the inhibition of forskolin-stimulated lipolysis in differentiated 3T3-L1 cells; Na = Not active,,8,11214,,H,Expert,,CHEMBL615541,620.0,BAO_0000219,,
520,1,Insulin-sensitizing activity; triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 1 uM expressed as percent activity of pioglitazone,Mus musculus,1,80006,,N,Expert,,CHEMBL615542,620.0,BAO_0000219,,
521,1,Compound was tested for insulin-sensitizing activity by measuring triglyceride accumulation from insulin regulated differentiation of 3T3-L1 cells at 10 uM expressed as percent activity of pioglitazone,Mus musculus,1,80006,,N,Intermediate,,CHEMBL615543,620.0,BAO_0000219,,
522,1,Stimulation of adipogenesis in 3T3-L1 cells is expressed as concentration equivalent to the [ 1-14C] uptake counts after treatment with 0.2 ug/mL troglitazone,Mus musculus,1,80006,,N,Expert,,CHEMBL615544,620.0,BAO_0000219,,
523,1,Effective concentration for enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,Mus musculus,1,80006,,N,Expert,,CHEMBL615545,620.0,BAO_0000219,,
524,1,Effective concentration for 50% enhancement of insulin-induced triglyceride accumulation in 3T3-L1 cells,Mus musculus,1,80006,,N,Expert,,CHEMBL615546,620.0,BAO_0000219,,
525,1,Percentage of rosiglitazone response for insulin-sensitizing activity at 1 uM concentration in 3T3-L1 cells,Mus musculus,1,80006,,N,Expert,,CHEMBL615547,620.0,BAO_0000219,,
526,1,In vitro glucose transport activity in 3T3-LI adipocytes at 10 uM concentration.,Mus musculus,1,80006,,N,Expert,,CHEMBL615548,620.0,BAO_0000219,,
527,1,In vitro glucose transport activity in 3T3-LI adipocytes at 3 uM concentration.,Mus musculus,1,80006,,N,Expert,,CHEMBL615549,620.0,BAO_0000219,,
528,1,In vitro glucose transport activity in 3T3-LI adipocytes at 30 uM concentration.,Mus musculus,1,80006,,N,Expert,,CHEMBL615550,620.0,BAO_0000219,,
529,1,Inhibitory activity against rat fibroblast (3Y1) cell line,Rattus norvegicus,1,80622,,N,Intermediate,,CHEMBL615551,1118.0,BAO_0000219,,
530,1,Mean concentration causing inhibition of cell growth in 3Y1 cells.,Rattus norvegicus,1,80622,,N,Expert,,CHEMBL615552,1118.0,BAO_0000219,,
531,1,Cytotoxicity in 3Y1 cells.,Rattus norvegicus,1,80622,,N,Expert,,CHEMBL615553,1118.0,BAO_0000219,,
532,1,Cytostatic effect in 3Y1 cells.,Rattus norvegicus,1,80622,,N,Expert,,CHEMBL615554,1118.0,BAO_0000219,,
533,1,"Mean averaged concentration for total growth inhibition, which signifies cytostatic effect",Rattus norvegicus,1,80622,,N,Intermediate,,CHEMBL615555,1118.0,BAO_0000219,,
534,1,Concentration to inhibit growth of normal rat fibroblast cells (3Y1-B cells) after 72 h exposure,Rattus norvegicus,1,80622,,N,Expert,,CHEMBL615556,1118.0,BAO_0000219,,
535,1,In vitro inhibitory activity against human adrenal 3-beta hydroxy-delta 5-teroid isomerase,,0,22226,,U,Autocuration,,CHEMBL615557,,BAO_0000019,,
536,1,Inhibition of recombinant human adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,,0,22226,,U,Autocuration,,CHEMBL615558,,BAO_0000019,,
537,1,Inhibition of recombinant rat adrenal 3-beta-hydroxy-delta-5-steroid dehydrogenase,,0,22226,,U,Autocuration,,CHEMBL872066,,BAO_0000019,,
538,1,In vitro inhibition against of 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) from pig liver by the enol borate method,Sus scrofa,9,11607,,D,Expert,,CHEMBL615559,,BAO_0000019,,
539,1,In vitro inhibitory concentration required against 4-hydroxyphenylpyruvate dioxygenase (4-HPPD) taken from pig liver,,8,11607,,H,Autocuration,,CHEMBL615560,,BAO_0000019,,
540,1,Inhibition of pig liver 4-Hydroxyphenylpyruvate dioxygenase (4-HPPD) enzyme,,8,11607,,H,Autocuration,,CHEMBL615561,,BAO_0000019,,
541,1,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver,,8,11607,,H,Expert,,CHEMBL857062,,BAO_0000019,,
542,1,Concentration required to achieve 50% inhibition against 4-Hydroxyphenylpyruvate dioxygenase (HPPD) from pig liver; (observed value),,8,11607,,H,Expert,,CHEMBL615562,,BAO_0000019,,
543,1,In vitro inhibitory activity against HPPD(4-hydroxyphenylpyruvate Dioxygenase) from pig liver using enol borate assay method,,8,11607,,H,Autocuration,,CHEMBL615563,,BAO_0000019,,
544,1,Compound was evaluated for complete competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD),,8,11607,,H,Autocuration,,CHEMBL615564,,BAO_0000357,,
545,1,In vitro inhibition of 4-hydroxyphenylpyruvate dioxygenase obtained from purified pig liver by enol-borate method,,8,11607,,H,Autocuration,,CHEMBL615565,,BAO_0000019,,
546,1,Inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated,,8,11607,,H,Autocuration,,CHEMBL615566,,BAO_0000019,,
547,1,Inhibition of 4-hydroxyphenylpyruvate dioxygenase of purified pig liver by enol-borate method,Sus scrofa,9,11607,,D,Expert,,CHEMBL615567,,BAO_0000019,,
548,1,The inhibitory activity on pig liver 4-hydroxyphenylpyruvate dioxygenase (HPPD) was evaluated.,,8,11607,,H,Autocuration,,CHEMBL615568,,BAO_0000019,,
549,1,Compound was evaluated for competitive inhibition of 4-hydroxyphenylpyruvate dioxygenase (HPPD) (complete inhibition was observed at a concentration of 0.5-1.0 mM),,8,11607,,H,Autocuration,,CHEMBL615569,,BAO_0000357,,
550,1,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver,,8,11607,,H,Autocuration,,CHEMBL615570,,BAO_0000019,,
551,1,Concentration required to achieve 50% inhibition against 4-hydroxyphenylpyruvate dioxygenase from pig liver; (observed value),,8,11607,,H,Autocuration,,CHEMBL615571,,BAO_0000019,,
552,1,Binding affinity against melatonin (MT1) receptor (pC1),,4,104733,,H,Autocuration,,CHEMBL615572,,BAO_0000224,,
553,1,Compound was tested for inhibitory activity against 5-hydroxytryptamine 1 receptor,,0,22226,,U,Autocuration,,CHEMBL615573,,BAO_0000019,,
554,1,Inhibition of [3H]- 5-HT binding to 5-hydroxytryptamine 1 receptor at 10e-5 M,,0,22226,,U,Autocuration,,CHEMBL615574,,BAO_0000019,,
555,1,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1 receptor of central nervous system,,0,22226,,U,Autocuration,,CHEMBL615575,,BAO_0000019,,
556,1,Inhibitory activity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand at 10e-5 M concentration,,8,10619,,H,Autocuration,,CHEMBL615576,,BAO_0000357,,
557,1,Binding affinity against 5-hydroxytryptamine 1 receptor using [3H]5-HT as radioligand,,8,10619,,H,Autocuration,,CHEMBL615577,,BAO_0000357,,
558,1,Binding affinity at 5-hydroxytryptamine 1A receptor in bovine hippocampal preparation using [3H]8-OH-DPAT,,8,51,,H,Autocuration,,CHEMBL615578,,BAO_0000221,10000000.0,
559,1,Binding affinity against 5-hydroxytryptamine 1A receptor was measured using [3H]8-OH-DPAT as radioligand,,8,51,,H,Expert,,CHEMBL615579,,BAO_0000357,,
560,1,Binding affinity for 5-hydroxytryptamine 1A receptor,,8,51,,H,Expert,,CHEMBL615580,,BAO_0000357,,
561,1,Affinity towards 5-hydroxytryptamine 1A receptor in membranes from bovine hippocampus using [3H]OH-DPAT,,8,51,,H,Expert,,CHEMBL615581,,BAO_0000019,,
562,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615582,,BAO_0000221,10000000.0,
563,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615583,,BAO_0000221,10000000.0,
564,1,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615584,,BAO_0000221,10000000.0,
565,1,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL833691,,BAO_0000221,10000000.0,
566,1,In vitro inhibition of azido-[125I]-IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615585,,BAO_0000221,10000000.0,
567,1,In vitro inhibition of [125I]IPAPP (0.25 nM) binding to 5-HT1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615586,,BAO_0000221,10000000.0,
568,1,In vitro inhibition of [125I]IPAPP (2.5 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL884524,,BAO_0000221,10000000.0,
569,1,Inhibitory concentration against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615587,,BAO_0000221,10000000.0,
570,1,"Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",,8,51,,H,Autocuration,,CHEMBL615588,,BAO_0000221,10000000.0,
571,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampal membranes,Rattus norvegicus,9,10576,Membranes,D,Expert,,CHEMBL615589,,BAO_0000249,,
572,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of bovine hippocampus.,Bos taurus,8,51,,H,Expert,,CHEMBL615442,,BAO_0000221,10000000.0,
573,1,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (0.5 nM) ligand in hippocampus + frontal bovine was determined,,8,51,,H,Autocuration,,CHEMBL615443,,BAO_0000221,10000000.0,
574,1,Compound was evaluated for its ability to displace [3H]DPAT from 5-HT1A receptor in homogenates of bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615444,,BAO_0000221,10000000.0,
575,1,Ability to displace [3H]-DPAT from 5-hydroxytryptamine 1A receptor in homogenates of bovine hippocampus.,,8,51,,H,Expert,,CHEMBL615445,,BAO_0000221,10000000.0,
576,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615446,,BAO_0000221,10000000.0,
577,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in CHO cells,,8,51,,H,Autocuration,,CHEMBL615447,449.0,BAO_0000219,,
578,1,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,8,51,,H,Expert,,CHEMBL615448,,BAO_0000221,10000000.0,
579,1,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus,,8,51,,H,Expert,,CHEMBL615449,,BAO_0000221,10000000.0,
580,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,8,51,,H,Autocuration,,CHEMBL615450,449.0,BAO_0000219,,
581,1,"Binding affinity against 5-hydroxytryptamine 1A receptor from bovine hippocampus, used [3H]8-OH-DPAT as radioligand",,8,51,,H,Expert,,CHEMBL615451,,BAO_0000221,10000000.0,
582,1,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,,8,51,,H,Autocuration,,CHEMBL615452,,BAO_0000357,,
583,1,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-HT1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615453,,BAO_0000221,10000000.0,
584,1,In vitro inhibition of [3H]5-HT (2 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615454,,BAO_0000221,10000000.0,
585,1,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615455,,BAO_0000221,10000000.0,
586,1,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-hydroxytryptamine 1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615456,,BAO_0000221,10000000.0,
587,1,In vitro inhibition of [3H]DPAT (1 nM) binding to 5-HT1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL615457,,BAO_0000221,10000000.0,
588,1,In vivo binding affinity towards [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in bovine hippocampus.,,8,51,,H,Expert,,CHEMBL615458,,BAO_0000218,10000000.0,
589,1,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,,8,51,,H,Expert,,CHEMBL615459,,BAO_0000221,10000000.0,
590,1,"Tested in vitro for the inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor, expressed in cloned CHO cells.",Homo sapiens,9,51,,D,Expert,,CHEMBL615460,449.0,BAO_0000219,,
591,1,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig,Cavia porcellus,8,51,,H,Autocuration,,CHEMBL615461,,BAO_0000019,,
592,1,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor in guinea pig; NT means not tested,Cavia porcellus,8,51,,H,Autocuration,,CHEMBL615462,,BAO_0000019,,
593,1,Effect on forskolin stimulated adenylate cyclase activity at 5-hydroxytryptamine 1A receptor of guinea pig hippocampus.,Cavia porcellus,8,51,,H,Autocuration,,CHEMBL615463,,BAO_0000221,10000000.0,
594,1,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,Cavia porcellus,8,51,,H,Autocuration,,CHEMBL615464,,BAO_0000221,2116.0,
595,1,Ability to antagonize Acetylcholine induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,Cavia porcellus,8,51,,H,Autocuration,,CHEMBL615465,,BAO_0000221,2116.0,
596,1,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor.,Cavia porcellus,8,51,,H,Autocuration,,CHEMBL615466,,BAO_0000221,2116.0,
597,1,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,Cavia porcellus,8,51,,H,Autocuration,,CHEMBL615467,,BAO_0000221,2116.0,
598,1,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor. Inactive at dose level of 1.0 uM,Cavia porcellus,8,51,,H,Autocuration,,CHEMBL615468,,BAO_0000221,2116.0,
599,1,Ability to antagonize electrical induced contractile responses in Guinea pig ileum for 5-HT1A receptor; Inactive at dose level of 1.0 uM,Cavia porcellus,8,51,,H,Autocuration,,CHEMBL615469,,BAO_0000221,2116.0,
600,1,Binding affinity against 5-hydroxytryptamine 1A receptor,Cavia porcellus,8,51,,H,Autocuration,,CHEMBL615470,,BAO_0000357,,
601,1,Compound is evaluated for in vitro receptor binding affinity against 5-hydroxytryptamine 1A receptor,Cavia porcellus,8,51,,H,Autocuration,,CHEMBL615471,,BAO_0000357,,
602,1,Binding affinity was determined against 5-hydroxytryptamine 1A receptor,Cavia porcellus,8,51,,H,Autocuration,,CHEMBL615472,,BAO_0000357,,
603,1,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,Cavia porcellus,8,106,,H,Autocuration,,CHEMBL883242,,BAO_0000221,10000000.0,
604,1,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1A receptor of guinea pig hippocampus,Cavia porcellus,8,106,,H,Autocuration,,CHEMBL615473,,BAO_0000221,10000000.0,
605,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),Cricetulus griseus,8,11863,,H,Autocuration,,CHEMBL615474,449.0,BAO_0000218,,
606,1,Fraction involved in salt bridge interactions with Asp3:11 part of the 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615475,,BAO_0000357,,
607,1,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-HT 1A receptor in HeLa cells; value ranges from 85-370,,8,51,,H,Autocuration,,CHEMBL615476,308.0,BAO_0000219,,
608,1,Compound was tested for its ability to inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1A receptor in HeLa cells; value ranges from 95-320,,8,51,,H,Autocuration,,CHEMBL615477,308.0,BAO_0000219,,
609,1,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615478,,BAO_0000019,,
610,1,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615160,449.0,BAO_0000219,,
611,1,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor,,8,51,,H,Expert,,CHEMBL615161,449.0,BAO_0000219,,
612,1,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=Not determined,,8,51,,H,Autocuration,,CHEMBL615162,449.0,BAO_0000219,,
613,1,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing human 5-hydroxytryptamine 1A receptor; nd=not determined,,8,51,,H,Autocuration,,CHEMBL615163,449.0,BAO_0000219,,
614,1,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,8,51,,H,Expert,,CHEMBL615164,449.0,BAO_0000219,,
615,1,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,8,51,,H,Expert,,CHEMBL615165,449.0,BAO_0000219,,
616,1,Effective concentration against human 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells; nd=not determined,,8,51,,H,Autocuration,,CHEMBL615166,449.0,BAO_0000219,,
617,1,In vitro potency at human 5-hydroxytryptamine 1A receptor in inhibiting forskolin-stimulated accumulation of intracellular cAMP,,8,51,,H,Autocuration,,CHEMBL615167,,BAO_0000219,,
618,1,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,Homo sapiens,9,51,,D,Expert,,CHEMBL615168,308.0,BAO_0000219,,
619,1,Stimulation of [35S]- GIPyS binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells; Inverse,Homo sapiens,9,51,,D,Expert,,CHEMBL615169,308.0,BAO_0000219,,
620,1,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor,Homo sapiens,9,51,,D,Expert,,CHEMBL615170,449.0,BAO_0000219,,
621,1,Tested for functional response on CHO cells expressing cloned human 5-hydroxytryptamine 1A receptor; Not determined,Homo sapiens,9,51,,D,Expert,,CHEMBL615171,449.0,BAO_0000219,,
622,1,Eudisimic ratio(ER) is the antilog of the defference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615694,,BAO_0000019,,
623,1,Eudisimic ratio(ER) is the antilog of the difference between the pKb and pD2 values against 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615695,,BAO_0000019,,
624,1,"Percent of maximum effect on binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,8,51,,H,Autocuration,,CHEMBL615696,,BAO_0000019,,
625,1,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,8,51,,H,Autocuration,,CHEMBL615697,449.0,BAO_0000219,,
626,1,Agonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),Homo sapiens,9,51,,D,Expert,,CHEMBL859410,449.0,BAO_0000219,,
627,1,Agonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),,8,51,,H,Autocuration,,CHEMBL615841,449.0,BAO_0000219,,
628,1,Agonistic efficacy in adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),Homo sapiens,9,51,,D,Expert,,CHEMBL615842,449.0,BAO_0000219,,
629,1,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,8,51,,H,Autocuration,,CHEMBL835003,449.0,BAO_0000219,,
630,1,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 1),,8,51,,H,Autocuration,,CHEMBL615843,449.0,BAO_0000219,,
631,1,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 1),Homo sapiens,9,51,,D,Expert,,CHEMBL615979,449.0,BAO_0000219,,
632,1,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor (experiment 2),,8,51,,H,Autocuration,,CHEMBL615980,449.0,BAO_0000219,,
633,1,Antagonistic efficacy as adenylyl cyclase assay in CHO cells expressing human 5-HT1A receptor (experiment 2),Homo sapiens,9,51,,D,Expert,,CHEMBL615981,449.0,BAO_0000219,,
634,1,Percent efficacy against cloned human 5-hydroxytryptamine 1A receptor normalized to the maximal 5-HT response,Homo sapiens,9,51,,D,Expert,,CHEMBL615982,,BAO_0000019,,
635,1,"Agonist activity at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",Homo sapiens,9,51,,D,Expert,,CHEMBL615983,,BAO_0000019,,
636,1,"Agonist activity at the 5-hydroxytryptamine 1A receptor in vitro using a [35S]GTP-gamma-S, No data",Homo sapiens,9,51,,D,Expert,,CHEMBL615984,,BAO_0000019,,
637,1,"Agonist activity at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S,",Homo sapiens,9,51,,D,Expert,,CHEMBL615985,,BAO_0000019,,
638,1,Agonistic effect against 5-HT1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,8,51,,H,Autocuration,,CHEMBL615986,449.0,BAO_0000219,,
639,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,8,51,,H,Autocuration,,CHEMBL615987,449.0,BAO_0000219,,
640,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,,8,51,,H,Autocuration,,CHEMBL615988,449.0,BAO_0000219,,
641,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells,,8,51,,H,Expert,,CHEMBL615989,449.0,BAO_0000219,,
642,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=Not determined,,8,51,,H,Autocuration,,CHEMBL615990,449.0,BAO_0000219,,
643,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using cAMP as radioligand relative to 5-HT in inhibiting forskolin-stimulated adenylate cyclase activity in CHO cells; nd=not determined,,8,51,,H,Autocuration,,CHEMBL615991,449.0,BAO_0000219,,
644,1,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,,8,51,,H,Autocuration,,CHEMBL615992,449.0,BAO_0000219,,
645,1,Agonistic effect against 5-HT 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=Not determined,,8,51,,H,Autocuration,,CHEMBL615993,449.0,BAO_0000219,,
646,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,,8,51,,H,Expert,,CHEMBL615994,449.0,BAO_0000219,,
647,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT; nd=not determined,,8,51,,H,Autocuration,,CHEMBL615995,449.0,BAO_0000219,,
648,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35S]GTP-gamma-S as radioligand in CHO cells relative to 5-HT,,8,51,,H,Autocuration,,CHEMBL615996,449.0,BAO_0000219,,
649,1,Agonistic effect against 5-hydroxytryptamine 1A receptor using [35]GTPgammaS as radioligand in CHO cells relative to 5-HT; nd=Not determined,,8,51,,H,Autocuration,,CHEMBL615997,449.0,BAO_0000219,,
650,1,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,8,51,,H,Autocuration,,CHEMBL615998,,BAO_0000019,,
651,1,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,8,51,,H,Autocuration,,CHEMBL615999,,BAO_0000019,,
652,1,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,,8,51,,H,Autocuration,,CHEMBL616000,,BAO_0000019,,
653,1,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,8,51,,H,Autocuration,,CHEMBL616001,722.0,BAO_0000219,,
654,1,"Evaluated for stimulation at 1 uM concentration expressed as percent of the maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine",Homo sapiens,9,51,,D,Expert,,CHEMBL616002,,BAO_0000019,,
655,1,"Stimulation of percent maximal [35S]GTP-gamma-S, binding induced by 5-hydroxytryptamine at 1 uM; nd = not determined",,8,51,,H,Expert,,CHEMBL616003,,BAO_0000019,,
656,1,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor,Homo sapiens,9,51,,D,Expert,,CHEMBL616004,,BAO_0000019,,
657,1,In vitro agonist activity at the 5-hydroxytryptamine 1A receptor; No data,Homo sapiens,9,51,,D,Expert,,CHEMBL616005,,BAO_0000019,,
658,1,"Maximal response as a result of 5-HT1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,8,51,,H,Autocuration,,CHEMBL616006,,BAO_0000019,,
659,1,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding",,8,51,,H,Expert,,CHEMBL616007,,BAO_0000019,,
660,1,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,8,51,,H,Autocuration,,CHEMBL616008,,BAO_0000019,,
661,1,"Maximal response as a result of 5-hydroxytryptamine 1A receptor-mediated stimulation of [35S]GTP-gamma-S, binding; Not determined",,8,51,,H,Autocuration,,CHEMBL616009,,BAO_0000019,,
662,1,"Maximal stimulation of expressed human 5-hydroxytryptamine 1A receptor assayed by [35S]GTP-gamma-S, binding",,8,51,,H,Expert,,CHEMBL616010,,BAO_0000019,,
663,1,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND means not determined",Homo sapiens,9,51,,D,Expert,,CHEMBL616011,,BAO_0000019,,
664,1,"Maximal response towards 5-hydroxytryptamine 1A receptor in human using [35S]GTP-gamma-S, as radioligand; ND=Not determined",Homo sapiens,9,51,,D,Expert,,CHEMBL615740,,BAO_0000019,,
665,1,"Maximal stimulation was expressed as percentage of the maximal 5-HT response in the [35S]GTP-gamma-S, binding assay on 5-hydroxytryptamine 1A receptor",,8,51,,H,Autocuration,,CHEMBL615741,,BAO_0000019,,
666,1,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",,8,51,,H,Expert,,CHEMBL615742,,BAO_0000019,,
667,1,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Emin (%): not determined",,8,51,,H,Autocuration,,CHEMBL615743,,BAO_0000019,,
668,1,Antagonist activity was measured against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay,,8,51,,H,Autocuration,,CHEMBL615744,449.0,BAO_0000219,,
669,1,Antagonist activity against CHO cells expressing the human 5-hydroxytryptamine 1A receptor in a forskolin stimulated adenylate cyclase (FSC) assay.,,8,51,,H,Expert,,CHEMBL615745,449.0,BAO_0000219,,
670,1,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,8,51,,H,Autocuration,,CHEMBL615746,,BAO_0000357,,
671,1,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,8,51,,H,Autocuration,,CHEMBL615747,,BAO_0000357,,
672,1,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,8,51,,H,Autocuration,,CHEMBL615748,,BAO_0000019,,
673,1,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay; NA indicates not available",,8,51,,H,Autocuration,,CHEMBL615749,,BAO_0000019,,
674,1,Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by forskolin stimulated cAMP assay,,8,51,,H,Autocuration,,CHEMBL615750,,BAO_0000019,,
675,1,Forskolin stimulated cAMP assessment of agonist activity for 5-hydroxytryptamine 1A receptor,Homo sapiens,9,51,,D,Expert,,CHEMBL616259,,BAO_0000019,,
676,1,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,8,51,,H,Autocuration,,CHEMBL616260,,BAO_0000019,,
677,1,Antagonism of 5-hydroxytryptamine 1A receptor determined in vitro,Homo sapiens,9,51,,D,Expert,,CHEMBL616261,,BAO_0000019,,
678,1,"Antagonism of 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",Homo sapiens,9,51,,D,Expert,,CHEMBL616262,,BAO_0000019,,
679,1,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",Homo sapiens,9,51,,D,Expert,,CHEMBL616263,,BAO_0000019,,
680,1,Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro; No data,Homo sapiens,9,51,,D,Expert,,CHEMBL616264,,BAO_0000019,,
681,1,Antagonism at the 5-hydroxytryptamine 1A receptor in vitro,Homo sapiens,9,51,,D,Expert,,CHEMBL616265,,BAO_0000019,,
682,1,"Antagonism at the 5-hydroxytryptamine 1A receptor was determined in vitro using a [35S]GTP-gamma-S,",Homo sapiens,9,51,,D,Expert,,CHEMBL616266,,BAO_0000019,,
683,1,"Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro using a [35S]GTP-gamma-S, No data",Homo sapiens,9,51,,D,Expert,,CHEMBL616267,,BAO_0000019,,
684,1,Antagonism at the 5-hydroxytryptamine 1A receptor determined in vitro; No data,Homo sapiens,9,51,,D,Expert,,CHEMBL616268,,BAO_0000019,,
685,1,Inhibition of human 5-hydroxytryptamine 1A receptor,Homo sapiens,9,51,,D,Expert,,CHEMBL616269,,BAO_0000357,,
686,1,Binding affinity against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,8,51,,H,Autocuration,,CHEMBL884528,449.0,BAO_0000219,,
687,1,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor alpha expressed in HEK 293 cells,,9,105,,D,Expert,,CHEMBL616270,722.0,BAO_0000219,,
688,1,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1A receptor stably expressed in CHO cells,,8,51,,H,Autocuration,,CHEMBL616271,449.0,BAO_0000219,,
689,1,Effective concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616272,449.0,BAO_0000219,,
690,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in human CYP3A4 assay,,8,51,,H,Expert,,CHEMBL616273,,BAO_0000357,,
691,1,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,Homo sapiens,9,51,,D,Expert,,CHEMBL616274,,BAO_0000357,,
692,1,Inhibition concentration against 5-HT 1A receptor using cAMP as radioligand in CHO cells,,8,51,,H,Autocuration,,CHEMBL616275,449.0,BAO_0000219,,
693,1,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,8,51,,H,Autocuration,,CHEMBL616276,449.0,BAO_0000219,,
694,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL616277,,BAO_0000218,,
695,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration; Inactive,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL616278,,BAO_0000218,,
696,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL616279,,BAO_0000218,,
697,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL616280,,BAO_0000218,,
698,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Partial response at the highest dose tested,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL616281,,BAO_0000218,,
699,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by sc administration; Inactive,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL616282,,BAO_0000218,,
700,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL616283,,BAO_0000218,,
701,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by po administration; Inactive,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL616284,,BAO_0000218,,
702,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL616285,,BAO_0000218,,
703,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; Inactive,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL616286,,BAO_0000218,,
704,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain limbic area by sc administration; partial response at the highest dose tested,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL616287,,BAO_0000218,,
705,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL616288,,BAO_0000218,,
706,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Inactive,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL616289,,BAO_0000218,,
707,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by po administration; Partial response at the highest dose tested,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615610,,BAO_0000218,,
708,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615611,,BAO_0000218,,
709,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Inactive,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615612,,BAO_0000218,,
710,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; Partial response at the highest dose tested,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615613,,BAO_0000218,,
711,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain striatal area by sc administration; partial response at the highest dose tested,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615614,,BAO_0000218,,
712,1,Effective dose for half-maximal decrease in the accumulation of 5-hydroxytryptophan (5-HTP) in reserpinized rat brain hemispheral area by po administration,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615615,,BAO_0000218,,
713,1,Affinity in displacing [125I](R)-DOI from rat cortical homogenate 5-HT2 receptor.,,4,105093,,H,Autocuration,,CHEMBL615616,,BAO_0000019,,
714,1,Binding affinity towards 5-HT 7 receptor in rat hypothalamus membranes using [3H]5-CT as radioligand,,8,11923,,H,Autocuration,,CHEMBL615617,,BAO_0000249,1898.0,
715,1,Inhibitory activity against 5-HT1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data,,8,10577,,H,Autocuration,,CHEMBL615618,,BAO_0000019,,
716,1,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand; nd is No Data.,,8,10577,,H,Autocuration,,CHEMBL615619,,BAO_0000019,,
717,1,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat striatal membrane homogenate using [3H]5-HT as the radioligand.,,8,10577,,H,Expert,,CHEMBL615620,,BAO_0000019,,
718,1,"Inhibitory activity against human whole blood, LTB4 5-lipoxygenase was evaluated",,8,55,,H,Autocuration,,CHEMBL615621,,BAO_0000357,,
719,1,"Inhibitory activity against intact human PMNL, LTB4 5-lipoxygenase was evaluated",,8,55,,H,Autocuration,,CHEMBL615622,,BAO_0000357,,
720,1,Compound was evaluated for the inhibition of 5-LO (lipoxygenase),,8,12166,,H,Autocuration,,CHEMBL615623,,BAO_0000019,,
721,1,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,8,12166,,H,Autocuration,,CHEMBL615624,,BAO_0000019,,
722,1,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,8,12166,,H,Autocuration,,CHEMBL615625,,BAO_0000019,,
723,1,Compound was evaluated for the inhibition of 5-LO (5-lipoxygenase).,,8,12166,,H,Autocuration,,CHEMBL767045,,BAO_0000019,,
724,1,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN,Cavia porcellus,8,55,,H,Autocuration,,CHEMBL615626,,BAO_0000019,,
725,1,Inhibition of [14C]arachidonic acid conversion to 5-HETE by broken cell 5-LO isolated from guinea pig PMN; not active at the highest concentration (3 ug/mL) tested; No activity,Cavia porcellus,8,55,,H,Autocuration,,CHEMBL615627,,BAO_0000019,,
726,1,The compound was tested for inhibitory activity against 5-Lipoxygenase in guinea pig polymorphonuclear leukocytes,Cavia porcellus,8,55,,H,Autocuration,,CHEMBL615628,,BAO_0000019,,
727,1,In vitro inhibitory activity against polymorphonuclear leukocyte 5-lipoxygenase using guinea pig supernatant at 10 uM,Cavia porcellus,8,55,,H,Autocuration,,CHEMBL615629,,BAO_0000357,,
728,1,Inhibitory concentration against 5-lipoxygenase from human whole blood,Homo sapiens,9,55,,D,Expert,,CHEMBL615630,,BAO_0000357,,
729,1,The compound was tested for inhibitory activity against 5-Lipoxygenase in human polymorphonuclear leukocytes[PMNS],,8,55,,H,Autocuration,,CHEMBL615631,,BAO_0000219,,
730,1,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,,8,17087,,H,Autocuration,,CHEMBL615632,,BAO_0000218,,
731,1,Inhibitory concentration against 5-lipoxygenase from mouse macrophage,,8,17087,,H,Autocuration,,CHEMBL615633,,BAO_0000357,,
732,1,In vivo inhibition of 5-lipoxygenase (LTC4) in the mouse zymosan peritonitis assay at an oral dose of 30 mg/Kg,,8,17087,,H,Autocuration,,CHEMBL615634,,BAO_0000218,,
733,1,Inhibition of arachidonate 5-lipoxygenase purified from porcine leukocytes.,Sus scrofa,8,55,,H,Expert,,CHEMBL615635,,BAO_0000019,,
734,1,In vitro inhibition of rat 5-Lipoxygenase,,8,12166,,H,Expert,,CHEMBL615636,,BAO_0000357,,
735,1,Inhibitory activity against 5-Lipoxygenase,Rattus norvegicus,9,12166,,D,Expert,,CHEMBL615637,,BAO_0000357,,
736,1,Inhibitory activity against 5-lipoxygenase in rat basophilic leukemia cells,,8,12166,,H,Expert,,CHEMBL615638,702.0,BAO_0000219,,
737,1,Inhibitory activity against 5-lipoxygenase (5-LO) in intact rat barophilic leukemia cells (RBL-1),,8,12166,,H,Autocuration,,CHEMBL615639,702.0,BAO_0000219,,
738,1,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat RBL-1,,8,12166,,H,Autocuration,,CHEMBL615640,702.0,BAO_0000219,,
739,1,The compound was tested for inhibitory activity against 5-Lipoxygenase in rat blood,,8,12166,,H,Autocuration,,CHEMBL615796,,BAO_0000019,,
740,1,The compound was tested for inhibitory activity against 5-Lipoxygenase receptor in rat polymorphonuclear leukocytes[PMNS],,8,12166,,H,Autocuration,,CHEMBL615845,,BAO_0000219,,
741,1,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,,8,12166,,H,Autocuration,,CHEMBL615846,,BAO_0000357,,
742,1,Inhibitory activity against 5-lipoxygenase (5-LO) using broken rat barophilic leukemia cells (RBL-1)at 10 uM,,8,12166,,H,Autocuration,,CHEMBL615847,702.0,BAO_0000219,,
743,1,The compound was tested for inhibition of isolated 5-Lipoxygenase,,8,12166,,H,Autocuration,,CHEMBL615848,,BAO_0000357,,
744,1,Ratio of IC50 against 5-LO and COX,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615849,,BAO_0000019,,
745,1,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM,,8,12166,,H,Autocuration,,CHEMBL615850,,BAO_0000357,,
746,1,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) in vitro at 1 uM; range is 20-35%,,8,12166,,H,Autocuration,,CHEMBL615851,,BAO_0000357,,
747,1,The compound was tested for inhibition against 5-Lipoxygenase in rat polymorphonuclear leukocytes at 10 uM concentration,,8,12166,,H,Autocuration,,CHEMBL615852,,BAO_0000219,,
748,1,Compound was evaluated for the inhibition of 5-Lipoxygenase (5-LO) ex vivo,,8,12166,,H,Autocuration,,CHEMBL615853,,BAO_0000019,,
749,1,Compound was tested for the inhibition of type 2 5-alpha-reductase of human prostates,,8,120,,H,Autocuration,,CHEMBL884527,,BAO_0000357,2367.0,
750,1,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-4 M inhibitory concentration,Columba livia,0,22226,,U,Autocuration,,CHEMBL872871,,BAO_0000019,,
751,1,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme at 10E-5 M inhibitory concentration,Columba livia,0,22226,,U,Autocuration,,CHEMBL615854,,BAO_0000019,,
752,1,Percent inhibition was measured against 5-amino-4-imidazolecarboxamide ribotide transformylase(pigeon liver) enzyme.,Columba livia,0,22226,,U,Autocuration,,CHEMBL767046,,BAO_0000019,,
753,1,Compound was evaluated for the inhibition of 5-aminoimidazole-4-carboxamide ribonucleotide transformylase obtained from human at 100 uM,,8,10732,,H,Autocuration,,CHEMBL615855,,BAO_0000357,,
754,1,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT); NT = Not Tested,Rattus norvegicus,9,12198,,D,Expert,,CHEMBL615856,,BAO_0000019,,
755,1,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),Rattus norvegicus,9,12198,,D,Expert,,CHEMBL615857,,BAO_0000019,,
756,1,Effect on synaptosomal uptake inhibition of 5-hydroxytryptamine (5-HT),Rattus norvegicus,9,12198,,D,Expert,,CHEMBL615858,,BAO_0000019,,
757,1,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,,8,10576,,H,Expert,,CHEMBL615859,,BAO_0000221,10000000.0,
758,1,Binding affinity towards human 5-hydroxytryptamine 1 receptor,,8,51,,H,Autocuration,,CHEMBL615860,,BAO_0000357,,
759,1,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,Oryctolagus cuniculus,0,22226,,U,Autocuration,,CHEMBL615861,,BAO_0000019,,
760,1,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,Oryctolagus cuniculus,0,22226,,U,Autocuration,,CHEMBL615862,,BAO_0000019,,
761,1,Binding affinity against 5-hydroxytryptamine 1D receptor using rabbit saphenous vein assay.,Oryctolagus cuniculus,0,22226,,U,Autocuration,,CHEMBL615863,,BAO_0000019,,
762,1,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,Oryctolagus cuniculus,0,22226,,U,Autocuration,,CHEMBL615864,,BAO_0000019,,
763,1,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,4,104744,,H,Autocuration,,CHEMBL615865,,BAO_0000221,10000000.0,
764,1,Ability to bind at 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,4,104744,,H,Autocuration,,CHEMBL615866,,BAO_0000221,10000000.0,
765,1,Ability to bind at serotonin 5-hydroxytryptamine 1 receptor of rat hippocampus by displacing [3H]5-HT,,4,104744,,H,Autocuration,,CHEMBL615867,,BAO_0000221,10000000.0,
766,1,Ability to inhibit binding of titreated serotonin to the 5-hydroxytryptamine 1 receptor in rat brain frontal cortex membranes,,4,104744,Membranes,H,Autocuration,,CHEMBL615868,,BAO_0000249,,
767,1,Binding affinity towards 5-hydroxytryptamine 1 receptor in brain cortical membranes of rat,Rattus norvegicus,5,104744,,D,Autocuration,,CHEMBL615869,,BAO_0000249,,
768,1,Binding affinity towards 5-hydroxytryptamine 1 receptor in rat frontal cortex homogenates using [3H]5-HT as a radioligand,Rattus norvegicus,5,104744,,D,Autocuration,,CHEMBL615870,,BAO_0000019,,
769,1,Binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT as a radioligand from rat frontal cortex homogenates,Rattus norvegicus,5,104744,,D,Autocuration,,CHEMBL615871,,BAO_0000019,,
770,1,Binding affinity towards 5-hydroxytryptamine 1 receptor was measured using radioligand ([3H]5-HT) binding assay,,4,104744,,H,Autocuration,,CHEMBL615872,,BAO_0000224,,
771,1,Binding affinity towards hippocampus 5-hydroxytryptamine 1 receptor was measured using radioligand [3H]5-HT,,4,104744,,H,Autocuration,,CHEMBL833492,,BAO_0000221,10000000.0,
772,1,Compound was evaluated for the inhibition of [3H]5-HT (concentration of 12 nM) specific binding to rat hippocampus,,4,104744,,H,Autocuration,,CHEMBL615873,,BAO_0000221,10000000.0,
773,1,Inhibitory activity against 5-hydroxytryptamine 1 receptor by 3H ligand binding experiments.,,4,104744,,H,Autocuration,,CHEMBL615479,,BAO_0000224,,
774,1,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat,,4,104744,,H,Autocuration,,CHEMBL615480,,BAO_0000019,,
775,1,Tested for its binding affinity towards 5-hydroxytryptamine 1 receptor in rat cortical membrane homogenates using radioligand ([3H]5-HT) binding assay.,Rattus norvegicus,5,104744,,D,Autocuration,,CHEMBL615481,,BAO_0000249,,
776,1,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,4,104744,,H,Autocuration,,CHEMBL872869,,BAO_0000019,,
777,1,Compound at 1 uM was tested for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,4,104744,,H,Autocuration,,CHEMBL615482,,BAO_0000019,,
778,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,4,104744,,H,Autocuration,,CHEMBL615483,,BAO_0000221,955.0,
779,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,4,104744,,H,Autocuration,,CHEMBL615484,,BAO_0000221,955.0,
780,1,Percent inhibition of 5-hydroxytryptamine 1 receptor from rat cortex membrane using [3H]- serotonin as radioligand at 33 uM,,4,104744,,H,Autocuration,,CHEMBL615485,,BAO_0000019,,
781,1,Inhibition of [3H]5-HT radioligand binding against 5-hydroxytryptamine 1 receptor,Rattus norvegicus,5,104744,,D,Autocuration,,CHEMBL615486,,BAO_0000224,,
782,1,Ancillary Binding affinity towards rat 5-hydroxytryptamine 1 receptor,,4,104744,,H,Autocuration,,CHEMBL615487,,BAO_0000224,,
783,1,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,4,104744,,H,Autocuration,,CHEMBL615488,,BAO_0000224,,
784,1,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,4,104744,,H,Autocuration,,CHEMBL615489,,BAO_0000224,,
785,1,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1 receptor,,4,104744,,H,Autocuration,,CHEMBL615389,,BAO_0000224,,
786,1,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,,4,104744,,H,Autocuration,,CHEMBL615390,,BAO_0000019,,
787,1,Binding affinity towards central 5-hydroxytryptamine 1 receptor was determined in rat cerebral cortex using [3H]5-HT as radioligand,,4,104744,,H,Autocuration,,CHEMBL615391,,BAO_0000019,,
788,1,Binding affinity towards 5-hydroxytryptamine 1 receptor was determined,,4,104744,,H,Autocuration,,CHEMBL615392,,BAO_0000224,,
789,1,Affinity for 5-hydroxytryptamine 1 receptor,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615393,,BAO_0000019,,
790,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex,,4,104744,,H,Autocuration,,CHEMBL615394,,BAO_0000221,955.0,
791,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1 receptor using [3H]5-HT in rat brain cortex at 10 uM,,4,104744,,H,Autocuration,,CHEMBL615395,,BAO_0000221,955.0,
792,1,Compound was evaluated for 5-hydroxytryptamine 1 receptor binding,,4,104744,,H,Autocuration,,CHEMBL615396,,BAO_0000224,,
793,1,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 1 receptor in rat brain using [3H]HT radioligand assay,,4,104744,,H,Autocuration,,CHEMBL615397,,BAO_0000221,955.0,
794,1,Displacement of binding of [3H]5-HT to 5-hydroxytryptamine 1 receptor in rat cerebral cortex,,4,104744,,H,Autocuration,,CHEMBL615398,,BAO_0000019,,
795,1,Displacement of [3H]spiperone from 5-hydroxytryptamine 1 receptor of rat cortex,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615399,,BAO_0000019,,
796,1,Evaluated for binding affinity towards rat cortical membranes at 5-hydroxytryptamine 1 receptor binding site by using [3H]-5-HT as a radioligand.,,4,104744,,H,Autocuration,,CHEMBL615400,,BAO_0000019,,
797,1,Binding affinity for 5-hydroxytryptamine 1 receptor of rat prefrontal cortex,Rattus norvegicus,5,104744,,D,Autocuration,,CHEMBL615401,,BAO_0000019,,
798,1,Displacement of [3H]5-HT from 5-hydroxytryptamine 1 receptor of rat cortical membrane homogenates,Rattus norvegicus,0,22226,,U,Autocuration,,CHEMBL615402,,BAO_0000019,,
799,1,The ability to inhibit [3H]5-HT binding to 5-hydroxytryptamine 1 receptor in rat cortex,,4,104744,,H,Autocuration,,CHEMBL615403,,BAO_0000019,,
800,1,The binding affinity was measured on serotonin 5-hydroxytryptamine 1 receptor in rat brain tissue,,4,104744,,H,Autocuration,,CHEMBL615404,,BAO_0000221,955.0,
801,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1 receptor by displacing [3H]5-HT radioligand in rat cerebral cortex,,4,104744,,H,Autocuration,,CHEMBL615781,,BAO_0000019,,
802,1,Tested for 5-hydroxytryptamine 1 receptor binding ability by displacement of [3H]5-HT from rat brain synaptosomes,,4,104744,,H,Autocuration,,CHEMBL615782,,BAO_0000220,955.0,
803,1,Inhibition constant (1 uM) was measured on 5-hydroxytryptamine 1 receptor/uptake using [3H]- serotonin as radioligand in rat brain cortex.,,4,104744,,H,Autocuration,,CHEMBL615783,,BAO_0000221,955.0,
804,1,Compound was tested for binding affinity against 5-HT1 receptor,,0,22226,,U,Autocuration,,CHEMBL873481,,BAO_0000019,,
805,1,Inhibitory concentration against 5-hydroxytryptamine 1 receptor,,0,22226,,U,Autocuration,,CHEMBL615784,,BAO_0000019,,
806,1,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,,8,10576,,H,Expert,,CHEMBL615785,,BAO_0000357,,
807,1,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",,8,10576,,H,Autocuration,,CHEMBL615786,,BAO_0000249,,
808,1,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,,8,10576,,H,Autocuration,,CHEMBL615787,,BAO_0000218,,
809,1,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,,8,10576,,H,Autocuration,,CHEMBL615788,,BAO_0000218,,
810,1,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL767044,,BAO_0000019,,
811,1,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while iv administration,,8,10576,,H,Autocuration,,CHEMBL615789,,BAO_0000218,,
812,1,Agonistic activity (induction of forepaw treading in rats)on postsynaptic 5-hydroxytryptamine 1A receptor while subcutaneous administration,,8,10576,,H,Autocuration,,CHEMBL615790,,BAO_0000218,,
813,1,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats,,8,10576,,H,Autocuration,,CHEMBL615813,,BAO_0000019,,
814,1,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 10 uM concentration,,8,10576,,H,Autocuration,,CHEMBL615814,,BAO_0000219,,
815,1,Percent inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation in GH4ZD10 cells expressing 5-HT1A receptor at 50 uM relative to 5-HT,,8,51,,H,Expert,,CHEMBL615815,,BAO_0000219,,
816,1,Percent of maximum response by 5-HT when tested for inhibition of vasoactive intestinal polypeptide-induced (VIP-induced) cAMP formation assessed in GH4ZD10 cells at 50 uM concentration; No effect,,8,10576,,H,Autocuration,,CHEMBL615816,,BAO_0000219,,
817,1,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes expressed as Hill values,,8,10576,,H,Expert,,CHEMBL615817,,BAO_0000249,,
818,1,Ability to bind at 5-hydroxytryptamine 1A receptor of rat hippocampus by displacing [3H]8-OH-DPAT,,8,10576,,H,Autocuration,,CHEMBL615818,,BAO_0000221,10000000.0,
819,1,Ability to bind at serotonin 5-hydroxytryptamine 1A receptors of rat hippocampus by displacing [3H]8-OH-DPAT,,8,10576,,H,Autocuration,,CHEMBL615819,,BAO_0000221,10000000.0,
820,1,Binding affinity against 5-hydroxytryptamine 1A receptor (5-HT1A) by displacement of [3H]8-OH-DPAT from rat hippocampus membranes,,8,10576,Membranes,H,Expert,,CHEMBL615820,,BAO_0000249,,
821,1,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]8-OH-DPAT,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615821,,BAO_0000221,10000000.0,
822,1,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615822,,BAO_0000221,10000000.0,
823,1,Binding affinity against 5-hydroxytryptamine 1A receptor using in rat hippocampal tissue using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Expert,,CHEMBL615823,,BAO_0000221,10000000.0,
824,1,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor; IA-Inactive,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615824,,BAO_0000221,10000000.0,
825,1,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue with [3H]5-HT,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615825,,BAO_0000221,10000000.0,
826,1,Binding affinity towards rat 5-hydroxytryptamine 1A receptor was evaluated using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Expert,,CHEMBL615826,,BAO_0000357,,
827,1,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Expert,,CHEMBL615827,,BAO_0000249,,
828,1,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus membrane using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Expert,,CHEMBL615828,,BAO_0000249,10000000.0,
829,1,Binding affinity by measuring displacement of [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,8,10576,,H,Expert,,CHEMBL615829,,BAO_0000221,10000000.0,
830,1,Binding affinity to 5-hydroxytryptamine 1A receptor of rat hippocampus with [3H]8-OH-DPAT as radioligand,,8,10576,,H,Autocuration,,CHEMBL615830,,BAO_0000221,10000000.0,
831,1,Binding affinity towards serotonin 5-HT1A receptor was determined in rat hippocampus using [3H]8-OH-DPAT as ligand,,8,10576,,H,Expert,,CHEMBL615831,,BAO_0000221,10000000.0,
832,1,Binding affinity was measured against serotonin 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL615832,,BAO_0000357,,
833,1,Binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH- DPAT as radioligand,,8,10576,,H,Autocuration,,CHEMBL615833,,BAO_0000019,,
834,1,Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]-8-OH- DPAT as radioligand,,8,10576,,H,Autocuration,,CHEMBL615834,,BAO_0000221,10000000.0,
835,1,Binding affinity against 5-hydroxytryptamine 1A (5-HT1A) receptor in rat hippocampus membranes,,8,10576,,H,Intermediate,,CHEMBL615835,,BAO_0000249,,
836,1,Binding affinity was measured at the serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampal membrane.,,8,10576,,H,Autocuration,,CHEMBL615836,,BAO_0000249,10000000.0,
837,1,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand.,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615837,,BAO_0000019,,
838,1,Binding affinity to 5-hydroxytryptamine 1A receptor in the rat brain using [3H]8-hydroxy-2-(di-n-propylamine)tetralin as radioligand; ND-Not determined,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615838,,BAO_0000019,,
839,1,"Binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding (NSB)",,8,10576,,H,Expert,,CHEMBL615839,,BAO_0000249,,
840,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]-8-OH-DPAT as radioligand,,8,10576,,H,Autocuration,,CHEMBL884525,,BAO_0000019,,
841,1,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonin 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,,8,10576,,H,Autocuration,,CHEMBL615840,,BAO_0000249,,
842,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,8,10576,,H,Expert,,CHEMBL615405,,BAO_0000221,10000000.0,
843,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,8,10576,,H,Expert,,CHEMBL615406,,BAO_0000019,,
844,1,Affinity for 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,,8,10576,,H,Expert,,CHEMBL615900,,BAO_0000221,10000000.0,
845,1,Inhibition of [3H]8-OH-DPAT binding at serotonin 5-hydroxytryptamine 1A receptor from rat hippocampus tissue.,,8,10576,,H,Expert,,CHEMBL615901,,BAO_0000221,10000000.0,
846,1,In vitro inhibition of [3H]8-OH-DPAT binding to rat 5-HT 1a receptors.,,8,10576,,H,Expert,,CHEMBL615902,,BAO_0000357,,
847,1,Compound was measured for affinity at 5-hydroxytryptamine 1A receptor labeled with [3H]8-OH-DPAT radioligand in hippocampus tissue,,8,10576,,H,Autocuration,,CHEMBL615903,,BAO_0000221,10000000.0,
848,1,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor<br>at 1 uM,,8,10576,,H,Autocuration,,CHEMBL615904,,BAO_0000357,,
849,1,Concentration necessary to achieve half maximal inhibition of [3H]8-Hydroxy-2-(di-n-propylamino)tetralin binding to 5-hydroxytryptamine 1A receptor at 1 uM,,8,10576,,H,Expert,,CHEMBL615905,,BAO_0000357,,
850,1,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,,8,10576,,H,Autocuration,,CHEMBL615906,,BAO_0000019,,
851,1,In vitro Inhibitory activity tested at 5-hydroxytryptamine 1A receptor binding site in rat,,8,10576,,H,Autocuration,,CHEMBL615907,,BAO_0000019,,
852,1,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,8,10576,,H,Expert,,CHEMBL615908,,BAO_0000019,,
853,1,In vitro affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT in rat hippocampus,,8,10576,,H,Autocuration,,CHEMBL615909,,BAO_0000221,10000000.0,
854,1,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]-8-OH-DPAT as the radioligand",,8,10576,,H,Autocuration,,CHEMBL615910,,BAO_0000019,,
855,1,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand.",,8,10576,,H,Autocuration,,CHEMBL615911,,BAO_0000019,,
856,1,"In vitro binding activity against 5-hydroxytryptamine 1A receptor from homogenized rat brain, using [3H]8-OH-DPAT as the radioligand",,8,10576,,H,Autocuration,,CHEMBL615912,,BAO_0000019,,
857,1,In vitro binding affinity for serotonin 5-hydroxytryptamine 1A receptor fof rat cerebral cortex using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Expert,,CHEMBL615913,,BAO_0000019,,
858,1,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,8,10576,,H,Expert,,CHEMBL615914,,BAO_0000357,,
859,1,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,,8,10576,,H,Autocuration,,CHEMBL615915,,BAO_0000221,10000000.0,
860,1,In vitro binding affinity towards the 5-hydroxytryptamine 1A receptor was evaluated,,8,10576,,H,Autocuration,,CHEMBL615916,,BAO_0000357,,
861,1,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 1A receptor by displacement of [3H]- tetralin,,8,10576,,H,Expert,,CHEMBL615917,,BAO_0000357,,
862,1,In vitro inhibitory activity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,8,10576,,H,Expert,,CHEMBL615918,,BAO_0000357,,
863,1,In vitro inhibitory concentration against radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane.,,8,10576,,H,Expert,,CHEMBL615919,,BAO_0000249,10000000.0,
864,1,In vitro radioligand binding assay on 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615920,,BAO_0000221,10000000.0,
865,1,Inhibition concentration against 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL615921,,BAO_0000357,,
866,1,Inhibitory concentration against 5-hydroxytryptamine 1A receptor (Inactive at >1000 nM concentration),,8,10576,,H,Expert,,CHEMBL615922,,BAO_0000357,,
867,1,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",Rattus norvegicus,9,10576,,D,Expert,,CHEMBL881290,,BAO_0000249,,
868,1,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Residual radioligand binding higher than 50%",,8,10576,,H,Autocuration,,CHEMBL615923,,BAO_0000221,10000000.0,
869,1,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,,8,10576,,H,Autocuration,,CHEMBL615924,,BAO_0000221,10000000.0,
870,1,Inhibition of forskolin-activated adenylate cyclase (cAMP) activity at 5-hydroxytryptamine 1A receptor in rat hippocampus,,8,10576,,H,Autocuration,,CHEMBL615925,,BAO_0000221,10000000.0,
871,1,Inhibition of radiolabeled [3H]-8-OH-DPAT ligand binding to 5-hydroxytryptamine 1A receptor,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615926,,BAO_0000357,,
872,1,Displacement of [3H]8-OH-DPAT from rat cortex 5-hydroxytryptamine 1A receptor,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615927,,BAO_0000019,,
873,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,8,10576,,H,Autocuration,,CHEMBL615928,,BAO_0000221,10000000.0,
874,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor subtype,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615929,,BAO_0000357,,
875,1,Inhibitory activity against [3H]DPAT binding to 5-HT1A receptor in rat hippocampus,,8,10576,,H,Autocuration,,CHEMBL615930,,BAO_0000221,10000000.0,
876,1,Inhibition concentration against 5-hydroxytryptamine 1A receptor using cAMP as radioligand in CHO cells,,8,51,,H,Autocuration,,CHEMBL615931,449.0,BAO_0000219,,
877,1,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615932,449.0,BAO_0000219,,
878,1,Inhibition concentration against binding of radioligand [35S]GTP-gamma-S in CHO cells expressing 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615933,449.0,BAO_0000219,,
879,1,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615934,,BAO_0000357,,
880,1,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT; Not tested,,8,51,,H,Autocuration,,CHEMBL615935,,BAO_0000357,,
881,1,"Agonistic activity of compound towards 5-hydroxytryptamine 1A receptor was evaluated by [35S]GTP-gamma-S, stimulated cAMP assay",,8,51,,H,Autocuration,,CHEMBL615936,,BAO_0000019,,
882,1,Ability to displace [3H]-8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor at a concentration of 1 uM,,8,51,,H,Autocuration,,CHEMBL615937,449.0,BAO_0000219,,
883,1,Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615938,,BAO_0000357,,
884,1,In vitro binding affinity against human 5-hydroxytryptamine 1A receptor at a concentration of 100 (nM),,8,51,,H,Autocuration,,CHEMBL615797,,BAO_0000357,,
885,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL615798,,BAO_0000357,,
886,1,Inhibition of [3H]8-OH-DPAT binding to human 5-hydroxytryptamine 1A receptor at 1000 nM compound concentration,,8,51,,H,Autocuration,,CHEMBL872870,,BAO_0000357,,
887,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand at 100 nM concentration,,8,51,,H,Autocuration,,CHEMBL615799,,BAO_0000357,,
888,1,Percent binding affinity against 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615800,,BAO_0000357,,
889,1,Intrinsic activity for human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,8,51,,H,Autocuration,,CHEMBL615801,722.0,BAO_0000219,,
890,1,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the absence of endothelium,,8,51,,H,Autocuration,,CHEMBL615802,,BAO_0000019,,
891,1,Dissociation constant against human 5-hydroxytryptamine 1A receptor receptor,,8,51,,H,Autocuration,,CHEMBL615803,,BAO_0000357,,
892,1,"Inhibition of 5-HT induced [35S]GTP-gamma-S, binding at human cloned 5-HT 1A receptors.",,8,51,,H,Expert,,CHEMBL835002,,BAO_0000019,,
893,1,"5-hydroxytryptamine 1A receptor antagonism was evaluated by the ability to inhibit [35S]GTP-gamma-S, binding that was induced by 5-HT; Ki (nM): not determined",,8,51,,H,Autocuration,,CHEMBL615804,,BAO_0000019,,
894,1,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor,,8,51,,H,Expert,,CHEMBL615805,308.0,BAO_0000219,,
895,1,Ability to displace [3H]8-OH-DPAT from CHO cells stably transfected with human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615806,449.0,BAO_0000219,,
896,1,Affinity towards human 5-hydroxytryptamine 1A serotonin receptor,Homo sapiens,9,51,,D,Expert,,CHEMBL615807,,BAO_0000357,,
897,1,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT-as radioligand,,8,51,,H,Autocuration,,CHEMBL615808,,BAO_0000357,,
898,1,Binding affinity against 5-hydroxytryptamine 1A receptor,Homo sapiens,9,51,,D,Expert,,CHEMBL615809,,BAO_0000357,,
899,1,Binding affinity against 5-hydroxytryptamine 1A receptor in HeLa cells was determined using [3H]5-HT,,8,51,,H,Autocuration,,CHEMBL615810,308.0,BAO_0000219,,
900,1,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL615811,,BAO_0000357,,
901,1,Binding affinity against [3H]- -8-OH-DPAT -labeled 5-hydroxytryptamine 1A sites in cloned CHO cells,,8,51,,H,Autocuration,,CHEMBL615812,449.0,BAO_0000219,,
902,1,Binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,8,51,,H,Autocuration,,CHEMBL615751,449.0,BAO_0000219,,
903,1,Binding affinity against human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615752,,BAO_0000357,,
904,1,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand,,8,51,,H,Expert,,CHEMBL615753,449.0,BAO_0000219,,
905,1,Binding affinity against human 5-hydroxytryptamine 1A receptor in CHO cells labeled with [3H]8-OH-DPAT radioligand; nd=not determined,,8,51,,H,Autocuration,,CHEMBL615754,449.0,BAO_0000219,,
906,1,Binding affinity of compound to human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615755,,BAO_0000357,,
907,1,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,Homo sapiens,9,51,,D,Expert,,CHEMBL615756,449.0,BAO_0000219,,
908,1,Binding affinity for 5-hydroxytryptamine 1A receptor in HeLa transfected cell type using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL615757,,BAO_0000019,,
909,1,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,,8,51,,H,Autocuration,,CHEMBL615758,,BAO_0000357,,
910,1,In vitro affinity at human cloned 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,,8,51,,H,Expert,,CHEMBL615759,,BAO_0000357,,
911,1,Binding affinity towards human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615760,,BAO_0000357,,
912,1,Binding affinity towards human 5-hydroxytryptamine 1A receptor by the displacement of [3H]5-HT radioligand from the cloned receptor expressed in HeLa cells,,8,51,,H,Expert,,CHEMBL615761,308.0,BAO_0000219,,
913,1,Binding affinity towards human 5-hydroxytryptamine 1A receptor was determined using [3H]-5-HT as radioligand,,8,51,,H,Autocuration,,CHEMBL872104,,BAO_0000357,,
914,1,Binding affinity towards recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL615762,,BAO_0000357,,
915,1,Binding affinity towards recombinant human Compound at 1 uM was tested for the inhibition of radioligand [3H]8-OH-DPAT binding to recombinant human 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL615763,,BAO_0000357,,
916,1,Binding affinity for recombinant human 5-hydroxytryptamine 1A receptor using [3H]5-HT as radioligand.,,8,51,,H,Autocuration,,CHEMBL615764,,BAO_0000357,,
917,1,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines (He La),,8,51,,H,Autocuration,,CHEMBL615765,1167.0,BAO_0000219,,
918,1,Binding affinity on human cloned 5-hydroxytryptamine 1A receptor transfected in human cell lines(He La),,8,51,,H,Autocuration,,CHEMBL615766,,BAO_0000019,,
919,1,Binding affinity towards 5-HT1A receptor using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL615767,,BAO_0000357,,
920,1,Binding affinity was determined towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,8,51,,H,Expert,,CHEMBL615768,,BAO_0000357,,
921,1,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL615769,,BAO_0000357,,
922,1,Binding affinity was evaluated at 5-hydroxytryptamine 1A receptor labeled with [3H]-8-OH-DPAT,,8,51,,H,Expert,,CHEMBL615770,,BAO_0000357,,
923,1,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL615771,,BAO_0000357,,
924,1,Binding affinity to human 5-hydroxytryptamine 1A receptor was measured using [3H]-8-hydroxy-2-(di-n-propylamine) tetraline [3H]8-OH-DPAT) as radioligand,,8,51,,H,Expert,,CHEMBL615772,,BAO_0000357,,
925,1,Binding affinity towards 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL615773,,BAO_0000357,,
926,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,,8,51,,H,Expert,,CHEMBL615774,,BAO_0000357,,
927,1,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL615775,,BAO_0000357,,
928,1,Binding affinity towards cloned human 5-hydroxytryptamine 1A receptor was determined,,8,51,,H,Autocuration,,CHEMBL615776,,BAO_0000357,,
929,1,Binding affinity towards human cloned 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,8,51,,H,Expert,,CHEMBL615777,,BAO_0000357,,
930,1,Binding affinity was measured on 5-hydroxytryptamine 1A receptor in AK cells transfected with human 5-HT1A gene labeled with [3H]-8-OH-DPAT,,8,51,,H,Autocuration,,CHEMBL615778,,BAO_0000219,,
931,1,Binding affinity was measured on cloned Human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,Homo sapiens,9,51,,D,Expert,,CHEMBL615779,,BAO_0000357,,
932,1,Binding affinity was measured on cloned human 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,8,51,,H,Autocuration,,CHEMBL615780,,BAO_0000357,,
933,1,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616298,,BAO_0000357,,
934,1,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616299,,BAO_0000357,,
935,1,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells.,,8,51,,H,Autocuration,,CHEMBL616300,485.0,BAO_0000219,,
936,1,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1A receptor in CHO-K1 cells,,8,51,,H,Expert,,CHEMBL616301,485.0,BAO_0000219,,
937,1,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616302,,BAO_0000019,,
938,1,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 1),,8,51,,H,Autocuration,,CHEMBL616117,,BAO_0000019,,
939,1,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor (Experiment 2),,8,51,,H,Autocuration,,CHEMBL616118,,BAO_0000019,,
940,1,In vitro inhibition of [3H]- 8-OH-DPAT binding to cloned cell line containing human 5-hydroxytryptamine 1A receptor by Panlabs assay,,8,51,,H,Autocuration,,CHEMBL616119,,BAO_0000019,,
941,1,Displacement of specific [3H]- 5-HT binding to cloned human 5-hydroxytryptamine 1A receptor stably expressed in HeLa cells,Homo sapiens,9,51,,D,Expert,,CHEMBL616120,308.0,BAO_0000219,,
942,1,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616121,,BAO_0000357,,
943,1,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor receptor,,8,51,,H,Autocuration,,CHEMBL616122,,BAO_0000357,,
944,1,In vitro binding affinity tested on human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616123,,BAO_0000357,,
945,1,In vitro binding affinity to human 5-hydroxytryptamine 1A receptor,Homo sapiens,9,51,,D,Expert,,CHEMBL616124,,BAO_0000357,,
946,1,In vitro binding affinity at 5-hydroxytryptamine 1A receptor by [3H]8-OH-DPAT displacement.,,8,51,,H,Expert,,CHEMBL616125,,BAO_0000357,,
947,1,In vitro binding affinity towards Human 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT,Rattus norvegicus,8,51,,H,Expert,,CHEMBL616126,,BAO_0000357,,
948,1,In vitro binding affinity towards cloned human 5-hydroxytryptamine 1A receptor expressed in Chinese hamster ovary (CHO) cells using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL616127,449.0,BAO_0000219,,
949,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor,,8,51,,H,Expert,,CHEMBL616128,,BAO_0000019,,
950,1,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand,,8,51,,H,Autocuration,,CHEMBL616129,,BAO_0000357,,
951,1,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor,,8,51,,H,Expert,,CHEMBL616130,,BAO_0000357,,
952,1,Inhibition of [3H]- OH-DPAT binding against 5-hydroxytryptamine 1A receptor from human recombinant,,8,51,,H,Autocuration,,CHEMBL616131,,BAO_0000357,,
953,1,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor serotonergic receptor in human HeLa cells,,8,51,,H,Autocuration,,CHEMBL616132,308.0,BAO_0000219,,
954,1,Receptor binding affinity for cloned human 5-hydroxytryptamine 1A receptor in HeLa cells,Homo sapiens,9,51,,D,Expert,,CHEMBL616133,308.0,BAO_0000219,,
955,1,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL616134,,BAO_0000357,,
956,1,The binding affinity at the 5-hydroxytryptamine 1A receptor determined using [3H]5-CT,,8,51,,H,Autocuration,,CHEMBL616135,,BAO_0000357,,
957,1,Affinity for 5-hydroxytryptamine 1A receptor subtype,Homo sapiens,9,51,,D,Expert,,CHEMBL616136,,BAO_0000357,,
958,1,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes,,8,51,,H,Autocuration,,CHEMBL616137,,BAO_0000019,,
959,1,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1A receptor from cloned Human membranes.,,8,51,,H,Autocuration,,CHEMBL872105,,BAO_0000019,,
960,1,The compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor receptor,,8,51,,H,Autocuration,,CHEMBL616138,,BAO_0000357,,
961,1,Binding affinity for cloned human 5-hydroxytryptamine 1A receptor,Homo sapiens,9,51,,D,Expert,,CHEMBL616139,,BAO_0000357,,
962,1,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor; Not active",,8,51,,H,Autocuration,,CHEMBL616140,,BAO_0000019,,
963,1,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1A receptor; ND means not determined,,8,51,,H,Expert,,CHEMBL616141,,BAO_0000019,,
964,1,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL616142,,BAO_0000357,,
965,1,Tested in vitro for its ability to bind to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; ND means Not determined,,8,51,,H,Autocuration,,CHEMBL616143,,BAO_0000357,,
966,1,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,,8,51,,H,Autocuration,,CHEMBL616144,308.0,BAO_0000219,,
967,1,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT=not tested,,8,51,,H,Autocuration,,CHEMBL616145,308.0,BAO_0000219,,
968,1,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,,8,51,,H,Autocuration,,CHEMBL616012,308.0,BAO_0000219,,
969,1,Ability to displace [3H]5-CT (2.0 nM) from HeLa cells of human 5-hydroxytryptamine 1A receptor; NT denotes not tested,,8,51,,H,Autocuration,,CHEMBL616013,308.0,BAO_0000219,,
970,1,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,8,51,,H,Autocuration,,CHEMBL616014,,BAO_0000019,,
971,1,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,8,51,,H,Autocuration,,CHEMBL616015,,BAO_0000019,,
972,1,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT.; NT is not tested",,8,51,,H,Autocuration,,CHEMBL616016,,BAO_0000019,,
973,1,Antagonist induction of hypothermia by 8-OH-DPAT in 5-hydroxytryptamine 1A receptor after subcutaneous administration; NT is not tested,,8,51,,H,Autocuration,,CHEMBL616017,,BAO_0000218,,
974,1,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]-8-OH-DPAT binding in Chinese hamster ovary cell line; NT is not tested,,8,51,,H,Autocuration,,CHEMBL616018,,BAO_0000019,,
975,1,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor receptor; Not tested,,8,51,,H,Autocuration,,CHEMBL616019,,BAO_0000019,,
976,1,EC50 for inhibition of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor; Not tested,,8,51,,H,Autocuration,,CHEMBL616020,,BAO_0000019,,
977,1,Evaluated for the binding constant at [3H]8-OH-DPAT-labeled human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL858018,,BAO_0000357,,
978,1,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,8,51,,H,Autocuration,,CHEMBL616021,722.0,BAO_0000219,,
979,1,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at 1 uM.",,8,51,,H,Expert,,CHEMBL616022,,BAO_0000019,,
980,1,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means Not determined",,8,51,,H,Autocuration,,CHEMBL616023,,BAO_0000019,,
981,1,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; ND means not determined",,8,51,,H,Autocuration,,CHEMBL616024,,BAO_0000019,,
982,1,"Stimulation of binding of [35S]GTP-gamma-S, to G protein mediated by human cloned 5-hydroxytryptamine 1A receptor tested in vitro at a concentration of 1 uM; Not determined",,8,51,,H,Autocuration,,CHEMBL616025,,BAO_0000019,,
983,1,Antagonistic efficacy was evaluated by adenylyl cyclase assay in CHO cells stably expressing the human 5-HT1A receptor,,8,51,,H,Autocuration,,CHEMBL616026,449.0,BAO_0000219,,
984,1,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared with 5-HT",,8,51,,H,Autocuration,,CHEMBL616027,,BAO_0000019,,
985,1,"Agonist efficacy of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor compared to 5-HT",Homo sapiens,9,51,,D,Expert,,CHEMBL616028,,BAO_0000019,,
986,1,Percent efficacy against human 5-hydroxytryptamine 1A receptor relative to maximal 5-HT response,Homo sapiens,9,51,,D,Expert,,CHEMBL616029,,BAO_0000019,,
987,1,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by incubating human 5-hydroxytryptamine 1A receptor transfected CHO cells with [3H]8-OH-DPAT,,8,51,,H,Expert,,CHEMBL616030,449.0,BAO_0000219,,
988,1,In vitro inhibition of [3H]8-OH-DPAT binding to human cloned 5-hydroxytryptamine 1A receptor on CHO cell membranes.,,8,51,,H,Expert,,CHEMBL616031,,BAO_0000019,,
989,1,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,Homo sapiens,9,51,,D,Expert,,CHEMBL616032,,BAO_0000019,,
990,1,Agonist efficacy on 5-hydroxytryptamine 1A receptor subtype,Homo sapiens,9,51,,D,Expert,,CHEMBL616033,,BAO_0000019,,
991,1,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,8,51,,H,Autocuration,,CHEMBL616034,,BAO_0000019,,
992,1,Maximum binding affinity was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,8,51,,H,Autocuration,,CHEMBL616035,,BAO_0000019,,
993,1,Maximum binding affinity was evaluated as ([35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616036,,BAO_0000019,,
994,1,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,8,51,,H,Autocuration,,CHEMBL616037,,BAO_0000019,,
995,1,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,8,51,,H,Autocuration,,CHEMBL616038,,BAO_0000019,,
996,1,Agonist efficacy was evaluated as ([35S]GTP binding on 5-hydroxytryptamine 1A serotonergic receptors.,,8,51,,H,Autocuration,,CHEMBL616039,,BAO_0000019,,
997,1,Agonist efficacy was evaluated as [35S]GTP binding on cloned human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616040,,BAO_0000019,,
998,1,Concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,Homo sapiens,9,51,,D,Expert,,CHEMBL616041,308.0,BAO_0000219,,
999,1,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,Homo sapiens,9,51,,D,Expert,,CHEMBL616042,308.0,BAO_0000219,,
1000,1,Negative logarithm of concentration required to obtain 50% maximal stimulation of [35S]GTP gamma-S binding to human cloned 5-HT1A receptors of cell membranes from HeLa cells,Homo sapiens,9,51,,D,Expert,,CHEMBL616043,308.0,BAO_0000219,,
1001,1,"Potency (pD2) for the stimulation of [35S]GTP-gamma-S, binding on 5-hydroxytryptamine 1A receptor",,8,51,,H,Autocuration,,CHEMBL616044,,BAO_0000019,,
1002,1,"Ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,8,51,,H,Autocuration,,CHEMBL616045,,BAO_0000019,,
1003,1,Binding affinity against human 5-hydroxytryptamine 1A receptors HEK 293 cell membranes using [35S]GTP gamma-S,,8,51,,H,Autocuration,,CHEMBL616046,722.0,BAO_0000219,,
1004,1,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),,8,51,,H,Autocuration,,CHEMBL616047,449.0,BAO_0000219,,
1005,1,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells,,8,51,,H,Autocuration,,CHEMBL616048,449.0,BAO_0000219,,
1006,1,Potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 1),Homo sapiens,9,51,,D,Expert,,CHEMBL616049,449.0,BAO_0000219,,
1007,1,Compound was tested for its potency against human 5-hydroxytryptamine 1A receptor expressed in CHO cells (experiment 2),,8,51,,H,Autocuration,,CHEMBL616050,449.0,BAO_0000219,,
1008,1,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor,,8,51,,H,Expert,,CHEMBL616051,,BAO_0000219,,
1009,1,In vitro effective concentration required to inhibit forskolin-stimulated cAMP levels in HA7 cells expressing human 5-HT1A receptor; Not tested,,8,51,,H,Autocuration,,CHEMBL616212,,BAO_0000219,,
1010,1,"ability to influence the binding of [35S]GTP-gamma-S, to HeLa cell membranes expressing the human 5-hydroxytryptamine 1A receptor",,8,51,,H,Autocuration,,CHEMBL616213,,BAO_0000019,,
1011,1,Ability to bind to 5-hydroxytryptamine 1A receptor from cloned human expressed in Ha7 cells,,8,51,,H,Expert,,CHEMBL616214,,BAO_0000219,,
1012,1,Ability to bind to 5-hydroxytryptamine 1A receptor subtype from cloned human expressed in Ha7 cells,,8,51,,H,Expert,,CHEMBL616215,,BAO_0000219,,
1013,1,Binding activity radioligand.,,8,51,,H,Autocuration,,CHEMBL616216,,BAO_0000357,,
1014,1,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,8,51,,H,Autocuration,,CHEMBL616217,,BAO_0000019,,
1015,1,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616218,,BAO_0000357,,
1016,1,Binding affinity for human cloned 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616219,,BAO_0000357,,
1017,1,binding affinity towards human recombinant 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616220,,BAO_0000357,,
1018,1,Displacement of [3H]8-hydroxy-2-(di-n-propylamino)tetralin from human 5-hydroxytryptamine 1A receptor,Homo sapiens,9,51,,D,Expert,,CHEMBL833493,,BAO_0000357,,
1019,1,Ability to displace the radioligand [3H]-8-OH-DPAT from human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616221,,BAO_0000357,,
1020,1,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,Homo sapiens,9,51,,D,Expert,,CHEMBL616222,449.0,BAO_0000219,,
1021,1,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616223,,BAO_0000019,,
1022,1,Antagonistic affinity against cloned human 5-hydroxytryptamine 1A receptor; Not determined,,8,51,,H,Autocuration,,CHEMBL616224,,BAO_0000019,,
1023,1,Binding affinity at human 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding in Chinese hamster ovary cell line,,8,51,,H,Expert,,CHEMBL616225,,BAO_0000019,,
1024,1,Binding affinity to human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]-8-OH- DPAT as radioligand,Homo sapiens,9,51,,D,Expert,,CHEMBL616226,722.0,BAO_0000219,,
1025,1,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells,,8,51,,H,Autocuration,,CHEMBL616227,722.0,BAO_0000219,,
1026,1,Binding affinity against 5-hydroxytryptamine 1A human cloned receptors in HEK293 cells using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL616228,722.0,BAO_0000219,,
1027,1,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,,8,51,,H,Autocuration,,CHEMBL616229,722.0,BAO_0000219,,
1028,1,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand; ND means no data,,8,51,,H,Autocuration,,CHEMBL616230,722.0,BAO_0000219,,
1029,1,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;ND means no data.,,8,51,,H,Autocuration,,CHEMBL616231,722.0,BAO_0000219,,
1030,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in human using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL616232,,BAO_0000357,,
1031,1,Binding affinity towards 5-hydroxytryptamine 1A receptor (human cloned receptor) in HEK293 cells using [3H]8-OH-DPAT as radioligand;,,8,51,,H,Autocuration,,CHEMBL616233,722.0,BAO_0000219,,
1032,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT as the radioligand,,8,51,,H,Autocuration,,CHEMBL857973,722.0,BAO_0000219,,
1033,1,Compound was evaluated for its ability to displace [3H]8-OH-DPAT binding from human 5-hydroxytryptamine 1A receptor in mammalian cells,,8,51,,H,Autocuration,,CHEMBL616234,,BAO_0000219,,
1034,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616235,,BAO_0000357,,
1035,1,Binding affinity at human cloned 5-hydroxytryptamine 1A receptor expressed in HeLa cells by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,,8,51,,H,Expert,,CHEMBL616236,308.0,BAO_0000219,,
1036,1,Binding affinity at native 5-hydroxytryptamine 1A receptor in rat by [3H]8-hydroxy-2-(di-n-propylamino)tetraline displacement.,,8,51,,H,Expert,,CHEMBL616237,,BAO_0000019,,
1037,1,Compound was tested for its binding affinity against 5-hydroxytryptamine 1A receptor in human cloned receptors in HEK 293 cells using [3H]8-OH-DPAT,,8,51,,H,Autocuration,,CHEMBL616238,722.0,BAO_0000219,,
1038,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1A receptor in HEK 293 using [3H]5-CT as a radioligand,,8,51,,H,Autocuration,,CHEMBL616239,722.0,BAO_0000219,,
1039,1,In vitro binding affinity at human recombinant 5-hydroxytryptamine 1A receptor in mammalian cells using 3[H]8-OH-DPAT as the radioligand,,8,51,,H,Autocuration,,CHEMBL616240,,BAO_0000219,,
1040,1,The binding affinity was evaluated on cloned human 5-hydroxytryptamine 1A receptor expressed in HeLa cells by using DPAT as radioligand.,Homo sapiens,9,51,,D,Expert,,CHEMBL616241,308.0,BAO_0000219,,
1041,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1A receptor in HEK 293 cells using [3H]8-OH-DPAT.,,8,51,,H,Autocuration,,CHEMBL616242,722.0,BAO_0000219,,
1042,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1A receptor in HEK293 cells, using [3H]8-OH-DPAT as radioligand",,8,51,,H,Autocuration,,CHEMBL616243,722.0,BAO_0000219,,
1043,1,In vitro inhibitory concentration required against [3H]8-OH-DPAT binding to cloned human 5-hydroxytryptamine 1A receptor,,9,51,,D,Expert,,CHEMBL616244,,BAO_0000357,,
1044,1,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1A receptor,Homo sapiens,9,51,,D,Autocuration,,CHEMBL616245,,BAO_0000357,,
1045,1,Binding affinity towards 5-HT1B receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,,8,106,,H,Autocuration,,CHEMBL616246,,BAO_0000357,,
1046,1,Binding affinity against 5-HT1D receptor,,8,105,,H,Autocuration,,CHEMBL616247,,BAO_0000357,,
1047,1,Binding affinity against 5-hydroxytryptamine 1A receptor,,8,105,,H,Autocuration,,CHEMBL616248,,BAO_0000357,,
1048,1,Affinity of compound towards 5-hydroxytryptamine 1A receptor was evaluated using radioligand binding technique,,8,107,,H,Autocuration,,CHEMBL616249,,BAO_0000357,,
1049,1,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,Homo sapiens,8,10576,,H,Autocuration,,CHEMBL616250,,BAO_0000357,,
1050,1,Inhibition of [3H]- 8-OH-DAPT binding against human recombinant 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616251,,BAO_0000357,,
1051,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 15 min after administration of the compound,,8,11863,,H,Autocuration,,CHEMBL616252,,BAO_0000218,,
1052,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 30 min after administration of the compound,,8,11863,,H,Autocuration,,CHEMBL616253,,BAO_0000218,,
1053,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice 60 min after administration of the compound,,8,11863,,H,Autocuration,,CHEMBL616254,,BAO_0000218,,
1054,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 15 min,Mus musculus,9,11863,,D,Expert,,CHEMBL616255,,BAO_0000218,,
1055,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 30 min,Mus musculus,9,11863,,D,Expert,,CHEMBL832872,,BAO_0000218,,
1056,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 10 mg/kg after 60 min,Mus musculus,9,11863,,D,Expert,,CHEMBL616256,,BAO_0000218,,
1057,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 15 min,Mus musculus,9,11863,,D,Expert,,CHEMBL616257,,BAO_0000218,,
1058,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 30 min,Mus musculus,9,11863,,D,Expert,,CHEMBL616258,,BAO_0000218,,
1059,1,Antagonist activity at 5-hydroxytryptamine 1A receptor against (+)-8-OH-DPAT induced hypothermia in mice at 1 mg/kg after 60 min,Mus musculus,9,11863,,D,Expert,,CHEMBL616384,,BAO_0000218,,
1060,1,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,,8,11863,,H,Autocuration,,CHEMBL616385,,BAO_0000221,10000000.0,
1061,1,Inhibitory activity against serotonin 5-hydroxytryptamine 1A receptor from mice.,,8,11863,,H,Expert,,CHEMBL616386,,BAO_0000357,,
1062,1,Inhibitory activity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,Mus musculus,9,11863,,D,Expert,,CHEMBL616387,,BAO_0000221,10000000.0,
1063,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,,8,11863,,H,Autocuration,,CHEMBL616388,,BAO_0000221,10000000.0,
1064,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus,Mus musculus,9,11863,,D,Expert,,CHEMBL616389,,BAO_0000221,10000000.0,
1065,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in mouse hippocampus; Not determined,,8,11863,,H,Autocuration,,CHEMBL616390,,BAO_0000221,10000000.0,
1066,1,Compound was tested for binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as a radioligand,,8,11863,,H,Autocuration,,CHEMBL616391,,BAO_0000357,,
1067,1,Hill number was determined for inhibition of of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in mouse hippocampus,Mus musculus,9,11863,,D,Expert,,CHEMBL616392,,BAO_0000221,10000000.0,
1068,1,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor,Sus scrofa,8,51,,H,Autocuration,,CHEMBL616393,,BAO_0000357,,
1069,1,Ability to displace [3H]8-OH-DPAT radioligand from porcine 5-hydroxytryptamine 1A receptor; ND denotes not determined,Sus scrofa,8,51,,H,Autocuration,,CHEMBL616394,,BAO_0000357,,
1070,1,Binding affinity of compound measured for 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT-labeled porcine brain homogenates,Sus scrofa,8,51,,H,Autocuration,,CHEMBL616395,,BAO_0000019,,
1071,1,Compound was evaluated for the binding affinity at 5- HT1A receptor,Sus scrofa,8,51,,H,Autocuration,,CHEMBL616396,,BAO_0000357,,
1072,1,Compound was tested in vitro for its ability to compete with [3H]8-OH-DPAT at 5-hydroxytryptamine 1A receptor in porcine brain homogenate,Sus scrofa,8,51,,H,Autocuration,,CHEMBL872907,,BAO_0000019,,
1073,1,In vitro for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in porcine brain homogenate,Sus scrofa,8,51,,H,Autocuration,,CHEMBL616397,,BAO_0000019,,
1074,1,Compound was tested for its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in pig cortex,Sus scrofa,8,51,,H,Autocuration,,CHEMBL616398,,BAO_0000019,,
1075,1,Displacement of [3H]- 8-OH-DPAT from porcine 5-hydroxytryptamine 1A receptor,Sus scrofa,8,51,,H,Expert,,CHEMBL616399,,BAO_0000357,,
1076,1,Binding activity radioligand.,Sus scrofa,8,51,,H,Autocuration,,CHEMBL857065,,BAO_0000357,,
1077,1,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,Sus scrofa,8,51,,H,Expert,,CHEMBL616400,,BAO_0000019,,
1078,1,Binding activity against 5-hydroxytryptamine 1A receptor from pig cortex membrane using [3H]8-OH-DPAT-HT as radioligand.,Sus scrofa,8,51,,H,Autocuration,,CHEMBL616401,,BAO_0000019,,
1079,1,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor from pig cortex,,8,10624,,H,Expert,,CHEMBL616402,,BAO_0000019,,
1080,1,Displacement of [3H]8-OH-DPAT from pig cortex 5-hydroxytryptamine 1A receptor,Sus scrofa,8,51,,H,Expert,,CHEMBL616403,,BAO_0000019,,
1081,1,Binding affinity for 5-hydroxytryptamine 1A receptor in piglet hippocampus using [3H]8-OH-DPAT,Sus scrofa,8,51,,H,Autocuration,,CHEMBL616404,,BAO_0000221,10000000.0,
1082,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in pig frontal cortex membranes using [8H]-OH-DPAT,Sus scrofa,8,51,,H,Autocuration,,CHEMBL616405,,BAO_0000249,,
1083,1,Binding affinity was evaluated by 5-hydroxytryptamine 1A receptor agonism in the pig cortex by displacing 8-OH-DPAT,Sus scrofa,8,51,,H,Autocuration,,CHEMBL616406,,BAO_0000019,,
1084,1,Agonistic activity against 5-hydroxytryptamine 1A receptor in pig cortex using [3H]8-OH-DPAT,Sus scrofa,8,51,,H,Expert,,CHEMBL616407,,BAO_0000019,,
1085,1,Binding affinity against 5-hydroxytryptamine 1 receptor using rabbit jugular vein assay in the presence of endothelium,Oryctolagus cuniculus,8,51,,H,Autocuration,,CHEMBL616408,,BAO_0000019,,
1086,1,Inhibition activity against 5-hydroxytryptamine 1A receptor in rat hippocampus membranes using radio binding assays,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616409,,BAO_0000249,,
1087,1,"Inhibition of [3H]8-hydroxy-2-dipropylamino-1,2,3,4-tetrahydronaphthalene binding to 5-hydroxytryptamine 1A receptor in hippocampus region of rat brain; Less active",Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616410,,BAO_0000221,10000000.0,
1088,1,Tested for the effect on binding at 5-hydroxytryptamine 1A receptor; No activity,,8,10576,,H,Autocuration,,CHEMBL616411,,BAO_0000357,,
1089,1,"Antagonist activity to stimulate binding of [35S]GTP-gamma-S, to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",Rattus norvegicus,9,10576,Membranes,D,Expert,,CHEMBL616412,,BAO_0000249,,
1090,1,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",Rattus norvegicus,9,10576,Membranes,D,Expert,,CHEMBL616413,,BAO_0000249,10000000.0,
1091,1,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,8,10576,,H,Autocuration,,CHEMBL616414,,BAO_0000221,10000000.0,
1092,1,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616415,,BAO_0000221,10000000.0,
1093,1,Binding affinity measured at the 5-hydroxytryptamine 1A receptor by the inhibition of [3H]8-OH-DPAT binding to rat cortex using unlabeled buspirone for nonspecific binding.,,8,10576,,H,Autocuration,,CHEMBL616416,,BAO_0000019,,
1094,1,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand.,,8,10576,,H,Expert,,CHEMBL616417,,BAO_0000357,,
1095,1,Binding affinity of [3H]- -8-OH-DPAT labelled towards Rat Hippocampal 5-hydroxytryptamine 1A receptor using radioligand binding assay,,8,10576,,H,Autocuration,,CHEMBL616418,,BAO_0000357,,
1096,1,Binding affinity of [3H]-8-OH-DPAT towards 5-hydroxytryptamine 1A receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,8,10576,,H,Autocuration,,CHEMBL616419,,BAO_0000219,,
1097,1,Binding affinity of compound against 5-hydroxytryptamine 1A receptor binding site using radioligand [3H]8-OH-DPAT,,8,10576,,H,Autocuration,,CHEMBL616420,,BAO_0000357,,
1098,1,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,,8,10576,Membranes,H,Autocuration,,CHEMBL616421,,BAO_0000249,,
1099,1,Binding affinity of compound towards 5-HT 1A receptor by measuring ability to displace [3H]OH-DPAT from 5-hydroxytryptamine 1A receptor in rat striatal membranes,,8,10576,Membranes,H,Autocuration,,CHEMBL616422,,BAO_0000249,,
1100,1,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor in rat striatal membranes by [3H]OH-DPAT displacement.,,8,10576,Membranes,H,Expert,,CHEMBL616423,,BAO_0000249,,
1101,1,Binding affinity for 5-hydroxytryptamine 1A receptor with [3H]5-HT,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616424,,BAO_0000357,,
1102,1,Binding affinity to the rat 5-hydroxytryptamine 1A receptor,,8,10576,,H,Expert,,CHEMBL616425,,BAO_0000357,,
1103,1,Binding affinity was tested on 5-hydroxytryptamine 1A receptor using radioligand [3H]5-HT binding assay.,,8,10576,,H,Expert,,CHEMBL616426,,BAO_0000357,,
1104,1,Binding affinity against 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as the radioligand.,,8,10576,,H,Autocuration,,CHEMBL616427,,BAO_0000221,10000000.0,
1105,1,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus tissue.,,8,10576,,H,Autocuration,,CHEMBL616428,,BAO_0000221,10000000.0,
1106,1,Binding affinity by measuring displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,8,10576,,H,Autocuration,,CHEMBL616290,,BAO_0000221,10000000.0,
1107,1,Displacement of [3H]8-OH-DPAT from rat striata 5-hydroxytryptamine 1A receptor,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616052,,BAO_0000357,,
1108,1,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616053,,BAO_0000357,,
1109,1,Binding affinity towards 5-HT 1A receptor in rat cerebral cortex membranes using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Autocuration,,CHEMBL616054,,BAO_0000249,,
1110,1,Binding affinity towards 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616055,,BAO_0000357,,
1111,1,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in competitive binding assay,,8,10576,,H,Autocuration,,CHEMBL616056,,BAO_0000357,,
1112,1,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,,8,10576,,H,Expert,,CHEMBL616057,,BAO_0000019,,
1113,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616058,,BAO_0000221,955.0,
1114,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,8,10576,,H,Autocuration,,CHEMBL616059,,BAO_0000221,955.0,
1115,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hypocampus membrane using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Autocuration,,CHEMBL616060,,BAO_0000249,,
1116,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in the rat brain (hippocampus) using [3H]8-OH-DPAT,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616061,,BAO_0000221,10000000.0,
1117,1,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]-8-hydroxy-2-(di-n-propylamine) tetralin (8-OH-DPAT) as a radioligand,,8,10576,,H,Expert,,CHEMBL616062,,BAO_0000221,10000000.0,
1118,1,Binding affinity towards 5-hydroxytryptamine 1A receptor sites in cortical membranes using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Autocuration,,CHEMBL616063,,BAO_0000249,,
1119,1,"Binding affinity towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",,8,10576,,H,Autocuration,,CHEMBL616064,,BAO_0000249,2435.0,
1120,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cortex membranes,Rattus norvegicus,9,10576,Membranes,D,Expert,,CHEMBL616065,,BAO_0000249,,
1121,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat cerebral cortex membranes,Rattus norvegicus,9,10576,Membranes,D,Expert,,CHEMBL616066,,BAO_0000249,,
1122,1,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Autocuration,,CHEMBL616067,,BAO_0000221,10000000.0,
1123,1,Binding affinity towards rat hippocampal 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand; Not tested,,8,10576,,H,Autocuration,,CHEMBL616068,,BAO_0000221,10000000.0,
1124,1,Binding affinity against rat hippocampal 5-hydroxytryptamine 1A (5-HT1A) receptor determined using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Intermediate,,CHEMBL616069,,BAO_0000221,10000000.0,
1125,1,Binding was determined on 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,,8,10576,,H,Expert,,CHEMBL616070,,BAO_0000249,,
1126,1,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Autocuration,,CHEMBL616071,,BAO_0000221,10000000.0,
1127,1,Binding affinity against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.,,8,10576,,H,Expert,,CHEMBL616072,,BAO_0000221,10000000.0,
1128,1,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand.; ND = Not determined,,8,10576,,H,Autocuration,,CHEMBL616073,,BAO_0000221,10000000.0,
1129,1,Binding affinity was evaluated against 5-hydroxytryptamine 1A receptor on rat hippocampus using [3H]8-OH-DPAT as radioligand; ND = Not determined,,8,10576,,H,Autocuration,,CHEMBL616074,,BAO_0000221,10000000.0,
1130,1,Binding affinity was evaluated by determining in vitro displacement of [3H]8-OH-DPAT from the central 5-hydroxytryptamine 1A receptor recognition site in rat frontal cortex homogenate.,,8,10576,,H,Expert,,CHEMBL616075,,BAO_0000019,,
1131,1,Binding affinity was evaluated by using [3H]8-OH-DPAT radioligand by using competitive binding assay on 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616076,,BAO_0000357,,
1132,1,Binding affinity for 5-HT1A measured by displacing [3H]8-OH-DPAT from rat cortical membranes; Not determined,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616077,,BAO_0000019,,
1133,1,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616078,,BAO_0000019,,
1134,1,Binding affinity for 5-hydroxytryptamine 1A receptor measured by displacing [3H]8-OH-DPAT from rat cortical membranes;ND-Not determined,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616079,,BAO_0000019,,
1135,1,Binding affinity against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616080,485.0,BAO_0000219,,
1136,1,Binding affinity towards 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616081,,BAO_0000357,,
1137,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [125I]trans-8-OH-PIPAT in membrane homogenates of hippocampal tissue of rat brain,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616082,,BAO_0000221,10000000.0,
1138,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in membrane homogenates of hippocampal tissue of rat brain,,8,10576,,H,Autocuration,,CHEMBL616083,,BAO_0000221,10000000.0,
1139,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,8,10576,,H,Autocuration,,CHEMBL616084,,BAO_0000019,,
1140,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates,,8,10576,,H,Expert,,CHEMBL616085,,BAO_0000019,,
1141,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT,,8,10576,,H,Autocuration,,CHEMBL616086,,BAO_0000019,,
1142,1,"Binding affinity towards 5-hydroxytryptamine 1A receptor using 0.1 nM [3H]-8-OH-DPAT (8-hydroxy-2-(di-n-propylamino)tet-ralin), from rat hippocampal homogenate",,8,10576,,H,Autocuration,,CHEMBL616087,,BAO_0000221,10000000.0,
1143,1,Binding affinity was determined against 5-hydroxytryptamine 1A receptor using [3H]WB-4101,,8,10576,,H,Expert,,CHEMBL616088,,BAO_0000357,,
1144,1,Binding affinity was determined against 5-hydroxytryptamine 1A receptor was determined in male Sprague-Dawley rat brain.,,8,10576,,H,Autocuration,,CHEMBL616089,,BAO_0000019,,
1145,1,Binding affinity was measured against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT by lysergic acid amides,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616090,,BAO_0000357,,
1146,1,Binding affinity was measured on cloned rat 5-hydroxytryptamine 1A receptor which is labeled by [3H]8-OH-DPAT,,8,10576,,H,Autocuration,,CHEMBL616091,,BAO_0000357,,
1147,1,"Binding affinity of the compound towards 5-hydroxytryptamine 1A receptor sites, in rat striatum membranes using [3H]- sandoz 205-501 as radioligand",,8,10576,Membranes,H,Autocuration,,CHEMBL616092,,BAO_0000249,2435.0,
1148,1,Binding constant against 5-hydroxytryptamine 1A receptor (in vitro),,8,10576,,H,Autocuration,,CHEMBL616093,,BAO_0000357,,
1149,1,Binding constant against 5-hydroxytryptamine 1A receptor (in vivo),,8,10576,,H,Autocuration,,CHEMBL616094,,BAO_0000218,,
1150,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex,,8,10576,,H,Autocuration,,CHEMBL616095,,BAO_0000221,955.0,
1151,1,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616096,,BAO_0000357,,
1152,1,Binding affinity at [3H]8-OH-DPAT-Labeled 5-hydroxytryptamine 1A receptor sites in rat brain hippocampal membranes,,8,10576,,H,Expert,,CHEMBL616097,,BAO_0000249,,
1153,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus membranes,Rattus norvegicus,9,10576,Membranes,D,Expert,,CHEMBL616098,,BAO_0000249,,
1154,1,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Autocuration,,CHEMBL616099,,BAO_0000221,10000000.0,
1155,1,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 1A receptor receptor in rat hippocampus using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Autocuration,,CHEMBL616100,,BAO_0000221,10000000.0,
1156,1,Ability to displace [3H]-8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,,8,10576,,H,Expert,,CHEMBL616101,,BAO_0000357,,
1157,1,Binding affinity at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes by [3H]8-OH-DPAT displacement.,,8,10576,,H,Expert,,CHEMBL616102,,BAO_0000249,,
1158,1,Compound was evaluated for its ability to displace [3H]8-OH-DPAT from serotonergic 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616103,,BAO_0000357,,
1159,1,Compound was evaluated for its binding affinity against 5-hydroxytryptamine 1A receptor from rat cerebral cortex,,8,10576,,H,Expert,,CHEMBL616104,,BAO_0000019,,
1160,1,"Binding affinity to 5-hydroxytryptamine 1A receptor (5-HT 1A receptor, serotonin receptor) from rat cortex using [3H]8-OH-DPAT as radioligand",,8,10576,,H,Expert,,CHEMBL616105,,BAO_0000019,,
1161,1,Displacement of [3H]prazosin from rat cortex membrane 5-hydroxytryptamine 1A receptor,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616106,,BAO_0000019,,
1162,1,Compound was evaluated for its binding affinity with 5-hydroxytryptamine 1A receptor using membranes prepared from rat cerebral cortex,,8,10576,,H,Autocuration,,CHEMBL616107,,BAO_0000019,,
1163,1,Binding affinity towards rat 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand.,,8,10576,,H,Expert,,CHEMBL616108,,BAO_0000357,,
1164,1,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,8,10576,,H,Expert,,CHEMBL616109,,BAO_0000221,10000000.0,
1165,1,In vitro ability to displace [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding from 5-hydroxytryptamine 1A receptor site.,,8,10576,,H,Autocuration,,CHEMBL616110,,BAO_0000357,,
1166,1,Binding affinity against rat 5-hydroxytryptamine 1A receptor in CHO cells.,,8,10576,,H,Expert,,CHEMBL616111,449.0,BAO_0000219,,
1167,1,Binding affinity towards 5-hydroxytryptamine 1A receptor from rat brain using [3H]-8-OH-DPAT as radioligand,,8,10576,,H,Expert,,CHEMBL616112,,BAO_0000019,,
1168,1,Compound was tested for the Binding affinity against rat hippocampal 5-hydroxytryptamine 1A receptor by Radio ligand [3H]8-OH-DPAT binding assay.,,8,10576,,H,Autocuration,,CHEMBL616113,,BAO_0000221,10000000.0,
1169,1,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616114,,BAO_0000019,,
1170,1,Compound was tested for the displacement of [3H]-8-OH- DPAT from rat brain 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616115,,BAO_0000019,,
1171,1,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616116,,BAO_0000357,,
1172,1,Binding affinity for 5-hydroxytryptamine 1A receptor in rat brain tissue using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Expert,,CHEMBL615844,,BAO_0000221,955.0,
1173,1,In vitro displacement of [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,8,10576,,H,Expert,,CHEMBL615939,,BAO_0000221,10000000.0,
1174,1,In vitro ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor sites of rat brain cortex.,,8,10576,,H,Expert,,CHEMBL615940,,BAO_0000019,,
1175,1,In vitro affinity at 5-hydroxytryptamine 1A receptor of rat hippocampus by [3H]8-OH-DPAT displacement.,,8,10576,,H,Expert,,CHEMBL615941,,BAO_0000221,10000000.0,
1176,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-HT1A receptor of rat hippocampus and the value ranges from 9 - 12,,8,10576,,H,Autocuration,,CHEMBL615942,,BAO_0000221,10000000.0,
1177,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,,8,10576,,H,Autocuration,,CHEMBL615943,,BAO_0000221,10000000.0,
1178,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 12 to 17,,8,10576,,H,Autocuration,,CHEMBL615944,,BAO_0000221,10000000.0,
1179,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus (94%CI) from 391-841,,8,10576,,H,Autocuration,,CHEMBL615945,,BAO_0000221,10000000.0,
1180,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 17.,,8,10576,,H,Autocuration,,CHEMBL615946,,BAO_0000221,10000000.0,
1181,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 12 to 20.,,8,10576,,H,Autocuration,,CHEMBL615947,,BAO_0000221,10000000.0,
1182,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 245 to 736,,8,10576,,H,Autocuration,,CHEMBL615948,,BAO_0000221,10000000.0,
1183,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 25 - 84,,8,10576,,H,Autocuration,,CHEMBL615949,,BAO_0000221,10000000.0,
1184,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 48 to 59,,8,10576,,H,Autocuration,,CHEMBL615950,,BAO_0000221,10000000.0,
1185,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and the value ranges from 3 -5,,8,10576,,H,Autocuration,,CHEMBL615951,,BAO_0000221,10000000.0,
1186,1,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 15 - 31,,8,10576,,H,Autocuration,,CHEMBL615952,,BAO_0000221,10000000.0,
1187,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 27 - 42,,8,10576,,H,Autocuration,,CHEMBL615953,,BAO_0000221,10000000.0,
1188,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus and value ranges from 6 - 13,,8,10576,,H,Autocuration,,CHEMBL615954,,BAO_0000221,10000000.0,
1189,1,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615955,,BAO_0000221,10000000.0,
1190,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.; ND is No Data.,,8,10576,,H,Autocuration,,CHEMBL615956,,BAO_0000221,10000000.0,
1191,1,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus. and the value ranges from 16 - 27,,8,10576,,H,Autocuration,,CHEMBL615957,,BAO_0000221,10000000.0,
1192,1,Displacement of [3H]2-(di-N-propylamino)-8-hydroxytetralin from central 5-hydroxytryptamine 1A receptor recognition sites in rat frontal cortex homogenates.,,8,10576,,H,Expert,,CHEMBL615958,,BAO_0000019,,
1193,1,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate,,8,10576,,H,Expert,,CHEMBL615959,,BAO_0000019,,
1194,1,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 1),,8,10576,,H,Autocuration,,CHEMBL615960,,BAO_0000019,,
1195,1,Displacement of radioligand [3H]2-(di-N-propylamino)-8-hydroxytetralin from 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenate (experiment 2),,8,10576,,H,Autocuration,,CHEMBL615961,,BAO_0000019,,
1196,1,Evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain,,8,10576,,H,Expert,,CHEMBL615962,,BAO_0000221,955.0,
1197,1,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand.,,8,10576,,H,Expert,,CHEMBL615963,,BAO_0000019,,
1198,1,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand; ND is no data.,,8,10576,,H,Autocuration,,CHEMBL615964,,BAO_0000019,,
1199,1,Evaluated for the binding affinity to hippocampus striatal membranes at 5-hydroxytryptamine 1A receptor binding site by using [3H]-8-OH- DPAT as a radioligand;ND means no data,,8,10576,,H,Autocuration,,CHEMBL615965,,BAO_0000019,,
1200,1,In vitro displacement of radioactively labeled ligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor site in CHO cells,,8,10576,,H,Expert,,CHEMBL615966,449.0,BAO_0000219,,
1201,1,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat cortical membranes,,8,10576,,H,Expert,,CHEMBL615967,,BAO_0000249,,
1202,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor of rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,,8,10576,,H,Expert,,CHEMBL615968,,BAO_0000019,,
1203,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand in CHO cells (sc),,8,10576,,H,Autocuration,,CHEMBL615969,449.0,BAO_0000218,,
1204,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT (agonist) as radioligand (sc),,8,10576,,H,Autocuration,,CHEMBL615970,,BAO_0000218,,
1205,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615971,,BAO_0000357,,
1206,1,In vitro binding affinity at 5-HT1A receptors assayed by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,,8,10576,Membranes,H,Expert,,CHEMBL615972,,BAO_0000249,,
1207,1,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes + cortex,,8,10576,,H,Autocuration,,CHEMBL615973,,BAO_0000249,,
1208,1,In vitro binding affinity at 5-HT1A receptor by measuring its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampal membranes+cortex,,8,10576,,H,Autocuration,,CHEMBL615974,,BAO_0000249,,
1209,1,Displacement of [3H]8-OH-DPAT from human 5-hydroxytryptamine 1A receptor expressed in CHO cells,Homo sapiens,9,51,,D,Expert,,CHEMBL615975,449.0,BAO_0000219,,
1210,1,In vitro binding affinity for 5-hydroxytryptamine 1A receptor in rat hippocampal membranes by [125I]-labeled agonist displacement.,,8,10576,,H,Expert,,CHEMBL615976,,BAO_0000249,,
1211,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL872106,,BAO_0000221,10000000.0,
1212,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Autocuration,,CHEMBL615977,,BAO_0000357,,
1213,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=100-230,,8,10576,,H,Autocuration,,CHEMBL615978,,BAO_0000357,,
1214,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=12-14,,8,10576,,H,Autocuration,,CHEMBL616166,,BAO_0000357,,
1215,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=16-20,,8,10576,,H,Autocuration,,CHEMBL616167,,BAO_0000357,,
1216,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=160-430,,8,10576,,H,Autocuration,,CHEMBL616168,,BAO_0000357,,
1217,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=174-224,,8,10576,,H,Autocuration,,CHEMBL616169,,BAO_0000357,,
1218,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=184-503,,8,10576,,H,Autocuration,,CHEMBL616170,,BAO_0000357,,
1219,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=19-23,,8,10576,,H,Autocuration,,CHEMBL616171,,BAO_0000357,,
1220,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=2.2-3.2,,8,10576,,H,Autocuration,,CHEMBL616172,,BAO_0000357,,
1221,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=2.7-3.6,,8,10576,,H,Autocuration,,CHEMBL616173,,BAO_0000357,,
1222,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=20-23,,8,10576,,H,Autocuration,,CHEMBL616174,,BAO_0000357,,
1223,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=21-28,,8,10576,,H,Autocuration,,CHEMBL616175,,BAO_0000357,,
1224,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=240-760,,8,10576,,H,Autocuration,,CHEMBL616176,,BAO_0000357,,
1225,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=39-87,,8,10576,,H,Autocuration,,CHEMBL616177,,BAO_0000357,,
1226,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=4.6-5.2,,8,10576,,H,Autocuration,,CHEMBL616178,,BAO_0000357,,
1227,1,Inhibitory activity tested in vitro at 5-hydroxytryptamine 1A receptor binding site in rat,,8,10576,,H,Autocuration,,CHEMBL616179,,BAO_0000019,,
1228,1,Inhibitory concentration against 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616180,,BAO_0000357,,
1229,1,Inhibitory concentration against binding of 5-hydroxytryptamine 1A receptor from striata of male Wistar rats by displacement of [3H]8-OH-DPAT,,8,10576,,H,Autocuration,,CHEMBL616181,,BAO_0000357,,
1230,1,Inhibitory concentration against radioligand [3H]hydroxy-2-(di-n-propylamino)-tetralin binding to 5-hydroxytryptamine 1A receptor in rat,,8,10576,,H,Autocuration,,CHEMBL616182,,BAO_0000019,,
1231,1,Inhibitory concentration against radioligand [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616183,,BAO_0000221,10000000.0,
1232,1,Inhibition of the 5-hydroxytryptamine 1A receptor in rat dorsal raphe,,8,10576,,H,Expert,,CHEMBL615874,,BAO_0000019,,
1233,1,Inhibitory concentration against [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor expressed in CHO-K1 cells,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615875,485.0,BAO_0000219,,
1234,1,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand,,8,10576,,H,Autocuration,,CHEMBL615876,,BAO_0000019,,
1235,1,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1A receptor in rat cortex using [3H]OH-DPAT radioligand; NT means not tested,,8,10576,,H,Autocuration,,CHEMBL615877,,BAO_0000019,,
1236,1,The compound was evaluated for the ability to displace [3H]- 8-OH -DPAT from 5-hydroxytryptamine 1A receptor ( striata of male wistar rats),,8,10576,,H,Autocuration,,CHEMBL615878,,BAO_0000357,,
1237,1,Binding affinity towards 5-hydroxytryptamine 1A receptor binding site using [3H]8-OH-DPAT. ,,8,10576,,H,Expert,,CHEMBL615879,,BAO_0000357,,
1238,1,Binding affinity towards 5-hydroxytryptamine 1A receptor using receptor binding assay,,8,10576,,H,Expert,,CHEMBL615880,,BAO_0000357,,
1239,1,"The compound was tested in vitro for inhibitory activity against 5-HT1A receptor in rats, using [3H]8-OH-DPAT as radioligand",,8,10576,,H,Autocuration,,CHEMBL615881,,BAO_0000019,,
1240,1,"Inhibitory activity against 5-hydroxytryptamine 1A receptor in rats, using [3H]8-OH-DPAT as radioligand",Rattus norvegicus,9,10576,,D,Expert,,CHEMBL615882,,BAO_0000019,,
1241,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat,,8,10576,,H,Autocuration,,CHEMBL615883,,BAO_0000218,,
1242,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.10-6.20),,8,10576,,H,Autocuration,,CHEMBL615884,,BAO_0000218,,
1243,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.60),,8,10576,,H,Autocuration,,CHEMBL615885,,BAO_0000218,,
1244,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.20-1.80),,8,10576,,H,Autocuration,,CHEMBL615886,,BAO_0000218,,
1245,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.37-4.27),,8,10576,,H,Autocuration,,CHEMBL615887,,BAO_0000218,,
1246,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-2.70),,8,10576,,H,Autocuration,,CHEMBL615888,,BAO_0000218,,
1247,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.40-4),,8,10576,,H,Autocuration,,CHEMBL615889,,BAO_0000218,,
1248,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.45-4.51),,8,10576,,H,Autocuration,,CHEMBL615890,,BAO_0000218,,
1249,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.50-5.30),,8,10576,,H,Autocuration,,CHEMBL615891,,BAO_0000218,,
1250,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.60-1.60),,8,10576,,H,Autocuration,,CHEMBL615892,,BAO_0000218,,
1251,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.72-2.87),,8,10576,,H,Autocuration,,CHEMBL615893,,BAO_0000218,,
1252,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (0.80-5.80),,8,10576,,H,Autocuration,,CHEMBL615894,,BAO_0000218,,
1253,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (1.50-16.5),,8,10576,,H,Autocuration,,CHEMBL615895,,BAO_0000218,,
1254,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges from (2.20-30.5),,8,10576,,H,Autocuration,,CHEMBL615896,,BAO_0000218,,
1255,1,Antagonistic activity at postsynaptic 5-hydroxytryptamine 1A receptor was measured by its ability to inhibit hypothermia elicited by s.c. administration of 8-OH-DPAT in rat;ranges is not computable,,8,10576,,H,Autocuration,,CHEMBL615897,,BAO_0000218,,
1256,1,"Percent increase of R(+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes",Rattus norvegicus,9,10576,Membranes,D,Expert,,CHEMBL615898,,BAO_0000249,,
1257,1,% inhibition towards 5-HT1A receptor from rat hippocampal membranes,,8,10576,,H,Autocuration,,CHEMBL615899,,BAO_0000019,,
1258,1,% inhibition towards 5-hydroxytryptamine 1A receptor from rat hippocampal membranes,,8,10576,,H,Autocuration,,CHEMBL616291,,BAO_0000019,,
1259,1,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor.,,8,10576,,H,Autocuration,,CHEMBL616292,,BAO_0000357,,
1260,1,"Ability to inhibit 5-HT sensitive,forskolin-stimulated adenylyl cyclase(FSC) activity in rat hippocampal membranes mediated through 5-hydroxytryptamine 1A receptor",,8,10576,,H,Autocuration,,CHEMBL616293,,BAO_0000249,,
1261,1,Measurement of binding affinity by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor in rat hippocampus,,8,10576,,H,Expert,,CHEMBL616294,,BAO_0000221,10000000.0,
1262,1,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membrane,,8,10576,,H,Autocuration,,CHEMBL616295,,BAO_0000249,10000000.0,
1263,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]-8-OH- -DPAT in rat brain cortex at 10 uM,,8,10576,,H,Autocuration,,CHEMBL616296,,BAO_0000221,955.0,
1264,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,,8,10576,,H,Autocuration,,CHEMBL616297,,BAO_0000019,,
1265,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0+ 1 uM 5-HT.,,8,10576,,H,Autocuration,,CHEMBL616605,,BAO_0000019,,
1266,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.01 uM+ 1 uM 5-HT.,,8,10576,,H,Autocuration,,CHEMBL616606,,BAO_0000019,,
1267,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,,8,10576,,H,Autocuration,,CHEMBL616607,,BAO_0000019,,
1268,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM,,8,10576,,H,Expert,,CHEMBL616608,,BAO_0000019,,
1269,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.05 uM+ 1 uM 5-HT.,,8,10576,,H,Autocuration,,CHEMBL616609,,BAO_0000019,,
1270,1,Effect against 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at 0.1 uM dose,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616610,,BAO_0000019,,
1271,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 10 uM 5-HT.,,8,10576,,H,Autocuration,,CHEMBL616611,,BAO_0000019,,
1272,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 1 uM 5-HT.,,8,10576,,H,Expert,,CHEMBL616612,,BAO_0000019,,
1273,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM + 0.1 uM 5-HT.,,8,10576,,H,Autocuration,,CHEMBL616613,,BAO_0000019,,
1274,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM,,8,10576,,H,Expert,,CHEMBL616614,,BAO_0000019,,
1275,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 10 uM+ 10 uM 5-HT.,,8,10576,,H,Autocuration,,CHEMBL616615,,BAO_0000019,,
1276,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,,8,10576,,H,Expert,,CHEMBL616616,,BAO_0000019,,
1277,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 0.1 uM 5-HT.,,8,10576,,H,Autocuration,,CHEMBL616617,,BAO_0000019,,
1278,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,,8,10576,,H,Autocuration,,CHEMBL616618,,BAO_0000019,,
1279,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 1 uM 5-HT.,,8,10576,,H,Autocuration,,CHEMBL616619,,BAO_0000019,,
1280,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 3 uM 5-HT.,,8,10576,,H,Expert,,CHEMBL616620,,BAO_0000019,,
1281,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,,8,10576,,H,Expert,,CHEMBL616621,,BAO_0000019,,
1282,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 30 uM,,8,10576,,H,Autocuration,,CHEMBL616622,,BAO_0000019,,
1283,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM,,8,10576,,H,Expert,,CHEMBL616146,,BAO_0000019,,
1284,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 50 uM+ 50 uM 5-HT.,,8,10576,,H,Autocuration,,CHEMBL832873,,BAO_0000019,,
1285,1,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 0.1 uM,,8,10576,,H,Autocuration,,CHEMBL616147,,BAO_0000019,,
1286,1,Effect on 5-hydroxytryptamine 1A receptor-mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 10 uM 5-HT.,,8,10576,,H,Autocuration,,CHEMBL872872,,BAO_0000019,,
1287,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM,,8,10576,,H,Autocuration,,CHEMBL616148,,BAO_0000019,,
1288,1,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue,,8,10576,,H,Autocuration,,CHEMBL616149,,BAO_0000221,10000000.0,
1289,1,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue at 1 uM,,8,10576,,H,Expert,,CHEMBL616150,,BAO_0000221,10000000.0,
1290,1,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor in rat hippocampal membranes at 10e-7 M,Rattus norvegicus,9,10576,Membranes,D,Expert,,CHEMBL616151,,BAO_0000249,,
1291,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue at 1 uM,,8,10576,,H,Expert,,CHEMBL872873,,BAO_0000221,10000000.0,
1292,1,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 0.1 uM concentration,,8,10576,,H,Autocuration,,CHEMBL616670,,BAO_0000221,10000000.0,
1293,1,Inhibitory activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor at 1 uM concentration,,8,10576,,H,Autocuration,,CHEMBL616671,,BAO_0000221,10000000.0,
1294,1,"Percent inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1A receptor in hippocampal membranes",Rattus norvegicus,9,10576,,D,Expert,,CHEMBL884861,,BAO_0000249,,
1295,1,Tested in vitro for % inhibition against (serotonin)5-HT 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616672,,BAO_0000357,,
1296,1,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,,8,10576,,H,Autocuration,,CHEMBL616673,,BAO_0000019,,
1297,1,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand.,,8,10576,,H,Expert,,CHEMBL616674,,BAO_0000019,,
1298,1,Binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,,8,10576,,H,Autocuration,,CHEMBL616675,,BAO_0000357,,
1299,1,In vitro binding affinity for 5-hydroxytryptamine 1A receptor was determined by measuring specific inhibition of [125I]-binding to rat hippocampal membrane preparations,,8,10576,,H,Autocuration,,CHEMBL616676,,BAO_0000221,10000000.0,
1300,1,Inhibition of binding of [125I]-8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,8,10576,,H,Autocuration,,CHEMBL616677,,BAO_0000221,10000000.0,
1301,1,The binding of [125I]MPPI ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,8,10576,,H,Autocuration,,CHEMBL616678,,BAO_0000221,10000000.0,
1302,1,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616679,,BAO_0000357,,
1303,1,Ability to bind to central serotonin 5-hydroxytryptamine 1A receptor in vitro in hippocampus of the rat brain using [3H]8-OH-DPAT radioligand,,8,10576,,H,Expert,,CHEMBL616680,,BAO_0000221,10000000.0,
1304,1,Ability to displace [3H]- -OH-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,,8,10576,,H,Autocuration,,CHEMBL616681,,BAO_0000221,10000000.0,
1305,1,Ability to displace [3H]- -(OH)-DPAT bound to 5-hydroxytryptamine 1A receptor in rat hippocampus,,8,10576,,H,Autocuration,,CHEMBL616682,,BAO_0000221,10000000.0,
1306,1,Ability to displace [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616683,,BAO_0000221,10000000.0,
1307,1,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616684,,BAO_0000221,10000000.0,
1308,1,Ability to displace [3H]-8-OH-DPAT from rat hippocampal homogenate 5-hydroxytryptamine 1A receptor; Not tested,,8,10576,,H,Autocuration,,CHEMBL616685,,BAO_0000221,10000000.0,
1309,1,Affinity at [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor in rat brain homogenate was determined,,8,10576,,H,Autocuration,,CHEMBL616686,,BAO_0000221,955.0,
1310,1,Affinity for 5-hydroxytryptamine 1A receptor site,,8,10576,,H,Autocuration,,CHEMBL616687,,BAO_0000357,,
1311,1,Affinity for 5-hydroxytryptamine 1A receptor site,,8,10576,,H,Autocuration,,CHEMBL616688,,BAO_0000357,,
1312,1,Affinity in displacing [3H]8-OH-DPAT from rat hippocampal 5-HT1A receptor.,,8,10576,,H,Autocuration,,CHEMBL616689,,BAO_0000221,10000000.0,
1313,1,Affinity on 5-hydroxytryptamine 1A receptor labeled by [3H]8-OH-DPAT,,8,10576,,H,Autocuration,,CHEMBL616690,,BAO_0000357,,
1314,1,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]-8-OH-DPAT as radioligand,,8,10576,,H,Expert,,CHEMBL616691,,BAO_0000357,,
1315,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus mambranes,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616692,,BAO_0000221,10000000.0,
1316,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane,,8,10576,,H,Expert,,CHEMBL616693,,BAO_0000249,,
1317,1,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616694,,BAO_0000019,,
1318,1,Binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal tissue,,8,10576,,H,Autocuration,,CHEMBL616695,,BAO_0000221,10000000.0,
1319,1,Binding affinity against 5-hydroxytryptamine 1A receptor of rat was determined using [3H]8-OH-DPAT in binding assay,,8,10576,,H,Autocuration,,CHEMBL616696,,BAO_0000357,,
1320,1,Binding affinity against 5-hydroxytryptamine 1A receptor using [3H]DOB as radioligand,,8,10576,,H,Autocuration,,CHEMBL616697,,BAO_0000357,,
1321,1,Binding affinity against rat 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616698,,BAO_0000357,,
1322,1,Binding affinity against rat brain 5-hydroxytryptamine 1A receptor,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616949,,BAO_0000019,,
1323,1,Binding affinity against the 5-hydroxytryptamine 1A receptor labelled with [3H]8-OH-DPAT in rat hippocampal homogenates,,8,10576,,H,Autocuration,,CHEMBL616950,,BAO_0000221,10000000.0,
1324,1,Binding affinity against serotonin 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT binding assay,,8,10576,,H,Autocuration,,CHEMBL832875,,BAO_0000357,,
1325,1,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,8,10576,,H,Expert,,CHEMBL616951,,BAO_0000221,955.0,
1326,1,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,8,10576,,H,Expert,,CHEMBL616952,,BAO_0000221,955.0,
1327,1,Binding affinity at rat 5-hydroxytryptamine 1A receptor by [3H]WB-4101 displacement.,,8,10576,,H,Expert,,CHEMBL616953,,BAO_0000357,,
1328,1,Binding affinity for 5-hydroxytryptamine 1A receptor by use of [3H]8-OH-DPAT in male rat,,8,10576,,H,Autocuration,,CHEMBL616954,,BAO_0000357,,
1329,1,GTPgammaS radioligand binding assay,,8,106,,H,Autocuration,,CHEMBL616955,,BAO_0000357,,
1330,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,,8,106,,H,Autocuration,,CHEMBL616956,,BAO_0000357,,
1331,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Partial agonist,,8,106,,H,Autocuration,,CHEMBL616957,,BAO_0000019,,
1332,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Slient antagonist,,8,106,,H,Autocuration,,CHEMBL616958,,BAO_0000019,,
1333,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,,8,106,,H,Autocuration,,CHEMBL616959,,BAO_0000357,,
1334,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; Not determined,,8,106,,H,Autocuration,,CHEMBL616960,,BAO_0000357,,
1335,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; silent antagonist,,8,106,,H,Autocuration,,CHEMBL616961,,BAO_0000019,,
1336,1,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor,,8,106,,H,Expert,,CHEMBL616962,308.0,BAO_0000219,,
1337,1,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor receptor,,8,106,,H,Autocuration,,CHEMBL616963,308.0,BAO_0000219,,
1338,1,Affinity towards human 5-hydroxytryptamine 1B serotonin receptor,Homo sapiens,9,106,,D,Expert,,CHEMBL616524,,BAO_0000357,,
1339,1,Binding affinity against 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,,8,106,,H,Autocuration,,CHEMBL616525,449.0,BAO_0000219,,
1340,1,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]5-CT as radioligand,,8,106,,H,Autocuration,,CHEMBL872908,,BAO_0000019,,
1341,1,Binding affinity for 5-hydroxytryptamine 1B receptor in C6-glial transfected cell type using [3H]GR-125743 as radioligand,,8,106,,H,Autocuration,,CHEMBL616526,,BAO_0000019,,
1342,1,Binding affinity to cloned human 5-hydroxytryptamine 1B receptor,Homo sapiens,9,106,,D,Expert,,CHEMBL616527,,BAO_0000357,,
1343,1,Binding affinity towards human 5-hydroxytryptamine 1B receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,,8,106,,H,Expert,,CHEMBL616528,,BAO_0000219,,
1344,1,Binding affinity for recombinant human 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,8,106,,H,Autocuration,,CHEMBL616529,,BAO_0000357,,
1345,1,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1B receptor using [3H]5-CT as radioligand,,8,106,,H,Autocuration,,CHEMBL616530,,BAO_0000357,,
1346,1,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,,8,106,,H,Expert,,CHEMBL616531,,BAO_0000357,,
1347,1,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1B receptor,,8,106,,H,Autocuration,,CHEMBL616532,,BAO_0000357,,
1348,1,Binding affinity towards 5-hydroxytryptamine 1B receptor,,8,106,,H,Autocuration,,CHEMBL616533,,BAO_0000357,,
1349,1,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,,8,106,,H,Expert,,CHEMBL616534,,BAO_0000357,,
1350,1,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT trifluoroacetate as radioligand,,8,106,,H,Expert,,CHEMBL616535,,BAO_0000357,,
1351,1,Binding affinity towards human 5-hydroxytryptamine 1B receptor using [3H]5-HT radioligand,,8,106,,H,Autocuration,,CHEMBL616536,,BAO_0000357,,
1352,1,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1B receptor,,8,106,,H,Autocuration,,CHEMBL616537,,BAO_0000357,,
1353,1,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1B receptor in CHO-K1 cells,,8,106,,H,Expert,,CHEMBL616538,485.0,BAO_0000219,,
1354,1,Agonist activity to the human recombinant 5-hydroxytryptamine 1B receptor,,8,106,,H,Expert,,CHEMBL616539,,BAO_0000019,,
1355,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor,,8,106,,H,Expert,,CHEMBL616540,,BAO_0000019,,
1356,1,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,,8,106,,H,Autocuration,,CHEMBL616429,,BAO_0000357,,
1357,1,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor,,8,106,,H,Expert,,CHEMBL616430,,BAO_0000357,,
1358,1,Receptor binding affinity for cloned human 5-hydroxytryptamine 1B receptor in Cos-7 cells,Homo sapiens,9,106,,D,Expert,,CHEMBL616431,,BAO_0000219,,
1359,1,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor,Homo sapiens,9,106,,D,Expert,,CHEMBL616432,,BAO_0000357,,
1360,1,Affinity for 5-hydroxytryptamine 1B receptor subtype,Homo sapiens,9,106,,D,Expert,,CHEMBL616433,,BAO_0000357,,
1361,1,Binding affinity for human 5-hydroxytryptamine 1B receptor,Homo sapiens,9,106,,D,Expert,,CHEMBL616434,,BAO_0000357,,
1362,1,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand; Not determined,,8,106,,H,Autocuration,,CHEMBL616435,449.0,BAO_0000219,,
1363,1,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1B receptor; ND means not determined,,8,106,,H,Expert,,CHEMBL616436,,BAO_0000019,,
1364,1,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,,8,106,,H,Autocuration,,CHEMBL616437,308.0,BAO_0000219,,
1365,1,Ability to displace [3H]5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT=not tested,,8,106,,H,Autocuration,,CHEMBL616438,308.0,BAO_0000219,,
1366,1,Ability to displace [3H]-5-CT (1.5 nM) from HeLa cells of human 5-hydroxytryptamine 1B receptor; NT denotes not tested,,8,106,,H,Autocuration,,CHEMBL616439,308.0,BAO_0000219,,
1367,1,Binding activity against human 5-hydroxytryptamine 1B receptor; NT means not tested,Homo sapiens,9,106,,D,Expert,,CHEMBL616440,,BAO_0000357,,
1368,1,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor; not tested,,8,106,,H,Autocuration,,CHEMBL616441,485.0,BAO_0000219,,
1369,1,Selectivity ratio against cloned human 5-HT1B receptor to that of h5-HT1D receptor,,8,106,,H,Expert,,CHEMBL616442,,BAO_0000357,,
1370,1,Selectivity ratio against cloned human 5-hydroxytryptamine 1B receptor to that of human 5-hydroxytryptamine 1D receptor,,8,106,,H,Autocuration,,CHEMBL616443,,BAO_0000357,,
1371,1,Binding affinity in CHO-K1 cells transfected with human recombinant 5-hydroxytryptamine 1B receptor,,8,106,,H,Expert,,CHEMBL616444,485.0,BAO_0000219,,
1372,1,Binding activity against human 5-hydroxytryptamine 1B receptor,Homo sapiens,9,106,,D,Expert,,CHEMBL616445,,BAO_0000357,,
1373,1,Binding activity against human 5-hydroxytryptamine 1B receptor,Homo sapiens,9,106,,D,Expert,,CHEMBL616446,,BAO_0000357,,
1374,1,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as radioligand,Homo sapiens,9,106,,D,Expert,,CHEMBL616447,449.0,BAO_0000219,,
1375,1,Binding affinity towards cloned human 5-hydroxytryptamine 1B receptor was determined,,8,106,,H,Autocuration,,CHEMBL616448,,BAO_0000357,,
1376,1,Binding affinity against cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-CT as radioligand,,8,106,,H,Autocuration,,CHEMBL616449,449.0,BAO_0000219,,
1377,1,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells,,8,106,,H,Autocuration,,CHEMBL616450,449.0,BAO_0000219,,
1378,1,Binding affinity against human 5-hydroxytryptamine 1B receptor cloned receptors in CHO cells using [3H]5-CT as radioligand,,8,106,,H,Autocuration,,CHEMBL857974,449.0,BAO_0000219,,
1379,1,Binding affinity towards 5-hydroxytryptamine 1B (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,,8,106,,H,Autocuration,,CHEMBL616451,449.0,BAO_0000219,,
1380,1,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,,8,106,,H,Autocuration,,CHEMBL616452,449.0,BAO_0000219,,
1381,1,Binding affinity towards 5-hydroxytryptamine 1B receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand;ND means no data.,,8,106,,H,Autocuration,,CHEMBL616453,449.0,BAO_0000219,,
1382,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT as the radioligand,,8,106,,H,Autocuration,,CHEMBL616454,449.0,BAO_0000219,,
1383,1,Binding affinity for human 5-hydroxytryptamine 1B receptor,Homo sapiens,9,106,,D,Expert,,CHEMBL616455,,BAO_0000357,,
1384,1,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,,8,106,,H,Autocuration,,CHEMBL616456,449.0,BAO_0000219,,
1385,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1B receptor in CHO using [3H]5-HT as a radioligand,,8,106,,H,Autocuration,,CHEMBL616457,,BAO_0000357,,
1386,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1B receptor in CHO cells using [3H]5-HT,,8,106,,H,Autocuration,,CHEMBL616458,449.0,BAO_0000219,,
1387,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1B receptor in CHO cells, using [3H]5-HT as radioligand",,8,106,,H,Autocuration,,CHEMBL616459,449.0,BAO_0000219,,
1388,1,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 1 uM,,8,106,,H,Expert,,CHEMBL616460,,BAO_0000019,,
1389,1,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1B receptor at concentration 10 uM,,8,106,,H,Expert,,CHEMBL616461,,BAO_0000019,,
1390,1,"Effect of compound on [35S]GTP-gamma-S, radioligand binding CHO cells expressing human 5-hydroxytryptamine 1B receptor",,8,106,,H,Autocuration,,CHEMBL616462,449.0,BAO_0000219,,
1391,1,"Effect of compound on [35S]GTP-gamma-S, radioligand binding in CHO cells expressing human 5-hydroxytryptamine 1B receptor",,8,106,,H,Autocuration,,CHEMBL616463,449.0,BAO_0000219,,
1392,1,"Compound was tested for maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-HT.",,8,105,,H,Autocuration,,CHEMBL616464,,BAO_0000019,,
1393,1,Compound was tested for the displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells.,,8,105,,H,Autocuration,,CHEMBL616465,449.0,BAO_0000219,,
1394,1,The compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,,8,17105,,H,Autocuration,,CHEMBL832874,,BAO_0000357,,
1395,1,5-hydroxytryptamine 1B receptor agonist potency determined in rabbit saphenous vein contraction model,Oryctolagus cuniculus,8,106,,H,Autocuration,,CHEMBL616184,,BAO_0000019,,
1396,1,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein (RbSV).,Oryctolagus cuniculus,8,106,,H,Autocuration,,CHEMBL616185,,BAO_0000019,,
1397,1,"Binding affinity against vascular 5-hydroxytryptamine 1B receptor, measured using ring preparations of rabbit saphenous vein (RbSV)",Oryctolagus cuniculus,8,106,,H,Intermediate,,CHEMBL616186,,BAO_0000019,,
1398,1,The vascular 5-hydroxytryptamine 1B receptor affinity was assessed using ring preparations of rabbit saphenous vein(RbSV).,Oryctolagus cuniculus,8,106,,H,Autocuration,,CHEMBL616187,,BAO_0000019,,
1399,1,Binding affinity towards 5-hydroxytryptamine 1B receptor was measured using [3H]5-HT as radioligand,,8,10577,,H,Expert,,CHEMBL616188,,BAO_0000357,,
1400,1,Binding affinity for 5-hydroxytryptamine 1B receptor,,9,10577,,D,Intermediate,,CHEMBL873475,,BAO_0000357,,
1401,1,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Less active,Rattus norvegicus,9,10577,,D,Expert,,CHEMBL616189,,BAO_0000019,2435.0,
1402,1,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,,8,10577,,H,Expert,,CHEMBL616190,,BAO_0000357,,
1403,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT as radioligand; range=48-77,,8,10576,,H,Autocuration,,CHEMBL616191,,BAO_0000357,,
1404,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=63-95,,8,10576,,H,Autocuration,,CHEMBL616192,,BAO_0000357,,
1405,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=710-980,,8,10576,,H,Autocuration,,CHEMBL616193,,BAO_0000357,,
1406,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=78-140,,8,10576,,H,Autocuration,,CHEMBL616194,,BAO_0000357,,
1407,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=85-130,,8,10576,,H,Autocuration,,CHEMBL616195,,BAO_0000357,,
1408,1,In vitro binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand; range=89-280,,8,10576,,H,Autocuration,,CHEMBL616196,,BAO_0000357,,
1409,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat hippocampus membrane.,,8,10576,,H,Autocuration,,CHEMBL616197,,BAO_0000249,10000000.0,
1410,1,Binding affinity at 5-hydroxytryptamine 1A (5-HT1A) receptor in rat cerebral cortex using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Intermediate,,CHEMBL616198,,BAO_0000019,,
1411,1,In vitro binding affinity to 5-hydroxytryptamine 1A receptor using [125I](R)-(+)-trans-8-OH-PIPAT as radioligand in rat hippocampal homogenate,,8,10576,,H,Autocuration,,CHEMBL616199,,BAO_0000221,10000000.0,
1412,1,In vitro binding affinity to 5-hydroxytryptamine 1A receptor in rat hippocampal homogenate by [125I](R)-(+)-trans-8-OH-PIPAT displacement.,,8,10576,,H,Expert,,CHEMBL616200,,BAO_0000221,10000000.0,
1413,1,In vitro binding affinity to rat hippocampal 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Expert,,CHEMBL616201,,BAO_0000221,10000000.0,
1414,1,In vitro binding affinity towards 5-hydroxytryptamine 1A r receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,,8,10576,,H,Expert,,CHEMBL616202,,BAO_0000221,10000000.0,
1415,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates,,8,10576,,H,Expert,,CHEMBL616203,,BAO_0000221,10000000.0,
1416,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; ND=not determined,,8,10576,,H,Expert,,CHEMBL616204,,BAO_0000221,10000000.0,
1417,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; Not determined,,8,10576,,H,Expert,,CHEMBL616205,,BAO_0000221,10000000.0,
1418,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT radioligand in rat hippocampal homogenates; not determined,,8,10576,,H,Expert,,CHEMBL616206,,BAO_0000221,10000000.0,
1419,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes,,8,10576,,H,Expert,,CHEMBL616207,,BAO_0000249,,
1420,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes,,8,10576,,H,Autocuration,,CHEMBL616208,,BAO_0000249,,
1421,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membranes; Inactive,,8,10576,,H,Autocuration,,CHEMBL616209,,BAO_0000249,,
1422,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor was determined using radioligand [3H]-8-OH-DPAT,,8,10576,,H,Expert,,CHEMBL616210,,BAO_0000357,,
1423,1,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue.,,8,10576,,H,Expert,,CHEMBL616211,,BAO_0000221,10000000.0,
1424,1,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue; NT=Not tested,,8,10576,,H,Autocuration,,CHEMBL616504,,BAO_0000221,10000000.0,
1425,1,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616505,,BAO_0000221,10000000.0,
1426,1,Inhibition constant of 50 uM forskolin-stimulated cAMP accumulation against 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616506,,BAO_0000019,,
1427,1,Inhibition of binding of [125I]8-OH-PIPAT ligand to 5-hydroxytryptamine 1A receptor of rat hippocampal homogenates,,8,10576,,H,Autocuration,,CHEMBL872107,,BAO_0000221,10000000.0,
1428,1,Displacement of [3H]5-HT from rat hippocampal 5-hydroxytryptamine 1A receptor with 10e-6 M ketanserin,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616507,,BAO_0000221,10000000.0,
1429,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor in rat cortical membranes using [3H]8-OH-DPAT as a radioligand,,8,10576,,H,Autocuration,,CHEMBL616303,,BAO_0000249,,
1430,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue,,8,10576,,H,Autocuration,,CHEMBL616304,,BAO_0000221,10000000.0,
1431,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor of rat hippocampal tissue using [3H]OH-DPAT as radioligand.,,8,10576,,H,Expert,,CHEMBL616305,,BAO_0000221,10000000.0,
1432,1,Antagonist activity against rat hippocampal tissue 5-hydroxytryptamine 1A receptor,,8,10576,,H,Intermediate,,CHEMBL616306,,BAO_0000221,10000000.0,
1433,1,Inhibitory affinity constant against 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616307,,BAO_0000357,,
1434,1,Displacement of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat brain hippocampus,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL881829,,BAO_0000221,10000000.0,
1435,1,Affinity against the 5-hydroxytryptamine receptor 1A using [3H]WB-4101.,,8,10576,,H,Expert,,CHEMBL616308,,BAO_0000357,,
1436,1,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain,,8,10576,,H,Autocuration,,CHEMBL616309,,BAO_0000019,,
1437,1,Tested for affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in homogenized rat brain tissue,,8,10576,,H,Expert,,CHEMBL616310,,BAO_0000019,,
1438,1,Tested for affinity against 5-hydroxytryptamine 1A receptors using [3H]8-OH-DPAT in homogenized rat cloned CHO cells,,8,10576,,H,Autocuration,,CHEMBL616311,449.0,BAO_0000219,,
1439,1,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Expert,,CHEMBL616312,,BAO_0000357,,
1440,1,Tested for binding affinity against 5-hydroxytryptamine 1A receptor from rat frontal cortical regions using [3H]8-OH-DPAT as radioligand; ND is Not Determined,,8,10576,,H,Autocuration,,CHEMBL616313,,BAO_0000357,,
1441,1,Displacement of [3H]8-OH-DPAT from rat hippocampal 5-hydroxytryptamine 1A receptor,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616314,,BAO_0000221,10000000.0,
1442,1,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus,,8,10576,,H,Autocuration,,CHEMBL616315,,BAO_0000221,10000000.0,
1443,1,Tested for binding affinity by measuring displacement of [3H]8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; NA means Not Active,,8,10576,,H,Autocuration,,CHEMBL616567,,BAO_0000221,10000000.0,
1444,1,Tested for binding affinity by measuring displacement of [3H]-8-OH-DPAT from rat serotonin 5-hydroxytryptamine 1A receptor in rat hippocampus; ND means Not Determined,,8,10576,,H,Autocuration,,CHEMBL616568,,BAO_0000221,10000000.0,
1445,1,Binding affinity to displace [3H]2-(di-N-propylamino)-8-hydroxy-tetralin from 5-hydroxytryptamine 1A (5-HT1A) receptor in rat frontal cortex homogenates,,8,10576,,H,Intermediate,,CHEMBL616569,,BAO_0000019,,
1446,1,Binding affinity to 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT radioligand assay.,,8,10576,,H,Expert,,CHEMBL616570,,BAO_0000357,,
1447,1,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 1A receptor agonist [3H]- 8-OH-DPAT,,8,10576,,H,Autocuration,,CHEMBL616571,,BAO_0000357,,
1448,1,Tested for the inhibitory activity against 5-hydroxytryptamine 1A receptor in rat hippocampal,,8,10576,,H,Autocuration,,CHEMBL616572,,BAO_0000221,10000000.0,
1449,1,Tested in vitro for binding affinity by measuring its ability to inhibit [3H]8-OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat cerebral cortex membranes.,,8,10576,,H,Expert,,CHEMBL616573,,BAO_0000249,,
1450,1,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 1A receptor using radioligand [3H]8-OH-DPAT,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616574,,BAO_0000357,,
1451,1,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation,,8,10576,,H,Expert,,CHEMBL616575,,BAO_0000221,10000000.0,
1452,1,The binding affinity by measuring its ability to displace [3H]8-OH-DPAT radioligand in 5-hydroxytryptamine 1A receptor on rat hippocampal preparation; ND=not determined,,8,10576,,H,Autocuration,,CHEMBL872108,,BAO_0000221,10000000.0,
1453,1,The binding affinity was measured on 5-hydroxytryptamine 1A receptor using [3H]- 8-OH-DPAT as radioligand.,,8,10576,,H,Autocuration,,CHEMBL616576,,BAO_0000357,,
1454,1,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 1 mM of MnCl2,,8,10576,,H,Autocuration,,CHEMBL616577,,BAO_0000249,,
1455,1,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 3*10e-5 M GTP gamma S,,8,10576,,H,Autocuration,,CHEMBL616578,,BAO_0000249,,
1456,1,Binding affinity at 5-hydroxytryptamine 1A receptor from striata of wistar rats by [3H]- 8-OH -DPAT displacement.,,8,10576,,H,Expert,,CHEMBL616579,,BAO_0000357,,
1457,1,Binding affinity towards 5-hydroxytryptamine 1A receptor of rat brain synaptosomal preparations,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616580,,BAO_0000019,,
1458,1,The compound was tested binding affinity against 5-hydroxytryptamine 1A receptor from rat brain using [3H]8-OH-DPAT as radioligand at 10e-6 M.,,8,10576,,H,Autocuration,,CHEMBL616581,,BAO_0000019,,
1459,1,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,,8,10576,,H,Autocuration,,CHEMBL616582,,BAO_0000221,10000000.0,
1460,1,The compound was tested for binding affinity on [3H]8-OH-DPAT as specific ligand on 5-hydroxytryptamine 1A receptor in rat hippocampus,,8,10576,,H,Expert,,CHEMBL616583,,BAO_0000221,10000000.0,
1461,1,Binding affinity against 5-hydroxytryptamine 1A receptor of rat hippocampus using [3H]8-OH-DPAT,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616584,,BAO_0000221,10000000.0,
1462,1,Binding affinity towards 5-hydroxytryptamine 1A receptor,,8,10576,,H,Expert,,CHEMBL616585,,BAO_0000357,,
1463,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 from rat hippocampus,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616586,,BAO_0000221,10000000.0,
1464,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1A receptor by displacing [3H]WB-4101 radioligand in rat hippocampus,,8,10576,,H,Autocuration,,CHEMBL616587,,BAO_0000221,10000000.0,
1465,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]-8-OH-DPAT as radioligand,,8,10576,,H,Autocuration,,CHEMBL616588,,BAO_0000221,10000000.0,
1466,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand.,,8,10576,,H,Autocuration,,CHEMBL616589,,BAO_0000221,10000000.0,
1467,1,Binding affinity for 5-hydroxytryptamine 1A receptor from rat hippocampus using [3H]8-OH-DPAT as radioligand,,8,10576,,H,Expert,,CHEMBL616590,,BAO_0000221,10000000.0,
1468,1,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1A receptor expressed in CHO cells, by using [3H]8-OH-DPAT as radioligand.",,8,10576,,H,Expert,,CHEMBL616591,449.0,BAO_0000219,,
1469,1,Displacement of the radioligand [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,8,10576,,H,Expert,,CHEMBL616592,,BAO_0000357,,
1470,1,The inhibition activity of 5-HT1A at 1 uM,,8,10576,,H,Autocuration,,CHEMBL616593,,BAO_0000357,,
1471,1,"Binding affinity against 5-hydroxytryptamine 1A receptor from CHO-K1 cells, using [3H]8-OH-DPAT as the radioligand.",,8,10576,,H,Expert,,CHEMBL616594,485.0,BAO_0000219,,
1472,1,Binding affinities against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in rat cerebral cortex membrane,,8,10576,,H,Expert,,CHEMBL616595,,BAO_0000249,,
1473,1,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-HT 1A receptor site.,,8,10576,,H,Autocuration,,CHEMBL616596,,BAO_0000357,,
1474,1,Compound was evaluated for its ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,8,10576,,H,Autocuration,,CHEMBL616597,,BAO_0000221,10000000.0,
1475,1,Ability to displace the protonated form of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding from labeled 5-hydroxytryptamine 1A receptor site in rat brain hippocampus,,8,10576,,H,Expert,,CHEMBL616598,,BAO_0000221,10000000.0,
1476,1,Antagonist activity to stimulate binding of [35S]-GTP-gamma S binding to 5-hydroxytryptamine 1A receptor in isolated rat hippocampal membranes,Rattus norvegicus,9,10576,Membranes,D,Expert,,CHEMBL616599,,BAO_0000249,,
1477,1,"Inhibition of (+)-8-OH-DPAT stimulated [35S]GTP-gamma-S, binding in rat hippocampal membranes",Rattus norvegicus,9,10576,Membranes,D,Expert,,CHEMBL616600,,BAO_0000249,10000000.0,
1478,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not -determined.,,8,10576,,H,Autocuration,,CHEMBL616601,,BAO_0000019,,
1479,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not defined.,,8,10576,,H,Autocuration,,CHEMBL616602,,BAO_0000019,,
1480,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is defined as not determined.,,8,10576,,H,Autocuration,,CHEMBL616603,,BAO_0000019,,
1481,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND means not determined.,,8,10576,,H,Autocuration,,CHEMBL616604,,BAO_0000019,,
1482,1,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; No data,,8,10576,,H,Autocuration,,CHEMBL616316,,BAO_0000249,,
1483,1,Binding affinity towards 5-hydroxytryptamine 1A receptor was determined in rat cortex membranes using [3H]8-OH-DPAT as radioligand; Not determined,,8,10576,,H,Autocuration,,CHEMBL616317,,BAO_0000249,,
1484,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex homogenates; ND means No data,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616318,,BAO_0000019,,
1485,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes,,8,10576,,H,Autocuration,,CHEMBL616319,,BAO_0000221,10000000.0,
1486,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT from rat hippocampus mambranes; Not tested,,8,10576,,H,Autocuration,,CHEMBL616320,,BAO_0000221,10000000.0,
1487,1,Binding affinity for rat hippocampus 5-hydroxytryptamine 1A receptor by inhibition of [3H]8-OH-DPAT binding; Not tested,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616321,,BAO_0000221,10000000.0,
1488,1,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,,8,10576,,H,Autocuration,,CHEMBL616322,,BAO_0000019,,
1489,1,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; not tested,,8,10576,,H,Autocuration,,CHEMBL616323,,BAO_0000019,,
1490,1,Ratio of binding affinity to 5-HT 1A and D2 receptor,,8,10576,,H,Autocuration,,CHEMBL616324,,BAO_0000357,,
1491,1,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,,8,10576,,H,Autocuration,,CHEMBL616325,,BAO_0000221,10000000.0,
1492,1,In vitro ability to inhibit [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus at 1 uM,,8,10576,,H,Autocuration,,CHEMBL616326,,BAO_0000221,10000000.0,
1493,1,In vitro ability to inhibit [3H]-8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat hippocampus.,,8,10576,,H,Autocuration,,CHEMBL616327,,BAO_0000221,10000000.0,
1494,1,Percentage inhibition against 5-hydroxytryptamine 1A receptor,,8,10576,,H,Autocuration,,CHEMBL616328,,BAO_0000357,,
1495,1,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),,8,10576,,H,Autocuration,,CHEMBL858110,,BAO_0000249,,
1496,1,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 1),,8,10576,,H,Autocuration,,CHEMBL616329,,BAO_0000249,,
1497,1,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),,8,10576,,H,Autocuration,,CHEMBL616330,,BAO_0000249,,
1498,1,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes (experiment 2),,8,10576,,H,Autocuration,,CHEMBL616331,,BAO_0000249,,
1499,1,Compound was tested for its potency against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,,8,10576,,H,Autocuration,,CHEMBL616332,,BAO_0000249,,
1500,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,8,10576,,H,Autocuration,,CHEMBL857063,,BAO_0000249,955.0,
1501,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat frontal cortex using [3H]8-OH-DPAT as a radioligand,,8,10576,,H,Autocuration,,CHEMBL616333,,BAO_0000019,,
1502,1,Antagonistic activity against 5-hydroxytryptamine 1A receptor in rat cerebral cortex using [3H]-8-OH-DPAT as radioligand.,,8,10576,,H,Expert,,CHEMBL616334,,BAO_0000019,,
1503,1,Binding affinity of 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,8,10576,,H,Autocuration,,CHEMBL616335,,BAO_0000221,10000000.0,
1504,1,Affinity pKi for 5-hydroxytryptamine 1A receptor was measured in rat cortex homogenates.,,8,10576,,H,Autocuration,,CHEMBL616336,,BAO_0000019,,
1505,1,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cerebral cortical membrane using [3H]-8-OH-DPAT as radioligand.,,8,10576,,H,Expert,,CHEMBL616337,,BAO_0000249,,
1506,1,Binding affinity against 5-hydroxytryptamine 1A receptor in rat cortex homogenates.,,8,10576,,H,Autocuration,,CHEMBL616338,,BAO_0000019,,
1507,1,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]- 8-hydri\oxy-2-(di-n-propylamino)tetraline) binding assay,,8,10576,,H,Autocuration,,CHEMBL616339,,BAO_0000221,10000000.0,
1508,1,Binding affinity against native 5-HT1A-receptors from rat hippocampus using radioligand ([3H]8-hydroxy-2-(di-n-propylamino)-tetraline) binding assay,,8,10576,,H,Autocuration,,CHEMBL616340,,BAO_0000221,10000000.0,
1509,1,Binding affinity of compound towards 5-hydroxytryptamine 1A receptor was determined,,8,10576,,H,Autocuration,,CHEMBL616341,,BAO_0000357,,
1510,1,Binding affinity against rat 5-hydroxytryptamine 1A receptor,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616342,,BAO_0000357,,
1511,1,Inhibition of [3H]2-(di-N-propylamino)-8-hydroxytetralin binding to 5-HT1A receptor of rat frontal cortex homogenates,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616343,,BAO_0000019,,
1512,1,Binding affinity of a compound to rat brain 5-hydroxytryptamine 1A (serotonin) receptor assayed by radiolabeled [3H]-8-OH-DPAT ligand displacement,,8,10576,,H,Expert,,CHEMBL616344,,BAO_0000019,,
1513,1,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,8,10576,,H,Expert,,CHEMBL616345,,BAO_0000357,,
1514,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat cortex using [3H]8-OH-DPAT as a radioligand,,8,10576,,H,Expert,,CHEMBL616346,,BAO_0000019,,
1515,1,Binding affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT in rat hippocampus,,8,10576,,H,Autocuration,,CHEMBL616347,,BAO_0000221,10000000.0,
1516,1,In vitro by displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor on rat cortical membrane,,8,10576,,H,Expert,,CHEMBL616348,,BAO_0000019,,
1517,1,Binding affinity at 5-hydroxytryptamine 1A receptor,,8,10576,,H,Expert,,CHEMBL616349,,BAO_0000357,,
1518,1,Inhibition of [3H]8-OH-DPAT binding to 5-hydroxytryptamine 1A receptor of rat frontal cortex membranes,Rattus norvegicus,9,10576,Membranes,D,Expert,,CHEMBL616152,,BAO_0000249,,
1519,1,Compound was tested for inhibition constant against 5-hydroxytryptamine 1A receptor in rat frontal cortex membranes.,,8,10576,,H,Autocuration,,CHEMBL616153,,BAO_0000249,,
1520,1,"Binding affinity for rat cortex 5-hydroxytryptamine 1A receptor, by displacement of 0.2 nM [3H]8-OH-DPAT radioligand",,8,10576,,H,Expert,,CHEMBL616154,,BAO_0000019,,
1521,1,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,,8,10576,,H,Autocuration,,CHEMBL616155,,BAO_0000019,,
1522,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus using [3H]8-OH-DPAT,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616156,,BAO_0000221,10000000.0,
1523,1,Binding affinity towards 5-hydroxytryptamine 1A receptor in rat hippocampus with [3H]8-OH-DPAT,Rattus norvegicus,9,10576,,D,Expert,,CHEMBL616157,,BAO_0000221,10000000.0,
1524,1,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]-SB 207710 as radioligand,,8,10576,,H,Autocuration,,CHEMBL616158,,BAO_0000221,10000000.0,
1525,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand.,,8,10576,,H,Autocuration,,CHEMBL616159,,BAO_0000357,,
1526,1,pKi value against rat 5-hydroxytryptamine 1A receptor.,,8,10576,,H,Expert,,CHEMBL616160,,BAO_0000357,,
1527,1,Binding affinity against 5-hydroxytryptamine 1A receptor by displacing [3H]8-OH-DPAT radioligand in rat cortex membrane;ND is define as non-determined.,,8,10576,,H,Autocuration,,CHEMBL616161,,BAO_0000019,,
1528,1,Evaluated for the 5-hydroxytryptamine 1A receptor agonist activity in LY-293284 trained rats; Not tested,,8,10576,,H,Autocuration,,CHEMBL616162,,BAO_0000019,,
1529,1,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL616163,,BAO_0000357,,
1530,1,Inhibition of specific [3H]OH-DPAT binding at 5-hydroxytryptamine 1A receptor in rat hippocampal membranes,,8,10626,Membranes,H,Expert,,CHEMBL616164,,BAO_0000249,,
1531,1,Concentration of compound required to inhibit cortical 5-hydroxytryptamine 1A receptor binding sites in rat brain was evaluated,,8,10576,,H,Autocuration,,CHEMBL616165,,BAO_0000221,955.0,
1532,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor isolated from rat hippocampus membranes membrane using [3H]5-HT as radioligand in the presence of 10e-6 M ketanserin as 5-HT2 blocker,Rattus norvegicus,8,51,,H,Autocuration,,CHEMBL616355,,BAO_0000019,,
1533,1,Effect on 5-hydroxytryptamine 1A receptor mediated inhibition of VIP-stimulated cAMP production at dose of 1 uM+ 50 uM 5-HT.,,8,10576,,H,Autocuration,,CHEMBL616356,,BAO_0000019,,
1534,1,Binding affinity at 5-hydroxytryptamine 1A receptor by the displacement of [3H]8-OH-DPAT in rat brain.,,8,10576,,H,Autocuration,,CHEMBL616357,,BAO_0000221,955.0,
1535,1,"Binding affinity against 5-hydroxytryptamine 1A receptor in homogenated rat brain tissue, using by [3H]8-OH-DPAT as radioligand",,8,10576,,H,Autocuration,,CHEMBL616358,,BAO_0000019,,
1536,1,Compound was tested for binding affinity against 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616359,,BAO_0000357,,
1537,1,Percent decrease in 5-hydroxytryptamine 1A receptor binding using 8-OH-DPAT,,8,51,,H,Expert,,CHEMBL616360,,BAO_0000357,,
1538,1,Binding affinity towards 5-hydroxytryptamine 1A receptor,,8,51,,H,Expert,,CHEMBL616361,,BAO_0000357,,
1539,1,Tested for binding affinity for 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616362,,BAO_0000357,,
1540,1,The compound was evaluated for its ability to displace [3H]-8-OH-DPAT from 5-hydroxytryptamine 1A receptor in cellular brain membranes,,8,51,Brain membranes,H,Autocuration,,CHEMBL616363,,BAO_0000249,,
1541,1,Inhibition of binding towards 5-hydroxytryptamine 1A receptor at 100 nM concentration,,8,51,,H,Autocuration,,CHEMBL616364,,BAO_0000357,,
1542,1,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616365,,BAO_0000357,,
1543,1,Binding affinity for 5-hydroxytryptamine 1A receptor determined using [3H]8-OH-DPAT as radioligand,,8,51,,H,Expert,,CHEMBL616366,,BAO_0000357,,
1544,1,Binding affinity towards 5-hydroxytryptamine 1A receptor,,8,51,,H,Expert,,CHEMBL872906,,BAO_0000357,,
1545,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1A receptor; inactive at 10 uM,,8,51,,H,Autocuration,,CHEMBL616367,,BAO_0000357,,
1546,1,Binding affinity against 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616368,,BAO_0000357,,
1547,1,Binding affinity to 5-hydroxytryptamine 1A receptor was determined,,8,51,,H,Autocuration,,CHEMBL616369,,BAO_0000357,,
1548,1,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H]-(+)-8-OH-DPAT.,Homo sapiens,9,51,,D,Expert,,CHEMBL616370,,BAO_0000357,,
1549,1,Binding affinity towards Serotonin 5-hydroxytryptamine 1A receptor by displacement of [3H](+)-8-OH-DPAT; inactive,Homo sapiens,9,51,,D,Expert,,CHEMBL616371,,BAO_0000357,,
1550,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,8,51,,H,Autocuration,,CHEMBL616372,449.0,BAO_0000219,,
1551,1,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor expressed in CHO cell membranes,,8,51,,H,Expert,,CHEMBL616373,,BAO_0000219,,
1552,1,Compound was measured in vivo for its binding affinity at 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand,,8,51,,H,Autocuration,,CHEMBL616374,,BAO_0000218,,
1553,1,Tested for activity against 5-hydroxytryptamine 1A receptor from bovine hippocampus,,8,51,,H,Autocuration,,CHEMBL616375,,BAO_0000221,10000000.0,
1554,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1A receptor was determined,,8,51,,H,Autocuration,,CHEMBL616376,,BAO_0000357,,
1555,1,Binding affinity towards 5-hydroxytryptamine 1A receptor by displacement of [3H]8-OH-DPAT.,,8,51,,H,Expert,,CHEMBL857064,,BAO_0000357,,
1556,1,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,,8,51,,H,Autocuration,,CHEMBL616377,,BAO_0000357,,
1557,1,Binding affinity for 5-hydroxytryptamine 1A receptor was determined,,8,51,,H,Autocuration,,CHEMBL616378,,BAO_0000357,,
1558,1,Evaluated for the binding affinity to 5-hydroxytryptamine 1A receptor,,8,51,,H,Autocuration,,CHEMBL616379,,BAO_0000357,,
1559,1,Ability to displace [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor,,8,11863,,H,Autocuration,,CHEMBL616380,,BAO_0000357,,
1560,1,Binding affinity against 5-hydroxytryptamine 1A receptor was determined using [3H]-8-OH-DPAT radioligand,,8,11863,,H,Autocuration,,CHEMBL616381,,BAO_0000357,,
1561,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 1A receptor,,8,11863,,H,Autocuration,,CHEMBL616382,,BAO_0000357,,
1562,1,Compound was tested for the binding affinity against 5-hydroxytryptamine 1A receptor by using [3H]DPAT as radioligand,,8,11863,,H,Autocuration,,CHEMBL616383,,BAO_0000357,,
1563,1,In vitro binding affinity against 5-hydroxytryptamine 1A receptor in CHO cells,Mus musculus,9,11863,,D,Expert,,CHEMBL616350,449.0,BAO_0000219,,
1564,1,Inhibition of 5-OH-DPAT binding to 5-hydroxytryptamine 1A receptor,,8,11863,,H,Autocuration,,CHEMBL616351,,BAO_0000357,,
1565,1,Inhibitory activity against 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand at 10e-5 M concentration,,8,11863,,H,Autocuration,,CHEMBL616352,,BAO_0000357,,
1566,1,Binding affinity against 5-hydroxytryptamine 1A receptor,,8,11863,,H,Autocuration,,CHEMBL616353,,BAO_0000357,,
1567,1,Binding affinity against serotonergic 5-HT1a receptor,,8,11863,,H,Autocuration,,CHEMBL616354,,BAO_0000357,,
1568,1,Binding affinity for 5-hydroxytryptamine 1A receptor was determined by using [3H]8-OH-DPAT as radioligand,,8,11863,,H,Autocuration,,CHEMBL616508,,BAO_0000357,,
1569,1,Binding affinity for 5-hydroxytryptamine 1A receptor,Mus musculus,9,11863,,D,Expert,,CHEMBL616559,,BAO_0000357,,
1570,1,Binding affinity at 5-hydroxytryptamine 1A receptor,,8,11863,,H,Autocuration,,CHEMBL616560,,BAO_0000357,,
1571,1,"Binding affinity towards 5-hydroxytryptamine 1A receptor receptor, using [3H]5-HT as radioligand.",,8,11863,,H,Autocuration,,CHEMBL616561,,BAO_0000357,,
1572,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,8,11863,,H,Autocuration,,CHEMBL616562,449.0,BAO_0000219,,
1573,1,Compound was evaluated for the binding affinity against [3H]8-OH-DPAT-labeled 5-hydroxytryptamine 1A receptor sites in cloned CHO cells,,8,11863,,H,Autocuration,,CHEMBL616563,449.0,BAO_0000219,,
1574,1,Compound was tested for binding affinity using [3H]8-OH-DPAT against 5-hydroxytryptamine 1A receptor,,8,11863,,H,Autocuration,,CHEMBL616564,,BAO_0000357,,
1575,1,In vitro binding affinity towards 5-hydroxytryptamine 1A receptor by using [3H]-8-OH-DPAT as radioligand,,8,11863,,H,Autocuration,,CHEMBL616565,,BAO_0000357,,
1576,1,In vivo binding affinity was evaluated against 5-hydroxytryptamine 1A receptor,,8,11863,,H,Autocuration,,CHEMBL616566,,BAO_0000218,,
1577,1,The binding affinity towards 5-hydroxytryptamine 1A receptor; No affinity,,8,11863,,H,Autocuration,,CHEMBL616989,,BAO_0000357,,
1578,1,Ability to displace [125I]iodosulpiride from 5-hydroxytryptamine 1A receptor,,8,11863,,H,Autocuration,,CHEMBL857975,,BAO_0000357,,
1579,1,Binding affinity against 5-hydroxytryptamine 1A receptor,Mus musculus,9,11863,,D,Expert,,CHEMBL616990,,BAO_0000357,,
1580,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor using radioligand binding assay,,8,11863,,H,Autocuration,,CHEMBL616991,,BAO_0000357,,
1581,1,Tested against 5-hydroxytryptamine 1A receptor,,8,11863,,H,Autocuration,,CHEMBL616992,,BAO_0000357,,
1582,1,The compound's binding affinity against 5-hydroxytryptamine 1A receptor,,8,11863,,H,Autocuration,,CHEMBL616993,,BAO_0000357,,
1583,1,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein,Oryctolagus cuniculus,8,106,,H,Expert,,CHEMBL616994,,BAO_0000019,,
1584,1,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 1B like receptor in the rabbit saphenous vein(RbSV); NS=non surmountable,Oryctolagus cuniculus,8,106,,H,Autocuration,,CHEMBL616995,,BAO_0000019,,
1585,1,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1B receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,Gorilla gorilla,9,105571,,D,Intermediate,,CHEMBL616996,722.0,BAO_0000219,,
1586,1,5-HT1B agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,Cavia porcellus,8,106,,H,Autocuration,,CHEMBL616997,,BAO_0000218,,
1587,1,5-hydroxytryptamine 1B receptor agonist potency was evaluated as effective dose that induced hypothermia in the guinea-pig upon intraperitoneal administration,Cavia porcellus,8,106,,H,Autocuration,,CHEMBL616998,,BAO_0000218,,
1588,1,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery,Cavia porcellus,8,106,,H,Autocuration,,CHEMBL616999,,BAO_0000019,,
1589,1,Affinity of compound towards 5-hydroxytryptamine 1B receptor in isolated guinea-pig iliac artery; n.d. indicates Not determined,Cavia porcellus,8,106,,H,Autocuration,,CHEMBL617000,,BAO_0000019,,
1590,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig,Cavia porcellus,8,106,,H,Autocuration,,CHEMBL617001,,BAO_0000019,,
1591,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 1B receptor of guinea pig; ND means not done,Cavia porcellus,8,106,,H,Autocuration,,CHEMBL858111,,BAO_0000019,,
1592,1,Intrinsic activity for Antagonism of 5-hydroxytryptamine 1B receptor-mediated stimulation of [35S]GTP gamma S binding,,8,106,,H,Autocuration,,CHEMBL617002,,BAO_0000019,,
1593,1,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine (5-CT),,8,106,,H,Autocuration,,CHEMBL617003,,BAO_0000019,,
1594,1,Antagonism tested at 1 uM against the agonist-induced inhibitory effect of 10 nM 5-carbamoyltryptamine(5-CT),,8,106,,H,Autocuration,,CHEMBL617004,,BAO_0000019,,
1595,1,Agonist activity at 5-hydroxytryptamine 1B receptor by measuring the inhibition of forskolin-stimulated cAMP formation,Homo sapiens,9,106,,D,Expert,,CHEMBL617005,,BAO_0000019,,
1596,1,Inhibition of forskolin-stimulated c-AMP formation by human 5-hydroxytryptamine 1B receptor expressed in CHO-K1 cells,Homo sapiens,9,106,,D,Expert,,CHEMBL616623,485.0,BAO_0000219,,
1597,1,Effective concentration determined by measuring inhibition of forskolin-stimulated c-AMP formation at 5-hydroxytryptamine 1B receptor stably transfected in CHO cell lines,,8,106,,H,Autocuration,,CHEMBL616624,449.0,BAO_0000219,,
1598,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor,,8,106,,H,Autocuration,,CHEMBL883243,,BAO_0000357,,
1599,1,The compound was evaluated for intrinsic activity against human cloned 5-hydroxytryptamine 1B receptor; full agonist,,8,106,,H,Autocuration,,CHEMBL616625,,BAO_0000019,,
1600,1,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1B receptor",,8,106,,H,Expert,,CHEMBL616626,449.0,BAO_0000219,,
1601,1,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line,,8,106,,H,Autocuration,,CHEMBL616627,449.0,BAO_0000219,,
1602,1,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Antagonist,,8,106,,H,Autocuration,,CHEMBL616628,449.0,BAO_0000219,,
1603,1,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Full Agonist,,8,106,,H,Autocuration,,CHEMBL616629,449.0,BAO_0000219,,
1604,1,The intrinsic activity was evaluated for its ability to inhibit forskolin-stimulated c-AMP formation mediated by cloned 5-hydroxytryptamine 1B receptor in CHO cell line; Partial Agonist,,8,106,,H,Autocuration,,CHEMBL616630,449.0,BAO_0000219,,
1605,1,"Efficacy was evaluated relative to human 5-HT1B receptor using [35S]GTP-gamma-S, as radioligand",,8,106,,H,Expert,,CHEMBL616631,,BAO_0000019,,
1606,1,"Efficacy of compound was evaluated relative to human 5-hydroxytryptamine 1B receptor using [35S]GTP-gamma-S, as radioligand",,8,106,,H,Autocuration,,CHEMBL616632,,BAO_0000019,,
1607,1,Percentage Maximal inhibition obtained with 1 uM 5-HT against 5-hydroxytryptamine 1B receptor,Homo sapiens,9,106,,D,Expert,,CHEMBL616633,,BAO_0000357,,
1608,1,Ability to displace [3H]5-HT from recombinant human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells determined in vitro,,8,106,,H,Expert,,CHEMBL616634,449.0,BAO_0000219,,
1609,1,Affinity of compound towards 5-hydroxytryptamine 1B receptor was evaluated using radioligand binding technique,,8,106,,H,Autocuration,,CHEMBL616635,,BAO_0000357,,
1610,1,Binding affinity against 5-hydroxytryptamine 1B receptor,Homo sapiens,9,106,,D,Expert,,CHEMBL885358,,BAO_0000357,,
1611,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1B receptor expressed in CHO cells,Homo sapiens,9,106,,D,Expert,,CHEMBL616636,449.0,BAO_0000219,,
1612,1,Binding affinity to human cloned 5-hydroxytryptamine 1B receptor in CHO cells by [3H]5-HT binding displacement.,,8,106,,H,Expert,,CHEMBL616637,449.0,BAO_0000219,,
1613,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 1B receptor,,8,106,,H,Autocuration,,CHEMBL616638,,BAO_0000357,,
1614,1,Displacement of [3H]5-HT binding to cloned 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,,8,106,,H,Expert,,CHEMBL616639,449.0,BAO_0000219,,
1615,1,Binding affinity at cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells by [3H]5-HT displacement.,,8,106,,H,Expert,,CHEMBL616640,449.0,BAO_0000219,,
1616,1,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells,,8,106,,H,Expert,,CHEMBL616641,449.0,BAO_0000219,,
1617,1,Displacement of [3H]5-HT binding from cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells.,,8,106,,H,Expert,,CHEMBL616642,449.0,BAO_0000219,,
1618,1,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1B receptor expressed in CHO cells,,8,106,,H,Expert,,CHEMBL616643,449.0,BAO_0000219,,
1619,1,In vitro binding affinity against human 5-hydroxytryptamine 1B receptor at a concentration of 100 (nM),,8,106,,H,Autocuration,,CHEMBL616644,,BAO_0000357,,
1620,1,Intrinsic activity for each compound is calculated as a percentage of the 5-hydroxytryptamine 1B receptor response,,8,106,,H,Autocuration,,CHEMBL616645,,BAO_0000357,,
1621,1,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),Oryctolagus cuniculus,8,105,,H,Autocuration,,CHEMBL616646,,BAO_0000019,,
1622,1,Tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),Oryctolagus cuniculus,8,105,,H,Expert,,CHEMBL616647,,BAO_0000019,,
1623,1,Affinity at 5-hydroxytryptamine 1D receptor (For sumatriptan = Ki (nM)-12+/-1.9),,8,105,,H,Autocuration,,CHEMBL616509,,BAO_0000357,,
1624,1,Affinity at 5-hydroxytryptamine 1D receptor from calf caudate using [3H]5-HT as radioligand (For sumatriptan = Ki(nM)-12+/-1.9),,8,105,,H,Autocuration,,CHEMBL616510,,BAO_0000357,,
1625,1,Binding affinity against calf caudate 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL616511,,BAO_0000357,,
1626,1,Inhibitory activity against 5-hydroxytryptamine 1D receptor subtype,Bos taurus,8,105,,H,Expert,,CHEMBL616512,,BAO_0000357,,
1627,1,Inhibitory concentration required against 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT,Bos taurus,8,105,,H,Autocuration,,CHEMBL616513,,BAO_0000357,,
1628,1,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,Bos taurus,8,105,,H,Autocuration,,CHEMBL616514,,BAO_0000019,2435.0,
1629,1,Ability to bind to 5-hydroxytryptamine 1D receptor of calf substantia nigra,Bos taurus,8,105,,H,Expert,,CHEMBL616515,,BAO_0000357,,
1630,1,Binding affinity against 5-hydroxytryptamine 1D receptor in calf caudate homogenates.,Bos taurus,8,105,,H,Autocuration,,CHEMBL616516,,BAO_0000019,,
1631,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,Bos taurus,8,105,,H,Autocuration,,CHEMBL616517,,BAO_0000357,,
1632,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]- serotonin as radioligand,Bos taurus,8,105,,H,Autocuration,,CHEMBL616518,,BAO_0000357,,
1633,1,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,Bos taurus,8,105,,H,Autocuration,,CHEMBL616519,,BAO_0000357,,
1634,1,Inhibitory activity against 5-hydroxytryptamine 1D receptor of bovine caudate using [3H]5-HT as the radioligand,Bos taurus,8,105,,H,Autocuration,,CHEMBL616520,,BAO_0000357,,
1635,1,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand,Bos taurus,8,105,,H,Autocuration,,CHEMBL616521,,BAO_0000357,,
1636,1,Tested in vitro for receptor binding affinity to 5-hydroxytryptamine 1D receptor in bovine caudate using [3H]5-HT radioligand; NT means not tested,Bos taurus,8,105,,H,Autocuration,,CHEMBL616522,,BAO_0000357,,
1637,1,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,Bos taurus,8,105,,H,Autocuration,,CHEMBL884531,,BAO_0000357,,
1638,1,Binding affinity towards 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand,Bos taurus,8,105,,H,Autocuration,,CHEMBL616523,,BAO_0000357,,
1639,1,Binding affinity towards 5-hydroxytryptamine 1D receptor was determined in calf striatum homogenate,Bos taurus,8,105,,H,Autocuration,,CHEMBL616731,,BAO_0000019,2435.0,
1640,1,Binding affinity was determined against 5-hydroxytryptamine 1D receptor in bovine caudate homogenate,Bos taurus,8,105,,H,Autocuration,,CHEMBL616732,,BAO_0000019,,
1641,1,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT,Bos taurus,8,105,,H,Autocuration,,CHEMBL616733,,BAO_0000357,,
1642,1,The binding affinity at 5-hydroxytryptamine 1D receptor was determined using [3H]5-CT; Not tested,Bos taurus,8,105,,H,Autocuration,,CHEMBL616734,,BAO_0000357,,
1643,1,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP,Bos taurus,8,105,,H,Autocuration,,CHEMBL616735,,BAO_0000249,,
1644,1,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex membranes using [125]ICYP; Not determined,Bos taurus,8,105,,H,Autocuration,,CHEMBL616736,,BAO_0000249,,
1645,1,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,Bos taurus,8,105,,H,Expert,,CHEMBL616737,,BAO_0000019,,
1646,1,Affinity pKi for 5-hydroxytryptamine 1D receptor was measured in calf caudate homogenate,Bos taurus,8,105,,H,Autocuration,,CHEMBL616738,,BAO_0000019,,
1647,1,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,Bos taurus,8,105,,H,Expert,,CHEMBL616739,,BAO_0000019,,
1648,1,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,Bos taurus,8,105,,H,Expert,,CHEMBL616740,,BAO_0000019,,
1649,1,Agonistic activity against 5-hydroxytryptamine 1D receptor in calf caudate using [3H]-GTI,Bos taurus,8,105,,H,Expert,,CHEMBL616741,,BAO_0000019,,
1650,1,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 1D receptor from cloned gorilla membranes expressed in cultured HEK 293 cells,Gorilla gorilla,8,105,,H,Autocuration,,CHEMBL616742,722.0,BAO_0000219,,
1651,1,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616743,,BAO_0000019,,
1652,1,Compound was tested for the inhibition of forskolin-stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor in guinea pig substantia nigra; NT means not tested,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616744,,BAO_0000019,,
1653,1,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptor by the agonist GR-46611,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616745,,BAO_0000019,,
1654,1,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616746,,BAO_0000019,,
1655,1,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611; range is 2-9,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616747,,BAO_0000019,,
1656,1,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-0.4,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616748,,BAO_0000019,,
1657,1,Oral effective dose against hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611;range is 0.2-1.2,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616648,,BAO_0000019,,
1658,1,Binding affinity against 5-hydroxytryptamine 1D receptor,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616649,,BAO_0000357,,
1659,1,Binding affinity towards guinea pig 5-hydroxytryptamine 1D receptor was determined,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616650,,BAO_0000357,,
1660,1,Compound at 3 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616651,,BAO_0000218,,
1661,1,Compound at 45 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616652,,BAO_0000218,,
1662,1,Compound at 50 mg/kg was tested for the inhibition of hypothermia in the guinea pig caused by stimulation of central 5-hydroxytryptamine 1D receptors by the agonist GR-46611,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616653,,BAO_0000218,,
1663,1,Compound at oral dose of 45 mg/kg was tested for percent inhibition against 5-hydroxytryptamine 1D receptor causes hypothermia in guinea pig,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616654,,BAO_0000218,,
1664,1,Binding affinity of 5-hydroxytryptamine 1D receptor using [3H]-8-HT in guinea pig cortex,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616655,,BAO_0000019,,
1665,1,Binding affinity against guinea pig 5-hydroxytryptamine 1D receptor,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616656,,BAO_0000357,,
1666,1,Binding affinity was determined against 5-hydroxytryptamine 4 receptor using [125I]SB 207710 as radioligand from piglet hippocampal membranes,Cavia porcellus,8,105,,H,Autocuration,,CHEMBL616657,,BAO_0000019,,
1667,1,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor in guinea-pig striatum in presence of BMY-7378 and mesulergine,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616658,,BAO_0000357,2435.0,
1668,1,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of guinea pig substantia nigra,Cavia porcellus,9,105570,,D,Intermediate,,CHEMBL616659,,BAO_0000357,,
1669,1,Binding affinity against 5-hydroxytryptamine 1D receptor,,8,51,,H,Autocuration,,CHEMBL616660,,BAO_0000357,,
1670,1,The compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta,,8,106,,H,Autocuration,,CHEMBL616661,,BAO_0000357,,
1671,1,Maximum stimulation of [35S]GTP gamma-S binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor,,8,105,,H,Expert,,CHEMBL616662,,BAO_0000019,,
1672,1,Ability to inhibit forskolin-stimulated adenylate cyclase in a cell line expressing human 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL616663,,BAO_0000019,,
1673,1,Ability to inhibit forskolin-stimulated adenylate cyclase activity in Chinese hamster ovary (CHO) stable cell lines expressing human 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL616664,,BAO_0000019,,
1674,1,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing 5-hydroxytryptamine 1D receptor",Homo sapiens,9,105,,D,Expert,,CHEMBL881820,449.0,BAO_0000219,,
1675,1,"Compound was evaluated for the stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor.",,8,105,,H,Autocuration,,CHEMBL616665,449.0,BAO_0000219,,
1676,1,Agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,,8,105,,H,Expert,,CHEMBL616666,449.0,BAO_0000219,,
1677,1,Compound was tested for measuring agonist-induced [35S]- GTPgammaS binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL616667,449.0,BAO_0000219,,
1678,1,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",,8,105,,H,Expert,,CHEMBL616668,449.0,BAO_0000219,,
1679,1,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the 5-hydroxytryptamine 1D receptor",Homo sapiens,9,105,,D,Expert,,CHEMBL616669,449.0,BAO_0000219,,
1680,1,"Stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing the human 5-hydroxytryptamine 1D receptor.",,8,105,,H,Expert,,CHEMBL617040,449.0,BAO_0000219,,
1681,1,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor",,8,105,,H,Autocuration,,CHEMBL617041,449.0,BAO_0000219,,
1682,1,"Measurement of agonist induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor.",,8,105,,H,Expert,,CHEMBL617042,449.0,BAO_0000219,,
1683,1,"Agonist-induced [35S]GTP-gamma-S, binding in CHO cells stably transfected with human 5-hydroxytryptamine 1D receptor",,8,105,,H,Expert,,CHEMBL617043,449.0,BAO_0000219,,
1684,1,Compound was evaluated for its agonistic activity on 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL617044,,BAO_0000019,,
1685,1,Measurement of agonist-induced [35S]-GTP gamma-S binding in CHO cells stably transfected with 5-hydroxytryptamine 1D receptor,,8,105,,H,Expert,,CHEMBL617045,449.0,BAO_0000219,,
1686,1,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",Homo sapiens,9,105,,D,Expert,,CHEMBL617046,449.0,BAO_0000219,,
1687,1,"Maximum stimulation of [35S]GTP-gamma-S, binding in CHO cells expressing human 5-HT-1d relative to 5-HT",Homo sapiens,9,105,,D,Expert,,CHEMBL617047,449.0,BAO_0000219,,
1688,1,"Efficacy was evaluated relative to human 5-hydroxytryptamine 1D receptor using [35S]GTP-gamma-S, as radioligand",,8,105,,H,Expert,,CHEMBL617048,,BAO_0000019,,
1689,1,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by 5-hydroxytryptamine 1D receptor.",,8,105,,H,Autocuration,,CHEMBL616897,,BAO_0000019,,
1690,1,"Maximum stimulation of [35S]GTP-gamma-S, binding to 5-hydroxytryptamine 1D receptor relative to 5-HT",Homo sapiens,9,105,,D,Expert,,CHEMBL616898,,BAO_0000019,,
1691,1,Percent efficacy relative to 5-HT treatment of CHO cells expressing 5-HT 1d receptor,Homo sapiens,9,105,,D,Expert,,CHEMBL858201,449.0,BAO_0000219,,
1692,1,Intrinsic activity for 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL616899,,BAO_0000019,,
1693,1,Ability to displace [3H]- -5-HT binding to cloned 5-hydroxytryptamine 1D receptor stably expressed in chinese hamster cells (CHO cells),,8,105,,H,Autocuration,,CHEMBL616900,,BAO_0000219,,
1694,1,Ability to displace [3H]-5-HT from recombinant human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells determined in vitro,,8,105,,H,Expert,,CHEMBL616901,449.0,BAO_0000219,,
1695,1,Affinity of compound towards 5-hydroxytryptamine 1D receptor was evaluated using radioligand binding technique,,8,105,,H,Autocuration,,CHEMBL616902,,BAO_0000357,,
1696,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,Homo sapiens,9,105,,D,Expert,,CHEMBL616903,449.0,BAO_0000219,,
1697,1,Binding affinity by displacement to human cloned 5-hydroxytryptamine 1D receptor in CHO cells by [3H]5-HT displacement.,,8,105,,H,Expert,,CHEMBL616904,449.0,BAO_0000219,,
1698,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL616905,,BAO_0000357,,
1699,1,Binding affinity at human cloned 5-hydroxytryptamine 1D receptor stably expressed in CHO cells by [3H]5-HT displacement.,,8,105,,H,Expert,,CHEMBL616906,449.0,BAO_0000219,,
1700,1,Displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,,8,105,,H,Expert,,CHEMBL616907,449.0,BAO_0000219,,
1701,1,Displacement of [3H]5-HT binding from the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,,8,105,,H,Expert,,CHEMBL616908,449.0,BAO_0000219,,
1702,1,Displacement of [3H]5-HT binding from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,Homo sapiens,9,105,,D,Expert,,CHEMBL616909,449.0,BAO_0000219,,
1703,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in CHO cells,Homo sapiens,9,105,,D,Expert,,CHEMBL616910,449.0,BAO_0000219,,
1704,1,Displacement of [3H]5-HT binding to the cloned human 5-hydroxytryptamine 1D receptor stably expressed in CHO cells,,8,105,,H,Expert,,CHEMBL616911,449.0,BAO_0000219,,
1705,1,Displacement of specific [3H]5-HT binding to cloned human 5-hydroxytryptamine 1D receptor expressed in CHO cells,,8,105,,H,Expert,,CHEMBL616912,449.0,BAO_0000219,,
1706,1,In vitro binding affinity against human 5-hydroxytryptamine 1D receptor at a concentration of 100 (nM),,8,105,,H,Autocuration,,CHEMBL616913,,BAO_0000357,,
1707,1,Inhibition of [3H]5-HT binding to human 5-hydroxytryptamine 1D receptor expressed in CHO cells at 1 uM,Homo sapiens,9,105,,D,Expert,,CHEMBL616914,449.0,BAO_0000219,,
1708,1,Binding affinity against 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,,8,105,,H,Autocuration,,CHEMBL616915,449.0,BAO_0000219,,
1709,1,Binding affinity for 5-hydroxytryptamine 1D receptor in Cos-7 transfected cell type using [3H]5-CT as radioligand,,8,105,,H,Autocuration,,CHEMBL616916,,BAO_0000019,,
1710,1,Binding affinity to cloned human 5-hydroxytryptamine 1D receptor,Homo sapiens,9,105,,D,Expert,,CHEMBL616917,,BAO_0000357,,
1711,1,"Binding affinity towards 5-HT1D receptor, using [3H]5-HT as radioligand.",,8,105,,H,Autocuration,,CHEMBL616918,,BAO_0000357,,
1712,1,Binding affinity towards human 5-hydroxytryptamine 1D receptor in L-M(tk-) cells using [3H]GR-125743 as radioligand,,8,105,,H,Expert,,CHEMBL616919,,BAO_0000219,,
1713,1,Binding affinity towards human 5-hydroxytryptamine 1D receptor was determined using [3H]5-HT as radioligand,,8,105,,H,Autocuration,,CHEMBL616920,,BAO_0000357,,
1714,1,Binding affinity for recombinant human 5-hydroxytryptamine 1D receptor using [3H]5-HT as radioligand.,,8,105,,H,Autocuration,,CHEMBL872914,,BAO_0000357,,
1715,1,Binding affinity was evaluated at human recombinant 5-hydroxytryptamine 1D receptor using [3H]-5-CT as radioligand,,8,105,,H,Autocuration,,CHEMBL616921,,BAO_0000357,,
1716,1,Binding affinity was evaluated at the cloned human 5-hydroxytryptamine 1D receptor,,8,105,,H,Expert,,CHEMBL616922,,BAO_0000357,,
1717,1,Binding affinity towards 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL616923,,BAO_0000357,,
1718,1,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,,8,105,,H,Expert,,CHEMBL616924,,BAO_0000357,,
1719,1,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand,,8,105,,H,Expert,,CHEMBL875909,,BAO_0000357,,
1720,1,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; Not determined,,8,105,,H,Autocuration,,CHEMBL616925,,BAO_0000357,,
1721,1,Binding affinity towards human 5-hydroxytryptamine 1D receptor using [3H]5-HT trifluoroacetate as radioligand; not determined,,8,105,,H,Autocuration,,CHEMBL616926,,BAO_0000357,,
1722,1,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL616927,,BAO_0000357,,
1723,1,Ability to inhibit the forskolin-stimulated c-AMP formation mediated by human 5-hydroxytryptamine 1D receptor in CHO-K1 cells,,8,105,,H,Expert,,CHEMBL616928,485.0,BAO_0000219,,
1724,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 1D receptor expressed in Chinese hamster ovary cells (CHO cells),Homo sapiens,9,105,,D,Expert,,CHEMBL616929,,BAO_0000219,,
1725,1,In vitro binding affinity to human 5-hydroxytryptamine 1D receptor,Homo sapiens,9,105,,D,Expert,,CHEMBL616930,,BAO_0000357,,
1726,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,,8,105,,H,Expert,,CHEMBL616931,,BAO_0000019,,
1727,1,In vitro binding affinity was determined towards cloned human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,,8,105,,H,Autocuration,,CHEMBL616932,,BAO_0000357,,
1728,1,In vitro receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor,,8,105,,H,Expert,,CHEMBL616933,,BAO_0000357,,
1729,1,Receptor binding affinity for cloned human 5-hydroxytryptamine 1D receptor in Cos-7 cells,Homo sapiens,9,105,,D,Expert,,CHEMBL616934,,BAO_0000219,,
1730,1,Binding affinity for human 5-hydroxytryptamine 1D receptor,Homo sapiens,9,105,,D,Expert,,CHEMBL616935,,BAO_0000357,,
1731,1,The binding affinity towards the 5-hydroxytryptamine 1D receptor; No affinity,,8,105,,H,Autocuration,,CHEMBL616936,,BAO_0000357,,
1732,1,Affinity for 5-hydroxytryptamine 1D receptor subtype,Homo sapiens,9,105,,D,Expert,,CHEMBL616937,,BAO_0000357,,
1733,1,Binding affinity for human 5-hydroxytryptamine 1D receptor,Homo sapiens,9,105,,D,Expert,,CHEMBL616938,,BAO_0000357,,
1734,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL616939,,BAO_0000019,,
1735,1,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1D receptor; ND means not determined,,8,105,,H,Expert,,CHEMBL616940,,BAO_0000019,,
1736,1,Binding activity against human 5-hydroxytryptamine 1D receptor; NT means not tested,Homo sapiens,9,105,,D,Expert,,CHEMBL616941,,BAO_0000357,,
1737,1,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; Not tested,,8,105,,H,Autocuration,,CHEMBL616942,485.0,BAO_0000219,,
1738,1,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor; not tested,,8,105,,H,Autocuration,,CHEMBL616943,485.0,BAO_0000219,,
1739,1,Selectivity towards 5-HT1D and to that of 5-HT1B in CHO cells,,4,104802,,H,Autocuration,,CHEMBL616944,449.0,BAO_0000219,,
1740,1,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect produced by the 5-HT",,8,105,,H,Autocuration,,CHEMBL616945,,BAO_0000019,,
1741,1,Binding activity radioligand.,,8,105,,H,Autocuration,,CHEMBL616946,,BAO_0000357,,
1742,1,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,8,105,,H,Autocuration,,CHEMBL616947,,BAO_0000019,,
1743,1,Binding affinity in CHO-K1 cells transfected with human 5-hydroxytryptamine 1D receptor,,8,105,,H,Expert,,CHEMBL616948,485.0,BAO_0000219,,
1744,1,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL616851,,BAO_0000357,,
1745,1,Binding affinity for human cloned 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL616852,,BAO_0000357,,
1746,1,Measured as -log Ka on 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL616853,,BAO_0000357,,
1747,1,Binding activity against human 5-hydroxytryptamine 1D receptor,Homo sapiens,9,105,,D,Expert,,CHEMBL616854,,BAO_0000357,,
1748,1,Binding affinity to human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand,Homo sapiens,9,105,,D,Expert,,CHEMBL616855,449.0,BAO_0000219,,
1749,1,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]-5-HT as radioligand.,,8,105,,H,Autocuration,,CHEMBL616856,449.0,BAO_0000219,,
1750,1,Binding affinity towards 5-hydroxytryptamine 1D (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,8,105,,H,Autocuration,,CHEMBL616857,449.0,BAO_0000219,,
1751,1,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL616858,,BAO_0000357,,
1752,1,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as radioligand.,,8,105,,H,Autocuration,,CHEMBL616859,449.0,BAO_0000219,,
1753,1,Binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]-5-HT as radioligand.;ND means no data.,,8,105,,H,Autocuration,,CHEMBL616860,449.0,BAO_0000219,,
1754,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,,8,105,,H,Autocuration,,CHEMBL616861,722.0,BAO_0000219,,
1755,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand,,8,105,,H,Autocuration,,CHEMBL616541,722.0,BAO_0000219,,
1756,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 1D receptor expressed in HEK 293 cells using [3H]LSD as radioligand; Not determined,,8,105,,H,Autocuration,,CHEMBL616542,722.0,BAO_0000219,,
1757,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT as the radioligand,,8,105,,H,Autocuration,,CHEMBL616543,449.0,BAO_0000219,,
1758,1,Binding affinity for human 5-hydroxytryptamine 1D receptor,Homo sapiens,9,105,,D,Expert,,CHEMBL616544,,BAO_0000357,,
1759,1,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT,,8,105,,H,Autocuration,,CHEMBL616545,449.0,BAO_0000219,,
1760,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1D receptor in CHO using [3H]5-HT as a radioligand,,8,105,,H,Autocuration,,CHEMBL616546,,BAO_0000357,,
1761,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1D receptor in CHO cells using [3H]5-HT.,,8,105,,H,Autocuration,,CHEMBL616547,449.0,BAO_0000219,,
1762,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1D receptor in CHO cells, using [3H]5-HT as radioligand",,8,105,,H,Autocuration,,CHEMBL616548,449.0,BAO_0000219,,
1763,1,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 1 uM,,8,105,,H,Expert,,CHEMBL616549,,BAO_0000019,,
1764,1,Adenyl cyclase activity was expressed as percent forskolin response against 5-hydroxytryptamine 1D receptor at concentration 10 uM,,8,105,,H,Expert,,CHEMBL616550,,BAO_0000019,,
1765,1,Binding affinity against 5-HT2C receptor,,8,108,,H,Autocuration,,CHEMBL857066,,BAO_0000357,,
1766,1,Binding affinity against 5-hydroxytryptamine 1D receptor,,8,108,,H,Autocuration,,CHEMBL616551,,BAO_0000357,,
1767,1,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,,8,10577,,H,Autocuration,,CHEMBL616552,,BAO_0000357,,
1768,1,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1B receptor of rat substantia nigra,,8,10577,,H,Autocuration,,CHEMBL832876,,BAO_0000019,,
1769,1,"Binding affinity for 5-hydroxytryptamine 1B receptor in rat cortex, striatum and globus pallidus",,8,10577,,H,Expert,,CHEMBL616553,,BAO_0000019,,
1770,1,Binding affinity towards 5-HT1B was determined,,8,10577,,H,Autocuration,,CHEMBL616554,,BAO_0000357,,
1771,1,Affinity towards 5-hydroxytryptamine 1B receptor in membranes from rat frontal cortex using [3H]5-HT,,8,10577,,H,Expert,,CHEMBL616555,,BAO_0000019,,
1772,1,"Binding affinity to 5-HT1B receptors using rat cortex+striatum + globus pallidus,[3H]-5-OH-tryptamine, and serotonin for NSB",,8,10577,,H,Expert,,CHEMBL616556,,BAO_0000019,,
1773,1,"Compound was evaluated for binding affinity on 5-HT1B receptors using rat cortex+striatum+ globus pallidus,[ 3H]-5-OH-tryptamine, and serotonin for NSB.",,8,10577,,H,Autocuration,,CHEMBL616557,,BAO_0000019,,
1774,1,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,8,10577,,H,Expert,,CHEMBL616558,,BAO_0000019,,
1775,1,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT,Rattus norvegicus,9,10577,,D,Expert,,CHEMBL616749,,BAO_0000019,,
1776,1,Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol binding to 5-hydroxytryptamine 1B receptor at 1 uM,,8,10577,,H,Autocuration,,CHEMBL616750,,BAO_0000357,,
1777,1,"Concentration necessary to achieve half maximal inhibition of [125I]- Iodocyanopindolol, binds to 5-hydroxytryptamine 1B receptor at 1 uM",,8,10577,,H,Autocuration,,CHEMBL616751,,BAO_0000357,,
1778,1,In vitro inhibitory concentration against radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,,8,10577,,H,Autocuration,,CHEMBL616752,,BAO_0000249,,
1779,1,Inhibition of [3H]-5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatum; Residual radioligand binding higher than 50%,,8,10577,,H,Autocuration,,CHEMBL616753,,BAO_0000019,2435.0,
1780,1,Inhibition of radiolabeled [3H]-5-HT ligand binding to 5-hydroxytryptamine 1B receptor,Rattus norvegicus,9,10577,,D,Expert,,CHEMBL616754,,BAO_0000357,,
1781,1,Inhibitory activity against 5-hydroxytryptamine 1B receptor of rat cortex using [3H]5-HT as the radioligand.,,8,10577,,H,Autocuration,,CHEMBL616755,,BAO_0000019,,
1782,1,Inhibitory activity against [3H]5-HT binding to 5-HT1B receptor in rat striatum,,8,10577,,H,Autocuration,,CHEMBL616756,,BAO_0000019,2435.0,
1783,1,Inhibitory concentration required against 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT,,8,10577,,H,Autocuration,,CHEMBL616757,,BAO_0000019,2435.0,
1784,1,compound was measured for affinity against 5-hydroxytryptamine 1B receptor labelled with [3H]5-HT radioligand in striatum tissue,,8,10577,,H,Autocuration,,CHEMBL616758,,BAO_0000357,2435.0,
1785,1,Compound at 10E-5 M was tested in vitro for the inhibition of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1B receptor in rat striatal membrane,,8,10577,,H,Autocuration,,CHEMBL616759,,BAO_0000249,,
1786,1,In vitro binding affinity towards the 5-hydroxytryptamine 1B receptor at 10 e-6 M,,8,10577,,H,Autocuration,,CHEMBL616760,,BAO_0000357,,
1787,1,Ability to displace [3H]5-HT bound to 5-hydroxytryptamine 1B receptor in rat striatum,,8,10577,,H,Autocuration,,CHEMBL616761,,BAO_0000019,2435.0,
1788,1,Binding affinity against 5-HT1B serotonin receptor in rat striatum,,8,10577,,H,Autocuration,,CHEMBL616762,,BAO_0000019,2435.0,
1789,1,Binding affinity against 5-hydroxytryptamine 1B receptor in membranes of Rat cerebral cortex,,8,10577,,H,Autocuration,,CHEMBL616763,,BAO_0000019,,
1790,1,Binding affinity at rat 5-hydroxytryptamine 1B receptor by [3H]5-HT displacement.,,8,10577,,H,Expert,,CHEMBL872909,,BAO_0000357,,
1791,1,Binding affinity determined in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,,8,10577,,H,Autocuration,,CHEMBL616764,,BAO_0000357,,
1792,1,Inhibition of [3H]5-HT binding to 5-hydroxytryptamine 1B receptor,Rattus norvegicus,9,10577,,D,Expert,,CHEMBL616765,,BAO_0000357,,
1793,1,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum,,8,10577,,H,Autocuration,,CHEMBL616766,,BAO_0000357,2435.0,
1794,1,Binding affinity against 5-hydroxytryptamine 1B receptor of rat striatum.,,8,10577,,H,Autocuration,,CHEMBL616767,,BAO_0000357,2435.0,
1795,1,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 1B receptor,,8,10577,,H,Autocuration,,CHEMBL616768,,BAO_0000357,,
1796,1,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,,8,10577,,H,Autocuration,,CHEMBL616769,,BAO_0000357,,
1797,1,Binding affinity towards 5-hydroxytryptamine 1B receptor in rat was determined using 50 uL of [125I]ICYP in binding assay,,8,10577,,H,Autocuration,,CHEMBL616770,,BAO_0000019,,
1798,1,Binding affinity was determined against 5-hydroxytryptamine 1B receptor was determined in male Sprague-Dawley rat brain.,,8,10577,,H,Autocuration,,CHEMBL616771,,BAO_0000019,,
1799,1,Binding affinity was measured on 5-hydroxytryptamine 1B receptor in rat striatum labeled with [3H]5-HT,,8,10577,,H,Autocuration,,CHEMBL616772,,BAO_0000019,2435.0,
1800,1,Binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand.,,8,10577,,H,Expert,,CHEMBL616773,,BAO_0000019,,
1801,1,Compound was evaluated for the binding affinity (Ki) to rat cortical membranes at 5-HT1B binding site by using [125 I] ICYP as a radioligand; ND is no data.,,8,10577,,H,Autocuration,,CHEMBL616774,,BAO_0000019,,
1802,1,Evaluated for binding affinity towards 5-hydroxytryptamine 1B receptor,,8,10577,,H,Autocuration,,CHEMBL616775,,BAO_0000357,,
1803,1,Inhibitory activity against 5-hydroxytryptamine 1B receptor in rat cortical membranes using [3H]5-HT as a radioligand,,8,10577,,H,Autocuration,,CHEMBL616776,,BAO_0000249,,
1804,1,The binding affinity was measured on 5-hydroxytryptamine 1B receptor using [3H]- serotonin as radioligand.,,8,10577,,H,Autocuration,,CHEMBL616777,,BAO_0000357,,
1805,1,The binding affinity towards the receptor rat 5-hydroxytryptamine 1B receptor; No affinity,,8,10577,,H,Autocuration,,CHEMBL616778,,BAO_0000357,,
1806,1,Binding affinity against 5-hydroxytryptamine 1B receptor in rat striatal membranes using [3H]5-HT as radioligand,Rattus norvegicus,9,10577,,D,Expert,,CHEMBL616779,,BAO_0000249,,
1807,1,Binding affinity towards 5-hydroxytryptamine 1B receptor,Rattus norvegicus,9,10577,,D,Expert,,CHEMBL616780,,BAO_0000357,,
1808,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 1B receptor by displacing [3H]serotonin radioligand in rat cerebral cortex,,8,10577,,H,Autocuration,,CHEMBL616781,,BAO_0000019,,
1809,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand,,8,10577,,H,Autocuration,,CHEMBL616782,,BAO_0000357,,
1810,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand.,,8,10577,,H,Autocuration,,CHEMBL616783,,BAO_0000357,,
1811,1,Binding affinity for 5-hydroxytryptamine 1B receptor in rat striatum using [3H]5-HT as radioligand,,8,10577,,H,Expert,,CHEMBL616784,,BAO_0000019,2435.0,
1812,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 1B receptor from rat striatum using [3H]5-HT as radioligand; Nonactive at 10 uM,,8,10577,,H,Autocuration,,CHEMBL616785,,BAO_0000357,,
1813,1,Binding affinity against 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,8,10577,,H,Autocuration,,CHEMBL857067,,BAO_0000249,955.0,
1814,1,Binding affinity against 5-HT1B receptor in rat frontal cortex using [3H]-5-HT in presence of 0.1 uM [3H]-8-OH-DPAT as a radioligand,,8,10577,,H,Autocuration,,CHEMBL616786,,BAO_0000019,,
1815,1,Binding affinity towards 5-HT1B receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,8,10577,,H,Autocuration,,CHEMBL616787,,BAO_0000249,955.0,
1816,1,Binding affinity towards 5-hydroxytryptamine 2C receptor of porcine choroid plexus using [3H]mesulergine,,8,10577,,H,Autocuration,,CHEMBL616788,,BAO_0000357,,
1817,1,Ability to displace the radioligand [125I](-)-iodocyanopindolol from rat striatal 5-hydroxytryptamine 1B receptor,,8,10577,,H,Autocuration,,CHEMBL616789,,BAO_0000357,,
1818,1,Displacement of [3H]5-HT from 5-HT1B receptor of rat frontal cortex homogenate,Rattus norvegicus,9,10577,,D,Expert,,CHEMBL616790,,BAO_0000019,,
1819,1,Binding affinity at 5-hydroxytryptamine 1B receptor,,8,10577,,H,Expert,,CHEMBL616791,,BAO_0000357,,
1820,1,In vitro binding affinity at 5-hydroxytryptamine 1B receptor in rat striatal muscles using [125I](-)-iodocyanopindolol as the radioligand,,8,10577,,H,Autocuration,,CHEMBL616792,,BAO_0000019,,
1821,1,In vitro binding affinity towards 5-hydroxytryptamine 1B receptor in rat striatal membrane with [125I]- iodocyanopindolol,Rattus norvegicus,9,10577,,D,Expert,,CHEMBL616793,,BAO_0000249,,
1822,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand,,8,10577,,H,Autocuration,,CHEMBL616794,,BAO_0000357,,
1823,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,8,10577,,H,Autocuration,,CHEMBL616795,,BAO_0000357,,
1824,1,Binding affinity towards 5-HT2 receptor by the displacement of [3H]-ketanserin] in rat cerebral cortex,,4,104686,,H,Autocuration,,CHEMBL616796,,BAO_0000019,,
1825,1,Compound was tested for binding affinity against 5-hydroxytryptamine 1B receptor,,8,106,,H,Autocuration,,CHEMBL616797,,BAO_0000357,,
1826,1,The compound was evaluated for its ability to displace [3H]5-HT from 5-hydroxytryptamine 1B receptor in cellular brain membranes,,8,106,Brain membranes,H,Autocuration,,CHEMBL616798,,BAO_0000249,,
1827,1,Compound was measured for its binding affinity at 5-hydroxytryptamine 1B receptor at a concentration of 100 nM using [125I]CYP as radioligand,,8,106,,H,Autocuration,,CHEMBL616799,,BAO_0000357,,
1828,1,Inhibition of binding towards 5-hydroxytryptamine 1B receptor at 100 nM concentration,,8,106,,H,Autocuration,,CHEMBL616800,,BAO_0000357,,
1829,1,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1B receptor,,8,106,,H,Autocuration,,CHEMBL616801,,BAO_0000357,,
1830,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1B receptor; inactive at 10 uM,,8,106,,H,Autocuration,,CHEMBL616802,,BAO_0000357,,
1831,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1B receptor was determined,,8,106,,H,Autocuration,,CHEMBL616803,,BAO_0000357,,
1832,1,Binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]5-HT.,,8,106,,H,Expert,,CHEMBL857068,,BAO_0000357,,
1833,1,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 1B receptor by displacement of [3H]ketanserin.,,8,106,,H,Autocuration,,CHEMBL616804,,BAO_0000357,,
1834,1,Binding affinity for 5-hydroxytryptamine 1B receptor was determined,,8,106,,H,Autocuration,,CHEMBL616805,,BAO_0000357,,
1835,1,Evaluated for the binding affinity to 5-hydroxytryptamine 1B receptor,,8,106,,H,Autocuration,,CHEMBL616806,,BAO_0000357,,
1836,1,Binding affinity against 5-hydroxytryptamine 1B receptor,,8,106,,H,Autocuration,,CHEMBL616807,,BAO_0000357,,
1837,1,Binding affinity for 5-hydroxytryptamine 1B receptor was determined by using [3H]5-HT as radioligand,,8,106,,H,Autocuration,,CHEMBL616808,,BAO_0000357,,
1838,1,Binding affinity towards 5-hydroxytryptamine 1B receptor using [3H]5-HT as radioligand.,,8,106,,H,Autocuration,,CHEMBL616809,,BAO_0000357,,
1839,1,Inhibitory constant against 5-hydroxytryptamine 1B receptor using with [125I]- cyanopindolol radioligand,,8,106,,H,Autocuration,,CHEMBL616810,,BAO_0000357,,
1840,1,Binding affinity against 5-hydroxytryptamine 1B receptor - 5-hydroxytryptamine 1D receptor using [3H]5-HT as the radioligand.,,4,104802,,H,Autocuration,,CHEMBL616811,,BAO_0000224,,
1841,1,Inhibitory concentration required against 5-hydroxytryptamine 1C receptor in bovine choroid plexus using [3H]mesulergine,Bos taurus,8,108,,H,Autocuration,,CHEMBL616812,,BAO_0000357,,
1842,1,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,Sus scrofa,8,108,,H,Autocuration,,CHEMBL616813,,BAO_0000357,,
1843,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 1C receptor in pig choroid plexus using [3H]mesulergine as radioligand,Sus scrofa,8,108,,H,Autocuration,,CHEMBL616814,,BAO_0000357,,
1844,1,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,Sus scrofa,8,108,,H,Autocuration,,CHEMBL616815,,BAO_0000357,,
1845,1,inhibitory activity against 5-hydroxytryptamine 1C receptor of pig choroid plexus using [3H]mesulergine as the radioligand,Sus scrofa,8,108,,H,Autocuration,,CHEMBL616816,,BAO_0000357,,
1846,1,Binding affinity of compound towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine (1.2 nM) ligand in choroid Plexus pig was determined,Sus scrofa,8,108,,H,Autocuration,,CHEMBL616817,,BAO_0000357,,
1847,1,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 1C receptor,Sus scrofa,8,108,,H,Autocuration,,CHEMBL616818,,BAO_0000357,,
1848,1,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand.,Sus scrofa,8,108,,H,Expert,,CHEMBL616819,,BAO_0000357,,
1849,1,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 1C receptor of pig choroid Plexus,Sus scrofa,8,108,,H,Expert,,CHEMBL616820,,BAO_0000357,,
1850,1,Displacement of [3H]mesulergine from pig cortex 5-hydroxytryptamine 1C receptor,Sus scrofa,8,108,,H,Expert,,CHEMBL616821,,BAO_0000019,,
1851,1,Binding affinity for 5-hydroxytryptamine 1C receptor in piglet choroid plexus using [3H]5-HT,Sus scrofa,8,108,,H,Autocuration,,CHEMBL616822,,BAO_0000357,,
1852,1,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,Oryctolagus cuniculus,8,108,,H,Autocuration,,CHEMBL616823,,BAO_0000019,,
1853,1,Tested for the effect on binding at 5-hydroxytryptamine 1C receptor; No activity,Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL616824,,BAO_0000357,,
1854,1,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL616825,,BAO_0000357,,
1855,1,In vitro binding affinity towards the 5-hydroxytryptamine 1C receptor at 10 e-6 M,Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL616826,,BAO_0000357,,
1856,1,Binding affinity against 5-hydroxytryptamine 1C receptor in rat using [3H]mesulergine as radioligand,Rattus norvegicus,9,12689,,D,Expert,,CHEMBL616827,,BAO_0000019,,
1857,1,Binding affinity towards 5-hydroxytryptamine 1C receptor using [125 I]-SCH23982 as radioligand in competitive binding assay,Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL616828,,BAO_0000357,,
1858,1,Binding affinity towards 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand,Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL616829,,BAO_0000357,,
1859,1,Binding affinity was determined against 5-hydroxytryptamine 1C receptor was determined in male Sprague-Dawley rat brain.,Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL616830,,BAO_0000019,,
1860,1,Binding affinity against 5-hydroxytryptamine 1C receptor,Rattus norvegicus,9,12689,,D,Expert,,CHEMBL616831,,BAO_0000357,,
1861,1,"Compound was tested for binding affinity towards 5-HT1C (5-HT1C) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL616832,,BAO_0000019,,
1862,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL616833,,BAO_0000019,,
1863,1,"Binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",Rattus norvegicus,9,12689,,D,Expert,,CHEMBL616834,,BAO_0000019,,
1864,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 1C receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]mesulergine as radioligand",Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL829595,,BAO_0000019,,
1865,1,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 1C receptor binding site by using [3H]- MES as a radioligand.,Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL616835,,BAO_0000357,,
1866,1,Inhibitory activity against 5-hydroxytryptamine 1C receptor in rat cortical membranes using [3H]mesulergine as a radioligand,Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL872910,,BAO_0000249,,
1867,1,Tested for binding affinity against 5-hydroxytryptamine 1C receptor from rat frontal cortical regions using [3H]mesulergine as radioligand,,8,12689,,H,Expert,,CHEMBL616836,,BAO_0000357,,
1868,1,The binding affinity was measured on 5-hydroxytryptamine 1C receptor using [3H]- serotonin as radioligand.,Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL616837,,BAO_0000357,,
1869,1,Binding affinity of 5-hydroxytryptamine 1C receptor using [3H]- ketanserin in rat frontal cortex,Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL616466,,BAO_0000019,,
1870,1,Binding affinity towards rat 5-hydroxytryptamine 1C receptor using [3H]mesulergine as radioligand expressed in 293 cells,Rattus norvegicus,9,12689,,D,Autocuration,,CHEMBL616467,722.0,BAO_0000219,,
1871,1,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,,8,108,,H,Autocuration,,CHEMBL616468,,BAO_0000357,,
1872,1,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,,8,108,,H,Autocuration,,CHEMBL616469,,BAO_0000357,,
1873,1,Compound was measured for its binding affinity at 5-hydroxytryptamine 1C receptor at a concentration of 100 nM using [3H]mesulergine as radioligand,,8,108,,H,Autocuration,,CHEMBL616470,,BAO_0000357,,
1874,1,Binding affinity against 5-hydroxytryptamine 1C receptor,,8,12689,,H,Autocuration,,CHEMBL616471,,BAO_0000357,,
1875,1,Compound was tested for its affinity towards 5-hydroxytryptamine 1C receptor,,8,12689,,H,Autocuration,,CHEMBL616472,,BAO_0000357,,
1876,1,Binding affinity against 5-hydroxytryptamine 1C receptor,,8,12689,,H,Autocuration,,CHEMBL616473,,BAO_0000357,,
1877,1,Binding affinity against serotonergic 5-HT1c receptor,,8,12689,,H,Autocuration,,CHEMBL616474,,BAO_0000357,,
1878,1,Binding affinity for 5-hydroxytryptamine 1C receptor was determined by using [3H]- mesulergine as radioligand,,8,12689,,H,Autocuration,,CHEMBL616475,,BAO_0000357,,
1879,1,Binding affinity for 5-hydroxytryptamine 1C receptor was determined,,8,12689,,H,Autocuration,,CHEMBL616476,,BAO_0000357,,
1880,1,Compound was tested for 5-hydroxytryptamine 1D like receptor-mediated vascular effect in rabbit saphenous vein (RSV),Oryctolagus cuniculus,8,105,,H,Autocuration,,CHEMBL616477,,BAO_0000019,,
1881,1,Binding affinity against 5-hydroxytryptamine 2 receptor using [125I]DOI as radioligand.,,4,104686,,H,Autocuration,,CHEMBL616478,,BAO_0000224,,
1882,1,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ket as radioligand.,,4,104686,,H,Autocuration,,CHEMBL616479,,BAO_0000224,,
1883,1,Binding affinity towards serotonin 5-HT2 receptor was determined in rat cortex using [3H]spiperone as ligand,,4,104686,,H,Autocuration,,CHEMBL616480,,BAO_0000019,,
1884,1,Binding affinity towards 5-hydroxytryptamine 2 receptor as antagonism of serotonin-induced contractions in rat jugular vein,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL616481,,BAO_0000019,,
1885,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain cortical membranes,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL616482,,BAO_0000249,,
1886,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain using [3H]spiroperidol,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL884713,,BAO_0000221,955.0,
1887,1,Binding affinity towards 5-hydroxytryptamine 2 receptor measured using radioligand ([3H]spiperone) binding assay,,4,104686,,H,Autocuration,,CHEMBL616483,,BAO_0000224,,
1888,1,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- spiroperidol,,4,104686,,H,Autocuration,,CHEMBL616484,,BAO_0000224,,
1889,1,Binding affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenates by [3H]-spiperone displacement.,,4,104686,,H,Autocuration,,CHEMBL616485,,BAO_0000019,,
1890,1,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,4,104686,,H,Autocuration,,CHEMBL616486,,BAO_0000224,,
1891,1,Binding affinity towards 5-hydroxytryptamine 2 receptor was measured using radioligand ([3H]spiperone) binding assay,,4,104686,,H,Autocuration,,CHEMBL616487,,BAO_0000224,,
1892,1,Binding affinity at serotonin 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,,4,104686,,H,Autocuration,,CHEMBL616488,,BAO_0000224,,
1893,1,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,4,104686,,H,Autocuration,,CHEMBL616489,,BAO_0000019,,
1894,1,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,4,104686,,H,Autocuration,,CHEMBL616490,,BAO_0000019,,
1895,1,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]-Ketanserin as radioligand; not determined,,4,104686,,H,Autocuration,,CHEMBL616491,,BAO_0000019,,
1896,1,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand; ND-Not determined,,4,104686,,H,Autocuration,,CHEMBL616492,,BAO_0000019,,
1897,1,Compound was evaluated In vitro for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,4,104686,,H,Autocuration,,CHEMBL616493,,BAO_0000019,,
1898,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [125I]DOI as radioligand,,4,104686,,H,Autocuration,,CHEMBL616494,,BAO_0000019,,
1899,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor in rat anterior cortex using [3H]ketanserin as radioligand,,4,104686,,H,Autocuration,,CHEMBL616495,,BAO_0000019,,
1900,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat pre frontal cortex,,4,104686,,H,Autocuration,,CHEMBL616496,,BAO_0000019,,
1901,1,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,4,104686,,H,Autocuration,,CHEMBL616497,,BAO_0000019,,
1902,1,Compound was evaluated for its activity by binding to 5-hydroxytryptamine 2 receptor in the rat brain using [3H]ketanserin as radioligand.,,4,104686,,H,Autocuration,,CHEMBL616498,,BAO_0000019,,
1903,1,Compound was evaluated for its inhibitory activity against 5-hydroxytryptamine 2 receptor of rat anterior cortex using [3H]ketanserin as the radioligand,,4,104686,,H,Autocuration,,CHEMBL616499,,BAO_0000019,,
1904,1,Compound was measured for affinity at 5-hydroxytryptamine 2 receptor in rat cortical by [3H]spiroperidol displacement.,,4,104686,,H,Autocuration,,CHEMBL616500,,BAO_0000019,,
1905,1,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL616501,,BAO_0000221,955.0,
1906,1,Compound was tested for its inhibitory effect on the binding profile in 5-hydroxytryptamine 2 receptor using [3H]spiroperidol in rat brain.,,4,104686,,H,Autocuration,,CHEMBL616502,,BAO_0000221,955.0,
1907,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor from rat cortical membranes.,,4,104686,Membranes,H,Autocuration,,CHEMBL884529,,BAO_0000249,,
1908,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,,4,104686,Membranes,H,Autocuration,,CHEMBL616503,,BAO_0000249,,
1909,1,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL616964,,BAO_0000224,,
1910,1,Compound was tested for the displacement of [3H]ketanserin from serotonin 5-hydroxytryptamine 2 receptor from rat cortical membranes.,,4,104686,Membranes,H,Autocuration,,CHEMBL616965,,BAO_0000249,,
1911,1,Inhibition of [3H]ketanserin binding to rat 5-hydroxytryptamine 2 receptors.,,4,104686,,H,Autocuration,,CHEMBL616966,,BAO_0000224,,
1912,1,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor; NT=Not tested,,4,104686,,H,Autocuration,,CHEMBL616967,,BAO_0000224,,
1913,1,Inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL616968,,BAO_0000224,,
1914,1,Compound was tested for the inhibition of [3H]ketanserin binding to dopamine 5-hydroxytryptamine 2 receptor; NT=Not tested,,4,104686,,H,Autocuration,,CHEMBL616969,,BAO_0000224,,
1915,1,Inhibition of [3H]ketanserin binding at 5-hydroxytryptamine 2 receptor from rat frontal cortex.,,4,104686,,H,Autocuration,,CHEMBL884530,,BAO_0000019,,
1916,1,Concentration necessary to achieve half maximal inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL616970,,BAO_0000224,,
1917,1,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,,4,104686,,H,Autocuration,,CHEMBL616971,,BAO_0000224,,
1918,1,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",,4,104686,,H,Autocuration,,CHEMBL616972,,BAO_0000224,,
1919,1,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]-spiperone,,4,104686,,H,Autocuration,,CHEMBL616973,,BAO_0000224,,
1920,1,Evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using radioligand [3H]spiperone; IA=Inactive,,4,104686,,H,Autocuration,,CHEMBL616974,,BAO_0000224,,
1921,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.,,4,104686,,H,Autocuration,,CHEMBL616975,,BAO_0000019,,
1922,1,Inhibition of binding of radioligand [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cerebral cortex,,4,104686,,H,Autocuration,,CHEMBL616976,,BAO_0000019,,
1923,1,In vitro binding affinity measured on serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand.,,4,104686,,H,Autocuration,,CHEMBL616977,,BAO_0000224,,
1924,1,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,,4,104686,,H,Autocuration,,CHEMBL616978,,BAO_0000224,,
1925,1,In vitro binding affinity was measured on serotonergic 5-hydroxytryptamine 2 receptor by displacement of [3H]- ketanserin,,4,104686,,H,Autocuration,,CHEMBL616979,,BAO_0000224,,
1926,1,In vitro inhibitory activity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL616980,,BAO_0000224,,
1927,1,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes,,4,104686,Membranes,H,Autocuration,,CHEMBL616981,,BAO_0000249,,
1928,1,Inhibition of [3H]spiperone binding to 5-hydroxytryptamine 2 receptor from rat cortical membranes; Not tested,,4,104686,Membranes,H,Autocuration,,CHEMBL616982,,BAO_0000249,,
1929,1,Inhibitory activity against 5-hydroxytryptamine 2 receptor by 3H ligand binding experiments.,,4,104686,,H,Autocuration,,CHEMBL616983,,BAO_0000224,,
1930,1,Inhibitory activity against [3H]spiroperidol binding to 5-HT2 receptor in rat cortex,,4,104686,,H,Autocuration,,CHEMBL616984,,BAO_0000019,,
1931,1,Inhibitory activity against 5-hydroxytryptamine 2 receptor,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL616985,,BAO_0000224,,
1932,1,Inhibitory concentration against 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,,4,104686,,H,Autocuration,,CHEMBL616986,,BAO_0000224,,
1933,1,Inhibitory concentration against binding of 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]-ketanserin,,4,104686,,H,Autocuration,,CHEMBL616987,,BAO_0000224,,
1934,1,Inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat,,4,104686,,H,Autocuration,,CHEMBL616988,,BAO_0000019,,
1935,1,Inhibitory concentration against radioligand [3H]spiperone binding to 5-hydroxytryptamine 2 receptor in rat cortex,,4,104686,,H,Autocuration,,CHEMBL617243,,BAO_0000019,,
1936,1,Inhibitory concentration required against 5-hydroxytryptamine 2 receptor in rat cortex using [3H]spiperone,,4,104686,,H,Autocuration,,CHEMBL617244,,BAO_0000019,,
1937,1,Inhibitory concentration against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617245,485.0,BAO_0000219,,
1938,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor in rat cortical membranes,,4,104686,Membranes,H,Autocuration,,CHEMBL617246,,BAO_0000249,,
1939,1,The compound was evaluated for the ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor ( striata of male wistar rats),,4,104686,,H,Autocuration,,CHEMBL617546,,BAO_0000224,,
1940,1,The concentration required to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat brain membranes (in vitro),,4,104686,Brain membranes,H,Autocuration,,CHEMBL617547,,BAO_0000249,,
1941,1,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,4,104686,,H,Autocuration,,CHEMBL617548,,BAO_0000219,,
1942,1,Binding affinity towards 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617549,,BAO_0000224,,
1943,1,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,,4,104686,,H,Autocuration,,CHEMBL617550,,BAO_0000224,,
1944,1,In vitro binding affinity towards the 5-hydroxytryptamine 2 receptor at 10 e-6 M,,4,104686,,H,Autocuration,,CHEMBL617551,,BAO_0000224,,
1945,1,Percent inhibition of binding of 1.0 nM [3H]ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e -5 M,,4,104686,Membranes,H,Autocuration,,CHEMBL617552,,BAO_0000249,,
1946,1,Percent inhibition of binding of 1.0 nM [3H]-ketanserin to 5-hydroxytryptamine 2 receptor in rat cortical membranes at 10 e-5 M.,,4,104686,Membranes,H,Autocuration,,CHEMBL617553,,BAO_0000249,,
1947,1,Tested for antagonistic activity against 5-hydroxytryptamine 2 receptor from rat thoracic aorta,,4,104686,,H,Autocuration,,CHEMBL617554,,BAO_0000019,1515.0,
1948,1,Binding affinity for membrane-bound 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617555,,BAO_0000019,,
1949,1,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,,4,104686,,H,Autocuration,,CHEMBL617556,,BAO_0000224,,
1950,1,Inhibitory constant against human 5-hydroxytryptamine 1B receptor using [3H]5-CT radioligand,,8,10624,,H,Autocuration,,CHEMBL617557,,BAO_0000357,,
1951,1,Inhibitory constant against human 5-hydroxytryptamine 1D receptor using [3H]5-CT radioligand,,8,10624,,H,Autocuration,,CHEMBL617558,,BAO_0000357,,
1952,1,Binding affinity against 5-hydroxytryptamine 1D receptor was measured using [3H]5-HT as radioligand,,8,17106,,H,Expert,,CHEMBL617559,,BAO_0000357,,
1953,1,Binding affinity for 5-hydroxytryptamine 1D receptor,,9,17106,,D,Expert,,CHEMBL617560,,BAO_0000357,,
1954,1,Compound was tested for its ability to displace [125I]GTI binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,8,17106,,H,Autocuration,,CHEMBL617561,,BAO_0000249,,
1955,1,Compound was tested for its ability to displace [3H]-5-HT binding to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,8,17106,,H,Autocuration,,CHEMBL617562,,BAO_0000249,,
1956,1,Binding affinity against 5-hydroxytryptamine 1D receptor using [3H]5-HT in pig striatum + frontalCortex,,8,17106,,H,Autocuration,,CHEMBL617563,,BAO_0000357,2435.0,
1957,1,Relative agonist efficacy against 1 uM 5-hydroxytryptamine 1D receptor,,8,17106,,H,Autocuration,,CHEMBL617564,,BAO_0000019,,
1958,1,Binding activity against 5-hydroxytryptamine 1D receptor from pig caudate membrane using [3H]5-HT as radioligand,,8,17106,,H,Expert,,CHEMBL617565,,BAO_0000019,,
1959,1,Binding activity radioligand.,,8,17106,,H,Autocuration,,CHEMBL856076,,BAO_0000357,,
1960,1,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,8,17106,,H,Autocuration,,CHEMBL617566,,BAO_0000019,,
1961,1,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,8,17106,,H,Expert,,CHEMBL875911,,BAO_0000019,,
1962,1,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,,8,17106,,H,Autocuration,,CHEMBL617567,,BAO_0000019,,
1963,1,Compound was tested for the displacement of [3H]-5-HT to 5-hydroxytryptamine 1D receptor recognition sites in pig caudate membranes,,8,17106,,H,Autocuration,,CHEMBL617568,,BAO_0000249,,
1964,1,Displacement of [3H]5-HT binding to 5-hydroxytryptamine 1D receptor from pig caudate membrane,,8,17106,,H,Expert,,CHEMBL617569,,BAO_0000019,,
1965,1,Displacement of radioligand [3H]5-HT binding to 5-hydroxytryptamine 1D receptor in pig caudate membrane,,8,17106,,H,Expert,,CHEMBL617570,,BAO_0000249,,
1966,1,Binding affinity for 5-hydroxytryptamine 1D receptor in piglet caudate using [3H]5-HT,,8,17106,,H,Autocuration,,CHEMBL617571,,BAO_0000357,,
1967,1,In Vitro Binding affinity againist 5-hydroxytryptamine 1D receptor by displacing [125I]GTI from pig caudate,Sus scrofa,8,105,,H,Autocuration,,CHEMBL617572,,BAO_0000357,,
1968,1,The compound was tested for intrinsic activity against 5-HT1D receptor,Oryctolagus cuniculus,8,105,,H,Expert,,CHEMBL617573,,BAO_0000357,,
1969,1,Intrinsic activity against 5-hydroxytryptamine 1 receptor using rabbit saphenous vein assay.,Oryctolagus cuniculus,8,105,,H,Autocuration,,CHEMBL617574,,BAO_0000019,,
1970,1,The compound was tested for binding affinity against 5-HT1D receptor,Oryctolagus cuniculus,8,105,,H,Expert,,CHEMBL617575,,BAO_0000357,,
1971,1,Tested for the effect on binding at 5-hydroxytryptamine 1D receptor; No activity,,8,10578,,H,Autocuration,,CHEMBL617576,,BAO_0000357,,
1972,1,Inhibition of Forskolin-stimulated adenylate cyclase activity against 5-hydroxytryptamine 1D receptor of rat substantia nigra,,8,10578,,H,Autocuration,,CHEMBL617577,,BAO_0000019,,
1973,1,Inhibition of forskolin stimulated adenylate cyclase at 5-hydroxytryptamine 1D receptor,,8,10578,,H,Autocuration,,CHEMBL617578,,BAO_0000019,,
1974,1,Binding affinity was measured against serotonin 5-hydroxytryptamine 1D receptor,,8,10578,,H,Autocuration,,CHEMBL617579,,BAO_0000357,,
1975,1,Binding affinity towards 5-hydroxytryptamine 1D receptor in rat frontal cortex using [125I]iodocyanopindolol as radio-ligand.,,8,10578,,H,Expert,,CHEMBL617580,,BAO_0000019,,
1976,1,Inhibitory activity against 5-hydroxytryptamine 1D receptor in rat cortical membranes using [3H]5-HT as a radioligand,,8,10578,,H,Autocuration,,CHEMBL617581,,BAO_0000249,,
1977,1,The binding affinity was measured on 5-hydroxytryptamine 1D receptor using [3H]- serotonin as radioligand.,,8,10578,,H,Autocuration,,CHEMBL617582,,BAO_0000357,,
1978,1,Binding affinity to 5-hydroxytryptamine 1D receptor in the rat forebrain by [3H]- SB-204269 displacement.,,8,10578,,H,Expert,,CHEMBL617583,,BAO_0000019,,
1979,1,Inhibition of binding towards 5-hydroxytryptamine 1D receptor at 100 nM concentration,,8,105,,H,Autocuration,,CHEMBL617584,,BAO_0000357,,
1980,1,Compound was tested for binding affinity against 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL617585,,BAO_0000357,,
1981,1,Compound was measured for its binding affinity at 5-hydroxytryptamine 1D receptor at a concentration of 10 uM using [3H]5-HT as radioligand,,8,105,,H,Autocuration,,CHEMBL875912,,BAO_0000357,,
1982,1,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL617586,,BAO_0000357,,
1983,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 1D receptor; inactive at 10 uM,,8,105,,H,Autocuration,,CHEMBL617587,,BAO_0000357,,
1984,1,Binding affinity for 5-hydroxytryptamine 1D receptor was determined,,8,105,,H,Autocuration,,CHEMBL617588,,BAO_0000357,,
1985,1,Evaluated for the binding affinity against 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL857980,,BAO_0000357,,
1986,1,Tested against 5-hydroxytryptamine 1D receptor,,8,105,,H,Autocuration,,CHEMBL617589,,BAO_0000357,,
1987,1,Binding affinity for 5-hydroxytryptamine 1D receptor was determined by using [3H]5-HT as radioligand,,8,105,,H,Autocuration,,CHEMBL617590,,BAO_0000357,,
1988,1,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,,8,105,,H,Autocuration,,CHEMBL617591,722.0,BAO_0000219,,
1989,1,Binding affinity against 5-Hydroxytryptamine 1D receptor,Homo sapiens,9,105,,D,Expert,,CHEMBL617592,,BAO_0000357,,
1990,1,,,8,105,,H,Autocuration,,CHEMBL617593,,BAO_0000357,,
1991,1,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,,8,106,,H,Autocuration,,CHEMBL617594,485.0,BAO_0000219,,
1992,1,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,,8,105,,H,Autocuration,,CHEMBL617595,485.0,BAO_0000219,,
1993,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line.,,8,105,,H,Autocuration,,CHEMBL617596,722.0,BAO_0000219,,
1994,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor alpha clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,,8,105,,H,Autocuration,,CHEMBL617597,722.0,BAO_0000219,,
1995,1,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,,8,105,,H,Autocuration,,CHEMBL617598,,BAO_0000019,,
1996,1,Binding affinity of compound against 5-HT1Dalpha Binding affinity of compound against 5-HT1D alpha receptors in human,,8,105,,H,Autocuration,,CHEMBL872916,,BAO_0000357,,
1997,1,In vitro affinity human cloned 5-hydroxytryptamine 1D receptor alpha by [3H]5-HT displacement.,,8,105,,H,Expert,,CHEMBL617599,,BAO_0000357,,
1998,1,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor alpha was determined,,8,105,,H,Autocuration,,CHEMBL617091,,BAO_0000357,,
1999,1,"Binding affinity against 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells, using [3H]-5-HT as the radioligand.",,8,105,,H,Expert,,CHEMBL617092,485.0,BAO_0000219,,
2000,1,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor alpha expressed in CHO-K1 cells.,,8,105,,H,Autocuration,,CHEMBL617093,485.0,BAO_0000219,,
2001,1,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor alpha measured as the reduction of forskolin-stimulated cAMP.,,8,105,,H,Autocuration,,CHEMBL617094,,BAO_0000019,,
2002,1,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,8,105,,H,Autocuration,,CHEMBL617095,,BAO_0000019,,
2003,1,Compound was tested for its agonist activity against human 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,8,105,,H,Autocuration,,CHEMBL617096,,BAO_0000019,,
2004,1,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,8,105,,H,Autocuration,,CHEMBL617097,,BAO_0000019,,
2005,1,Compound was tested for its agonist activity against human recombinant 5-hydroxytryptamine 1D receptor alpha for comparison purpose.,,8,105,,H,Autocuration,,CHEMBL617098,,BAO_0000019,,
2006,1,In vitro binding affinity towards 5-HT1D alpha receptor by using [3H]5-HT as radioligand,,8,105,,H,Autocuration,,CHEMBL617301,,BAO_0000357,,
2007,1,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]5-HT as radioligand,,8,105,,H,Autocuration,,CHEMBL617302,,BAO_0000357,,
2008,1,Selectivity towards 5-hydroxytryptamine 1D receptor beta to that of 5-hydroxytryptamine 1D receptor alpha,,8,105,,H,Autocuration,,CHEMBL617303,,BAO_0000357,,
2009,1,Binding affinity to recombinant human 5-hydroxytryptamine 1D receptor alpha,,8,105,,H,Expert,,CHEMBL617304,,BAO_0000357,,
2010,1,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor alpha expressed in CHO cells, by using [3H]5-HT as radioligand",,8,105,,H,Expert,,CHEMBL617305,449.0,BAO_0000219,,
2011,1,Binding affinity was measured on 5-hydroxytryptamine 1D receptor alpha in COS cells transfected with human 5-HT1D alpha gene labeled with [3H]5-HT,Homo sapiens,9,105,,D,Autocuration,,CHEMBL617306,,BAO_0000219,,
2012,1,Binding affinity (in vitro) against 5-hydroxytryptamine 1D receptor alpha using radio-ligand binding assay,,8,17106,,H,Autocuration,,CHEMBL617307,,BAO_0000357,,
2013,1,Binding affinity against 5-hydroxytryptamine 4 receptor using rabbit saphenous vein assay.,Oryctolagus cuniculus,8,105,,H,Autocuration,,CHEMBL617308,,BAO_0000019,,
2014,1,Binding affinities against 5-hydroxytryptamine 1D receptor alpha,,8,105,,H,Autocuration,,CHEMBL617309,,BAO_0000357,,
2015,1,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,,8,105,,H,Autocuration,,CHEMBL617310,,BAO_0000357,,
2016,1,Binding affinities towards 5-hydroxytryptamine 1D receptor alpha,,8,105,,H,Autocuration,,CHEMBL617311,,BAO_0000357,,
2017,1,Binding affinity towards 5-hydroxytryptamine 1D receptor alpha using [3H]8-OH-DPAT as radioligand,,8,105,,H,Autocuration,,CHEMBL617312,,BAO_0000357,,
2018,1,Affinity against 5-hydroxytryptamine 1D receptor alpha,,8,105,,H,Autocuration,,CHEMBL617313,,BAO_0000357,,
2019,1,Binding affinity against 5-hydroxytryptamine 1D receptor alpha,,8,105,,H,Expert,,CHEMBL617314,,BAO_0000357,,
2020,1,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,8,106,,H,Autocuration,,CHEMBL617315,,BAO_0000019,,
2021,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line.,,8,106,,H,Autocuration,,CHEMBL617316,722.0,BAO_0000219,,
2022,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1D receptor beta clones expressed in human embryonic kidney (HEK 293) cells line; NT= not tested,,8,106,,H,Autocuration,,CHEMBL617317,722.0,BAO_0000219,,
2023,1,"The compound was tested in vitro for binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",,8,106,,H,Autocuration,,CHEMBL617318,449.0,BAO_0000219,,
2024,1,Binding affinity against 5-hydroxytryptamine 1D receptor beta using rabbit saphenous vein assay.,,8,106,,H,Autocuration,,CHEMBL617319,,BAO_0000019,,
2025,1,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,9,106,,D,Expert,,CHEMBL617320,,BAO_0000357,,
2026,1,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,9,106,,D,Expert,,CHEMBL617321,,BAO_0000357,,
2027,1,Displacement of [3H]-5-HT from human 5-hydroxytryptamine 1D receptor beta,,9,106,,D,Expert,,CHEMBL617322,,BAO_0000357,,
2028,1,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined using [3H]8-OH-DPAT as radioligand,,8,106,,H,Autocuration,,CHEMBL616862,,BAO_0000357,,
2029,1,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor was determined using [3H]8-OH-DPAT as radioligand,,8,106,,H,Autocuration,,CHEMBL616863,,BAO_0000357,,
2030,1,Binding affinity was measured on 5-hydroxytryptamine 1D receptor beta in CHO cells transfected with human 5-HT1D beta gene labeled with [3H]5-HT,,8,106,,H,Autocuration,,CHEMBL616864,449.0,BAO_0000219,,
2031,1,Compound was tested for binding affinity against cloned human 5-HT1D beta receptor expressed in CHO-K1 cells.,,8,106,,H,Autocuration,,CHEMBL616865,485.0,BAO_0000219,,
2032,1,Compound was tested for binding affinity against cloned human 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells.,,8,106,,H,Autocuration,,CHEMBL616866,485.0,BAO_0000219,,
2033,1,Compound was tested for intrinsic efficacy against human 5-hydroxytryptamine 1D receptor beta measured as the reduction of forskolin-stimulated cAMP.,,8,106,,H,Autocuration,,CHEMBL616867,,BAO_0000019,,
2034,1,"Binding affinity against 5-hydroxytryptamine 1D receptor beta expressed in CHO-K1 cells, using [3H]5-HT as the radioligand.",,8,106,,H,Expert,,CHEMBL616868,485.0,BAO_0000219,,
2035,1,Binding affinity for cloned human 5-hydroxytryptamine 1D receptor beta,,8,105,,H,Expert,,CHEMBL616869,,BAO_0000357,,
2036,1,"In vitro binding affinity against cloned mammalian 5-hydroxytryptamine 1D receptor beta expressed in CHO cells, by using [3H]5-HT as radioligand",,8,106,,H,Expert,,CHEMBL616870,449.0,BAO_0000219,,
2037,1,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.24-0.55,,8,105,,H,Autocuration,,CHEMBL616871,485.0,BAO_0000219,,
2038,1,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 0.6-2.0,,8,105,,H,Autocuration,,CHEMBL616872,485.0,BAO_0000219,,
2039,1,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 2.8-6.5,,8,105,,H,Autocuration,,CHEMBL616873,485.0,BAO_0000219,,
2040,1,Compound was tested for its ability inhibit forskolin-stimulated activity of adenylate cyclase coupled to human 5-hydroxytryptamine 1D receptor beta in CHO-K1 cells; value ranges from 30-70,,8,105,,H,Autocuration,,CHEMBL616838,485.0,BAO_0000219,,
2041,1,Binding affinity towards cloned human 5-hydroxytryptamine 1D receptor beta was determined,,8,105,,H,Autocuration,,CHEMBL616839,,BAO_0000357,,
2042,1,Binding affinity against 5-hydroxytryptamine 3 receptor using rabbit saphenous vein assay.,Oryctolagus cuniculus,8,106,,H,Autocuration,,CHEMBL616840,,BAO_0000019,,
2043,1,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor alpha by using [3H]-5-HT as radioligand,,8,105,,H,Autocuration,,CHEMBL616841,,BAO_0000357,,
2044,1,In vitro binding affinity towards 5-hydroxytryptamine 1D receptor beta by using [3H]5-HT as radioligand,,8,105,,H,Autocuration,,CHEMBL616842,,BAO_0000357,,
2045,1,Binding affinity against 5-hydroxytryptamine 1D receptor beta,,8,105,,H,Expert,,CHEMBL857976,,BAO_0000357,,
2046,1,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1E receptor stably expressed in CHO cells,,8,10618,,H,Autocuration,,CHEMBL616843,449.0,BAO_0000219,,
2047,1,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype,Homo sapiens,9,10618,,D,Expert,,CHEMBL616844,,BAO_0000357,,
2048,1,Inhibitory activity against 5-hydroxytryptamine 1E receptor subtype; NA denotes data not available,,8,10618,,H,Autocuration,,CHEMBL616845,,BAO_0000357,,
2049,1,Binding affinity to cloned human 5-hydroxytryptamine 1E receptor,Homo sapiens,9,10618,,D,Expert,,CHEMBL616846,,BAO_0000357,,
2050,1,Binding affinity towards human 5-hydroxytryptamine 1E receptor was determined using [3H]5-HT as radioligand,,8,10618,,H,Autocuration,,CHEMBL616847,,BAO_0000357,,
2051,1,Binding affinity was determined against 5-hydroxytryptamine 1E receptor in human cortical homogenate,,8,10618,,H,Autocuration,,CHEMBL616848,,BAO_0000019,,
2052,1,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 1E receptor,,8,10618,,H,Autocuration,,CHEMBL616849,,BAO_0000357,,
2053,1,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 1E receptor,,8,10618,,H,Autocuration,,CHEMBL872911,,BAO_0000357,,
2054,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1E receptor,,8,10618,,H,Autocuration,,CHEMBL616850,,BAO_0000019,,
2055,1,Binding affinity against human 5-hydroxytryptamine 1E receptor expressed in CHO cells,Homo sapiens,9,10618,,D,Expert,,CHEMBL616699,449.0,BAO_0000219,,
2056,1,Binding affinity towards cloned human 5-hydroxytryptamine 1E receptor was determined,,8,10618,,H,Autocuration,,CHEMBL616700,,BAO_0000357,,
2057,1,Binding affinity towards 5-hydroxytryptamine 1E receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,8,10618,,H,Autocuration,,CHEMBL616701,449.0,BAO_0000219,,
2058,1,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand.,,8,10618,,H,Autocuration,,CHEMBL616702,449.0,BAO_0000219,,
2059,1,Binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as radioligand;ND means no data.,,8,10618,,H,Autocuration,,CHEMBL616703,449.0,BAO_0000219,,
2060,1,Binding affinity was determined against 5-hydroxytryptamine 1D receptor,,8,10618,,H,Autocuration,,CHEMBL616704,,BAO_0000357,,
2061,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT as the radioligand,,8,10618,,H,Autocuration,,CHEMBL616705,449.0,BAO_0000219,,
2062,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1E receptor,,8,10618,,H,Autocuration,,CHEMBL616706,,BAO_0000357,,
2063,1,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]-5-HT,,8,10618,,H,Autocuration,,CHEMBL616707,449.0,BAO_0000219,,
2064,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1E receptor in CHO using [3H]5-HT as a radioligand,,8,10618,,H,Autocuration,,CHEMBL616708,,BAO_0000357,,
2065,1,Tested for binding affinity towards cloned human 5-hydroxytryptamine 1E receptor using [3H]5-HT as radioligand,,8,10618,,H,Autocuration,,CHEMBL616709,,BAO_0000357,,
2066,1,The binding affinity (pKi) measured against 5-hydroxytryptamine 1E receptor (cloned human receptors in CHO cells) using [3H]5-HT1E as radioligand,,8,10618,,H,Autocuration,,CHEMBL616710,449.0,BAO_0000219,,
2067,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1E receptor in CHO cells using [3H]5-HT.,,8,10618,,H,Autocuration,,CHEMBL616711,449.0,BAO_0000219,,
2068,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1E receptor in CHO cells, using [3H]5-HT as radioligand",,8,10618,,H,Autocuration,,CHEMBL616712,449.0,BAO_0000219,,
2069,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1E receptor was determined,,8,10618,,H,Autocuration,,CHEMBL616713,,BAO_0000357,,
2070,1,Binding affinity for 5-hydroxytryptamine 1E receptor was determined,,8,10618,,H,Autocuration,,CHEMBL616714,,BAO_0000357,,
2071,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 1E receptor,,8,10618,,H,Autocuration,,CHEMBL616715,,BAO_0000357,,
2072,1,Binding affinity towards 5-hydroxytryptamine 1E receptor,,8,10618,,H,Autocuration,,CHEMBL616716,,BAO_0000357,,
2073,1,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-HT1F receptor",,8,279,,H,Autocuration,,CHEMBL616717,,BAO_0000019,,
2074,1,"In vitro effective concentration for stimulation of [35S]GTP-gamma-S, binding in mouse LM(tk-)cells expressing the human 5-hydroxytryptamine 1F receptor",,8,279,,H,Expert,,CHEMBL616718,,BAO_0000019,,
2075,1,In vitro effective concentration for inhibition of skolin-stimulated adenylate cyclase in cell line expressing human 5-hydroxytryptamine 1F receptor,,8,279,,H,Autocuration,,CHEMBL875905,,BAO_0000019,,
2076,1,In vitro agonist potency against human 5-hydroxytryptamine 1F receptor,,8,279,,H,Autocuration,,CHEMBL616719,,BAO_0000019,,
2077,1,"Maximum stimulation of of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine 1F receptor",,8,279,,H,Expert,,CHEMBL616720,,BAO_0000019,,
2078,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 1F receptor,,8,279,,H,Autocuration,,CHEMBL616721,,BAO_0000357,,
2079,1,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 1F receptor stably expressed in CHO cells,,8,279,,H,Autocuration,,CHEMBL616722,449.0,BAO_0000219,,
2080,1,In vitro binding affinity against human 5-hydroxytryptamine 1F receptor at a concentration of 100 (nM),,8,279,,H,Autocuration,,CHEMBL616723,,BAO_0000357,,
2081,1,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT radioligand,,8,279,,H,Autocuration,,CHEMBL616724,449.0,BAO_0000219,,
2082,1,Binding affinity against 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT radioligand,,8,279,,H,Autocuration,,CHEMBL616725,,BAO_0000357,,
2083,1,Binding affinity towards human 5-hydroxytryptamine 1F receptor,,8,279,,H,Autocuration,,CHEMBL616726,,BAO_0000357,,
2084,1,Binding affinity towards human 5-hydroxytryptamine 1F receptor was determined,,8,279,,H,Autocuration,,CHEMBL616727,,BAO_0000357,,
2085,1,Binding affinity towards human 5-hydroxytryptamine 1F receptor using [3H]-5-HT radioligand,,8,279,,H,Autocuration,,CHEMBL616728,,BAO_0000357,,
2086,1,In vitro binding affinity for human 5-hydroxytryptamine 1F receptor,,8,279,,H,Autocuration,,CHEMBL616729,,BAO_0000357,,
2087,1,In vitro binding affinity was determined by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 1F receptor,,8,279,,H,Expert,,CHEMBL616730,,BAO_0000019,,
2088,1,Binding affinity towards human recombinant 5-hydroxytryptamine 1F receptor,,8,279,,H,Autocuration,,CHEMBL617125,,BAO_0000357,,
2089,1,Binding affinity towards cloned human 5-hydroxytryptamine 1F receptor was determined,,8,279,,H,Autocuration,,CHEMBL857977,,BAO_0000357,,
2090,1,Binding affinity towards 5-hydroxytryptamine 1F receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand.,,8,279,,H,Autocuration,,CHEMBL617126,449.0,BAO_0000219,,
2091,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 1F receptor in CHO cells using [3H]-5-HT as the radioligand,,8,279,,H,Autocuration,,CHEMBL617127,449.0,BAO_0000219,,
2092,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 1F receptor,,8,279,,H,Autocuration,,CHEMBL617128,,BAO_0000357,,
2093,1,Compound was tested for its binding affinity against 5-hydroxytryptamine 1F receptor in human cloned receptors in CHO cells using [3H]5-HT,,8,279,,H,Autocuration,,CHEMBL617129,449.0,BAO_0000219,,
2094,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 1F receptor in CHO using [3H]5-HT as a radioligand,,8,279,,H,Autocuration,,CHEMBL617130,,BAO_0000357,,
2095,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 1F receptor in CHO cells using [3H]5-HT.,,8,279,,H,Autocuration,,CHEMBL617131,449.0,BAO_0000219,,
2096,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",,8,279,,H,Autocuration,,CHEMBL617132,449.0,BAO_0000219,,
2097,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 1F receptor in CHO cells, using [3H]5-HT as radioligand",,8,279,,H,Autocuration,,CHEMBL617133,449.0,BAO_0000219,,
2098,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 1F receptor was determined,,8,279,,H,Autocuration,,CHEMBL617134,,BAO_0000357,,
2099,1,Binding affinity for 5-hydroxytryptamine 1F receptor was determined,,8,279,,H,Autocuration,,CHEMBL617135,,BAO_0000357,,
2100,1,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 1F receptor,,8,279,,H,Autocuration,,CHEMBL617136,,BAO_0000357,,
2101,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]-ketanserin as radioligand",,4,104686,,H,Autocuration,,CHEMBL617137,,BAO_0000019,,
2102,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",,4,104686,,H,Autocuration,,CHEMBL617138,,BAO_0000019,,
2103,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 (5-hydroxytryptamine-2) receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,4,104686,,H,Autocuration,,CHEMBL617139,,BAO_0000019,,
2104,1,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617140,,BAO_0000019,,
2105,1,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-HT2 receptor 1 hr after oral administration",,4,104686,,H,Autocuration,,CHEMBL617141,,BAO_0000218,,
2106,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,4,104686,,H,Autocuration,,CHEMBL858112,,BAO_0000019,,
2107,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in calf frontal cortex,,8,17005,,H,Intermediate,,CHEMBL617142,,BAO_0000019,,
2108,1,"Binding affinity to 5-hydroxytryptamine 2 receptor using calf frontal cortex, [3H]- ketanserin, and spiperone for NSB",Bos taurus,0,22226,,U,Autocuration,,CHEMBL617143,,BAO_0000019,,
2109,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex at 10e-7 M,Bos taurus,0,22226,,U,Autocuration,,CHEMBL617144,,BAO_0000019,,
2110,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of bovine frontal cortex,Bos taurus,0,22226,,U,Autocuration,,CHEMBL617145,,BAO_0000019,,
2111,1,Binding affinity of compound towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin (0.8 nM) ligand in frontal cortex bovine was determined,,0,22226,,U,Autocuration,,CHEMBL617146,,BAO_0000019,,
2112,1,Binding affinity for serotonin 5-hydroxytryptamine 2 receptor using [3H]ketanserin in guinea pig frontal cortex,Cavia porcellus,4,104784,,H,Autocuration,,CHEMBL617147,,BAO_0000019,,
2113,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of guinea pig frontal cortex membranes,Cavia porcellus,4,104784,,H,Autocuration,,CHEMBL617148,,BAO_0000019,,
2114,1,Compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin from guinea pig frontal cortex,Cavia porcellus,4,104784,,H,Autocuration,,CHEMBL617149,,BAO_0000019,,
2115,1,Binding affinity towards cloned human 5-hydroxytryptamine 2 receptor was determined,,4,104784,,H,Autocuration,,CHEMBL617150,,BAO_0000224,,
2116,1,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,4,104784,,H,Autocuration,,CHEMBL617151,,BAO_0000224,,
2117,1,In vitro binding affinity of compound against neuronal 5-hydroxytryptamine 2 receptor,,4,104784,,H,Autocuration,,CHEMBL617201,,BAO_0000224,,
2118,1,Binding affinity towards 5-HT7 receptor by the displacement of [3H]-5-CT] in human recombinant receptors in mammalian cell,,8,10209,,H,Autocuration,,CHEMBL617202,,BAO_0000357,,
2119,1,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,,4,104826,,H,Autocuration,,CHEMBL617203,,BAO_0000218,,
2120,1,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,,4,104826,,H,Autocuration,,CHEMBL617204,,BAO_0000019,,
2121,1,Inhibitory activity against serotonin 5-hydroxytryptamine 2 receptor from mice.,,4,104826,,H,Autocuration,,CHEMBL617205,,BAO_0000224,,
2122,1,Inhibitory activity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in mouse cerebral cortex,Mus musculus,5,104826,,D,Autocuration,,CHEMBL617206,,BAO_0000019,,
2123,1,Effective dose through peroral route for in vivo inhibition against 5-hydroxytryptamine 2 receptor in male CF-1 mice by using radioligand [3H]ketanserin,,4,104826,,H,Autocuration,,CHEMBL617207,,BAO_0000218,,
2124,1,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]-ketanserin in mouse cerebral cortex,Mus musculus,5,104826,,D,Autocuration,,CHEMBL617208,,BAO_0000019,,
2125,1,The compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2 receptor,,4,104826,,H,Autocuration,,CHEMBL617209,,BAO_0000224,,
2126,1,In vitro binding affinity for serotonin 5-hydroxytryptamine (5-HT) 2 receptors,,4,104826,,H,Autocuration,,CHEMBL617210,,BAO_0000224,,
2127,1,The compound was tested in vitro for its binding affinity towards serotonin 5-hydroxytryptamine 2 receptor; nd = no data,,4,104826,,H,Autocuration,,CHEMBL617211,,BAO_0000224,,
2128,1,Hill number was determined for inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in mouse cerebral cortex,Mus musculus,5,104826,,D,Autocuration,,CHEMBL617212,,BAO_0000019,,
2129,1,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin,Sus scrofa,4,104784,,H,Autocuration,,CHEMBL617213,,BAO_0000224,,
2130,1,Binding affinity for porcine 5-hydroxytryptamine 2 receptor using [3H]- ketanserin with 10 uM prazosin,Sus scrofa,4,104784,,H,Autocuration,,CHEMBL617214,,BAO_0000224,,
2131,1,Compound was tested in vitro for its ability to compete with [3H]-ketanserin at 5-hydroxytryptamine 2 receptor in porcine brain homogenate,,0,22226,,U,Autocuration,,CHEMBL617215,,BAO_0000221,,
2132,1,In vitro for its ability to displace [3H]- ketanserin from 5-hydroxytryptamine 2 receptor in porcine brain homogenate,,0,22226,,U,Autocuration,,CHEMBL617216,,BAO_0000221,,
2133,1,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2 receptor,Sus scrofa,8,17005,,H,Autocuration,,CHEMBL617217,,BAO_0000357,,
2134,1,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617218,,BAO_0000019,,
2135,1,Inhibition of [3H]- Ketanserin binding against rat brain 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL872913,,BAO_0000019,,
2136,1,Binding affinity against 5-hydroxytryptamine 2 receptor from rat cortical synaptosomal membrane using radioligand [3H]ketanserin.,,4,104826,,H,Autocuration,,CHEMBL617219,,BAO_0000019,,
2137,1,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL873482,,BAO_0000224,,
2138,1,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; ND means no data,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617220,,BAO_0000019,,
2139,1,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein.,,4,104686,,H,Autocuration,,CHEMBL617221,,BAO_0000019,,
2140,1,Affinity towards 5-hydroxytryptamine 2 receptor by measuring its ability to antagonize serotonin-induced contractions in the rat jugular vein; no appreciable 5-HT2 receptor affinity,,4,104686,,H,Autocuration,,CHEMBL617222,,BAO_0000019,,
2141,1,Antagonistic activity against (5-hydroxytryptamine 2 receptor) serotonin-induced contractions in the rat jugular vein,,4,104686,,H,Autocuration,,CHEMBL875906,,BAO_0000019,,
2142,1,Binding affinity to the 5-hydroxytryptamine 2 receptor assayed by antagonism of serotonin-induced contractions in the rat jugular vein,,4,104686,,H,Autocuration,,CHEMBL617223,,BAO_0000019,,
2143,1,Binding affinity against serotonin 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617224,,BAO_0000224,,
2144,1,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617225,,BAO_0000224,,
2145,1,Tested for the effect on binding at 5-hydroxytryptamine 2 receptor; No activity,,4,104686,,H,Autocuration,,CHEMBL617226,,BAO_0000224,,
2146,1,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.4 nM dose of [3H]- spiperone as a radioligand.,,4,104686,,H,Autocuration,,CHEMBL617227,,BAO_0000224,,
2147,1,Effect of 2 week administration of compound on 5-hydroxytryptamine 2 receptor binding by using 0.6 nM dose of [3H]- spiperone as a radioligand.,,4,104686,,H,Autocuration,,CHEMBL617228,,BAO_0000224,,
2148,1,Compound was tested for its effect on 5-hydroxytryptamine 2 receptor saturation analysis,,4,104686,,H,Autocuration,,CHEMBL617229,,BAO_0000224,,
2149,1,Concentration necessary to achieve half maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 1 uM,,4,104686,,H,Autocuration,,CHEMBL617230,,BAO_0000224,,
2150,1,"Concentration necessary to achieve half maximal inhibition of [3H]ketanserin, binds to 5-hydroxytryptamine 2 receptor at 1 uM",,4,104686,,H,Autocuration,,CHEMBL617231,,BAO_0000224,,
2151,1,Compound was tested for the inhibition of quipazine binding at 5-HT2 receptor,,4,104686,,H,Autocuration,,CHEMBL617232,,BAO_0000224,,
2152,1,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617233,,BAO_0000224,,
2153,1,Compound was tested for the inhibition of quipazine binding at 5-hydroxytryptamine 2 receptor; NT=Not tested,,4,104686,,H,Autocuration,,CHEMBL617234,,BAO_0000224,,
2154,1,Compound was tested for the inhibition of quipazine induced head twitches in rats,,4,104686,,H,Autocuration,,CHEMBL617235,,BAO_0000019,,
2155,1,Compound was tested for the inhibition of quipazine induced head twitches in rats; NT=Not tested,,4,104686,,H,Autocuration,,CHEMBL617236,,BAO_0000019,,
2156,1,Ability to bind at 5-hydroxytryptamine 2 receptor of rat hippocampus by displacing [3H]spiperone,,4,104686,,H,Autocuration,,CHEMBL617237,,BAO_0000221,10000000.0,
2157,1,Ability to bind at serotonin 5-hydroxytryptamine 2 receptors of rat hippocampus by displacing [3H]spiperone,,4,104686,,H,Autocuration,,CHEMBL617238,,BAO_0000221,10000000.0,
2158,1,Displacement of [3H]spiroperidol from 5-hydroxytryptamine 2 receptor in rat brain,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617239,,BAO_0000221,955.0,
2159,1,Ability to inhibit binding of [3H]KET to 5-hydroxytryptamine 2 receptor in rat cortex,,4,104686,,H,Autocuration,,CHEMBL617240,,BAO_0000019,,
2160,1,Ability to inhibit binding of titreated spiperone to 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,,4,104686,Membranes,H,Autocuration,,CHEMBL617241,,BAO_0000249,,
2161,1,Ability to inhibit binding of titreated spiperone to the 5-hydroxytryptamine 2 receptor in rat brain frontal cortex membranes,,4,104686,Membranes,H,Autocuration,,CHEMBL875907,,BAO_0000249,,
2162,1,Affinity for 5-hydroxytryptamine 2 receptor binding sites by its ability to displace [3H]spiperone from rat frontal cortex.,,4,104686,,H,Autocuration,,CHEMBL617242,,BAO_0000019,,
2163,1,Antagonistic activity against 5-hydroxytryptamine 2 receptor on rat frontal cortex membrane.,,4,104686,,H,Autocuration,,CHEMBL617152,,BAO_0000019,,
2164,1,Binding affinity against serotonin-2 receptor in rat brain using [3H]spiroperidol,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617153,,BAO_0000221,955.0,
2165,1,Binding affinity at 5-hydroxytryptamine 2 receptor by the inhibition of binding to [3H]ketanserin in rat cortical membranes,Rattus norvegicus,5,104686,Membranes,D,Autocuration,,CHEMBL617154,,BAO_0000249,,
2166,1,Binding affinity against 5-hydroxytryptamine 2 receptor in rat brain using [3H]ketanserin as radioligand,,4,104686,,H,Autocuration,,CHEMBL617155,,BAO_0000221,955.0,
2167,1,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,,4,104686,,H,Autocuration,,CHEMBL617156,,BAO_0000019,,
2168,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-HT2 receptor in rat thoracic aortic strips,,4,104686,,H,Autocuration,,CHEMBL617157,,BAO_0000019,,
2169,1,In vitro antagonistic activity tested against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,4,104686,,H,Autocuration,,CHEMBL617158,,BAO_0000019,,
2170,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,,4,104686,,H,Autocuration,,CHEMBL617159,,BAO_0000019,,
2171,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips; NC=non competitive antagonism,,4,104686,,H,Autocuration,,CHEMBL617160,,BAO_0000019,,
2172,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,4,104686,,H,Autocuration,,CHEMBL858113,,BAO_0000019,,
2173,1,Tested for 5-hydroxytryptamine 2 receptor binding ability by displacement of [3H]spiperone from rat brain frontal cortex synaptosomes,,4,104686,,H,Autocuration,,CHEMBL617247,,BAO_0000220,955.0,
2174,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,,4,104686,,H,Autocuration,,CHEMBL617248,,BAO_0000019,,
2175,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat brain membrane using [3H]8-OH-DPAT as a selective ligand.,,4,104686,,H,Autocuration,,CHEMBL617249,,BAO_0000249,955.0,
2176,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex,,4,104686,,H,Autocuration,,CHEMBL617250,,BAO_0000019,,
2177,1,Binding affinity towards 5-hydroxytryptamine 2 receptor in rat frontal cortex using [3H]ketanserin as radioligand,,4,104686,,H,Autocuration,,CHEMBL617251,,BAO_0000019,,
2178,1,isplacement of [3H]DOB from rat cortex homogenate 5-hydroxytryptamine 2 receptor,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617252,,BAO_0000019,,
2179,1,Binding affinity of 5-hydroxytryptamine 2 receptor using [3H]- ketanserin in rat frontal cortex,,4,104686,,H,Autocuration,,CHEMBL617006,,BAO_0000019,,
2180,1,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat frontal cortex,,4,104686,,H,Autocuration,,CHEMBL617007,,BAO_0000019,,
2181,1,"5-hydroxytryptamine 2 receptor antagonistic activity at concentrations of<br>3,10 and 30 uM on the rat tail artery.",,4,104686,,H,Autocuration,,CHEMBL617008,,BAO_0000019,,
2182,1,Binding affinity for 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- ketanserin,,4,104686,,H,Autocuration,,CHEMBL617009,,BAO_0000019,,
2183,1,Binding affinity against 5-hydroxytryptamine 2 receptor in serotonin-induced contraction of the rat aorta,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617010,,BAO_0000224,,
2184,1,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL857978,,BAO_0000019,,
2185,1,Displacement of [3H]ketanserin from rat brain 5-hydroxytryptamine 2 receptor,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617011,,BAO_0000019,,
2186,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat frontal cortex homogenate,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617012,,BAO_0000019,,
2187,1,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand.,,4,104686,,H,Autocuration,,CHEMBL617013,,BAO_0000224,,
2188,1,Binding affinity towards 5-hydroxytryptamine 2 receptor by the displacement of [3H]ketanserin in rat cerebral cortex membrane,,4,104686,,H,Autocuration,,CHEMBL617014,,BAO_0000249,,
2189,1,Compound was evaluated for its ability to displace [3H]ketanserin binding from cloned rat cerebral cortex membranes 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617015,,BAO_0000019,,
2190,1,In vitro binding affinity to 5-hydroxytryptamine 2 receptor of rat cerebral cortex membranes using [3H]ketanserin as the radioligand,,4,104686,,H,Autocuration,,CHEMBL617016,,BAO_0000019,,
2191,1,pKi value for 5-hydroxytryptamine 2 receptor binding site,,4,104686,,H,Autocuration,,CHEMBL617017,,BAO_0000224,,
2192,1,Inhibitory constant (1 uM) was measured on 5-hydroxytryptamine 2 receptor/uptake using [3H]- ketanserin as radioligand in rat brain cortex.,,4,104686,,H,Autocuration,,CHEMBL617018,,BAO_0000221,955.0,
2193,1,5-hydroxytryptamine 2 receptor antagonistic activity on the rat tail artery determined by Schild plot.,,4,104686,,H,Autocuration,,CHEMBL617019,,BAO_0000019,,
2194,1,Binding affinity at 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,4,105075,,H,Autocuration,,CHEMBL617020,,BAO_0000019,,
2195,1,Binding affinity at 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,4,105075,,H,Autocuration,,CHEMBL617021,,BAO_0000019,,
2196,1,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,4,105075,,H,Autocuration,,CHEMBL617022,,BAO_0000019,,
2197,1,Binding affinity at [3H]DOB labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,4,105075,,H,Autocuration,,CHEMBL617023,,BAO_0000019,,
2198,1,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor determined using [125I]- DOI as radioligand in rat frontal cortex,,4,105075,,H,Autocuration,,CHEMBL617024,,BAO_0000019,,
2199,1,Binding affinity at [3H]KET labeled sites of 5-hydroxytryptamine 2 receptor was determined using [125I]- DOI as radioligand in rat frontal cortex,,4,105075,,H,Autocuration,,CHEMBL617025,,BAO_0000019,,
2200,1,Hill coefficient of compound was determined,,4,105075,,H,Autocuration,,CHEMBL617026,,BAO_0000224,,
2201,1,Ancillary Binding affinity towards rat 5-hydroxytryptamine 2 receptor,,0,22226,,U,Autocuration,,CHEMBL617027,,BAO_0000019,,
2202,1,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-ketanserin) from 5-hydroxytryptamine 2 receptor of rat cerebral cortex membrane,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617028,,BAO_0000019,,
2203,1,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand,,8,12687,,H,Expert,,CHEMBL617029,,BAO_0000019,,
2204,1,Binding affinity against rat 5-hydroxytryptamine 2 receptor in rat cerebral cortex tissue using [3H]spiperone as radioligand; IA-Inactive,,8,12687,,H,Expert,,CHEMBL875908,,BAO_0000019,,
2205,1,Affinity at 5-hydroxytryptamine 2 receptor (For ketanserin = Ki(nM)= 0.7+/-0.09),,8,12687,,H,Autocuration,,CHEMBL617030,,BAO_0000357,,
2206,1,Affinity at 5-hydroxytryptamine 2 receptor from rat frontal cortex using [3H]ketanserin as radioligand (For ketanserin = Ki(nM)=0.7+/-0.09),,8,12687,,H,Autocuration,,CHEMBL617031,,BAO_0000019,,
2207,1,Binding affinity for 5-hydroxytryptamine 2 receptor of rat cortical membrane using [3H]DOB radioligand,,8,12687,,H,Autocuration,,CHEMBL617032,,BAO_0000019,,
2208,1,Tested in vitro for receptor binding affinity against 5-hydroxytryptamine 2 receptor using radioligand [3H]ketanserin,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617033,,BAO_0000224,,
2209,1,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand",,4,104686,,H,Autocuration,,CHEMBL617034,,BAO_0000224,,
2210,1,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand,,4,104686,,H,Autocuration,,CHEMBL617035,,BAO_0000224,,
2211,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,4,104686,,H,Autocuration,,CHEMBL617036,,BAO_0000019,,
2212,1,Inhibitory concentration against 5-hydroxytryptamine 2 receptor,,4,104784,,H,Autocuration,,CHEMBL617037,,BAO_0000224,,
2213,1,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2 receptor from mammalian clones expressed in CHO cell membranes using [3H]-ketanserin as radioligand,,0,22226,,U,Autocuration,,CHEMBL617038,,BAO_0000219,,
2214,1,"Binding affinity towards 5-hydroxytryptamine 2 receptor expressed in CHO cell membranes using [3H]ketanserin (60 Ci/mmol, 1 nM)",,4,104784,,H,Autocuration,,CHEMBL617039,,BAO_0000219,,
2215,1,Compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor,,4,104784,,H,Autocuration,,CHEMBL617161,,BAO_0000224,,
2216,1,Compound was tested for inhibitory activity against 5-hydroxytryptamine 2 receptor,,4,104784,,H,Autocuration,,CHEMBL617162,,BAO_0000224,,
2217,1,Compound was tested for its affinity towards 5-hydroxytryptamine 2 receptor,,4,104784,,H,Autocuration,,CHEMBL617163,,BAO_0000224,,
2218,1,Tested for binding affinity for 5-hydroxytryptamine 2 receptor,,4,104784,,H,Autocuration,,CHEMBL617164,,BAO_0000224,,
2219,1,The compound was evaluated for its ability to displace [3H]ketanserin from 5-hydroxytryptamine 2 receptor in cellular brain membranes,,4,104784,Brain membranes,H,Autocuration,,CHEMBL617165,,BAO_0000249,,
2220,1,Compound was measured for its binding affinity at 5-hydroxytryptamine 2 receptor at a concentration of 10 uM using [3H]ketanserin as radioligand,,4,104784,,H,Autocuration,,CHEMBL617166,,BAO_0000224,,
2221,1,Binding affinity towards 5-HT2 receptor,,4,104784,,H,Autocuration,,CHEMBL617167,,BAO_0000224,,
2222,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,4,104784,,H,Autocuration,,CHEMBL872912,,BAO_0000224,,
2223,1,Compound was evaluated for 5-hydroxytryptamine 2 receptor binding,,4,104784,,H,Autocuration,,CHEMBL617168,,BAO_0000224,,
2224,1,In vitro binding affinity against rat 5-hydroxytryptamine 2 receptor.,,4,104686,,H,Autocuration,,CHEMBL617169,,BAO_0000224,,
2225,1,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,,4,104784,,H,Autocuration,,CHEMBL617170,,BAO_0000224,,
2226,1,The compound was tested for binding affinity against 5-hydroxytryptamine 2 receptor using ketanserin as radioligand,,4,104784,,H,Autocuration,,CHEMBL617171,,BAO_0000224,,
2227,1,Binding affinity for 5-hydroxytryptamine 2 receptor was determined,,4,104784,,H,Autocuration,,CHEMBL617172,,BAO_0000224,,
2228,1,In vitro binding affinity for 5-hydroxytryptamine 2 receptor,,4,104784,,H,Autocuration,,CHEMBL617173,,BAO_0000224,,
2229,1,In Vitro binding affinity for 5-hydroxytryptamine 2 receptor,,0,22226,,U,Autocuration,,CHEMBL617174,,BAO_0000019,,
2230,1,5-hydroxytryptamine 2 receptor binding affinity,,4,104784,,H,Autocuration,,CHEMBL617175,,BAO_0000224,,
2231,1,Binding affinity against 5-hydroxytryptamine 2 receptor was determined using [ [3H]spiperone radioligand,,8,17005,,H,Autocuration,,CHEMBL617176,,BAO_0000357,,
2232,1,Compound was tested for the binding affinity against 5-hydroxytryptamine 2 receptor by using [3H]ketanserin as radioligand,,8,17005,,H,Autocuration,,CHEMBL617177,,BAO_0000357,,
2233,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,,4,104784,,H,Autocuration,,CHEMBL617178,,BAO_0000224,,
2234,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor of central nervous system,,4,104784,,H,Autocuration,,CHEMBL617179,,BAO_0000224,,
2235,1,Ketanserin binding to 5-hydroxytryptamine 2 receptor at 10e-5 M,,4,104784,,H,Autocuration,,CHEMBL617180,,BAO_0000224,,
2236,1,Inhibitory activity against 5-hydroxytryptamine 2 receptor using [3H]-ketanserin as radioligand at 10e-5 M concentration,,8,17005,,H,Autocuration,,CHEMBL617181,,BAO_0000357,,
2237,1,Binding affinity against 5-hydroxytryptamine 2 receptor,,8,17005,,H,Autocuration,,CHEMBL617182,,BAO_0000357,,
2238,1,Binding affinity against 5-hydroxytryptamine 2 receptor,,8,17005,,H,Autocuration,,CHEMBL617183,,BAO_0000357,,
2239,1,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,,8,17005,,H,Autocuration,,CHEMBL617184,,BAO_0000357,,
2240,1,Binding affinity against serotonergic 5-HT2 receptor,,8,17005,,H,Autocuration,,CHEMBL617185,,BAO_0000357,,
2241,1,Binding affinity for 5-hydroxytryptamine 2 receptor was determined by using [3H]ketanserin as radioligand,,8,17005,,H,Autocuration,,CHEMBL617186,,BAO_0000357,,
2242,1,Compound was evaluated for the binding affinity at 5- HT2 receptor,,8,17005,,H,Autocuration,,CHEMBL617187,,BAO_0000357,,
2243,1,Compound was tested for binding affinity using [3H]ketanserin against 5-hydroxytryptamine 2 receptor,,8,17005,,H,Autocuration,,CHEMBL617188,,BAO_0000357,,
2244,1,In vivo binding affinity was evaluated against 5-hydroxytryptamine 2 receptor,,8,17005,,H,Autocuration,,CHEMBL617189,,BAO_0000218,,
2245,1,Inhibitory activity against cloned human 5-HT2 receptor,Homo sapiens,5,104784,,D,Autocuration,,CHEMBL617190,,BAO_0000224,,
2246,1,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells",Homo sapiens,5,104784,,D,Autocuration,,CHEMBL617191,449.0,BAO_0000219,,
2247,1,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells.",Homo sapiens,5,104784,,D,Autocuration,,CHEMBL617192,449.0,BAO_0000219,,
2248,1,"Tested in vitro for the inhibition of [3H]-ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; Inactive",Homo sapiens,5,104784,,D,Autocuration,,CHEMBL617193,449.0,BAO_0000219,,
2249,1,"Tested in vitro for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor, expressed in cloned CHO cells; not tested",Homo sapiens,5,104784,,D,Autocuration,,CHEMBL617194,449.0,BAO_0000219,,
2250,1,Binding affinity towards 5-hydroxytryptamine 2 receptor,,4,104784,,H,Autocuration,,CHEMBL617195,,BAO_0000224,,
2251,1,Percent decrease in 5-hydroxytryptamine 2 receptor binding using ketanserin,,4,104784,,H,Autocuration,,CHEMBL881830,,BAO_0000224,,
2252,1,Binding affinity towards 5-hydroxytryptamine 2 receptor,,8,17005,,H,Autocuration,,CHEMBL617196,,BAO_0000357,,
2253,1,Binding affinity towards 5-hydroxytryptamine 2- receptor using [3H]ketanserin as radioligand in competitive binding assay,,4,104686,,H,Autocuration,,CHEMBL617197,,BAO_0000224,,
2254,1,Binding affinity against 5-hydroxytryptamine 2A receptor was measured using [3H]ketanserin as radioligand,,8,17005,,H,Expert,,CHEMBL617198,,BAO_0000357,,
2255,1,Binding affinity towards 5-hydroxytryptamine 2A receptor,,8,17005,,H,Expert,,CHEMBL873476,,BAO_0000357,,
2256,1,Affinity towards 5-hydroxytryptamine 2A receptor in membranes from bovine frontal cortex using [3H]ketanserin,,8,17005,,H,Expert,,CHEMBL617199,,BAO_0000019,,
2257,1,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,Cavia porcellus,8,107,,H,Autocuration,,CHEMBL617200,,BAO_0000357,,
2258,1,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,8,51,,H,Autocuration,,CHEMBL617484,,BAO_0000357,,
2259,1,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,8,107,,H,Autocuration,,CHEMBL617485,,BAO_0000357,,
2260,1,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,8,51,,H,Autocuration,,CHEMBL617486,,BAO_0000357,,
2261,1,Binding affinity analysed on 5-HT 2A human clone using [3H]ketanserin as radioligand,,8,107,,H,Autocuration,,CHEMBL858022,,BAO_0000357,,
2262,1,Effective concentration against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,,8,107,,H,Autocuration,,CHEMBL617049,449.0,BAO_0000219,,
2263,1,Functional activity against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader,Homo sapiens,9,107,,D,Expert,,CHEMBL617050,449.0,BAO_0000219,,
2264,1,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,,8,107,,H,Autocuration,,CHEMBL617051,,BAO_0000219,,
2265,1,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line; no data,,8,107,,H,Autocuration,,CHEMBL617052,,BAO_0000219,,
2266,1,Functional antagonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2a receptor cell line,,8,107,,H,Autocuration,,CHEMBL617053,,BAO_0000219,,
2267,1,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand, expressed as Emax",,8,107,,H,Autocuration,,CHEMBL617054,449.0,BAO_0000219,,
2268,1,"Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells, expressed as Emax",,8,107,,H,Autocuration,,CHEMBL617055,449.0,BAO_0000219,,
2269,1,Affinity of compound towards human 5-hydroxytryptamine 2A receptor was evaluated using radioligand binding technique,,8,107,,H,Autocuration,,CHEMBL882924,,BAO_0000357,,
2270,1,Inhibition of human 5-hydroxytryptamine 2A receptor,Homo sapiens,9,107,,D,Expert,,CHEMBL617056,,BAO_0000357,,
2271,1,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,8,107,,H,Autocuration,,CHEMBL617057,449.0,BAO_0000219,,
2272,1,Inhibitory concentration against human 5-HT2A receptor in BEK cells,,8,107,,H,Expert,,CHEMBL617058,,BAO_0000219,,
2273,1,In vitro binding affinity against human 5-hydroxytryptamine 2A receptor at a concentration of 100 (nM),,8,107,,H,Autocuration,,CHEMBL617059,,BAO_0000357,,
2274,1,Ability to displace [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor was determined,,8,107,,H,Autocuration,,CHEMBL617060,449.0,BAO_0000219,,
2275,1,Displacement of [3H]ketanserin from CHO cells expressing human 5-hydroxytryptamine 2A receptor.,,8,107,,H,Expert,,CHEMBL617061,449.0,BAO_0000219,,
2276,1,Ability to displace [125I]R91150 from human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells,,8,107,,H,Expert,,CHEMBL617062,307.0,BAO_0000219,,
2277,1,Ability to displace [3H]ketanserin binding to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,8,107,,H,Expert,,CHEMBL617063,449.0,BAO_0000219,,
2278,1,Agonist activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand,,8,107,,H,Autocuration,,CHEMBL617064,,BAO_0000019,,
2279,1,Agonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,8,107,,H,Autocuration,,CHEMBL617065,,BAO_0000019,,
2280,1,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand,,8,107,,H,Autocuration,,CHEMBL617066,449.0,BAO_0000219,,
2281,1,Agonistic binding affinity against human 5-hydroxytryptamine 2A receptor in CHO cells using 8-OH-DPA radioligand; Nd means not done,,8,107,,H,Autocuration,,CHEMBL617067,449.0,BAO_0000219,,
2282,1,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]-Ketanserin radioligand,,8,107,,H,Autocuration,,CHEMBL617068,,BAO_0000019,,
2283,1,Antagonist activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand; Not tested,,8,107,,H,Autocuration,,CHEMBL617069,,BAO_0000019,,
2284,1,Antagonistic activity at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,8,107,,H,Autocuration,,CHEMBL617070,,BAO_0000019,,
2285,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [125 I]DOI as radioligand,,8,107,,H,Autocuration,,CHEMBL617071,,BAO_0000357,,
2286,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,8,107,,H,Autocuration,,CHEMBL872915,,BAO_0000357,,
2287,1,Binding activity against cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand.,,8,107,,H,Autocuration,,CHEMBL617072,,BAO_0000357,,
2288,1,Binding affinity against 5-hydroxytryptamine 2A receptor in humans,,8,107,,H,Autocuration,,CHEMBL617073,,BAO_0000357,,
2289,1,Binding affinity against the cloned human 5-hydroxytryptamine 2A receptor using [125I]DOI as the radioligand,,8,107,,H,Autocuration,,CHEMBL617074,,BAO_0000357,,
2290,1,Binding affinity for displacement of [3H]ketanserin to human 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,8,107,,H,Expert,,CHEMBL617075,449.0,BAO_0000219,,
2291,1,Binding affinity of compound to human 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617076,,BAO_0000357,,
2292,1,Affinity for human 5-hydroxytryptamine 2A receptor expressed in mammalian cell line,Homo sapiens,9,107,,D,Expert,,CHEMBL617077,,BAO_0000019,,
2293,1,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI radioligand.,,8,107,,H,Expert,,CHEMBL617078,,BAO_0000357,,
2294,1,Binding affinity to cloned human 5-hydroxytryptamine 2A receptor,Homo sapiens,9,107,,D,Expert,,CHEMBL617079,,BAO_0000357,,
2295,1,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,,8,107,,H,Autocuration,,CHEMBL617080,,BAO_0000357,,
2296,1,Binding affinity towards human 5-hydroxytryptamine 2A receptor by the displacement of [3H]ketanserin radioligand from the cloned receptor expressed in CHO cells,,8,107,,H,Expert,,CHEMBL617081,449.0,BAO_0000219,,
2297,1,Binding affinity towards human 5-HT2A receptor in BEK cells,,8,107,,H,Expert,,CHEMBL617082,,BAO_0000219,,
2298,1,Binding affinity towards human serotonin 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617083,,BAO_0000357,,
2299,1,Binding affinity for recombinant human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand.,,8,107,,H,Autocuration,,CHEMBL617084,,BAO_0000357,,
2300,1,Binding affinity for human 5-hydroxytryptamine 2A receptor,Homo sapiens,9,107,,D,Expert,,CHEMBL617085,,BAO_0000357,,
2301,1,Binding affinity towards human 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,8,107,,H,Autocuration,,CHEMBL617086,,BAO_0000357,,
2302,1,Binding affinity was measured on 5-hydroxytryptamine 2A receptor in GF6 cells transfected with human 5-HT2A gene labeled with [3H]ketanserin,,8,107,,H,Autocuration,,CHEMBL617087,,BAO_0000219,,
2303,1,Compound was tested for the displacement of [125I]-DOI from clone human 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617088,,BAO_0000357,,
2304,1,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617089,,BAO_0000357,,
2305,1,"Tested on genetically transfected COS7 cell membranes selectively expressing human 5-hydroxytryptamine 2A receptor, using [3H]ketanserin as radioligand",,8,107,,H,Expert,,CHEMBL617090,,BAO_0000019,,
2306,1,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in human using [3H]ketanserin as radioligand,,8,107,,H,Autocuration,,CHEMBL617513,,BAO_0000357,,
2307,1,In vitro binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells was determined using [3H]ketanserin as radioligand,,8,107,,H,Autocuration,,CHEMBL617514,722.0,BAO_0000219,,
2308,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617515,,BAO_0000019,,
2309,1,Inhibitory constant against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,,8,107,,H,Autocuration,,CHEMBL617516,,BAO_0000357,,
2310,1,Inhibitory constant determined against cloned human 5-hydroxytryptamine 2A receptor using with [125I]- DOI radioligand,Homo sapiens,9,107,,D,Expert,,CHEMBL617517,,BAO_0000357,,
2311,1,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in CHO cells,Homo sapiens,9,107,,D,Expert,,CHEMBL617518,449.0,BAO_0000219,,
2312,1,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617519,,BAO_0000357,,
2313,1,Displacement of [3H]DOB from human 5-hydroxytryptamine 2A receptor,Homo sapiens,9,107,,D,Expert,,CHEMBL617520,,BAO_0000357,,
2314,1,Tested for binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]DOB as labeled ligand; binding data not obtained,,8,107,,H,Autocuration,,CHEMBL617521,,BAO_0000357,,
2315,1,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor,Homo sapiens,9,107,,D,Expert,,CHEMBL617522,,BAO_0000357,,
2316,1,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]5-HT as radioligand,,8,107,,H,Autocuration,,CHEMBL617523,,BAO_0000357,,
2317,1,Tested for binding affinity towards human 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,8,107,,H,Autocuration,,CHEMBL617524,,BAO_0000357,,
2318,1,Ability to displace 0.75 nM [3H]ketanserin in 5-hydroxytryptamine 2 receptor from rat frontal cortex homogenate,,4,104686,,H,Autocuration,,CHEMBL617525,,BAO_0000019,,
2319,1,Ability to inhibit [3H]spiperone binding to 5-hydroxytryptamine 2 receptor determined in rat,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617526,,BAO_0000019,,
2320,1,Affinity on 5-hydroxytryptamine 2 receptor labeled by [125I]DOI,,4,104686,,H,Autocuration,,CHEMBL617527,,BAO_0000224,,
2321,1,Affinity towards [3H]- DOB -labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,,4,104686,,H,Autocuration,,CHEMBL617528,,BAO_0000019,,
2322,1,Affinity towards [3H]- ketanserin-labeled 5-hydroxytryptamine 2 receptor sites in rat cortical homogenates,,4,104686,,H,Autocuration,,CHEMBL617529,,BAO_0000019,,
2323,1,Inhibition of 5-hydroxytryptamine 2 induced vasoconstriction of rat caudal artery.,,4,104686,,H,Autocuration,,CHEMBL617530,,BAO_0000224,,
2324,1,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,,4,104686,,H,Autocuration,,CHEMBL617531,,BAO_0000019,,
2325,1,Binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortex using [125]-(R)-DOI as radioligand,,4,104686,,H,Autocuration,,CHEMBL617532,,BAO_0000019,,
2326,1,Binding affinity against 5-hydroxytryptamine 2 receptor in rat using [3H]ketanserin as radioligand,,4,104686,,H,Autocuration,,CHEMBL617533,,BAO_0000019,,
2327,1,Binding affinity against 5-hydroxytryptamine 2 receptor of rat frontal cortex using [3H]ketanserin radioligand,,4,104686,,H,Autocuration,,CHEMBL617534,,BAO_0000019,,
2328,1,Binding affinity against 5-hydroxytryptamine 2 receptor using [3H]ketanserin as radioligand,,4,104686,,H,Autocuration,,CHEMBL617535,,BAO_0000224,,
2329,1,Binding affinity at rat 5-hydroxytryptamine 2 receptor by [3H]ketanserin displacement.,,4,104686,,H,Autocuration,,CHEMBL617536,,BAO_0000224,,
2330,1,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617537,,BAO_0000224,,
2331,1,Binding affinity determined in radioreceptor binding assay by using [3H]ketanserin radioligand against 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617538,,BAO_0000224,,
2332,1,Binding affinity of [3H]ketanserin towards 5-hydroxytryptamine 2 receptor in cloned mammalian receptor expressed in cultured cells or from rat whole brain.,,4,104686,,H,Autocuration,,CHEMBL617539,,BAO_0000219,,
2333,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617540,,BAO_0000224,,
2334,1,Binding affinity for 5-hydroxytryptamine 2 receptor from striata of male Wistar rats by displacement of [3H]ketanserin,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617541,,BAO_0000224,,
2335,1,Binding affinity in radioreceptor binding assay by using [3H]5-HT radioligand against 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617542,,BAO_0000224,,
2336,1,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]DOB as,,4,104686,,H,Autocuration,,CHEMBL617543,,BAO_0000224,,
2337,1,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617544,485.0,BAO_0000219,,
2338,1,Binding affinity against [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor expressed in CHO-K1 cells,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617545,485.0,BAO_0000219,,
2339,1,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617413,,BAO_0000019,,
2340,1,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- DOB as a radioligand.,,4,104686,,H,Autocuration,,CHEMBL617414,,BAO_0000019,,
2341,1,Binding affinity to 5-hydroxytryptamine 2 receptor of rat cortical membranes using [3H]- DOB; ND means no data.,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617415,,BAO_0000019,,
2342,1,Binding affinity towards 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617416,,BAO_0000224,,
2343,1,Binding affinity towards 5-hydroxytryptamine 2 receptor at 1.0 uM concentration,,4,104686,,H,Autocuration,,CHEMBL617417,,BAO_0000224,,
2344,1,"Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- 1-(4-bromo-2,5-dimethoxy-phenyl)-2-aminopropane (D) as radioligand in rat frontal cortex",,4,104686,,H,Autocuration,,CHEMBL617418,,BAO_0000019,,
2345,1,Binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]- ketanserin as radioligand in rat frontal cortex,,4,104686,,H,Autocuration,,CHEMBL617419,,BAO_0000019,,
2346,1,Binding affinity towards 5-hydroxytryptamine 2 receptor was determined,,4,104686,,H,Autocuration,,CHEMBL617420,,BAO_0000224,,
2347,1,Affinity for 5-hydroxytryptamine 2 receptor,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617421,,BAO_0000224,,
2348,1,Binding affinity towards serotonin 5-hydroxytryptamine 2 receptor of rat determined using 0.5 nM of [3H]ketanserin in binding assay,,4,104686,,H,Autocuration,,CHEMBL617422,,BAO_0000224,,
2349,1,Binding affinity was determined against 5-hydroxytryptamine 2 receptor from male Sprague-Dawley rat brain.,,4,104686,,H,Autocuration,,CHEMBL617423,,BAO_0000019,,
2350,1,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor from rat tissue homogenate,,4,104686,,H,Autocuration,,CHEMBL617424,,BAO_0000019,,
2351,1,Binding affinity which represents concentration giving half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor rat tissue homogenate,,4,104686,,H,Autocuration,,CHEMBL617425,,BAO_0000019,,
2352,1,Binding constant against 5-hydroxytryptamine 2 receptor (in vitro),,4,104686,,H,Autocuration,,CHEMBL617426,,BAO_0000224,,
2353,1,Binding constant against 5-hydroxytryptamine 2 receptor (in vivo),,4,104686,,H,Autocuration,,CHEMBL617427,,BAO_0000218,,
2354,1,Compound is evaluated for binding affinity towards 5-hydroxytryptamine 2 receptor using [3H]ketanserin in rat brain,,4,104686,,H,Autocuration,,CHEMBL617428,,BAO_0000221,955.0,
2355,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2 receptor from rat,,4,104686,,H,Autocuration,,CHEMBL617429,,BAO_0000224,,
2356,1,Compound was evaluated for in vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,,4,104686,,H,Autocuration,,CHEMBL617430,,BAO_0000019,,
2357,1,Compound was evaluated for in vitro binding affinity towards serotonin 5-hydroxytryptamine 2 receptor in rat cortex using [3H]- spiperone as radioligand,,4,104686,,H,Autocuration,,CHEMBL617431,,BAO_0000019,,
2358,1,Compound was evaluated for its ability to displace 0.25 nM [125I](R)-DOI from binding sites in rat frontal cortex.,,4,104686,,H,Autocuration,,CHEMBL617432,,BAO_0000019,1870.0,
2359,1,Ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617433,,BAO_0000224,,
2360,1,Compound was evaluated for its ability to displace [3H]ketanserin from serotonergic 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617434,,BAO_0000224,,
2361,1,Binding affinity against 5-Hydroxy tryptamine 2 (5-hydroxytryptamine 2)receptor,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617435,,BAO_0000224,,
2362,1,Compound was evaluated for its binding affinity to 5-hydroxytryptamine 2 receptor in rat cortex using [3H]ketanserin radioligand assay,,4,104686,,H,Autocuration,,CHEMBL617436,,BAO_0000019,,
2363,1,Binding affinity against 5-hydroxytryptamine 2 receptor in rat striatum using [3H]-RP62203,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617437,,BAO_0000019,2435.0,
2364,1,"Binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand",,4,104686,,H,Autocuration,,CHEMBL617438,,BAO_0000019,,
2365,1,"Compound was tested for binding affinity towards 5-hydroxytryptamine 2 receptor from frontal cortical regions of male Sprague-Dawley rat homogenates, using [3H]ketanserin as radioligand; Not Determined",,4,104686,,H,Autocuration,,CHEMBL617439,,BAO_0000019,,
2366,1,Compound was tested in vitro for binding affinity for 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617440,,BAO_0000224,,
2367,1,Evaluated for binding activity against [3H]ketanserin as radioligand for 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617441,,BAO_0000224,,
2368,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortical membrane homogenates,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL872918,,BAO_0000019,,
2369,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2 receptor of rat cortex,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617442,,BAO_0000019,,
2370,1,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,,4,104686,,H,Autocuration,,CHEMBL617443,,BAO_0000019,,
2371,1,Binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 (5-HT2) receptor using [3H]KET as a radioligand,,4,104686,,H,Autocuration,,CHEMBL617444,,BAO_0000019,,
2372,1,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand; ND means no data.,,4,104686,,H,Autocuration,,CHEMBL617445,,BAO_0000019,,
2373,1,Evaluated for the binding affinity to rat cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.,,4,104686,,H,Autocuration,,CHEMBL617446,,BAO_0000019,,
2374,1,Binding affinity to 5-hydroxytryptamine 2 receptor in rat frontal cortical membranes by [3H]- KET displacement.,,4,104686,,H,Autocuration,,CHEMBL617447,,BAO_0000249,,
2375,1,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand.;ND is not determined,,4,104686,,H,Autocuration,,CHEMBL617448,,BAO_0000019,,
2376,1,Evaluated for the binding affinity to rat frontal cortical membranes at 5-hydroxytryptamine 2 receptor binding site by using [3H]- KET as a radioligand;ND means no data,,4,104686,,H,Autocuration,,CHEMBL617449,,BAO_0000019,,
2377,1,In vitro binding affinity at 5-hydroxytryptamine 2 receptor in rat cortical tissue by [3H]spiperone displacement; No data.,,4,104686,,H,Autocuration,,CHEMBL617450,,BAO_0000019,,
2378,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 165 to 263,,4,104686,,H,Autocuration,,CHEMBL617451,,BAO_0000019,,
2379,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 2.4 to 5.3,,4,104686,,H,Autocuration,,CHEMBL617452,,BAO_0000019,,
2380,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue.,,4,104686,,H,Autocuration,,CHEMBL617453,,BAO_0000019,,
2381,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 140 to 980,,4,104686,,H,Autocuration,,CHEMBL617660,,BAO_0000019,,
2382,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue.; value may range from 76 to 299,,4,104686,,H,Autocuration,,CHEMBL617661,,BAO_0000019,,
2383,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]-Spiperone as the radioligand in rat cortical tissue; value may range from 12 to 66,,4,104686,,H,Autocuration,,CHEMBL617662,,BAO_0000019,,
2384,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 136 to 220,,4,104686,,H,Autocuration,,CHEMBL872919,,BAO_0000019,,
2385,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 197 to 341,,4,104686,,H,Autocuration,,CHEMBL617663,,BAO_0000019,,
2386,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 23 to 187,,4,104686,,H,Autocuration,,CHEMBL617664,,BAO_0000019,,
2387,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 29 to 132,,4,104686,,H,Autocuration,,CHEMBL617665,,BAO_0000019,,
2388,1,In vitro 5-hydroxytryptamine 2 receptor affinity by using [3H]spiperone as the radioligand in rat cortical tissue; value may range from 6 to 75,,4,104686,,H,Autocuration,,CHEMBL617666,,BAO_0000019,,
2389,1,In vitro binding affinity on 5-hydroxytryptamine 2 receptor is inhibition of binding of [125I]- I-LSD to P11 cells,,4,104686,,H,Autocuration,,CHEMBL617667,,BAO_0000019,,
2390,1,In vitro binding affinity towards 5-hydroxytryptamine 2 receptor in rat striatal membranes by [3H]ketanserin displacement.,,4,104686,,H,Autocuration,,CHEMBL617668,,BAO_0000249,,
2391,1,Inhibitory activity against 5-hydroxytryptamine 2 receptor in rat cortical membranes using [3H]ketanserin as a radioligand,,4,104686,,H,Autocuration,,CHEMBL617669,,BAO_0000249,,
2392,1,Inhibitory activity against rat cortical 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617670,,BAO_0000224,,
2393,1,Inhibitory constant against 5-hydroxytryptamine 2 receptor,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617671,,BAO_0000224,,
2394,1,Percentage specific displacement of radioligand [3H]-ketanserin from 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617672,,BAO_0000224,,
2395,1,Potency to displace [3H]- Spiperone from 5-hydroxytryptamine 2 receptor in rat striatum,,4,104686,,H,Autocuration,,CHEMBL617673,,BAO_0000019,,
2396,1,Tested for binding affinity against 5-hydroxytryptamine 2 receptor from rat frontal cortical regions using [3H]ketanserin as radioligand,,4,104686,,H,Autocuration,,CHEMBL617674,,BAO_0000224,,
2397,1,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex,,4,104686,,H,Autocuration,,CHEMBL617675,,BAO_0000019,,
2398,1,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; NA means Not Active,,4,104686,,H,Autocuration,,CHEMBL617676,,BAO_0000019,,
2399,1,Tested for binding affinity by measuring displacement of [3H]ketanserin from rat serotonin 5-hydroxytryptamine 2 receptor in rat cortex; not determined,,4,104686,,H,Autocuration,,CHEMBL617677,,BAO_0000019,,
2400,1,Displacement of [3H]ketanserin from rat prefrontal cortex 5-hydroxytryptamine 2 receptor,,5,104686,,D,Autocuration,,CHEMBL617678,,BAO_0000019,,
2401,1,Binding affinity to 5-hydroxytryptamine 2 receptor using [3H]ketanserin radioligand assay.,,4,104686,,H,Autocuration,,CHEMBL617679,,BAO_0000224,,
2402,1,Tested for its binding affinity to Tested for its binding affinity to 5-hydroxytryptamine 2 receptor using [3H]-ketanserin radioligand assay using [3H]-ketanserin radioligand assay,,4,104686,,H,Autocuration,,CHEMBL617680,,BAO_0000224,,
2403,1,The ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2 receptor in rat whole brain,,4,104686,,H,Autocuration,,CHEMBL617681,,BAO_0000019,,
2404,1,The binding affinity was measured on 5-hydroxytryptamine 2 receptor in rat brain tissue,,4,104686,,H,Autocuration,,CHEMBL617682,,BAO_0000221,955.0,
2405,1,The binding affinity was measured on 5-hydroxytryptamine 2 receptor using [3H]- spiperone as radioligand.,,4,104686,,H,Autocuration,,CHEMBL617683,,BAO_0000224,,
2406,1,Binding affinity at 5-hydroxytryptamine 2 receptor from striata wistar rats by [3H]ketanserin displacement.,,4,104686,,H,Autocuration,,CHEMBL617684,,BAO_0000224,,
2407,1,Binding affinity towards 5-hydroxytryptamine 2 receptor,Rattus norvegicus,5,104686,,D,Autocuration,,CHEMBL617685,,BAO_0000224,,
2408,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [3H]ketanserin radioligand in rat cerebral cortex,,4,104686,,H,Autocuration,,CHEMBL617686,,BAO_0000019,,
2409,1,The compound was tested in vitro for binding affinity towards 5-hydroxytryptamine 2 receptor by displacing [125]I-LSD radioligand,,4,104686,,H,Autocuration,,CHEMBL617687,,BAO_0000224,,
2410,1,Percentage specific displacement of radioligand [3H]ketanserin from 5-hydroxytryptamine 2 receptor,,4,104686,,H,Autocuration,,CHEMBL617688,,BAO_0000224,,
2411,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,4,104686,,H,Autocuration,,CHEMBL617689,,BAO_0000019,,
2412,1,In vitro antagonistic activity against the contraction induced by 5-HT through 5-hydroxytryptamine 2 receptor in rat thoracic aortic strips,,4,104686,,H,Autocuration,,CHEMBL617690,,BAO_0000019,,
2413,1,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",,4,104686,,H,Autocuration,,CHEMBL617691,,BAO_0000218,,
2414,1,"In vivo inhibitory activity of 10 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",,4,104686,,H,Autocuration,,CHEMBL617692,,BAO_0000218,,
2415,1,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 1 hr after oral administration",,4,104686,,H,Autocuration,,CHEMBL617693,,BAO_0000218,,
2416,1,"In vivo inhibitory activity of 3 mg/kg compound in rats against elevation of BP caused by 5-HT (300 ug/kg, iv) through 5-hydroxytryptamine 2 receptor 3h after oral administration",,4,104686,,H,Autocuration,,CHEMBL617694,,BAO_0000218,,
2417,1,Affinity for 5-hydroxytryptamine 2A receptor in rat brain cortex by ability to displace [3H]ketanserin,,8,12687,,H,Expert,,CHEMBL857985,,BAO_0000221,955.0,
2418,1,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617695,,BAO_0000019,,
2419,1,Affinity pKi for 5-hydroxytryptamine 2A receptor was measured in rat cortex homogenates,,8,12687,,H,Autocuration,,CHEMBL617696,,BAO_0000019,,
2420,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor was determined,,8,12687,,H,Autocuration,,CHEMBL617697,,BAO_0000357,,
2421,1,Displacement of [3H]ketanserin from 5-HT2A receptor of rat frontal cortex,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617257,,BAO_0000019,,
2422,1,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617258,,BAO_0000357,,
2423,1,Binding affinity was evaluated in vitro by displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor on rat cortical membrane,,8,12687,,H,Expert,,CHEMBL617259,,BAO_0000019,,
2424,1,In vitro affinity against serotonin ( 5-hydroxytryptamine 2A receptor ) receptor,,8,12687,,H,Autocuration,,CHEMBL617260,,BAO_0000357,,
2425,1,In vitro affinity against serotonin 5-hydroxytryptamine 2A receptor,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617261,,BAO_0000357,,
2426,1,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]-ketanserin as radioligand,,8,12687,,H,Autocuration,,CHEMBL617262,,BAO_0000019,,
2427,1,Half-maximal inhibition of [3H]- Ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,,8,12687,,H,Expert,,CHEMBL617263,,BAO_0000019,,
2428,1,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat tissue homogenate,,8,12687,,H,Autocuration,,CHEMBL617264,,BAO_0000019,,
2429,1,Displacement of [3H]-ketanserin from rat brain 5-hydroxytryptamine 2A receptor,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617265,,BAO_0000019,,
2430,1,Inhibition constant for in vitro inhibition of [3H]ketanserin binding to rat frontal cortex membranes 5-hydroxytryptamine 2A receptor,,8,12687,Membranes,H,Autocuration,,CHEMBL617266,,BAO_0000249,,
2431,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor rat frontal cortex membrane,,8,12687,,H,Autocuration,,CHEMBL617267,,BAO_0000019,,
2432,1,Inhibitory constant on 5-hydroxytryptamine 2A receptor of Rat frontal cortex,,8,12687,,H,Expert,,CHEMBL617268,,BAO_0000019,,
2433,1,Inhibitory constant on human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,,8,12687,,H,Autocuration,,CHEMBL617269,449.0,BAO_0000219,,
2434,1,Kinetic inhibition constant evaluated by measuring serotonergic activity,,8,12687,,H,Expert,,CHEMBL617323,,BAO_0000357,,
2435,1,Serotonergic activity of the compound.,,8,12687,,H,Autocuration,,CHEMBL617324,,BAO_0000357,,
2436,1,Tested in vitro for its ability to inhibit [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat frontal cortex membranes,,8,12687,,H,Autocuration,,CHEMBL617325,,BAO_0000249,,
2437,1,The binding affinity was evaluated on 5-hydroxytryptamine 2A receptor expressed in rat cortex by using [3H]ketanserin as radioligand.,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617326,,BAO_0000019,,
2438,1,In vitro ability to displace [3H]ketanserin binding from 5-hydroxytryptamine 2A receptor in rat striatal membrane.,,8,12687,,H,Expert,,CHEMBL617327,,BAO_0000249,,
2439,1,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617328,,BAO_0000019,,
2440,1,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617329,,BAO_0000019,,
2441,1,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617330,,BAO_0000019,,
2442,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,8,12687,,H,Autocuration,,CHEMBL617331,,BAO_0000357,,
2443,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand.,,8,12687,,H,Autocuration,,CHEMBL617332,,BAO_0000357,,
2444,1,Binding affinity towards 5-hydroxytryptamine 2A receptor,,8,107,,H,Expert,,CHEMBL617333,,BAO_0000357,,
2445,1,Binding affinity against serotonin 5-hydroxytryptamine 2A receptor was determined using human [125I]-eotaxin,,8,107,,H,Autocuration,,CHEMBL617334,,BAO_0000357,,
2446,1,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.000001 mol/L,,8,107,,H,Autocuration,,CHEMBL617335,,BAO_0000357,,
2447,1,Binding affinity towards 5-hydroxytryptamine 2A receptor was determined at a concentration of 0.00001 mol/L,,8,107,,H,Autocuration,,CHEMBL617336,,BAO_0000357,,
2448,1,Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration,,8,107,,H,Autocuration,,CHEMBL617337,,BAO_0000357,,
2449,1,Percent inhibition against 5-hydroxytryptamine 2A receptor using [3H]ketanserin at 1 uM,Homo sapiens,9,107,,D,Expert,,CHEMBL617338,,BAO_0000357,,
2450,1,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617339,,BAO_0000357,,
2451,1,Binding affinity towards 5-hydroxytryptamine 2A receptor,,8,107,,H,Expert,,CHEMBL617340,,BAO_0000357,,
2452,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2A receptor; inactive at 10 uM,,8,107,,H,Autocuration,,CHEMBL617341,,BAO_0000357,,
2453,1,Inhibition of [125I]-eotaxin binding to serotonin 5-hydroxytryptamine 2A receptor,,8,107,,H,Expert,,CHEMBL617342,,BAO_0000357,,
2454,1,Affinity for 5-hydroxytryptamine 2A receptor,,8,107,,H,Expert,,CHEMBL617343,,BAO_0000357,,
2455,1,Binding affinity was performed using [3H]ketanserin as the radioligand and stably transfected NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor (GF-62 cells).,,8,107,,H,Expert,,CHEMBL617344,723.0,BAO_0000219,,
2456,1,Binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin,,8,107,,H,Expert,,CHEMBL617345,,BAO_0000357,,
2457,1,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand.,,8,107,,H,Expert,,CHEMBL617346,,BAO_0000357,,
2458,1,Compound was evaluated for its binding against 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617347,,BAO_0000357,,
2459,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2A receptor was determined,,8,107,,H,Autocuration,,CHEMBL617348,,BAO_0000357,,
2460,1,Binding affinity relative to indolopiperidine (compound 1)for 5-hydroxytryptamine 2A receptor was determined,,8,107,,H,Autocuration,,CHEMBL617349,,BAO_0000357,,
2461,1,Compound was evaluated for its inverse agonist activity against 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617350,,BAO_0000019,,
2462,1,Binding affinity towards 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin,,8,107,,H,Expert,,CHEMBL872339,,BAO_0000357,,
2463,1,Binding affinity for 5-hydroxytryptamine 2A receptor was determined,,8,107,,H,Autocuration,,CHEMBL617351,,BAO_0000357,,
2464,1,Binding affinity towards serotonin 5-hydroxytryptamine 2A receptor,,8,107,,H,Expert,,CHEMBL617352,,BAO_0000357,,
2465,1,Evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617353,,BAO_0000357,,
2466,1,Ability to displace [3H]-ketanserin from 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617354,,BAO_0000357,,
2467,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617355,,BAO_0000357,,
2468,1,In vitro binding affinity against 5-hydroxytryptamine 2A receptor in CHO cells,Mus musculus,8,107,,H,Expert,,CHEMBL617356,449.0,BAO_0000219,,
2469,1,Inhibition of ketanserin binding to 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617357,,BAO_0000357,,
2470,1,Binding affinity at 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617358,,BAO_0000357,,
2471,1,Binding affinity towards Serotonin 5-hydroxytryptamine 2A receptor,,8,107,,H,Expert,,CHEMBL617359,,BAO_0000357,,
2472,1,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor was determined,,8,107,,H,Autocuration,,CHEMBL617360,,BAO_0000357,,
2473,1,The binding affinity towards 5-hydroxytryptamine 2A receptor; No affinity,,8,107,,H,Autocuration,,CHEMBL875913,,BAO_0000357,,
2474,1,Affinity against 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617361,,BAO_0000357,,
2475,1,Binding affinity against 5-Hydroxytryptamine 2A receptor,Homo sapiens,9,107,,D,Expert,,CHEMBL617362,,BAO_0000357,,
2476,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using radioligand binding assay,,8,107,,H,Autocuration,,CHEMBL617363,,BAO_0000357,,
2477,1,Tested against 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617364,,BAO_0000357,,
2478,1,Binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,,4,105075,,H,Autocuration,,CHEMBL617365,,BAO_0000224,,
2479,1,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H] ketanserin,,4,105075,,H,Autocuration,,CHEMBL617366,,BAO_0000224,,
2480,1,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor agonist [125I]- - (+/-)DOI,,4,105075,,H,Autocuration,,CHEMBL617367,,BAO_0000224,,
2481,1,Tested for the binding affinity against the site labelled by the 5-hydroxytryptamine 2A receptor - 5-hydroxytryptamine 2C receptor antagonist [3H]- ketanserin,,4,105075,,H,Autocuration,,CHEMBL617368,,BAO_0000224,,
2482,1,Selectivity ratio towards 5-hydroxytryptamine 2A receptor to Dopamine receptor D2 (5-HT2A/D2 ),,8,107,,H,Autocuration,,CHEMBL617369,,BAO_0000357,,
2483,1,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND means no data,Homo sapiens,9,227,,D,Expert,,CHEMBL617370,722.0,BAO_0000219,,
2484,1,Functional activity against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader,Homo sapiens,9,227,,D,Expert,,CHEMBL617371,449.0,BAO_0000219,,
2485,1,In vitro binding affinity against human 5-HT2B receptor at a concentration of 100 (nM),,8,227,,H,Autocuration,,CHEMBL617372,,BAO_0000357,,
2486,1,Affinity towards human 5-hydroxytryptamine 2B serotonin receptor,Homo sapiens,9,227,,D,Expert,,CHEMBL617373,,BAO_0000357,,
2487,1,Agonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT radioligand,,8,227,,H,Autocuration,,CHEMBL617374,,BAO_0000019,,
2488,1,Agonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]-5-HT as radioligand,,8,227,,H,Autocuration,,CHEMBL617375,,BAO_0000019,,
2489,1,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand,,8,227,,H,Autocuration,,CHEMBL617376,,BAO_0000019,,
2490,1,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine radioligand; Not tested,,8,227,,H,Autocuration,,CHEMBL617377,,BAO_0000019,,
2491,1,Antagonist activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine radioligand,,8,227,,H,Autocuration,,CHEMBL617378,,BAO_0000019,,
2492,1,Antagonistic activity at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,,8,227,,H,Autocuration,,CHEMBL617379,,BAO_0000019,,
2493,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]- rauwolscine as radioligand,,8,227,,H,Autocuration,,CHEMBL617380,,BAO_0000357,,
2494,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT 2B as radioligand,,8,227,,H,Autocuration,,CHEMBL617381,,BAO_0000357,,
2495,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand,,8,227,,H,Autocuration,,CHEMBL617382,,BAO_0000357,,
2496,1,The compound evaluated for its affinity against 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617383,,BAO_0000357,,
2497,1,Affinity against 5-hydroxytryptamine 2A receptor (D) labeled with [125I]DOI.,,8,107,,H,Expert,,CHEMBL617384,,BAO_0000357,,
2498,1,Affinity against 5-hydroxytryptamine 2A receptor (K) labeled with [3H]ketanserin.,,8,107,,H,Expert,,CHEMBL617385,,BAO_0000357,,
2499,1,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes,,8,107,,H,Autocuration,,CHEMBL617386,,BAO_0000019,,
2500,1,The compound was tested for CNS binding affinity towards 5-hydroxytryptamine 2A receptor from cloned Human membranes.,,8,107,,H,Autocuration,,CHEMBL617387,,BAO_0000019,,
2501,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,8,107,,H,Autocuration,,CHEMBL617388,723.0,BAO_0000219,,
2502,1,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,,8,107,,H,Autocuration,,CHEMBL617389,449.0,BAO_0000219,,
2503,1,Relative efficacy against human 5-hydroxytryptamine 2A receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,Homo sapiens,9,107,,D,Expert,,CHEMBL617390,449.0,BAO_0000219,,
2504,1,Selectivity ratio of binding affinity of 5-hydroxytryptamine 2A receptor to that of 5-hydroxytryptamine 2C receptor.,,4,104817,,H,Autocuration,,CHEMBL617391,,BAO_0000224,,
2505,1,Binding activity radioligand.,,8,107,,H,Autocuration,,CHEMBL617392,,BAO_0000357,,
2506,1,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,8,107,,H,Autocuration,,CHEMBL617393,,BAO_0000019,,
2507,1,Binding affinity for human cloned 5-HT2A receptor expressed in L929 cells using [125I]R91150 as radioligand,,8,107,,H,Autocuration,,CHEMBL617394,307.0,BAO_0000219,,
2508,1,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand,,8,107,,H,Expert,,CHEMBL617395,307.0,BAO_0000219,,
2509,1,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells by [125I]R91150 displacement.,,8,107,,H,Expert,,CHEMBL617396,307.0,BAO_0000219,,
2510,1,Binding affinity for human cloned 5-hydroxytryptamine 2A receptor expressed in L929 cells using [125I]R91150 as radioligand; Not tested,,8,107,,H,Autocuration,,CHEMBL617397,307.0,BAO_0000219,,
2511,1,Binding affinity against 5-HT2A receptor,,8,107,,H,Autocuration,,CHEMBL617398,,BAO_0000357,,
2512,1,Binding affinity against 5-hydroxytryptamine 2A receptor,,8,107,,H,Autocuration,,CHEMBL617399,,BAO_0000357,,
2513,1,Antagonistic binding affinity measured against 5-hydroxytryptamine 2A receptor (human clone expressed in 293 cells) using [3H]ketanserin as radioligand,,8,107,,H,Autocuration,,CHEMBL617400,722.0,BAO_0000219,,
2514,1,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,,8,107,,H,Autocuration,,CHEMBL617401,722.0,BAO_0000219,,
2515,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells,Homo sapiens,9,107,,D,Expert,,CHEMBL617402,722.0,BAO_0000219,,
2516,1,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,Homo sapiens,9,107,,D,Expert,,CHEMBL617403,722.0,BAO_0000219,,
2517,1,Binding affinity against human 5-hydroxytryptamine 2A receptor using displacement of [3H]5-HT,,8,107,,H,Expert,,CHEMBL617404,,BAO_0000357,,
2518,1,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,Homo sapiens,9,107,,D,Expert,,CHEMBL857981,722.0,BAO_0000219,,
2519,1,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,Homo sapiens,9,107,,D,Expert,,CHEMBL617405,722.0,BAO_0000219,,
2520,1,Binding affinity to human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]- ketanserin as radioligand,Homo sapiens,9,107,,D,Expert,,CHEMBL617253,722.0,BAO_0000219,,
2521,1,Binding affinity at human cloned 5-hydroxytryptamine 2A receptor.,,8,107,,H,Expert,,CHEMBL617254,,BAO_0000357,,
2522,1,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,,8,107,,H,Autocuration,,CHEMBL617255,722.0,BAO_0000219,,
2523,1,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptors in HEK 293 cells using [3H]ketanserin as radioligand,,8,107,,H,Autocuration,,CHEMBL617256,722.0,BAO_0000219,,
2524,1,Binding affinity against 5-hydroxytryptamine 2A receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]ketanserin as radioligand,,8,107,,H,Autocuration,,CHEMBL616874,722.0,BAO_0000219,,
2525,1,Binding affinity towards 5-hydroxytryptamine 2A receptor (human cloned receptor) in HEK 293 cells using [3H]ketanserin as radioligand.,Homo sapiens,9,107,,D,Expert,,CHEMBL616875,722.0,BAO_0000219,,
2526,1,Binding affinity towards human 5-hydroxytryptamine 2A receptor expressed in HEK 293 cells using [3H]ketanserin as radioligand,,8,107,,H,Expert,,CHEMBL616876,722.0,BAO_0000219,,
2527,1,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2A in HEK293 cells, using [3H]ketanserin as radioligand.",,8,107,,H,Expert,,CHEMBL616877,722.0,BAO_0000219,,
2528,1,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2A receptor expressed in HEK293 cells; compound is insoluble,Homo sapiens,9,107,,D,Expert,,CHEMBL616878,722.0,BAO_0000219,,
2529,1,Binding affinity towards human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by displacement of [3H]ketanserin,,8,107,,H,Expert,,CHEMBL616879,722.0,BAO_0000219,,
2530,1,In vitro binding affinity at human cloned 5-hydroxytryptamine 2A receptor of HEK293 cells by [3H]ketanserin displacement.,,8,107,,H,Expert,,CHEMBL616880,722.0,BAO_0000219,,
2531,1,Binding affinity against human 5-hydroxytryptamine 2A receptor expressed in 293 cells using [3H]ketanserin,Homo sapiens,9,107,,D,Expert,,CHEMBL616881,722.0,BAO_0000219,,
2532,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand,,8,107,,H,Autocuration,,CHEMBL616882,723.0,BAO_0000219,,
2533,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,8,107,,H,Autocuration,,CHEMBL616883,723.0,BAO_0000219,,
2534,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2A receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,8,107,,H,Autocuration,,CHEMBL616884,723.0,BAO_0000219,,
2535,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2A receptor in HEK 293 cells using [3H]ketanserin as the radioligand,,8,107,,H,Autocuration,,CHEMBL616885,722.0,BAO_0000219,,
2536,1,Compound was evaluated for displacement of [3H]ketanserin from human cloned 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells,,8,107,,H,Autocuration,,CHEMBL616886,485.0,BAO_0000219,,
2537,1,Displacement of [3H]-ketanserin from human cloned 5-hydroxytryptamine 2A receptor expressed in CHO-K1 cells.,,8,107,,H,Expert,,CHEMBL616887,485.0,BAO_0000219,,
2538,1,Binding affinity for human 5-hydroxytryptamine 2A receptor,Homo sapiens,9,107,,D,Expert,,CHEMBL616888,,BAO_0000357,,
2539,1,Compound was tested for its binding affinity against 5-hydroxytryptamine 2A receptor in human cloned receptors in HEK 293 cells using [3H]ketanserin,,8,107,,H,Autocuration,,CHEMBL616889,722.0,BAO_0000219,,
2540,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2A receptor in HEK 293 using [3H]ketanserin as a radioligand,,8,107,,H,Autocuration,,CHEMBL616890,722.0,BAO_0000219,,
2541,1,Inhibitory constant for human 5-hydroxytryptamine 2A receptor transfected in to CHO cells,Homo sapiens,9,107,,D,Expert,,CHEMBL616891,449.0,BAO_0000219,,
2542,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2A receptor in HEK293 cells using [3H]-ketanserin.,,8,107,,H,Autocuration,,CHEMBL616892,722.0,BAO_0000219,,
2543,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2A receptor in HEK293 cells, using [3H]ketanserin as radioligand",,8,107,,H,Autocuration,,CHEMBL616893,722.0,BAO_0000219,,
2544,1,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2A receptor in 3T3 cells,,8,10620,,H,Autocuration,,CHEMBL616894,723.0,BAO_0000219,,
2545,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells,,8,107,,H,Expert,,CHEMBL616895,723.0,BAO_0000219,,
2546,1,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2A receptor,,8,10620,,H,Autocuration,,CHEMBL616896,,BAO_0000019,,
2547,1,Ability to displace [3H]-Ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor,,8,10621,,H,Autocuration,,CHEMBL617099,,BAO_0000357,,
2548,1,Ability to displace [3H]ketanserin radioligand from porcine 5-hydroxytryptamine 2A receptor; ND denotes not determined,,8,10621,,H,Autocuration,,CHEMBL617100,,BAO_0000357,,
2549,1,Binding affinity against rabbit aorta 5-HT2A receptor,Oryctolagus cuniculus,8,107,,H,Autocuration,,CHEMBL884532,,BAO_0000357,,
2550,1,Binding affinity for 5-hydroxytryptamine 2A receptor of rabbit aorta ring preparations,Oryctolagus cuniculus,8,107,,H,Expert,,CHEMBL617101,,BAO_0000357,,
2551,1,Dissociation equilibrium constant against the vascular 5-hydroxytryptamine 2A receptor in the rabbit saphenous aorta,Oryctolagus cuniculus,8,107,,H,Expert,,CHEMBL617102,,BAO_0000357,,
2552,1,Binding affinity against 5-hydroxytryptamine 1D receptor alpha using rabbit saphenous vein assay.,Oryctolagus cuniculus,8,107,,H,Autocuration,,CHEMBL617103,,BAO_0000019,,
2553,1,The compound was tested for binding affinity against 5-HT2A receptor,Oryctolagus cuniculus,8,107,,H,Expert,,CHEMBL617104,,BAO_0000357,,
2554,1,Compound was evaluated for displacement of [3H]ketanserin from cloned rat 5-hydroxytryptamine 2A receptor in transfected CHO-K1 cells.,,8,10576,,H,Autocuration,,CHEMBL857979,485.0,BAO_0000219,,
2555,1,Binding affinity analysed towards 5-HT 2A in rat jugular vein,,8,12687,,H,Autocuration,,CHEMBL857502,,BAO_0000019,,
2556,1,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,,8,12687,,H,Autocuration,,CHEMBL617105,,BAO_0000019,,
2557,1,Binding affinity analysed on 5-HT 2A in rat stomach fundus.,,8,12687,,H,Autocuration,,CHEMBL858021,,BAO_0000019,945.0,
2558,1,Binding affinity for 5-HT 2A in rat stomach fundus,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL875910,,BAO_0000019,945.0,
2559,1,Binding affinity analysed towards 5-HT 2A in rat jugular vein.,,8,12687,,H,Autocuration,,CHEMBL617106,,BAO_0000019,,
2560,1,Ability to stimulate phosphoinositide hydrolysis in NIH3T3 cells expressing the 5-hydroxytryptamine 2A receptor,,8,12687,,H,Expert,,CHEMBL617107,723.0,BAO_0000219,,
2561,1,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617108,,BAO_0000019,,
2562,1,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast expressing 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617109,,BAO_0000019,,
2563,1,Evaluated for the effective concentration at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617110,,BAO_0000357,,
2564,1,Functional potency at the rat 5-hydroxytryptamine 2A receptor as effective concentration EC50 for stimulating Phosphoinositide accumulation,,8,12687,,H,Autocuration,,CHEMBL617111,,BAO_0000357,,
2565,1,In vitro relative agonist activity against 5-hydroxytryptamine 2A using PI assay in rat vascular smooth muscle cells,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617112,,BAO_0000019,,
2566,1,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617113,,BAO_0000357,,
2567,1,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617114,,BAO_0000357,,
2568,1,Tested for its ability to activate phospholipase c by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617115,,BAO_0000357,,
2569,1,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,8,12687,,H,Autocuration,,CHEMBL617116,,BAO_0000219,,
2570,1,Efficacy at 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617117,,BAO_0000019,,
2571,1,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),,8,12687,,H,Autocuration,,CHEMBL617118,,BAO_0000357,,
2572,1,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor was determined by using CA+ assay (Emax),Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617119,,BAO_0000357,,
2573,1,In vitro efficacy against rat 5-hydroxytryptamine 2A receptor determined by using PI assay (Emax),Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617120,,BAO_0000357,,
2574,1,The receptor (5-hydroxytryptamine 2A ) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617121,,BAO_0000219,,
2575,1,The receptor (5-hydroxytryptamine 2A) mediated mobilization of intracellular calcium [Ca2+] was studied in rat smooth muscle cells,,8,12687,,H,Autocuration,,CHEMBL617122,,BAO_0000219,,
2576,1,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617123,,BAO_0000019,,
2577,1,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes,,8,12687,,H,Expert,,CHEMBL617124,,BAO_0000019,,
2578,1,Binding affinity to serotonin 5-hydroxytryptamine 2A receptors using a radioligand [3H]ketanserin binding assay in rat cortical membranes,,8,12687,,H,Expert,,CHEMBL617600,,BAO_0000249,,
2579,1,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was evaluated using [3H]- ketanserin as radioligand,,8,12687,,H,Expert,,CHEMBL617601,,BAO_0000357,,
2580,1,In vitro affinity towards 5-hydroxytryptamine 2A receptor using [3H]spiroperidol as radioligand in cortex,,8,12687,,H,Expert,,CHEMBL882923,,BAO_0000019,,
2581,1,Compound was tested for it's binding affinity towards 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617602,,BAO_0000357,,
2582,1,Compound was tested for its ability to displace [3H]DOB from 5-hydroxytryptamine 2A receptor in rat cortex homogenates,,8,12687,,H,Autocuration,,CHEMBL617603,,BAO_0000019,,
2583,1,Compound was tested for the inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617604,,BAO_0000357,,
2584,1,Binding affinity towards 5-hydroxytryptamine 2A receptor from rat frontal cortex using [3H]ketanserin as radioligand,,8,12687,,H,Expert,,CHEMBL617605,,BAO_0000019,,
2585,1,In vitro binding affinity for serotonin 5-hydroxytryptamine 2A receptor of rat cerebral cortex using [3H]ketanserin as radioligand,,8,12687,,H,Expert,,CHEMBL617606,,BAO_0000019,,
2586,1,Inhibition of [3H]ketanserin binding to rat frontal cortex membrane 5-hydroxytryptamine 2A receptor,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617607,,BAO_0000019,,
2587,1,In vitro inhibitory concentration against radioligand [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cortical membrane,,8,12687,,H,Autocuration,,CHEMBL617455,,BAO_0000249,,
2588,1,In vitro inhibition of [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617456,,BAO_0000019,,
2589,1,Inhibitory concentration against 5-hydroxytryptamine 2A receptor (Inactive at >1000 nM concentration),,8,12687,,H,Expert,,CHEMBL617457,,BAO_0000357,,
2590,1,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2A receptor,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617458,,BAO_0000357,,
2591,1,Inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor from rat brain,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617459,,BAO_0000019,,
2592,1,Binding affinity towards 5-hydroxytryptamine 2A receptor binding site using [3H]ketanserin. ,,8,12687,,H,Expert,,CHEMBL617460,,BAO_0000357,,
2593,1,"Binding affinity for 5-hydroxytryptamine 2A receptor, activity is expressed as IC50 values.",,8,12687,,H,Expert,,CHEMBL617461,,BAO_0000357,,
2594,1,Displacement of [3H]ketanserin from rat cortical membrane 5-hydroxytryptamine 2A receptor at 10e-7 M,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617462,,BAO_0000019,,
2595,1,Intrinsic activity was determined at 5-hydroxytryptamine 2A receptor which is percentage response given compared with the response produced by 10 uM serotonin.,,8,12687,,H,Autocuration,,CHEMBL617463,,BAO_0000357,,
2596,1,"Compound was tested for binding affinity at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate using [125I]-2,5-Dimethoxy -4-iodoamphetamine (DOI).",,8,12687,,H,Autocuration,,CHEMBL617464,,BAO_0000019,,
2597,1,"Compound was tested for binding affinity using [3H]MDL-100,907 at 5-hydroxytryptamine 2A receptor sites in rat cortical homogenate.",,8,12687,,H,Autocuration,,CHEMBL617465,,BAO_0000019,,
2598,1,Ability to bind to central serotonin 5-hydroxytryptamine 2A receptor in vitro in cortex of the rat brain using [3H]ketanserin radioligand,,8,12687,,H,Expert,,CHEMBL617466,,BAO_0000019,,
2599,1,Ability to displace [3H]- ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,,8,12687,,H,Autocuration,,CHEMBL617467,,BAO_0000019,,
2600,1,Displacement of [3H]ketanserin (0.5 nM) from rat cerebral cortex 5-hydroxytryptamine 2A receptors,,8,12687,,H,Expert,,CHEMBL617468,,BAO_0000019,,
2601,1,Ability to displace [3H]ketanserin bound to 5-hydroxytryptamine 2A receptor in rat pre-frontal cortex,,8,12687,,H,Autocuration,,CHEMBL617469,,BAO_0000019,,
2602,1,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617470,,BAO_0000019,,
2603,1,Ability to displace [3H]ketanserin from rat cortical homogenate 5-hydroxytryptamine 2A receptor; Not tested,,8,12687,,H,Autocuration,,CHEMBL617471,,BAO_0000019,,
2604,1,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor in NIH3T3 cell line membranes,,8,12687,,H,Expert,,CHEMBL617472,723.0,BAO_0000219,,
2605,1,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2A serotonin receptor.,,8,12687,,H,Expert,,CHEMBL617473,,BAO_0000357,,
2606,1,Affinity 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617474,,BAO_0000019,,
2607,1,Affinity at 5-hydroxytryptamine 2A receptor of the rat brain cortex was assessed on the basis of their ability to displace [3H]ketanserin,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617475,,BAO_0000019,,
2608,1,Affinity at [3H]ketanserin-labeled 5-hydroxytryptamine 2A receptor in rat brain homogenate was determined,,8,12687,,H,Autocuration,,CHEMBL617476,,BAO_0000221,955.0,
2609,1,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2A receptor,,8,12687,,H,Expert,,CHEMBL617477,,BAO_0000357,,
2610,1,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2A receptor,,8,12687,,H,Expert,,CHEMBL617478,723.0,BAO_0000219,,
2611,1,"Antagonistic activity measured for 5-hydroxytryptamine 2A receptor using [3H]-MDL- 100,907 as radioligand in rat cortical homogenates.",,8,12687,,H,Autocuration,,CHEMBL617479,,BAO_0000221,,
2612,1,Binding affinity towards rat 5-hydroxytryptamine 2A receptor was determined using [125I]- DOI as radioligand,,8,12687,,H,Autocuration,,CHEMBL617480,,BAO_0000357,,
2613,1,Binding affinity against 5-hydroxytryptamine 2A receptor,,8,12687,,H,Expert,,CHEMBL617481,,BAO_0000357,,
2614,1,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat prefrontal cerebral cortex mambranes,,8,12687,,H,Expert,,CHEMBL617482,,BAO_0000019,,
2615,1,Binding affinity against 5-hydroxytryptamine 2A receptor from rat forebrain using [3H]ketanserin as radioligand,,8,12687,,H,Autocuration,,CHEMBL617483,,BAO_0000019,,
2616,1,Binding affinity against 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,8,12687,,H,Autocuration,,CHEMBL621528,,BAO_0000357,,
2617,1,Binding affinity against 5-hydroxytryptamine 2A receptor expressed NIH3T3 cells using [3H]ketanserin,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL621529,723.0,BAO_0000219,,
2618,1,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,8,12687,,H,Expert,,CHEMBL621530,,BAO_0000357,,
2619,1,Binding affinity against rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,8,12687,,H,Expert,,CHEMBL621531,,BAO_0000357,,
2620,1,Binding affinity against rat brain 5-hydroxytryptamine 2A receptor,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL621532,,BAO_0000019,,
2621,1,Binding affinity at cloned rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,8,12687,,H,Expert,,CHEMBL621533,,BAO_0000357,,
2622,1,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells,,8,12687,,H,Expert,,CHEMBL621534,449.0,BAO_0000219,,
2623,1,Binding affinity measured at the 5-hydroxytryptamine 2A receptor by the inhibition of [3H]ketanserin binding to rat cortex using unlabeled mianserin for nonspecific binding.,,8,12687,,H,Autocuration,,CHEMBL621535,,BAO_0000019,,
2624,1,Binding affinity of [3H]- ketanserin labelled towards Rat cortical 5-hydroxytryptamine 2A receptor using radioligand binding assay,,8,12687,,H,Autocuration,,CHEMBL621536,,BAO_0000357,,
2625,1,Binding affinity of compound was tested for 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL621537,,BAO_0000357,,
2626,1,Binding affinity for 5-hydroxytryptamine 2A receptor,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL621538,,BAO_0000357,,
2627,1,Binding affinity against 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as the radioligand.,,8,12687,,H,Autocuration,,CHEMBL621539,,BAO_0000019,,
2628,1,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex,,8,12687,,H,Autocuration,,CHEMBL621540,,BAO_0000019,,
2629,1,Binding affinity against 5-hydroxytryptamine 2A receptor of rat pre-frontal cortex.,,8,12687,,H,Autocuration,,CHEMBL621541,,BAO_0000019,,
2630,1,Binding affinity towards 5-HT 2A receptor in rat cerebral frontal cortex membranes using [3H]ketanserin as radioligand,,8,12687,,H,Autocuration,,CHEMBL621542,,BAO_0000019,,
2631,1,Binding affinity at 5-hydroxytryptamine 2A receptor of rat.,,8,12687,,H,Expert,,CHEMBL621543,,BAO_0000357,,
2632,1,Binding affinity towards 5-hydroxytryptamine 2A receptor sites by using [3H]ketanserin as radioligand,,8,12687,,H,Expert,,CHEMBL621544,,BAO_0000357,,
2633,1,Binding affinity for 5-hydroxytryptamine 2A serotonin receptor,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL621545,,BAO_0000357,,
2634,1,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,8,12687,,H,Autocuration,,CHEMBL621546,,BAO_0000357,,
2635,1,Binding affinity towards rat cortical 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand; Not tested,,8,12687,,H,Autocuration,,CHEMBL621547,,BAO_0000357,,
2636,1,Displacement of [3H]ketanserin from NIH3T3 cells stably expressing rat 5-hydroxytryptamine 2A receptor,,8,12687,,H,Expert,,CHEMBL618692,723.0,BAO_0000219,,
2637,1,Binding affinity towards 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL618693,,BAO_0000357,,
2638,1,Binding affinity towards 5-hydroxytryptamine 2A receptor using [125I]DOI as radioligand,,8,12687,,H,Autocuration,,CHEMBL872922,,BAO_0000357,,
2639,1,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor from fundus tissue was determined using [3H]mesulergine as radioligand,,8,12687,,H,Autocuration,,CHEMBL618694,,BAO_0000357,,
2640,1,Binding affinity for rat 5-hydroxytryptamine 2A receptor using [3H]DOB,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL618695,,BAO_0000357,,
2641,1,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor was determined using [3H]DOB as radioligand; ND=No data,,8,12687,,H,Autocuration,,CHEMBL618696,,BAO_0000357,,
2642,1,Binding affinity towards cloned rat 5-hydroxytryptamine 2A receptor by [3H]ketanserin displacement.,,8,12687,,H,Expert,,CHEMBL618697,,BAO_0000357,,
2643,1,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]DOB as radioligand,,8,12687,,H,Autocuration,,CHEMBL618892,,BAO_0000357,,
2644,1,Binding affinity towards cloned rat Inhibition of binding towards 5-hydroxytryptamine 2A receptor at 100 nM concentration was determined using [3H]ketanserin as radioligand,,8,12687,,H,Autocuration,,CHEMBL618893,,BAO_0000357,,
2645,1,Binding affinity towards rat 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL618894,,BAO_0000357,,
2646,1,Binding affinity towards rat 5-hydroxytryptamine 2A receptor expressed in NIH3T3 cells using [3H]ketanserin as radioligand,,8,12687,,H,Expert,,CHEMBL618895,723.0,BAO_0000219,,
2647,1,Binding affinity was measured against 5-hydroxytryptamine 2A receptor by displacement of [3H]- ketanserin by lysergic acid amides,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL618896,,BAO_0000357,,
2648,1,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2A receptor in homogenate of caudate putamen tissue from rat brain,,8,12687,,H,Autocuration,,CHEMBL618897,,BAO_0000019,5383.0,
2649,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand,,8,12687,,H,Autocuration,,CHEMBL618898,,BAO_0000357,,
2650,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2A receptor using [3H]ketanserin as a radioligand; Not determined,,8,12687,,H,Autocuration,,CHEMBL618899,,BAO_0000357,,
2651,1,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2A receptor in cloned rat cell culture,,8,12687,,H,Autocuration,,CHEMBL618900,,BAO_0000357,,
2652,1,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2A receptor in cloned rat prefrontal cortex homogenate,,8,12687,,H,Autocuration,,CHEMBL618901,,BAO_0000019,,
2653,1,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL618902,,BAO_0000357,,
2654,1,Displacement of [3H]8-OH-DPAT from rat hippocampus membrane 5-hydroxytryptamine 2A receptor,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL618903,,BAO_0000221,10000000.0,
2655,1,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL618904,,BAO_0000357,,
2656,1,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]ketanserin radioligand.,,8,12687,,H,Autocuration,,CHEMBL618905,,BAO_0000357,,
2657,1,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2A receptor using [3H]-ketanserin radioligand.,,8,12687,,H,Autocuration,,CHEMBL618906,,BAO_0000357,,
2658,1,Binding affinity against rat 5-hydroxytryptamine 2A receptor in NIH3T3 cells.,,8,12687,,H,Expert,,CHEMBL618907,723.0,BAO_0000219,,
2659,1,Compound was tested for the Binding affinity against rat frontal cortex 5-hydroxytryptamine 2A receptor by Radio ligand [3H]ketanserin binding assay.,,8,12687,,H,Autocuration,,CHEMBL618908,,BAO_0000019,,
2660,1,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617909,,BAO_0000357,,
2661,1,Half-maximal inhibition of [3H]ketanserin binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex homogenate,,8,12687,,H,Expert,,CHEMBL617910,,BAO_0000019,,
2662,1,In vitro ability to displace [3H]ketanserin from 5-hydroxytryptamine 2A receptor in rat brain.,,8,12687,,H,Autocuration,,CHEMBL617911,,BAO_0000221,955.0,
2663,1,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,8,12687,,H,Autocuration,,CHEMBL872923,,BAO_0000249,,
2664,1,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,8,12687,,H,Autocuration,,CHEMBL617912,,BAO_0000249,,
2665,1,In vitro binding affinity at 5-hydroxytryptamine 2A receptor by displacement of [3H]ketanserin from rat cortex,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617913,,BAO_0000019,,
2666,1,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,8,12687,,H,Expert,,CHEMBL617914,,BAO_0000249,,
2667,1,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane,,8,12687,,H,Autocuration,,CHEMBL617915,,BAO_0000249,,
2668,1,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane,,8,12687,,H,Autocuration,,CHEMBL617916,,BAO_0000249,,
2669,1,Displacement of [3H]- Ketanserin from rat cortex 5-hydroxytryptamine 2A receptor,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617917,,BAO_0000019,,
2670,1,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand,,8,12687,,H,Expert,,CHEMBL617918,,BAO_0000019,,
2671,1,In vitro binding affinity towards 5-hydroxytryptamine 2A receptor in rat tissue homogenate using [3H]ketanserin as radioligand; Not active at 10-5 M,,8,12687,,H,Autocuration,,CHEMBL617919,,BAO_0000019,,
2672,1,In vitro inhibitory constant against [125I]DOI binding to 5-hydroxytryptamine 2A receptor in rat cerebral cortex,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617920,,BAO_0000019,,
2673,1,Displacement of [3H]ketanserin from 5-hydroxytryptamine 2A receptor of rat brain cortex,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617921,,BAO_0000019,,
2674,1,"Relative binding affinity for D2 receptor and 5-hydroxytryptamine 2A receptor, ratio of Ki",Rattus norvegicus,5,105102,,D,Expert,,CHEMBL617922,,BAO_0000224,,
2675,1,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]DOB as radioligand,,8,12687,,H,Autocuration,,CHEMBL617923,,BAO_0000357,,
2676,1,Tested for binding affinity towards rat 5-hydroxytryptamine 2A receptor using [3H]ketanserin as radioligand,,8,12687,,H,Autocuration,,CHEMBL617924,,BAO_0000357,,
2677,1,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2A receptor using [125 I]-DOI as radioligand,,8,12687,,H,Autocuration,,CHEMBL617925,,BAO_0000357,,
2678,1,In vitro binding to 5-hydroxytryptamine 2A receptor using [125 I]-DOI,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617926,,BAO_0000357,,
2679,1,The binding affinity at 5-hydroxytryptamine 2A receptor was determined using [3H]ketanserin,,8,12687,,H,Autocuration,,CHEMBL617927,,BAO_0000357,,
2680,1,The compound was tested for binding affinity against 5-hydroxytryptamine 2A receptor,,8,12687,,H,Autocuration,,CHEMBL617928,,BAO_0000357,,
2681,1,Binding affinity for 5-hydroxytryptamine 2A receptor in rat cortex using [3H]ketanserin,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617929,,BAO_0000019,,
2682,1,Binding affinity to 5-hydroxytryptamine 2A receptor from rat cortex assayed using [3H]ketanserin as radioligand.,,8,12687,,H,Expert,,CHEMBL617930,,BAO_0000019,,
2683,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]ketanserin as radioligand.; Nonactive at 10 uM,,8,12687,,H,Autocuration,,CHEMBL617931,,BAO_0000019,,
2684,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 2A receptor from rat cortex using [3H]-ketanserin as radioligand; Nonactive at 10 uM,,8,12687,,H,Autocuration,,CHEMBL617932,,BAO_0000019,,
2685,1,Binding affinity for displacement of [3H]ketanserin to rat 5-hydroxytryptamine 2A receptor stably expressed in CHO cells; ND is No Data,,8,12687,,H,Autocuration,,CHEMBL617933,449.0,BAO_0000219,,
2686,1,In vitro binding affinity at 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,,8,12687,,H,Autocuration,,CHEMBL617934,,BAO_0000019,,
2687,1,In vitro binding affinity at serotonin 5-hydroxytryptamine 2A receptor in rat cortical membrane; ND means no data,,8,12687,,H,Autocuration,,CHEMBL617935,,BAO_0000019,,
2688,1,Tested for its ability to activate phospholipase C by quantification of IP3 at cloned rat 5-hydroxytryptamine 2A receptor; Not determined,,8,12687,,H,Autocuration,,CHEMBL617936,,BAO_0000357,,
2689,1,Ability to displace [3H]ketanserin (0.5 nM) from cerebral cortex of rat 5-hydroxytryptamine 2A receptor; NT=not tested,,8,12687,,H,Autocuration,,CHEMBL617937,,BAO_0000019,,
2690,1,Binding affinity against 5-hydroxytryptamine 2A receptor by displacement of [3H]-ketanserin from rat prefrontal cerebral cortex mambranes; Not tested,,8,12687,,H,Autocuration,,CHEMBL617938,,BAO_0000019,,
2691,1,Compound was evaluated for effective dose measured in nmol/kg following a dose of 0.04 mg/kg and 0.093 uM/kg (95%CI); range 32-63,,8,12687,,H,Autocuration,,CHEMBL617939,,BAO_0000218,,
2692,1,Compound was evaluated for the percentage of rats disrupted following a dose of 0.04 mg/kg and 0.097 uM/kg,,8,12687,,H,Autocuration,,CHEMBL617940,,BAO_0000218,,
2693,1,Compound was evaluated for the percentage of rats disrupted following a dose of 0.08 mg/kg and 0.194 uM/kg,,8,12687,,H,Autocuration,,CHEMBL617941,,BAO_0000218,,
2694,1,Ratio of pKi of 5-HT2A to that of 5-HT2C receptor,,8,12687,,H,Expert,,CHEMBL617942,,BAO_0000357,,
2695,1,Ratio of pKi of 5-HT2A to that of D2 receptor,,8,12687,,H,Expert,,CHEMBL617943,,BAO_0000357,,
2696,1,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,,4,105093,,H,Expert,,CHEMBL617944,,BAO_0000224,,
2697,1,Selectivity ratio towards KB of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2B receptor,,4,105093,,H,Expert,,CHEMBL617945,,BAO_0000224,,
2698,1,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor,,4,105075,,H,Expert,,CHEMBL617946,,BAO_0000224,,
2699,1,Selectivity ratio towards Ki of 5-hydroxytryptamine 2A receptor to 5-hydroxytryptamine 2C receptor; ND is no data,,8,12687,,H,Autocuration,,CHEMBL617947,,BAO_0000357,,
2700,1,Percent maximal 5-HT stimulation at cloned rat 5-hydroxytryptamine 2A receptor (phosphoinositide hydrolysis study) at a conc of 100 uM,,8,12687,,H,Expert,,CHEMBL617948,,BAO_0000357,,
2701,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat,,8,12687,,H,Autocuration,,CHEMBL858116,,BAO_0000019,,
2702,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 2A receptor of rat; ND means not done,,8,12687,,H,Autocuration,,CHEMBL617949,,BAO_0000019,,
2703,1,Effectiveness of compound in blocking 5-hydroxytryptamine 2A receptor-mediated contractions of rat tail artery,,8,12687,,H,Autocuration,,CHEMBL617950,,BAO_0000019,,
2704,1,Negative log concentration of antagonist on 5-hydroxytryptamine 2A receptor in rat thoracic aorta,,8,12687,,H,Expert,,CHEMBL617951,,BAO_0000019,1515.0,
2705,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta,,8,12687,,H,Expert,,CHEMBL617952,,BAO_0000019,1515.0,
2706,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2A receptor of Rat thoracic aorta; ND is not determined.,,8,12687,,H,Autocuration,,CHEMBL617953,,BAO_0000019,1515.0,
2707,1,Binding activity radioligand.,,8,12687,,H,Autocuration,,CHEMBL617954,,BAO_0000357,,
2708,1,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,8,12687,,H,Expert,,CHEMBL617955,,BAO_0000019,,
2709,1,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,,8,12687,,H,Autocuration,,CHEMBL857071,,BAO_0000019,,
2710,1,Displacement of [3H]DOB binding to 5-hydroxytryptamine 2A receptor from rat cortex homogenate,,8,12687,,H,Expert,,CHEMBL617270,,BAO_0000019,,
2711,1,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930,,8,12687,,H,Autocuration,,CHEMBL617271,339.0,BAO_0000219,,
2712,1,Binding affinity towards 5-hydroxytryptamine 3 receptor in membranes of N1E-115 neuroblastoma cells using [3H]-ICS 205-930; Not determined,,8,12687,,H,Autocuration,,CHEMBL617272,339.0,BAO_0000219,,
2713,1,Binding affinity was evaluated by 5-hydroxytryptamine 2A receptor agonism in the rat cortex by displacing ketanserin,,8,12687,,H,Autocuration,,CHEMBL617273,,BAO_0000019,,
2714,1,Agonistic activity against 5-hydroxytryptamine 2A receptor in rat cortex using [3H]-ketanserin,Rattus norvegicus,9,12687,,D,Expert,,CHEMBL617274,,BAO_0000019,,
2715,1,Binding affinity towards human serotonin 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL617275,,BAO_0000357,,
2716,1,Binding affinity towards 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL617276,,BAO_0000357,,
2717,1,Binding affinity towards human 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL617277,,BAO_0000357,,
2718,1,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,,8,108,,H,Expert,,CHEMBL617278,,BAO_0000019,,
2719,1,Binding affinity using [125I]DOI as radioligand with membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor; Not determined,,8,108,,H,Expert,,CHEMBL617279,,BAO_0000019,,
2720,1,Binding affinity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor,,8,108,,H,Expert,,CHEMBL617280,,BAO_0000019,,
2721,1,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL617281,,BAO_0000357,,
2722,1,Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL617282,,BAO_0000357,,
2723,1,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]mesulergine,,8,108,,H,Expert,,CHEMBL617283,,BAO_0000019,,
2724,1,Tested on transfected cell membranes selectively expressing human 5-hydroxytryptamine 2C receptor using [3H]-mesulergine; ND is No Data.,,8,108,,H,Expert,,CHEMBL617284,,BAO_0000019,,
2725,1,In vitro binding affinity towards human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells was determined using [3H]mesulergine as radioligand,,8,108,,H,Autocuration,,CHEMBL617285,722.0,BAO_0000219,,
2726,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL617286,,BAO_0000019,,
2727,1,Inhibitory constant against cloned human 5-hydroxytryptamine 2C receptor using with [125I]- DOI radioligand,Homo sapiens,9,108,,D,Expert,,CHEMBL617287,,BAO_0000357,,
2728,1,Binding affinity towards human 5-hydroxytryptamine 2C receptor.,,8,108,,H,Expert,,CHEMBL617288,,BAO_0000357,,
2729,1,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]DOB as radioligand,,8,108,,H,Autocuration,,CHEMBL617289,,BAO_0000357,,
2730,1,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,8,108,,H,Autocuration,,CHEMBL872917,,BAO_0000357,,
2731,1,Tested for binding affinity towards human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,,8,108,,H,Autocuration,,CHEMBL617290,,BAO_0000357,,
2732,1,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,,8,108,,H,Autocuration,,CHEMBL617291,449.0,BAO_0000219,,
2733,1,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells; ND is no data,,8,108,,H,Autocuration,,CHEMBL617292,449.0,BAO_0000219,,
2734,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand; Not determined,,8,108,,H,Autocuration,,CHEMBL617293,723.0,BAO_0000219,,
2735,1,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,Homo sapiens,9,108,,D,Expert,,CHEMBL617294,449.0,BAO_0000219,,
2736,1,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,,8,108,,H,Expert,,CHEMBL617295,,BAO_0000019,,
2737,1,Binding activity radioligand.,,8,108,,H,Autocuration,,CHEMBL617296,,BAO_0000357,,
2738,1,Binding activity against 5-hydroxytryptamine 2C receptor from human brain cortex using [3H]mesulergine as radioligand.,,8,108,,H,Autocuration,,CHEMBL617297,,BAO_0000019,,
2739,1,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand,,8,108,,H,Expert,,CHEMBL617298,449.0,BAO_0000219,,
2740,1,Binding affinity at human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells by [3H]mesulergine displacement.,,8,108,,H,Expert,,CHEMBL617299,449.0,BAO_0000219,,
2741,1,Binding affinity for human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells using [3H]mesulergine as radioligand; NT means not tested,,8,108,,H,Autocuration,,CHEMBL617300,449.0,BAO_0000219,,
2742,1,Binding affinity against 5-HT2C receptor,,8,108,,H,Autocuration,,CHEMBL617454,,BAO_0000357,,
2743,1,Antagonistic binding affinity measured against 5-hydroxytryptamine 2C receptor (human clone expressed in 293 cells) using [3H]mesulergine as radioligand,,8,108,,H,Autocuration,,CHEMBL617505,722.0,BAO_0000219,,
2744,1,Displacement of [3H]mesulergine from 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells,Homo sapiens,9,108,,D,Expert,,CHEMBL617506,722.0,BAO_0000219,,
2745,1,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,Homo sapiens,9,108,,D,Expert,,CHEMBL617507,722.0,BAO_0000219,,
2746,1,Binding affinity against human 5-hydroxytryptamine 2C receptor using displacement of [3H]DOB,,8,108,,H,Expert,,CHEMBL617508,,BAO_0000357,,
2747,1,Binding affinity against human 5-hydroxytryptamine 2C receptor expressed in 293 cells using [3H]mesulergine,Homo sapiens,9,108,,D,Expert,,CHEMBL857982,722.0,BAO_0000219,,
2748,1,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand,Homo sapiens,9,108,,D,Expert,,CHEMBL617509,722.0,BAO_0000219,,
2749,1,Binding affinity to human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]- mesulergine as radioligand; Nd means not determined,Homo sapiens,9,108,,D,Expert,,CHEMBL617510,722.0,BAO_0000219,,
2750,1,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor was determined,,8,108,,H,Autocuration,,CHEMBL617511,,BAO_0000357,,
2751,1,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptors in HEK 293 cells using [3H]mesulergine as radioligand,,8,108,,H,Autocuration,,CHEMBL617512,722.0,BAO_0000219,,
2752,1,Binding affinity against 5-hydroxytryptamine 2C receptor human cloned receptorswithouteffect in HEK 293 cells using [3H]mesulergine as radioligand,,8,108,,H,Autocuration,,CHEMBL617749,722.0,BAO_0000219,,
2753,1,Binding affinity towards 5-HT2C (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,8,108,,H,Autocuration,,CHEMBL617750,722.0,BAO_0000219,,
2754,1,Binding affinity towards 5-hydroxytryptamine 2C receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,8,108,,H,Autocuration,,CHEMBL617751,722.0,BAO_0000219,,
2755,1,Binding affinity towards cloned human 5-hydroxytryptamine 2C receptor expressed in HEK 293 cells using [3H]mesulergine as radioligand,,8,108,,H,Expert,,CHEMBL617752,722.0,BAO_0000219,,
2756,1,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand",,8,108,,H,Autocuration,,CHEMBL617753,722.0,BAO_0000219,,
2757,1,"Binding affinity towards human cloned 5-hydroxytryptamine receptor 2C in HEK293 cells, using [3H]mesulergine as radioligand.",,8,108,,H,Expert,,CHEMBL617754,722.0,BAO_0000219,,
2758,1,Displacement of [3H]mesulergine from human 5-hydroxytryptamine 2C receptor expressed in HEK293 cells; compound insoluble,Homo sapiens,9,108,,D,Expert,,CHEMBL617755,722.0,BAO_0000219,,
2759,1,"Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]mesulergine as radioligand; no data",,8,108,,H,Autocuration,,CHEMBL617756,722.0,BAO_0000219,,
2760,1,Binding affinity towards human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by displacement of [3H]mesulergine,,8,108,,H,Expert,,CHEMBL617757,722.0,BAO_0000219,,
2761,1,In vitro binding affinity at human cloned 5-hydroxytryptamine 2C receptor of HEK293 cells by [3H]mesulergine displacement.,,8,108,,H,Expert,,CHEMBL617758,722.0,BAO_0000219,,
2762,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 2C receptor expressed in 3T3 cells using [3H]5-HT as radioligand,,8,108,,H,Autocuration,,CHEMBL617759,723.0,BAO_0000219,,
2763,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine as the radioligand,,8,108,,H,Autocuration,,CHEMBL617760,722.0,BAO_0000219,,
2764,1,Displacement of [3H]mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO-K1 cells,,8,108,,H,Expert,,CHEMBL617761,485.0,BAO_0000219,,
2765,1,Binding affinity against 5-hydroxytryptamine 2C receptor,Homo sapiens,9,108,,D,Expert,,CHEMBL617762,,BAO_0000357,,
2766,1,Compound was tested for binding affinity against human 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL617763,,BAO_0000357,,
2767,1,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 2C receptor in HEK 293 cells using [3H]mesulergine,,8,108,,H,Autocuration,,CHEMBL857983,722.0,BAO_0000219,,
2768,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2C receptor in HEK 293 using [3H]mesulergine as a radioligand,,8,108,,H,Autocuration,,CHEMBL617764,722.0,BAO_0000219,,
2769,1,Inhibitory constant on human 5-hydroxytryptamine 2C receptor transfected in to HeLa cells,,8,108,,H,Autocuration,,CHEMBL617765,308.0,BAO_0000219,,
2770,1,Selectivity as the ratio of Ki value towards 5-hydroxytryptamine 2C receptor to that of pA2 value towards 5-hydroxytryptamine 2B receptor,,8,108,,H,Autocuration,,CHEMBL617766,,BAO_0000019,,
2771,1,The binding affinity (pKi) measured against 5-hydroxytryptamine 3 receptor of rat hippocampus and entorhinal cortex using [3H]granisetron as radioligand,,8,108,,H,Autocuration,,CHEMBL617767,,BAO_0000221,10000000.0,
2772,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2C receptor in HEK293 cells using [3H]mesulergine.,,8,108,,H,Autocuration,,CHEMBL617768,722.0,BAO_0000219,,
2773,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2C receptor in HEK293 cells, using [3H]5-mesulergine as radioligand",,8,108,,H,Autocuration,,CHEMBL617769,722.0,BAO_0000219,,
2774,1,Binding affinity analysed on 5-HT 2C in human clone using [3H]mesulergine as radioligand,,8,11864,,H,Autocuration,,CHEMBL858023,,BAO_0000357,,
2775,1,Binding affinity analysed on 5-HT 2C in rat stomach fundus,,8,11864,,H,Autocuration,,CHEMBL617770,,BAO_0000019,945.0,
2776,1,Binding affinity analysed towards 5-HT 2C in rat stomach fundus,,8,11864,,H,Autocuration,,CHEMBL617771,,BAO_0000019,945.0,
2777,1,Percent of maximum stimulation of phosphatidylinositol turnover at cloned 5-hydroxytryptamine 2C receptor in A9 cells,,8,11864,,H,Autocuration,,CHEMBL617772,625.0,BAO_0000219,,
2778,1,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,,8,11864,,H,Autocuration,,CHEMBL617773,723.0,BAO_0000219,,
2779,1,Binding affinity to 5-hydroxytryptamine 2C receptor measured using radioligand [3H]Mesulergine in stably transfected NIH3T3 cells,,8,11864,,H,Autocuration,,CHEMBL617850,723.0,BAO_0000219,,
2780,1,Binding affinity to 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand in stably transfected NIH3T3 cells,,8,11864,,H,Autocuration,,CHEMBL617851,723.0,BAO_0000219,,
2781,1,The maximum responses of [3H]- inositol monophosphate accumulation in cells expressing the 5-hydroxytryptamine 2C receptor,,8,11864,,H,Autocuration,,CHEMBL617852,,BAO_0000019,,
2782,1,Binding affinity analysed on 5-HT 2C in rat stomach fundus.,Mus musculus,8,12689,,H,Autocuration,,CHEMBL858024,,BAO_0000019,945.0,
2783,1,Binding affinity towards 5-HT 2C receptor in rat stomach fundus,Rattus norvegicus,9,12689,,D,Expert,,CHEMBL617853,,BAO_0000019,945.0,
2784,1,Binding affinity against 5-Hydroxytryptamine 2C Receptor was measured using [3H]N-methyl-mesulergine as radioligand,,8,108,,H,Expert,,CHEMBL617854,,BAO_0000357,,
2785,1,Binding affinity for 5-hydroxytryptamine 2C receptor,Sus scrofa,8,108,,H,Expert,,CHEMBL873477,,BAO_0000357,,
2786,1,Binding affinity towards 5-hydroxytryptamine 2C receptor,,8,108,,H,Expert,,CHEMBL617855,,BAO_0000357,,
2787,1,Affinity towards 5-hydroxytryptamine 2C receptor in membranes from pig choroid plexus using [3H]N-methyl-mesulergine,,8,108,,H,Expert,,CHEMBL617856,,BAO_0000019,,
2788,1,Compound was tested for its ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor in pig cortex,,8,108,,H,Autocuration,,CHEMBL617857,,BAO_0000019,,
2789,1,In vitro inhibitory concentration against radioligand [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in pig cortical membrane,,8,108,,H,Autocuration,,CHEMBL617858,,BAO_0000249,,
2790,1,Binding affinity towards pig 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL617859,,BAO_0000357,,
2791,1,The compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL617860,,BAO_0000357,,
2792,1,Binding activity radioligand.,,8,108,,H,Autocuration,,CHEMBL617861,,BAO_0000357,,
2793,1,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,8,108,,H,Expert,,CHEMBL617862,,BAO_0000019,,
2794,1,Binding activity against 5-hydroxytryptamine 3 receptor from pig cortex membrane using [3H]mesulergine as radioligand; NA Not Available,,8,108,,H,Autocuration,,CHEMBL617863,,BAO_0000019,,
2795,1,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT,,8,108,,H,Autocuration,,CHEMBL617864,,BAO_0000249,,
2796,1,Binding affinity towards 5-hydroxytryptamine 1D receptor in calf caudate membranes using [3H]5-HT; Not determined,,8,108,,H,Autocuration,,CHEMBL617649,,BAO_0000249,,
2797,1,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,Sus scrofa,8,108,,H,Expert,,CHEMBL617650,,BAO_0000019,,
2798,1,Agonistic activity against 5-hydroxytryptamine 2C receptor in pig choroid plexus using [3H]mesulergine,Sus scrofa,8,108,,H,Expert,,CHEMBL617651,,BAO_0000019,,
2799,1,In vitro binding affinity at 5-hydroxytryptamine 2C receptor in pig choroid plexus using 3[H]mesulergine as the radioligand,Sus scrofa,8,108,,H,Autocuration,,CHEMBL617652,,BAO_0000357,,
2800,1,In Vitro Binding affinity againist 5-hydroxytryptamine 2C receptor by displacing [3H]mesulergine from pig cortex,Sus scrofa,8,108,,H,Autocuration,,CHEMBL857072,,BAO_0000019,,
2801,1,Ability to displace the radioligand [3H]mesulergine from pig choroid plexus 5-hydroxytryptamine 2C receptor,Sus scrofa,8,108,,H,Autocuration,,CHEMBL617653,,BAO_0000357,,
2802,1,Binding activity against 5-hydroxytryptamine 2C receptor from pig cortex membrane using [3H]mesulergine as radioligand.,,8,12687,,H,Autocuration,,CHEMBL617654,,BAO_0000019,,
2803,1,Effect on phosphoinositide hydrolysis in NIH 3T3 fibroblast 5-hydroxytryptamine 2C receptor,,8,12689,,H,Autocuration,,CHEMBL617655,,BAO_0000019,,
2804,1,Binding affinity towards 5-HT2C receptor from rat using [3H]mesulergine as radioligand,,8,12689,,H,Expert,,CHEMBL617656,,BAO_0000357,,
2805,1,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand,,8,12689,,H,Autocuration,,CHEMBL617657,,BAO_0000357,,
2806,1,Compound was tested in vitro for its binding affinity towards 5-hydroxytryptamine 2C receptor from rat using [3H]mesulergine as radioligand; Not tested,,8,12689,,H,Autocuration,,CHEMBL617658,,BAO_0000357,,
2807,1,Inhibition of radiolabeled [3H]-Ketanserin ligand binding to 5-hydroxytryptamine 2C receptor,Rattus norvegicus,9,12689,,D,Expert,,CHEMBL617659,,BAO_0000357,,
2808,1,Inhibition of radiolabeled [3H]mesulergine ligand binding to 5-hydroxytryptamine 2C receptor,Rattus norvegicus,9,12689,,D,Expert,,CHEMBL617838,,BAO_0000357,,
2809,1,Inhibition of [3H]mesulergine binding to 5-hydroxytryptamine 2C receptor in rat brain membranes,Rattus norvegicus,9,12689,Brain membranes,D,Expert,,CHEMBL617839,,BAO_0000249,,
2810,1,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine; Not tested,,8,12689,,H,Autocuration,,CHEMBL617840,,BAO_0000357,,
2811,1,Ability to displace [3H]mesulergine bound to 5-hydroxytryptamine 2C receptor in rat cortex,,8,12689,,H,Autocuration,,CHEMBL617841,,BAO_0000019,,
2812,1,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-HT2C receptor,,8,12689,,H,Autocuration,,CHEMBL875915,,BAO_0000019,,
2813,1,Displacement of [3H]mesulergine (0.5 nM) from rat 5-hydroxytryptamine 2C receptor expressed in SR-3T3 cells,,8,12689,,H,Expert,,CHEMBL617842,,BAO_0000219,,
2814,1,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor in NIH3T3 cell line membranes,,8,12689,,H,Expert,,CHEMBL617843,723.0,BAO_0000219,,
2815,1,Ability to inhibit the binding of iodine-125-labelled lysergic acid diethylamide([125I]-LSD) to the S-2C serotonin receptor.,,8,12689,,H,Expert,,CHEMBL617844,,BAO_0000357,,
2816,1,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 2C receptor,,8,12689,,H,Expert,,CHEMBL617845,,BAO_0000357,,
2817,1,Affinity was evaluated by inhibition of [125I]LSD binding to NIH 3T3 cells transfected with cloned rat 5-hydroxytryptamine 2C receptor,,8,12689,,H,Expert,,CHEMBL617846,723.0,BAO_0000219,,
2818,1,Binding affinity towards rat 5-hydroxytryptamine 2C receptor was determined using [125I]- DOI as radioligand,,8,12689,,H,Autocuration,,CHEMBL617847,,BAO_0000357,,
2819,1,Binding affinity against 5-hydroxytryptamine 2C receptor,,8,12689,,H,Expert,,CHEMBL617848,,BAO_0000357,,
2820,1,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,8,12689,,H,Autocuration,,CHEMBL617849,,BAO_0000357,,
2821,1,Binding affinity against rat 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,8,12689,,H,Expert,,CHEMBL621507,,BAO_0000357,,
2822,1,Binding affinity at cloned rat 5-hydroxytryptamine 2C receptor using [3H]DOI as radioligand,,8,12689,,H,Expert,,CHEMBL621508,,BAO_0000357,,
2823,1,Binding affinity against 5-hydroxytryptamine 2C receptor from rat cortex using [3H]mesulergine as the radioligand.,,8,12689,,H,Autocuration,,CHEMBL621509,,BAO_0000019,,
2824,1,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex,,8,12689,,H,Autocuration,,CHEMBL621510,,BAO_0000019,,
2825,1,Binding affinity against 5-hydroxytryptamine 2C receptor of rat cortex.,,8,12689,,H,Autocuration,,CHEMBL621511,,BAO_0000019,,
2826,1,Displacement of [3H]mesulergine from A9 cells stably expressing rat 5-hydroxytryptamine 2C receptor,,8,12689,,H,Expert,,CHEMBL621512,625.0,BAO_0000219,,
2827,1,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,8,12689,,H,Autocuration,,CHEMBL621513,,BAO_0000357,,
2828,1,Binding affinity towards cloned rat 5-hydroxytryptamine 2C receptor from fundus tissue by [3H]mesulergine displacement.,,8,12689,,H,Expert,,CHEMBL621514,,BAO_0000357,,
2829,1,Binding affinity towards rat 5-hydroxytryptamine 2C receptor expressed in A-9 cells using [3H]mesulergine as radioligand,,8,12689,,H,Expert,,CHEMBL621515,,BAO_0000219,,
2830,1,Binding affinity was measured on 5-hydroxytryptamine 2C receptor in J1 cells transfected with rat 5-HT2C gene labeled with [3H]mesulergine,,8,12689,,H,Autocuration,,CHEMBL621516,,BAO_0000219,,
2831,1,Compound was evaluated for affinity towards cerebral 5-hydroxytryptamine 2C receptor in homogenate of caudate putamen tissue from rat brain,,8,12689,,H,Autocuration,,CHEMBL621517,,BAO_0000019,5383.0,
2832,1,Compound was evaluated for its ability to displace (+/-)[125I]-DOI from 5-hydroxytryptamine 2C receptor in cloned rat cell culture,,8,12689,,H,Autocuration,,CHEMBL621518,,BAO_0000357,,
2833,1,Compound was evaluated for its ability to displace [125I](R)-DOI from 5-hydroxytryptamine 2C receptor in cloned rat prefrontal cortex homogenate; ND denotes no data,,8,12689,,H,Autocuration,,CHEMBL621519,,BAO_0000019,,
2834,1,Compound was evaluated for its binding affinity for rat 5-hydroxytryptamine 2C receptor,,8,12689,,H,Autocuration,,CHEMBL621520,,BAO_0000357,,
2835,1,Compound was evaluated for its binding affinity towards rat 5-hydroxytryptamine 2C receptor,,8,12689,,H,Autocuration,,CHEMBL621521,,BAO_0000357,,
2836,1,Compound was evaluated for its binding affinity towards rat r5-hydroxytryptamine 2C receptor,,8,12689,,H,Autocuration,,CHEMBL621522,,BAO_0000357,,
2837,1,Binding affinity against rat 5-hydroxytryptamine 2C receptor in A-9 cells.,,8,12689,,H,Expert,,CHEMBL621523,,BAO_0000219,,
2838,1,Evaluated for the binding constant at [125I]-DOI-labeled rat 5-hydroxytryptamine 2C receptor,,8,12689,,H,Autocuration,,CHEMBL621524,,BAO_0000357,,
2839,1,In vitro binding to 5-hydroxytryptamine 2C receptor using [125 I]-DOI,Rattus norvegicus,9,12689,,D,Expert,,CHEMBL621525,,BAO_0000357,,
2840,1,The binding affinity at 5-hydroxytryptamine 2C receptor was determined using [3H]mesulergine,,8,12689,,H,Autocuration,,CHEMBL872921,,BAO_0000357,,
2841,1,The compound evaluated for its affinity against 5-hydroxytryptamine 2C receptor,,8,12689,,H,Autocuration,,CHEMBL621526,,BAO_0000357,,
2842,1,Affinity against 5-hydroxytryptamine 2C receptor in J1 cells transfected with the rat 5-HT2C gene labeled with [3H]mesulergine.,,8,12689,,H,Expert,,CHEMBL621527,,BAO_0000219,,
2843,1,Binding affinity against 5-hydroxytryptamine 2C receptor in rat choroid plexus using [3H]N-methyl-mesulergine,Rattus norvegicus,9,12689,,D,Expert,,CHEMBL617865,,BAO_0000019,,
2844,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor,,8,12689,,H,Autocuration,,CHEMBL617866,,BAO_0000357,,
2845,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor from rat cortex using [3H]-citalopram as radioligand; Nonactive at 10 uM,,8,12689,,H,Autocuration,,CHEMBL617867,,BAO_0000019,,
2846,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand; Nonactive at 10 uM,,8,12689,,H,Autocuration,,CHEMBL617487,,BAO_0000357,,
2847,1,Binding affinity for 5-hydroxytryptamine 2C receptor,,8,12689,,H,Expert,,CHEMBL617488,,BAO_0000357,,
2848,1,Tested in vitro for its ability to bind to 5-hydroxytryptamine 2C receptor using [125 I]-DOI as radioligand; Not determined,,8,12689,,H,Autocuration,,CHEMBL617489,,BAO_0000357,,
2849,1,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT denotes not tested,,8,12689,,H,Autocuration,,CHEMBL617490,,BAO_0000019,,
2850,1,Ability to displace [3H]mesulergine (0.5 nM) from SR-3T3 cells of rat 5-hydroxytryptamine 2C receptor; NT=not tested,,8,12689,,H,Autocuration,,CHEMBL617491,,BAO_0000019,,
2851,1,Affinity pKi for 5-hydroxytryptamine 2C receptor was measured in rat cortex homogenates.,,8,12689,,H,Autocuration,,CHEMBL617492,,BAO_0000019,,
2852,1,Binding affinity against 5-hydroxytryptamine 2C receptor in rat cortex homogenates.,,8,12689,,H,Autocuration,,CHEMBL617493,,BAO_0000019,,
2853,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 2C receptor was determined,,8,12689,,H,Autocuration,,CHEMBL617494,,BAO_0000357,,
2854,1,Displacement of [3H]mesulergine from rat 5-HT2C receptor expressed in HEK293,Rattus norvegicus,9,12689,,D,Expert,,CHEMBL617495,,BAO_0000019,,
2855,1,Binding affinity was determined against cloned human 5-hydroxytryptamine 2C receptor using [3H]5-HT as radioligand,,8,12689,,H,Autocuration,,CHEMBL617496,,BAO_0000357,,
2856,1,Compound was evaluated for displacement of [3H]mesulergine from cloned rat 5-hydroxytryptamine 2C receptor in transfected CHO-K1 cells.,,8,12689,,H,Autocuration,,CHEMBL617497,485.0,BAO_0000219,,
2857,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,8,12689,,H,Autocuration,,CHEMBL617498,,BAO_0000357,,
2858,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 2C receptor using [3H]Mesulergine as radioligand.,,8,12689,,H,Autocuration,,CHEMBL617499,,BAO_0000357,,
2859,1,Compound tested for relative response using 0.1 uM 5-HT as agonist against 5-hydroxytryptamine 2C receptor,,8,12689,,H,Autocuration,,CHEMBL617500,,BAO_0000019,,
2860,1,Compound was tested for binding affinity against 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL617501,,BAO_0000357,,
2861,1,Binding affinity towards 5-hydroxytryptamine 2C receptor,,8,108,,H,Expert,,CHEMBL617502,,BAO_0000357,,
2862,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2B receptor using [3H]rauwolscine as radioligand; Not Tested,,8,227,,H,Autocuration,,CHEMBL617503,,BAO_0000357,,
2863,1,Binding activity against cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand.,,8,227,,H,Autocuration,,CHEMBL617504,,BAO_0000357,,
2864,1,Binding affinity against the cloned human 5-hydroxytryptamine 2B receptor using [3H]5-HT as the radioligand,,8,227,,H,Autocuration,,CHEMBL617406,,BAO_0000357,,
2865,1,Affinity for human 5-hydroxytryptamine 2B receptor expressed in mammalian cell line,Homo sapiens,9,227,,D,Expert,,CHEMBL617407,,BAO_0000019,,
2866,1,Binding affinity towards human 5-hydroxytryptamine 2B receptor using [3H]5-HT as radioligand,,8,227,,H,Autocuration,,CHEMBL617408,,BAO_0000357,,
2867,1,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,,8,227,,H,Autocuration,,CHEMBL617409,,BAO_0000357,,
2868,1,Compound was tested for the displacement of [3H]5-HT from clone human 5-hydroxytryptamine 2B receptor,,8,227,,H,Autocuration,,CHEMBL617410,,BAO_0000357,,
2869,1,Compound was tested for the displacement of [3H]5-HT from cloned human 5-hydroxytryptamine 2B receptor,,8,227,,H,Autocuration,,CHEMBL617411,,BAO_0000357,,
2870,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 2B receptor,,8,227,,H,Autocuration,,CHEMBL617412,,BAO_0000019,,
2871,1,Inhibitory constant against cloned human 5-hydroxytryptamine 2B receptor using with [125I]- DOI radioligand,Homo sapiens,9,227,,D,Expert,,CHEMBL617774,,BAO_0000357,,
2872,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,Homo sapiens,9,227,,D,Expert,,CHEMBL617775,722.0,BAO_0000219,,
2873,1,Displacement of [3H]ketanserin from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; ND = no data,Homo sapiens,9,227,,D,Expert,,CHEMBL617776,722.0,BAO_0000219,,
2874,1,Relative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,Homo sapiens,9,227,,D,Expert,,CHEMBL617777,449.0,BAO_0000219,,
2875,1,Rleative efficacy against human 5-hydroxytryptamine 2B receptor expressed in CHO cells using fluorometric imaging plate reader relative to 10 uM 5-HT,Homo sapiens,9,227,,D,Expert,,CHEMBL617778,449.0,BAO_0000219,,
2876,1,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",,8,227,,H,Autocuration,,CHEMBL617779,722.0,BAO_0000219,,
2877,1,Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells using [3H]5-HT as radioligand.,,8,227,,H,Expert,,CHEMBL617780,722.0,BAO_0000219,,
2878,1,"Binding affinities towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand; no data",,8,227,,H,Autocuration,,CHEMBL617781,722.0,BAO_0000219,,
2879,1,Displacement of [3H]5-HT from 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells,Homo sapiens,9,227,,D,Expert,,CHEMBL617782,722.0,BAO_0000219,,
2880,1,Binding affinity to human cloned 5-HT2B receptor in HEK 293 cells using [3H]- -5-HT as radioligand,Homo sapiens,9,227,,D,Expert,,CHEMBL617783,722.0,BAO_0000219,,
2881,1,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor was determined,,8,227,,H,Autocuration,,CHEMBL617784,,BAO_0000357,,
2882,1,Binding affinity towards 5-hydroxytryptamine 2B receptor (human cloned receptor) in HEK 293 cells using [3H]5-HT as radioligand.,,8,227,,H,Autocuration,,CHEMBL617785,722.0,BAO_0000219,,
2883,1,Binding affinity towards cloned human 5-hydroxytryptamine 2B receptor expressed in HEK 293 cells using [3H]5-HT as radioligand,,8,227,,H,Expert,,CHEMBL857984,722.0,BAO_0000219,,
2884,1,Binding affinity towards human cloned 5-HT2B receptor of HEK293 cells by displacement of [3H]5-HT,,8,227,,H,Expert,,CHEMBL617786,722.0,BAO_0000219,,
2885,1,In vitro binding affinity at human cloned 5-hydroxytryptamine 2B receptor of HEK293 cells by [3H]5-HT displacement.,,8,227,,H,Expert,,CHEMBL617787,722.0,BAO_0000219,,
2886,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells,Homo sapiens,9,227,,D,Expert,,CHEMBL617788,722.0,BAO_0000219,,
2887,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 2B receptor expressed in HEK293 cells; compound is insoluble,Homo sapiens,9,227,,D,Expert,,CHEMBL617789,722.0,BAO_0000219,,
2888,1,Compound was evaluated for binding affinity against human cloned 5-HT2B receptor in HEK 293 cells using [3H]5-HT as the radioligand,,8,227,,H,Autocuration,,CHEMBL617790,722.0,BAO_0000219,,
2889,1,Displacement of [3H]-5-5HT from human cloned 5-hydroxytryptamine 2B receptor expressed in CHO-K1 cells,,8,227,,H,Expert,,CHEMBL617791,485.0,BAO_0000219,,
2890,1,Binding affinity against 5-hydroxytryptamine 2B receptor,,8,227,,H,Expert,,CHEMBL617608,,BAO_0000357,,
2891,1,Compound was tested for its binding affinity against cloned human 5-hydroxytryptamine 2B receptor in HEK 293 cells using [3H]5-HT,,8,227,,H,Autocuration,,CHEMBL617609,722.0,BAO_0000219,,
2892,1,Compound was tested for its binding affinity for human cloned 5-hydroxytryptamine 2B receptor in HEK 293 using [3H]ketanserin as a radioligand,,8,227,,H,Autocuration,,CHEMBL617610,722.0,BAO_0000219,,
2893,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 2B receptors in HEK293 cells using [3H]5-HT.,,8,227,,H,Autocuration,,CHEMBL617611,722.0,BAO_0000219,,
2894,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",,8,227,,H,Autocuration,,CHEMBL617612,722.0,BAO_0000219,,
2895,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 2B receptor in HEK293 cells, using [3H]5-HT as radioligand",,8,227,,H,Autocuration,,CHEMBL617613,722.0,BAO_0000219,,
2896,1,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 2B receptor in the endothelium intact rabbit jugular vein.,Oryctolagus cuniculus,8,227,,H,Autocuration,,CHEMBL617614,,BAO_0000019,,
2897,1,Binding affinity analysed for 5-HT 2B receptor in rat stomach fundus,,8,12688,,H,Expert,,CHEMBL617615,,BAO_0000019,945.0,
2898,1,Affinity against 5-hydroxytryptamine 2B receptor in the isolated rat stomach fundus,,8,12688,,H,Expert,,CHEMBL858114,,BAO_0000357,945.0,
2899,1,Affinity against serotonergic receptor in the isolated rat stomach fundus,,8,12688,,H,Autocuration,,CHEMBL617616,,BAO_0000357,945.0,
2900,1,Antagonistic activity against 5-hydroxytryptamine 2B receptor obtained from rat stomach fundus preparation,Rattus norvegicus,9,12688,,D,Expert,,CHEMBL617617,,BAO_0000019,945.0,
2901,1,Antagonistic against 5-hydroxytryptamine 2B receptor,Rattus norvegicus,9,12688,,D,Expert,,CHEMBL875914,,BAO_0000019,,
2902,1,Antagonistic affinity measured as pA2 value on 5-hydroxytryptamine 2B receptor of the rat stomach fundus,,8,12688,,H,Autocuration,,CHEMBL617618,,BAO_0000019,945.0,
2903,1,Inhibition of 5-HT binding to 5-HT2B receptor of Rat stomach fundus,Rattus norvegicus,9,12688,,D,Expert,,CHEMBL617619,,BAO_0000357,945.0,
2904,1,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor,,8,12688,,H,Autocuration,,CHEMBL617620,,BAO_0000019,,
2905,1,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B receptor ) receptor; No data,,8,12688,,H,Autocuration,,CHEMBL617621,,BAO_0000019,,
2906,1,Compound was evaluated for antagonism against serotonin (5-hydroxytryptamine 2B) receptor,,8,12688,,H,Autocuration,,CHEMBL617622,,BAO_0000019,,
2907,1,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,Rattus norvegicus,9,12688,,D,Expert,,CHEMBL617623,,BAO_0000357,945.0,
2908,1,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,Rattus norvegicus,9,12688,,D,Expert,,CHEMBL617624,,BAO_0000357,945.0,
2909,1,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,Rattus norvegicus,9,12688,,D,Expert,,CHEMBL617625,,BAO_0000357,945.0,
2910,1,Inhibitory potency against rat stomach fundus 5-hydroxytryptamine 2B receptor,Rattus norvegicus,9,12688,,D,Expert,,CHEMBL617626,,BAO_0000357,945.0,
2911,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,8,12688,,H,Autocuration,,CHEMBL617627,,BAO_0000019,945.0,
2912,1,Negative log concentration of antagonist was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,,8,12688,,H,Expert,,CHEMBL617628,,BAO_0000019,945.0,
2913,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is No Data.,,8,12688,,H,Autocuration,,CHEMBL617629,,BAO_0000019,945.0,
2914,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus; ND is not determined.,,8,12688,,H,Autocuration,,CHEMBL858115,,BAO_0000019,945.0,
2915,1,Antagonistic activity on 5-hydroxytryptamine 2B receptor of Rat stomach fundus;ND is not determined,Rattus norvegicus,9,12688,,D,Expert,,CHEMBL617630,,BAO_0000019,945.0,
2916,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat thoracic aorta; ND is not determined,,8,12688,,H,Autocuration,,CHEMBL617631,,BAO_0000019,1515.0,
2917,1,The binding affinity of compound to 5-HT receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,,8,12688,,H,Autocuration,,CHEMBL617632,,BAO_0000357,,
2918,1,The binding affinity to 5-hydroxytryptamine 2B receptor of rat fundus,,8,12688,,H,Expert,,CHEMBL617633,,BAO_0000357,,
2919,1,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus was expressed as pA2 value; Unable to determine valid PA2 value due to slope of Schild plot,,8,12688,,H,Autocuration,,CHEMBL617634,,BAO_0000357,,
2920,1,The binding affinity of compound to 5-hydroxytryptamine 2B receptor of rat fundus; Unable to determine valid PA2 value due to slope of Schild plot,,8,12688,,H,Autocuration,,CHEMBL617635,,BAO_0000357,,
2922,1,Negative log concentration of antagonistic compound was determined on 5-hydroxytryptamine 2B receptor of Rat stomach fundus,Rattus norvegicus,9,12688,,D,Autocuration,,CHEMBL617637,,BAO_0000019,945.0,
2923,1,Binding affinity against 5-hydroxytryptamine 1A receptor,,8,227,,H,Autocuration,,CHEMBL617638,,BAO_0000357,,
2924,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2B receptor was determined,,8,227,,H,Autocuration,,CHEMBL617639,,BAO_0000357,,
2925,1,Binding affinity for 5-hydroxytryptamine 2B receptor was determined,,8,227,,H,Autocuration,,CHEMBL617640,,BAO_0000357,,
2926,1,Evaluated for the binding affinity to 5-HT 2B receptor,,8,227,,H,Autocuration,,CHEMBL617641,,BAO_0000357,,
2927,1,Ability to displace [3H]5-HT from 5-hydroxytryptamine 2B receptor,,8,227,,H,Autocuration,,CHEMBL617642,,BAO_0000357,,
2928,1,Binding affinities against 5-hydroxytryptamine 2B receptor,,8,227,,H,Autocuration,,CHEMBL617643,,BAO_0000357,,
2929,1,Binding affinities towards 5-hydroxytryptamine 2B receptor,,8,227,,H,Autocuration,,CHEMBL617644,,BAO_0000357,,
2930,1,Binding affinity towards 5-hydroxytryptamine 2B receptor using [125I]DOI as radioligand,,8,227,,H,Autocuration,,CHEMBL617645,,BAO_0000357,,
2931,1,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,,8,108,,H,Expert,,CHEMBL617646,,BAO_0000357,,
2932,1,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,Bos taurus,8,108,,H,Autocuration,,CHEMBL617647,,BAO_0000357,,
2933,1,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10E-6 M,Bos taurus,8,108,,H,Autocuration,,CHEMBL617648,,BAO_0000357,,
2934,1,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at a concentration of 10e-6 M,Bos taurus,8,108,,H,Autocuration,,CHEMBL617875,,BAO_0000357,,
2935,1,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor at concentration of 10e-6 M,Bos taurus,8,108,,H,Autocuration,,CHEMBL617876,,BAO_0000357,,
2936,1,Inhibitory constant was determined on 5-hydroxytryptamine 2C receptor of Bovine choroid plexus,Bos taurus,8,108,,H,Expert,,CHEMBL617877,,BAO_0000357,,
2937,1,In vitro ability to displace [3H]mesulergine binding from 5-hydroxytryptamine 2C receptor from bovine choroid plexus.,Bos taurus,8,108,,H,Expert,,CHEMBL617878,,BAO_0000357,,
2938,1,In vitro affinity against serotonin (5-hydroxytryptamine 2C) receptor,Bos taurus,8,108,,H,Autocuration,,CHEMBL617879,,BAO_0000357,,
2939,1,Binding affinity against guinea pig cortex 5-HT2C receptor in the presence of [3H]mesulergine,Cavia porcellus,8,108,,H,Autocuration,,CHEMBL617880,,BAO_0000019,,
2940,1,Binding affinity towards 5-HT4 receptor by the displacement of [3H]GR-113808 in guinea-pig striatum,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL617881,,BAO_0000357,2435.0,
2941,1,Binding affinity against 5-HT1A receptor,,8,51,,H,Autocuration,,CHEMBL857073,,BAO_0000357,,
2942,1,Agonistic activity for 5-HT2c (5-HT2C) by measuring [3H]inositol monophosphate fromation in CHO cells in which the human 5-HT2C receptor subtype was stably expressed,,8,108,,H,Expert,,CHEMBL617882,449.0,BAO_0000219,,
2943,1,Functional activity against human 5-hydroxytryptamine 2C receptor expressed in CHO cells using fluorometric imaging plate reader,Homo sapiens,9,108,,D,Expert,,CHEMBL617883,449.0,BAO_0000219,,
2944,1,Functional agonist activity of compound was determined by fluorescence-based assay measuring intracellular calcium mobilization for 5-HT2c receptor cell line,,8,108,,H,Autocuration,,CHEMBL617884,,BAO_0000219,,
2945,1,Agonistic binding efficacy against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand,,8,108,,H,Autocuration,,CHEMBL617885,449.0,BAO_0000219,,
2946,1,"Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI radioligand, expressed as Emax",,8,108,,H,Autocuration,,CHEMBL617886,449.0,BAO_0000219,,
2947,1,Inhibition of human 5-hydroxytryptamine 2C receptor,Homo sapiens,9,108,,D,Expert,,CHEMBL617887,,BAO_0000357,,
2948,1,In vitro binding affinity against human 5-hydroxytryptamine 2C receptor at a concentration of 100 (nM),,8,108,,H,Autocuration,,CHEMBL617888,,BAO_0000357,,
2949,1,Inhibitory activity using [3H]mesulergine as radioligand with receptor membranes isolated from a CHO-k cell line expressing the human 5-hydroxytryptamine 2C receptor at a concentration of 1 uM,,8,108,,H,Autocuration,,CHEMBL617889,,BAO_0000019,,
2950,1,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL617890,,BAO_0000357,,
2951,1,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,,8,108,,H,Autocuration,,CHEMBL617891,,BAO_0000357,,
2952,1,Intrinsic efficacy against 5-hydroxytryptamine 2C receptor; Intrinsic efficacy (%) not determined,,8,108,,H,Autocuration,,CHEMBL617892,,BAO_0000357,,
2953,1,Displacement of [H]-mesulergine from CHO cells expressing human 5-hydroxytryptamine 2C receptor.,,8,108,,H,Expert,,CHEMBL617893,449.0,BAO_0000219,,
2954,1,Ability to displace [3H]- mesulergine from human cloned 5-hydroxytryptamine 2C receptor expressed in CHO cells,,8,108,,H,Expert,,CHEMBL617894,449.0,BAO_0000219,,
2955,1,Ability to displace [3H]mesulergine binding to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,,8,108,,H,Expert,,CHEMBL617895,449.0,BAO_0000219,,
2956,1,Ability to displace [3H]mesulergine (0.5 nM) from CHO cells of human 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL617896,449.0,BAO_0000219,,
2957,1,Affinity towards human 5-hydroxytryptamine 2C serotonin receptor,Homo sapiens,9,108,,D,Expert,,CHEMBL617897,,BAO_0000357,,
2958,1,Agonist activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand,,8,108,,H,Autocuration,,CHEMBL617898,,BAO_0000019,,
2959,1,Agonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand,,8,108,,H,Autocuration,,CHEMBL617899,,BAO_0000019,,
2960,1,Agonistic binding affinity against human 5-hydroxytryptamine 2C receptor in CHO cells using [125I]- DOI ,Rattus norvegicus,8,108,,H,Expert,,CHEMBL617900,449.0,BAO_0000219,,
2961,1,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand,,8,108,,H,Autocuration,,CHEMBL617901,,BAO_0000019,,
2962,1,Antagonist activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine radioligand; Not tested,,8,108,,H,Autocuration,,CHEMBL617902,,BAO_0000019,,
2963,1,Antagonistic activity at cloned human 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,8,108,,H,Autocuration,,CHEMBL617903,,BAO_0000019,,
2964,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [125 I]DOI as radioligand,,8,108,,H,Autocuration,,CHEMBL617904,,BAO_0000357,,
2965,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand,,8,108,,H,Autocuration,,CHEMBL617905,,BAO_0000357,,
2966,1,Binding ability of compound at cloned human 5-hydroxytryptamine 2C receptor using [3H]- mesulergine as radioligand;not tested,,8,108,,H,Autocuration,,CHEMBL617906,,BAO_0000357,,
2967,1,Binding activity against cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand.,,8,108,,H,Autocuration,,CHEMBL617907,,BAO_0000357,,
2968,1,Binding affinity against the cloned human 5-hydroxytryptamine 2C receptor using [125I]DOI as the radioligand,,8,108,,H,Autocuration,,CHEMBL617908,,BAO_0000357,,
2969,1,Binding affinity for displacement of [3H]mesulergine to human 5-hydroxytryptamine 2C receptor stably expressed in CHO cells,,8,108,,H,Expert,,CHEMBL620617,449.0,BAO_0000219,,
2970,1,Affinity for human 5-hydroxytryptamine 2C receptor expressed in mammalian cell line,Homo sapiens,9,108,,D,Expert,,CHEMBL620618,,BAO_0000019,,
2971,1,Binding affinity against 5-hydroxytryptamine 2C receptor using [125I]DOI radioligand.,,8,108,,H,Expert,,CHEMBL620619,,BAO_0000357,,
2972,1,Binding affinity to cloned human 5-hydroxytryptamine 2C receptor,Homo sapiens,9,108,,D,Expert,,CHEMBL620620,,BAO_0000357,,
2973,1,Binding affinity towards human 5-HT2C receptor was determined using [125I]- DOI as radioligand,,8,108,,H,Autocuration,,CHEMBL620621,,BAO_0000357,,
2974,1,Binding affinity for 5-HT3 receptor by displacement of [3H]-LY 278584 in rat cerebral cortex membranes,Rattus norvegicus,7,104698,Membranes,D,Autocuration,,CHEMBL872920,,BAO_0000249,,
2975,1,Binding affinity towards rat 5-hydroxytryptamine 3 receptor was evaluated,,6,104698,,H,Autocuration,,CHEMBL620622,,BAO_0000223,,
2976,1,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 in rat posterior cortex,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL620623,,BAO_0000019,,
2977,1,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex,,6,104698,,H,Autocuration,,CHEMBL620624,,BAO_0000019,,
2978,1,Binding affinity against 5-hydroxytryptamine 3 receptor using [3H]BRL-43694 as radioligand in rat posterior cortex; Not tested,,6,104698,,H,Autocuration,,CHEMBL620625,,BAO_0000019,,
2979,1,Binding affinity was measured on 5-hydroxytryptamine 3 receptor in NG-108 cells labeled with [3H]GR-65630,,6,104698,,H,Autocuration,,CHEMBL620626,,BAO_0000219,,
2980,1,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex,,6,104698,,H,Autocuration,,CHEMBL621307,,BAO_0000019,,
2981,1,Binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]-BRL 43694 as radioligand in rat posterior cortex.,,6,104698,,H,Autocuration,,CHEMBL621308,,BAO_0000019,,
2982,1,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-5-HT,,6,104698,,H,Autocuration,,CHEMBL621309,,BAO_0000223,,
2983,1,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]GR-65630,,6,104698,,H,Autocuration,,CHEMBL621310,,BAO_0000223,,
2984,1,Binding affinity for central 5-hydroxytryptamine 3 receptor was determined by displacement of [3H]-ketanserin,,6,104698,,H,Autocuration,,CHEMBL621311,,BAO_0000223,,
2985,1,"Compound was evaluated for its in vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",,6,104698,,H,Autocuration,,CHEMBL621502,,BAO_0000249,,
2986,1,"In vitro affinity at serotonergic 5-hydroxytryptamine 3 receptor by radioligand binding assay, using [3H]-LY 278584 in rat cerebral cortex membranes.",,6,104698,,H,Autocuration,,CHEMBL621503,,BAO_0000249,,
2987,1,Displacement of the 5-hydroxytryptamine 3 receptor ligand [3H]GR-65630 from rat brain cortical membranes.,,6,104698,Membranes,H,Autocuration,,CHEMBL621504,,BAO_0000249,,
2988,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor,,6,104698,,H,Autocuration,,CHEMBL621505,,BAO_0000223,,
2989,1,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,,6,104698,,H,Autocuration,,CHEMBL621506,,BAO_0000019,,
2990,1,Ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15.,,6,104698,,H,Autocuration,,CHEMBL619781,,BAO_0000223,,
2991,1,Compound was evaluated for its ability to displace [3H]quipazine binding to 5-hydroxytryptamine 3 receptor sites in NG 108-15. ,,6,104698,,H,Autocuration,,CHEMBL619782,,BAO_0000223,,
2992,1,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex,,6,104698,,H,Autocuration,,CHEMBL619783,,BAO_0000019,,
2993,1,Displacement of [3H]ketanserin from rat cortex 5-HT3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL619784,,BAO_0000019,,
2994,1,Ability to displace [3H]granisetron specifically bound to 5-hydroxytryptamine 3 receptor in rat cortical membrane,,6,104698,,H,Autocuration,,CHEMBL619785,,BAO_0000249,,
2995,1,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,,6,104698,,H,Autocuration,,CHEMBL619786,,BAO_0000223,,
2996,1,Displacement of binding of [3H]-BRL 43694 to 5-hydroxytryptamine 3 receptor in rat cerebral cortex,,6,104698,,H,Autocuration,,CHEMBL619787,,BAO_0000019,,
2997,1,In vitro affinity for 5-hydroxytryptamine 3 (5-HT3) receptor by displacement of [3H]BRL-43694 from rat entorhinal cortex,,6,104698,,H,Autocuration,,CHEMBL872925,,BAO_0000019,,
2998,1,In vitro binding affinity at serotonin 5-hydroxytryptamine 3 receptor in rat cortex by [3H]granisetron displacement.,,6,104698,,H,Autocuration,,CHEMBL619788,,BAO_0000019,,
2999,1,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]- 1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,,6,104698,,H,Autocuration,,CHEMBL619789,,BAO_0000249,,
3000,1,Inhibitory activity against 5-hydroxytryptamine 3 receptor in rat cortical membranes using [3H]-1-Methyl-1H-indazole-3-carboxylic acid (8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-amide as a radioligand,,6,104698,,H,Autocuration,,CHEMBL619790,,BAO_0000249,,
3001,1,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,,6,104698,,H,Autocuration,,CHEMBL619791,,BAO_0000019,,
3002,1,Binding affinity at 5-hydroxytryptamine 3 receptor in rat entorhinal cortex by [3H]BRL-43694 displacement.,,6,104698,,H,Autocuration,,CHEMBL619792,,BAO_0000019,,
3003,1,Displacement of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortical membranes,,6,104698,Membranes,H,Autocuration,,CHEMBL619793,,BAO_0000249,,
3004,1,Inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL619794,,BAO_0000223,,
3005,1,The ability to inhibit [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor in rat brain cortices,,6,104698,,H,Autocuration,,CHEMBL619795,,BAO_0000221,955.0,
3006,1,Binding affinity at 5-hydroxytryptamine 3 receptor in rat posterior cortex by [3H]-BRL 43694 displacement.,,6,104698,,H,Autocuration,,CHEMBL619796,,BAO_0000019,,
3007,1,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584,,6,104698,,H,Autocuration,,CHEMBL620448,,BAO_0000223,,
3008,1,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,,6,104698,,H,Autocuration,,CHEMBL620449,,BAO_0000223,,
3009,1,The binding affinity was measured on 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand.,,6,104698,,H,Autocuration,,CHEMBL620450,,BAO_0000223,,
3010,1,The compound was evaluated for the binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630,,6,104698,,H,Autocuration,,CHEMBL620451,,BAO_0000223,,
3011,1,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of radioligand [3H]GR-65630.,,6,104698,,H,Autocuration,,CHEMBL620631,,BAO_0000223,,
3012,1,Binding affinity for 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand,,6,104698,,H,Autocuration,,CHEMBL620632,,BAO_0000019,,
3013,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor from rat cortex using [3H]BRL-43694 as radioligand; NA means Not active,,6,104698,,H,Autocuration,,CHEMBL620633,,BAO_0000019,,
3014,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 3 receptor; Nonactive at 10 uM,,6,104698,,H,Autocuration,,CHEMBL620634,,BAO_0000223,,
3015,1,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand; NA Not Available,,6,104698,,H,Autocuration,,CHEMBL620635,,BAO_0000019,,
3016,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 0.5 hours in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620636,,BAO_0000218,,
3017,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 1 hour in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620637,,BAO_0000218,,
3018,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 3 hours in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620638,,BAO_0000218,,
3019,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg at 6 hours in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620639,,BAO_0000218,,
3020,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 0.5 hours in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620640,,BAO_0000218,,
3021,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 1 hour in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620641,,BAO_0000218,,
3022,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 16 hours in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620642,,BAO_0000218,,
3023,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 3 hours in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620643,,BAO_0000218,,
3024,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.1 mg/kg at 6 hours in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620644,,BAO_0000218,,
3025,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 0.5 hours in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620645,,BAO_0000218,,
3026,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 1 hour in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620646,,BAO_0000218,,
3027,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 3 hours in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620647,,BAO_0000218,,
3028,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.3 mg/kg at 6 hours in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620648,,BAO_0000218,,
3029,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 0.5 hours in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620649,,BAO_0000218,,
3030,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 3 hours in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620650,,BAO_0000218,,
3031,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 1 hour in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620651,,BAO_0000218,,
3032,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 mg/kg at 3 hours in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL872875,,BAO_0000218,,
3033,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1 mg/kg at 1 hour in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL620652,,BAO_0000218,,
3034,1,5-hydroxytryptamine 3 receptor antagonist activity was confirmed by its ability to antagonize 5-HT evoked tachycardia of rabbit isolated heart,,6,104698,,H,Autocuration,,CHEMBL620653,,BAO_0000019,,
3035,1,Binding activity against 5-hydroxytryptamine 2A receptor from rat cortex homogenates using [3H]DOB as radioligand.,,6,104698,,H,Autocuration,,CHEMBL857076,,BAO_0000019,,
3036,1,Inhibition of [3H]-Q-ICS 205-930 binding to rat cortex homogenate 5-hydroxytryptamine 3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL620654,,BAO_0000019,,
3037,1,Binding activity radioligand.,,6,104698,,H,Autocuration,,CHEMBL620655,,BAO_0000223,,
3038,1,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor in rat brain membranes,,6,104698,Brain membranes,H,Autocuration,,CHEMBL620656,,BAO_0000249,,
3039,1,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes.,,6,104698,Brain membranes,H,Autocuration,,CHEMBL620657,,BAO_0000249,,
3040,1,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.000001 mol/L,,8,108,,H,Autocuration,,CHEMBL620658,,BAO_0000357,,
3041,1,Binding affinity towards 5-hydroxytryptamine 2C receptor was determined at a concentration of 0.00001 mol/L,,8,108,,H,Autocuration,,CHEMBL620659,,BAO_0000357,,
3042,1,Inhibition of binding towards 5-hydroxytryptamine 2C receptor at 100 nM concentration,,8,108,,H,Autocuration,,CHEMBL620660,,BAO_0000357,,
3043,1,Percent inhibition (at 1 uM) against 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL620661,,BAO_0000357,,
3044,1,Binding affinity of compound towards 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL620662,,BAO_0000357,,
3045,1,Affinity for 5-hydroxytryptamine 2C receptor,,8,108,,H,Expert,,CHEMBL620663,,BAO_0000357,,
3046,1,Binding affinity towards 5-hydroxytryptamine 2C receptor using [3H]mesulergine as radioligand,,8,108,,H,Autocuration,,CHEMBL620664,,BAO_0000357,,
3047,1,Binding affinity towards 5-hydroxytryptamine 2C receptor using [125I]DOI as radioligand.,,8,108,,H,Expert,,CHEMBL620665,,BAO_0000357,,
3048,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 2C receptor was determined,,8,108,,H,Autocuration,,CHEMBL620666,,BAO_0000357,,
3049,1,Compound was evaluated for the binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]-Ketanserin,,8,108,,H,Autocuration,,CHEMBL620667,,BAO_0000357,,
3050,1,Binding affinity towards 5-hydroxytryptamine 2C receptor by displacement of [3H]N-methyl-mesulergine,,8,108,,H,Expert,,CHEMBL620668,,BAO_0000357,,
3051,1,Binding affinity for 5-hydroxytryptamine 2C receptor was determined,,8,108,,H,Autocuration,,CHEMBL620669,,BAO_0000357,,
3052,1,Binding affinity towards serotonin 5-hydroxytryptamine 2C receptor,,8,108,,H,Expert,,CHEMBL620670,,BAO_0000357,,
3053,1,Evaluated for the binding affinity to 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL620671,,BAO_0000357,,
3054,1,Tested agains t5-hydroxytryptamine 2C receptor in experiment 1,,8,108,,H,Autocuration,,CHEMBL620672,,BAO_0000357,,
3055,1,Tested against 5-hydroxytryptamine 2C receptor in experiment 2,,8,108,,H,Autocuration,,CHEMBL620673,,BAO_0000357,,
3056,1,Ability to displace [3H]mesulergine from 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL620674,,BAO_0000357,,
3057,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL620675,,BAO_0000357,,
3058,1,The binding affinity towards 5-hydroxytryptamine 2C receptor; No affinity,,8,108,,H,Autocuration,,CHEMBL620676,,BAO_0000357,,
3059,1,Affinity against 5-hydroxytryptamine 2C receptor,,8,108,,H,Autocuration,,CHEMBL621382,,BAO_0000357,,
3060,1,Binding affinity against 5-hydroxytryptamine 2C receptor,Homo sapiens,9,108,,D,Expert,,CHEMBL621383,,BAO_0000357,,
3061,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 2C receptor using radioligand binding assay,,8,108,,H,Autocuration,,CHEMBL621384,,BAO_0000357,,
3062,1,Inhibitory concentration required against 5-HT3 receptor in bovine area postrema using [3H]GR-65630,Bos taurus,8,144,,H,Autocuration,,CHEMBL621385,,BAO_0000357,,
3063,1,Binding affinity towards 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand,Bos taurus,8,144,,H,Autocuration,,CHEMBL617989,,BAO_0000357,,
3064,1,Antagonistic potency against serotonin 5-hydroxytryptamine 3 receptor in GPI assay,Cavia porcellus,4,104714,,H,Expert,,CHEMBL617990,,BAO_0000019,,
3065,1,Binding affinity to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL875085,,BAO_0000221,2116.0,
3066,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617991,,BAO_0000019,,
3067,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 3 receptor of guinea pig; ND means not done,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617992,,BAO_0000019,,
3068,1,Potency to 5-hydroxytryptamine 3 receptor entirely in guinea pig ileum,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617993,,BAO_0000221,2116.0,
3069,1,In vitro binding affinity was measured for 5-hydroxytryptamine 3 receptor in the guinea pig ileum.,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617994,,BAO_0000221,2116.0,
3070,1,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea colon at a concentration 0.01 uM,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617995,,BAO_0000019,,
3071,1,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.1 uM,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617996,,BAO_0000019,,
3072,1,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617997,,BAO_0000019,,
3073,1,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 1 uM in the presence of 30 uM MDL 72222,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617998,,BAO_0000019,,
3074,1,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 0.01 uM,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617999,,BAO_0000019,,
3075,1,Percent of control response to 5-HT3 antagonistic activity on guinea colon at a concentration 1 uM,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL618000,,BAO_0000019,,
3076,1,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum",Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617815,,BAO_0000221,2116.0,
3077,1,"Concentration required to produce 50% of maximal contraction induced by 5-HT through 5-HT3 receptors in the presence of the compound, in isolated guinea pig ileum.",Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617816,,BAO_0000221,2116.0,
3078,1,Tested for the antagonistic activity against 5-hydroxytryptamine 3 receptor from guinea pig ileum,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617817,,BAO_0000221,2116.0,
3079,1,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617818,,BAO_0000221,2116.0,
3080,1,In vitro 5-hydroxytryptamine 3 receptor activity in guinea pig ileum; Not tested,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617819,,BAO_0000221,2116.0,
3081,1,Binding affinity towards [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in HG108-15,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617820,,BAO_0000223,,
3082,1,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617821,,BAO_0000221,2116.0,
3083,1,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617822,,BAO_0000221,2116.0,
3084,1,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor of isolated guinea pig ileum (GPI),Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617823,,BAO_0000221,2116.0,
3085,1,Tested for antagonistic activity on 5-hydroxytryptamine 3 receptor mediated effects of 5-HT in guinea pig isolated ileum,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617824,,BAO_0000221,2116.0,
3086,1,Agonistic activity against 5-hydroxytryptamine 3 receptor in guinea pig ileum assay,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617825,,BAO_0000221,2116.0,
3087,1,5-hydroxytryptamine 3 receptor agonism in the guinea pig ileum by functional 5-HT3 receptor assay,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617826,,BAO_0000221,2116.0,
3088,1,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617827,,BAO_0000221,2116.0,
3089,1,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617828,,BAO_0000221,2116.0,
3090,1,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617829,,BAO_0000221,2116.0,
3091,1,Binding affinity against 5-hydroxytryptamine 3 receptor of guinea pig ileum; Not determined,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617830,,BAO_0000221,2116.0,
3092,1,Binding affinity towards 5-hydroxytryptamine 3 receptor of guinea pig ileum; not determined,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617831,,BAO_0000221,2116.0,
3093,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor in guinea pig ileum.,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL617832,,BAO_0000221,2116.0,
3094,1,Binding affinity was determined against 5-hydroxytryptamine 2A receptor,Cavia porcellus,0,22226,,U,Autocuration,,CHEMBL617833,,BAO_0000019,,
3095,1,Binding affinity towards 5-HT1A receptor by the displacement of [3H]-8-OH-DPAT] in human recombinant receptors in mammalian cell,,8,51,,H,Autocuration,,CHEMBL617834,,BAO_0000357,,
3096,1,Affinity towards human 5-hydroxytryptamine 3 serotonin receptor,Homo sapiens,5,104714,,D,Expert,,CHEMBL617835,,BAO_0000223,,
3097,1,Binding affinity towards 5-HT3 receptor,,4,104714,,H,Autocuration,,CHEMBL617836,,BAO_0000223,,
3098,1,Binding activity radioligand.,,4,104714,,H,Autocuration,,CHEMBL617837,,BAO_0000223,,
3099,1,Binding activity against 5-hydroxytryptamine 1A receptor from human brain cortex using [3H]8-OH-DPAT-HT as radioligand.,,4,104714,,H,Autocuration,,CHEMBL620392,,BAO_0000019,,
3100,1,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,,4,104714,,H,Autocuration,,CHEMBL620393,,BAO_0000223,,
3101,1,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor,,4,104714,,H,Autocuration,,CHEMBL620394,,BAO_0000223,,
3102,1,Binding affinity for human cloned 5-hydroxytryptamine 3 receptor; NT means Not tested,,4,104714,,H,Autocuration,,CHEMBL620395,,BAO_0000223,,
3103,1,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 3 receptor,,0,22226,,U,Autocuration,,CHEMBL620396,,BAO_0000019,,
3104,1,Displacement of [3H]-BRC 36694 from 5-hydroxytryptamine 3 receptor in NG108-15 cells,,4,105030,,H,Expert,,CHEMBL620582,433.0,BAO_0000219,,
3105,1,"Percent inhibition of [3H]5 binding to 5-hydroxytryptamine 3 receptor was evaluated by injection of compound (75 microCi/kg, 1.32 ug/kg) into the tail vein of mice (in vivo)",,4,105030,,H,Autocuration,,CHEMBL620583,,BAO_0000218,,
3106,1,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),,4,105030,,H,Autocuration,,CHEMBL620584,,BAO_0000019,,
3107,1,Compound was evaluated for the binding affinity at 5- HT3 receptor subtype,,4,105030,,H,Autocuration,,CHEMBL620585,,BAO_0000224,,
3108,1,Compound was evaluated for the binding affinity at 5- HT3 receptor,,4,105030,,H,Autocuration,,CHEMBL620586,,BAO_0000224,,
3109,1,The binding affinity was measured for 5-hydroxytryptamine 3 receptor on NG 108-15 cell line of mouse neuroblastoma-glioma cells in presence of [3H]5 radioligand (in vitro),,4,105030,,H,Autocuration,,CHEMBL620587,,BAO_0000019,,
3110,1,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,,4,105030,,H,Autocuration,,CHEMBL620588,,BAO_0000019,,
3111,1,5-hydroxytryptamine 3 receptor agonism in mouse,,4,105030,,H,Autocuration,,CHEMBL620589,,BAO_0000218,,
3112,1,Binding affinity towards 5-hydroxytryptamine 3 receptor was determined by using [3H]-ICS 205-930 as radioligand in mouse N1E 115 cells,,4,105030,,H,Autocuration,,CHEMBL620590,,BAO_0000219,,
3113,1,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,,4,105030,,H,Autocuration,,CHEMBL617956,,BAO_0000019,,
3114,1,Binding affinity towards 5-hydroxytryptamine 2A receptor in rat cortex preparations using [3H]ketanserin,,4,105030,,H,Autocuration,,CHEMBL617957,,BAO_0000019,,
3115,1,Binding affinity was evaluated by 5-hydroxytryptamine 3 receptor agonism in the mouse NIE-115 by displacing tropisetron,,4,105030,,H,Autocuration,,CHEMBL617958,,BAO_0000224,,
3116,1,Compound was evaluated for binding to 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,,4,105030,,H,Autocuration,,CHEMBL617959,,BAO_0000219,,
3117,1,Compound was evaluated for binding to Serotonin 5-hydroxytryptamine 3 receptor in N1E cells using [3H]- -Tropisetron as radioligand,,4,105030,,H,Autocuration,,CHEMBL617960,,BAO_0000219,,
3118,1,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,,4,105030,,H,Autocuration,,CHEMBL617961,,BAO_0000224,,
3119,1,Ability to displace the radioligand [3H]GR-65630 from 5-hydroxytryptamine 3 receptor expressed in NIE-115 cells,,4,105030,,H,Autocuration,,CHEMBL617962,,BAO_0000219,,
3120,1,In vitro binding affinity at 5-hydroxytryptamine 3 receptor in N1E-115 cells using 3[H]GR-65630 as the radioligand,,4,105030,,H,Autocuration,,CHEMBL617963,339.0,BAO_0000219,,
3121,1,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,8,11765,,H,Autocuration,,CHEMBL617964,,BAO_0000019,,
3122,1,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in NG cells 108-15,,8,11765,,H,Autocuration,,CHEMBL617965,,BAO_0000219,,
3123,1,Compound was tested for the Binding affinity against N1e-115 neuroblastoma 5-hydroxytryptamine 3 receptor by Radio ligand [3H]GR-65630 binding assay.,Mus musculus,9,10630,,D,Autocuration,,CHEMBL617966,,BAO_0000357,,
3124,1,Binding activity against 5-hydroxytryptamine 3 receptor from rat cortex homogenate using [3H]-Q-ICS 205-930 as radioligand.,,8,17106,,H,Autocuration,,CHEMBL857074,,BAO_0000019,,
3125,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor,Sus scrofa,8,144,,H,Autocuration,,CHEMBL617967,,BAO_0000357,,
3126,1,Binding activity radioligand.,Sus scrofa,8,144,,H,Autocuration,,CHEMBL617968,,BAO_0000357,,
3127,1,Binding affinity to 5-hydroxytryptamine 3 receptor of neuronal in the afferent rabbit vagus,Oryctolagus cuniculus,4,104714,,H,Autocuration,,CHEMBL617969,,BAO_0000223,,
3128,1,Potency at neuronal 5-hydroxytryptamine 3 receptor in the rabbit heart,Oryctolagus cuniculus,4,104714,,H,Autocuration,,CHEMBL617970,,BAO_0000223,,
3129,1,Potency at neuronal 5-hydroxytryptamine 3 receptors in the rabbit heart,Oryctolagus cuniculus,4,104714,,H,Autocuration,,CHEMBL617971,,BAO_0000223,,
3130,1,Potency to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,Oryctolagus cuniculus,4,104714,,H,Autocuration,,CHEMBL617972,,BAO_0000019,,
3131,1,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),Oryctolagus cuniculus,4,104714,,H,Autocuration,,CHEMBL617973,,BAO_0000019,,
3132,1,Evaluated for the antagonistic activity against 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),Oryctolagus cuniculus,4,104714,,H,Autocuration,,CHEMBL617974,,BAO_0000019,,
3133,1,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated guinea pig ileum (GPI),Oryctolagus cuniculus,4,104714,,H,Autocuration,,CHEMBL617975,,BAO_0000221,2116.0,
3134,1,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),Oryctolagus cuniculus,4,104714,,H,Autocuration,,CHEMBL617976,,BAO_0000019,,
3135,1,Antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),Oryctolagus cuniculus,4,104714,,H,Autocuration,,CHEMBL617977,,BAO_0000019,,
3136,1,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated perfused rabbit heart (RH),Oryctolagus cuniculus,4,104714,,H,Autocuration,,CHEMBL617978,,BAO_0000019,,
3137,1,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 3 receptor in isolated rabbit vagus nerve (RVN),Oryctolagus cuniculus,4,104714,,H,Autocuration,,CHEMBL617979,,BAO_0000019,,
3138,1,Binding affinity against 5-hydroxytryptamine 3 receptor in CHO cells using [3H]5-HT as radioligand,Oryctolagus cuniculus,4,104714,,H,Autocuration,,CHEMBL617980,449.0,BAO_0000219,,
3139,1,In vitro displacement of [3H]-LY 278584 from rat cerebral cortex 5-hydroxytryptamine 3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617981,,BAO_0000019,,
3140,1,Affinity at 5-hydroxytryptamine 3 receptor from rat frontal cortex using [3H]granisetron as radioligand (For granisetron = Ki(nM)=0.3+/-0.01),,8,12020,,H,Autocuration,,CHEMBL617982,,BAO_0000019,,
3141,1,Affinity at 5-hydroxytryptamine 3 receptor (For granisetron = Ki (nM)=0.3+/-0.01),,8,12020,,H,Autocuration,,CHEMBL617983,,BAO_0000357,,
3142,1,In vitro displacement of [3H]ICS-205-930 from 5-hydroxytryptamine 3 receptor in cultured NG-108-15 rat glioma cells,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617984,,BAO_0000019,,
3143,1,"Binding affinity for 5-hydroxytryptamine 3 receptor in rat cerebral cortex, determined by displacement of [3H]GR-65630",,6,104698,,H,Autocuration,,CHEMBL617985,,BAO_0000019,,
3144,1,"5-Hydroxy tryptamine 3 receptor showing agonist activity (in vivo) in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",,6,104698,,H,Autocuration,,CHEMBL617986,,BAO_0000218,948.0,
3145,1,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",,6,104698,,H,Autocuration,,CHEMBL617987,,BAO_0000019,948.0,
3146,1,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 120 (ug/kg), evaluated as change in heart rate",,6,104698,,H,Autocuration,,CHEMBL617988,,BAO_0000019,948.0,
3147,1,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as change in heart rate",,6,104698,,H,Autocuration,,CHEMBL617792,,BAO_0000019,948.0,
3148,1,"Agonistic activity of compound towards 5-hydroxytryptamine 3 receptorr in Von Bezold-Jarisch Reflex in rats at 100 (ug/kg), evaluated as change in heart rate",,6,104698,,H,Autocuration,,CHEMBL617793,,BAO_0000019,948.0,
3149,1,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 100(ug/kg), evaluated as percent inhibition of bradycardia",,6,104698,,H,Autocuration,,CHEMBL617794,,BAO_0000019,,
3150,1,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch Reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",,6,104698,,H,Autocuration,,CHEMBL617795,,BAO_0000019,,
3151,1,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60 (ug/kg), evaluated as percent inhibition of bradycardia",,6,104698,,H,Autocuration,,CHEMBL617796,,BAO_0000019,,
3152,1,"Antagonistic activity of compound towards 5-hydroxytryptamine 3 receptor in Von Bezold-Jarisch reflex in rats at 60(ug/kg), evaluated as percent inhibition of bradycardia",,6,104698,,H,Autocuration,,CHEMBL617797,,BAO_0000019,,
3153,1,Antagonism of 5-HT-induced Von Bezold-Jarisch reflex in rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor antagonism),Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617798,,BAO_0000218,,
3154,1,Ability to antagonise the 5-HT- induced Von Bezold-Jarisch reflex in the rat after intravenous administration of 30 ug/kg of HT (5-hydroxytryptamine 3 receptor),,6,104698,,H,Autocuration,,CHEMBL617799,,BAO_0000218,,
3155,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617800,,BAO_0000218,,
3156,1,Inhibition of 5-HT-induced bradycardia by 5-hydroxytryptamine 3+,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617801,,BAO_0000019,,
3157,1,In vivo inhibitory concentration after 5 minutes against 5-hydroxytryptamine 3 receptor induced bradycardia [bezold-jarisch (B-J) reflex test] in rat by intravenous administration,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617802,,BAO_0000218,,
3158,1,Inhibition of 5-HT (1 ug/mL) induced depolarization in rat vagus nerve (5-hydroxytryptamine 3 receptor antagonism),Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617803,,BAO_0000019,,
3159,1,Binding affinity towards 5-HT3 receptor in rat was evaluated,,6,104698,,H,Autocuration,,CHEMBL617804,,BAO_0000019,,
3160,1,Inhibition of [3H]GR-65630 binding to rat cortical membrane 5-hydroxytryptamine 3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617805,,BAO_0000019,,
3161,1,Binding affinity was evaluated in vitro by displacement of [3H]zacopride radioligand from 5-hydroxytryptamine 3 receptor,,6,104698,,H,Autocuration,,CHEMBL617806,,BAO_0000223,,
3162,1,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement [3H]GR-65630 in rat cerebral cortex.,,6,104698,,H,Autocuration,,CHEMBL617807,,BAO_0000019,,
3163,1,Compound was evaluated for its binding affinity for 5-hydroxytryptamine 3 receptor by measuring displacement of [3H]granisetron from rat cerebral cortex,,6,104698,,H,Autocuration,,CHEMBL617808,,BAO_0000019,,
3164,1,Binding affinity against 5-hydroxytryptamine 3 receptor in rat cortical membrane using [3H]GR-65630 as radioligand,,6,104698,,H,Autocuration,,CHEMBL617809,,BAO_0000249,,
3165,1,Compound was tested for its ability to displace [3H]-Q-ICS 205-930 from 5-hydroxytryptamine 3 receptor in rat cortex homogenates,,6,104698,,H,Autocuration,,CHEMBL617810,,BAO_0000019,,
3166,1,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to 5-hydroxytryptamine 3 receptor in rat brain cortical membrane,,6,104698,,H,Autocuration,,CHEMBL617811,,BAO_0000249,955.0,
3167,1,Concentration required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine-3 receptor (5-HT 3 receptor)in rat brain cortical membrane,,6,104698,,H,Autocuration,,CHEMBL617812,,BAO_0000221,955.0,
3168,1,Concentration of compound required to inhibit the binding of radioligand [3H]GR-65630 to serotonin 5-hydroxytryptamine 3 receptor in rat cortical membrane,,6,104698,,H,Autocuration,,CHEMBL617813,,BAO_0000249,,
3169,1,In vitro inhibitory concentration against radioligand [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor in rat cortical membrane,,6,104698,,H,Autocuration,,CHEMBL617814,,BAO_0000249,,
3170,1,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate.,,6,104698,,H,Autocuration,,CHEMBL617698,,BAO_0000019,,
3171,1,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; Not active at 10000 nm,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617699,,BAO_0000019,,
3172,1,Inhibition of [3H]BRL-43694 binding to 5-hydroxytryptamine 3 receptor of rat cortical homogenate; not active at 10000 nM,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617700,,BAO_0000019,,
3173,1,Inhibition of radiolabeled [3H]-Zacopride ligand binding to 5-hydroxytryptamine 3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617701,,BAO_0000223,,
3174,1,Inhibitory concentration against 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-LY 278584 as radioligand,,6,104698,,H,Autocuration,,CHEMBL617702,,BAO_0000019,,
3175,1,"Tested for inhibition of binding of [3H]GR-65630 to rat cortical membranes, expressed as IC50",,6,104698,Membranes,H,Autocuration,,CHEMBL617703,,BAO_0000249,,
3176,1,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617704,,BAO_0000019,,
3177,1,The binding affinity at 5-hydroxytryptamine 3 receptor was determined using [3H]LY-278584; Not tested,,6,104698,,H,Autocuration,,CHEMBL617705,,BAO_0000223,,
3178,1,Inhibition of [3H]BRL-43694 binding to rat 5-hydroxytryptamine 3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617706,,BAO_0000223,,
3179,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells (using [3H]zacopride as radioligand),,6,104698,,H,Autocuration,,CHEMBL617707,433.0,BAO_0000219,,
3180,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from NG108-15 cells using [3H]zacopride as radioligand,,6,104698,,H,Autocuration,,CHEMBL617708,433.0,BAO_0000219,,
3181,1,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor from rat cortical homogenate using [3H]zacopride as radioligand,,6,104698,,H,Autocuration,,CHEMBL617709,,BAO_0000019,,
3182,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA= Not active,,6,104698,,H,Autocuration,,CHEMBL617710,,BAO_0000019,,
3183,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; NA=Not active,,6,104698,,H,Autocuration,,CHEMBL882925,,BAO_0000019,,
3184,1,The compound was tested for binding affinity against 5-hydroxytryptamine 3 receptor from rat cortical homogenate using [3H]zacopride as radioligand; not active,,6,104698,,H,Autocuration,,CHEMBL617711,,BAO_0000019,,
3185,1,Antagonist potency to 5-hydroxytryptamine 3 receptor was assayed by antagonism of the 5-HT-evoked reflex bradycardia [Bezold-Jarisch(BJ) reflex] in rats,,6,104698,,H,Autocuration,,CHEMBL617712,,BAO_0000019,,
3186,1,Antagonistic activity against 5-hydroxytryptamine 3 receptor as inhibition of 5-HT-induced bradycardia (von Bezold-jarisch reflex) in anesthetized rat,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617713,,BAO_0000019,,
3187,1,"Compound was tested as a 5-hydroxytryptamine 3 receptor antagonist in the rat by assessment of the inhibition of the Bezold-Jarisch effect, when administered intravenously",,6,104698,,H,Autocuration,,CHEMBL617714,,BAO_0000019,,
3188,1,In vivo 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) antagonistic activity expressed as ability to inhibit Bezold-Jarich reflex evoked by 5-HT in rats,,6,104698,,H,Autocuration,,CHEMBL617715,,BAO_0000218,,
3189,1,Inhibition dose for 50 percent antagonism for 5-hydroxytryptamine 3 receptor in vivo in rats,,6,104698,,H,Autocuration,,CHEMBL617716,,BAO_0000218,,
3190,1,Inhibition of 5-HT evoked reflex bradycardia in rat.,,6,104698,,H,Autocuration,,CHEMBL617717,,BAO_0000218,,
3191,1,5-HT3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617718,,BAO_0000218,,
3192,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617719,,BAO_0000218,,
3193,1,5-hydroxytryptamine 3 receptor antagonistic activity measured by inhibition of 5-HT-induced bradycardia (iv administration 10 ug/kg dose in urethane-anesthetized rats),,6,104698,,H,Autocuration,,CHEMBL617720,,BAO_0000218,,
3194,1,5-hydroxytryptamine 3 receptor antagonistic activity as inhibition of 5-HT-induced bradycardia after iv administration of 100 ug/kg dose in urethane-anesthetized rats,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL617721,,BAO_0000218,,
3195,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617722,,BAO_0000218,,
3196,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 1000 ug/kgetized rats,,6,104698,,H,Autocuration,,CHEMBL617723,,BAO_0000218,,
3197,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after iv administration of 3 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617724,,BAO_0000218,,
3198,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 10 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617725,,BAO_0000218,,
3199,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 100 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617726,,BAO_0000218,,
3200,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 1000 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617727,,BAO_0000218,,
3201,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 30 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617728,,BAO_0000218,,
3202,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 300 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617729,,BAO_0000218,,
3203,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5H+ T-induced bradycardia after po administration of 3ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617730,,BAO_0000218,,
3204,1,5-hydroxytryptamine 3 receptor antagonistic activity was measured by the inhibition of 5-HT-induced bradycardia after iv administration of 1000 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617731,,BAO_0000218,,
3205,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 0.3 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617732,,BAO_0000218,,
3206,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 1 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617733,,BAO_0000218,,
3207,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after intravenous administration of 30 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617734,,BAO_0000218,,
3208,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 0.05 hour,,6,104698,,H,Autocuration,,CHEMBL872874,,BAO_0000218,,
3209,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 1 hour,,6,104698,,H,Autocuration,,CHEMBL617735,,BAO_0000218,,
3210,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 16 hour,,6,104698,,H,Autocuration,,CHEMBL617736,,BAO_0000218,,
3211,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 3 hour,,6,104698,,H,Autocuration,,CHEMBL617737,,BAO_0000218,,
3212,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 0.03 mg/kg dose in urethane-anesthetized rats at 6 hour,,6,104698,,H,Autocuration,,CHEMBL617738,,BAO_0000218,,
3213,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617739,,BAO_0000218,,
3214,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 100 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617740,,BAO_0000218,,
3215,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 1000 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617741,,BAO_0000218,,
3216,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 10 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617742,,BAO_0000218,,
3217,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 3 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617743,,BAO_0000218,,
3218,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 30 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617744,,BAO_0000218,,
3219,1,Compound was tested for the inhibition of 5-HT-induced bradycardia after peroral administration of 300 ug/kg dose in urethane-anesthetized rats,,6,104698,,H,Autocuration,,CHEMBL617745,,BAO_0000218,,
3220,1,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.)",,6,104698,,H,Autocuration,,CHEMBL617746,,BAO_0000218,,
3221,1,"In vivo 5-hydroxytryptamine 3 receptor antagonist activity by antagonism of the von Bezold-Jarisch (B-J) reflex in anesthetized rats, (i.v.); Not tested",,6,104698,,H,Autocuration,,CHEMBL617747,,BAO_0000218,,
3222,1,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 10 ug/Kg,,6,104698,,H,Autocuration,,CHEMBL617748,,BAO_0000218,,
3223,1,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 100 ug/Kg,,6,104698,,H,Autocuration,,CHEMBL618909,,BAO_0000218,,
3224,1,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 2 ug/Kg,,6,104698,,H,Autocuration,,CHEMBL618910,,BAO_0000218,,
3225,1,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 20 ug/Kg,,6,104698,,H,Autocuration,,CHEMBL618911,,BAO_0000218,,
3226,1,Serotonin receptor antagonist activity was measured as ability to block the serotonin-induced Bezold-Jarisch reflex in rats after iv administration of 5 ug/Kg,,6,104698,,H,Autocuration,,CHEMBL618912,,BAO_0000218,,
3227,1,Tested for inhibition of Bezold-Jarisch (B-J) reflex mediated by 5-hydroxytryptamine 3 receptor in rats after intravenous administration (2.0 ug/kg),,6,104698,,H,Autocuration,,CHEMBL618913,,BAO_0000218,,
3228,1,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,,6,104698,,H,Autocuration,,CHEMBL618914,,BAO_0000019,,
3229,1,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; A means pure agonist,,6,104698,,H,Autocuration,,CHEMBL618915,,BAO_0000019,,
3230,1,Intrinsic efficacy for rat 5-hydroxytryptamine 3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL618916,,BAO_0000223,,
3231,1,Intrinsic efficacy against 5-hydroxytryptamine 3 receptor; PA means partial agonist,,6,104698,,H,Autocuration,,CHEMBL618917,,BAO_0000019,,
3232,1,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor (5-HT 3 receptor) of rat cortex and hippocampus tissue,,7,104698,,D,Intermediate,,CHEMBL618918,,BAO_0000221,10000000.0,
3233,1,Inhibition of [3H]granisetron binding to 5-hydroxytryptamine 3 receptor of rat cortical membrane,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL618919,,BAO_0000019,,
3234,1,Inhibition of [3H]GR-65630 binding to rat cortical membrane serotonin 5-hydroxytryptamine 3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL618920,,BAO_0000019,,
3235,1,Affinity was evaluated as inhibition constant for serotonin 5-hydroxytryptamine 3 receptor,,6,104698,,H,Autocuration,,CHEMBL618921,,BAO_0000223,,
3236,1,Affinity was evaluated by inhibition of [3H]GR-65630 binding to NG108-15 cell transfected with cloned rat 5-hydroxytryptamine 3 receptor,,6,104698,,H,Autocuration,,CHEMBL618922,,BAO_0000019,,
3237,1,Binding affinity against radioligand [3H]quipazine labeled 5-hydroxytryptamine 3 receptor sites in neuroblastoma-glioma (NG108-15) cells.,,6,104698,,H,Autocuration,,CHEMBL618923,,BAO_0000019,,
3238,1,Binding affinity for 5-hydroxytryptamine 3 receptor was determined by measuring displacement of [3H]GR-65630 from rat brain cortices,,6,104698,,H,Autocuration,,CHEMBL618924,,BAO_0000019,,
3239,1,Binding affinity to 5-hydroxytryptamine 3 receptor in rat entorhinal cortex using [3H]-BRL 43694 as radioligand,,6,104698,,H,Autocuration,,CHEMBL618925,,BAO_0000019,,
3240,1,Binding affinity towards 5-HT3 receptor in rat was evaluated,,6,104698,,H,Autocuration,,CHEMBL618926,,BAO_0000019,,
3241,1,5-hydroxytryptamine 4 receptor agonist activity as increased response to electrical stimulation in guinea pig ileum,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL618927,,BAO_0000221,2116.0,
3242,1,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum; Not tested,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL618928,,BAO_0000221,2116.0,
3243,1,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum",Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL618929,,BAO_0000221,2116.0,
3244,1,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Inactive up to 10E-5 M",Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL618930,,BAO_0000221,2116.0,
3245,1,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL618931,,BAO_0000221,2116.0,
3246,1,"5-hydroxytryptamine 4 receptor agonist activity, concentration which gave 50% increase in the response to electrically-stimulated myenteric plexus and longitudinal muscle of the guinea pig ileum; Not tested",Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619594,,BAO_0000221,2116.0,
3247,1,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not capable of evaluation",Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619595,,BAO_0000221,2116.0,
3248,1,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619596,,BAO_0000221,2116.0,
3249,1,concentration which gave a 50% increase in the response to electrical stimulation against 5-hydroxytryptamine 4 receptor in the guinea pig ileum. Activity expressed as percent of the maximum 5-HT response given in brackets.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619755,,BAO_0000221,2116.0,
3250,1,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619756,,BAO_0000221,2116.0,
3251,1,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not evaluable,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619757,,BAO_0000221,2116.0,
3252,1,5-hydroxytryptamine 4 receptor antagonist activity expressed as the concentration which produced a 50% reduction of 5-HT induced contraction in guinea pig ileum; Not tested,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619758,,BAO_0000221,2116.0,
3253,1,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum",Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619759,,BAO_0000221,2116.0,
3254,1,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10-5 M",Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619760,,BAO_0000221,2116.0,
3255,1,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Inactive up to 10E-5 M",Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619761,,BAO_0000221,2116.0,
3256,1,5-hydroxytryptamine 4 receptor antagonist activity as inhibition of 5-HT-induced contractions in guinea pig ileum; Not capable of evaluation.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619762,,BAO_0000221,2116.0,
3257,1,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619763,,BAO_0000221,2116.0,
3258,1,"5-hydroxytryptamine 4 receptor antagonist activity, concentration which gave 50% reduction of the 5-HT-induced contractions in the guinea pig ileum; Not tested",Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL617868,,BAO_0000221,2116.0,
3259,1,Displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor in guinea pig striatum,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL617869,,BAO_0000357,,
3260,1,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL882926,,BAO_0000249,2435.0,
3261,1,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL617870,,BAO_0000249,2435.0,
3262,1,Inhibitory activity against 5-hydroxytryptamine 4 receptor of guinea pig striatum using [3H]GR-113808 as radioligand,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL617871,,BAO_0000357,2435.0,
3263,1,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea pig striatum,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL617872,,BAO_0000357,2435.0,
3264,1,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to 5-hydroxytryptamine 4 receptor in guinea-pig striatum,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL617873,,BAO_0000357,2435.0,
3265,1,Concentration of compound required to inhibit the binding of radioligand [3H]GR-113808 to serotonin 5-hydroxytryptamine 4 receptor in guinea-pig striatum,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL617874,,BAO_0000357,2435.0,
3266,1,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619067,,BAO_0000221,2116.0,
3267,1,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum. 95% confidence limits are in brackets.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619068,,BAO_0000221,2116.0,
3268,1,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619069,,BAO_0000221,2116.0,
3269,1,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-6 M in guinea pig,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619070,,BAO_0000357,,
3270,1,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor at concentration of 10e-8 M in guinea pig,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619071,,BAO_0000357,,
3271,1,Agonistic activity against 5-hydroxytryptamine 4 receptor,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619072,,BAO_0000019,,
3272,1,Agonistic activity against 5-hydroxytryptamine 4 receptor; not tested,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619073,,BAO_0000019,,
3273,1,Compound was evaluated for the relative potency with respect to serotonin against 5-hydroxytryptamine 4 receptor,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619074,,BAO_0000019,,
3274,1,Ability to displace [3H]GR-113808 from 5-hydroxytryptamine 4 receptor,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619075,,BAO_0000357,,
3275,1,Inhibition of [3H]GR-113808 binding to guinea pig striatum 5-hydroxytryptamine 4 receptor,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619076,,BAO_0000357,2435.0,
3276,1,Binding affinity against 5-hydroxytryptamine 4 receptor in guinea pig striatum using [3H]GR-113808 as radioligand,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619077,,BAO_0000357,2435.0,
3277,1,Binding affinity towards 5-HT4 receptor in striatum membranes of guinea-pig brain was evaluated,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619078,,BAO_0000249,2435.0,
3278,1,Binding affinity towards 5-hydroxytryptamine 4 receptor in striatum membranes of guinea-pig brain was evaluated,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619079,,BAO_0000249,2435.0,
3279,1,Tested for affinity against 5-hydroxytryptamine 4 receptor in the myenteric plexus of the guinea pig ileum.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619080,,BAO_0000221,2116.0,
3280,1,Displacement of [3H]-GR113808 from 5-HT4 receptor of guinea pig striatum,Cavia porcellus,9,20033,,D,Expert,,CHEMBL619081,,BAO_0000357,,
3281,1,The compound was tested for their binding affinity towards 5-HT4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619082,,BAO_0000357,,
3282,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619083,,BAO_0000357,,
3283,1,The compound was tested for their binding affinity towards 5-hydroxytryptamine 4 receptor from guinea pig striatum using [3H]GR-113808 as radioligand; Nonactive at 10 uM,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619084,,BAO_0000357,,
3284,1,Evaluated for the antagonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL859397,,BAO_0000221,2116.0,
3285,1,5-hydroxytryptamine 4 receptor agonist activity in the guinea pig ileum assay,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619085,,BAO_0000221,2116.0,
3286,1,5-hydroxytryptamine 4 receptor agonistic activity was measured by twitch response enhancing activity in electrically stimulated guinea pig ileum preparation,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619086,,BAO_0000221,2116.0,
3287,1,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in low frequency field stimulation of guinea-pig ileum (FSGPI).,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619087,,BAO_0000221,2116.0,
3288,1,Agonistic activity against Serotonin 5-hydroxytryptamine 4 receptor in non-electrically stimulated guinea-pig ileum.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619088,,BAO_0000221,2116.0,
3289,1,Ability to antagonize 5-HT-evoked contractions mediated through 5-hydroxytryptamine 4 receptor activation in the guinea pig distal colon LMMP,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619089,,BAO_0000357,,
3290,1,Binding affinity was determined against 5-hydroxytryptamine 3 receptor,Cavia porcellus,8,168,,H,Autocuration,,CHEMBL619090,,BAO_0000357,,
3291,1,Antagonistic activity against 5-hydroxytryptamine 4 receptor,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619091,,BAO_0000019,,
3292,1,Ability to displace the radioligand [3H]GR-113808 from guinea pig striatum 5-hydroxytryptamine 4 receptor,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619092,,BAO_0000357,,
3293,1,Binding affinity for 5-hydroxytryptamine 4 receptor by displacement of [3H]GR-113808 from guinea pig brain striatum.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619093,,BAO_0000019,,
3294,1,Binding affinity was determined against 5-hydroxytryptamine 2C receptor using cloned rat receptors expressed in 293 cells radiolabeled with [3H]mesulergine,Cavia porcellus,8,168,,H,Autocuration,,CHEMBL619094,722.0,BAO_0000219,,
3295,1,In vitro by displacement of [3H]GR-113808 from 5-hydroxytryptamine 4 receptor on guinea pig striatal membrane,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619095,,BAO_0000019,,
3296,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 4 receptor using radioligand binding assay using [3H]GR as radioligand,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL857988,,BAO_0000357,,
3297,1,Compound was evaluated for its ability to displace [3H]GR-113808 binding from 5-hydroxytryptamine 4 receptor in guinea pig striatum.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619096,,BAO_0000357,,
3298,1,In vitro binding affinity at 5-hydroxytryptamine 4 receptor in guinea pig striatum using 3[H]GR-113808 as the radioligand,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619097,,BAO_0000357,2435.0,
3299,1,The compound was tested for its binding affinity towards 5-hydroxytryptamine 4 receptor in guinea pig hippocampus using [125I]SB-207710.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619098,,BAO_0000221,10000000.0,
3300,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619751,,BAO_0000357,,
3301,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619752,,BAO_0000357,,
3302,1,The antagonist activity was calculated as the concentration which produced a 50% reduction against 5-hydroxytryptamine 4 receptor in guinea pig ileum;ne=not capable of evaluation.,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL875096,,BAO_0000221,2116.0,
3303,1,Binding affinity towards 5-HT2C receptor by the displacement of [3H]mesulergine] in human recombinant receptors in mammalian cell,,8,108,,H,Autocuration,,CHEMBL619004,,BAO_0000357,,
3304,1,Binding affinity towards human 5-hydroxytryptamine 4 receptor using [3H]5-HT as radioligand,,8,168,,H,Autocuration,,CHEMBL619005,,BAO_0000357,,
3305,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 4 receptor,,8,168,,H,Autocuration,,CHEMBL619006,,BAO_0000019,,
3306,1,Compound was evaluated for the binding affinity against human cloned 5-hydroxytryptamine 4 receptor in HeLa cells using [3H]-LSD as the radioligand,,8,168,,H,Autocuration,,CHEMBL619007,308.0,BAO_0000219,,
3307,1,Compound was tested for its binding affinity against 5-hydroxytryptamine 4 receptor,,8,168,,H,Autocuration,,CHEMBL619008,,BAO_0000357,,
3308,1,Compound was tested for its binding affinity for 5-hydroxytryptamine 4 receptor,,8,168,,H,Autocuration,,CHEMBL619009,,BAO_0000357,,
3309,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 4 receptor in HeLa cells, using [3H]LSD as radioligand",,8,168,,H,Autocuration,,CHEMBL619010,308.0,BAO_0000219,,
3310,1,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons,,8,10622,,H,Autocuration,,CHEMBL619011,,BAO_0000357,,
3311,1,Tested for ability to stimulate production of cAMP mediated by 5-hydroxytryptamine 4 receptor in mouse Coliculi neurons; IA means inactive,,8,10622,,H,Autocuration,,CHEMBL619012,,BAO_0000357,,
3312,1,Ability to displace [3H]GR-113808 from mouse 5-hydroxytryptamine 4 receptor in COS7 cells,,8,10622,,H,Autocuration,,CHEMBL619013,,BAO_0000219,,
3313,1,Tested for ability to stimulate 5-hydroxytryptamine 4 receptors in mouse Coliculi neurons,,8,10622,,H,Autocuration,,CHEMBL619014,,BAO_0000357,,
3314,1,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model,,8,11249,,H,Autocuration,,CHEMBL857503,,BAO_0000019,2081.0,
3315,1,Evaluated for the 5-hydroxytryptamine 4 receptor antagonistic activity in piglet atrium model; compound found inactive at 1 uM,,8,11249,,H,Autocuration,,CHEMBL619015,,BAO_0000019,2081.0,
3316,1,The compound was tested for binding affinity against 5-hydroxytryptamine 4 receptor,,8,11249,,H,Autocuration,,CHEMBL619016,,BAO_0000357,,
3317,1,Compound was tested for binding affinity against piglet hippocampus 5-hydroxytryptamine 4 receptor,,8,11249,,H,Autocuration,,CHEMBL619017,,BAO_0000221,10000000.0,
3318,1,The binding affinity (pKi) was measured against 5-hydroxytryptamine 4 receptor of piglet hippocampus using [125I]SB 207710 as radioligand,Sus scrofa,8,168,,H,Autocuration,,CHEMBL619018,,BAO_0000221,10000000.0,
3319,1,Binding affinity against 5-hydroxytryptamine 2A receptor using rabbit saphenous vein assay.,Oryctolagus cuniculus,8,168,,H,Autocuration,,CHEMBL619019,,BAO_0000019,,
3320,1,Displacement of [3H]GR-113808 from rat striatum 5-hydroxytryptamine 4 receptor,Rattus norvegicus,9,10623,,D,Expert,,CHEMBL619020,,BAO_0000357,,
3321,1,Tested for its agonist potency against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,,8,10623,,H,Autocuration,,CHEMBL619021,,BAO_0000019,,
3322,1,Tested for affinity towards 5-hydroxytryptamine 4 receptor in relaxation of rat oesophagus,,8,10623,,H,Autocuration,,CHEMBL619022,,BAO_0000357,,
3323,1,Tested for the effect on binding at 5-hydroxytryptamine 4 receptor; No activity,,8,10623,,H,Autocuration,,CHEMBL619023,,BAO_0000357,,
3324,1,lntrinsic activity relative to 5-HT receptor,,8,10623,,H,Autocuration,,CHEMBL619024,,BAO_0000019,,
3325,1,Compound was evaluated for the agonistic activity towards 5-hydroxytryptamine 4 receptor using the rat tunica muscularis mucosae (TMM) esophagus strip assay,,8,10623,,H,Autocuration,,CHEMBL619025,,BAO_0000019,,
3326,1,In vitro relaxation of carbachol pre-contracted rat oesophageal TMM.,,8,10623,,H,Expert,,CHEMBL619026,,BAO_0000019,,
3327,1,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay,,8,10623,,H,Autocuration,,CHEMBL619027,,BAO_0000019,,
3328,1,Compound was tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay; IN = Inactive,,8,10623,,H,Autocuration,,CHEMBL619028,,BAO_0000019,,
3329,1,Efficient 5-hydroxytryptamine 4 agonist in the rat tunica muscularis mucosae,,8,10623,,H,Autocuration,,CHEMBL619029,,BAO_0000019,,
3330,1,Tested for agonist activity at the 5-hydroxytryptamine 4 receptor in the rat tunica muscularis mucosae (TMM) assay of racemate mixture,,8,10623,,H,Autocuration,,CHEMBL619030,,BAO_0000019,,
3331,1,Relaxation of carbachol induced contractions of rat tunica muscularis mucosae,,8,10623,,H,Expert,,CHEMBL619031,,BAO_0000357,,
3332,1,5-hydroxytryptamine 4 receptor agonist activity was determined by the relaxation of the carbachol-contracted rat esophageal tunica muscularis mucosae,,8,10623,,H,Autocuration,,CHEMBL619032,,BAO_0000019,,
3333,1,Inhibition of radiolabeled [3H]GR-113808 ligand binding to 5-hydroxytryptamine 4 receptor,Rattus norvegicus,9,10623,,D,Expert,,CHEMBL619033,,BAO_0000357,,
3334,1,Tested for its efficacy against the 5-hydroxytryptamine 4 receptor located in the rat esophageal tunica muscularis mucosae,,8,10623,,H,Autocuration,,CHEMBL619034,,BAO_0000357,,
3335,1,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae.,,8,10623,,H,Autocuration,,CHEMBL619035,,BAO_0000357,,
3336,1,In vitro 5-hydroxytryptamine 4 receptor activity by using carbachol-precontracted esophageal tunica muscularis mucosae; No activity up to 104M concentration,,8,10623,,H,Autocuration,,CHEMBL619036,,BAO_0000357,,
3337,1,Binding affinity (Ki+/-SEM) against 5-hydroxytryptamine 4 receptor from cheng Prusoff equation by using [3H]GR-113808 in rat striatum,Rattus norvegicus,9,10623,,D,Expert,,CHEMBL619037,,BAO_0000019,,
3338,1,Binding affinity towards 5-HT 4 receptor in rat striatum membranes using [3H]GR-113808 as radioligand,,8,10623,,H,Autocuration,,CHEMBL619038,,BAO_0000249,2435.0,
3339,1,Binding affinity towards 5-HT4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand; Not tested,,8,10623,,H,Autocuration,,CHEMBL619039,,BAO_0000249,,
3340,1,Binding affinity towards 5-hydroxytryptamine 4 receptor was determined in rat striatal membranes using [3H]GR-113808 as radioligand,,8,10623,,H,Expert,,CHEMBL619040,,BAO_0000249,,
3341,1,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,Rattus norvegicus,9,10623,,D,Expert,,CHEMBL619041,,BAO_0000019,2435.0,
3342,1,Binding affinity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum,,8,10623,,H,Autocuration,,CHEMBL619042,,BAO_0000019,2435.0,
3343,1,Binding affinity to 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand in rat striatum membrane,,8,10623,,H,Expert,,CHEMBL619043,,BAO_0000249,2435.0,
3344,1,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatum by [3H]GR-113808 displacement.,,8,10623,,H,Expert,,CHEMBL619044,,BAO_0000019,2435.0,
3345,1,In vitro affinity at serotonergic 5-hydroxytryptamine 4 receptor by radioligand binding assay using [3H]GR-113808 in rat striatum membranes.,,8,10623,,H,Expert,,CHEMBL619045,,BAO_0000249,2435.0,
3346,1,In vitro binding affinity to 5-hydroxytryptamine 4 receptor in rat striatum membrane,,8,10623,,H,Expert,,CHEMBL619046,,BAO_0000249,2435.0,
3347,1,Binding affinity at 5-hydroxytryptamine 4 receptor in rat striatal membranes by [3H]GR-113808 displacement.,,8,10623,,H,Expert,,CHEMBL619047,,BAO_0000249,,
3348,1,Tested for potency against 5-hydroxytryptamine 4 receptor agonist in rat brain,,8,10623,,H,Autocuration,,CHEMBL619048,,BAO_0000221,955.0,
3349,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat,,8,10623,,H,Autocuration,,CHEMBL859398,,BAO_0000019,,
3350,1,Compound was evaluated for its antagonist affinity towards 5-hydroxytryptamine 4 receptor of rat; ND means not done,,8,10623,,H,Autocuration,,CHEMBL619049,,BAO_0000019,,
3351,1,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae,,8,10623,,H,Autocuration,,CHEMBL857886,,BAO_0000019,,
3352,1,5-hydroxytryptamine 4 receptor agonist activity in the rat esophageal muscularis mucosae; Not tested,,8,10623,,H,Autocuration,,CHEMBL619050,,BAO_0000019,,
3353,1,Antagonist activity against 5-hydroxytryptamine 4 receptor mediated relaxation of rat carbachol contracted esophageal muscularis mucosae,,8,10623,,H,Autocuration,,CHEMBL620591,,BAO_0000019,,
3354,1,Binding affinity against rat 5-hydroxytryptamine 4 receptor,Rattus norvegicus,9,10623,,D,Expert,,CHEMBL620592,,BAO_0000357,,
3355,1,pKi against 5-hydroxytryptamine 4 receptor in rat striatum membrane,,8,10623,,H,Expert,,CHEMBL620593,,BAO_0000249,2435.0,
3356,1,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-5 M.,Rattus norvegicus,9,10623,,D,Expert,,CHEMBL620594,,BAO_0000019,,
3357,1,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-6 M.,,8,10623,,H,Expert,,CHEMBL875079,,BAO_0000019,,
3358,1,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,,8,10623,,H,Expert,,CHEMBL620595,,BAO_0000019,,
3359,1,Antagonistic activity evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-8 M.,Rattus norvegicus,9,10623,,D,Expert,,CHEMBL620596,,BAO_0000019,,
3360,1,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-7 M.,,8,10623,,H,Autocuration,,CHEMBL620597,,BAO_0000019,,
3361,1,Antagonistic activity evaluated by ability to block serotonin induced relaxation (via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 3*10e-8 M.,,8,10623,,H,Expert,,CHEMBL620598,,BAO_0000019,,
3362,1,Antagonistic activity evaluated by ability to block serotonin induced relaxation via 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 0.1 mg/kg (p.o.),,8,10623,,H,Expert,,CHEMBL620599,,BAO_0000218,,
3363,1,Antagonistic activity of compound was evaluated by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-7 M.,,8,10623,,H,Autocuration,,CHEMBL620600,,BAO_0000019,,
3364,1,Estimate from relaxation of carbachol-contracted rat esophageal muscularis mucosae,Rattus norvegicus,8,168,,H,Autocuration,,CHEMBL620601,,BAO_0000019,,
3365,1,Compound was tested for agonistic activity against 5-hydroxytryptamine 4 receptor on guinea colon at a concentration 0.1 uM,,8,168,,H,Autocuration,,CHEMBL620602,,BAO_0000019,,
3366,1,Tested for affinity towards 5-hydroxytryptamine 4 receptor,,8,168,,H,Autocuration,,CHEMBL620603,,BAO_0000357,,
3367,1,Tested for affinity towards 5-hydroxytryptamine 4 receptor.,,8,168,,H,Autocuration,,CHEMBL620604,,BAO_0000357,,
3368,1,Compound was tested for 5-hydroxytryptamine 4 binding affinity,,8,168,,H,Autocuration,,CHEMBL620605,,BAO_0000357,,
3369,1,Compound was tested for its affinity towards 5-hydroxytryptamine 4 receptor,,8,168,,H,Autocuration,,CHEMBL620606,,BAO_0000357,,
3370,1,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,8,168,,H,Autocuration,,CHEMBL620607,,BAO_0000019,,
3371,1,In vitro binding affinity towards 5-HT4 receptor was determined,,8,168,,H,Autocuration,,CHEMBL620608,,BAO_0000357,,
3372,1,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,8,168,,H,Autocuration,,CHEMBL620609,,BAO_0000019,,
3373,1,Tested for agonist activity against 5-hydroxytryptamine 4 receptor,,8,168,,H,Autocuration,,CHEMBL620610,,BAO_0000019,,
3374,1,Tested for selectivity for 5-hydroxytryptamine 4 receptor,,8,168,,H,Autocuration,,CHEMBL620611,,BAO_0000357,,
3375,1,Tested for 5-hydroxytryptamine 4 binding affinity against cisapride,,8,168,,H,Autocuration,,CHEMBL620612,,BAO_0000357,,
3376,1,Tested for 5-hydroxytryptamine 4 binding affinity against renzapride,,8,168,,H,Autocuration,,CHEMBL620613,,BAO_0000357,,
3377,1,Tested for 5-hydroxytryptamine 4 binding affinity against zacopride,,8,168,,H,Autocuration,,CHEMBL620614,,BAO_0000357,,
3378,1,Binding affinity against 5-Hydroxytryptamine 4 receptor,,8,168,,H,Expert,,CHEMBL620615,,BAO_0000357,,
3379,1,Compound was evaluated for the displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 recognition sites in rat brain membranes,,6,104698,Brain membranes,H,Autocuration,,CHEMBL857075,,BAO_0000249,,
3380,1,Compound was evaluated for the displacement of [3H]Q-ICS-205-930 from 5-HT3 recognition sites in rat brain membranes,,6,104698,Brain membranes,H,Autocuration,,CHEMBL620616,,BAO_0000249,,
3381,1,Displacement of [3H]Q-ICS-205-930 from 5-hydroxytryptamine 3 receptor recognition sites in rat brain membranes,,6,104698,Brain membranes,H,Autocuration,,CHEMBL619411,,BAO_0000249,,
3382,1,Displacement of [3H]-Q-ICS 205-930 binding to 5-hydroxytryptamine 3 receptor from rat cortex homogenate,,6,104698,,H,Autocuration,,CHEMBL619412,,BAO_0000019,,
3383,1,Displacement of [3H]-Q-ICS 205-930 from rat cortex homogenate 5-hydroxytryptamine 3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL619413,,BAO_0000019,,
3384,1,Binding affinity of 5-hydroxytryptamine 3 receptor using [3H]granisetron in rat hippocampus and entorhinal cortex,,6,104698,,H,Autocuration,,CHEMBL619414,,BAO_0000221,10000000.0,
3385,1,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]GR-65630 as radioligand in rat cortex,,6,104698,,H,Autocuration,,CHEMBL619415,,BAO_0000019,,
3386,1,Binding affinity to 5-hydroxytryptamine 3 receptor using [3H]quipazine as radioligand in rat cortex,,6,104698,,H,Autocuration,,CHEMBL619416,,BAO_0000019,,
3387,1,Rat 5-hydroxytryptamine 3 receptor (5-HT3) antagonist,,6,104698,,H,Autocuration,,CHEMBL619417,,BAO_0000019,,
3388,1,Binding affinity against rat 5-hydroxytryptamine 3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL619418,,BAO_0000223,,
3389,1,Binding affinity against 5-Hydroxytryptamine 3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL619419,,BAO_0000223,,
3390,1,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of racemic [3H]zacopride from rat cortex,,6,104698,,H,Autocuration,,CHEMBL619420,,BAO_0000019,,
3391,1,Binding affinity to 5-hydroxytryptamine 3 receptor was determined in rat cerebro cortical membranes using [3H]quipazine.,,6,104698,,H,Autocuration,,CHEMBL619421,,BAO_0000249,,
3392,1,Displacement of [3H]granisetron from 5-hydroxytryptamine 3 receptor of rat cortex,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL619422,,BAO_0000019,,
3393,1,In vitro by displacement of [3H]LY-278584 from 5-hydroxytryptamine 3 receptor on rat entorhinal cortex,,6,104698,,H,Autocuration,,CHEMBL619423,,BAO_0000019,,
3394,1,Tested for its binding affinity by measuring its ability to displace [3H]granisetron from 5-hydroxytryptamine 3 receptor in rat cortex,,6,104698,,H,Autocuration,,CHEMBL875080,,BAO_0000019,,
3395,1,The binding affinity (pKi) measured against 5-hydroxytryptamine 1A receptor of rat cortex using [3H]8-OH-DPAT as radioligand,,6,104698,,H,Autocuration,,CHEMBL619424,,BAO_0000019,,
3396,1,Binding affinity at 5-hydroxytryptamine 3 receptor in rat cortical membrane by [3H]graniestron displacement.,,6,104698,,H,Autocuration,,CHEMBL619425,,BAO_0000249,,
3397,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand,,6,104698,,H,Autocuration,,CHEMBL619426,,BAO_0000223,,
3398,1,The compound was tested for the binding affinity against 5-hydroxytryptamine 3 receptor using [3H]zacopride as radioligand.,,6,104698,,H,Autocuration,,CHEMBL619427,,BAO_0000223,,
3399,1,pKi value for inhibition of [3H]LY-278584 binding to 5-hydroxytryptamine 3 receptor,Rattus norvegicus,7,104698,,D,Autocuration,,CHEMBL619645,,BAO_0000223,,
3400,1,"Compound was evaluated for binding affinity on 5-hydroxytryptamine 1A receptor in rat hippocampus membranes,3H-8-OH-DPAT and buspirone for nonspecific binding",,9,10576,,D,Expert,,CHEMBL619646,,BAO_0000249,,
3401,1,Compound was tested for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat brain using [3H]zacopride as the radioligand.,,8,12020,,H,Autocuration,,CHEMBL619647,,BAO_0000221,955.0,
3402,1,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor,,8,12020,,H,Autocuration,,CHEMBL619648,,BAO_0000019,,
3403,1,Compound was tested in vitro for its antagonistic activity against 5-hydroxytryptamine 3 receptor in rat CNS.,,8,12020,,H,Autocuration,,CHEMBL619165,,BAO_0000019,,
3404,1,Compound was evaluated in vivo for the antagonistic activity towards 5-hydroxytryptamine 3 receptor,,8,12020,,H,Autocuration,,CHEMBL620719,,BAO_0000218,,
3405,1,Compound was tested for its binding affinity towards 5-HT-3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,,8,12020,,H,Autocuration,,CHEMBL872924,,BAO_0000019,,
3406,1,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor,,8,12020,,H,Autocuration,,CHEMBL620720,,BAO_0000357,,
3407,1,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using (S)-[125I]-zacopride as the radioligand.,,8,12020,,H,Autocuration,,CHEMBL620721,,BAO_0000019,,
3408,1,Compound was tested for its binding affinity towards 5-hydroxytryptamine 3 receptor in whole rat brain using [125I]DAIZAC as the radioligand.,,8,12020,,H,Autocuration,,CHEMBL620722,,BAO_0000019,,
3409,1,"Concentration that inhibits the binding of radioligand, [3H]-ICS 205930, to 5-hydroxytryptamine 3 receptor from rat cortex",,6,104698,,H,Autocuration,,CHEMBL620723,,BAO_0000019,,
3410,1,In Vitro Binding affinity againist 5-hydroxytryptamine 3 receptor by displacing [3H]-Q-ICS 205-930 from rat cortex homogenates,,8,12020,,H,Autocuration,,CHEMBL620724,,BAO_0000019,,
3411,1,Binding affinity against 5-hydroxytryptamine 3 (5-HT3) receptor in rat brain cortical membranes using radioligand [3H]quipazine,,6,104698,,H,Autocuration,,CHEMBL620725,,BAO_0000249,,
3412,1,Antagonist activity (100 ug/kg) for the Bezold Jarisch reflex evoked by 30 (ug/Kg) of 5-hydroxytryptamine 3 receptor in ethylurethane anesthetized rats i.v.,Rattus norvegicus,9,12020,,D,Autocuration,,CHEMBL620726,,BAO_0000019,,
3413,1,Binding affinity towards 5-hydroxytryptamine 3 receptor,,8,144,,H,Expert,,CHEMBL620727,,BAO_0000357,,
3414,1,Compound was evaluated for 5-hydroxytryptamine 3 receptor binding,,4,104714,,H,Autocuration,,CHEMBL620728,,BAO_0000223,,
3415,1,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,0,22226,,U,Autocuration,,CHEMBL620729,,BAO_0000019,,
3416,1,Tested for 5-hydroxytryptamine 3 receptor antagonist activity by inhibiting the 5-HT evoked Bezold-Jarisch reflex,,4,104714,,H,Autocuration,,CHEMBL858288,,BAO_0000019,,
3417,1,Compound was tested for binding affinity towards 5-hydroxytryptamine 3 receptor,,4,104714,,H,Autocuration,,CHEMBL620730,,BAO_0000223,,
3418,1,Binding affinity towards 5-hydroxytryptamine 3 receptor,,4,104714,,H,Autocuration,,CHEMBL620731,,BAO_0000223,,
3419,1,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 0.3 uM,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL620732,,BAO_0000019,,
3420,1,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL618042,,BAO_0000019,,
3421,1,Compound was tested for antagonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 30 uM,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL618043,,BAO_0000019,,
3422,1,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,,4,104714,,H,Autocuration,,CHEMBL618044,,BAO_0000223,,
3423,1,Evaluated for the 5-hydroxytryptamine 3 receptor antagonistic activity in Bezold-Jarisch model expressed as inhibition of the reflex bradycardia induced by an intravenous injection,,4,104714,,H,Autocuration,,CHEMBL618045,,BAO_0000019,,
3424,1,Compound was measured for its binding affinity at 5-hydroxytryptamine 3 receptor at a concentration of 10 uM using [3H]BRL-43694 as radioligand,,4,104714,,H,Autocuration,,CHEMBL618046,,BAO_0000223,,
3425,1,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); A: agonist,,4,104714,,H,Autocuration,,CHEMBL618047,,BAO_0000019,,
3426,1,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: agonist,,4,104714,,H,Autocuration,,CHEMBL875084,,BAO_0000019,,
3427,1,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); ANT: antagonist,,4,104714,,H,Autocuration,,CHEMBL618048,,BAO_0000019,,
3428,1,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); NA means data not available,,4,104714,,H,Autocuration,,CHEMBL618049,,BAO_0000223,,
3429,1,Intrinsic activity towards 5-hydroxytryptamine 3 receptor was determined by Benzold-Jarisch reflex (peripheral assay); PA: Partial agonist,,4,104714,,H,Autocuration,,CHEMBL619764,,BAO_0000019,,
3430,1,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; A: agonist,,4,104714,,H,Autocuration,,CHEMBL619765,,BAO_0000019,,
3431,1,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; ANT: Antagonist,,4,104714,,H,Autocuration,,CHEMBL619766,,BAO_0000019,,
3432,1,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA: not active,,4,104714,,H,Autocuration,,CHEMBL619767,,BAO_0000223,,
3433,1,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; NA means data not available,,4,104714,,H,Autocuration,,CHEMBL619768,,BAO_0000223,,
3434,1,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; PA: Partial agonist,,4,104714,,H,Autocuration,,CHEMBL619769,,BAO_0000019,,
3435,1,Intrinsic activity towards CNS 5-hydroxytryptamine 3 receptor was determined; na means data not available,,4,104714,,H,Autocuration,,CHEMBL619770,,BAO_0000223,,
3436,1,Binding affinity towards 5-hydroxytryptamine 3 receptor,,4,104714,,H,Autocuration,,CHEMBL619771,,BAO_0000223,,
3437,1,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor using [3H]-BRL-43694 (1 nM) ligand in NG cells 108-15 was determined,,4,104714,,H,Autocuration,,CHEMBL619772,,BAO_0000219,,
3438,1,Binding affinity of compound towards 5-hydroxytryptamine 3 receptor; NA: not active,,4,104714,,H,Autocuration,,CHEMBL619773,,BAO_0000223,,
3439,1,Binding affinity for 5-HT3 receptor of NG108-15 cells using [3H]GR-65630,,4,104714,,H,Autocuration,,CHEMBL619774,433.0,BAO_0000219,,
3440,1,Binding affinity to 5-HT3 serotonin receptor in NG 108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand.,,4,104714,,H,Autocuration,,CHEMBL875083,,BAO_0000019,,
3441,1,Binding affinity to 5-HT3 serotonin receptor in NG108-15 neuroblastoma glioma cells using [3H]GR-65630 radioligand,,4,104714,,H,Autocuration,,CHEMBL620718,433.0,BAO_0000219,,
3442,1,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,,4,104714,,H,Autocuration,,CHEMBL618127,,BAO_0000223,,
3443,1,Compound was tested for selectivity against 5-hydroxytryptamine 3 receptor binding affinity,,4,104714,,H,Autocuration,,CHEMBL618128,,BAO_0000223,,
3444,1,Compound was tested for the inhibition of [3H]GR-65630 binding to 5-hydroxytryptamine 3 receptor expressed in NG 108-15 cells,,4,104714,,H,Autocuration,,CHEMBL618129,,BAO_0000219,,
3445,1,In vitro Binding affinity towards 5-hydroxytryptamine 3 receptor was determined,,4,104714,,H,Autocuration,,CHEMBL618130,,BAO_0000223,,
3446,1,Tested for 5-hydroxytryptamine 3 receptor antagonist activity,,4,104714,,H,Autocuration,,CHEMBL618131,,BAO_0000019,,
3447,1,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 1 uM,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL618132,,BAO_0000019,,
3448,1,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL618133,,BAO_0000019,,
3449,1,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 10 uM in the presence of 30 uM MDL 72222,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL618134,,BAO_0000019,,
3450,1,Compound was tested for agonistic activity against 5-hydroxytryptamine 3 receptor on guinea pig colon at a concentration of 3 uM,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL618135,,BAO_0000019,,
3451,1,Binding affinity for the 5-hydroxytryptamine 3 receptor was evaluated in vitro by examining its ability to displace [3H]-BRL 43694.,,4,104714,,H,Autocuration,,CHEMBL618136,,BAO_0000223,,
3452,1,Binding affinity towards 5-hydroxytryptamine 3 receptor,,4,104714,,H,Autocuration,,CHEMBL618137,,BAO_0000223,,
3453,1,Compound was evaluated for binding affinity against 5-hydroxytryptamine 3 receptor using radioligand binding assay,,4,104714,,H,Autocuration,,CHEMBL618138,,BAO_0000223,,
3454,1,Tested against 5-hydroxytryptamine 3 receptor in experiment 1,,4,104714,,H,Autocuration,,CHEMBL618139,,BAO_0000223,,
3455,1,Tested against 5-hydroxytryptamine 3 receptor in experiment 2,,4,104714,,H,Autocuration,,CHEMBL618140,,BAO_0000223,,
3456,1,Binding affinity against 5-hydroxytryptamine 3 receptor was measured using [3H]granisetron as radioligand,,4,104714,,H,Autocuration,,CHEMBL618141,,BAO_0000223,,
3457,1,Binding affinity for 5-hydroxytryptamine 2C receptor,,8,108,,H,Expert,,CHEMBL873478,,BAO_0000357,,
3458,1,Binding affinity towards 5-hydroxytryptamine 3 receptor,,6,104698,,H,Autocuration,,CHEMBL618142,,BAO_0000223,,
3459,1,Compound was evaluated for the affinity at 5-hydroxytryptamine 3 receptor,,8,144,,H,Autocuration,,CHEMBL618143,,BAO_0000357,,
3460,1,Compound was tested for its affinity towards 5-hydroxytryptamine 3 receptor,,8,144,,H,Autocuration,,CHEMBL618144,,BAO_0000357,,
3461,1,Inhibition of GR-65630 binding to 5-hydroxytryptamine 3 receptor,,8,144,,H,Autocuration,,CHEMBL618145,,BAO_0000357,,
3462,1,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,,4,104714,,H,Autocuration,,CHEMBL618146,,BAO_0000223,,
3463,1,Inhibition of [3H]-BRL 43 694 binding to 5-hydroxytryptamine 3 receptor of central nervous system,,4,104714,,H,Autocuration,,CHEMBL618147,,BAO_0000223,,
3464,1,Inhibition of [3H]- BRL 43 694 binding to 5-hydroxytryptamine 3 receptor at 10e-5 M,,4,104714,,H,Autocuration,,CHEMBL618148,,BAO_0000223,,
3465,1,Binding affinity towards 5-hydroxytryptamine 3 receptor by displacement of [3H]2 in Neuroblastoma-Glioma NG-108-15 cells,,8,144,,H,Autocuration,,CHEMBL618149,,BAO_0000019,,
3466,1,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,8,144,,H,Autocuration,,CHEMBL872927,,BAO_0000357,,
3467,1,Compound was evaluated for its binding affinity towards 5-hydroxytryptamine 3 receptor,,8,144,,H,Autocuration,,CHEMBL618150,,BAO_0000357,,
3468,1,Compound was tested for 5-hydroxytryptamine 3 receptor binding affinity,,8,144,,H,Autocuration,,CHEMBL618151,,BAO_0000357,,
3469,1,Compound was tested for its binding affinity for the 5-hydroxytryptamine 3 receptor,,8,144,,H,Autocuration,,CHEMBL875094,,BAO_0000357,,
3470,1,In vitro binding affinity for the 5-hydroxytryptamine 3 receptor was determined with NG-108-15 mouse neuroblastoma-glioma cells,,8,144,,H,Autocuration,,CHEMBL618152,,BAO_0000019,,
3471,1,In vitro binding affinity towards 5-hydroxytryptamine 3 receptor was determined,,8,144,,H,Autocuration,,CHEMBL618153,,BAO_0000357,,
3472,1,Inhibitory constant against 5-hydroxytryptamine 3 receptor using [3H]GR-65630 radioligand,,8,144,,H,Autocuration,,CHEMBL618888,,BAO_0000357,,
3473,1,Tested for 5-hydroxytryptamine 3 receptor agonist activity,,8,144,,H,Autocuration,,CHEMBL618889,,BAO_0000019,,
3474,1,The binding affinity towards 5-hydroxytryptamine 3 receptor; No affinity,,8,144,,H,Autocuration,,CHEMBL618890,,BAO_0000357,,
3475,1,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H](R)-zacopride from ondansetron-treated NG-108-15 cell membranes,,8,144,,H,Autocuration,,CHEMBL618891,,BAO_0000019,,
3476,1,Binding affinity for 5-hydroxytryptamine 3 receptor by displacement of [3H]-BRL 43694 from NG-108-15 cell membranes,,8,144,,H,Autocuration,,CHEMBL619054,,BAO_0000019,,
3477,1,Binding affinity against the 5-hydroxytryptamine 3 receptor,,4,104714,,H,Autocuration,,CHEMBL619055,,BAO_0000223,,
3478,1,Binding affinity against human 5-hydroxytryptamine 3A receptor,,8,144,,H,Autocuration,,CHEMBL619056,,BAO_0000357,,
3479,1,Percent efficacy against 5-hydroxytryptamine 3A receptor,,8,144,,H,Autocuration,,CHEMBL619057,,BAO_0000019,,
3480,1,Binding affinity against human 5-hydroxytryptamine 3A receptor,,8,144,,H,Autocuration,,CHEMBL619058,,BAO_0000357,,
3481,1,Response at rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes,Rattus norvegicus,9,12020,,D,Expert,,CHEMBL619059,,BAO_0000219,,
3482,1,Ability to block serotonin (30 uM)-evoked responses at rat 5HT3-alpha receptor expressed in xenopus oocytes,Rattus norvegicus,9,12020,,D,Expert,,CHEMBL619060,,BAO_0000219,,
3483,1,Effect on rat 5-hydroxytryptamine 3a receptor expressed in xenopus oocytes at concentration up to 100 uM,Rattus norvegicus,9,12020,,D,Expert,,CHEMBL875095,,BAO_0000219,,
3484,1,5-hydroxytryptamine 4 receptor agonist activity as percent maximum 5-HT effect in response to electrical stimulation in male guinea pig ileum,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619061,,BAO_0000221,2116.0,
3485,1,5-hydroxytryptamine 4 receptor agonist activity expressed as the concentration which gave a 50% increase in the response to the electrical stimulation in male guinea pig ileum,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619062,,BAO_0000221,2116.0,
3486,1,5-hydroxytryptamine 4 receptor agonist activity is expressed as percent of the maximum 5-HT response,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619063,,BAO_0000019,,
3487,1,Tested for affinity towards 5-hydroxytryptamine 4 receptor in electrically stimulated longitudinal muscle preparation of guinea pig ileum,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619064,,BAO_0000221,2116.0,
3488,1,Tested for affinity towards 5-hydroxytryptamine 4 receptor in guinea pig distal colon preparation,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619065,,BAO_0000357,,
3489,1,Tested for affinity towards 5-hydroxytryptamine 4 receptor in isolated guinea pig ileum longitudinal muscle preparation,Cavia porcellus,9,20033,,D,Intermediate,,CHEMBL619066,,BAO_0000221,2116.0,
3490,1,Maximal relaxation effect induced by 3 uM compound on substance P stimulated guinea pig ileum with 5-hydroxytryptamine 7 receptor nondesensitization,,8,10209,,H,Autocuration,,CHEMBL619775,,BAO_0000221,2116.0,
3491,1,Affinity against 5-hydroxytryptamine 7 receptor,,8,10209,,H,Autocuration,,CHEMBL619776,,BAO_0000357,,
3492,1,Ability to displace [3H]5-HT binding from 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,Cavia porcellus,4,104841,,H,Autocuration,,CHEMBL619777,,BAO_0000224,,
3493,1,Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand,Cavia porcellus,4,104841,,H,Autocuration,,CHEMBL619778,,BAO_0000224,,
3494,1,Evaluated for inhibition of 5-hydroxytryptamine receptor on guinea pig ileum at 10 uM; No effect,Cavia porcellus,4,104841,,H,Autocuration,,CHEMBL619779,,BAO_0000221,2116.0,
3495,1,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor site using 1 uM LSD as masking ligand, activity is expressed as Kd.",Cavia porcellus,4,104841,,H,Autocuration,,CHEMBL619780,,BAO_0000224,,
3496,1,"Ability to displace [3H]5-HT binding to 5-hydroxytryptamine receptor using 1 uM LSD as masking ligand, activity is expressed as Kd.",Cavia porcellus,4,104841,,H,Autocuration,,CHEMBL619166,,BAO_0000224,,
3497,1,5-HT level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,Cavia porcellus,4,104841,,H,Autocuration,,CHEMBL619167,,BAO_0000019,,
3498,1,5-hydroxytryptamine level in K+ induced 5-hydroxytryptamine release in guinea pig cortex.,Cavia porcellus,4,104841,,H,Autocuration,,CHEMBL619168,,BAO_0000019,,
3499,1,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor in the presence of 10 nM compound in isolated human atrial myocytes,Homo sapiens,9,168,,D,Expert,,CHEMBL619169,,BAO_0000219,2081.0,
3500,1,Concentration required to produce half-maximal response against 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes,Homo sapiens,9,168,,D,Expert,,CHEMBL619170,,BAO_0000219,2081.0,
3501,1,"Maximum stimulation of [35S]GTP-gamma-S, binding expressed relative to the maximal effect of 5-hydroxytryptamine",Homo sapiens,5,104841,,D,Autocuration,,CHEMBL619171,,BAO_0000019,,
3502,1,",Antagonism of stimulation of 5-hydroxytryptamine receptor on the L-type calcium current (I Ca) in isolated human atrial myocytes",Homo sapiens,9,168,,D,Expert,,CHEMBL619172,,BAO_0000219,2081.0,
3503,1,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to 5-hydroxytryptamine receptor in mice,Mus musculus,0,22226,,U,Autocuration,,CHEMBL619173,,BAO_0000019,,
3504,1,Percent inhibition of radioligand [3H]-LSD binding to 5-HT receptor at 10 uM concentration,Mus musculus,0,22226,,U,Autocuration,,CHEMBL619174,,BAO_0000019,,
3505,1,5-hydroxytryptamine receptor binding affinity was determined in rats,,4,104705,,H,Autocuration,,CHEMBL619175,,BAO_0000019,,
3506,1,Binding affinity at rat 5-hydroxytryptamine receptor.,,4,104705,,H,Autocuration,,CHEMBL619176,,BAO_0000224,,
3507,1,Affinity against 5-hydroxytryptamine receptors in rat fundus model,,4,104705,,H,Autocuration,,CHEMBL619177,,BAO_0000019,,
3508,1,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation,,4,104705,,H,Autocuration,,CHEMBL619178,,BAO_0000224,,
3509,1,Affinity for 5-hydroxytryptamine receptor was determined using male Dawley rat fundus preparation; Not determined,,4,104705,,H,Autocuration,,CHEMBL619179,,BAO_0000224,,
3510,1,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation,,4,104705,,H,Autocuration,,CHEMBL619180,,BAO_0000019,945.0,
3511,1,Antagonistic activity against serotonin 5-HT receptor obtained from rat stomach fundus preparation (resulted in discoloration in the oxygenated muscle bath to give varying results).,,4,104705,,H,Autocuration,,CHEMBL619181,,BAO_0000019,945.0,
3512,1,Antagonistic activity of corresponding methoxy compound against serotonin 5-HT receptor,,4,104705,,H,Autocuration,,CHEMBL619182,,BAO_0000019,,
3513,1,Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2,,4,104705,,H,Autocuration,,CHEMBL619183,,BAO_0000224,,
3514,1,"Compound was evaluated for binding affinity towards 5-hydroxytryptamine receptor in isolated rat fundus preparation measured as pA2; Valid pA2, can not be determined because of slope of Schild plot.",,4,104705,,H,Autocuration,,CHEMBL619184,,BAO_0000224,,
3515,1,In vitro affinity towards 5-hydroxytryptamine 1A receptor using [3H]8-OH-DPAT as radioligand in hippocampus,,8,10576,,H,Autocuration,,CHEMBL619185,,BAO_0000221,10000000.0,
3516,1,Binding affinity for rat 5-hydroxytryptamine transporter.,,8,12198,,H,Expert,,CHEMBL619186,,BAO_0000357,,
3517,1,Evaluated for inhibition of specific [3H]5-HT receptor binding in rat cortex.,,4,104705,,H,Autocuration,,CHEMBL619187,,BAO_0000019,,
3518,1,Binding affinity at serotonin 5-HT1-type site receptor in rat cortex by displacing [3H]5-HT,Rattus norvegicus,5,104705,,D,Autocuration,,CHEMBL619188,,BAO_0000019,,
3519,1,Compound was tested for its inhibitory activity against 5-hydroxytryptamine receptor,Rattus norvegicus,5,104705,,D,Autocuration,,CHEMBL619189,,BAO_0000224,,
3520,1,Inhibitory activity against [3H]- 5-hydroxytryptamine reuptake in whole rat brain minus cerebellum,Rattus norvegicus,9,12198,,D,Expert,,CHEMBL619190,,BAO_0000019,955.0,
3521,1,Inhibition of [3H]5-HT reuptake in whole rat brain (minus cerebellum) homogenate.,Rattus norvegicus,9,12198,,D,Expert,,CHEMBL619191,,BAO_0000221,2037.0,
3522,1,Displacement of [3H]-citalopram from rat forebrain membrane 5-hydroxytryptamine receptor at 10e-7 M,Rattus norvegicus,5,104705,,D,Autocuration,,CHEMBL619192,,BAO_0000019,,
3523,1,Percent binding affinity against 5-hydroxytryptamine receptor,Rattus norvegicus,5,104705,,D,Autocuration,,CHEMBL619193,,BAO_0000224,,
3524,1,Ability to displace 0.4 nM [3H]paroxetine binding to 5-hydroxytryptamine receptor in rat frontal cortex,,0,22226,,U,Autocuration,,CHEMBL619194,,BAO_0000019,,
3525,1,The binding affinity was measured on 5-hydroxytryptamine receptor uptake receptor using [3H]- paroxetine as radioligand.,Rattus norvegicus,5,104705,,D,Autocuration,,CHEMBL619195,,BAO_0000224,,
3526,1,Affinity against 5-hydroxytryptamine receptor was determined,Rattus norvegicus,5,104705,,D,Autocuration,,CHEMBL619196,,BAO_0000224,,
3527,1,Affinity against 5-hydroxytryptamine receptor was determined in rat stomach fundus strip,Rattus norvegicus,5,104705,,D,Autocuration,,CHEMBL619197,,BAO_0000019,945.0,
3528,1,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,Homo sapiens,9,121,,D,Expert,,CHEMBL619198,,BAO_0000219,,
3529,1,Inhibition of [3H]5-HT uptake in HEK cells expressing human SERT,Homo sapiens,9,121,,D,Expert,,CHEMBL875081,,BAO_0000219,,
3530,1,Ability to compete with radioactive ligands specific to the Serotonergic 5-HT receptor at 10 uM; NA means compound failed to compete,,8,18065,,H,Autocuration,,CHEMBL884712,,BAO_0000357,,
3531,1,Inhibition of 5-hydroxytryptamine reuptake,,8,121,,H,Expert,,CHEMBL884710,,BAO_0000357,,
3532,1,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding",,8,18065,,H,Autocuration,,CHEMBL619199,,BAO_0000019,,
3533,1,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 1)",,8,18065,,H,Autocuration,,CHEMBL619200,,BAO_0000019,,
3534,1,"Receptor-linked G protein activation at 5-hydroxytryptamine receptor was determined by measuring the stimulation of [35S]GTP-gamma-S, binding (Experiment 2)",,8,18065,,H,Autocuration,,CHEMBL619201,,BAO_0000019,,
3535,1,Tested for 5-hydroxytryptamine receptor uptake,,8,18065,,H,Autocuration,,CHEMBL619202,,BAO_0000019,,
3536,1,Affinity constant on CHO cells expressing Human recombinant 5-hydroxytryptamine receptor 1A,Homo sapiens,9,51,,D,Expert,,CHEMBL619203,449.0,BAO_0000219,,
3537,1,Antagonistic affinity tested against isolated human cloned alpha-1d adrenoceptor subtype,Homo sapiens,9,51,,D,Expert,,CHEMBL619204,,BAO_0000019,,
3538,1,In vitro binding affinity towards 5-hydroxytryptamine receptor 1A receptor by using [3H]8-OH-DPAT in rat hippocampal membranes.,Homo sapiens,8,10576,,H,Autocuration,,CHEMBL619205,,BAO_0000249,,
3539,1,Tested in vitro for % inhibition against 5-hydroxytryptamine receptor 1A,,8,10576,,H,Autocuration,,CHEMBL619206,,BAO_0000357,,
3540,1,In vitro binding affinity at 5-hydroxytryptamine receptor 1A receptor in rat hippocampal membranes by [3H]8-OH-DPAT displacement.,,8,10576,,H,Expert,,CHEMBL619207,,BAO_0000249,,
3541,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 0.10 umol/kg,,8,10825,,H,Autocuration,,CHEMBL619208,,BAO_0000019,2435.0,
3542,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats corpus striatum at a dosage of 10 umol/kg,,8,10825,,H,Autocuration,,CHEMBL619209,,BAO_0000019,2435.0,
3543,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 0.32 umol/kg,,8,10825,,H,Autocuration,,CHEMBL619210,,BAO_0000019,2435.0,
3544,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 3.2 umol/kg,,8,10825,,H,Autocuration,,CHEMBL619211,,BAO_0000019,2435.0,
3545,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP in rats in corpus striatum at a dosage of 32 umol/kg,,8,10825,,H,Autocuration,,CHEMBL619212,,BAO_0000019,2435.0,
3546,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 0.032 umol/kg,,8,10825,,H,Autocuration,,CHEMBL620681,,BAO_0000019,2435.0,
3547,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 1.0 umol/kg,,8,10825,,H,Autocuration,,CHEMBL620682,,BAO_0000019,2435.0,
3548,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 10 umol/kg,,8,10825,,H,Autocuration,,CHEMBL620683,,BAO_0000019,2435.0,
3549,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 100 umol/kg,,8,10825,,H,Autocuration,,CHEMBL620684,,BAO_0000019,2435.0,
3550,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 3.2 umol/kg,,8,10825,,H,Autocuration,,CHEMBL620685,,BAO_0000019,2435.0,
3551,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 32 umol/kg,,8,10825,,H,Autocuration,,CHEMBL620686,,BAO_0000019,2435.0,
3552,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.032 umol/kg,,8,10825,,H,Autocuration,,CHEMBL620687,,BAO_0000019,349.0,
3553,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.10 umol/kg,,8,10825,,H,Autocuration,,CHEMBL620688,,BAO_0000019,349.0,
3554,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 0.32 umol/kg,,8,10825,,H,Autocuration,,CHEMBL620689,,BAO_0000019,349.0,
3555,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 1.0 umol/kg,,8,10825,,H,Autocuration,,CHEMBL620690,,BAO_0000019,349.0,
3556,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 10 umol/kg,,8,10825,,H,Autocuration,,CHEMBL620691,,BAO_0000019,349.0,
3557,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 100 umol/kg,,8,10825,,H,Autocuration,,CHEMBL620692,,BAO_0000019,349.0,
3558,1,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in limbic system at a dosage of 3.2 umol/kg,,8,10825,,H,Autocuration,,CHEMBL620693,,BAO_0000019,349.0,
3559,1,Binding affinity against 5-hydroxytryptamine 4 receptor,,8,168,,H,Expert,,CHEMBL620694,,BAO_0000357,,
3560,1,Tested for 5-hydroxytryptamine 4 receptor antagonist activity,,8,168,,H,Autocuration,,CHEMBL857986,,BAO_0000019,,
3561,1,Inhibitory activity against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 as radioligand at 10e-5 M concentration,,8,168,,H,Autocuration,,CHEMBL620695,,BAO_0000357,,
3562,1,Binding affinity towards Serotonin 5-hydroxytryptamine 4 receptor,,8,168,,H,Expert,,CHEMBL620696,,BAO_0000357,,
3563,1,Inhibitory constant against 5-hydroxytryptamine 4 receptor using [3H]GR-113808 radioligand,,8,168,,H,Autocuration,,CHEMBL620697,,BAO_0000357,,
3564,1,Binding affinity towards 5-hydroxytryptamine 4 receptor,,8,168,,H,Autocuration,,CHEMBL620698,,BAO_0000357,,
3565,1,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,,8,168,,H,Autocuration,,CHEMBL620699,,BAO_0000357,,
3566,1,Binding affinity towards 5-hydroxytryptamine 4 receptor; ND means no data.,,8,168,,H,Autocuration,,CHEMBL620700,,BAO_0000357,,
3567,1,Binding affinity was determined against cloned 5-hydroxytryptamine 4A receptor isoform expressed in COS-7 cells,,8,168,,H,Autocuration,,CHEMBL620701,643.0,BAO_0000219,,
3568,1,Binding affinity was determined against cloned 5-hydroxytryptamine 4B receptor isoform expressed in COS-7 cells,,8,168,,H,Autocuration,,CHEMBL875082,643.0,BAO_0000219,,
3569,1,Binding affinity was determined against cloned 5-hydroxytryptamine 4C receptor isoform expressed in COS-7 cells,,8,168,,H,Autocuration,,CHEMBL620702,643.0,BAO_0000219,,
3570,1,Binding affinity was determined against cloned 5-hydroxytryptamine 4D receptor isoform expressed in COS-7 cells,,8,168,,H,Autocuration,,CHEMBL620703,643.0,BAO_0000219,,
3571,1,Binding affinity of compound towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,,8,168,,H,Autocuration,,CHEMBL620704,673.0,BAO_0000219,,
3572,1,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand,,8,168,,H,Expert,,CHEMBL620705,673.0,BAO_0000219,,
3573,1,Binding affinity was determined against cloned 5-hydroxytryptamine 4E receptor isoform expressed in C6 glial cells incubated with 0.2 nM [3H]GR-113808,,8,168,,H,Expert,,CHEMBL620706,673.0,BAO_0000219,,
3574,1,Binding affinity towards cloned human 5-hydroxytryptamine 4E receptor expressed in C6 glial cells using [3H]GR-113808 as radioligand; Not determined,,8,168,,H,Expert,,CHEMBL620707,673.0,BAO_0000219,,
3575,1,Binding affinity towards 5-hydroxytryptamine 5 receptor,,8,10624,,H,Expert,,CHEMBL620708,,BAO_0000357,,
3576,1,Inhibitory constant against human 5-hydroxytryptamine 5A receptor using [3H]LSD radioligand,,8,105,,H,Autocuration,,CHEMBL620709,,BAO_0000357,,
3577,1,Binding affinity against 5-hydroxytryptamine 5A receptor,Homo sapiens,9,10624,,D,Expert,,CHEMBL620710,,BAO_0000357,,
3578,1,Compound was tested for the displacement of [3H]5-HT binding to cloned human 5-hydroxytryptamine 5A receptor stably expressed in CHO cells,,8,10624,,H,Autocuration,,CHEMBL620711,449.0,BAO_0000219,,
3579,1,Affinity towards human 5-hydroxytryptamine 5A serotonin receptor,Homo sapiens,9,10624,,D,Expert,,CHEMBL620712,,BAO_0000357,,
3580,1,Binding affinity towards human 5-hydroxytryptamine 5A receptor,Homo sapiens,9,10624,,D,Expert,,CHEMBL620713,,BAO_0000357,,
3581,1,Binding affinity towards human 5-hydroxytryptamine 5A receptor was evaluated using [3H]-5-CT as radioligand,Homo sapiens,9,10624,,D,Expert,,CHEMBL620714,,BAO_0000357,,
3582,1,Binding affinity to cloned human 5-hydroxytryptamine 5A receptor,Homo sapiens,9,10624,,D,Expert,,CHEMBL620715,,BAO_0000357,,
3583,1,Binding affinity towards 5-HT5A receptor,,8,10624,,H,Autocuration,,CHEMBL620716,,BAO_0000357,,
3584,1,Binding affinity towards human 5-hydroxytryptamine 5A receptor using LSD as radioligand,,8,10624,,H,Expert,,CHEMBL620717,,BAO_0000357,,
3585,1,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 5A receptor,,8,10624,,H,Autocuration,,CHEMBL618072,,BAO_0000357,,
3586,1,Binding affinity towards cloned human 5-HT5A receptor was determined,,8,10624,,H,Autocuration,,CHEMBL857987,,BAO_0000357,,
3587,1,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,8,10624,,H,Autocuration,,CHEMBL618073,722.0,BAO_0000219,,
3588,1,Binding affinity towards 5-hydroxytryptamine 5A receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,,8,10624,,H,Autocuration,,CHEMBL618074,722.0,BAO_0000219,,
3589,1,Compound was tested for its binding affinity in 5-hydroxytryptamine 5A receptor (using human cloned receptors in HEK 293 and [3H]5-CTas a radioligand ),,8,10624,,H,Autocuration,,CHEMBL618075,722.0,BAO_0000219,,
3590,1,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor,Mus musculus,9,10625,,D,Expert,,CHEMBL618076,,BAO_0000357,,
3591,1,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [125I]-2-iodo LSD as radioligand,Mus musculus,9,10625,,D,Expert,,CHEMBL618077,,BAO_0000357,,
3592,1,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]- LSD as radioligand,Mus musculus,9,10625,,D,Expert,,CHEMBL618078,,BAO_0000357,,
3593,1,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor was evaluated using [3H]LSD as radioligand,Mus musculus,9,10625,,D,Expert,,CHEMBL881821,,BAO_0000357,,
3594,1,Binding affinity towards murine 5-hydroxytryptamine 5A receptor,Mus musculus,9,10625,,D,Expert,,CHEMBL618079,,BAO_0000357,,
3595,1,Binding affinity towards mouse 5-hydroxytryptamine 5A receptor using LSD as radioligand,,8,10625,,H,Expert,,CHEMBL618080,,BAO_0000357,,
3596,1,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,,8,10576,,H,Autocuration,,CHEMBL618081,722.0,BAO_0000219,,
3597,1,Binding affinity against 5-hydroxytryptamine 5A receptor in HEK 293 cells was determined using [3H]LSD as radioligand,,8,10626,,H,Autocuration,,CHEMBL618082,722.0,BAO_0000219,,
3598,1,Binding affinity towards 5-HT5a receptor,,8,10624,,H,Expert,,CHEMBL618083,,BAO_0000357,,
3599,1,Binding affinity towards 5-hydroxytryptamine 5A receptor,Homo sapiens,9,10624,,D,Expert,,CHEMBL618084,,BAO_0000357,,
3600,1,Binding affinity for rodent 5-hydroxytryptamine 5A receptor,,8,10624,,H,Expert,,CHEMBL618085,,BAO_0000357,,
3601,1,Binding affinity towards 5-hydroxytryptamine 5A receptor using lysergic acid diethylamide (LSD) as radioligand,,8,10624,,H,Expert,,CHEMBL618086,,BAO_0000357,,
3602,1,Binding affinities against 5-hydroxytryptamine 5A receptor,,8,10624,,H,Autocuration,,CHEMBL875092,,BAO_0000357,,
3603,1,Binding affinities towards 5-hydroxytryptamine 5A receptor,,8,10624,,H,Autocuration,,CHEMBL618087,,BAO_0000357,,
3604,1,The binding affinity towards 5-hydroxytryptamine 5A receptor; No affinity,,8,10624,,H,Autocuration,,CHEMBL872926,,BAO_0000357,,
3605,1,Percent of control response to 5-HT3 agonistic activity on guinea colon at a concentration 0.01 uM,Cavia porcellus,4,104714,,H,Autocuration,,CHEMBL618088,,BAO_0000019,,
3606,1,Binding affinity towards 5-HT3 receptor by the displacement of [3H]GR-65630] in human recombinant receptors in mammalian cell,,4,104714,,H,Autocuration,,CHEMBL618089,,BAO_0000223,,
3607,1,Inhibition of human 5-hydroxytryptamine 6 receptor,Homo sapiens,9,10627,,D,Expert,,CHEMBL618090,,BAO_0000357,,
3608,1,Binding affinity towards 5-hydroxytryptamine 6 receptor using [3H]- LSD as radioligand,Homo sapiens,9,10627,,D,Expert,,CHEMBL618091,,BAO_0000357,,
3609,1,Inhibition against human 5-hydroxytryptamine 6 receptor,,8,10627,,H,Autocuration,,CHEMBL618092,,BAO_0000357,,
3610,1,Affinity towards human 5-hydroxytryptamine 6 serotonin receptor,Homo sapiens,9,10627,,D,Expert,,CHEMBL618093,,BAO_0000357,,
3611,1,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells.,,8,10627,,H,Expert,,CHEMBL618094,308.0,BAO_0000219,,
3612,1,Binding affinity towards [3H]LSD-labeled human 5-hydroxytryptamine 6 receptor,Homo sapiens,9,10627,,D,Expert,,CHEMBL618095,,BAO_0000357,,
3613,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor,Homo sapiens,9,10627,,D,Expert,,CHEMBL875093,,BAO_0000357,,
3614,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [125I]-2-iodo LSD as radioligand,Homo sapiens,9,10627,,D,Expert,,CHEMBL618096,,BAO_0000357,,
3615,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor was evaluated using [3H]-LSD as radioligand,Homo sapiens,9,10627,,D,Expert,,CHEMBL618118,,BAO_0000357,,
3616,1,Binding affinity against 5-hydroxytryptamine 6 receptor,Homo sapiens,9,10627,,D,Expert,,CHEMBL618119,,BAO_0000357,,
3617,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,8,10627,,H,Expert,,CHEMBL618120,,BAO_0000357,,
3618,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,8,10627,,H,Autocuration,,CHEMBL618121,,BAO_0000357,,
3619,1,"Binding affinity for human 5-hydroxytryptamine 6 receptor expressed in HEK 293 human embryonic kidney cells, [3H]-lysergic acid diethylamide as radioligand",,8,10627,,H,Expert,,CHEMBL618122,722.0,BAO_0000219,,
3620,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor using [3H]LSD as radioligand,,8,10627,,H,Autocuration,,CHEMBL618123,,BAO_0000357,,
3621,1,Binding affinity against human 5-hydroxytryptamine 6 receptor stably transfected to HEK 293 human embryonic kidney cells using [3H]-lysergic acid diethylamide as radioligand,,8,10627,,H,Expert,,CHEMBL618124,722.0,BAO_0000219,,
3622,1,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 6 receptor,,8,10627,,H,Autocuration,,CHEMBL618125,,BAO_0000357,,
3623,1,Displacement of [3H]LSD from human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,Homo sapiens,9,10627,,D,Expert,,CHEMBL618126,722.0,BAO_0000219,,
3624,1,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD,,8,10627,,H,Expert,,CHEMBL618236,,BAO_0000019,,
3625,1,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 6 receptor incubated with 1 nM [3H]LSD; ND is No Data.,,8,10627,,H,Expert,,CHEMBL618237,,BAO_0000019,,
3626,1,Ability to displace [3H]LSD from human 5-hydroxytryptamine 6 receptor transiently expressed in COS-7 cells,,8,10627,,H,Expert,,CHEMBL618238,643.0,BAO_0000219,,
3627,1,In vitro binding affinity to human 5-hydroxytryptamine 6 receptor,Homo sapiens,9,10627,,D,Expert,,CHEMBL618239,,BAO_0000357,,
3628,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 6 receptor,,8,10627,,H,Autocuration,,CHEMBL618240,,BAO_0000019,,
3629,1,Inhibitory constant against human 5-hydroxytryptamine 6 receptor using [3H]LSD radioligand,,8,10627,,H,Autocuration,,CHEMBL618241,,BAO_0000357,,
3630,1,Antagonism assessed in a functional cAMP binding assay using 5-CT to stimulate human 5-hydroxytryptamine 6 receptor expressed in HEK 293 cells,,8,10627,,H,Autocuration,,CHEMBL859399,722.0,BAO_0000219,,
3631,1,The compound was tested for antagonist activity by inhibition of human 5-HT6 stimulated adenylate cyclase,,8,10627,,H,Autocuration,,CHEMBL618242,,BAO_0000019,,
3632,1,Ability to displace the radioligand [3H]LSD from human 5-hydroxytryptamine 6 receptor,,8,10627,,H,Autocuration,,CHEMBL857991,,BAO_0000357,,
3633,1,Binding affinity against human 5-hydroxytryptamine 6 receptor,,8,10627,,H,Expert,,CHEMBL619951,,BAO_0000357,,
3634,1,Binding affinity to human cloned 5-HT6 receptor in HeLa cells using [3H]- LSD as radioligand,Homo sapiens,9,10627,,D,Expert,,CHEMBL619952,308.0,BAO_0000219,,
3635,1,Binding affinity to human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]- LSD as radioligand,Homo sapiens,9,10627,,D,Expert,,CHEMBL619953,308.0,BAO_0000219,,
3636,1,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells,,8,10627,,H,Autocuration,,CHEMBL619954,308.0,BAO_0000219,,
3637,1,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,,8,10627,,H,Autocuration,,CHEMBL619955,308.0,BAO_0000219,,
3638,1,Binding affinity against 5-hydroxytryptamine 6 human cloned receptors in HeLa cells using [3H]LSD as radioligand,,8,10627,,H,Autocuration,,CHEMBL619956,308.0,BAO_0000219,,
3639,1,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in CHO cells using [3H]5-HT as radioligand,,8,10627,,H,Autocuration,,CHEMBL619957,449.0,BAO_0000219,,
3640,1,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand.,,8,10627,,H,Autocuration,,CHEMBL619958,722.0,BAO_0000219,,
3641,1,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand; ND means no data.,,8,10627,,H,Autocuration,,CHEMBL620627,722.0,BAO_0000219,,
3642,1,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HEK 293 cells using [3H]mesulergine as radioligand;ND means no data.,,8,10627,,H,Autocuration,,CHEMBL620628,722.0,BAO_0000219,,
3643,1,Binding affinity towards 5-hydroxytryptamine 6 receptor (human cloned receptor) in HeLa cells using [3H]LSD as radioligand;ND means no data.,,8,10627,,H,Autocuration,,CHEMBL620629,308.0,BAO_0000219,,
3644,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,8,10627,,H,Autocuration,,CHEMBL620630,,BAO_0000357,,
3645,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 6 receptor expressed in HeLa cells using [3H]LSD as radioligand,,8,10627,,H,Autocuration,,CHEMBL620782,308.0,BAO_0000219,,
3646,1,Compound was evaluated for its ability to displace [3H]LSD binding from human recombinant 5-hydroxytryptamine 6 receptor,,8,10627,,H,Autocuration,,CHEMBL620783,,BAO_0000357,,
3647,1,Binding affinity against human 5-hydroxytryptamine 6 receptor,,8,10627,,H,Expert,,CHEMBL620784,,BAO_0000357,,
3648,1,Binding affinity against human cloned 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]LSD,,8,10627,,H,Expert,,CHEMBL620785,308.0,BAO_0000219,,
3649,1,Compound was tested for its binding affinity in 5-hydroxytryptamine 6 receptor (using human cloned receptors in HeLa and [3H]LSD as a radioligand ),,8,10627,,H,Autocuration,,CHEMBL857992,,BAO_0000357,,
3650,1,In vitro binding affinity at human recombinant 5-hydroxytryptamine 6 receptor in mammalian cells using 3[H]LSD as the radioligand,,8,10627,,H,Autocuration,,CHEMBL620786,,BAO_0000219,,
3651,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 6 receptor in HeLa cells using [3H]5-LSD.,,8,10627,,H,Autocuration,,CHEMBL620787,308.0,BAO_0000219,,
3652,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=3",,8,10627,,H,Autocuration,,CHEMBL620788,308.0,BAO_0000219,,
3653,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]5-LSD as radioligand; n=9",,8,10627,,H,Autocuration,,CHEMBL620789,308.0,BAO_0000219,,
3654,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 6 receptor in HeLa cells, using [3H]LSD as radioligand; n=3",,8,10627,,H,Autocuration,,CHEMBL620790,308.0,BAO_0000219,,
3655,1,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 6 receptor stably expressed in CHO cells,,8,10628,,H,Autocuration,,CHEMBL620791,449.0,BAO_0000219,,
3656,1,Binding affinity against 5-hydroxytryptamine 6 receptor from CHO cell membranes using [3H]5-HT as the radioligand.,,8,10628,,H,Autocuration,,CHEMBL620792,,BAO_0000019,,
3657,1,The compound was tested for binding affinity against 5-hydroxytryptamine 6 receptor,,8,10628,,H,Autocuration,,CHEMBL620793,,BAO_0000357,,
3658,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor was determined,,8,10628,,H,Autocuration,,CHEMBL620794,,BAO_0000357,,
3659,1,Binding affinity as displacement of [3H]5-HT binding to 5-hydroxytryptamine 6 receptor in HeLa cells,Homo sapiens,9,10627,,D,Autocuration,,CHEMBL620795,308.0,BAO_0000219,,
3660,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,8,10627,,H,Expert,,CHEMBL620796,,BAO_0000357,,
3661,1,Percentage of displacement at 5-hydroxytryptamine 6 receptor at 10e-8 M,,8,10627,,H,Autocuration,,CHEMBL620797,,BAO_0000357,,
3662,1,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,Homo sapiens,9,10627,,D,Expert,,CHEMBL620798,,BAO_0000019,,
3663,1,Inhibition of binding towards 5-hydroxytryptamine 6 receptor at 100 nM concentration,,8,10627,,H,Autocuration,,CHEMBL620799,,BAO_0000357,,
3664,1,Binding affinity towards human 5-hydroxytryptamine 6 receptor,,8,10627,,H,Expert,,CHEMBL620800,,BAO_0000357,,
3665,1,Binding affinity of compound towards serotonin 5-hydroxytryptamine 6 receptor; inactive at 10 uM,,8,10627,,H,Autocuration,,CHEMBL620801,,BAO_0000357,,
3666,1,Compound was tested for its binding affinity towards 5-hydroxytryptamine 6 receptor,,8,10627,,H,Autocuration,,CHEMBL875100,,BAO_0000357,,
3667,1,Binding affinity relative to indolopiperidine (compound 1) for 5-hydroxytryptamine 6 receptor was determined,,8,10627,,H,Autocuration,,CHEMBL620802,,BAO_0000357,,
3668,1,Antagonistic activity towards 5-hydroxytryptamine 6 receptor,,8,10627,,H,Expert,,CHEMBL620803,,BAO_0000019,,
3669,1,Antagonistic activity towards 5-hydroxytryptamine 6 receptor was evaluated in cAMP assay,,8,10627,,H,Expert,,CHEMBL620804,,BAO_0000019,,
3670,1,Binding affinity for 5-hydroxytryptamine 6 receptor was determined,,8,10627,,H,Autocuration,,CHEMBL620805,,BAO_0000357,,
3671,1,Evaluated for the binding affinity towards 5-hydroxytryptamine 6 receptor,,8,10627,,H,Autocuration,,CHEMBL620806,,BAO_0000357,,
3672,1,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-6 M,,8,10627,,H,Autocuration,,CHEMBL620807,,BAO_0000357,,
3673,1,Ability to displace [125I]LSD 113808 from 5-hydroxytryptamine 6 receptor at concentration of 10e-8 M,,8,10627,,H,Autocuration,,CHEMBL620808,,BAO_0000357,,
3674,1,Binding affinities against 5-hydroxytryptamine 6 receptor,,8,10627,,H,Autocuration,,CHEMBL620809,,BAO_0000357,,
3675,1,Binding affinities towards 5-hydroxytryptamine 6 receptor,,8,10627,,H,Autocuration,,CHEMBL620810,,BAO_0000357,,
3676,1,Binding affinity towards 5-hydroxytryptamine 6 receptor,Homo sapiens,9,10627,,D,Expert,,CHEMBL620811,,BAO_0000357,,
3677,1,The binding affinity towards 5-hydroxytryptamine 6 receptor; No affinity,,8,10627,,H,Autocuration,,CHEMBL620812,,BAO_0000357,,
3678,1,Affinity against 5-hydroxytryptamine 6 receptor,,8,10627,,H,Autocuration,,CHEMBL620813,,BAO_0000357,,
3679,1,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-CT],,8,10627,,H,Autocuration,,CHEMBL620814,,BAO_0000357,,
3680,1,Inhibition of human 5-hydroxytryptamine 7 receptor,Homo sapiens,9,10209,,D,Expert,,CHEMBL620815,,BAO_0000357,,
3681,1,Compound was tested for its binding affinity towards human 5-hydroxytryptamine 7 receptor from HEK293 cells using radioligand [3H]LSD,,8,10209,,H,Autocuration,,CHEMBL620816,722.0,BAO_0000219,,
3682,1,Compound at 1 uM was tested for the inhibition of radioligand [3H]LSD binding to recombinant human 5-hydroxytryptamine 7 receptor,,8,10209,,H,Autocuration,,CHEMBL620817,,BAO_0000357,,
3683,1,In vitro binding affinity against human 5-hydroxytryptamine 7 receptor at a concentration of 100 (nM),,8,10209,,H,Autocuration,,CHEMBL620818,,BAO_0000357,,
3684,1,Inhibition (at 1 uM) of radioligand [3H]LSD binding to human 5-hydroxytryptamine 7 receptor on HEK293 cells,,8,10209,,H,Expert,,CHEMBL620819,722.0,BAO_0000219,,
3685,1,Affinity towards human 5-hydroxytryptamine 7 serotonin receptor,Homo sapiens,9,10209,,D,Expert,,CHEMBL620820,,BAO_0000357,,
3686,1,Binding affinity for 5-hydroxytryptamine 7 receptor human cloned receptors in CHO cells using [3H]5-HT,,8,10209,,H,Autocuration,,CHEMBL620821,449.0,BAO_0000219,,
3687,1,Binding affinity towards human 5-hydroxytryptamine 7 receptor,Homo sapiens,9,10209,,D,Expert,,CHEMBL620822,,BAO_0000357,,
3688,1,Displacement of [3H]5-HT from human 5-hydroxytryptamine 7 receptor,Homo sapiens,9,10209,,D,Expert,,CHEMBL620823,,BAO_0000357,,
3689,1,Binding affinity against 5-hydroxytryptamine 7 receptor,Homo sapiens,9,10209,,D,Expert,,CHEMBL620824,,BAO_0000357,,
3690,1,Binding affinity towards human 5-hydroxytryptamine 7 receptor by the displacement of [3H]-5-HT radioligand from the cloned receptor expressed in CHO cells,,8,10209,,H,Expert,,CHEMBL620825,449.0,BAO_0000219,,
3691,1,Binding affinity towards recombinant human 5-hydroxytryptamine 7 receptor was determined using [3H]LSD as radioligand,,8,10209,,H,Autocuration,,CHEMBL872930,,BAO_0000357,,
3692,1,Binding affinity towards 5-hydroxytryptamine 7 receptor,,8,10209,,H,Autocuration,,CHEMBL620826,,BAO_0000357,,
3693,1,Binding affinity towards human 5-hydroxytryptamine 7 receptor using [3H]5-HT as radioligand,,8,10209,,H,Autocuration,,CHEMBL620827,,BAO_0000357,,
3694,1,Compound was evaluated for its binding affinity for human 5-hydroxytryptamine 7 receptor,,8,10209,,H,Autocuration,,CHEMBL620828,,BAO_0000357,,
3695,1,Compound was evaluated for its binding affinity towards human 5-hydroxytryptamine 7 receptor,,8,10209,,H,Autocuration,,CHEMBL620829,,BAO_0000357,,
3696,1,Binding affinity towards human 5-hydroxytryptamine 7 receptor on HEK293 cells using radioligand [3H]LSD,,8,10209,,H,Expert,,CHEMBL620830,722.0,BAO_0000219,,
3697,1,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD,,8,10209,,H,Expert,,CHEMBL620831,,BAO_0000019,,
3698,1,Tested on cell membranes from transfected cells selectively expressing human 5-hydroxytryptamine 7 receptor incubated with 1 nM [3H]LSD; ND is No Data.,,8,10209,,H,Expert,,CHEMBL620832,,BAO_0000019,,
3699,1,In vitro binding affinity to human 5-hydroxytryptamine 7 receptor,Homo sapiens,9,10209,,D,Expert,,CHEMBL621548,,BAO_0000357,,
3700,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor,,8,10209,,H,Autocuration,,CHEMBL621549,,BAO_0000019,,
3701,1,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]LSD radioligand,,8,10209,,H,Autocuration,,CHEMBL621550,,BAO_0000357,,
3702,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]-LSD as radioligand; Not determined,,8,10209,,H,Autocuration,,CHEMBL621551,449.0,BAO_0000219,,
3703,1,In vitro binding affinity by radioligand binding assay using cell line expressing human 5-hydroxytryptamine 7 receptor; ND means not determined,,8,10209,,H,Autocuration,,CHEMBL621552,,BAO_0000019,,
3704,1,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor,,8,10209,,H,Autocuration,,CHEMBL857077,,BAO_0000357,,
3705,1,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor; Not tested,,8,10209,,H,Autocuration,,CHEMBL618158,,BAO_0000357,,
3706,1,Ability to displace the radioligand [3H]5-carboxyamidotryptamine ([3H]5-CT) from human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,Homo sapiens,9,10209,,D,Expert,,CHEMBL618159,643.0,BAO_0000219,,
3707,1,Ability to displace the radioligand [3H]5-carboximidotryptamine ([3H]-5-CT) from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells,,8,10209,,H,Autocuration,,CHEMBL875101,643.0,BAO_0000219,,
3708,1,Binding affinity to human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]-5-CT as radioligand,Homo sapiens,9,10209,,D,Expert,,CHEMBL618160,722.0,BAO_0000219,,
3709,1,Binding affinity at human cloned 5-hydroxytryptamine 7 receptor.,,8,10209,,H,Expert,,CHEMBL618161,,BAO_0000357,,
3710,1,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor was determined in HEK293 cells using [3H]5-CT as radioligand,,8,10209,,H,Expert,,CHEMBL618162,722.0,BAO_0000219,,
3711,1,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor was determined using [3H]5-CT as radioligand,,8,10209,,H,Expert,,CHEMBL618163,,BAO_0000357,,
3712,1,Binding affinity against 5-hydroxytryptamine 7 human receptors,,8,10209,,H,Autocuration,,CHEMBL618164,,BAO_0000357,,
3713,1,Binding affinity to human recombinant 5-hydroxytryptamine 7 receptor in mammalian cells using [3H]5-CT as radioligand,,8,10209,,H,Expert,,CHEMBL618165,,BAO_0000219,,
3714,1,Binding affinity toward 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]-5-CT as radioligand.,,8,10209,,H,Autocuration,,CHEMBL618166,722.0,BAO_0000219,,
3715,1,Binding affinity towards 5-hydroxytryptamine 7 receptor (a) (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,,8,10209,,H,Autocuration,,CHEMBL857989,722.0,BAO_0000219,,
3716,1,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,,8,10209,,H,Autocuration,,CHEMBL619888,722.0,BAO_0000219,,
3717,1,Binding affinity towards 5-hydroxytryptamine 7 receptor (human cloned receptor) in HEK 293 cells using [3H]5-CT as radioligand.,,8,10209,,H,Autocuration,,CHEMBL619889,722.0,BAO_0000219,,
3718,1,Binding affinity towards 5-hydroxytryptamine 7 receptor 7(a) (human cloned receptor in HEK 293 cells using [3H]5-CT as radioligand.,,8,10209,,H,Autocuration,,CHEMBL619890,722.0,BAO_0000219,,
3719,1,Binding constant towards serotonin receptor subtype 5-hydroxytryptamine 7 receptor expressed in CHO cells using [3H]LSD as radioligand,,8,10209,,H,Autocuration,,CHEMBL619891,449.0,BAO_0000219,,
3720,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand (n=3),,8,10209,,H,Autocuration,,CHEMBL619892,722.0,BAO_0000219,,
3721,1,Displacement of [3H]-5-CT from human 5-hydroxytryptamine 7 receptor expressed in HEK-293 cells,,9,10209,,D,Expert,,CHEMBL619893,722.0,BAO_0000219,,
3722,1,Compound was evaluated for binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT as the radioligand(n=6),,8,10209,,H,Autocuration,,CHEMBL619894,722.0,BAO_0000219,,
3723,1,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells,,9,10209,,D,Intermediate,,CHEMBL619895,722.0,BAO_0000219,,
3724,1,Binding affinity towards human recombinant 5-hydroxytryptamine 7 receptor using [3H]5-CT as radioligand,,9,10209,,D,Intermediate,,CHEMBL619896,,BAO_0000357,,
3725,1,Compound was evaluated for its ability to displace [3H]5-CT binding from cloned human 5-hydroxytryptamine 7 receptor expressed in COS-7 cells.,,8,10209,,H,Autocuration,,CHEMBL619897,643.0,BAO_0000219,,
3726,1,Compound was tested for its binding affinity against human cloned 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT,,8,10209,,H,Autocuration,,CHEMBL619898,722.0,BAO_0000219,,
3727,1,Binding affinity for human cloned 5-hydroxytryptamine 7 receptor in HEK 293 using [3H]5-CT as a radioligand,,8,10209,,H,Expert,,CHEMBL619899,722.0,BAO_0000219,,
3728,1,Compound was tested for its binding affinity in 5-hydroxytryptamine 7 receptor (using human cloned receptors in HEK 293 and [3H]5-CT as a radioligand ),,8,10209,,H,Autocuration,,CHEMBL619900,722.0,BAO_0000219,,
3729,1,Binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT,Homo sapiens,9,10209,,D,Expert,,CHEMBL619901,722.0,BAO_0000219,,
3730,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor expressed in HEK 293 cells using [3H]5-CT. ,,8,10209,,H,Autocuration,,CHEMBL620580,722.0,BAO_0000219,,
3731,1,The compound was tested for its binding affinity towards cloned human 5-hydroxytryptamine 7 receptor in HEK 293 cells using [3H]5-CT.,,8,10209,,H,Autocuration,,CHEMBL620581,722.0,BAO_0000219,,
3732,1,"The compound was tested for the binding affinity towards human cloned 5-hydroxytryptamine 7 receptor in HEK293 cells, using [3H]5-CT as radioligand",,8,10209,,H,Autocuration,,CHEMBL620733,722.0,BAO_0000219,,
3733,1,Inhibitory constant against human 5-hydroxytryptamine 7 receptor using [3H]-LSD radioligand; Not determined,Homo sapiens,9,10209,,D,Autocuration,,CHEMBL620734,,BAO_0000357,,
3734,1,Binding affinity towards mouse 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,Mus musculus,9,10022,,D,Expert,,CHEMBL620735,,BAO_0000357,,
3735,1,The dissociation equilibrium constant (pKB=-log KB) of compound was determined against the vascular 5-hydroxytryptamine 7 receptor in the endothelium denuded rabbit jugular vein.,Oryctolagus cuniculus,8,10209,,H,Autocuration,,CHEMBL620736,,BAO_0000019,,
3736,1,Compound was tested for the displacement of [3H]5-HT binding to cloned rat 5-hydroxytryptamine 7 receptor stably expressed in CHO cells,,8,11923,,H,Autocuration,,CHEMBL620737,449.0,BAO_0000219,,
3737,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 10000 nM,,8,11923,,H,Autocuration,,CHEMBL620738,449.0,BAO_0000219,,
3738,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 100 nM,,8,11923,,H,Autocuration,,CHEMBL620739,449.0,BAO_0000219,,
3739,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors at a concentration of 1 nM,,8,11923,,H,Autocuration,,CHEMBL620740,449.0,BAO_0000219,,
3740,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 10000 nM 5-HT.,,8,11923,,H,Autocuration,,CHEMBL620741,449.0,BAO_0000219,,
3741,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 100 nM 5-HT.,,8,11923,,H,Autocuration,,CHEMBL620742,449.0,BAO_0000219,,
3742,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT 7 receptors by 1 nM 5-HT,,8,11923,,H,Autocuration,,CHEMBL620743,449.0,BAO_0000219,,
3743,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 10000 nM,,8,11923,,H,Autocuration,,CHEMBL620744,449.0,BAO_0000219,,
3744,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 100 nM,,8,11923,,H,Autocuration,,CHEMBL620745,449.0,BAO_0000219,,
3745,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors at a concentration of 1 nM,,8,11923,,H,Autocuration,,CHEMBL620746,449.0,BAO_0000219,,
3746,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 10000 nM 5-HT.,,8,11923,,H,Autocuration,,CHEMBL620747,449.0,BAO_0000219,,
3747,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 100 nM 5-HT.,,8,11923,,H,Autocuration,,CHEMBL620748,449.0,BAO_0000219,,
3748,1,Percent inhibition of 5-HT7-induced stimulation of cAMP production in CHO cells expressing rat 5-HT receptors by 1 nM 5-HT.,,8,11923,,H,Autocuration,,CHEMBL620749,449.0,BAO_0000219,,
3749,1,Binding affinity towards rat 5-hydroxytryptamine 7 receptor,,8,11923,,H,Expert,,CHEMBL620750,,BAO_0000357,,
3750,1,Binding affinity towards rat 5-hydroxytryptamine 7 receptor was evaluated using [3H]5-HT as radioligand,Rattus norvegicus,9,11923,,D,Expert,,CHEMBL620751,,BAO_0000357,,
3751,1,Binding affinity to the rat 5-hydroxytryptamine 7 receptor,,8,11923,,H,Expert,,CHEMBL620752,,BAO_0000357,,
